{"people": [
    {

        "content_length": 2605,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Angina de peito inst&#225;vel ou durante as primeiras 4 semanas posteriores a um infarto do mioc&#225;rdio</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca congestiva n&#227;o tratada</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal severa</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia hep&#225;tica de intensidade moderada a severa</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">Dose inicial: 10 mg, VO, 1x/dia;</li>\r\n<li class=\"MsoNormal\">Dose m&#225;xima: 20 mg, VO, 1x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>O uso &#233; contraindicado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 243,
        "indications": "<div>\r\n<p>- Hipertens&#227;o arterial essencial;</p>\r\n<p>- Hipertens&#227;o em pacientes com altera&#231;&#245;es renais e/ou diabetes.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 38,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-01-13 19:18:19",
        "name": "Manivasc",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 10 mg e 20 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "manivasc",
        "substance": "Manidipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia hep&#225;tica m&#233;dia: n&#227;o exceder 10 mg/dia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Fogachos</p>\r\n<p class=\"MsoNormal\">- Edema</p>\r\n<p class=\"MsoNormal\">- Dor de cabe&#231;a</p>\r\n<p class=\"MsoNormal\">- Tontura e vertigens</p>\r\n</div>"
    },

    {
        "content_length": 4750,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- An&#250;ria devido &#224; doen&#231;a renal grave</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca progressiva ou congest&#227;o pulmonar, ap&#243;s institui&#231;&#227;o da terap&#234;utica com manitol</p>\r\n<p class=\"MsoNormal\">- Desidrata&#231;&#227;o grave</p>\r\n<p class=\"MsoNormal\">- Congest&#227;o vascular pulmonar grave pr&#233;-existente ou edema pulmonar</p>\r\n<p class=\"MsoNormal\">- Hemorragia intracraniana ativa, exceto durante a craniotomia</p>\r\n<p class=\"MsoNormal\">- Falta de resposta durante o teste de dose</p>\r\n<p class=\"MsoNormal\">- Dano ou disfun&#231;&#227;o progressiva renal ap&#243;s utiliza&#231;&#227;o da terapia com manitol, incluindo olig&#250;ria crescente e azotemia</p>\r\n<p class=\"MsoNormal\">- Hiperosmolaridade plasm&#225;tica pr&#233;-existente</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><strong>Teste na olig&#250;ria:</strong> 0,2 g/kg/dose, IV, infundida em 3-5 min.</li>\r\n<li class=\"MsoNormal\"><strong>Redu&#231;&#227;o da press&#227;o intraocular e intracraniana:</strong> 1,5 a 2 g/kg da solu&#231;&#227;o a 20% (7,5 a 10 ml/kg), IV, em 30-60 min.</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong> 0,25 g/kg/dose, IV, administrado por 30-60 min, a cada 6 a 8 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><strong>Teste na olig&#250;ria:</strong> 0,2 g/kg, IV ou 6 g/m&#178; de &#225;rea corporal administrada durante um per&#237;odo de 5 min.</li>\r\n<li class=\"MsoNormal\"><strong>Edema:</strong> 0,25 g/kg, IV, administrado por 30-60 min, a cada 6 a 8 horas.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 244,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Edema cerebral de origem card&#237;aca e renal</p>\r\n<p class=\"MsoNormal\">- Glaucoma</p>\r\n<p class=\"MsoNormal\">- Pr&#233;-operat&#243;rio de neurocirurgia</p>\r\n<p class=\"MsoNormal\">- Rabdomi&#243;lise</p>\r\n<p class=\"MsoNormal\">- Promo&#231;&#227;o da diurese, na preven&#231;&#227;o da fal&#234;ncia renal aguda durante cirurgias cardiovasculares e/ou ap&#243;s trauma</p>\r\n<p class=\"MsoNormal\">- Promo&#231;&#227;o da excre&#231;&#227;o urin&#225;ria de subst&#226;ncias t&#243;xicas</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 39,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 19:18:39",
        "name": "Manitol 20%",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 200 mg/ml, frasco com 250 ml e 500 ml.</p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "manitol-20",
        "substance": "Manitol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Desitrata&#231;&#227;o tissular</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca congestiva</p>\r\n<p class=\"MsoNormal\">- Edema pulmonar</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito</p>\r\n<p class=\"MsoNormal\">- Sede</p>\r\n<p class=\"MsoNormal\">- Cefaleia, tontura, tremores</p>\r\n<p class=\"MsoNormal\">- Febre</p>\r\n<p class=\"MsoNormal\">- Taquicardia, dor no peito</p>\r\n<p class=\"MsoNormal\">- Desidrata&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- Vis&#227;o borrada</p>\r\n<p class=\"MsoNormal\">- Urtic&#225;ria</p>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal com olig&#250;ria em pacientes recebendo manitol para tratamento da hipertens&#227;o intracraniana</p>\r\n<p class=\"MsoNormal\">- Desidrata&#231;&#227;o cerebral (particularmente em pacientes com insufici&#234;ncia renal)</p>\r\n<p class=\"MsoNormal\">- Hipernatremia</p>\r\n</div>"
    },
    {
        "content_length": 5322,
        "contraindications": "<div>\r\n<p><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Hipersensibilidade a maprotilina ou sensibilidade cruzada com antidepressivos tric&#237;clicos. </span></p>\r\n<p><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Transtorno convulsivo ou limiar convulsivo diminu&#237;do. </span></p>\r\n<p><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Presen&#231;a de dist&#250;rbios da condu&#231;&#227;o card&#237;aca ou infarto agudo do mioc&#225;rdio pr&#233;vio. </span></p>\r\n<p><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Tratamento concomitante com inibidor da MAO. </span></p>\r\n<p><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Uso em v&#237;timas de intoxica&#231;&#227;o aguda com &#225;lcool, hipn&#243;ticos ou psicotr&#243;picos.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong><span lang=\"EN\">Utilizar a menor dosagem poss&#237;vel que cause al&#237;vio dos sintomas:</span></strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Depress&#227;o: 25mg VO 1 a 3x/dia ou 75mg VO 1x/dia</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Outros transtornos depressivos: 10mg VO 3x/dia ou 25mg VO 1x/dia</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Uso injet&#225;vel</strong>: para depress&#227;o refrat&#225;ria ou que n&#227;o respondam a via oral;</span></p>\r\n<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Diluir em 01 ou 02 ampolas (25-50mg) em 250 mL de solu&#231;&#227;o salina isot&#244;nica ou glicosada e infundir lentamente em 2 horas. Se doses maiores forem necess&#225;rias, pode-se fazer de 3 at&#233; 6 ampolas (75-150mg) em 500mL<span style=\"mso-spacerun: yes;\">&#160; </span>e correr durante 3 horas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o h&#225; experi&#234;ncia cl&#237;nica com uso de maprotilina em crian&#231;as, efic&#225;cia e seguran&#231;a n&#227;o estabelecidas.</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Recomenda-se 10mg VO at&#233; 3x/dia ou 25mg VO 1x/dia.</span></li>\r\n<li><span lang=\"EN\">N&#227;o utilizar solu&#231;&#227;o injet&#225;vel em crian&#231;as.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 245,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Formas de depress&#227;o mascarada, al&#233;m de depress&#227;o end&#243;gena, depress&#227;o causada por exaust&#227;o, depress&#227;o na menopausa e depress&#227;o somatog&#234;nica. Tamb&#233;m pode ser usado para outros transtornos depressivos caracterizados como ansiedade, disforia e irritabilidade.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 01:10:36",
        "name": "Ludiomil",
        "presentation": "<ul>\r\n<li><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\"><strong>Comprimidos:</strong> 25mg e 75mg;</span></li>\r\n<li><span lang=\"EN\" style=\"line-height: 115%; mso-fareast- mso-ansi-language: EN; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/5mL.</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "ludiomil",
        "substance": "Maprotilina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o s&#227;o necess&#225;rios ajustes</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Como antidepressivos tric&#237;clicos, h&#225; possibilidade de efeitos adversos anticolin&#233;rgicos e no sistema nervoso central.</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Sonol&#234;ncia, fadiga, aumento do apetite, inquieta&#231;&#227;o, ansiedade, agita&#231;&#227;o, mania, cefal&#233;ia, tremor leve, mioclonia, pertuba&#231;&#245;es no sono, disartria, ativa&#231;&#227;o de sintomas psic&#243;ticos latentes, despersonaliza&#231;&#227;o, altera&#231;&#227;o de mem&#243;ria, ins&#244;nia, pesadelos, del&#237;rios, confus&#245;es e alucina&#231;&#245;es (em idosos), acatisia, convuls&#245;es, ataxia, boca seca, constipa&#231;&#227;o, sudorese, n&#226;useas e v&#244;mitos.</span></p>\r\n</div>"
    },
    {
        "content_length": 3904,
        "contraindications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Hipersensibilidade ao maraviroque ou outros componentes da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li><span lang=\"EN\">Recomenda-se que o maraviroque seja utilizado logo ap&#243;s confirma&#231;&#227;o do tropismo do HIV-1, n&#227;o utilizando-o em pacientes CXCR4-tr&#243;picos ou com tropismo duplo/misto.<br><br></span></li>\r\n<li>Utilizar 150mg, 300mg ou 600mg de 12/12h, dependendo dos outros medicamentos antiretrovirais:\r\n<ul>\r\n<li>inibidores de protease, delavirdina, cetoconazol, itraconazol, claritromicina, nefazodona, telitromicina = 150mg a cada 12 horas</li>\r\n<li>efavirenz, rifampicina, etravirina, carbamazepina, fenobarbital, fenito&#237;na = 600mg a cada 12 horas</li>\r\n<li>tipranavir/ritonavir, nevirapina, raltegravir, todos os ITRNs e enfuvirtina = 300mg a cada 12 horas<br><br></li>\r\n</ul>\r\n</li>\r\n<li>Dose m&#225;xima = 1200mg/dia. N&#227;o h&#225; ant&#237;doto para superdosagem.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o h&#225; estudos em popula&#231;&#227;o pedi&#225;trica. N&#227;o &#233; recomendado o uso em crian&#231;as.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 246,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Utilizado, em combina&#231;&#227;o com outros anti-retrovirais, para tratar pacientes adultos infectados com HIV-1 CCR5-tr&#243;pico.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 19:18:49",
        "name": "Celsentri",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 150mg e 300mg.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C4 - antirretrovirais).</p>",
        "record_status": 1,
        "slug": "celsentri",
        "substance": "Maraviroque",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">- <strong>Pacientes com insufici&#234;ncia renal (clearence de creatinina<span style=\"mso-spacerun: yes;\">&#160; </span>&lt; 80mL/min) com uso concomitante com inibidores de CYP3A4 (inibidores da protease, cetoconazol, itraconazol) ou com insufici&#234;ncia renal (clearence de creatinia &lt; 50mL/min) devem ter ajuste de dose segundo tabela a seguir:</strong></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">- se administrado sem inibidores potentes da CYP34A ou se coadministrado com tipranavir/ritonavir: n&#227;o &#233; necess&#225;rio nenhum ajuste (300mg 12/12h)</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">- se coadministrado com fosamprenavir/ritonavir: 150mg 12/12h</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">- se coadministrado com inibidores porentes da CYP34A (ex: saquinavir/ritonavir, lopinavir/ritonavir, darunavir/ritonavir, atazanavir/ritonavir, cetoconazol): 150mg a cada 24h</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">- Hipotens&#227;o postural, agravamento de insufici&#234;ncia hep&#225;tica pr&#233;via, hepatite medicamentosa e S&#237;ndrome de Reconstitui&#231;&#227;o Imunol&#243;gica. Diminui&#231;&#227;o do peso, ins&#244;nia, neuropatia, tosse e dor abdominal.</span></p>\r\n</div>"
    },
    {
        "content_length": 3488,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 247,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-01-13 19:19:25",
        "name": "Mebendazol",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mebendazol",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3485,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 248,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 02:04:41",
        "name": "Belmirax",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "belmirax",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3489,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 249,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 40,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 00:34:16",
        "name": "Eraverm",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "eraverm",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3434,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1cp de 100mg ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2cp de 100mg ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 250,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 00:50:10",
        "name": "Licor de Cacau Xavier",
        "presentation": "<ul>\r\n<li><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL;</span></li>\r\n<li><strong>Comprimidos:</strong> 100 e 500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "licor-de-cacau-xavier",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3488,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 251,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 42,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 01:21:51",
        "name": "Averpan",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "averpan",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3490,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 252,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 43,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 22:14:15",
        "name": "Kildemin",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "kindelmin",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3265,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido por 3 dias;&#160;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 1 comprimido 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 253,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-05 00:33:21",
        "name": "Moben",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos: </strong>200mg.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "moben",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3490,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 254,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 45,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-06 17:00:26",
        "name": "Panfugan",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "panfugan",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 5076,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade ao abacavir, lamivudina ou zidovudina</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica moderada a grave</p>\r\n<p>- Suspender o produto ao primeiro sinal de hipersensibilidade, toxicidade no f&#237;gado ou acidose l&#225;tica</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>HIV/AIDS:&#160;</strong>01 comprimido VO 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\">N&#227;o deve ser administrado a adultos ou adolescentes com peso inferior a 40 kg porque &#233; um comprimido de dose fixa que n&#227;o&#160;pode ser reduzida.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>HIV/AIDS (crian&#231;as acima de 12 anos e pesando pelo menos 40kg):&#160;</strong>01 comprimido VO 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>N&#227;o deve ser administrado a adultos ou adolescentes com peso inferior a 40 kg porque &#233; um comprimido de dose fixa que n&#227;o&#160;pode ser reduzida.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C</strong>: Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 255,
        "indications": "<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">- Tratamento de infec&#231;&#227;o por HIV&#160;</span>em adultos e em adolescentes acima dos 12 anos de idade e pesando mais de 40 kg.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p><strong>- Baixo risco</strong>: Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 04:31:45",
        "name": "Triumeq",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong>Comprimido:</strong>&#160;600mg abacavir + 300mg lamivudina + 50 mg dolutegravir</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receita de controle especial (C4 - anti-retrovirais - Formul&#225;rio pr&#243;prio/DST/AIDS).</span></p>",
        "record_status": 1,
        "slug": "ziagenavir",
        "substance": "Abacavir + Lamivudina + Dolutegravir",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">- N&#225;usea, v&#244;mito, diarreia,&#160;</span>dor e distens&#227;o abdominal, gastrite,&#160;anorexia, cefaleia, acidose l&#225;tica, hepatotoxicidade, eleva&#231;&#227;o das enzimas hep&#225;ticas AST e ALT, aumento nos n&#237;veis s&#233;ricos de colesterol e triglicer&#237;deos, alopecia, artralgia, dist&#250;rbios musculares, mialgia, ins&#244;nia e outros dist&#250;rbios do sono, depress&#227;o, ansiedade, convuls&#227;o, fadiga, letargia e febre.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">- ClCr &lt;50mL/min: utilizar prepara&#231;&#227;o com compostos separados de abacavir, lamivudina e zidovudina</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">- Na insufici&#234;ncia hep&#225;tica: utilizar prepara&#231;&#227;o com os compostos separados nos casos de insufici&#234;ncia hep&#225;tica leve (Child-Pugh A); c</span><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">ontraindicado em casos de insufici&#234;ncia hep&#225;tica moderada a severa (Child-Pugh B ou C).<br></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; mso-fareast- mso-fareast-language: PT-BR;\">- Altera&#231;&#245;es hematol&#243;gicas: ajuste nas doses de zidovudina pode ser necess&#225;rio se o n&#237;vel de hemoglobina cair a menos de 9g/dL ou 5,59 mmol/L ou se a contagem de neutr&#243;filos ficar abaixo de 1,0 X 109/L. U</span>tilizar prepara&#231;&#227;o com compostos separados de abacavir, lamivudina e zidovudina</p>\r\n</div>"
    },
    {
        "content_length": 3498,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 256,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-06 17:01:05",
        "name": "Pantelmin",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "pantelmin",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3492,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 257,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 47,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-06 17:03:46",
        "name": "Panvermin",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "panvermin",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3491,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 258,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 24,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-06 17:39:53",
        "name": "Pluriverm",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "pluriverm",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3502,
        "contraindications": "<p>-&#160;<span lang=\"EN\">Hipersensibilidade ao mebendazol.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Ascaris</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma </em>e <em style=\"mso-bidi-font-style: normal;\">Necator</em>: 1 comprimido ou 5mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias;</span></li>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">Tratamento para <em style=\"mso-bidi-font-style: normal;\">Taenia sp</em>: 2 comprimidos ou 10mL da solu&#231;&#227;o l&#237;quida 2x ao dia por 3 dias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span lang=\"EN\">N&#227;o utilizar em crian&#231;as menores de 1 ano de idade, exceto em casos de desnutri&#231;&#227;o significativas ou dist&#250;rbio de desenvolvimento causada pelas parasitoses.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 259,
        "indications": "<p class=\"MsoNormal\"><span lang=\"EN\">- Infesta&#231;&#245;es por helmitos, isoladas ou mistas, causadas por <em style=\"mso-bidi-font-style: normal;\">Ascaris lumbricoides</em>, <em style=\"mso-bidi-font-style: normal;\">Trichuris trichiura</em>, <em style=\"mso-bidi-font-style: normal;\">Enterobius vermicularis</em>, <em style=\"mso-bidi-font-style: normal;\">Ancylostoma duodenale</em>, <em style=\"mso-bidi-font-style: normal;\">Necator americanus</em>, <em style=\"mso-bidi-font-style: normal;\">Taenia solium</em> e <em style=\"mso-bidi-font-style: normal;\">Taenia saginata.</em></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-09 16:43:54",
        "name": "Sirben",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Comprimidos:</strong> 100mg; </span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span lang=\"EN\"><strong>Suspens&#227;o l&#237;quida:</strong> 100mg/5mL.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "sirben",
        "substance": "Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">N&#227;o &#233; necess&#225;rio fazer ajuste de dose. Deve-se evitar utiliza&#231;&#227;o concomitante com o metronidazol.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span lang=\"EN\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN\">Diarr&#233;ia e dor abdominal (principalmente quando alta carga parasit&#225;ria). Muito raro: neutropenia, dist&#250;rbios sistema imune, S&#237;ndrome de Steven-Johnson, exantema, angioedema, glomerulonefrite.</span></p>\r\n</div>"
    },
    {
        "content_length": 3916,
        "contraindications": "<p>Mebendazol + tiabendazol s&#227;o contraindicados em pacientes que apresentam hipersensibilidade ao mebendazol, tiabendazol ou a qualquer um dos componentes da formula&#231;&#227;o.Tamb&#233;m s&#227;o contraindicados durante a gravidez e a lacta&#231;&#227;o, devendo ser avaliados caso a caso nestas situa&#231;&#245;es.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>10mL 12/12h por 3 dias</li>\r\n</ul>\r\n<p><strong><br>Comprimidos mastig&#225;veis:</strong></p>\r\n<ul>\r\n<li>1cp 12/12h por 3 dias</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Crian&#231;as de 5-10 anos: 5mL 12/12h por 3 dias</li>\r\n<li>Crian&#231;as menores de 5 anos: a crit&#233;rio m&#233;dico</li>\r\n</ul>\r\n<p><strong><br>Comprimidos mastig&#225;veis:</strong></p>\r\n<ul>\r\n<li>Crian&#231;as acima de 15 anos: 1cp 12/12h por 3 dias</li>\r\n<li>Crian&#231;as entre 5-10 anos: 1/2cp 12/12h por 3 dias</li>\r\n<li>Crian&#231;as entre 11-15 anos: 1/2cp 8/8h por 3 dias</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 260,
        "indications": "<div>\r\n<p>Tratamento de helmint&#237;ases intestinais, em infesta&#231;&#245;es simples ou mistas causadas por Trichuris trichiura, Enterobius vermicularis, Ascaris lumbricoides, Necator americanus, Ancylostoma braziliense, Ancylostoma duodenale, Strongyloides stercoralis, Taenia solium, Taenia saginata, Echinococcus granulosus, Echinococcus multilocularis e Dracunculus sp.</p>\r\n<p>Mebendazol + Tiabendazol tamb&#233;m s&#227;o eficazes no tratamento da larva migrans cut&#226;nea. Na triquinose, podem aliviar sintomas como a febre e reduzir a eosinofilia durante o est&#225;gio de invas&#227;o. O efeito sobre a larva da Trichinella spiralis que migrou para o m&#250;sculo n&#227;o &#233; consistentemente eficaz</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\">N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 19:20:41",
        "name": "Mebendazol + Tiabendazol",
        "presentation": "<ul>\r\n<li>Comprimidos com 332mg de Tiabendazol + 200mg de Mebendazol.</li>\r\n<li>Suspens&#227;o oral com 33,2mg/mL de Tiabendazol + 20mg/mL de Mebendazol</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mebendazoltiabendazol",
        "substance": "Mebendazol + Tiabendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"text-decoration: underline;\">Comuns</span> (&gt; 1% e &lt; 10%): perda do apetite, diarr&#233;ia, tontura, sonol&#234;ncia, n&#225;usea, v&#244;mito, xeroftalmia, vertigem, cefal&#233;ia, dispepsia, irritabilidade, dor abdominal, astenia, helmintos na boca e nariz.</p>\r\n<p><span style=\"text-decoration: underline;\">Raros</span>&#160;( &gt; 0,01% e &lt; 0,1%): rea&#231;&#245;es de hipersensibilidade (febre, eritema, erup&#231;&#245;es cut&#226;neas, prurido, s&#237;ndrome de Stevens-Jonhson), neutropenia, alop&#233;cia, s&#237;ncope, convuls&#245;es, enurese, hiperglicemia, hipotens&#227;o, colestase, les&#227;o hepatoc&#237;tica, vis&#227;o subnormal e xantopsia.</p>\r\n<hr>\r\n<p>&#160;</p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 4162,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- N&#227;o usar junto de inibidores de fator de necrose tumoral</p>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Interromper o uso em pacientes com infec&#231;&#227;o grave.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><strong>Artrite reumatoide:&#160;</strong></li>\r\n<li class=\"MsoNormal\"><span style=\"text-decoration: underline;\">Regime de administra&#231;&#227;o&#160;IV:</span>&#160;De acordo com a dosagem inicial, repita a infus&#227;o IV (usando a mesma refer&#234;ncia de dosagem por peso abaixo) na segunda semana e na quarta semana ap&#243;s a infus&#227;o inicial, e toda quarta semana ap&#243;s a &#250;ltima aplica&#231;&#227;o.</li>\r\n<li class=\"MsoNormal\">&lt; 60 kg: 500 mg</li>\r\n<li class=\"MsoNormal\">60 &#8211; 100 kg: 750 mg</li>\r\n<li class=\"MsoNormal\">&gt; 100 kg: 1000 mg</li>\r\n<li class=\"MsoNormal\"><span style=\"text-decoration: underline;\">Regime de administra&#231;&#227;o SC:</span><strong>&#160;</strong>administrado uma vez por semana por inje&#231;&#227;o subcut&#226;nea na dose de 125 mg, independentemente do peso, e pode ser iniciado com ou sem uma dose de ataque IV.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\"><strong>Artrite Idiop&#225;tica Juvenil: </strong>pacientes pedi&#225;tricos com peso igual ou superior a 75 kg segue-se o esquema posol&#243;gico para adultos, n&#227;o superando uma dose m&#225;xima de 1000 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><strong>Artrite Idiop&#225;tica Juvenil:</strong></li>\r\n<li class=\"MsoNormal\"><span style=\"text-decoration: underline;\">Crian&#231;as &gt;= 6 anos e &lt; 75kg: </span>10 mg/kg IV, repetir a infus&#227;o na segunda semana e na quarta semana ap&#243;s a infus&#227;o inicial e toda a quarta semana ap&#243;s a &#250;ltima aplica&#231;&#227;o.</li>\r\n<li class=\"MsoNormal\"><span style=\"text-decoration: underline;\">Crian&#231;as &gt;= 6 anos e &gt; 75 kg:</span><strong>&#160;</strong>segue-se o esquema posol&#243;gico para adultos, n&#227;o superando uma dose m&#225;xima de 1000 mg; repetir a infus&#227;o na segunda semana e na quarta semana ap&#243;s a infus&#227;o inicial e toda a quarta semana ap&#243;s a &#250;ltima aplica&#231;&#227;o.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C</strong>: Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 261,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Artrite reumatoide refrat&#225;ria.</p>\r\n<p class=\"MsoNormal\">- Artrite idiop&#225;tica juvenil.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 50,
        "lactation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- <strong>N&#227;o recomendado.</strong></p>",
        "last_update": "2019-03-06 16:43:05",
        "name": "Orencia",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Solu&#231;&#227;o injet&#225;vel:&#160;</span></strong><span style=\"line-height: 107%;\">250 mg em frasco</span><strong><span style=\"line-height: 107%;\">-</span></strong>ampola de 15 ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "orencia",
        "substance": "Abatacepte",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Infec&#231;&#245;es respirat&#243;rias, aumento do risco de tumores, tonteira, dor de cabe&#231;a, n&#225;usea, v&#244;mitos, hipertens&#227;o, tosse, sibilos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 5786,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hemorragias ativas;</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- AVC h&#225; menos de dois anos;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Cirurgia ou trauma craniano ou medular;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Cirurgia de grande porte h&#225; menos de dois meses;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Vasculite;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tumor cerebral;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Retinopatia diab&#233;tica;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Retinopatia hipertensiva;</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Pacientes em hemodi&#225;lise;</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"mso-add-space: auto; text-align: justify; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipertens&#227;o grave n&#227;o controlada.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Bolus inicial de 0,25 mg/kg IV administrado entre 10 &#8211; 60 minutos antes do in&#237;cio da interven&#231;&#227;o seguido de infus&#227;o de 0,125 &#956;g/kg por minuto (m&#225;ximo 10 &#956;g/minuto por 12 horas). Associar AAS e hepariniza&#231;&#227;o.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 21px;\">Medica&#231;&#227;o n&#227;o recomendada para faixa et&#225;ria pedi&#225;trica</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 262,
        "indications": "<div>\r\n<p><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento auxiliar do infarto do mioc&#225;rdio desde o diagn&#243;stico.</span></p>\r\n<p>- Preven&#231;&#227;o de complica&#231;&#245;es de isquemia card&#237;aca em pacientes que realizaram interven&#231;&#227;o percut&#226;nea coron&#225;ria.</p>\r\n<p>- Preven&#231;&#245;es de complica&#231;&#245;es de isquemia card&#237;aca em pacientes com angina inst&#225;vel, ou infarto do mioc&#225;rdio sem supra de ST.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 51,
        "lactation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 02:35:28",
        "name": "ReoPro",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong><span style=\"line-height: 107%;\">Solu&#231;&#227;o injet&#225;vel</span></strong><span style=\"line-height: 107%;\">:&#160;</span>2 mg/ml em frasco com 5ml.</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Uso hospitalar.</p>",
        "record_status": 1,
        "slug": "reopro",
        "substance": "Abciximab",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 150%; tab-stops: 7.1pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hemorragia, hipotens&#227;o, trombocitopenia, anafilaxia, febre, n&#225;useas, v&#244;mitos, dor nas costas e no peito.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 150%; tab-stops: 7.1pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; line-height: 150%; tab-stops: 7.1pt;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3250,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Gestantes ou que planejam gravidez;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Indiv&#237;duos com hipersensibilidade aos componentes da f&#243;rmula.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">C&#226;ncer metast&#225;tico de pr&#243;stata:&#160;</span></strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">1g VO em dose &#250;nica di&#225;ria, longe das refei&#231;&#245;es em combina&#231;&#227;o com predinisona ou predinisolona (5mg/dia).</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Medica&#231;&#227;o n&#227;o recomendada para faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 263,
        "indications": "<p>- C&#226;ncer metast&#225;tico de pr&#243;stata.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 15:12:39",
        "name": "Zytiga",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido:</strong> 250 mg</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "zytiga",
        "substance": "Abiraterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Edema perif&#233;rico, hipertens&#227;o, taquicardia, fal&#234;ncia card&#237;aca, hipopotassemia, aumento de enzimas hep&#225;ticas e hepatotoxidade.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\">- Doen&#231;a hep&#225;tica moderada (CHILD-PUGH class B) 250 mg/dia.</p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\">- Doen&#231;a hep&#225;tica severa (CHILD-PUGH class C) n&#227;o usar.</p>\r\n</div>"
    },
    {
        "content_length": 4350,
        "contraindications": "<div>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Insufici&#234;ncia renal (ClCr&lt; 25 ml/minuto;</span></p>\r\n<p><span style=\"text-indent: -18pt;\">- Cirrose hep&#225;tica;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Gestantes e lactantes;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Pacientes abaixo de 18 anos;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Doen&#231;as intestinais cr&#244;nicas associadas a dist&#250;rbios definidos de digest&#227;o e absor&#231;&#227;o;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Hipersensibilidade a componentes da f&#243;rmula.</span></p>\r\n<p class=\"MsoNormalCxSpMiddle\" style=\"mso-add-space: auto; text-indent: -18.0pt; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 35.45pt;\">&#160;</p>\r\n<p class=\"MsoNormalCxSpMiddle\" style=\"mso-add-space: auto; text-indent: -18.0pt; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 35.45pt;\">&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>DM tipo II:</strong></li>\r\n<li><span style=\"text-decoration: underline;\">Dose inicial:</span> 25 mg VO 8/8 horas; aumentar a dose em intervalos de 1 m&#234;s a 2 meses com base nos n&#237;veis de glicose, toler&#226;ncia oral a glicose dentro do per&#237;odo de uma hora p&#243;s-prandial ou hemoglobina glicada at&#233; o alcance da dose de manuten&#231;&#227;o (50 a 100 mg de 8/8 horas).</li>\r\n<li><span style=\"text-decoration: underline;\">Dose m&#225;xima &lt;= 60 kg:</span> 50 mg 8/8 horas.</li>\r\n<li><span style=\"text-decoration: underline;\">Dose m&#225;xima &gt; 60 kg:</span> 100 mg 8/8 horas.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 264,
        "indications": "<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Tratamento de DM2.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\">- N&#227;o recomendado.</strong></p>",
        "last_update": "2019-03-03 19:52:28",
        "name": "Glucobay",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\"><strong>Comprimido:</strong> 50 mg e 100 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glucobay",
        "substance": "Acarbose",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Dor abdominal, n&#225;useas, v&#244;mitos, diarreia, flatul&#234;ncia, n&#237;veis elevados de transaminases.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- N&#227;o estabelecido.</span></p>\r\n</div>"
    },
    {
        "content_length": 3900,
        "contraindications": "<div>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Insufici&#234;ncia renal (ClCr&lt; 25 ml/minuto;</span></p>\r\n<p><span style=\"text-indent: -18pt;\">- Cirrose hep&#225;tica;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Gestantes e lactantes;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Pacientes abaixo de 18 anos;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Doen&#231;as intestinais cr&#244;nicas associadas a dist&#250;rbios definidos de digest&#227;o e absor&#231;&#227;o;</span></p>\r\n<p><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Hipersensibilidade a componentes da f&#243;rmula.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>DM tipo II:</strong></li>\r\n<li><span style=\"text-decoration: underline;\">Dose inicial:</span> 25 mg VO 8/8 horas; aumentar a dose em intervalos de 1 m&#234;s a 2 meses com base nos n&#237;veis de glicose, toler&#226;ncia oral a glicose dentro do per&#237;odo de uma hora p&#243;s-prandial ou hemoglobina glicada at&#233; o alcance da dose de manuten&#231;&#227;o (50 a 100 mg de 8/8 horas).</li>\r\n<li><span style=\"text-decoration: underline;\">Dose m&#225;xima &lt;= 60 kg: </span>50 mg 8/8 horas.</li>\r\n<li><span style=\"text-decoration: underline;\">Dose m&#225;xima &gt; 60 kg:</span> 100 mg 8/8 horas.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 266,
        "indications": "<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Tratamento de DM2.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 53,
        "lactation_text": "<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\">- N&#227;o recomendado.</strong></p>",
        "last_update": "2019-03-03 17:04:52",
        "name": "Aglucose",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\"><strong>Comprimido:</strong> 50 mg e 100 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "aglucose",
        "substance": "Acarbose",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">- Dor abdominal, n&#225;useas, v&#244;mitos, diarreia, flatul&#234;ncia, n&#237;veis elevados de transaminases.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 4936,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bloqueio atrioventricular 2&#186; ou 3&#186; graus, bradicardias;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Broncoespasmo grave;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Suspeita de IAM enquanto frequ&#234;ncia card&#237;aca for &lt;45 bpm, intervalo PQ &gt; 0,24 segundos ou PAs &lt; 100 mmHg;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Choque cardiog&#234;nico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- ICC n&#227;o compensada inst&#225;vel;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arteriopatia perif&#233;rica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Hipertens&#227;o leve a moderada:</strong>&#160;50 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Angina:</strong>&#160;100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>ICC:</strong>&#160;25 mg/dia, dobrando dose a cada duas semanas, at&#233; dose m&#225;xima de 200 mg/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Profilaxia de enxaqueca:</strong>&#160;100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>P&#243;s-infarto:</strong>&#160;50 a 200 mg, via oral, de 12/12 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-2mg/kg VO 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1076,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Angina, arritmias, fibrila&#231;&#227;o atrial, taquicardia atrial multifocal, insufici&#234;ncia card&#237;aca, infarto agudo do mioc&#225;rdio, hipertens&#227;o arterial, profilaxia de enxaqueca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-03 20:54:56",
        "name": "Inephoros Xr",
        "presentation": "<ul>\r\n<li><strong>Comprimidos de libera&#231;&#227;o prolongada:</strong>&#160;25mg, 50mg e 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "inephoros-xr",
        "substance": "Metoprolol Succinato",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, broncoespasmo, tosse e dispneia, hipotens&#227;o ortost&#225;tica (n&#227;o retirar abruptamente), sonol&#234;ncia e fraqueza, vertigem, cefaleia, fadiga, astenia, dor abdominal, diarreia, constipa&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4928,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bloqueio atrioventricular 2&#186; ou 3&#186; graus, bradicardias;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Broncoespasmo grave;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Suspeita de IAM enquanto frequ&#234;ncia card&#237;aca for &lt;45 bpm, intervalo PQ &gt; 0,24 segundos ou PAs &lt; 100 mmHg;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Choque cardiog&#234;nico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- ICC n&#227;o compensada inst&#225;vel;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arteriopatia perif&#233;rica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Hipertens&#227;o leve a moderada:</strong>&#160;50 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Angina:</strong>&#160;100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>ICC:</strong>&#160;25 mg/dia, dobrando dose a cada duas semanas, at&#233; dose m&#225;xima de 200 mg/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Profilaxia de enxaqueca:</strong>&#160;100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>P&#243;s-infarto:</strong>&#160;50 a 200 mg, via oral, de 12/12 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-2mg/kg VO 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1077,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Angina, arritmias, fibrila&#231;&#227;o atrial, taquicardia atrial multifocal, insufici&#234;ncia card&#237;aca, infarto agudo do mioc&#225;rdio, hipertens&#227;o arterial, profilaxia de enxaqueca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:27:01",
        "name": "Minola",
        "presentation": "<ul>\r\n<li><strong>Comprimidos de libera&#231;&#227;o prolongada:</strong>&#160;25mg, 50mg e 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "minola",
        "substance": "Metoprolol Succinato",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, broncoespasmo, tosse e dispneia, hipotens&#227;o ortost&#225;tica (n&#227;o retirar abruptamente), sonol&#234;ncia e fraqueza, vertigem, cefaleia, fadiga, astenia, dor abdominal, diarreia, constipa&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5507,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bloqueio atrioventricular 2&#186; ou 3&#186; graus, bradicardias;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Broncoespasmo grave;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Suspeita de IAM enquanto frequ&#234;ncia card&#237;aca for &lt;45 bpm, intervalo PQ &gt; 0,24 segundos ou PAs &lt; 100 mmHg;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Choque cardiog&#234;nico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- ICC n&#227;o compensada inst&#225;vel;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arteriopatia perif&#233;rica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Hipertens&#227;o leve a moderada:</strong> 50 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Angina:</strong> 100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>ICC:</strong> 25 mg/dia, dobrando dose a cada duas semanas, at&#233; dose m&#225;xima de 200 mg/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Profilaxia de enxaqueca:</strong> 100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>P&#243;s-infarto:</strong> 50 a 200 mg, via oral, de 12/12 horas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de ataque:</strong> 2,5 a 5 mg (1/2 &#8211; 1 ampola), IV, em 2 minutos. Repetir dose ate obter controle da frequ&#234;ncia card&#237;aca (dose m&#225;xima: 20 mg ou 4 ampolas);</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Fibrila&#231;&#227;o atrial:</strong> 5 mg (1 ampola), intravenosa em 5 minutos. Repetir ate 2 vezes, com intervalos de 5 minutos.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-2mg/kg VO 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1078,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Angina, arritmias, fibrila&#231;&#227;o atrial, taquicardia atrial multifocal, insufici&#234;ncia card&#237;aca, infarto agudo do mioc&#225;rdio, hipertens&#227;o arterial, profilaxia de enxaqueca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-09 16:24:37",
        "name": "Seloken",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;100mg;</li>\r\n<li><strong>Ampolas:</strong>&#160;5mg/5mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "seloken",
        "substance": "Metoprolol Tartarato",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, broncoespasmo, tosse e dispneia, hipotens&#227;o ortost&#225;tica (n&#227;o retirar abruptamente), sonol&#234;ncia e fraqueza, vertigem, cefaleia, fadiga, astenia, dor abdominal, diarreia, constipa&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4759,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bloqueio atrioventricular 2&#186; ou 3&#186; graus, bradicardias;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Broncoespasmo grave;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Suspeita de IAM enquanto frequ&#234;ncia card&#237;aca for &lt;45 bpm, intervalo PQ &gt; 0,24 segundos ou PAs &lt; 100 mmHg;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Choque cardiog&#234;nico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- ICC n&#227;o compensada inst&#225;vel;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arteriopatia perif&#233;rica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Hipertens&#227;o leve a moderada:</strong> 50 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Angina:</strong> 100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>ICC:</strong> 25 mg/dia, dobrando dose a cada duas semanas, at&#233; dose m&#225;xima de 200 mg/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Profilaxia de enxaqueca:</strong> 100 a 200 mg/dia VO;<strong>P&#243;s-infarto:</strong> 50 a 200 mg, via oral, de 12/12 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-2mg/kg VO 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1079,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Angina, arritmias, fibrila&#231;&#227;o atrial, taquicardia atrial multifocal, insufici&#234;ncia card&#237;aca, infarto agudo do mioc&#225;rdio, hipertens&#227;o arterial, profilaxia de enxaqueca.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:15:25",
        "name": "Metoprolol Tartarato",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tartarato-de-metoprolol",
        "substance": "Metoprolol Tartarato",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, broncoespasmo, tosse e dispneia, hipotens&#227;o ortost&#225;tica (n&#227;o retirar abruptamente), sonol&#234;ncia e fraqueza, vertigem, cefaleia, fadiga, astenia, dor abdominal, diarreia, constipa&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4736,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bloqueio atrioventricular 2&#186; ou 3&#186; graus, bradicardias;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Broncoespasmo grave;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Suspeita de IAM enquanto frequ&#234;ncia card&#237;aca for &lt;45 bpm, intervalo PQ &gt; 0,24 segundos ou PAs &lt; 100 mmHg;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Choque cardiog&#234;nico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- ICC n&#227;o compensada inst&#225;vel;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arteriopatia perif&#233;rica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Hipertens&#227;o leve a moderada:</strong> 50 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Angina:</strong> 100 a 200 mg/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>ICC:</strong> 25 mg/dia, dobrando dose a cada duas semanas, at&#233; dose m&#225;xima de 200 mg/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Profilaxia de enxaqueca:</strong> 100 a 200 mg/dia VO;<strong>P&#243;s-infarto:</strong> 50 a 200 mg, via oral, de 12/12 horas;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-2mg/kg VO 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1080,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Angina, arritmias, fibrila&#231;&#227;o atrial, taquicardia atrial multifocal, insufici&#234;ncia card&#237;aca, infarto agudo do mioc&#225;rdio, hipertens&#227;o arterial, profilaxia de enxaqueca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 75,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:19:33",
        "name": "Miclox",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "miclox",
        "substance": "Metoprolol Tartarato",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, broncoespasmo, tosse e dispneia, hipotens&#227;o ortost&#225;tica (n&#227;o retirar abruptamente), sonol&#234;ncia e fraqueza, vertigem, cefaleia, fadiga, astenia, dor abdominal, diarreia, constipa&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 7409,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1081,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 58,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:15:45",
        "name": "Metrexato",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "metrexato",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7409,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1082,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 60,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-10 03:33:20",
        "name": "Tecnomet",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tecnomet",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7456,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1083,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 151,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-10 03:57:44",
        "name": "Tevametho",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/mL e 100mg/mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "tevametho",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7449,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1084,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-03 20:45:35",
        "name": "Hytas",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/mL e 100mg/mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "hytas",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7457,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1086,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-04 00:46:53",
        "name": "Lexato",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>ampolas de 50mg e 500mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "lexato",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7463,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1087,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 150,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-04 00:58:19",
        "name": "Litrexate",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "litrexate",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7443,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1088,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 58,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:40:10",
        "name": "MTX",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/mL e 100mg/mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "mtx",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7489,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1089,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 149,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:15:35",
        "name": "Metotrexato",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>ampolas de 50mg e 500mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "metotrexato",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 7461,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia hep&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo (pacientes com psor&#237;ase);&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o da medula &#243;ssea;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#245;es graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ulcera p&#233;ptica ou colite ulcerativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tumores: </strong>20-50 mg/m<sup>2</sup> ate 12 g/m&#178;; avaliar protocolos espec&#237;ficos;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Artrite reumatoide:</strong> 7,5 a 15 mg/dose semanal; associar 1mg de acido f&#243;lico/dia ou 5mg de &#225;cido fol&#237;nico semanal;</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Psor&#237;ase:</strong> 10 a 25 mg/dose, semanal em dose &#250;nica ou divididos em 3x; doses acima de 40 mg/m&#178; exigem resgate com Leucovorin 36 horas depois.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Leucemia men&#237;ngea:</strong></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&lt;1 ano</span>: 6 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;1 ano</span>: 8 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">&gt;2 anos</span>: 10 mg, via intratecal, com intervalos de 2 a 5 dias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"text-decoration: underline;\">Maior ou igual a 3 anos</span>: 12 mg, via intratecal, com intervalos de 2 a 5 dias.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Artrite reumatoide juvenil:</strong> 0,3 mg/kg/dose semana;&#160;aumentar a dose progressivamente ate 0,8 mg/kg/dose semanal.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dermatomiosite:</strong> 0,1 a 0,3 mg/kg/dose semanal.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1090,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Neoplasias trofobl&#225;sticas gestacionais;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucemias linfoc&#237;ticas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer pulmonar de c&#233;lulas pequenas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de cabe&#231;a e pesco&#231;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">C&#226;ncer de mama;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Osteossarcoma;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento e profilaxia de linfoma ou leucemia men&#237;ngea;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Terapia paliativa de tumores s&#243;lidos inoper&#225;veis;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Psor&#237;ase grave;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Artrite reumat&#243;ide.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:18:33",
        "name": "Miantrex CS",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/mL e 100mg/mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "miantrex-cs",
        "substance": "Metotrexato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Depress&#227;o da medula &#243;ssea, mucosite, n&#225;useas, v&#244;mitos e diarreia, erup&#231;&#245;es cut&#226;neas eritematosas, urticaria e prurido, pneumonia intersticial, fibrose intersticial e infiltrados pulmonares eosinofilicos revers&#237;veis, febre, tosse, dispneia, dor tor&#225;cica, hipoxemia, cefaleia, dor nas costas e rigidez de nuca, estado confusional, estupor, convuls&#245;es, ataxia e dem&#234;ncia, insufici&#234;ncia renal, azotemia, cistite e hemat&#250;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50 &#8211; 80mL/min: 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 10 &#8211; 50mL/min: 30 a 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 10mL/min: evitar o uso.</p>\r\n</div>"
    },
    {
        "content_length": 3645,
        "contraindications": "<div>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Hipersensibilidade ao felodipino ou ao metoprolol (incluindo outros diidropiridinos ou beta- bloqueadores) ou a qualquer outro componente da f&#243;rmula;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Gravidez;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Infarto agudo do mioc&#225;rdio;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Angina do peito inst&#225;vel;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Bloqueio atrioventricular de segundo ou terceiro grau;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Obstru&#231;&#227;o hemodinamicamente significativa da v&#225;lvula card&#237;aca;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\"> - Obstru&#231;&#227;o din&#226;mica do fluxo de sa&#237;da;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Pacientes com insufici&#234;ncia card&#237;aca n&#227;o compensada inst&#225;vel (edema pulmonar, hipoperfus&#227;o ou hipotens&#227;o) e pacientes com terapia inotr&#243;pica cont&#237;nua ou intermitente agindo atrav&#233;s de agonista do receptor beta;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Bradicardia sinusal clinicamente relevante;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- S&#237;ndrome do n&#243; sino-atrial (a n&#227;o ser que um marcapasso permanente esteja em uso);</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Choque cardiog&#234;nico;</span></p>\r\n<p><span style=\"color: #333333; text-align: justify;\">- Arteriopatia perif&#233;rica grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>1-2cp 1x/dia, pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o deve ser utilizado por crian&#231;as.</li>\r\n</ul>",
        "gestation": null,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1091,
        "indications": "<p><span style=\"color: #333333; text-align: justify;\">- Tratamento da hipertens&#227;o ap&#243;s falha terap&#234;utica na monoterapia e para pacientes com perfil de fator de risco cardiovascular alto e/ou muito alto.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-09 16:25:04",
        "name": "Selozok Fix",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;50mg de Metoprolol + 5mg de Felodipino.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "selozok-fix",
        "substance": "Metoprolol + Felodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Hipotens&#227;o arterial;</p>\r\n<p>- Hipertrofia gengival;</p>\r\n<p>- Tonturas;</p>\r\n<p>- N&#225;useas;</p>\r\n<p>- Edema distal de membros inferiores.</p>\r\n</div>"
    },
    {
        "content_length": 6617,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consular o m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tratamento de candid&#237;ase invasiva:</strong> &gt; 40 kg: 100 mg/dia;&#160;&lt; 40 kg: 2 mg/kg/dia.</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">- administrar por no m&#237;nimo 14 dias</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">&#160;<strong>Tratamento de candid&#237;ase esof&#225;gica:</strong> &gt; 40 kg: 150mg/dia;&#160;&lt; 40 kg: 3 mg/kg/dia.</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">- administrar por ao menos uma semana ap&#243;s o desaparecimento dos sinais e sintomas cl&#237;nicos.</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">&#160;<strong>Profilaxia de infec&#231;&#227;o por c&#226;ndida:</strong> &gt; 40 kg: 50 mg/dia;&#160;&lt; 40 kg: 1 mg/kg/dia.</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">- administrar at&#233; pelo menos uma semana ap&#243;s a recupera&#231;&#227;o dos neutr&#243;filos.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tratamento de candid&#237;ase invasiva:</strong>&#160;&gt; 40 kg: 100 mg/dia;&#160;&lt; 40 kg: 2 mg/kg/dia.</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">- administrar por no m&#237;nimo 14 dias</p>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">&#160;<strong>Profilaxia de infec&#231;&#227;o por c&#226;ndida:</strong>&#160;&gt; 40 kg: 50 mg/dia;&#160;&lt; 40 kg: 1 mg/kg/dia.</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">&#160;- administrar at&#233; pelo menos uma semana ap&#243;s a recupera&#231;&#227;o dos neutr&#243;filos.</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1093,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento de candid&#237;ase invasiva;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Tratamento de candid&#237;ase esof&#225;gica em doentes para quem a terap&#234;utica intravenosa &#233; apropriada;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Profilaxia de infec&#231;&#227;o por c&#226;ndida em doentes submetidos a transplante de c&#233;lulas estaminais hematopoi&#233;ticas ou doentes onde &#233; esperada neutropenia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><em>S&#243; deve ser usado se outros antif&#250;ngicos n&#227;o forem adequados.</em></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-05 00:45:33",
        "name": "Mycamine",
        "presentation": "<ul>\r\n<li><strong>P&#243; para solu&#231;&#227;o injet&#225;vel:</strong>&#160;50mg e 100mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Uso restrito a hospitais.</p>",
        "record_status": 1,
        "slug": "mycamine",
        "substance": "Micafungina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Leucopenia, neutropenia, anemia, pancitopenia, trombocitopenia, eosinofilia e hipoalbuminemia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade e anafilaxia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipocalemia, hipomagnesemia, hipocalcemia, hiponatremia, hipercalemia e hipofosfatemia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ins&#244;nia, ansiedade, confus&#227;o, cefaleia, sonol&#234;ncia, tremores, tonturas e disgeusia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Taquicardia, palpita&#231;&#245;es, bradicardia, flebite, hipotens&#227;o, hipertens&#227;o e rubor;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, diarreia, dor abdominal, dispepsia e obstipa&#231;&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Disfun&#231;&#227;o hep&#225;tica e renal.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5197,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres em idade f&#233;rtil que n&#227;o est&#227;o utilizando m&#233;todos contraceptivos altamente efetivos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Gravidez.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o renal:</strong> 1g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o card&#237;aca ou hep&#225;tica:</strong> 1,5g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem para o tratamento da primeira rejei&#231;&#227;o e da rejei&#231;&#227;o refrat&#225;ria renal:</strong> 1,5g 2x/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1094,
        "indications": "<p>- Transplantes renais, card&#237;aco e hep&#225;tico.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-01-13 20:27:39",
        "name": "CellCept",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cellcept",
        "substance": "Micofenolato de Mofetila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ascite, aumento abdominal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Astenia, calafrios,&#160;febre, cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o, dor, edema, peritonite e sepse;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Abscesso, celulite, cistos, s&#237;ndrome gripal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hemorragia, mal estar e dor no pesco&#231;o, anemia, equimose, leucopenia, leucocitose e trombocitopenia, pet&#233;quias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, hipertens&#227;o, hipotens&#227;o, taquicardia, insufici&#234;ncia card&#237;aca e derrame peric&#225;rdico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asma, tosse, dispneia, faringite, pneumonia, rinite, sinusite e derrame pleural, apneia, atelectasia, bronquite, epistaxe, hemoptise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Solu&#231;o, neoplasma, acne, herpes simples, herpes zoster e erup&#231;&#227;o cut&#226;nea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>Insufici&#234;ncia renal grave:</strong> dose maior que 2 g/dia deve ser evitada.</p>\r\n</div>"
    },
    {
        "content_length": 5225,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres em idade f&#233;rtil que n&#227;o est&#227;o utilizando m&#233;todos contraceptivos altamente efetivos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Gravidez.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o renal:</strong> 1g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o card&#237;aca ou hep&#225;tica:</strong> 1,5g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem para o tratamento da primeira rejei&#231;&#227;o e da rejei&#231;&#227;o refrat&#225;ria renal:</strong> 1,5g 2x/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1095,
        "indications": "<p>- Transplantes renais, card&#237;aco e hep&#225;tico.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:19:41",
        "name": "Micofenolato de Mofetila",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "micofenolato-de-mofetila",
        "substance": "Micofenolato de Mofetila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ascite, aumento abdominal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Astenia, calafrios,&#160;febre, cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o, dor, edema, peritonite e sepse;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Abscesso, celulite, cistos, s&#237;ndrome gripal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hemorragia, mal estar e dor no pesco&#231;o, anemia, equimose, leucopenia, leucocitose e trombocitopenia, pet&#233;quias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, hipertens&#227;o, hipotens&#227;o, taquicardia, insufici&#234;ncia card&#237;aca e derrame peric&#225;rdico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asma, tosse, dispneia, faringite, pneumonia, rinite, sinusite e derrame pleural, apneia, atelectasia, bronquite, epistaxe, hemoptise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Solu&#231;o, neoplasma, acne, herpes simples, herpes zoster e erup&#231;&#227;o cut&#226;nea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>Insufici&#234;ncia renal grave:</strong> dose maior que 2 g/dia deve ser evitada.</p>\r\n</div>"
    },
    {
        "content_length": 4325,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres em idade f&#233;rtil que n&#227;o est&#227;o utilizando m&#233;todos contraceptivos altamente efetivos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Gravidez e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Dose recomendada:</strong> 720mg VO 12/12h.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1096,
        "indications": "<p>- Profilaxia de rejei&#231;&#227;o em transplantes renais.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:46:05",
        "name": "Myfortic",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;180mg e 360mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "myfortic",
        "substance": "Micofenolato de Sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ascite, aumento abdominal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Astenia, calafrios,&#160;febre, cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o, dor, edema, peritonite e sepse;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Abscesso, celulite, cistos, s&#237;ndrome gripal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hemorragia, mal estar e dor no pesco&#231;o, anemia, equimose, leucopenia, leucocitose e trombocitopenia, pet&#233;quias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, hipertens&#227;o, hipotens&#227;o, taquicardia, insufici&#234;ncia card&#237;aca e derrame peric&#225;rdico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asma, tosse, dispneia, faringite, pneumonia, rinite, sinusite e derrame pleural, apneia, atelectasia, bronquite, epistaxe, hemoptise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Solu&#231;o, neoplasma, acne, herpes simples, herpes zoster e erup&#231;&#227;o cut&#226;nea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5206,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres em idade f&#233;rtil que n&#227;o est&#227;o utilizando m&#233;todos contraceptivos altamente efetivos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Gravidez.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o renal:</strong> 1g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o card&#237;aca ou hep&#225;tica:</strong> 1,5g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem para o tratamento da primeira rejei&#231;&#227;o e da rejei&#231;&#227;o refrat&#225;ria renal:</strong> 1,5g 2x/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1097,
        "indications": "<p>- Transplantes renais, card&#237;aco e hep&#225;tico.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:33:51",
        "name": "Mofecell",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mofecell",
        "substance": "Micofenolato de Mofetila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ascite, aumento abdominal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Astenia, calafrios,&#160;febre, cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o, dor, edema, peritonite e sepse;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Abscesso, celulite, cistos, s&#237;ndrome gripal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hemorragia, mal estar e dor no pesco&#231;o, anemia, equimose, leucopenia, leucocitose e trombocitopenia, pet&#233;quias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, hipertens&#227;o, hipotens&#227;o, taquicardia, insufici&#234;ncia card&#237;aca e derrame peric&#225;rdico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asma, tosse, dispneia, faringite, pneumonia, rinite, sinusite e derrame pleural, apneia, atelectasia, bronquite, epistaxe, hemoptise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Solu&#231;o, neoplasma, acne, herpes simples, herpes zoster e erup&#231;&#227;o cut&#226;nea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>Insufici&#234;ncia renal grave:</strong> dose maior que 2 g/dia deve ser evitada.</p>\r\n</div>"
    },
    {
        "content_length": 5201,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres em idade f&#233;rtil que n&#227;o est&#227;o utilizando m&#233;todos contraceptivos altamente efetivos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Gravidez.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o renal:</strong> 1g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem padr&#227;o para profilaxia da rejei&#231;&#227;o card&#237;aca ou hep&#225;tica:</strong> 1,5g 2x/dia;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dosagem para o tratamento da primeira rejei&#231;&#227;o e da rejei&#231;&#227;o refrat&#225;ria renal:</strong> 1,5g 2x/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1098,
        "indications": "<p>- Transplantes renais, card&#237;aco e hep&#225;tico.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 111,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:34:19",
        "name": "Mofilen",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mofilen",
        "substance": "Micofenolato de Mofetila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ascite, aumento abdominal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Astenia, calafrios,&#160;febre, cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o, dor, edema, peritonite e sepse;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Abscesso, celulite, cistos, s&#237;ndrome gripal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hemorragia, mal estar e dor no pesco&#231;o, anemia, equimose, leucopenia, leucocitose e trombocitopenia, pet&#233;quias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, hipertens&#227;o, hipotens&#227;o, taquicardia, insufici&#234;ncia card&#237;aca e derrame peric&#225;rdico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asma, tosse, dispneia, faringite, pneumonia, rinite, sinusite e derrame pleural, apneia, atelectasia, bronquite, epistaxe, hemoptise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Solu&#231;o, neoplasma, acne, herpes simples, herpes zoster e erup&#231;&#227;o cut&#226;nea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>Insufici&#234;ncia renal grave:</strong> dose maior que 2 g/dia deve ser evitada.</p>\r\n</div>"
    },
    {
        "content_length": 4349,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres em idade f&#233;rtil que n&#227;o est&#227;o utilizando m&#233;todos contraceptivos altamente efetivos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Gravidez e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Dose recomendada:</strong> 720mg VO 12/12h.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1099,
        "indications": "<p>- Profilaxia de rejei&#231;&#227;o em transplantes renais.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:19:50",
        "name": "Micofenolato de Sódio",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;180mg e 360mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "micofenolato-de-sodio",
        "substance": "Micofenolato de Sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ascite, aumento abdominal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Astenia, calafrios,&#160;febre, cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o, dor, edema, peritonite e sepse;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Abscesso, celulite, cistos, s&#237;ndrome gripal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hemorragia, mal estar e dor no pesco&#231;o, anemia, equimose, leucopenia, leucocitose e trombocitopenia, pet&#233;quias;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, hipertens&#227;o, hipotens&#227;o, taquicardia, insufici&#234;ncia card&#237;aca e derrame peric&#225;rdico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asma, tosse, dispneia, faringite, pneumonia, rinite, sinusite e derrame pleural, apneia, atelectasia, bronquite, epistaxe, hemoptise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Solu&#231;o, neoplasma, acne, herpes simples, herpes zoster e erup&#231;&#227;o cut&#226;nea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4836,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o previa do sistema nervoso ou obstru&#231;&#227;o de vias a&#233;reas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Estado de choque;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Glaucoma de &#226;ngulo fechado;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o:</strong> (50 mg/10ml) 30 ml + 120 ml de SG 5% - concentra&#231;&#227;o: 1000 mcg/ml;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usal:</strong> 20 a 100 mcg/kg/h;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 1 mg/h (10 ml/h) com ajuste conforme necess&#225;rio;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o anest&#233;sica:</strong> 0,3 mg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ventila&#231;&#227;o mec&#226;nica:</strong>&#160;Ataque: 0,01 a 0,05 mg/kg; Manuten&#231;&#227;o: 0,02 a 0,1 mg/kg/h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Pr&#233;-intuba&#231;&#227;o: </strong>0,1 a 0,2 mg/kg/dose IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Crise convulsiva:</strong>&#160;ataque: 0,15 a 0,2 mg/kg;&#160;manuten&#231;&#227;o: 1 a 2 mcg/kg/min.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1100,
        "indications": "<div>\r\n<p>- Indu&#231;&#227;o anest&#233;sica;</p>\r\n<p>- Seda&#231;&#227;o consciente para procedimento;</p>\r\n<p>- Seda&#231;&#227;o no pr&#233;-operat&#243;rio;</p>\r\n<p>- Seda&#231;&#227;o em CTI e adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Tratamento de curta dura&#231;&#227;o da ins&#244;nia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-02-28 23:37:04",
        "name": "Dormonid",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:&#160;</strong>7,5mg e 15mg;</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5mg/5mL, 20mg/10mL, 15mg/3mL ou 50mg/10mL.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Azul (B1 - psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "dormonid",
        "substance": "Midazolam",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Apneia ou depress&#227;o respirat&#243;ria, broncoespasmo, laringoespasmo e tosse;</p>\r\n<p>- Depend&#234;ncia qu&#237;mica e psicossocial;</p>\r\n<p>- Hipotens&#227;o arterial, seda&#231;&#227;o prolongada, ataxia, amn&#233;sia, fadiga, cefaleia, fraqueza muscular, tontura, confus&#227;o mental, redu&#231;&#227;o da aten&#231;&#227;o, embotamento emocional, sonol&#234;ncia diurna.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3493,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o previa do sistema nervoso ou obstru&#231;&#227;o de vias a&#233;reas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Estado de choque;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Glaucoma de &#226;ngulo fechado;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">7,5-15mg VO &#224; noite ou 30 minutos antes do procedimento.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o estabelecido.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1101,
        "indications": "<div>\r\n<p>- Indu&#231;&#227;o anest&#233;sica;</p>\r\n<p>- Seda&#231;&#227;o consciente para procedimento;</p>\r\n<p>- Seda&#231;&#227;o no pr&#233;-operat&#243;rio;</p>\r\n<p>- Tratamento de curta dura&#231;&#227;o da ins&#244;nia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-04 01:16:43",
        "name": "Maleato de Midazolam",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;7,5mg e 15mg.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Azul (B1 - psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "maleato-de-midazolam",
        "substance": "Midazolam",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Apneia ou depress&#227;o respirat&#243;ria, broncoespasmo, laringoespasmo e tosse;</p>\r\n<p>- Depend&#234;ncia qu&#237;mica e psicossocial;</p>\r\n<p>- Hipotens&#227;o arterial, seda&#231;&#227;o prolongada, ataxia, amn&#233;sia, fadiga, cefaleia, fraqueza muscular, tontura, confus&#227;o mental, redu&#231;&#227;o da aten&#231;&#227;o, embotamento emocional, sonol&#234;ncia diurna.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4751,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o previa do sistema nervoso ou obstru&#231;&#227;o de vias a&#233;reas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Estado de choque;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Glaucoma de &#226;ngulo fechado;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o:</strong> (50 mg/10ml) 30 ml + 120 ml de SG 5% - concentra&#231;&#227;o: 1000 mcg/ml;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usal:</strong> 20 a 100 mcg/kg/h;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 1 mg/h (10 ml/h) com ajuste conforme necess&#225;rio;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o anest&#233;sica:</strong> 0,3 mg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ventila&#231;&#227;o mec&#226;nica:</strong>&#160;Ataque: 0,01 a 0,05 mg/kg; Manuten&#231;&#227;o: 0,02 a 0,1 mg/kg/h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Pr&#233;-intuba&#231;&#227;o: </strong>0,1 a 0,2 mg/kg/dose IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Crise convulsiva:</strong>&#160;ataque: 0,15 a 0,2 mg/kg;&#160;manuten&#231;&#227;o: 1 a 2 mcg/kg/min.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1102,
        "indications": "<div>\r\n<p>- Indu&#231;&#227;o anest&#233;sica;</p>\r\n<p>- Seda&#231;&#227;o consciente para procedimento;</p>\r\n<p>- Seda&#231;&#227;o no pr&#233;-operat&#243;rio;</p>\r\n<p>- Seda&#231;&#227;o em CTI e adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Tratamento de curta dura&#231;&#227;o da ins&#244;nia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-02-28 23:36:30",
        "name": "Dormant",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 15mg/3mL.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Azul (B1 - psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "dormant",
        "substance": "Midazolam",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Apneia ou depress&#227;o respirat&#243;ria, broncoespasmo, laringoespasmo e tosse;</p>\r\n<p>- Depend&#234;ncia qu&#237;mica e psicossocial;</p>\r\n<p>- Hipotens&#227;o arterial, seda&#231;&#227;o prolongada, ataxia, amn&#233;sia, fadiga, cefaleia, fraqueza muscular, tontura, confus&#227;o mental, redu&#231;&#227;o da aten&#231;&#227;o, embotamento emocional, sonol&#234;ncia diurna.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4852,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o previa do sistema nervoso ou obstru&#231;&#227;o de vias a&#233;reas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Estado de choque;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Glaucoma de &#226;ngulo fechado;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o:</strong> (50 mg/10ml) 30 ml + 120 ml de SG 5% - concentra&#231;&#227;o: 1000 mcg/ml;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usal:</strong> 20 a 100 mcg/kg/h;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 1 mg/h (10 ml/h) com ajuste conforme necess&#225;rio;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o anest&#233;sica:</strong> 0,3 mg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ventila&#231;&#227;o mec&#226;nica:</strong>&#160;Ataque: 0,01 a 0,05 mg/kg; Manuten&#231;&#227;o: 0,02 a 0,1 mg/kg/h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Pr&#233;-intuba&#231;&#227;o: </strong>0,1 a 0,2 mg/kg/dose IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Crise convulsiva:</strong>&#160;ataque: 0,15 a 0,2 mg/kg;&#160;manuten&#231;&#227;o: 1 a 2 mcg/kg/min.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1103,
        "indications": "<div>\r\n<p>- Indu&#231;&#227;o anest&#233;sica;</p>\r\n<p>- Seda&#231;&#227;o consciente para procedimento;</p>\r\n<p>- Seda&#231;&#227;o no pr&#233;-operat&#243;rio;</p>\r\n<p>- Seda&#231;&#227;o em CTI e adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Tratamento de curta dura&#231;&#227;o da ins&#244;nia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-02-28 23:36:55",
        "name": "Dormium",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;7,5mg e 15mg;</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5mg/5mL, 20mg/10mL, 15mg/3mL ou 50mg/10mL.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Azul (B1 - psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "dormium",
        "substance": "Midazolam",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Apneia ou depress&#227;o respirat&#243;ria, broncoespasmo, laringoespasmo e tosse;</p>\r\n<p>- Depend&#234;ncia qu&#237;mica e psicossocial;</p>\r\n<p>- Hipotens&#227;o arterial, seda&#231;&#227;o prolongada, ataxia, amn&#233;sia, fadiga, cefaleia, fraqueza muscular, tontura, confus&#227;o mental, redu&#231;&#227;o da aten&#231;&#227;o, embotamento emocional, sonol&#234;ncia diurna.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4761,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o previa do sistema nervoso ou obstru&#231;&#227;o de vias a&#233;reas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Estado de choque;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Glaucoma de &#226;ngulo fechado;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o:</strong> (50 mg/10ml) 30 ml + 120 ml de SG 5% - concentra&#231;&#227;o: 1000 mcg/ml;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usal:</strong> 20 a 100 mcg/kg/h;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 1 mg/h (10 ml/h) com ajuste conforme necess&#225;rio;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o anest&#233;sica:</strong> 0,3 mg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ventila&#231;&#227;o mec&#226;nica:</strong>&#160;Ataque: 0,01 a 0,05 mg/kg; Manuten&#231;&#227;o: 0,02 a 0,1 mg/kg/h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Pr&#233;-intuba&#231;&#227;o: </strong>0,1 a 0,2 mg/kg/dose IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Crise convulsiva:</strong>&#160;ataque: 0,15 a 0,2 mg/kg;&#160;manuten&#231;&#227;o: 1 a 2 mcg/kg/min.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1104,
        "indications": "<div>\r\n<p>- Indu&#231;&#227;o anest&#233;sica;</p>\r\n<p>- Seda&#231;&#227;o consciente para procedimento;</p>\r\n<p>- Seda&#231;&#227;o no pr&#233;-operat&#243;rio;</p>\r\n<p>- Seda&#231;&#227;o em CTI e adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Tratamento de curta dura&#231;&#227;o da ins&#244;nia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 111,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-05 00:23:58",
        "name": "Midadorm",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 15mg/3mL ou 50mg/10mL.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Azul (B1 - psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "midadorm",
        "substance": "Midazolam",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Apneia ou depress&#227;o respirat&#243;ria, broncoespasmo, laringoespasmo e tosse;</p>\r\n<p>- Depend&#234;ncia qu&#237;mica e psicossocial;</p>\r\n<p>- Hipotens&#227;o arterial, seda&#231;&#227;o prolongada, ataxia, amn&#233;sia, fadiga, cefaleia, fraqueza muscular, tontura, confus&#227;o mental, redu&#231;&#227;o da aten&#231;&#227;o, embotamento emocional, sonol&#234;ncia diurna.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4825,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o previa do sistema nervoso ou obstru&#231;&#227;o de vias a&#233;reas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Estado de choque;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Glaucoma de &#226;ngulo fechado;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o:</strong> (50 mg/10ml) 30 ml + 120 ml de SG 5% - concentra&#231;&#227;o: 1000 mcg/ml;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usal:</strong> 20 a 100 mcg/kg/h;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 1 mg/h (10 ml/h) com ajuste conforme necess&#225;rio;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o anest&#233;sica:</strong> 0,3 mg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ventila&#231;&#227;o mec&#226;nica:</strong>&#160;Ataque: 0,01 a 0,05 mg/kg; Manuten&#231;&#227;o: 0,02 a 0,1 mg/kg/h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Pr&#233;-intuba&#231;&#227;o: </strong>0,1 a 0,2 mg/kg/dose IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Crise convulsiva:</strong>&#160;ataque: 0,15 a 0,2 mg/kg;&#160;manuten&#231;&#227;o: 1 a 2 mcg/kg/min.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1105,
        "indications": "<div>\r\n<p>- Indu&#231;&#227;o anest&#233;sica;</p>\r\n<p>- Seda&#231;&#227;o consciente para procedimento;</p>\r\n<p>- Seda&#231;&#227;o no pr&#233;-operat&#243;rio;</p>\r\n<p>- Seda&#231;&#227;o em CTI e adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Tratamento de curta dura&#231;&#227;o da ins&#244;nia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-02-28 23:36:47",
        "name": "Dormire",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong>&#160;15mg;</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5mg/5mL, 5mg/3mL ou 50mg/10mL.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Azul (B1 - psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "dormire",
        "substance": "Midazolam",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Apneia ou depress&#227;o respirat&#243;ria, broncoespasmo, laringoespasmo e tosse;</p>\r\n<p>- Depend&#234;ncia qu&#237;mica e psicossocial;</p>\r\n<p>- Hipotens&#227;o arterial, seda&#231;&#227;o prolongada, ataxia, amn&#233;sia, fadiga, cefaleia, fraqueza muscular, tontura, confus&#227;o mental, redu&#231;&#227;o da aten&#231;&#227;o, embotamento emocional, sonol&#234;ncia diurna.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3091,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade ao componente;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres gr&#225;vidas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres que est&#227;o amamentando;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres que pretendem engravidar.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Doen&#231;a de Gaucher tipo 1:</strong> 100 mg 3x/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Doen&#231;a de Niemann-Pick C:</strong> 200 mg 3x/dia VO.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o &#233; recomendado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><strong>- Categoria X</strong>: Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1106,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Doen&#231;a de Gaucher tipo 1 leve a moderada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Manifesta&#231;&#245;es neurol&#243;gicas progressivas da doen&#231;a de Niemann-Pick C.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 14:52:02",
        "name": "Zavesca",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong>&#160;100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "zavesca",
        "substance": "Miglustate",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Perda de peso, diminui&#231;&#227;o do apetite, tremor, tontura, cefaleia, c&#226;imbra nas pernas, parestesia, neuropatia perif&#233;rica, dist&#250;rbios visuais, n&#225;usea, dor abdominal, flatul&#234;ncia, diarreia, v&#244;mito, dispepsia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4668,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de ataque:</strong> 50 mcg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 0,375 a 0,75 mcg/kg/min;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o:</strong> 1 ampola (20 mg/20 ml) + 80 ml de SG 5%.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose de ataque:</strong> 50 mcg/kg IV, 10 a 60 minutos;</li>\r\n</ul>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 0,25 a 0,75 mcg/kg/min IV.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1107,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia card&#237;aca descompensada;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- P&#243;s-operat&#243;rio de cirurgia card&#237;aca.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-06 18:37:55",
        "name": "Primacor",
        "presentation": "<ul>\r\n<li><strong>Frasco ampola:</strong> 10mg/10mL e 20 mg/20mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Uso restrito a hospitais.</p>",
        "record_status": 1,
        "slug": "primacor",
        "substance": "Milrinona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Arritmias, aumento da taxa de resposta ventricular nos pacientes com flutter ou fibrila&#231;&#227;o atrial n&#227;o controlada, hipotens&#227;o arterial, agravamento de valvulopatias obstrutivas a&#243;rtica ou pulmonar graves, ou estenose suba&#243;rtica hipertr&#243;fica.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>-</strong> <strong>ClCr &lt; 50mL/min:</strong> 0,43mcg/kg/min;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>- ClCr &lt; 40mL/min:</strong> 0,38mcg/kg/min;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>- ClCr &lt; 30mL/min:</strong> 0,33mcg/kg/min;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>- ClCr &lt; 20mL/min:</strong> 0,28mcg/kg/min;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>- ClCr &lt; 10mL/min:</strong> 0,23mcg/kg/min;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>- ClCr &lt; 5mL/min:</strong> 0,20mcg/kg/min.</p>\r\n</div>"
    },
    {
        "content_length": 8946,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>",
        "dosage_adults": "<div>\r\n<p>&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Monoterapia no tratamento de crises parciais, com ou sem generaliza&#231;&#227;o secund&#225;ria em pacientes a partir dos 16 anos com diagn&#243;stico recente de epilepsia:\r\n<ul>\r\n<li class=\"MsoNormal\">Dose inicial: 250mg VO duas vezes ao dia</li>\r\n<li class=\"MsoNormal\">Pode ser aumentada para uma dose de 500 mg duas vezes ao dia, ap&#243;s duas semanas</li>\r\n<li class=\"MsoNormal\">Pode-se ainda realizar incrementos de 250mg duas vezes ao dia, a cada duas semanas</li>\r\n<li class=\"MsoNormal\">A dose m&#225;xima &#233; de 1500 mg duas vezes ao dia</li>\r\n</ul>\r\n</li>\r\n<li>Terapia adjuvante para o tratamento de: crises parciais com ou sem generaliza&#231;&#227;o secund&#225;ria; crises miocl&#244;nicas; crises t&#244;nico-cl&#244;nicas prim&#225;rias generalizadas;\r\n<ul>\r\n<li>Dose inicial de 500mg VO duas vezes</li>\r\n<li>Pode ser aumentada at&#233; o m&#225;ximo de 1500mg VO duas vezes ao dia</li>\r\n<li>Pode-se realizar incrementos ou redu&#231;&#245;es de 500mg VO duas vezes ao dia, a cada duas a quatro semanas&#160;</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Terapia adjuvante em crian&#231;as entre 1 e 6 meses: dose inicial de 7 mg/kg, VO, 2x/dia</li>\r\n<li>Crian&#231;as &gt; 6 meses: dose inicial de 10 mg/kg, VO, 2x/dia</li>\r\n<li>OBS: Crian&#231;as com peso igual ou inferior a 25 kg devem, preferencialmente, iniciar o tratamento com solu&#231;&#227;o oral.</li>\r\n<li>OBS2: A posologia em crian&#231;as com 50 kg ou mais &#233; igual &#224; dos adultos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1108,
        "indications": "<ul>\r\n<li class=\"MsoNormal\">Monoterapia para o tratamento de crises parciais, com ou sem generaliza&#231;&#227;o secund&#225;ria em pacientes a partir dos 16 anos com diagn&#243;stico recente de epilepsia;</li>\r\n<li class=\"MsoNormal\">Terapia adjuvante no tratamento de:\r\n<ul>\r\n<li class=\"MsoNormal\">Crises convulsivas parciais com ou sem generaliza&#231;&#227;o secund&#225;ria em adultos, adolescentes e crian&#231;as com idade superior a 6 anos, com epilepsia</li>\r\n<li class=\"MsoNormal\">Crises convulsivas miocl&#244;nicas em adultos, adolescentes e crian&#231;as com idade superior a 12 anos, com epilepsia miocl&#244;nica juvenil</li>\r\n<li class=\"MsoNormal\">Crises convulsivas t&#244;nico-cl&#244;nicas prim&#225;rias generalizadas em adultos, adolescentes e crian&#231;as com mais de 6 anos de idade, com epilepsia idiop&#225;tica generalizada&#160;</li>\r\n</ul>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 93,
        "lactation_text": "<p class=\"MsoNormal\">N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 22:13:20",
        "name": "Keppra",
        "presentation": "<ul>\r\n<li>Solu&#231;&#227;o oral: 100 mg/ml</li>\r\n<li>Comprimido revestido: 250 mg e 750 mg</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">Receita de controle especial (C1 em duas vias)</p>",
        "record_status": 1,
        "slug": "keppra",
        "substance": "Levetiracetam",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Astenia, fadiga e dor de cabe&#231;a</p>\r\n<p class=\"MsoNormal\">- Sonol&#234;ncia</p>\r\n<p class=\"MsoNormal\">- Trombocitopenia, leucopenia, neutropenia, pancitopenia (com supress&#227;o da medula &#243;ssea identificada em alguns dos casos) e agranulocitose.</p>\r\n<p class=\"MsoNormal\">- Dor abdominal, diarreia, dispepsia, n&#225;usea, v&#244;mito, hepatite, insufici&#234;ncia hep&#225;tica e pancreatite.</p>\r\n<p class=\"MsoNormal\">- Amn&#233;sia, coordena&#231;&#227;o anormal/ataxia, crise, tontura, hipercinesia, tremor, desordem de equil&#237;brio, dist&#250;rbio de aten&#231;&#227;o, preju&#237;zo de mem&#243;ria, parestesia, coreoatetose, discinesia, letargia, dist&#250;rbio de marcha.</p>\r\n<p class=\"MsoNormal\">- Agressividade, agita&#231;&#227;o, depress&#227;o, instabilidade emocional/mudan&#231;a de humor, hostilidade, ins&#244;nia, irritabilidade, nervosismo, dist&#250;rbios de personalidade, pensamento anormal, comportamento anormal, raiva, ataque de p&#226;nico, ansiedade, estado de confus&#227;o, alucina&#231;&#227;o, dist&#250;rbios psic&#243;ticos, suic&#237;dio, tentativa de suic&#237;dio e idea&#231;&#227;o suicida.</p>\r\n<p class=\"MsoNormal\">- Anorexia ou aumento de peso</p>\r\n<p class=\"MsoNormal\">- Vertigem</p>\r\n<p class=\"MsoNormal\">- Diplopia, vis&#227;o borrada</p>\r\n<p class=\"MsoNormal\">- Mialgia,&#160; fraqueza muscular, rabdomi&#243;lise e aumento da enzima creatina-fosfoquinase no sangue.</p>\r\n<p class=\"MsoNormal\">- Nasofaringite, tosse</p>\r\n<p class=\"MsoNormal\">- Eczema, prurido, rash, necr&#243;lise t&#243;xica epid&#233;rmica, s&#237;ndrome de StevensJohnson, eritema multiforme, alopecia e angioedema.&#160;</p>\r\n<p class=\"MsoNormal\">&#160;- Rea&#231;&#227;o ao medicamento com eosinofilia e sintomas sist&#234;micos (DRESS), rea&#231;&#245;es anafil&#225;ticas</p>\r\n<p class=\"MsoNormal\">- Hiponatremia, dano renal agudo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- Adultos e adolescentes com peso &gt; 50 kg:</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr &gt; 80 ml/min: 500-1500 mg de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr 50-79 ml/min: 500-1000 mg de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr 30-49 ml/min: 250-750 mg de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr &lt; 30 ml/min: 250-500 mg de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- Hemodi&#225;lise: 500-1000 mg de 24/24h com dose suplementar de 250-500 mg ap&#243;s di&#225;lise</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as e adolescentes, a partir de 6 meses, com peso &lt; 50 kg:</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr &gt; 80 ml/min: 10 a 30 mg/kg (0,1 a 0,3 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr 50-79 ml/min: 10 a 20 mg/kg (0,1 a 0,2 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr 30-49 ml/min: 5 a 15 mg/kg (0,05 a 0,15 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr &lt; 30 ml/min: 5 a 10 mg/kg (0,05 a 0,1 ml/kg) mg de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- Hemodi&#225;lise: 10 a 20 mg/kg (0,1 a 0,2 ml/kg) de 24/24h, com dose suplementar de 5 a 10 mg/kg (0,05 a 0,1 ml/kg) ap&#243;s di&#225;lise</p>\r\n<p class=\"MsoNormal\">- Beb&#234;s a partir de 1 m&#234;s at&#233; 6 meses de idade:</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr &gt; 80 ml/min: 7 a 21 mg/kg (0,07 a 0,21 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr 50-79 ml/min: 7 a 14 mg/kg (0,07 a 0,14 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr 30-49 ml/min: 3,5 a 10,5 mg/kg (0,035 a 0,105 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- ClCr &lt; 30 ml/min: 3,5 a 7 mg/kg (0,035 a 0,07 ml/kg) de 12/12h</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- Hemodi&#225;lise: 7 a 14 mg/kg (0,07 a 0,14 ml/kg) de 24/24h com dose suplementar de 3,5 a 7 mg/kg ap&#243;s di&#225;lise</p>\r\n<p class=\"MsoNormal\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;- Pacientes com comprometimento hep&#225;tico grave: redu&#231;&#227;o de 50% da dose di&#225;ria de manuten&#231;&#227;o, quando a depura&#231;&#227;o de creatinina for &lt; 60 ml/min/1,73 m&#178;.</p>\r\n</div>"
    },
    {
        "content_length": 3679,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Doen&#231;a pulmonar obstrutiva cr&#244;nica grave</p>\r\n<p class=\"MsoNormal\">- Broncoespasmo, incluindo asma br&#244;nquica ou com hist&#243;ria de asma br&#244;nquica</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca congestiva n&#227;o controlada</p>\r\n<p class=\"MsoNormal\">- Bloqueio atrioventricular de segundo e terceiro grau n&#227;o controlado por marcapasso</p>\r\n<p class=\"MsoNormal\">- Bradicardia sinusal</p>\r\n<p class=\"MsoNormal\">- S&#237;ndrome do n&#243;dulo sinusal</p>\r\n<p class=\"MsoNormal\">- Choque cardiog&#234;nico</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Dose usual: 1 gota no(s) olho(s) afetado(s), 2 vezes ao dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1109,
        "indications": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Controle da press&#227;o intra-ocular em glaucoma cr&#244;nico de &#226;ngulo aberto e hipertens&#227;o ocular</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 6,
        "lactation_text": "<p class=\"MsoNormal\">N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 02:23:33",
        "name": "Betagan",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Solu&#231;&#227;o oft&#225;lmica: 5 mg/ml em frascos de 5ml e 10ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "betagan",
        "substance": "Levobunolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Irrita&#231;&#227;o ocular, dor ocular, hiperemia ocular,&#160;eritema palpebral, eczema palpebral</p>\r\n<p class=\"MsoNormal\">- Blefarite, conjuntivite,&#160;conjuntivite al&#233;rgica, diminui&#231;&#227;o do reflexo da c&#243;rnea, secre&#231;&#227;o nos olhos, edema ocular/palpebral, prurido ocular/palpebral, iridociclite, ceratite, aumento do lacrimejamento, ceratite, vis&#227;o borrada</p>\r\n<p class=\"MsoNormal\">- Edema facial, fadiga/astenia, confus&#227;o, tontura, cefaleia, ins&#244;nia, letargia, sonol&#234;ncia, depress&#227;o, bloqueio atrioventricular, bradicardia, palpita&#231;&#227;o, s&#237;ncope, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Fen&#244;meno de Raynaud, crise de asma, dispneia, desconforto nasal, irrita&#231;&#227;o da garganta, n&#225;useas, dermatite de contato, queratose liquen&#243;ide, prurido, rash e urtic&#225;ria</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 3685,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Doen&#231;a pulmonar obstrutiva cr&#244;nica grave</p>\r\n<p class=\"MsoNormal\">- Broncoespasmo, incluindo asma br&#244;nquica ou com hist&#243;ria de asma br&#244;nquica</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca congestiva n&#227;o controlada</p>\r\n<p class=\"MsoNormal\">- Bloqueio atrioventricular de segundo e terceiro grau n&#227;o controlado por marcapasso</p>\r\n<p class=\"MsoNormal\">- Bradicardia sinusal</p>\r\n<p class=\"MsoNormal\">- S&#237;ndrome do n&#243;dulo sinusal</p>\r\n<p class=\"MsoNormal\">- Choque cardiog&#234;nico</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Dose usual: 1 gota no(s) olho(s) afetado(s), 2 vezes ao dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1111,
        "indications": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Controle da press&#227;o intra-ocular em glaucoma cr&#244;nico de &#226;ngulo aberto e hipertens&#227;o ocular</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 109,
        "lactation_text": "<p class=\"MsoNormal\">N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 01:47:59",
        "name": "B-Tablok",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Solu&#231;&#227;o oft&#225;lmica: 5 mg/ml em frascos de 5ml e 10ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "betagan",
        "substance": "Levobunolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Irrita&#231;&#227;o ocular, dor ocular, hiperemia ocular,&#160;eritema palpebral, eczema palpebral</p>\r\n<p class=\"MsoNormal\">- Blefarite, conjuntivite,&#160;conjuntivite al&#233;rgica, diminui&#231;&#227;o do reflexo da c&#243;rnea, secre&#231;&#227;o nos olhos, edema ocular/palpebral, prurido ocular/palpebral, iridociclite, ceratite, aumento do lacrimejamento, ceratite, vis&#227;o borrada</p>\r\n<p class=\"MsoNormal\">- Edema facial, fadiga/astenia, confus&#227;o, tontura, cefaleia, ins&#244;nia, letargia, sonol&#234;ncia, depress&#227;o, bloqueio atrioventricular, bradicardia, palpita&#231;&#227;o, s&#237;ncope, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Fen&#244;meno de Raynaud, crise de asma, dispneia, desconforto nasal, irrita&#231;&#227;o da garganta, n&#225;useas, dermatite de contato, queratose liquen&#243;ide, prurido, rash e urtic&#225;ria</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 3418,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal grave com cleareance de creatinina inferior a 10 ml/min</p>\r\n<p class=\"MsoNormal\">- Di&#225;lise</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\">Dose recomendada: 5 mg, VO, 1x/dia</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>Dura&#231;&#227;o do tratamento:\r\n<ul>\r\n<li>Rinite al&#233;rgica sazonal aguda ou&#160;febre do feno: de 3 a 6 semanas</li>\r\n<li>Exposi&#231;&#245;es ao p&#243;len durante certos per&#237;odos de tempo: 5-7 dias</li>\r\n<li>Para urtic&#225;ria cr&#244;nica e rinite al&#233;rgica cr&#244;nica: at&#233; um ano</li>\r\n<li>Prurido associado com dermatite at&#243;pica: at&#233; 18 meses</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Crian&#231;as a partir de 12 anos (comprimido ou solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n<li>Crian&#231;as de 6 a 12 anos (solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1114,
        "indications": "<ul>\r\n<li>Rinite al&#233;rgica sazonal (incluindo os sintomas oculares)</li>\r\n<li>Rinite al&#233;rgica perene</li>\r\n<li>Urtic&#225;ria cr&#244;nica idiop&#225;tica</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 22:37:44",
        "name": "Levocetirizina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Comprimido revestido: 5 mg em caixa com 10 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dicloridrato-de-levocetirizina",
        "substance": "Levocetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Xerostomia, cefaleia, fadiga&#160;e sonol&#234;ncia</p>\r\n<p>- Astenia</p>\r\n<p>- Dor abdominal</p>\r\n<p>- Palpita&#231;&#227;o, taquicardia e dispneia</p>\r\n<p>- Altera&#231;&#245;es visuais, vis&#227;o emba&#231;ada e vertigem</p>\r\n<p>- Hepatite, n&#225;usea, v&#244;mitos, edema</p>\r\n<p>- Prurido,&#160;<em style=\"box-sizing: border-box; -webkit-font-smoothing: antialiased;\">rash</em>, urtic&#225;ria, erup&#231;&#245;es na pele</p>\r\n<p>- Agita&#231;&#227;o, depress&#227;o, agress&#227;o, alucina&#231;&#227;o, ins&#244;nia, idea&#231;&#227;o suicida, pesadelos, convuls&#245;es, parestesia, tontura, s&#237;ncope, tremor, disgeusia</p>\r\n<p>- Mialgia, artralgia</p>\r\n<p>- Dis&#250;ria e reten&#231;&#227;o urin&#225;ria</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- ClCr 30-49 ml/min: 5 mg, uma vez a cada 2 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 30 ml/min: 5 mg, uma vez a cada 3 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 10 ml/min (di&#225;lise): contraindicado</p>\r\n</div>"
    },
    {
        "content_length": 4489,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Crian&#231;as menores de 8 anos;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consular o m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>50-100mg VO 12/12h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Somente indicado para maiores de 8 anos;</li>\r\n<li>50-100mg VO 12/12h.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1115,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Acne vulgar;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Celulite purulenta;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o gnococcica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o endocervical, ureteral e retal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Linfadenite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infec&#231;&#227;o em ferida pro Vibrio sp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- S&#237;filis;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Endocardite infecciosa.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:26:51",
        "name": "Minociclina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;100mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em duas vias.</span></p>",
        "record_status": 1,
        "slug": "minociclina",
        "substance": "Minociclina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Descolora&#231;&#227;o dentaria, anorexia, n&#225;useas, v&#244;mitos, diarreia, pirose e glossite, disfagia, pancreatite, entrecolite e proctite, hepatite, fotosensibilidade, erup&#231;&#227;o cut&#226;nea, urticaria e s&#237;ndrome Steven Johnson, hem&#243;lise, neutropenia e eosinofilia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr 50&#8211;90mL/min: 50-100mg 12/12 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- CICr &lt; 50mL/min: 50-100mg 24/24 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Hemodi&#225;lise: sem necessidade de dose adicional.</p>\r\n</div>"
    },
    {
        "content_length": 3419,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal grave com cleareance de creatinina inferior a 10 ml/min</p>\r\n<p class=\"MsoNormal\">- Di&#225;lise</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\">Dose recomendada: 5 mg, VO, 1x/dia</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>Dura&#231;&#227;o do tratamento:\r\n<ul>\r\n<li>Rinite al&#233;rgica sazonal aguda ou&#160;febre do feno: de 3 a 6 semanas</li>\r\n<li>Exposi&#231;&#245;es ao p&#243;len durante certos per&#237;odos de tempo: 5-7 dias</li>\r\n<li>Para urtic&#225;ria cr&#244;nica e rinite al&#233;rgica cr&#244;nica: at&#233; um ano</li>\r\n<li>Prurido associado com dermatite at&#243;pica: at&#233; 18 meses</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Crian&#231;as a partir de 12 anos (comprimido ou solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n<li>Crian&#231;as de 6 a 12 anos (solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1116,
        "indications": "<ul>\r\n<li>Rinite al&#233;rgica sazonal (incluindo os sintomas oculares)</li>\r\n<li>Rinite al&#233;rgica perene</li>\r\n<li>Urtic&#225;ria cr&#244;nica idiop&#225;tica</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 92,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 14:37:25",
        "name": "Vocety",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Comprimido revestido: 5 mg em caixa com 10, 30 e 90 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dicloridrato-de-levocetirizina",
        "substance": "Levocetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Xerostomia, cefaleia, fadiga&#160;e sonol&#234;ncia</p>\r\n<p>- Astenia</p>\r\n<p>- Dor abdominal</p>\r\n<p>- Palpita&#231;&#227;o, taquicardia e dispneia</p>\r\n<p>- Altera&#231;&#245;es visuais, vis&#227;o emba&#231;ada e vertigem</p>\r\n<p>- Hepatite, n&#225;usea, v&#244;mitos, edema</p>\r\n<p>- Prurido,&#160;<em style=\"box-sizing: border-box; -webkit-font-smoothing: antialiased;\">rash</em>, urtic&#225;ria, erup&#231;&#245;es na pele</p>\r\n<p>- Agita&#231;&#227;o, depress&#227;o, agress&#227;o, alucina&#231;&#227;o, ins&#244;nia, idea&#231;&#227;o suicida, pesadelos, convuls&#245;es, parestesia, tontura, s&#237;ncope, tremor, disgeusia</p>\r\n<p>- Mialgia, artralgia</p>\r\n<p>- Dis&#250;ria e reten&#231;&#227;o urin&#225;ria</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- ClCr 30-49 ml/min: 5 mg, uma vez a cada 2 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 30 ml/min: 5 mg, uma vez a cada 3 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 10 ml/min (di&#225;lise): contraindicado</p>\r\n</div>"
    },
    {
        "content_length": 3409,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal grave com cleareance de creatinina inferior a 10 ml/min</p>\r\n<p class=\"MsoNormal\">- Di&#225;lise</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\">Dose recomendada: 5 mg, VO, 1x/dia</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>Dura&#231;&#227;o do tratamento:\r\n<ul>\r\n<li>Rinite al&#233;rgica sazonal aguda ou&#160;febre do feno: de 3 a 6 semanas</li>\r\n<li>Exposi&#231;&#245;es ao p&#243;len durante certos per&#237;odos de tempo: 5-7 dias</li>\r\n<li>Para urtic&#225;ria cr&#244;nica e rinite al&#233;rgica cr&#244;nica: at&#233; um ano</li>\r\n<li>Prurido associado com dermatite at&#243;pica: at&#233; 18 meses</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Crian&#231;as a partir de 12 anos (comprimido ou solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n<li>Crian&#231;as de 6 a 12 anos (solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1117,
        "indications": "<ul>\r\n<li>Rinite al&#233;rgica sazonal (incluindo os sintomas oculares)</li>\r\n<li>Rinite al&#233;rgica perene</li>\r\n<li>Urtic&#225;ria cr&#244;nica idiop&#225;tica</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 15:00:04",
        "name": "Zina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Comprimido revestido: 5 mg em caixa com 10 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dicloridrato-de-levocetirizina",
        "substance": "Levocetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Xerostomia, cefaleia, fadiga&#160;e sonol&#234;ncia</p>\r\n<p>- Astenia</p>\r\n<p>- Dor abdominal</p>\r\n<p>- Palpita&#231;&#227;o, taquicardia e dispneia</p>\r\n<p>- Altera&#231;&#245;es visuais, vis&#227;o emba&#231;ada e vertigem</p>\r\n<p>- Hepatite, n&#225;usea, v&#244;mitos, edema</p>\r\n<p>- Prurido,&#160;<em style=\"box-sizing: border-box; -webkit-font-smoothing: antialiased;\">rash</em>, urtic&#225;ria, erup&#231;&#245;es na pele</p>\r\n<p>- Agita&#231;&#227;o, depress&#227;o, agress&#227;o, alucina&#231;&#227;o, ins&#244;nia, idea&#231;&#227;o suicida, pesadelos, convuls&#245;es, parestesia, tontura, s&#237;ncope, tremor, disgeusia</p>\r\n<p>- Mialgia, artralgia</p>\r\n<p>- Dis&#250;ria e reten&#231;&#227;o urin&#225;ria</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- ClCr 30-49 ml/min: 5 mg, uma vez a cada 2 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 30 ml/min: 5 mg, uma vez a cada 3 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 10 ml/min (di&#225;lise): contraindicado</p>\r\n</div>"
    },
    {
        "content_length": 3540,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal grave com cleareance de creatinina inferior a 10 ml/min</p>\r\n<p class=\"MsoNormal\">- Di&#225;lise</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\">Dose recomendada: 5 mg, VO, 1x/dia</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>Dura&#231;&#227;o do tratamento:\r\n<ul>\r\n<li>Rinite al&#233;rgica sazonal aguda ou&#160;febre do feno: de 3 a 6 semanas</li>\r\n<li>Exposi&#231;&#245;es ao p&#243;len durante certos per&#237;odos de tempo: 5-7 dias</li>\r\n<li>Para urtic&#225;ria cr&#244;nica e rinite al&#233;rgica cr&#244;nica: at&#233; um ano</li>\r\n<li>Prurido associado com dermatite at&#243;pica: at&#233; 18 meses</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Crian&#231;as a partir de 12 anos (comprimido ou solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n<li>Crian&#231;as de 6 a 12 anos (solu&#231;&#227;o oral): 5 mg, VO, 1x/dia</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1118,
        "indications": "<ul>\r\n<li>Rinite al&#233;rgica sazonal (incluindo os sintomas oculares)</li>\r\n<li>Rinite al&#233;rgica perene</li>\r\n<li>Urtic&#225;ria cr&#244;nica idiop&#225;tica</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 130,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 15:13:02",
        "name": "Zyxem",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Comprimido revestido: 5 mg em caixa com 4, 7, 10, 14 e 21 comprimidos</li>\r\n<li><span style=\"color: #000000;\">Solu&#231;&#227;o oral com 5mg/ml em frasco de 10ml, 15ml e 20ml</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dicloridrato-de-levocetirizina",
        "substance": "Levocetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Xerostomia, cefaleia, fadiga&#160;e sonol&#234;ncia</p>\r\n<p>- Astenia</p>\r\n<p>- Dor abdominal</p>\r\n<p>- Palpita&#231;&#227;o, taquicardia e dispneia</p>\r\n<p>- Altera&#231;&#245;es visuais, vis&#227;o emba&#231;ada e vertigem</p>\r\n<p>- Hepatite, n&#225;usea, v&#244;mitos, edema</p>\r\n<p>- Prurido,&#160;<em style=\"box-sizing: border-box; -webkit-font-smoothing: antialiased;\">rash</em>, urtic&#225;ria, erup&#231;&#245;es na pele</p>\r\n<p>- Agita&#231;&#227;o, depress&#227;o, agress&#227;o, alucina&#231;&#227;o, ins&#244;nia, idea&#231;&#227;o suicida, pesadelos, convuls&#245;es, parestesia, tontura, s&#237;ncope, tremor, disgeusia</p>\r\n<p>- Mialgia, artralgia</p>\r\n<p>- Dis&#250;ria e reten&#231;&#227;o urin&#225;ria</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- ClCr 30-49 ml/min: 5 mg, uma vez a cada 2 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 30 ml/min: 5 mg, uma vez a cada 3 dias</p>\r\n<p class=\"MsoNormal\">- ClCr &lt; 10 ml/min (di&#225;lise): contraindicado</p>\r\n</div>"
    },
    {
        "content_length": 2778,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Feocromocitoma.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>5-100mg VO 1x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>0,2-1mg/kg VO 1x/dia;</li>\r\n<li>N&#227;o exceder 50mg/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1119,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Hipertens&#227;o arterial n&#227;o responsiva as doses toleradas de diur&#233;tico mais dois outros agentes anti-hipertensivos.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-04 01:01:49",
        "name": "Loniten",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "loniten",
        "substance": "Minoxidil",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Taquicardia, pericardite, derrame peric&#225;rdico, tamponamento card&#237;aco, hipertricose, altera&#231;&#245;es da cor do cabelo, ECG anormal, reten&#231;&#227;o de liquido e edema, dist&#250;rbios gastrointestinais.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal/Hep&#225;tica:&#160;</strong>ajustar a dose at&#233; a menor dose eficaz para obten&#231;&#227;o do efeito terap&#234;utico.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2023,
        "contraindications": "<div>\r\n<p>- Hipernsensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Contraindicado em mulheres e crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 1mL no couro cabeludo 2x/dia, sobre a &#225;rea acometida por calv&#237;cie.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Uso n&#227;o recomendado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1120,
        "indications": "<p>- Tratamento da alop&#233;cia androgen&#233;tica em homens adultos.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 137,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-03 23:43:58",
        "name": "Aloxidil",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o capilar:&#160;</strong>5% (50mg/mL).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio Simples.</p>",
        "record_status": 1,
        "slug": "aloxidil",
        "substance": "Minoxidil",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Palpita&#231;&#245;es, dor tor&#225;cica, dbilidade, vertigem, aumento de peso, edema de membros inferiores, sudorese em m&#227;os e p&#233;s;</p>\r\n<p>- Hipertricose, rea&#231;&#227;o al&#233;rgica local, coceira, descama&#231;&#227;o de pele de couro cabeludo;</p>\r\n<p>- Exacerba&#231;&#227;o da perda de pelos.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2017,
        "contraindications": "<div>\r\n<p>- Hipernsensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Contraindicado em mulheres e crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 1mL no couro cabeludo 2x/dia, sobre a &#225;rea acometida por calv&#237;cie.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Uso n&#227;o recomendado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1121,
        "indications": "<p>- Tratamento da alop&#233;cia androgen&#233;tica em homens adultos.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-06 17:00:44",
        "name": "Pant",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o capilar:&#160;</strong>5% (50mg/mL).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio Simples.</p>",
        "record_status": 1,
        "slug": "aloxidil",
        "substance": "Minoxidil",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Palpita&#231;&#245;es, dor tor&#225;cica, dbilidade, vertigem, aumento de peso, edema de membros inferiores, sudorese em m&#227;os e p&#233;s;</p>\r\n<p>- Hipertricose, rea&#231;&#227;o al&#233;rgica local, coceira, descama&#231;&#227;o de pele de couro cabeludo;</p>\r\n<p>- Exacerba&#231;&#227;o da perda de pelos.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2045,
        "contraindications": "<div>\r\n<p>- Hipernsensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Contraindicado em mulheres e crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 1mL no couro cabeludo 2x/dia, sobre a &#225;rea acometida por calv&#237;cie.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Uso n&#227;o recomendado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1122,
        "indications": "<p>- Tratamento da alop&#233;cia androgen&#233;tica em homens adultos.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 82,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-08 19:23:45",
        "name": "Regaine",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o capilar:&#160;</strong>2% (20mg/mL) ou 5% (50mg/mL).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio Simples.</p>",
        "record_status": 1,
        "slug": "aloxidil",
        "substance": "Minoxidil",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Palpita&#231;&#245;es, dor tor&#225;cica, dbilidade, vertigem, aumento de peso, edema de membros inferiores, sudorese em m&#227;os e p&#233;s;</p>\r\n<p>- Hipertricose, rea&#231;&#227;o al&#233;rgica local, coceira, descama&#231;&#227;o de pele de couro cabeludo;</p>\r\n<p>- Exacerba&#231;&#227;o da perda de pelos.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2985,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>15-45mg VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1123,
        "indications": "<div>\r\n<p>- S&#237;ndromes depressivas (depress&#227;o associada a ansiedade, melancolia, depress&#227;o reativa);</p>\r\n<p>- Transtorno bipolar;</p>\r\n<p>- Tabagismo (depend&#234;ncia).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 65,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-09 02:32:37",
        "name": "Remeron Soltab",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;15mg, 30mg e 45mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- Receita de controle especial (C1 - branca em 2 vias).</p>",
        "record_status": 1,
        "slug": "remeron-soltab",
        "substance": "Mirtazapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Sonol&#234;ncia, seda&#231;&#227;o e hipotens&#227;o ortost&#225;tica, ganho ponderal e hiperfagia, depress&#227;o medular, neutropenia, convuls&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Reduzir a a dose em pacientes com ClCr &lt; 40mL/min e/ou com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3002,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>15-45mg VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1124,
        "indications": "<div>\r\n<p>- S&#237;ndromes depressivas (depress&#227;o associada a ansiedade, melancolia, depress&#227;o reativa);</p>\r\n<p>- Transtorno bipolar;</p>\r\n<p>- Tabagismo (depend&#234;ncia).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 116,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:29:34",
        "name": "Menelat",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;30mg e 45mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita de controle especial (C1 - branca em 2 vias).</span></p>",
        "record_status": 1,
        "slug": "remeron-soltab",
        "substance": "Mirtazapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Sonol&#234;ncia, seda&#231;&#227;o e hipotens&#227;o ortost&#225;tica, ganho ponderal e hiperfagia, depress&#227;o medular, neutropenia, convuls&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Reduzir a a dose em pacientes com ClCr &lt; 40mL/min e/ou com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2958,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>15-45mg VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1125,
        "indications": "<div>\r\n<p>- S&#237;ndromes depressivas (depress&#227;o associada a ansiedade, melancolia, depress&#227;o reativa);</p>\r\n<p>- Transtorno bipolar;</p>\r\n<p>- Tabagismo (depend&#234;ncia).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 34,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-08 19:14:36",
        "name": "Razapina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;30mg e 45mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- Receita de controle especial (C1 - branca em 2 vias).</p>",
        "record_status": 1,
        "slug": "razapina",
        "substance": "Mirtazapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Sonol&#234;ncia, seda&#231;&#227;o e hipotens&#227;o ortost&#225;tica, ganho ponderal e hiperfagia, depress&#227;o medular, neutropenia, convuls&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Reduzir a a dose em pacientes com ClCr &lt; 40mL/min e/ou com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2983,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>15-45mg VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1126,
        "indications": "<div>\r\n<p>- S&#237;ndromes depressivas (depress&#227;o associada a ansiedade, melancolia, depress&#227;o reativa);</p>\r\n<p>- Transtorno bipolar;</p>\r\n<p>- Tabagismo (depend&#234;ncia).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 34,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-08 19:14:50",
        "name": "Razapina ODT",
        "presentation": "<ul>\r\n<li><strong>Comprimidos orodispers&#237;veis:</strong>&#160;30mg e 45mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- Receita de controle especial (C1 - branca em 2 vias).</p>",
        "record_status": 1,
        "slug": "razapina",
        "substance": "Mirtazapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Sonol&#234;ncia, seda&#231;&#227;o e hipotens&#227;o ortost&#225;tica, ganho ponderal e hiperfagia, depress&#227;o medular, neutropenia, convuls&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Reduzir a a dose em pacientes com ClCr &lt; 40mL/min e/ou com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2986,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>15-45mg VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1127,
        "indications": "<div>\r\n<p>- S&#237;ndromes depressivas (depress&#227;o associada a ansiedade, melancolia, depress&#227;o reativa);</p>\r\n<p>- Transtorno bipolar;</p>\r\n<p>- Tabagismo (depend&#234;ncia).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:31:39",
        "name": "Mirtazapina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos orodispers&#237;veis:</strong>&#160;15mg, 30mg e 45mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- Receita de controle especial (C1 - branca em 2 vias).</p>",
        "record_status": 1,
        "slug": "mirtazapina",
        "substance": "Mirtazapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Sonol&#234;ncia, seda&#231;&#227;o e hipotens&#227;o ortost&#225;tica, ganho ponderal e hiperfagia, depress&#227;o medular, neutropenia, convuls&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Reduzir a a dose em pacientes com ClCr &lt; 40mL/min e/ou com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 4069,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cicatriz uterina;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Ces&#225;rea anterior;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Doen&#231;a vascular cerebral;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Doen&#231;a coronariana.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o do parto a termo ou pr&#243;ximo a termo:</strong> 25 mcg, intravaginal, 6/6 horas;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Interrup&#231;&#227;o da gesta&#231;&#227;o em torno de 30 semanas:</strong> 50 mcg, intravaginal, dose &#250;nica;</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Indu&#231;&#227;o do parto com feto morto antes de 30 semanas:</strong> 50 mcg, intravaginal, 1x; se n&#227;o houver resposta ap&#243;s 6 horas, administrar 100 mcg.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1131,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Interrup&#231;&#227;o da gravidez em gesta&#231;&#245;es a termo ou pr&#243;ximas ao termo;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Indu&#231;&#227;o de parto com feto morto antes das 30 semanas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de aborto legal.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 18:49:29",
        "name": "Prostokos",
        "presentation": "<ul>\r\n<li><strong>Comprimidos vaginais:</strong>&#160;25mg, 100mg e 200mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita de controle especial - uso hospitalar.</span></p>",
        "record_status": 1,
        "slug": "prostokos",
        "substance": "Misoprostol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Diarreia e dor abdominal, arritmias, ruptura uterina, perda auditiva, doen&#231;a tromboemb&#243;lica</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4021,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Associado a inibidores da monoaminoxidase n&#227;o seletivos (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crinas, nos rins, no f&#237;gado e no cora&#231;&#227;o, assim como pacientes com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de doen&#231;as psiqui&#225;tricas graves com componente psic&#243;tico</p>\r\n<p class=\"MsoNormal\">- Menores de 25 anos</p>\r\n<p>-&#160;A interrup&#231;&#227;o abrupta pode produzir quadro semelhante &#224; s&#237;ndrome neurol&#233;ptica maligna, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e dist&#250;rbios ps&#237;quicos (como delirium), com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Dose inicial: &#188; do comprimido, VO, 3-4x/dia, aumentando lentamente</li>\r\n<li>A dose deve ser estabelecida individualmente e aumentada gradativamente at&#233; otimiza&#231;&#227;o do efeito.</li>\r\n<li>Otimiza&#231;&#227;o do efeito: 300-800 mg de levodopa + 75-200 mg de benserazida, VO, dividida em 3 ou mais administra&#231;&#245;es</li>\r\n<li>Dose de manuten&#231;&#227;o: &#189;&#160;comprimido de Levodopa + cloridrato de benserazida, tr&#234;s a seis vezes ao dia, ou seja, de 300mg a 600mg de levodopa ao dia.</li>\r\n<li>O n&#250;mero ideal de administra&#231;&#245;es (n&#227;o inferior a tr&#234;s) e sua distribui&#231;&#227;o ao longo do dia devem ser titulados para um efeito ideal.</li>\r\n<li>Pacientes com grandes flutua&#231;&#245;es no efeito do medicamento ao longo do dia (fen&#244;meno on-off) devem receber doses individuais menores e mais frequentes.</li>\r\n<li>Deve ser administrado 30 minutos antes ou 1 horas ap&#243;s as refei&#231;&#245;es</li>\r\n</ul>",
        "dosage_children": "<p class=\"MsoNormal\">Este medicamento n&#227;o &#233; indicado para crian&#231;as.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1141,
        "indications": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Doen&#231;a de Parkinson</p>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 00:44:59",
        "name": "Levodopa + Cloridrato de benserazida",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"display: inline !important;\"><span style=\"color: #000000;\">Levodopa 200mg + cloridrato de benserazida 50mg, frasco com 30 comprimidos.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-cloridrato-de-benserazida",
        "substance": "Levodopa + Cloridrato de benserazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito e diarreia</p>\r\n<p class=\"MsoNormal\">- Aumento tempor&#225;rio de transaminases e fosfatase alcalina</p>\r\n<p class=\"MsoNormal\">- Movimentos involunt&#225;rios, epis&#243;dios psic&#243;ticos, angina pectoris, constipa&#231;&#227;o, perda de peso e falta de ar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 3992,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Associado a inibidores da monoaminoxidase n&#227;o seletivos (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crinas, nos rins, no f&#237;gado e no cora&#231;&#227;o, assim como pacientes com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de doen&#231;as psiqui&#225;tricas graves com componente psic&#243;tico</p>\r\n<p class=\"MsoNormal\">- Menores de 25 anos</p>\r\n<p>-&#160;A interrup&#231;&#227;o abrupta pode produzir quadro semelhante &#224; s&#237;ndrome neurol&#233;ptica maligna, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e dist&#250;rbios ps&#237;quicos (como delirium), com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Dose inicial: &#188; do comprimido, VO, 3-4x/dia, aumentando lentamente</li>\r\n<li>A dose deve ser estabelecida individualmente e aumentada gradativamente at&#233; otimiza&#231;&#227;o do efeito.</li>\r\n<li>Otimiza&#231;&#227;o do efeito: 300-800 mg de levodopa + 75-200 mg de benserazida, VO, dividida em 3 ou mais administra&#231;&#245;es</li>\r\n<li>Dose de manuten&#231;&#227;o: &#189;&#160;comprimido de Levodopa + cloridrato de benserazida, tr&#234;s a seis vezes ao dia, ou seja, de 300mg a 600mg de levodopa ao dia.</li>\r\n<li>O n&#250;mero ideal de administra&#231;&#245;es (n&#227;o inferior a tr&#234;s) e sua distribui&#231;&#227;o ao longo do dia devem ser titulados para um efeito ideal.</li>\r\n<li>Pacientes com grandes flutua&#231;&#245;es no efeito do medicamento ao longo do dia (fen&#244;meno on-off) devem receber doses individuais menores e mais frequentes.</li>\r\n<li>Deve ser administrado 30 minutos antes ou 1 horas ap&#243;s as refei&#231;&#245;es</li>\r\n</ul>",
        "dosage_children": "<p class=\"MsoNormal\">Este medicamento n&#227;o &#233; indicado para crian&#231;as.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1142,
        "indications": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Doen&#231;a de Parkinson</p>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 18:43:44",
        "name": "Prolopa HBS",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"display: inline !important;\"><span style=\"color: #000000;\">Levodopa 100mg+ cloridrato de benserazida 25mg, frasco com 30 comprimidos.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-cloridrato-de-benserazida",
        "substance": "Levodopa + Cloridrato de benserazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito e diarreia</p>\r\n<p class=\"MsoNormal\">- Aumento tempor&#225;rio de transaminases e fosfatase alcalina</p>\r\n<p class=\"MsoNormal\">- Movimentos involunt&#225;rios, epis&#243;dios psic&#243;ticos, angina pectoris, constipa&#231;&#227;o, perda de peso e falta de ar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 5045,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Pacientes com hipersensibilidade &#224; amissulprida ou a qualquer outro componente da f&#243;rmula;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Associa&#231;&#227;o com os seguintes medicamentos que podem induzir torsades de pointes: antiarr&#237;tmicos classe Ia (quinidina, disopiramida), antiarr&#237;tmicos classe III (amiodarona, sotalol), outros medicamentos tais como bepridil, cisaprida, sultoprida, tioridazina, metadona, eritromicina IV, vincamina IV, halofantrina, pentamidina e esparfloxacino.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Associa&#231;&#227;o com levodopa.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Este medicamento &#233; contraindicado em pacientes com tumores dependentes da prolactina, como prolactinoma da hip&#243;fise e c&#226;ncer de mama.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Este medicamento &#233; contraindicado em pacientes com feocromocitoma;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Este medicamento &#233; contraindicado na popula&#231;&#227;o pedi&#225;trica at&#233; a puberdade.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Este medicamento &#233; contraindicado durante a gravidez e a lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimido 50 mg:</strong> 1x/dia, no caf&#233; da manh&#227;. Utilizado no tratamento de estados deficit&#225;rios e de inibi&#231;&#227;o.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimido 200mg:</strong> 600 a 1200mg/dia. Utilizado no tratamento de estados produtivos.</li>\r\n</ul>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1143,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- S&#237;ndromes psic&#243;ticas progressivas</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Estados deficit&#225;rios, incluindo distimia.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Estado produtivo (alucina&#231;&#227;o e delirium)</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 16:54:32",
        "name": "Socian",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimido:</strong> 50mg e 200mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>- Receitu&#225;rio de controle especial (C1 branca em duas vias)</p>",
        "record_status": 1,
        "slug": "socian",
        "substance": "Amissulprida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- podem ocorrer sintomas extrapiramidais, tais como: tremores, rigidez, hipocinesia, hipersaliva&#231;&#227;o, acatisia, discinesia, sonol&#234;ncia; pode ocorrer distonia aguda (torcicolo espasm&#243;dico, crises &#243;culo-girat&#243;rias, trismo).</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- ins&#244;nia, ansiedade, agita&#231;&#227;o, disfun&#231;&#227;o org&#225;stica.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- constipa&#231;&#227;o, n&#225;usea, v&#244;mito, boca seca.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- causa um aumento nos n&#237;veis plasm&#225;ticos de prolactina.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Prolongamento do intervalo QT</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- hipotens&#227;o.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- ganho de peso.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- vis&#227;o emba&#231;ada</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Como este medicamento &#233; eliminado pela via renal, a dose deve ser reduzida &#224; metade em pacientes com depura&#231;&#227;o da creatinina entre 30-60 mL/min, e para um ter&#231;o em pacientes &#160;entre 10-30 mL/min. N&#227;o h&#225; dados em pacientes com insufici&#234;ncia renal severa.</p>\r\n</div>"
    },
    {
        "content_length": 3997,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Associado a inibidores da monoaminoxidase n&#227;o seletivos (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crinas, nos rins, no f&#237;gado e no cora&#231;&#227;o, assim como pacientes com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de doen&#231;as psiqui&#225;tricas graves com componente psic&#243;tico</p>\r\n<p class=\"MsoNormal\">- Menores de 25 anos</p>\r\n<p>-&#160;A interrup&#231;&#227;o abrupta pode produzir quadro semelhante &#224; s&#237;ndrome neurol&#233;ptica maligna, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e dist&#250;rbios ps&#237;quicos (como delirium), com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Dose inicial: &#188; do comprimido, VO, 3-4x/dia, aumentando lentamente</li>\r\n<li>A dose deve ser estabelecida individualmente e aumentada gradativamente at&#233; otimiza&#231;&#227;o do efeito.</li>\r\n<li>Otimiza&#231;&#227;o do efeito: 300-800 mg de levodopa + 75-200 mg de benserazida, VO, dividida em 3 ou mais administra&#231;&#245;es</li>\r\n<li>Dose de manuten&#231;&#227;o: &#189;&#160;comprimido de Levodopa + cloridrato de benserazida, tr&#234;s a seis vezes ao dia, ou seja, de 300mg a 600mg de levodopa ao dia.</li>\r\n<li>O n&#250;mero ideal de administra&#231;&#245;es (n&#227;o inferior a tr&#234;s) e sua distribui&#231;&#227;o ao longo do dia devem ser titulados para um efeito ideal.</li>\r\n<li>Pacientes com grandes flutua&#231;&#245;es no efeito do medicamento ao longo do dia (fen&#244;meno on-off) devem receber doses individuais menores e mais frequentes.</li>\r\n<li>Deve ser administrado 30 minutos antes ou 1 horas ap&#243;s as refei&#231;&#245;es</li>\r\n</ul>",
        "dosage_children": "<p class=\"MsoNormal\">Este medicamento n&#227;o &#233; indicado para crian&#231;as.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1144,
        "indications": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Doen&#231;a de Parkinson</p>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 18:43:36",
        "name": "Prolopa DR",
        "presentation": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"display: inline !important;\"><span style=\"color: #000000;\">Comprimido de libera&#231;&#227;o modificada: 250 mg, frasco com 30 comprimidos.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-cloridrato-de-benserazida",
        "substance": "Levodopa + Cloridrato de benserazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito e diarreia</p>\r\n<p class=\"MsoNormal\">- Aumento tempor&#225;rio de transaminases e fosfatase alcalina</p>\r\n<p class=\"MsoNormal\">- Movimentos involunt&#225;rios, epis&#243;dios psic&#243;ticos, angina pectoris, constipa&#231;&#227;o, perda de peso e falta de ar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 4142,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Associado a inibidores da monoaminoxidase n&#227;o seletivos (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crinas, nos rins, no f&#237;gado e no cora&#231;&#227;o, assim como pacientes com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de doen&#231;as psiqui&#225;tricas graves com componente psic&#243;tico</p>\r\n<p class=\"MsoNormal\">- Menores de 25 anos</p>\r\n<p>-&#160;A interrup&#231;&#227;o abrupta pode produzir quadro semelhante &#224; s&#237;ndrome neurol&#233;ptica maligna, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e dist&#250;rbios ps&#237;quicos (como delirium), com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Dose inicial: &#188; do comprimido, VO, 3-4x/dia, aumentando lentamente</li>\r\n<li>A dose deve ser estabelecida individualmente e aumentada gradativamente at&#233; otimiza&#231;&#227;o do efeito.</li>\r\n<li>Otimiza&#231;&#227;o do efeito: 300-800 mg de levodopa + 75-200 mg de benserazida, VO, dividida em 3 ou mais administra&#231;&#245;es</li>\r\n<li>Dose de manuten&#231;&#227;o: &#189;&#160;comprimido de Levodopa + cloridrato de benserazida, tr&#234;s a seis vezes ao dia, ou seja, de 300mg a 600mg de levodopa ao dia.</li>\r\n<li>O n&#250;mero ideal de administra&#231;&#245;es (n&#227;o inferior a tr&#234;s) e sua distribui&#231;&#227;o ao longo do dia devem ser titulados para um efeito ideal.</li>\r\n<li>Pacientes com grandes flutua&#231;&#245;es no efeito do medicamento ao longo do dia (fen&#244;meno on-off) devem receber doses individuais menores e mais frequentes.</li>\r\n<li>Deve ser administrado 30 minutos antes ou 1 horas ap&#243;s as refei&#231;&#245;es</li>\r\n</ul>",
        "dosage_children": "<p class=\"MsoNormal\">Este medicamento n&#227;o &#233; indicado para crian&#231;as.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1146,
        "indications": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Doen&#231;a de Parkinson</p>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 18:43:25",
        "name": "Prolopa",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 200 mg + cloridrato de benserazida 50 mg,&#160;frasco com 30 comprimidos.</li>\r\n<li class=\"MsoNormal\">Levodopa 100 mg + cloridrato de benserazida 25 mg, frasco com 30 comprimidos.</li>\r\n<li class=\"MsoNormal\">Levodopa 100 mg + cloridrato de benserazida 25 mg, frasco com 30 comprimidos dispers&#237;veis.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-cloridrato-de-benserazida",
        "substance": "Levodopa + Cloridrato de benserazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito e diarreia</p>\r\n<p class=\"MsoNormal\">- Aumento tempor&#225;rio de transaminases e fosfatase alcalina</p>\r\n<p class=\"MsoNormal\">- Movimentos involunt&#225;rios, epis&#243;dios psic&#243;ticos, angina pectoris, constipa&#231;&#227;o, perda de peso e falta de ar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 3910,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Associado a inibidores da monoaminoxidase n&#227;o seletivos (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crinas, nos rins, no f&#237;gado e no cora&#231;&#227;o, assim como pacientes com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de doen&#231;as psiqui&#225;tricas graves com componente psic&#243;tico</p>\r\n<p class=\"MsoNormal\">- Menores de 25 anos</p>\r\n<p>-&#160;A interrup&#231;&#227;o abrupta pode produzir quadro semelhante &#224; s&#237;ndrome neurol&#233;ptica maligna, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e dist&#250;rbios ps&#237;quicos (como delirium), com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Dose inicial: &#188; do comprimido, VO, 3-4x/dia, aumentando lentamente</li>\r\n<li>A dose deve ser estabelecida individualmente e aumentada gradativamente at&#233; otimiza&#231;&#227;o do efeito.</li>\r\n<li>Otimiza&#231;&#227;o do efeito: 300-800 mg de levodopa + 75-200 mg de benserazida, VO, dividida em 3 ou mais administra&#231;&#245;es</li>\r\n<li>Dose de manuten&#231;&#227;o: &#189;&#160;comprimido de Levodopa + cloridrato de benserazida, tr&#234;s a seis vezes ao dia, ou seja, de 300mg a 600mg de levodopa ao dia.</li>\r\n<li>O n&#250;mero ideal de administra&#231;&#245;es (n&#227;o inferior a tr&#234;s) e sua distribui&#231;&#227;o ao longo do dia devem ser titulados para um efeito ideal.</li>\r\n<li>Pacientes com grandes flutua&#231;&#245;es no efeito do medicamento ao longo do dia (fen&#244;meno on-off) devem receber doses individuais menores e mais frequentes.</li>\r\n<li>Deve ser administrado 30 minutos antes ou 1 horas ap&#243;s as refei&#231;&#245;es</li>\r\n</ul>",
        "dosage_children": "<p class=\"MsoNormal\">Este medicamento n&#227;o &#233; indicado para crian&#231;as.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1150,
        "indications": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Doen&#231;a de Parkinson</p>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 01:56:55",
        "name": "Ekson",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 200 mg + cloridrato de benserazida 50 mg,&#160;frasco com 10 e 30 comprimidos.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-cloridrato-de-benserazida",
        "substance": "Levodopa + Cloridrato de benserazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito e diarreia</p>\r\n<p class=\"MsoNormal\">- Aumento tempor&#225;rio de transaminases e fosfatase alcalina</p>\r\n<p class=\"MsoNormal\">- Movimentos involunt&#225;rios, epis&#243;dios psic&#243;ticos, angina pectoris, constipa&#231;&#227;o, perda de peso e falta de ar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 3564,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Trombocitopenia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Dist&#250;rbios de coagula&#231;&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Tend&#234;ncia elevada a hemorragias.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose recomendada: 0,5 mg/kg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de administra&#231;&#227;o intravesical: 20-40 mg 1x/semana por 8 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1160,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Adenocarcinoma de estomago;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Adenocarcinoma de p&#226;ncreas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Carcinoma superficial de c&#233;lulas de transi&#231;&#227;o da bexiga.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 50,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:32:27",
        "name": "Mitocin",
        "presentation": "<ul>\r\n<li><strong>Frasco-ampola:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples - uso restrito a hospitais.</p>",
        "record_status": 1,
        "slug": "mitocin",
        "substance": "Mitomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Trombocitopenia, leucopenia, celulite no local da inje&#231;&#227;o, estomatite, alopecia, edema pulmonar, anormalidades neurol&#243;gicas e hipertens&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3942,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma de &#226;ngulo estreito</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Pacientes com les&#245;es cut&#226;neas suspeitas e n&#227;o diagnosticadas ou com hist&#243;rico de melanoma</p>\r\n<p class=\"MsoNormal\">- Pacientes com doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crina, nos rins, no f&#237;gado e no cora&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\">Dose inicial: &#189; comprimido, VO, 1-2x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Dose ajuste: acrescente &#189; comprimido, VO, a cada dia, ou em dias alternados at&#233; ser atiginda a dose &#243;tima</span></li>\r\n<li><span style=\"color: #000000;\">Dose de manuten&#231;&#227;o: 1 comprimido, VO, 3-4x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Se necess&#225;rio, a posologia pode ser aumentada em &#189;&#160;a 1 comprimido a cada dia, ou em dias alternados, at&#233; o m&#225;ximo de 8 comprimidos por dia.</span></li>\r\n<li><span style=\"color: #000000;\">Dose m&#225;xima di&#225;ria: 200mg de carbidopa.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1161,
        "indications": "<ul>\r\n<li>Tratamento da doen&#231;a e da s&#237;ndrome de Parkinson</li>\r\n<li>Controle do tremor, da disfagia, da sialorreia e da instabilidade postural, associados com a doen&#231;a e a s&#237;ndrome de Parkinson</li>\r\n<li>Pacientes com todos os tipos de flutua&#231;&#227;o (por exemplo, discinesias de pico de dose e deteriora&#231;&#227;o de final de dose &#8211; como acinesia noturna)</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 00:44:43",
        "name": "Levodopa + Carbidopa",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 250mg + Carbidopa 25mg, caixa com 30 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-carbidopa",
        "substance": "Levodopa + Carbidopa",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Alucina&#231;&#245;es e confus&#227;o mental</p>\r\n<p class=\"MsoNormal\">- S&#237;ncope, tonteira, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Rash, prurido</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios visuais</p>\r\n<p class=\"MsoNormal\">- Irregularidades card&#237;acas e/ou palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- Anemia</p>\r\n<p class=\"MsoNormal\">- Discinesia</p>\r\n<p class=\"MsoNormal\">- Diarreia, n&#225;useas</p>\r\n<p class=\"MsoNormal\">- Artralgia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">Recomenda-se cautela em pacientes com obstru&#231;&#227;o biliar ou doen&#231;a hep&#225;tica incluindo insufici&#234;ncia hep&#225;tica leve a moderada. A redu&#231;&#227;o de dose pode ser necess&#225;ria.</p>\r\n</div>"
    },
    {
        "content_length": 3923,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma de &#226;ngulo estreito</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Pacientes com les&#245;es cut&#226;neas suspeitas e n&#227;o diagnosticadas ou com hist&#243;rico de melanoma</p>\r\n<p class=\"MsoNormal\">- Pacientes com doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crina, nos rins, no f&#237;gado e no cora&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\">Dose inicial: &#189; comprimido, VO, 1-2x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Dose ajuste: acrescente &#189; comprimido, VO, a cada dia, ou em dias alternados at&#233; ser atiginda a dose &#243;tima</span></li>\r\n<li><span style=\"color: #000000;\">Dose de manuten&#231;&#227;o: 1 comprimido, VO, 3-4x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Se necess&#225;rio, a posologia pode ser aumentada em &#189;&#160;a 1 comprimido a cada dia, ou em dias alternados, at&#233; o m&#225;ximo de 8 comprimidos por dia.</span></li>\r\n<li><span style=\"color: #000000;\">Dose m&#225;xima di&#225;ria: 200mg de carbidopa.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1162,
        "indications": "<ul>\r\n<li>Tratamento da doen&#231;a e da s&#237;ndrome de Parkinson</li>\r\n<li>Controle do tremor, da disfagia, da sialorreia e da instabilidade postural, associados com a doen&#231;a e a s&#237;ndrome de Parkinson</li>\r\n<li>Pacientes com todos os tipos de flutua&#231;&#227;o (por exemplo, discinesias de pico de dose e deteriora&#231;&#227;o de final de dose &#8211; como acinesia noturna)</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-01-13 18:53:23",
        "name": "Carbidol",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 250mg + Carbidopa 25mg, caixa com 30 e 50 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-carbidopa",
        "substance": "Levodopa + Carbidopa",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Alucina&#231;&#245;es e confus&#227;o mental</p>\r\n<p class=\"MsoNormal\">- S&#237;ncope, tonteira, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Rash, prurido</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios visuais</p>\r\n<p class=\"MsoNormal\">- Irregularidades card&#237;acas e/ou palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- Anemia</p>\r\n<p class=\"MsoNormal\">- Discinesia</p>\r\n<p class=\"MsoNormal\">- Diarreia, n&#225;useas</p>\r\n<p class=\"MsoNormal\">- Artralgia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">Recomenda-se cautela em pacientes com obstru&#231;&#227;o biliar ou doen&#231;a hep&#225;tica incluindo insufici&#234;ncia hep&#225;tica leve a moderada. A redu&#231;&#227;o de dose pode ser necess&#225;ria.</p>\r\n</div>"
    },
    {
        "content_length": 3928,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma de &#226;ngulo estreito</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Pacientes com les&#245;es cut&#226;neas suspeitas e n&#227;o diagnosticadas ou com hist&#243;rico de melanoma</p>\r\n<p class=\"MsoNormal\">- Pacientes com doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crina, nos rins, no f&#237;gado e no cora&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\">Dose inicial: &#189; comprimido, VO, 1-2x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Dose ajuste: acrescente &#189; comprimido, VO, a cada dia, ou em dias alternados at&#233; ser atiginda a dose &#243;tima</span></li>\r\n<li><span style=\"color: #000000;\">Dose de manuten&#231;&#227;o: 1 comprimido, VO, 3-4x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Se necess&#225;rio, a posologia pode ser aumentada em &#189;&#160;a 1 comprimido a cada dia, ou em dias alternados, at&#233; o m&#225;ximo de 8 comprimidos por dia.</span></li>\r\n<li><span style=\"color: #000000;\">Dose m&#225;xima di&#225;ria: 200mg de carbidopa.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1163,
        "indications": "<ul>\r\n<li>Tratamento da doen&#231;a e da s&#237;ndrome de Parkinson</li>\r\n<li>Controle do tremor, da disfagia, da sialorreia e da instabilidade postural, associados com a doen&#231;a e a s&#237;ndrome de Parkinson</li>\r\n<li>Pacientes com todos os tipos de flutua&#231;&#227;o (por exemplo, discinesias de pico de dose e deteriora&#231;&#227;o de final de dose &#8211; como acinesia noturna)</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 17:07:38",
        "name": "Parkidopa",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 250mg + Carbidopa 25mg, caixa com 30 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-carbidopa",
        "substance": "Levodopa + Carbidopa",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Alucina&#231;&#245;es e confus&#227;o mental</p>\r\n<p class=\"MsoNormal\">- S&#237;ncope, tonteira, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Rash, prurido</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios visuais</p>\r\n<p class=\"MsoNormal\">- Irregularidades card&#237;acas e/ou palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- Anemia</p>\r\n<p class=\"MsoNormal\">- Discinesia</p>\r\n<p class=\"MsoNormal\">- Diarreia, n&#225;useas</p>\r\n<p class=\"MsoNormal\">- Artralgia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">Recomenda-se cautela em pacientes com obstru&#231;&#227;o biliar ou doen&#231;a hep&#225;tica incluindo insufici&#234;ncia hep&#225;tica leve a moderada. A redu&#231;&#227;o de dose pode ser necess&#225;ria.</p>\r\n</div>"
    },
    {
        "content_length": 3918,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma de &#226;ngulo estreito</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Pacientes com les&#245;es cut&#226;neas suspeitas e n&#227;o diagnosticadas ou com hist&#243;rico de melanoma</p>\r\n<p class=\"MsoNormal\">- Pacientes com doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crina, nos rins, no f&#237;gado e no cora&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\">Dose inicial: &#189; comprimido, VO, 1-2x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Dose ajuste: acrescente &#189; comprimido, VO, a cada dia, ou em dias alternados at&#233; ser atiginda a dose &#243;tima</span></li>\r\n<li><span style=\"color: #000000;\">Dose de manuten&#231;&#227;o: 1 comprimido, VO, 3-4x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Se necess&#225;rio, a posologia pode ser aumentada em &#189;&#160;a 1 comprimido a cada dia, ou em dias alternados, at&#233; o m&#225;ximo de 8 comprimidos por dia.</span></li>\r\n<li><span style=\"color: #000000;\">Dose m&#225;xima di&#225;ria: 200mg de carbidopa.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1164,
        "indications": "<ul>\r\n<li>Tratamento da doen&#231;a e da s&#237;ndrome de Parkinson</li>\r\n<li>Controle do tremor, da disfagia, da sialorreia e da instabilidade postural, associados com a doen&#231;a e a s&#237;ndrome de Parkinson</li>\r\n<li>Pacientes com todos os tipos de flutua&#231;&#227;o (por exemplo, discinesias de pico de dose e deteriora&#231;&#227;o de final de dose &#8211; como acinesia noturna)</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 26,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-01-13 18:53:27",
        "name": "Cronomet",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 250mg + Carbidopa 25mg, caixa com 20 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-carbidopa",
        "substance": "Levodopa + Carbidopa",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Alucina&#231;&#245;es e confus&#227;o mental</p>\r\n<p class=\"MsoNormal\">- S&#237;ncope, tonteira, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Rash, prurido</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios visuais</p>\r\n<p class=\"MsoNormal\">- Irregularidades card&#237;acas e/ou palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- Anemia</p>\r\n<p class=\"MsoNormal\">- Discinesia</p>\r\n<p class=\"MsoNormal\">- Diarreia, n&#225;useas</p>\r\n<p class=\"MsoNormal\">- Artralgia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">Recomenda-se cautela em pacientes com obstru&#231;&#227;o biliar ou doen&#231;a hep&#225;tica incluindo insufici&#234;ncia hep&#225;tica leve a moderada. A redu&#231;&#227;o de dose pode ser necess&#225;ria.</p>\r\n</div>"
    },
    {
        "content_length": 2887,
        "contraindications": "<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Hipersensibilidade aos componentes.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose inicial:</strong> 2-6 g/dia VO em doses 8/8h ou 6/6h;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usual:</strong> 9-10 g/dia VO;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose m&#225;xima:</strong> 16 g/dia VO.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1165,
        "indications": "<p>- Carcinoma inoper&#225;vel do c&#243;rtex da adrenal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 50,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-04 00:57:07",
        "name": "Lisodren",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lisodren",
        "substance": "Mitotano",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Depress&#227;o, letargia, sonol&#234;ncia, tontura, vertigem, vis&#227;o turva, diplopia, opacidade do cristalino, retinopatia toxica, hipertens&#227;o, hipotens&#227;o ortost&#225;tica e rubor, anorexia, n&#225;usea, vomito, diarreia, rash cut&#226;neo, hemat&#250;ria, cistite hemorr&#225;gica e albumin&#250;ria.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4040,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma de &#226;ngulo estreito</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs)</p>\r\n<p class=\"MsoNormal\">- Pacientes com les&#245;es cut&#226;neas suspeitas e n&#227;o diagnosticadas ou com hist&#243;rico de melanoma</p>\r\n<p class=\"MsoNormal\">- Pacientes com doen&#231;as n&#227;o controladas nas gl&#226;ndulas end&#243;crina, nos rins, no f&#237;gado e no cora&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\">Dose inicial: &#189; comprimido, VO, 1-2x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Dose ajuste: acrescente &#189; comprimido, VO, a cada dia, ou em dias alternados at&#233; ser atiginda a dose &#243;tima</span></li>\r\n<li><span style=\"color: #000000;\">Dose de manuten&#231;&#227;o: 1 comprimido, VO, 3-4x/dia</span></li>\r\n<li><span style=\"color: #000000;\">Se necess&#225;rio, a posologia pode ser aumentada em &#189;&#160;a 1 comprimido a cada dia, ou em dias alternados, at&#233; o m&#225;ximo de 8 comprimidos por dia.</span></li>\r\n<li><span style=\"color: #000000;\">Dose m&#225;xima di&#225;ria: 200mg de carbidopa.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1166,
        "indications": "<ul>\r\n<li>Tratamento da doen&#231;a e da s&#237;ndrome de Parkinson</li>\r\n<li>Controle do tremor, da disfagia, da sialorreia e da instabilidade postural, associados com a doen&#231;a e a s&#237;ndrome de Parkinson</li>\r\n<li>Pacientes com todos os tipos de flutua&#231;&#227;o (por exemplo, discinesias de pico de dose e deteriora&#231;&#227;o de final de dose &#8211; como acinesia noturna)</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 17:08:05",
        "name": "Parklen",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Levodopa 250mg + Carbidopa 25mg, caixa com 30 comprimidos</li>\r\n<li class=\"MsoNormal\">Levodopa 250mg + Carbidopa 25mg, caixa com 20 bl&#237;steres com 10 comprimidos</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levodopa-carbidopa",
        "substance": "Levodopa + Carbidopa",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Alucina&#231;&#245;es e confus&#227;o mental</p>\r\n<p class=\"MsoNormal\">- S&#237;ncope, tonteira, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Rash, prurido</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios visuais</p>\r\n<p class=\"MsoNormal\">- Irregularidades card&#237;acas e/ou palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Anorexia</p>\r\n<p class=\"MsoNormal\">- Anemia</p>\r\n<p class=\"MsoNormal\">- Discinesia</p>\r\n<p class=\"MsoNormal\">- Diarreia, n&#225;useas</p>\r\n<p class=\"MsoNormal\">- Artralgia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">Recomenda-se cautela em pacientes com obstru&#231;&#227;o biliar ou doen&#231;a hep&#225;tica incluindo insufici&#234;ncia hep&#225;tica leve a moderada. A redu&#231;&#227;o de dose pode ser necess&#225;ria.</p>\r\n</div>"
    },
    {
        "content_length": 4245,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mulheres gravidas ou em fase de lacta&#231;&#227;o;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiopatia grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Disfun&#231;&#227;o hep&#225;tica grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Disfun&#231;&#227;o renal grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mielodepressao grave preexistente;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Discrasias sangu&#237;neas graves preexistentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>C&#226;ncer de mama e linfoma n&#227;o-Hodgkin:</strong> 12 a 14 mg/m&#178; em intervalos de 21-28 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Leucemias mieloides agudas:</strong> 10 a 12 mg/m&#178;/dia por 5 dias, IV com dura&#231;&#227;o de 10 a 15 minutos.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Seguran&#231;a n&#227;o estabelecida na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1167,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- C&#226;ncer de mama;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Leucemias agudas miel&#243;ides;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Linfomas n&#227;o-Hodgkin.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 181,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 17:35:23",
        "name": "Evomixan",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;frasco com 20mg/10mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples, uso hospitalar.</p>",
        "record_status": 1,
        "slug": "evomixan",
        "substance": "Mitoxantrona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Leucopenia e trombocitopenia, mielossupress&#227;o, n&#225;useas e v&#244;mitos, redu&#231;&#227;o da fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda, altera&#231;&#245;es no ECG e arritmias agudas, ICC, alopecia, hipotens&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes em Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3648,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiopatia grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Asm&#225;tico ou com hist&#243;rico al&#233;rgico;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose recomendada:</strong> 0,07-0,15 mg/kg/dose, em bolus, repetido a cada 20-40 minutos;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dilui&#231;&#227;o: </strong>mivac&#250;rio 10 ml + SF 0,9% 30 ml (concentra&#231;&#227;o: 0,5 mg/ml);</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Efeito esperado</strong> em 2 minutos, com <strong>dura&#231;&#227;o</strong> de 15 minutos.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose inicial:</strong> 0,1 a 0,2 mg/kg, em bolus; se necess&#225;rio repetir 0,1 mg/kg a cada 15 minutos.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeito esperado</strong> em 2 minutos, com <strong>dura&#231;&#227;o</strong> de 15 minutos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1168,
        "indications": "<div>\r\n<p>- Intuba&#231;&#227;o orotraqueal;</p>\r\n<p>- Melhor adapta&#231;&#227;o &#224; ventila&#231;&#227;o mec&#226;nica (em pacientes j&#225; com seda&#231;&#227;o profunda).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:32:54",
        "name": "Mivacron",
        "presentation": "<ul>\r\n<li><strong>Ampolas:&#160;</strong>2mg/2mL.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Uso restrito a hospitais.</p>",
        "record_status": 1,
        "slug": "mivacron",
        "substance": "Mivacúrio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia e hipotens&#227;o, anafilaxia, rubor, rash e broncoespasmo.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes em Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3981,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipertens&#227;o n&#227;o controlada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Feocromocitoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Doen&#231;a renal avan&#231;ada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Tireotoxicose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Doen&#231;a hep&#225;tica ou card&#237;aca graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Doen&#231;a c&#233;rebro-vascular;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>150-300mg VO 12/12h, ap&#243;s as refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1169,
        "indications": "<div>\r\n<p>- Depress&#227;o;</p>\r\n<p>- Fobia social.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 59,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-04 01:18:19",
        "name": "Aurorix",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;150mg ou 300mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p><span class=\"normaltextrun\"><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Receita de controle especial (C1 - branca em 2 vias).</span></span></p>",
        "record_status": 1,
        "slug": "aurorix",
        "substance": "Moclobemida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos Adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Hipertens&#227;o grave, dist&#250;rbio do sono, psicose, tonteira, vertigem, confus&#227;o mental e sonol&#234;ncia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2557,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as menores de 2 anos de idade</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">Dose usual: 10ml de xarope ou 30 gotas de 8/8h por 5 dias;</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p>&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">A dose pedi&#225;trica &#233; de 1mg/kg at&#233; tr&#234;s vezes ao dia, totalizando uma dose di&#225;ria de 3mg/kg.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">Acima de 12 anos: 10 ml do xarope ou 30 gotas de 8/8h</p>\r\n</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1170,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento de tosse n&#227;o produtiva, seca</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 00:40:21",
        "name": "Antux",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">6mg/ml, xarope, frasco com 120ml + copo medidor</li>\r\n<li class=\"MsoNormal\">30mg/ml, solu&#231;&#227;o oral, frasco gotejador, com 20ml</li>\r\n<li class=\"MsoNormal\">30mg/5ml, gotas, 10ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "antux",
        "substance": "Levodropropizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Dor abdominal, v&#244;mito, diarreia, palpita&#231;&#227;o, astenia, sonol&#234;ncia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">ClCr &lt; 35 ml/min: administrar com cautela</p>\r\n<p class=\"MsoNormal\">Insufici&#234;ncia hep&#225;tica grave: n&#227;o administrar</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2412,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as menores de 2 anos de idade</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">Dose usual: 10ml de xarope ou 30 gotas de 8/8h por 5 dias;</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p>&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">A dose pedi&#225;trica &#233; de 1mg/kg at&#233; tr&#234;s vezes ao dia, totalizando uma dose di&#225;ria de 3mg/kg.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">Acima de 12 anos: 10 ml do xarope ou 30 gotas de 8/8h</p>\r\n</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1171,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento de tosse n&#227;o produtiva, seca</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 17:16:36",
        "name": "Percof",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">6mg/ml, xarope, frasco com 120ml + copo medidor</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "antux",
        "substance": "Levodropropizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Dor abdominal, v&#244;mito, diarreia, palpita&#231;&#227;o, astenia, sonol&#234;ncia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">ClCr &lt; 35 ml/min: administrar com cautela</p>\r\n<p class=\"MsoNormal\">Insufici&#234;ncia hep&#225;tica grave: n&#227;o administrar</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2503,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as menores de 2 anos de idade</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">Dose usual: 10ml de xarope ou 30 gotas de 8/8h por 5 dias;</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p>&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">A dose pedi&#225;trica &#233; de 1mg/kg at&#233; tr&#234;s vezes ao dia, totalizando uma dose di&#225;ria de 3mg/kg.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">Acima de 12 anos: 10 ml do xarope ou 30 gotas de 8/8h</p>\r\n</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1172,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento de tosse n&#227;o produtiva, seca</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 15:12:09",
        "name": "Zyplo",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">6mg/ml, xarope, frasco com 120ml + copo medidor</li>\r\n<li class=\"MsoNormal\">60mg/ml, solu&#231;&#227;o oral, frasco gotejador, com 15ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "antux",
        "substance": "Levodropropizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Dor abdominal, v&#244;mito, diarreia, palpita&#231;&#227;o, astenia, sonol&#234;ncia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">ClCr &lt; 35 ml/min: administrar com cautela</p>\r\n<p class=\"MsoNormal\">Insufici&#234;ncia hep&#225;tica grave: n&#227;o administrar</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>"
    },
    {
        "content_length": 4347,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipertens&#227;o moderada a grave n&#227;o controlada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arritmias card&#237;acas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Menores de 18 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>200mg/dia VO em dose &#250;nica pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendada para a popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1173,
        "indications": "<div>\r\n<p>- Sonol&#234;ncia excessiva diurna;</p>\r\n<p>- Adjuvante no tratamento de depress&#227;o.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Alto risco:</strong></span><span class=\"normaltextrun\">&#160;Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2019-03-09 17:15:37",
        "name": "Stavigile",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;100mg ou 200mg.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Amarela.</span></p>",
        "record_status": 1,
        "slug": "stavigile",
        "substance": "Modafinila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- S&#237;ndrome gripal, herpes simples, infec&#231;&#227;o viral, bronquite, infec&#231;&#227;o do trato urin&#225;rio, infec&#231;&#245;es;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Diminui&#231;&#227;o do apetite, ins&#244;nia, ansiedade, pensamentos anormais, confus&#227;o, nervosismo;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Tontura, parestesia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Vis&#227;o turva, conjuntivite, ambliopia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Taquicardia, palpita&#231;&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Diarreia, constipa&#231;&#227;o, dor abdominal, n&#225;usea, anorexia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Equimoses, artrite, pi&#250;ria, astenia, dismenorreia, edema, fun&#231;&#227;o hep&#225;tica anormal, dor de ouvido.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Em pacientes com insufic&#234;ncia hep&#225;tica, fazer metade da dose.</p>\r\n</div>"
    },
    {
        "content_length": 4331,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipertens&#227;o moderada a grave n&#227;o controlada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arritmias card&#237;acas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Menores de 18 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>200mg/dia VO em dose &#250;nica pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para a popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1174,
        "indications": "<ul>\r\n<li>Sonol&#234;ncia excessiva diurna;</li>\r\n<li>Adjuvante no tratamento de depress&#227;o.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 104,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Alto risco:</strong></span><span class=\"normaltextrun\">&#160;Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2019-03-10 14:23:49",
        "name": "Vigil",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;200mg.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita Amarela.</span></p>",
        "record_status": 1,
        "slug": "vigil",
        "substance": "Modafinila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- S&#237;ndrome gripal, herpes simples, infec&#231;&#227;o viral, bronquite, infec&#231;&#227;o do trato urin&#225;rio, infec&#231;&#245;es;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Diminui&#231;&#227;o do apetite, ins&#244;nia, ansiedade, pensamentos anormais, confus&#227;o, nervosismo;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Tontura, parestesia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Vis&#227;o turva, conjuntivite, ambliopia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Taquicardia, palpita&#231;&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Diarreia, constipa&#231;&#227;o, dor abdominal, n&#225;usea, anorexia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Equimoses, artrite, pi&#250;ria, astenia, dismenorreia, edema, fun&#231;&#227;o hep&#225;tica anormal, dor de ouvido.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Em pacientes com insufic&#234;ncia hep&#225;tica, fazer metade da dose.</p>\r\n</div>"
    },
    {
        "content_length": 3134,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- P&#250;rpura trombocitop<em><span style=\"font-style: normal;\">&#234;</span></em>nica autoimune.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usual:</strong> 1 a 3 mcg/kg SC ou 10 mcg/kg IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>S&#237;ndromes mielodispl&#225;sicas:</strong> 3 mcg/kg SC 1x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>AIDS:</strong> 1 mcg/kg SC 1x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Transplante de medula &#243;ssea:</strong> 5 a 10 mcg/kg IV.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1175,
        "indications": "<div>\r\n<p>- Revers&#227;o ou preven&#231;&#227;o de leucopenia de origem distinta;</p>\r\n<p>- Leucopenia associado a s&#237;ndromes mielodispl&#225;sicas, AIDS, tratamento com azitromicina e ganciclovir, quimioterapia do c&#226;ncer e transplante de medula &#243;ssea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 58,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 22:35:04",
        "name": "Leucocitim",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> ampolas com 150mcg, 300mcg ou 400mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "leucocitim",
        "substance": "Molgramostim",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Febre, erup&#231;&#245;es cut&#226;neas, n&#225;useas, edema, hipotens&#227;o, dor no peito, dor &#243;ssea e diarreia.</span></p>\r\n<hr>\r\n<p><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3144,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- P&#250;rpura trombocitop<em><span style=\"font-style: normal;\">&#234;</span></em>nica autoimune.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usual:</strong> 1 a 3 mcg/kg SC ou 10 mcg/kg IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>S&#237;ndromes mielodispl&#225;sicas:</strong> 3 mcg/kg SC 1x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>AIDS:</strong> 1 mcg/kg SC 1x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Transplante de medula &#243;ssea:</strong> 5 a 10 mcg/kg IV.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos em popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1176,
        "indications": "<div>\r\n<p>- Revers&#227;o ou preven&#231;&#227;o de leucopenia de origem distinta;</p>\r\n<p>- Leucopenia associado a s&#237;ndromes mielodispl&#225;sicas, AIDS, tratamento com azitromicina e ganciclovir, quimioterapia do c&#226;ncer e transplante de medula &#243;ssea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 176,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 22:35:36",
        "name": "Leumostim",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;ampolas com 300mcg ou 400mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "leumostim",
        "substance": "Molgramostim",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Febre, erup&#231;&#245;es cut&#226;neas, n&#225;useas, edema, hipotens&#227;o, dor no peito, dor &#243;ssea e diarreia.</span></p>\r\n<hr>\r\n<p><strong>Ajustes na Insufic&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3667,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiomiopatia hipertr&#243;fica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipotens&#227;o arterial grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infarto ventricular direito;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Angina cr&#244;nica: 10 a 40 mg VO 2-3x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Recomenda-se intervalo m&#237;nimo de 12 horas entre a &#250;ltima dose de um dia e a primeira dose do dia seguinte.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">N&#227;o recomendado para popula&#231;&#227;o pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1177,
        "indications": "<div>\r\n<p>- Angina de repouso, de esfor&#231;o, p&#243;s infarto;</p>\r\n<p>- Edema pulmonar cardiog&#234;nico;</p>\r\n<p>- Insufici&#234;ncia card&#237;aca associada a infarto;</p>\r\n<p>- Isquemia coronariana.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:36:04",
        "name": "Mononitrato de Isossorbida",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;20mg ou 40mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mononitrato-de-isossorbida",
        "substance": "Mononitrato de Isossorbida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, dor tor&#225;cica, hipotens&#227;o, n&#225;useas e v&#244;mitos, rea&#231;&#245;es al&#233;rgicas, sudorese.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3882,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiomiopatia hipertr&#243;fica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipotens&#227;o arterial grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infarto ventricular direito;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Angina cr&#244;nica:</strong> 10 a 40 mg VO 2-3x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Na emerg&#234;ncia:</strong> 5 mg SL, podendo se repetir a cada 2-3 horas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Recomenda-se intervalo m&#237;nimo de 12 horas entre a &#250;ltima dose de um dia e a primeira dose do dia seguinte.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">N&#227;o recomendado para popula&#231;&#227;o pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1178,
        "indications": "<div>\r\n<p>- Angina de repouso, de esfor&#231;o, p&#243;s infarto;</p>\r\n<p>- Edema pulmonar cardiog&#234;nico;</p>\r\n<p>- Insufici&#234;ncia card&#237;aca associada a infarto;</p>\r\n<p>- Isquemia coronariana.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 160,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:35:46",
        "name": "Monocordil",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;5mg, 10mg, 20mg ou 40mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "monocordil",
        "substance": "Mononitrato de Isossorbida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, dor tor&#225;cica, hipotens&#227;o, n&#225;useas e v&#244;mitos, rea&#231;&#245;es al&#233;rgicas, sudorese.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3452,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiomiopatia hipertr&#243;fica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipotens&#227;o arterial grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infarto ventricular direito;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Angina cr&#244;nica:</strong> 1/2 a 1cp VO 1x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">N&#227;o recomendado para popula&#231;&#227;o pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1180,
        "indications": "<div>\r\n<p>- Angina de repouso, de esfor&#231;o, p&#243;s infarto;</p>\r\n<p>- Edema pulmonar cardiog&#234;nico;</p>\r\n<p>- Insufici&#234;ncia card&#237;aca associada a infarto;</p>\r\n<p>- Isquemia coronariana.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 160,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:35:55",
        "name": "Monocordil Retard",
        "presentation": "<ul>\r\n<li><strong>Comprimidos de libera&#231;&#227;o prolongada:</strong>&#160;50mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "monocordil-retard",
        "substance": "Mononitrato de Isossorbida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, dor tor&#225;cica, hipotens&#227;o, n&#225;useas e v&#244;mitos, rea&#231;&#245;es al&#233;rgicas, sudorese.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3652,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiomiopatia hipertr&#243;fica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipotens&#227;o arterial grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infarto ventricular direito;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Angina cr&#244;nica:</strong> 10 a 40 mg VO 2-3x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Recomenda-se intervalo m&#237;nimo de 12 horas entre a &#250;ltima dose de um dia e a primeira dose do dia seguinte.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">N&#227;o recomendado para popula&#231;&#227;o pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1181,
        "indications": "<div>\r\n<p>- Angina de repouso, de esfor&#231;o, p&#243;s infarto;</p>\r\n<p>- Edema pulmonar cardiog&#234;nico;</p>\r\n<p>- Insufici&#234;ncia card&#237;aca associada a infarto;</p>\r\n<p>- Isquemia coronariana.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:34:46",
        "name": "Cincordil",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;20mg ou 40mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cincordil",
        "substance": "Mononitrato de Isossorbida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Bradicardia, dor tor&#225;cica, hipotens&#227;o, n&#225;useas e v&#244;mitos, rea&#231;&#245;es al&#233;rgicas, sudorese.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4954,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Infarto do mioc&#225;rdio recente</p>\r\n<p class=\"MsoNormal\">- Tireotoxicose e hipertiroidismo n&#227;o tratado</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia adrenal n&#227;o corrigida</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\"><strong>Hipotireoidismo</strong>:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\"><strong>Dose inicial</strong> de 50mcg/dia, aumentando-se 25mcg a cada 2 ou 3 semanas</span></li>\r\n<li><span style=\"color: #000000;\">Em pacientes com hipotireoidismo de longa data, particularmente com suspeita de altera&#231;&#245;es cardiovasculares, a dose inicial dever&#225; ser ainda mais baixa (25mcg/dia).</span></li>\r\n<li><strong><span style=\"color: #000000;\">Manuten&#231;&#227;o:&#160;</span></strong><span style=\"color: #000000;\">75 a 125mcg di&#225;rios sendo que alguns pacientes, com m&#225; absor&#231;&#227;o, podem necessitar de at&#233; 200mcg/dia.</span></li>\r\n<li><span style=\"color: #000000;\"> A falta de resposta &#224;s doses de 200mcg/dia sugere m&#225; absor&#231;&#227;o, n&#227;o obedi&#234;ncia ao tratamento ou erro diagn&#243;stico.</span></li>\r\n</ul>\r\n</li>\r\n<li><strong><span style=\"color: #000000;\">Supress&#227;o do TSH (<a style=\"box-sizing: border-box; background-color: transparent; color: #000000; -webkit-font-smoothing: antialiased; transition: all 0.15s ease;\" href=\"https://minutosaudavel.com.br/o-que-e-neoplasia-maligna-cancer-cura-sintomas-e-mais/\" target=\"_blank\" rel=\"noopener\">c&#226;ncer</a>&#160;de tireoide) / n&#243;dulos / b&#243;cios eutireoidianos:</span></strong>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Dose supressiva m&#233;dia de levotiroxina (T4): 2,6mcg/kg/dia, durante 7 a 10 dias.&#160;</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">No idoso, a integridade do sistema cardiovascular pode estar comprometida. Por isso, neste paciente a terapia com levotiroxina deve ser iniciada com doses baixas, como por exemplo: 25- 50mcg/dia.</span></li>\r\n<li>Devem ser ingeridos com est&#244;mago vazio (1 hora antes ou 2 horas ap&#243;s o caf&#233; da manh&#227; ou ingest&#227;o de alimento), a fim de aumentar sua absor&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>No rec&#233;m-nascido: 5 a 6mcg/kg/dia</li>\r\n<li>Na crian&#231;a: em geral 3mcg/kg/dia, devendo ser definida de acordo com os n&#237;veis s&#233;ricos dos horm&#244;nios tireoideanos</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 1183,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Hipotireoidismo de qualquer etiologia</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Supress&#227;o do TSH hipofis&#225;rio </span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento ou preven&#231;&#227;o de b&#243;cio eutireoidiano</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Agente diagn&#243;stico nos testes de supress&#227;o</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Adjuvante nas cirurgias ou radioterapia para controle do c&#226;ncer tireoidiano</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 26,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 17:30:27",
        "name": "Euthyrox",
        "presentation": "<ul>\r\n<li>Comprimidos de: 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg e 200mcg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levotiroxina-sodica",
        "substance": "Levotiroxina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Palpita&#231;&#245;es, taquicardia, arritmias card&#237;acas, angina, rash cut&#226;neo, urtic&#225;ria, sudorese, ins&#244;nia, nervosismo, excitabilidade, fraqueza muscular, c&#227;ibras, osteoporose, fogachos, irregularidades menstruais, diarreia, v&#244;mitos, cefaleia, intoler&#226;ncia ao calor, febre, hipertireoidismo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 4954,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Infarto do mioc&#225;rdio recente</p>\r\n<p class=\"MsoNormal\">- Tireotoxicose e hipertiroidismo n&#227;o tratado</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia adrenal n&#227;o corrigida</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\"><strong>Hipotireoidismo</strong>:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\"><strong>Dose inicial</strong> de 50mcg/dia, aumentando-se 25mcg a cada 2 ou 3 semanas</span></li>\r\n<li><span style=\"color: #000000;\">Em pacientes com hipotireoidismo de longa data, particularmente com suspeita de altera&#231;&#245;es cardiovasculares, a dose inicial dever&#225; ser ainda mais baixa (25mcg/dia).</span></li>\r\n<li><strong><span style=\"color: #000000;\">Manuten&#231;&#227;o:&#160;</span></strong><span style=\"color: #000000;\">75 a 125mcg di&#225;rios sendo que alguns pacientes, com m&#225; absor&#231;&#227;o, podem necessitar de at&#233; 200mcg/dia.</span></li>\r\n<li><span style=\"color: #000000;\"> A falta de resposta &#224;s doses de 200mcg/dia sugere m&#225; absor&#231;&#227;o, n&#227;o obedi&#234;ncia ao tratamento ou erro diagn&#243;stico.</span></li>\r\n</ul>\r\n</li>\r\n<li><strong><span style=\"color: #000000;\">Supress&#227;o do TSH (<a style=\"box-sizing: border-box; background-color: transparent; color: #000000; -webkit-font-smoothing: antialiased; transition: all 0.15s ease;\" href=\"https://minutosaudavel.com.br/o-que-e-neoplasia-maligna-cancer-cura-sintomas-e-mais/\" target=\"_blank\" rel=\"noopener\">c&#226;ncer</a>&#160;de tireoide) / n&#243;dulos / b&#243;cios eutireoidianos:</span></strong>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Dose supressiva m&#233;dia de levotiroxina (T4): 2,6mcg/kg/dia, durante 7 a 10 dias.&#160;</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">No idoso, a integridade do sistema cardiovascular pode estar comprometida. Por isso, neste paciente a terapia com levotiroxina deve ser iniciada com doses baixas, como por exemplo: 25- 50mcg/dia.</span></li>\r\n<li>Devem ser ingeridos com est&#244;mago vazio (1 hora antes ou 2 horas ap&#243;s o caf&#233; da manh&#227; ou ingest&#227;o de alimento), a fim de aumentar sua absor&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>No rec&#233;m-nascido: 5 a 6mcg/kg/dia</li>\r\n<li>Na crian&#231;a: em geral 3mcg/kg/dia, devendo ser definida de acordo com os n&#237;veis s&#233;ricos dos horm&#244;nios tireoideanos</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 1185,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Hipotireoidismo de qualquer etiologia</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Supress&#227;o do TSH hipofis&#225;rio </span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento ou preven&#231;&#227;o de b&#243;cio eutireoidiano</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Agente diagn&#243;stico nos testes de supress&#227;o</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Adjuvante nas cirurgias ou radioterapia para controle do c&#226;ncer tireoidiano</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:45:14",
        "name": "Levoid",
        "presentation": "<ul>\r\n<li>Comprimidos de: 25mcg, 38mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 150mcg, 175mcg e 200mcg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levotiroxina-sodica",
        "substance": "Levotiroxina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Palpita&#231;&#245;es, taquicardia, arritmias card&#237;acas, angina, rash cut&#226;neo, urtic&#225;ria, sudorese, ins&#244;nia, nervosismo, excitabilidade, fraqueza muscular, c&#227;ibras, osteoporose, fogachos, irregularidades menstruais, diarreia, v&#244;mitos, cefaleia, intoler&#226;ncia ao calor, febre, hipertireoidismo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 4979,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Infarto do mioc&#225;rdio recente</p>\r\n<p class=\"MsoNormal\">- Tireotoxicose e hipertiroidismo n&#227;o tratado</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia adrenal n&#227;o corrigida</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\"><strong>Hipotireoidismo</strong>:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\"><strong>Dose inicial</strong> de 50mcg/dia, aumentando-se 25mcg a cada 2 ou 3 semanas</span></li>\r\n<li><span style=\"color: #000000;\">Em pacientes com hipotireoidismo de longa data, particularmente com suspeita de altera&#231;&#245;es cardiovasculares, a dose inicial dever&#225; ser ainda mais baixa (25mcg/dia).</span></li>\r\n<li><strong><span style=\"color: #000000;\">Manuten&#231;&#227;o:&#160;</span></strong><span style=\"color: #000000;\">75 a 125mcg di&#225;rios sendo que alguns pacientes, com m&#225; absor&#231;&#227;o, podem necessitar de at&#233; 200mcg/dia.</span></li>\r\n<li><span style=\"color: #000000;\"> A falta de resposta &#224;s doses de 200mcg/dia sugere m&#225; absor&#231;&#227;o, n&#227;o obedi&#234;ncia ao tratamento ou erro diagn&#243;stico.</span></li>\r\n</ul>\r\n</li>\r\n<li><strong><span style=\"color: #000000;\">Supress&#227;o do TSH (<a style=\"box-sizing: border-box; background-color: transparent; color: #000000; -webkit-font-smoothing: antialiased; transition: all 0.15s ease;\" href=\"https://minutosaudavel.com.br/o-que-e-neoplasia-maligna-cancer-cura-sintomas-e-mais/\" target=\"_blank\" rel=\"noopener\">c&#226;ncer</a>&#160;de tireoide) / n&#243;dulos / b&#243;cios eutireoidianos:</span></strong>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Dose supressiva m&#233;dia de levotiroxina (T4): 2,6mcg/kg/dia, durante 7 a 10 dias.&#160;</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">No idoso, a integridade do sistema cardiovascular pode estar comprometida. Por isso, neste paciente a terapia com levotiroxina deve ser iniciada com doses baixas, como por exemplo: 25- 50mcg/dia.</span></li>\r\n<li>Devem ser ingeridos com est&#244;mago vazio (1 hora antes ou 2 horas ap&#243;s o caf&#233; da manh&#227; ou ingest&#227;o de alimento), a fim de aumentar sua absor&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>No rec&#233;m-nascido: 5 a 6mcg/kg/dia</li>\r\n<li>Na crian&#231;a: em geral 3mcg/kg/dia, devendo ser definida de acordo com os n&#237;veis s&#233;ricos dos horm&#244;nios tireoideanos</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 1186,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Hipotireoidismo de qualquer etiologia</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Supress&#227;o do TSH hipofis&#225;rio </span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento ou preven&#231;&#227;o de b&#243;cio eutireoidiano</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Agente diagn&#243;stico nos testes de supress&#227;o</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Adjuvante nas cirurgias ou radioterapia para controle do c&#226;ncer tireoidiano</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-08 18:57:29",
        "name": "Puran T4",
        "presentation": "<ul>\r\n<li>Comprimidos de: 25mcg, 38mcg, 50mcg, 62,5mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 150mcg, 175mcg, 200mcg e 300mcg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levotiroxina-sodica",
        "substance": "Levotiroxina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Palpita&#231;&#245;es, taquicardia, arritmias card&#237;acas, angina, rash cut&#226;neo, urtic&#225;ria, sudorese, ins&#244;nia, nervosismo, excitabilidade, fraqueza muscular, c&#227;ibras, osteoporose, fogachos, irregularidades menstruais, diarreia, v&#244;mitos, cefaleia, intoler&#226;ncia ao calor, febre, hipertireoidismo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 4886,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Infarto do mioc&#225;rdio recente</p>\r\n<p class=\"MsoNormal\">- Tireotoxicose e hipertiroidismo n&#227;o tratado</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia adrenal n&#227;o corrigida</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\"><strong>Hipotireoidismo</strong>:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\"><strong>Dose inicial</strong> de 50mcg/dia, aumentando-se 25mcg a cada 2 ou 3 semanas</span></li>\r\n<li><span style=\"color: #000000;\">Em pacientes com hipotireoidismo de longa data, particularmente com suspeita de altera&#231;&#245;es cardiovasculares, a dose inicial dever&#225; ser ainda mais baixa (25mcg/dia).</span></li>\r\n<li><strong><span style=\"color: #000000;\">Manuten&#231;&#227;o:&#160;</span></strong><span style=\"color: #000000;\">75 a 125mcg di&#225;rios sendo que alguns pacientes, com m&#225; absor&#231;&#227;o, podem necessitar de at&#233; 200mcg/dia.</span></li>\r\n<li><span style=\"color: #000000;\"> A falta de resposta &#224;s doses de 200mcg/dia sugere m&#225; absor&#231;&#227;o, n&#227;o obedi&#234;ncia ao tratamento ou erro diagn&#243;stico.</span></li>\r\n</ul>\r\n</li>\r\n<li><strong><span style=\"color: #000000;\">Supress&#227;o do TSH (<a style=\"box-sizing: border-box; background-color: transparent; color: #000000; -webkit-font-smoothing: antialiased; transition: all 0.15s ease;\" href=\"https://minutosaudavel.com.br/o-que-e-neoplasia-maligna-cancer-cura-sintomas-e-mais/\" target=\"_blank\" rel=\"noopener\">c&#226;ncer</a>&#160;de tireoide) / n&#243;dulos / b&#243;cios eutireoidianos:</span></strong>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Dose supressiva m&#233;dia de levotiroxina (T4): 2,6mcg/kg/dia, durante 7 a 10 dias.&#160;</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">No idoso, a integridade do sistema cardiovascular pode estar comprometida. Por isso, neste paciente a terapia com levotiroxina deve ser iniciada com doses baixas, como por exemplo: 25- 50mcg/dia.</span></li>\r\n<li>Devem ser ingeridos com est&#244;mago vazio (1 hora antes ou 2 horas ap&#243;s o caf&#233; da manh&#227; ou ingest&#227;o de alimento), a fim de aumentar sua absor&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>No rec&#233;m-nascido: 5 a 6mcg/kg/dia</li>\r\n<li>Na crian&#231;a: em geral 3mcg/kg/dia, devendo ser definida de acordo com os n&#237;veis s&#233;ricos dos horm&#244;nios tireoideanos</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 1188,
        "indications": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Hipotireoidismo de qualquer etiologia</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Supress&#227;o do TSH hipofis&#225;rio </span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Tratamento ou preven&#231;&#227;o de b&#243;cio eutireoidiano</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Agente diagn&#243;stico nos testes de supress&#227;o</span></li>\r\n<li class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Adjuvante nas cirurgias ou radioterapia para controle do c&#226;ncer tireoidiano</span></li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:06:52",
        "name": "Tiroidin",
        "presentation": "<ul>\r\n<li>Comprimidos de: 100mcg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levotiroxina-sodica",
        "substance": "Levotiroxina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">Palpita&#231;&#245;es, taquicardia, arritmias card&#237;acas, angina, rash cut&#226;neo, urtic&#225;ria, sudorese, ins&#244;nia, nervosismo, excitabilidade, fraqueza muscular, c&#227;ibras, osteoporose, fogachos, irregularidades menstruais, diarreia, v&#244;mitos, cefaleia, intoler&#226;ncia ao calor, febre, hipertireoidismo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 3586,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1189,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-09 16:38:29",
        "name": "Singulair",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg e 10mg;</li>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "singulair",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3525,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1191,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-09 16:38:46",
        "name": "Singulair Baby",
        "presentation": "<ul>\r\n<li><strong>Sach&#234;s dispers&#237;veis</strong> de 4mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "singulair",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2542,
        "contraindications": "<div>\r\n<p>- Gr&#225;vidas e lactantes</p>\r\n<p>- Hipersensibilidade aos componentes</p>\r\n</div>",
        "dosage_adults": "<p><strong>Dose usual:&#160;</strong>1 mg,VO, 1x/dia.</p>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria X:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1193,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Tratamento do c&#226;ncer de mama inicial em mulheres na p&#243;s-menopausa.</p>\r\n<p class=\"MsoNormal\">- Redu&#231;&#227;o da incid&#234;ncia de c&#226;ncer de mama contralateral em pacientes recebendo anastrozol como tratamento adjuvante para c&#226;ncer de mama inicial.</p>\r\n<p class=\"MsoNormal\">- Tratamento do c&#226;ncer de mama avan&#231;ado em mulheres na p&#243;s-menopausa.</p>\r\n<p class=\"MsoNormal\">- Pacientes com tumores receptor hormonal posisitvo.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-04 00:53:07",
        "name": "Arimidex",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>&#160;Comprimido:</strong> 1 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Arimidex",
        "substance": "Anastrozol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Ondas de calor, astenia, artralgia, enrijecimento articular, artrite, dor de cabe&#231;a, n&#225;usea, les&#245;es na pele com vermelhid&#227;o, alopecia, rea&#231;&#245;es al&#233;rgicas, diarreia, v&#244;mitos, sonol&#234;ncia, s&#237;ndrome do t&#250;nel do carpo, secura e dor vaginal, anorexia, hipercolesterolemia, dor nos ossos, dor muscular, dist&#250;rbios sensoriais, perda e altera&#231;&#227;o do paladar, aumento de enzimas hep&#225;ticas.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3582,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1195,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 162,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-01-13 20:35:04",
        "name": "Aria",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg e 10mg;</li>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "aria",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3614,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1196,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-05 00:36:35",
        "name": "Montelair Comprimido",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg e 10mg;</li>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "montelair-comprimido",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3567,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1197,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-05 00:36:44",
        "name": "Montelair Granulado",
        "presentation": "<ul>\r\n<li><strong>Gr&#226;nulos dispers&#237;veis:</strong>&#160;sach&#234; com 4mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "montelair-comprimido",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3699,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1198,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-05 00:36:53",
        "name": "Montelucaste de Sódio",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg e 10mg;</li>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg;</li>\r\n<li><strong>Sach&#234;s</strong> com 4mg em gr&#226;nulos dispers&#237;veis.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "montelucaste-de-sodio",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4332,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\"><strong>Infec&#231;&#245;es mic&#243;ticas sist&#234;micas:</strong>&#160;iniciar com 3 mg/kg/dia. A dura&#231;&#227;o m&#233;dia &#233; de 14 a 15 dias.</p>\r\n<p class=\"MsoNormal\"><strong>Neutropenia febril:&#160;</strong>3 mg/kg/dia</p>\r\n<p class=\"MsoNormal\"><strong>Meningite Criptoc&#243;cica:</strong>&#160;iniciar com 3 a 6 mg/kg/dia, administrados por 14 dias.</p>\r\n<p class=\"MsoNormal\"><strong>Leishmaniose visceral:</strong> 1 a 1,5 mg/kg/dia durante 21 dias ou 3 mg/kg/dia durante 10 dias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Modo de uso:</strong>&#160;infus&#227;o, IV, de 30 a 120 min (deve ser reconstitu&#237;do em &#193;gua Est&#233;ril para Inje&#231;&#227;o (sem agente bacteriost&#225;tico) e dilu&#237;do em solu&#231;&#227;o de dextrose (5%) pr&#243;pria para infus&#227;o).</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong>Infec&#231;&#245;es mic&#243;ticas sist&#234;micas:</strong>&#160;iniciar com 3 mg/kg/dia. A dura&#231;&#227;o m&#233;dia &#233; de 14 a 15 dias.</p>\r\n<p class=\"MsoNormal\"><strong>Neutropenia febril:&#160;</strong>3 mg/kg/dia</p>\r\n<p class=\"MsoNormal\"><strong>Meningite Criptoc&#243;cica:</strong>&#160;iniciar com 3 a 6 mg/kg/dia, administrados por 14 dias.</p>\r\n<p class=\"MsoNormal\"><strong>Leishmaniose visceral:</strong>&#160;1 a 1,5 mg/kg/dia durante 21 dias ou 3 mg/kg/dia durante 10 dias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Modo de uso:</strong>&#160;infus&#227;o, IV, de 30 a 120 min (deve ser reconstitu&#237;do em &#193;gua Est&#233;ril para Inje&#231;&#227;o (sem agente bacteriost&#225;tico) e dilu&#237;do em solu&#231;&#227;o de dextrose (5%) pr&#243;pria para infus&#227;o).</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1199,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Candid&#237;ase disseminada</p>\r\n<p class=\"MsoNormal\">- Aspergilose invasiva</p>\r\n<p class=\"MsoNormal\">- Mucormicose</p>\r\n<p class=\"MsoNormal\">- Criptococose</p>\r\n<p class=\"MsoNormal\">- Coccidioidomicose</p>\r\n<p class=\"MsoNormal\">- Paracoccidioidomicose</p>\r\n<p class=\"MsoNormal\">- Histoplasmose</p>\r\n<p class=\"MsoNormal\">- Meningite criptoc&#243;cica em pacientes infectados por HIV</p>\r\n<p class=\"MsoNormal\">- Leishmaniose cut&#226;nea e visceral</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 192,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 23:51:44",
        "name": "AmBisome",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50 mg</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples (duas vias).</p>",
        "record_status": 1,
        "slug": "ambisome",
        "substance": "Anfotericina B lipossomal",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Hipocalemia, hipomagnesemia.</p>\r\n<p class=\"MsoNormal\">- Cefal&#233;ia</p>\r\n<p class=\"MsoNormal\">- Taquicardia, hipotens&#227;o, vasodilata&#231;&#227;o, rubor.</p>\r\n<p class=\"MsoNormal\">- Dispneia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito, diarreia, dor abdominal.</p>\r\n<p class=\"MsoNormal\">- Erup&#231;&#227;o cut&#226;nea</p>\r\n<p class=\"MsoNormal\">- Dorsalgia</p>\r\n<p class=\"MsoNormal\">- Calafrio, pirexia, dor tor&#225;cica.</p>\r\n<p class=\"MsoNormal\">- Anemia, trombocitopenia, leucopenia, hipocalcemia, aumento de transaminases e bilirrubinas.</p>\r\n<p class=\"MsoNormal\">- Aumento da creatinina e da uremia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido (Monitorar fun&#231;&#227;o renal).</p>\r\n</div>"
    },
    {
        "content_length": 3591,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1200,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-06 17:21:47",
        "name": "Piemonte",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg e 10mg;</li>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "piemonte",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3680,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1201,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 65,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-10 14:19:50",
        "name": "Viatine",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg e 10mg;</li>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg;</li>\r\n<li><strong>Sach&#234;s</strong> com 4mg em gr&#226;nulos dispers&#237;veis.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "viatine",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3508,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1202,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 156,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-10 15:10:55",
        "name": "Zylcas",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "zylcas",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3513,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1204,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 74,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-01-13 20:35:06",
        "name": "Bronsecur",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bronsecur",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3522,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1205,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 155,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-05 00:37:01",
        "name": "Monty",
        "presentation": "<ul>\r\n<li><strong>Comprimidos mastig&#225;veis</strong> de 4mg e 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "monty",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4864,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n<p class=\"MsoNormal\">- N&#227;o usar Anfotericina B comum se a creatinina for &gt; 3 mg/dl.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><strong>Modo de uso:</strong> Infus&#227;o IV lenta por 2 a 6 horas</li>\r\n<li class=\"MsoNormal\"><strong>Dilui&#231;&#227;o:</strong> (50 mg/10 ml) 10 ml + 490 ml de SG 5%.</li>\r\n<li class=\"MsoNormal\"><strong>Dose m&#225;xima:</strong> 1,5 mg/kg</li>\r\n</ul>\r\n<p class=\"MsoNormal\"><strong>Candid&#237;ase:</strong> 0,4 a 0,6 mg/kg/dia, IV, por 4 semanas ou mais.</p>\r\n<p class=\"MsoNormal\"><strong>Criptococose:</strong> 0,3 mg/kg/dia, IV, por per&#237;odos de aproximadamente 4-6 semanas.</p>\r\n<p class=\"MsoNormal\"><strong>Blastomicose:</strong> 0,3 a 1 mg/kg/dia, IV, com dose acumulada de 1,5 a 2,5 g.</p>\r\n<p class=\"MsoNormal\"><strong>Histoplasmose:</strong> 0,5 a 1 mg/kg/dia, IV, com doses acumuladas de 2 a 2,5 g.</p>\r\n<p class=\"MsoNormal\"><strong>Aspergilose:</strong> 0,5 a 1 mg/kg/dia, IV, com doses acumuladas de 2 a 4 g.</p>\r\n<p class=\"MsoNormal\"><strong>Mucormicose rinocerebral:</strong> 0,7 a 1,5 mg/kg/dia, IV.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong>Dose habitual:</strong>&#160;dose inicial de 0,5 mg/kg/dia (0,25 mg/kg/dia em rec&#233;m-nascidos) em infus&#227;o lenta (2 a 6 horas) e aumentar progressivamente (0,25 mg/kg/dia) at&#233; 1 mg/kg/dia.</p>\r\n<p class=\"MsoNormal\"><strong>Nos casos graves e em imunodeprimidos:</strong>&#160;usar a dose de 1 mg/kg/dia j&#225; no primeiro dia. Na manuten&#231;&#227;o pode-se usar doses de at&#233; 1,5 mg/kg/dia em dias alternados. Dose m&#225;xima: 1,5 mg/kg/dia;</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1211,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Candid&#237;ase disseminada</p>\r\n<p class=\"MsoNormal\">- Aspergilose</p>\r\n<p class=\"MsoNormal\">- Blastomicose</p>\r\n<p class=\"MsoNormal\">- Coccidiodomicose</p>\r\n<p class=\"MsoNormal\">- Criptococose</p>\r\n<p class=\"MsoNormal\">- Endocardite f&#250;ngica</p>\r\n<p class=\"MsoNormal\">- Endoftalmite candidi&#225;sica</p>\r\n<p class=\"MsoNormal\">- Infec&#231;&#245;es intra-abdominais, incluindo peritonites relacionadas e n&#227;o relacionadas com o processo de di&#225;lise</p>\r\n<p class=\"MsoNormal\">- Leishmaniose mucocut&#226;nea, embora n&#227;o seja uma droga de tratamento prim&#225;rio</p>\r\n<p class=\"MsoNormal\">- Meningite criptoc&#243;cica</p>\r\n<p class=\"MsoNormal\">- Meningite f&#250;ngica de outras origens</p>\r\n<p class=\"MsoNormal\">- Mucormicose (ficomicose)</p>\r\n<p class=\"MsoNormal\">- Septicemia f&#250;ngica</p>\r\n<p class=\"MsoNormal\">- Esporotricose disseminada</p>\r\n<p class=\"MsoNormal\">- Infec&#231;&#245;es f&#250;ngicas das vias urin&#225;rias</p>\r\n<p class=\"MsoNormal\">- Meningoencefalite amebiana prim&#225;ria</p>\r\n<p class=\"MsoNormal\">- Paracoccidioidomicose.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 04:42:39",
        "name": "Unianf",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50 mg</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples (duas vias).</p>",
        "record_status": 1,
        "slug": "Unianf",
        "substance": "Anfotericina B",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Hipocalemia, hipomagnesemia.</p>\r\n<p class=\"MsoNormal\">- Cefal&#233;ia</p>\r\n<p class=\"MsoNormal\">- Taquicardia, hipotens&#227;o, vasodilata&#231;&#227;o, rubor.</p>\r\n<p class=\"MsoNormal\">- Dispneia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito, diarreia, dor abdominal.</p>\r\n<p class=\"MsoNormal\">- Erup&#231;&#227;o cut&#226;nea</p>\r\n<p class=\"MsoNormal\">- Dorsalgia</p>\r\n<p class=\"MsoNormal\">- Calafrio, pirexia, dor tor&#225;cica.</p>\r\n<p class=\"MsoNormal\">- Anemia, trombocitopenia, leucopenia, hipocalcemia, aumento de transaminases e bilirrubinas.</p>\r\n<p class=\"MsoNormal\">- Aumento da creatinina e da uremia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido (Monitorar fun&#231;&#227;o renal).</p>\r\n</div>"
    },
    {
        "content_length": 3504,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1212,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-05 00:43:04",
        "name": "Multiler",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "multiler",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3513,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1-5 anos: 4mg VO em dose &#250;nica &#224; noite;</li>\r\n<li>6-14 anos: 5mg VO em dose &#250;nica &#224; noite.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria B:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1213,
        "indications": "<div>\r\n<p>- Profilaxia e o tratamento cr&#244;nico da asma;</p>\r\n<p>- Alivio dos sintomas diurnos e noturnos da rinite al&#233;rgica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-10 04:42:31",
        "name": "Uniair",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 4mg, 5mg ou 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "uniair",
        "substance": "Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#227;o de hipersensibilidade;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alucina&#231;&#245;es, sonol&#234;ncia, irritabilidade, agita&#231;&#227;o, ins&#244;nia e convuls&#227;o;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, dispepsia e diarr&#233;ia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Mialgia, hemorragias e hematoma;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Edema.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2797,
        "contraindications": "<p>- Hipersensibilidade aos componentes</p>",
        "dosage_adults": "<div>\r\n<p><strong>Dilui&#231;&#227;o:</strong>&#160;infus&#227;o IV, (100 mg/30 ml) 30 ml + 100 ml de SF 0,9 % ou SG 5%. Velocidade m&#225;xima de infus&#227;o: 1,1 mg/min ou 65 ml/h.</p>\r\n<p><strong>Dose usual:</strong>&#160;dose de ataque de 200 mg no dia 1, seguida de 100mg/dia a partir de ent&#227;o, por no m&#237;nimo 14 dias ap&#243;s a &#250;ltima cultura positiva.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Dilui&#231;&#227;o:</strong>&#160;infus&#227;o IV, (100 mg/30 ml) 30 ml + 100 ml de SF 0,9 % ou SG 5%. Velocidade m&#225;xima de infus&#227;o: 1,1 mg/min ou 65 ml/h.</p>\r\n<p><strong>Dose usual:</strong>&#160;dose de ataque de 200 mg no dia 1, seguida de 100mg/dia a partir de ent&#227;o, por no m&#237;nimo 14 dias ap&#243;s a &#250;ltima cultura positiva.</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1214,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Candid&#237;ase refrat&#225;ria</p>\r\n<p class=\"MsoNormal\">- Aspergilose refrat&#225;ria</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 00:35:51",
        "name": "Anidulafungina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 100 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "anidulafungina",
        "substance": "Anidulafungina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Coagulopatia</p>\r\n<p class=\"MsoNormal\">- Hipercalemia, hipocalemia, hipomagnesemia</p>\r\n<p class=\"MsoNormal\">- Convuls&#227;o, cefaleia</p>\r\n<p class=\"MsoNormal\">- Rubor</p>\r\n<p class=\"MsoNormal\">- Diarreia</p>\r\n<p class=\"MsoNormal\">- Erup&#231;&#227;o cut&#226;nea, prurido</p>\r\n<p class=\"MsoNormal\">- Prolongamento do intervalo QT no ECG</p>\r\n<p class=\"MsoNormal\">- Eleva&#231;&#227;o da bilirrubina plasm&#225;tica, plaquetopenia, eleva&#231;&#227;o da creatinina, eleva&#231;&#227;o da GGT, FA, AST e ALT.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2019,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Insufici&#234;ncia renal grave (ClCr&lt;10mL/min);</p>\r\n<p>- Intoler&#226;ncia a galactase, defici&#234;ncia de lactase ou de absor&#231;&#227;o de glicose-galactose;</p>\r\n<p>- Menores de 12 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>1cp VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "id": 1217,
        "indications": "<p>- Al&#237;vio dos sintomas relacionados a rinite al&#233;rgica sazonal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 92,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-04 00:45:22",
        "name": "Levolukast",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> com montelucaste 10mg + levocetirizina 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "levolukast",
        "substance": "Levocetirizina + Montelucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Infe&#231;&#227;o respirat&#243;ria alta;</p>\r\n<p>- Diarr&#233;ia, n&#225;useas e v&#244;mitos;</p>\r\n<p>- Rash cut&#226;neo;</p>\r\n<p>- Aumento de transaminases.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2233,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Dose usual:</strong> 5 - 10 mg/dia, VO.</p>\r\n<p><strong>Dose m&#225;xima:</strong> 10 mg/dia</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1229,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o arterial sist&#234;mica</p>\r\n<p class=\"MsoNormal\">-&#160;Angina Est&#225;vel Cr&#244;nica</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 03:46:32",
        "name": "Tenlopin",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimido:</strong> 5 mg e 10 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "Tensaliv",
        "substance": "Anlodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia, tontura, sonol&#234;ncia</p>\r\n<p class=\"MsoNormal\">- Palpita&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Rubor</p>\r\n<p class=\"MsoNormal\">- Dor abdominal, n&#225;usea</p>\r\n<p class=\"MsoNormal\">- Edema</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<p class=\"MsoNormal\">- Leucopenia, trombocitopenia, hiperglicemia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 4310,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>",
        "dosage_adults": "<ul>\r\n<li>Uretra masculina: utilizar aproximadamente metade do conte&#250;do da bisnaga; aplicar uma pin&#231;a peniana por alguns minutos, ap&#243;s o qual o restante da geleia pode ser instilado. A anestesia &#233; suficiente para cateterismos.</li>\r\n<li>Uretra feminina: instilar 3-5 g da geleia. Para obter-se a anestesia adequada, deve-se aguardar alguns minutos para realizar o exame.</li>\r\n<li>N&#227;o se deve administrar mais do que quatro doses em um per&#237;odo de 24 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Em crian&#231;as com idade entre 5 a 12 anos, a dose n&#227;o deve exceder 6 mg/kg.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1239,
        "indications": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><span style=\"mso-fareast- mso-fareast-language: PT-BR;\">Cistoscopia, cateteriza&#231;&#227;o, explora&#231;&#227;o por sonda e outros procedimentos endouretrais;</span></p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">Tratamento sintom&#225;tico da dor relacionada a cistite e uretrite.</p>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:50:25",
        "name": "Lidocaína tópico",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Cloridrato de lidoca&#237;na geleia 2%, bisnaga com 30g</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lidocaina-topico",
        "substance": "Lidocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Toxicidade sist&#234;mica aguda por&#160;</span><span style=\"color: #000000;\">excesso de dose, r&#225;pida absor&#231;&#227;o, hipersensibilidade ou idiossincrasia reduzida toler&#226;ncia do paciente.</span></li>\r\n<li><span style=\"color: #000000;\">Nervosismo, tontura, convuls&#245;es, inconsci&#234;ncia</span></li>\r\n<li><span style=\"color: #000000;\">Hipotens&#227;o, depress&#227;o&#160;mioc&#225;rdica, bradicardia e parada card&#237;aca</span></li>\r\n<li><span style=\"color: #000000;\">Choque anafil&#225;tico</span></li>\r\n<li><span style=\"color: #000000;\">Se a dose ou a administra&#231;&#227;o resultar em altos n&#237;veis sangu&#237;neos, &#233; prov&#225;vel que alguns pacientes necessitem de aten&#231;&#227;o especial para prevenir efeitos adversos potencialmente perigosos:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Pacientes com bloqueio card&#237;aco parcial ou completo;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes idosos e pacientes debilitados;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com doen&#231;a hep&#225;tica avan&#231;ada ou disfun&#231;&#227;o renal grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com bradicardia;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com choque grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com epilepsia.</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">Cloridrato de lidoca&#237;na geleia 2% &#233; possivelmente um porfirinog&#234;nico e deve ser somente prescrito a pacientes com porfiria aguda em indica&#231;&#245;es fortes ou urgentes. Precau&#231;&#245;es apropriadas devem ser tomadas para todos pacientes porf&#237;ricos.&#160;</span></li>\r\n<li><span style=\"color: #000000;\">Outros locais de administra&#231;&#227;o n&#227;o recomendados devem ser evitados devido aos efeitos indesej&#225;veis desconhecidos.</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3829,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Pacientes com insufici&#234;ncia renal, hep&#225;tica e card&#237;aca.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\"><strong>Leishmaniose visceral em fase n&#227;o final</strong></p>\r\n<p class=\"MsoNormal\">- 20 mg/kg/dia (Sb<sup>5+</sup>), IV ou IM, durante 20 dias. Em caso de recorr&#234;ncia, reiniciar tratamento imediatamente.</p>\r\n<p class=\"MsoNormal\"><strong>Leishmaniose tegumentar</strong></p>\r\n<p class=\"MsoNormal\">- Les&#245;es cut&#226;neas: 15 mg/kg/dia (Sb<sup>5+</sup>), IV ou IM, durante 20 dias. Se n&#227;o houver cicatriza&#231;&#227;o completa ap&#243;s 12 semanas do t&#233;rmino do tratamento, repetir o tratamento por 30 dias. Na aus&#234;ncia de melhora, utilizar drogas de segunda escolha.</p>\r\n<p class=\"MsoNormal\">- Na forma difusa: 20 mg/kg/dia (Sb<sup>5+</sup>), IV ou IM, durante 20 dias.</p>\r\n<p class=\"MsoNormal\">- Les&#245;es mucosas: 20 mg/kg/dia (Sb<sup>5+</sup>), IV ou IM, durante 30 dias. Se n&#227;o houver cicatriza&#231;&#227;o completa ap&#243;s 12 semanas do t&#233;rmino do tratamento, o esquema dever&#225; ser repetido apenas uma vez.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong>Leishmaniose tegumentar</strong></p>\r\n<p class=\"MsoNormal\">- Les&#245;es cut&#226;neas: 15 mg/kg/dia (Sb<sup>5+</sup>), IV ou IM, durante 20 dias. Se n&#227;o houver cicatriza&#231;&#227;o completa ap&#243;s 12 semanas do t&#233;rmino do tratamento, repetir o tratamento por 30 dias. Na aus&#234;ncia de melhora, utilizar drogas de segunda escolha.</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria X:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1240,
        "indications": "<p class=\"MsoNormal\">- Tratamento de leishmaniose tegumentar americana ou cut&#226;neo-mucosa e tratamento de Leishmaniose visceral ou calazar.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-08-05 19:49:12",
        "name": "Glucantime",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 300 mg/ml (ampola com 5 ml)</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glucantime",
        "substance": "Antimoniato de Meglumina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Dor nas articula&#231;&#245;es</p>\r\n<p class=\"MsoNormal\">- Dores musculares</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito</p>\r\n<p class=\"MsoNormal\">- Cefaleia</p>\r\n<p class=\"MsoNormal\">- Febre</p>\r\n<p class=\"MsoNormal\">- Anorexia, hiporexia</p>\r\n<p class=\"MsoNormal\">- Aumento da lipase e amilase</p>\r\n<p class=\"MsoNormal\">- Prolongamento do intervalo QT e invers&#227;o da onda T no ECG (dose dependentes e geralmente revers&#237;veis)</p>\r\n<p class=\"MsoNormal\">- Leucopenia</p>\r\n<p class=\"MsoNormal\">- Eleva&#231;&#227;o das transaminases e fosfatase alcalina</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Contraindicado na insufici&#234;ncia renal e hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 4430,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>",
        "dosage_adults": "<ul>\r\n<li>Uretra masculina: utilizar aproximadamente metade do conte&#250;do da bisnaga; aplicar uma pin&#231;a peniana por alguns minutos, ap&#243;s o qual o restante da geleia pode ser instilado. A anestesia &#233; suficiente para cateterismos.</li>\r\n<li>Uretra feminina: instilar 3-5 g da geleia. Para obter-se a anestesia adequada, deve-se aguardar alguns minutos para realizar o exame.</li>\r\n<li>N&#227;o se deve administrar mais do que quatro doses em um per&#237;odo de 24 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Em crian&#231;as com idade entre 5 a 12 anos, a dose n&#227;o deve exceder 6 mg/kg.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1241,
        "indications": "<ul>\r\n<li>Indicado para tratar pequenos ferimentos em geral</li>\r\n<li>Indicada como anest&#233;sico de superf&#237;cie e lubrificante para&#160;a&#160;uretra feminina e masculina durante cistoscopia, cateteriza&#231;&#227;o, explora&#231;&#227;o por sonda e outros procedimentos endouretrais</li>\r\n<li>O tratamento sintom&#225;tico da dor em conec&#231;&#227;o com cistite e uretrite</li>\r\n<li>&#201; indicado no tratamento e profilaxia de hemorr&#243;idas internas e externas e varizes</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 19:03:45",
        "name": "Dermomax",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Cloridrato de lidoca&#237;na 40mg/g, bisnaga com 5g e 30g</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lidocaina-topico",
        "substance": "Lidocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Toxicidade sist&#234;mica aguda por&#160;</span><span style=\"color: #000000;\">excesso de dose, r&#225;pida absor&#231;&#227;o, hipersensibilidade ou idiossincrasia reduzida toler&#226;ncia do paciente.</span></li>\r\n<li><span style=\"color: #000000;\">Nervosismo, tontura, convuls&#245;es, inconsci&#234;ncia</span></li>\r\n<li><span style=\"color: #000000;\">Hipotens&#227;o, depress&#227;o&#160;mioc&#225;rdica, bradicardia e parada card&#237;aca</span></li>\r\n<li><span style=\"color: #000000;\">Choque anafil&#225;tico</span></li>\r\n<li><span style=\"color: #000000;\">Se a dose ou a administra&#231;&#227;o resultar em altos n&#237;veis sangu&#237;neos, &#233; prov&#225;vel que alguns pacientes necessitem de aten&#231;&#227;o especial para prevenir efeitos adversos potencialmente perigosos:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Pacientes com bloqueio card&#237;aco parcial ou completo;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes idosos e pacientes debilitados;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com doen&#231;a hep&#225;tica avan&#231;ada ou disfun&#231;&#227;o renal grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com bradicardia;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com choque grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com epilepsia.</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">Cloridrato de lidoca&#237;na geleia 2% &#233; possivelmente um porfirinog&#234;nico e deve ser somente prescrito a pacientes com porfiria aguda em indica&#231;&#245;es fortes ou urgentes. Precau&#231;&#245;es apropriadas devem ser tomadas para todos pacientes porf&#237;ricos.&#160;</span></li>\r\n<li><span style=\"color: #000000;\">Outros locais de administra&#231;&#227;o n&#227;o recomendados devem ser evitados devido aos efeitos indesej&#225;veis desconhecidos.</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 6981,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>",
        "dosage_adults": "<div>\r\n<p>Labca&#237;na geleia:</p>\r\n<ul>\r\n<li>Uretra masculina: utilizar aproximadamente metade do conte&#250;do da bisnaga; aplicar uma pin&#231;a peniana por alguns minutos, ap&#243;s o qual o restante da geleia pode ser instilado. A anestesia &#233; suficiente para cateterismos.</li>\r\n<li>Uretra feminina: instilar 3-5 g da geleia. Para obter-se a anestesia adequada, deve-se aguardar alguns minutos para realizar o exame.</li>\r\n<li>N&#227;o se deve administrar mais do que quatro doses em um per&#237;odo de 24 horas.</li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\">Labca&#237;na pomada:&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Intuba&#231;&#227;o endotraqueal: dose recomendada 1-2g (dose m&#225;xima:&#160;2g)</li>\r\n<li class=\"MsoNormal\">Anestesia da gengiva para remo&#231;&#227;o de t&#225;rtaro: dose recomendada 1-5g (dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Anestesia de mucosas, al&#237;vio da dor durante instrumenta&#231;&#227;o: dose recomendada 1-5g (dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Pequenas queimaduras, queimaduras de sol, prurido, herpes zoster e labial, rachadura dos seios e picadas de insetos&#160;0,2-0,5g por 10 cm2&#160;(dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Ap&#243;s a aplica&#231;&#227;o de uma dose m&#225;xima endotraqueal ou nas mucosas, a pr&#243;xima dose n&#227;o deve ser aplicada em at&#233; 4 horas.</li>\r\n<li class=\"MsoNormal\">Ap&#243;s uma dose m&#225;xima aplicada no reto ou em queimaduras, o intervalo m&#237;nimo de dose deve ser de 8 horas.</li>\r\n<li class=\"MsoNormal\">N&#227;o mais que 20 g da pomada deve ser administrada em um per&#237;odo de 24 horas em pacientes sadios.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p>Labca&#237;na geleia:</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Em crian&#231;as com idade entre 5 a 12 anos, a dose n&#227;o deve exceder 6 mg/kg.</li>\r\n</ul>\r\n<hr>\r\n<p>Labca&#237;na pomada:</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Crian&#231;as entre 5 a 12 anos de idade e maiores que 20 kg de peso: a&#160;dose &#250;nica n&#227;o deve exceder 0,1g de pomada/kg de peso corp&#243;reo (corresponde a 5 mg de lidoca&#237;na/kg de peso corp&#243;reo).</li>\r\n<li class=\"MsoNormal\">O intervalo de dose m&#237;nimo em crian&#231;as deve ser de 8 horas.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1242,
        "indications": "<div>\r\n<ul>\r\n<li>Labca&#237;na geleia:\r\n<ul>\r\n<li>Indicado para tratar pequenos ferimentos em geral</li>\r\n<li>Indicada como anest&#233;sico de superf&#237;cie e lubrificante para&#160;a&#160;uretra feminina e masculina durante cistoscopia, cateteriza&#231;&#227;o, explora&#231;&#227;o por sonda e outros procedimentos endouretrais</li>\r\n<li>O tratamento sintom&#225;tico da dor em conec&#231;&#227;o com cistite e uretrite</li>\r\n<li>&#201; indicado no tratamento e profilaxia de hemorr&#243;idas internas e externas e varizes</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\">Labca&#237;na pomada\r\n<ul>\r\n<li class=\"MsoNormal\">Al&#237;vio da dor durante realiza&#231;&#227;o de exames e instrumenta&#231;&#227;o (ex.: proctoscopia, sigmoidoscopia, cistoscopia, intuba&#231;&#227;o endotraqueal)</li>\r\n<li class=\"MsoNormal\">Al&#237;vio tempor&#225;rio da dor associada a queimaduras leves e abras&#245;es da pele (ex.: queimadura de sol, herpes zoster e labial, prurido, rachadura de seios, picada de inseto)</li>\r\n<li class=\"MsoNormal\">Anestesia de mucosas (ex.: casos de hemorroidas e fissura).</li>\r\n<li>Odontologia: anestesia superficial da gengiva antes da inje&#231;&#227;o de anest&#233;sicos, remo&#231;&#227;o de t&#225;rtaro.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 69,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 22:19:54",
        "name": "Labcaína",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Geleia 20mg/g, bisnaga com 30g</li>\r\n<li class=\"MsoNormal\">Pomada 50mg/g, bisnaga com 25g</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lidocaina-topico",
        "substance": "Lidocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Toxicidade sist&#234;mica aguda por&#160;</span><span style=\"color: #000000;\">excesso de dose, r&#225;pida absor&#231;&#227;o, hipersensibilidade ou idiossincrasia reduzida toler&#226;ncia do paciente.</span></li>\r\n<li><span style=\"color: #000000;\">Nervosismo, tontura, convuls&#245;es, inconsci&#234;ncia</span></li>\r\n<li><span style=\"color: #000000;\">Hipotens&#227;o, depress&#227;o&#160;mioc&#225;rdica, bradicardia e parada card&#237;aca</span></li>\r\n<li><span style=\"color: #000000;\">Choque anafil&#225;tico</span></li>\r\n<li><span style=\"color: #000000;\">Se a dose ou a administra&#231;&#227;o resultar em altos n&#237;veis sangu&#237;neos, &#233; prov&#225;vel que alguns pacientes necessitem de aten&#231;&#227;o especial para prevenir efeitos adversos potencialmente perigosos:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Pacientes com bloqueio card&#237;aco parcial ou completo;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes idosos e pacientes debilitados;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com doen&#231;a hep&#225;tica avan&#231;ada ou disfun&#231;&#227;o renal grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com bradicardia;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com choque grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com epilepsia.</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">Cloridrato de lidoca&#237;na geleia 2% &#233; possivelmente um porfirinog&#234;nico e deve ser somente prescrito a pacientes com porfiria aguda em indica&#231;&#245;es fortes ou urgentes. Precau&#231;&#245;es apropriadas devem ser tomadas para todos pacientes porf&#237;ricos.&#160;</span></li>\r\n<li><span style=\"color: #000000;\">Outros locais de administra&#231;&#227;o n&#227;o recomendados devem ser evitados devido aos efeitos indesej&#225;veis desconhecidos.</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 6886,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>",
        "dosage_adults": "<div>\r\n<p>Geleia:</p>\r\n<ul>\r\n<li>Uretra masculina: utilizar aproximadamente metade do conte&#250;do da bisnaga; aplicar uma pin&#231;a peniana por alguns minutos, ap&#243;s o qual o restante da geleia pode ser instilado. A anestesia &#233; suficiente para cateterismos.</li>\r\n<li>Uretra feminina: instilar 3-5 g da geleia. Para obter-se a anestesia adequada, deve-se aguardar alguns minutos para realizar o exame.</li>\r\n<li>N&#227;o se deve administrar mais do que quatro doses em um per&#237;odo de 24 horas.</li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\">Pomada:&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Intuba&#231;&#227;o endotraqueal: dose recomendada 1-2g (dose m&#225;xima:&#160;2g)</li>\r\n<li class=\"MsoNormal\">Anestesia da gengiva para remo&#231;&#227;o de t&#225;rtaro: dose recomendada 1-5g (dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Anestesia de mucosas, al&#237;vio da dor durante instrumenta&#231;&#227;o: dose recomendada 1-5g (dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Pequenas queimaduras, queimaduras de sol, prurido, herpes zoster e labial, rachadura dos seios e picadas de insetos&#160;0,2-0,5g por 10 cm2&#160;(dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Ap&#243;s a aplica&#231;&#227;o de uma dose m&#225;xima endotraqueal ou nas mucosas, a pr&#243;xima dose n&#227;o deve ser aplicada em at&#233; 4 horas.</li>\r\n<li class=\"MsoNormal\">Ap&#243;s uma dose m&#225;xima aplicada no reto ou em queimaduras, o intervalo m&#237;nimo de dose deve ser de 8 horas.</li>\r\n<li class=\"MsoNormal\">N&#227;o mais que 20 g da pomada deve ser administrada em um per&#237;odo de 24 horas em pacientes sadios.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p>Geleia:</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Em crian&#231;as com idade entre 5 a 12 anos, a dose n&#227;o deve exceder 6 mg/kg.</li>\r\n</ul>\r\n<hr>\r\n<p>Pomada:</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Crian&#231;as entre 5 a 12 anos de idade e maiores que 20 kg de peso: a&#160;dose &#250;nica n&#227;o deve exceder 0,1g de pomada/kg de peso corp&#243;reo (corresponde a 5 mg de lidoca&#237;na/kg de peso corp&#243;reo).</li>\r\n<li class=\"MsoNormal\">O intervalo de dose m&#237;nimo em crian&#231;as deve ser de 8 horas.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1243,
        "indications": "<div>\r\n<ul>\r\n<li>Geleia:\r\n<ul>\r\n<li>Indicado para tratar pequenos ferimentos em geral</li>\r\n<li>Indicada como anest&#233;sico de superf&#237;cie e lubrificante para&#160;a&#160;uretra feminina e masculina durante cistoscopia, cateteriza&#231;&#227;o, explora&#231;&#227;o por sonda e outros procedimentos endouretrais</li>\r\n<li>O tratamento sintom&#225;tico da dor em conec&#231;&#227;o com cistite e uretrite</li>\r\n<li>&#201; indicado no tratamento e profilaxia de hemorr&#243;idas internas e externas e varizes</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\">Pomada:\r\n<ul>\r\n<li class=\"MsoNormal\">Al&#237;vio da dor durante realiza&#231;&#227;o de exames e instrumenta&#231;&#227;o (ex.: proctoscopia, sigmoidoscopia, cistoscopia, intuba&#231;&#227;o endotraqueal)</li>\r\n<li class=\"MsoNormal\">Al&#237;vio tempor&#225;rio da dor associada a queimaduras leves e abras&#245;es da pele (ex.: queimadura de sol, herpes zoster e labial, prurido, rachadura de seios, picada de inseto)</li>\r\n<li class=\"MsoNormal\">Anestesia de mucosas (ex.: casos de hemorroidas e fissura).</li>\r\n<li>Odontologia: anestesia superficial da gengiva antes da inje&#231;&#227;o de anest&#233;sicos, remo&#231;&#227;o de t&#225;rtaro.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 94,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:50:18",
        "name": "Lidial",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Geleia 5%, bisnaga com 25g</li>\r\n<li class=\"MsoNormal\">Pomada 50mg/g, bisnaga com 25g</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lidocaina-topico",
        "substance": "Lidocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Toxicidade sist&#234;mica aguda por&#160;</span><span style=\"color: #000000;\">excesso de dose, r&#225;pida absor&#231;&#227;o, hipersensibilidade ou idiossincrasia reduzida toler&#226;ncia do paciente.</span></li>\r\n<li><span style=\"color: #000000;\">Nervosismo, tontura, convuls&#245;es, inconsci&#234;ncia</span></li>\r\n<li><span style=\"color: #000000;\">Hipotens&#227;o, depress&#227;o&#160;mioc&#225;rdica, bradicardia e parada card&#237;aca</span></li>\r\n<li><span style=\"color: #000000;\">Choque anafil&#225;tico</span></li>\r\n<li><span style=\"color: #000000;\">Se a dose ou a administra&#231;&#227;o resultar em altos n&#237;veis sangu&#237;neos, &#233; prov&#225;vel que alguns pacientes necessitem de aten&#231;&#227;o especial para prevenir efeitos adversos potencialmente perigosos:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Pacientes com bloqueio card&#237;aco parcial ou completo;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes idosos e pacientes debilitados;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com doen&#231;a hep&#225;tica avan&#231;ada ou disfun&#231;&#227;o renal grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com bradicardia;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com choque grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com epilepsia.</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">Cloridrato de lidoca&#237;na geleia 2% &#233; possivelmente um porfirinog&#234;nico e deve ser somente prescrito a pacientes com porfiria aguda em indica&#231;&#245;es fortes ou urgentes. Precau&#231;&#245;es apropriadas devem ser tomadas para todos pacientes porf&#237;ricos.&#160;</span></li>\r\n<li><span style=\"color: #000000;\">Outros locais de administra&#231;&#227;o n&#227;o recomendados devem ser evitados devido aos efeitos indesej&#225;veis desconhecidos.</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4536,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>",
        "dosage_adults": "<div>\r\n<p>Geleia:</p>\r\n<ul>\r\n<li>Uretra masculina: utilizar aproximadamente metade do conte&#250;do da bisnaga; aplicar uma pin&#231;a peniana por alguns minutos, ap&#243;s o qual o restante da geleia pode ser instilado. A anestesia &#233; suficiente para cateterismos.</li>\r\n<li>Uretra feminina: instilar 3-5 g da geleia. Para obter-se a anestesia adequada, deve-se aguardar alguns minutos para realizar o exame.</li>\r\n<li>N&#227;o se deve administrar mais do que quatro doses em um per&#237;odo de 24 horas.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p>Geleia:</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Em crian&#231;as com idade entre 5 a 12 anos, a dose n&#227;o deve exceder 6 mg/kg.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1244,
        "indications": "<ul>\r\n<li>Geleia:\r\n<ul>\r\n<li>Indicado para tratar pequenos ferimentos em geral</li>\r\n<li>Indicada como anest&#233;sico de superf&#237;cie e lubrificante para&#160;a&#160;uretra feminina e masculina durante cistoscopia, cateteriza&#231;&#227;o, explora&#231;&#227;o por sonda e outros procedimentos endouretrais</li>\r\n<li>O tratamento sintom&#225;tico da dor em conec&#231;&#227;o com cistite e uretrite</li>\r\n<li>&#201; indicado no tratamento e profilaxia de hemorr&#243;idas internas e externas e varizes</li>\r\n</ul>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 94,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:50:35",
        "name": "Lidogel",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Geleia 2%, bisnaga com 30g</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lidocaina-topico",
        "substance": "Lidocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Toxicidade sist&#234;mica aguda por&#160;</span><span style=\"color: #000000;\">excesso de dose, r&#225;pida absor&#231;&#227;o, hipersensibilidade ou idiossincrasia reduzida toler&#226;ncia do paciente.</span></li>\r\n<li><span style=\"color: #000000;\">Nervosismo, tontura, convuls&#245;es, inconsci&#234;ncia</span></li>\r\n<li><span style=\"color: #000000;\">Hipotens&#227;o, depress&#227;o&#160;mioc&#225;rdica, bradicardia e parada card&#237;aca</span></li>\r\n<li><span style=\"color: #000000;\">Choque anafil&#225;tico</span></li>\r\n<li><span style=\"color: #000000;\">Se a dose ou a administra&#231;&#227;o resultar em altos n&#237;veis sangu&#237;neos, &#233; prov&#225;vel que alguns pacientes necessitem de aten&#231;&#227;o especial para prevenir efeitos adversos potencialmente perigosos:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Pacientes com bloqueio card&#237;aco parcial ou completo;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes idosos e pacientes debilitados;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com doen&#231;a hep&#225;tica avan&#231;ada ou disfun&#231;&#227;o renal grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com bradicardia;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com choque grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com epilepsia.</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">Cloridrato de lidoca&#237;na geleia 2% &#233; possivelmente um porfirinog&#234;nico e deve ser somente prescrito a pacientes com porfiria aguda em indica&#231;&#245;es fortes ou urgentes. Precau&#231;&#245;es apropriadas devem ser tomadas para todos pacientes porf&#237;ricos.&#160;</span></li>\r\n<li><span style=\"color: #000000;\">Outros locais de administra&#231;&#227;o n&#227;o recomendados devem ser evitados devido aos efeitos indesej&#225;veis desconhecidos.</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5566,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\">Pomada:&#160;</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Intuba&#231;&#227;o endotraqueal: dose recomendada 1-2g (dose m&#225;xima:&#160;2g)</li>\r\n<li class=\"MsoNormal\">Anestesia da gengiva para remo&#231;&#227;o de t&#225;rtaro: dose recomendada 1-5g (dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Anestesia de mucosas, al&#237;vio da dor durante instrumenta&#231;&#227;o: dose recomendada 1-5g (dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Pequenas queimaduras, queimaduras de sol, prurido, herpes zoster e labial, rachadura dos seios e picadas de insetos&#160;0,2-0,5g por 10 cm2&#160;(dose m&#225;xima:&#160;10g)</li>\r\n<li class=\"MsoNormal\">Ap&#243;s a aplica&#231;&#227;o de uma dose m&#225;xima endotraqueal ou nas mucosas, a pr&#243;xima dose n&#227;o deve ser aplicada em at&#233; 4 horas.</li>\r\n<li class=\"MsoNormal\">Ap&#243;s uma dose m&#225;xima aplicada no reto ou em queimaduras, o intervalo m&#237;nimo de dose deve ser de 8 horas.</li>\r\n<li class=\"MsoNormal\">N&#227;o mais que 20 g da pomada deve ser administrada em um per&#237;odo de 24 horas em pacientes sadios.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p>Pomada:</p>\r\n<ul>\r\n<li class=\"MsoNormal\">Crian&#231;as entre 5 a 12 anos de idade e maiores que 20 kg de peso: a&#160;dose &#250;nica n&#227;o deve exceder 0,1g de pomada/kg de peso corp&#243;reo (corresponde a 5 mg de lidoca&#237;na/kg de peso corp&#243;reo).</li>\r\n<li class=\"MsoNormal\">O intervalo de dose m&#237;nimo em crian&#231;as deve ser de 8 horas.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1245,
        "indications": "<ul>\r\n<li>Pomada:\r\n<ul>\r\n<li class=\"MsoNormal\">Al&#237;vio da dor durante realiza&#231;&#227;o de exames e instrumenta&#231;&#227;o (ex.: proctoscopia, sigmoidoscopia, cistoscopia, intuba&#231;&#227;o endotraqueal)</li>\r\n<li class=\"MsoNormal\">Al&#237;vio tempor&#225;rio da dor associada a queimaduras leves e abras&#245;es da pele (ex.: queimadura de sol, herpes zoster e labial, prurido, rachadura de seios, picada de inseto)</li>\r\n<li class=\"MsoNormal\">Anestesia de mucosas (ex.: casos de hemorroidas e fissura).</li>\r\n<li>Odontologia: anestesia superficial da gengiva antes da inje&#231;&#227;o de anest&#233;sicos, remo&#231;&#227;o de t&#225;rtaro.</li>\r\n</ul>\r\n</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 94,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:50:43",
        "name": "Lidopass",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\">Pomada 50mg/g, bisnaga com 25g, sabor laranja</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lidocaina-topico",
        "substance": "Lidocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Toxicidade sist&#234;mica aguda por&#160;</span><span style=\"color: #000000;\">excesso de dose, r&#225;pida absor&#231;&#227;o, hipersensibilidade ou idiossincrasia reduzida toler&#226;ncia do paciente.</span></li>\r\n<li><span style=\"color: #000000;\">Nervosismo, tontura, convuls&#245;es, inconsci&#234;ncia</span></li>\r\n<li><span style=\"color: #000000;\">Hipotens&#227;o, depress&#227;o&#160;mioc&#225;rdica, bradicardia e parada card&#237;aca</span></li>\r\n<li><span style=\"color: #000000;\">Choque anafil&#225;tico</span></li>\r\n<li><span style=\"color: #000000;\">Se a dose ou a administra&#231;&#227;o resultar em altos n&#237;veis sangu&#237;neos, &#233; prov&#225;vel que alguns pacientes necessitem de aten&#231;&#227;o especial para prevenir efeitos adversos potencialmente perigosos:</span>\r\n<ul>\r\n<li><span style=\"color: #000000;\">Pacientes com bloqueio card&#237;aco parcial ou completo;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes idosos e pacientes debilitados;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com doen&#231;a hep&#225;tica avan&#231;ada ou disfun&#231;&#227;o renal grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com bradicardia;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com choque grave;</span></li>\r\n<li><span style=\"color: #000000;\">Pacientes com epilepsia.</span></li>\r\n</ul>\r\n</li>\r\n<li><span style=\"color: #000000;\">Cloridrato de lidoca&#237;na geleia 2% &#233; possivelmente um porfirinog&#234;nico e deve ser somente prescrito a pacientes com porfiria aguda em indica&#231;&#245;es fortes ou urgentes. Precau&#231;&#245;es apropriadas devem ser tomadas para todos pacientes porf&#237;ricos.&#160;</span></li>\r\n<li><span style=\"color: #000000;\">Outros locais de administra&#231;&#227;o n&#227;o recomendados devem ser evitados devido aos efeitos indesej&#225;veis desconhecidos.</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2833,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Hepatopatia (Child B ou C)</p>\r\n<p class=\"MsoNormal\">- Hemorragia ativa</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Preven&#231;&#227;o de AVC:</strong> 5 mg VO 2x/dia</p>\r\n<p><strong>Preven&#231;&#227;o de tromboembolismo venoso:</strong> 2,5 mg VO, 2x/dia (iniciar 12h a 24h ap&#243;s a cirurgia e manter por 14 dias para artroplastia de joelho e 35 dias para artroplastia de quadril).</p>\r\n<p><strong>Tratamento de trombose venosa profunda (TVP) e embolia pulmonar (EP):</strong>&#160;10 mg VO, 2x/dia, durante 7 dias, seguida de dose de 5 mg VO 2x/dia.</p>\r\n<p><strong>Preven&#231;&#227;o da TVP e EP recorrentes:</strong>&#160;2,5mg VO, 2x/dia, ap&#243;s pelo menos 6 meses de tratamento para a TVP ou EP.</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1246,
        "indications": "<div>\r\n<p class=\"MsoNormal\">-&#160;Preven&#231;&#227;o de tromboembolismo venoso: artroplastia eletiva de quadril ou de joelho</p>\r\n<p class=\"MsoNormal\">- Preven&#231;&#227;o de AVC em pacientes com fibrila&#231;&#227;o atrial n&#227;o valvar</p>\r\n<p class=\"MsoNormal\">- Trombose e tromboembolismo venoso</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:53:11",
        "name": "Eliquis",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong> 2,5 mg e 5 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "eliquis",
        "substance": "Apixabana",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Sangramentos espont&#226;neos ou p&#243;s-traum&#225;ticos</p>\r\n<p class=\"MsoNormal\">- N&#225;usea</p>\r\n<p class=\"MsoNormal\">- Anemia</p>\r\n<p class=\"MsoNormal\">- Equimose</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- ClCr&lt; 15 ml/min: n&#227;o recomendado.</p>\r\n<p class=\"MsoNormal\">- Hemodi&#225;lise: 5 mg, VO, 2x/dia.</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia hep&#225;tica: evitar.</p>\r\n</div>"
    },
    {
        "content_length": 3542,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser usado concomitantemente com Pimozida, Terfenadina, Astemizol ou Cisaprida. A inibi&#231;&#227;o da isoenzima 3A4 do citocromo P450 pelo aprepitanto pode resultar em aumento das concentra&#231;&#245;es plasm&#225;ticas desses medicamentos, o que pode causar rea&#231;&#245;es graves ou potencialmente fatais.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>P&#243; liofilizado:</strong> 150 mg no 1&#186; dia de infus&#227;o IV, durante 20-30 min, iniciada aproximadamente 30 minutos antes da quimioterapia. Nenhuma c&#225;psula &#233; administrada no 2&#186; ou 3&#186; dia. Deve ser administrado junto com um corticosteroide e um antagonista da 5-HT3.</p>\r\n<p>- A dexametasona deve ser administrada 30 min antes da quimioterapia no 1&#186; dia e na manh&#227; do 2&#186; e 4&#186; dias e tamb&#233;m deve ser administrada nas noites do 3&#186; e 4&#186; dias.</p>\r\n<p>- A ondansetrona deve ser administrada 30 min antes da quimioterapia no 1&#186; dia.</p>\r\n<hr>\r\n<p><strong>C&#225;psulas:</strong> 125 mg VO 1 hora antes de iniciar o tratamento quimioter&#225;pico e 80 mg VO pela manh&#227; por 2 dias ap&#243;s o tratamento quimioter&#225;pico.</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1247,
        "indications": "<p class=\"MsoNormal\">- Indicado em associa&#231;&#227;o com outros antiem&#233;ticos para a preven&#231;&#227;o de n&#225;useas e v&#244;mitos agudos e tardios associados a ciclos iniciais e repetidos de quimioterapia antineopl&#225;sica moderadamente e altamente emetog&#234;nica.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 191,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 01:45:14",
        "name": "Emend",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 150 mg em 1 frasco-ampola</li>\r\n<li class=\"MsoNormal\"><strong>C&#225;psula:</strong> embalagem com 3 c&#225;psulas, sendo uma de 125 mg e duas de 80 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "emend",
        "substance": "Aprepipanto",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Redu&#231;&#227;o do apetite</p>\r\n<p class=\"MsoNormal\">- Solu&#231;os</p>\r\n<p class=\"MsoNormal\">- Dispepsia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<p class=\"MsoNormal\">- Prurido, erup&#231;&#245;es cut&#226;neas, urtic&#225;ria</p>\r\n<p class=\"MsoNormal\">- Rubor, eritema, dispneia</p>\r\n<p class=\"MsoNormal\">- ALT elevada</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3806,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser aplicado intravascularmente.</p>\r\n<p class=\"MsoNormal\">- Sangramento arterial e venoso abundantes.</p>\r\n<p class=\"MsoNormal\">- Hipersensibilidade conhecida a prote&#237;nas de origem bovina ou a qualquer outro componente da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose usual:</strong></p>\r\n<ul>\r\n<li>A aplica&#231;&#227;o deve ser individualizada.</li>\r\n<li>A dosagem individual tem uma t&#237;pica extens&#227;o de 0,5ml a 4 ml.</li>\r\n<li>Para alguns procedimentos (exemplo: trauma no f&#237;gado ou selagem em grandes queimaduras) podem ser exigidos volumes maiores (10 ml ou mais).</li>\r\n<li>O volume inicial a ser aplicado na parte anat&#244;mica escolhida ou no alvo da &#225;rea de superf&#237;cie, deve ser suficiente para cobrir inteiramente a &#225;rea pretendida de aplica&#231;&#227;o e este pode ser repetido, se necess&#225;rio.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1248,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Ades&#227;o de tecido;</p>\r\n<p class=\"MsoNormal\">- Suporte para sutura;</p>\r\n<p class=\"MsoNormal\">- Hemostasia;</p>\r\n<p class=\"MsoNormal\">- Cuidado da ferida cir&#250;rgica;</p>\r\n<p class=\"MsoNormal\">- Selagem de cavidades corporais e espa&#231;os subaracnoides.&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 171,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:18:37",
        "name": "Beriplast P",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Solu&#231;&#227;o injet&#225;vel:</span></strong>&#160; &#233; constitu&#237;do por dois conjuntos:&#160;<span style=\"text-decoration: underline;\">Combi-Set I:</span> um frasco de p&#243; liofilizado contendo fibrinog&#234;nio e fator XIII de coagula&#231;&#227;o; um frasco de solu&#231;&#227;o de aprotinina; um dispositivo de transfer&#234;ncia. <span style=\"text-decoration: underline;\">Combi-Set II:</span> um frasco de p&#243; liofilizado contendo trombina; um frasco de solu&#231;&#227;o de cloreto de c&#225;lcio; um dispositivo de transfer&#234;ncia; sendo 1ml p&#243; li&#243;fito injet&#225;vel + 3 ml de solu&#231;&#227;o diluente.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "trasylol",
        "substance": "Fibrinogênio + Fator XIII + Aprotinina + Trombina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Dispneia, rubor facial/erup&#231;&#227;o cut&#226;nea, urtic&#225;ria, hipotens&#227;o, broncoespasmo</p>\r\n<p class=\"MsoNormal\">- Risco de anafilaxia, principalmente quando usado em uma segunda vez</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2493,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong> 10 ou 15 mg VO 1x/dia</p>\r\n<p><strong>Transtorno bipolar:</strong> 15 mg/dia VO, inicialmente. Manuten&#231;&#227;o com 15-30 mg/dia, VO.</p>\r\n</div>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1252,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Esquizofrenia</p>\r\n<p class=\"MsoNormal\">- Transtornos bipolares</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 156,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 22:10:48",
        "name": "Kavium",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Comprimido:</strong> 10mg, 15mg</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 branca em duas vias).</p>",
        "record_status": 1,
        "slug": "Kavium",
        "substance": "Aripiprazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia, vertigem, acatisia, ansiedade, ins&#244;nia, sonol&#234;ncia e inquieta&#231;&#227;o;</p>\r\n<p class=\"MsoNormal\">- N&#225;useas, anorexia, v&#244;mitos e constipa&#231;&#227;o;</p>\r\n<p class=\"MsoNormal\">- Edema, taquicardia, bradicardia, hipertens&#227;o, hipotens&#227;o;</p>\r\n<p class=\"MsoNormal\">- Tosse, dispneia, perda de peso, incontin&#234;ncia urin&#225;ria.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3564,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<p><strong>- Se peso entre 69 - 80 kg:</strong>&#160;3 comprimidos de maior pot&#234;ncia (100+200) diariamente por tr&#234;s dias e aconselhar o paciente a retornar se n&#227;o houver melhora cl&#237;nica dentro das primeiras 48 a 72 horas.&#160;&#160;</p>",
        "dosage_children": "<ul>\r\n<li><strong>&#160;6 - 11 meses com 5 kg a &lt; 8 kg:</strong> 1 comprimido de (25+50) mg em dose &#250;nica di&#225;ria por 3 dias (artesunato 25 mg + mefloquina 50 mg);</li>\r\n<li><strong>1 - 6 anos com 9 a &lt; 17 kg:</strong> 2 comprimidos de (25+50) mg em dose &#250;nica di&#225;ria por 3 dias (artesunato 50mg + mefloquina 100 mg);</li>\r\n<li><strong>7 &#8211;12 anos com 18 a 29 kg:</strong> 1 comprimido de (100+200) mg em dose &#250;nica di&#225;ria por 3 dias (artesunato 100 mg + mefloquina 200 mg);</li>\r\n<li><strong>13 anos com &#8805; 30 kg:</strong> 2 comprimidos de (100+200) mg em dose &#250;nica di&#225;ria por 3 dias (artesunato 200mg + mefloquina 400 mg).</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\">- N&#227;o recomendado no primeiro trimestre.</p>\r\n</div>",
        "id": 1254,
        "indications": "<div>\r\n<p>- Tratamento de primeira linha para Mal&#225;ria por <em>Plasmodium falciparum</em> n&#227;o-complicada.</p>\r\n<p>- Tratamento de infec&#231;&#245;es mistas por <em>Plasmodium falciparum</em> e <em>P. vivax</em> ou <em>P. ovale</em> (com tratamento subsequente de suas formas hipnozoitas).</p>\r\n<p>- Tratamento de infec&#231;&#245;es mistas por <em>Plasmodium falciparum</em> e <em>P. malariae</em>.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 210,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2018-10-05 00:16:40",
        "name": "Artesunato + Mefloquina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:&#160;</strong>25 mg de artesunato + 50 mg de mefloquina e 100 de artesunato + 200 mg de mefloquina</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "artesunato-mefloquina",
        "substance": "Artesunato + Mefloquina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Neurotoxicidade</p>\r\n<p class=\"MsoNormal\">- Tontura</p>\r\n<p class=\"MsoNormal\">- Taquicardia</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mitos, diarreia</p>\r\n<p class=\"MsoNormal\">- Aumento das transaminases, redu&#231;&#227;o transit&#243;ria de reticul&#243;citos, agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 0,
        "contraindications": "<div>\r\n<p>- Al&#233;rgico (hipersens&#237;vel) ao artem&#233;ter, lumefantrina ou a qualquer outro componente da f&#243;rmula;</p>\r\n<p>- Tipo de mal&#225;ria que afeta o c&#233;rebro, ou qualquer outra complica&#231;&#227;o da mal&#225;ria grave;</p>\r\n<p>- Primeiros tr&#234;s meses de gravidez ou potencial de gravidez, caso seja poss&#237;vel&#160;administrar um outro medicamento;</p>\r\n<p>- Arritmias ou doen&#231;as card&#237;acas graves;</p>\r\n<p>- Uso de antiarr&#237;tmicos;&#160;</p>\r\n<p>- N&#237;veis sangu&#237;neos de pot&#225;ssio ou magn&#233;sio baixos.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>- 1&#170; dose:</strong>&#160;no momento do diagnostico inicial - 4 comprimidos</p>\r\n<p><strong>- 2&#170; dose:</strong>&#160;8 horas ap&#243;s a 1&#170; dose - 4 comprimidos</p>\r\n<p><strong>- 3&#170; dose:</strong>&#160;24 horas ap&#243;s a 1&#170; dose - 4 comprimidos</p>\r\n<p><strong>- 4&#170; dose:</strong>&#160;36 horas ap&#243;s a 1&#170; dose - 4 comprimidos</p>\r\n<p><strong>- 5&#170; dose:</strong>&#160;48 horas ap&#243;s a 1&#170; dose - 4 comprimidos</p>\r\n<p><strong>- 6&#170; dose:</strong>&#160;60 horas ap&#243;s a 1&#170; dose - 4 comprimidos&#160;</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>- 1&#170; dose:</strong> no momento do diagnostico inicial - 5-15 Kg:1 cp; 15-25 Kg: 2 cp; 25-35 Kg: 3 cp</p>\r\n<p><strong>- 2&#170; dose:</strong> 8 horas ap&#243;s a 1&#170; dose - 5-15 Kg:1 cp; 15-25 Kg: 2 cp; 25-35 Kg: 3 cp</p>\r\n<p><strong>- 3&#170; dose:</strong> 24 horas ap&#243;s a 1&#170; dose - 5-15 Kg:1 cp; 15-25 Kg: 2 cp; 25-35 Kg: 3 cp</p>\r\n<p><strong>- 4&#170; dose:</strong> 36 horas ap&#243;s a 1&#170; dose - 5-15 Kg:1 cp; 15-25 Kg: 2 cp; 25-35 Kg: 3 cp</p>\r\n<p><strong>- 5&#170; dose:</strong> 48 horas ap&#243;s a 1&#170; dose - 5-15 Kg:1 cp; 15-25 Kg: 2 cp; 25-35 Kg: 3 cp</p>\r\n<p><strong>- 6&#170; dose:</strong> 60 horas ap&#243;s a 1&#170; dose - 5-15 Kg:1 cp; 15-25 Kg: 2 cp; 25-35 Kg: 3 cp</p>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>\r\n<hr>\r\n<p>- N&#227;o deve ser utilizada no primeiro trimestre.</p>\r\n</div>",
        "id": 1255,
        "indications": "<div>\r\n<p>- Tratamento da mal&#225;ria, inclusive tratamento de emerg&#234;ncia.</p>\r\n<p>- Tratamento de adultos, crian&#231;as e rec&#233;m-nascidos com mal&#225;ria causada por Plasmodium falciparum ou por infec&#231;&#245;es mistas que incluem o Plasmodium falciparum.</p>\r\n<p>- Recomendado tamb&#233;m para mal&#225;ria adquirida em &#225;reas onde os parasitas podem ser resistentes a outras drogas antimal&#225;ricas.&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-06-24 20:08:43",
        "name": "Coartem",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>artemeter 20 mg + lumefantrina 120 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Artemeter-lumefantrina",
        "substance": "Artemeter + lumefantrina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Perda de apetite;</p>\r\n<p>- Dist&#250;rbios do sono;</p>\r\n<p>- Dor de cabe&#231;a;</p>\r\n<p>- Tontura;</p>\r\n<p>- Batimento card&#237;aco acelerado;</p>\r\n<p>- Tosse;</p>\r\n<p>- Dor de est&#244;mago;</p>\r\n<p>- N&#225;usea e/ou v&#244;mito;</p>\r\n<p>- Dores nas juntas e m&#250;sculos;</p>\r\n<p>- Cansa&#231;o e fraqueza generalizada.&#160;</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2511,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong> 5 mg sublingual de 12/12h</p>\r\n<p><strong>Mania:</strong> 10 mg sublingual de 12/12h.</p>\r\n<p class=\"MsoNormal\"><strong>Dose m&#225;xima:</strong> 20 mg/dia</p>\r\n<hr>\r\n<p class=\"MsoNormal\">N&#227;o partir, mastigar ou engolir o comprimido, e evitar &#225;gua ou alimentos por 10 min.</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1256,
        "indications": "<div>\r\n<p>- Esquizofrenia</p>\r\n<p>- Transtorno bipolar (epis&#243;dios man&#237;acos ou mistos)</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 65,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-09 03:18:49",
        "name": "Saphris",
        "presentation": "<ul>\r\n<li><strong>Comprimido sublingual:</strong> 5 mg e 10 mg</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<div>\r\n<p>-&#160;Receita de controle especial&#160;(C1 branca em duas vias).</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "record_status": 1,
        "slug": "saphris",
        "substance": "Asenapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Fadiga, sonol&#234;ncia, ins&#244;nia, ansiedade, acatisia, inquieta&#231;&#227;o, parkinsonismo</p>\r\n<p class=\"MsoNormal\">- Tontura, distonia, disgeusia, discinesia</p>\r\n<p class=\"MsoNormal\">- Aumento do apetite, aumento de peso</p>\r\n<p class=\"MsoNormal\">- Hipoestesia oral</p>\r\n<p class=\"MsoNormal\">- Aumento de transaminases</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 4562,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Pancreatite ativa ou hist&#243;rico de pancreatite</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\"><strong>Leucemia linfoc&#237;tica aguda: </strong></p>\r\n<p class=\"MsoNormal\">- Infus&#227;o intravenosa (indu&#231;&#227;o): 200 UI/kg/dia, por 28 dias. A remiss&#227;o total &#233; obtida entre 1 e 3 meses.</p>\r\n<p class=\"MsoNormal\">- Infus&#227;o intravenosa (consolida&#231;&#227;o): 5.000 a 10.000 UI/m&#178; ao dia, a cada 3 semanas, por 7 dias; ou</p>\r\n<p class=\"MsoNormal\">- Infus&#227;o intravenosa (a cada 2 a 3 semanas): 10.000 a 40.000 UI; ou</p>\r\n<p class=\"MsoNormal\">- Inje&#231;&#227;o intramuscular profunda: 6.000 a 12.000 UI/m&#178;, com uso de solu&#231;&#227;o com concentra&#231;&#227;o de 10.000 UI/ml.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong>Leucemia linfoc&#237;tica aguda:</strong></p>\r\n<p class=\"MsoNormal\">- Infus&#227;o intravenosa (indu&#231;&#227;o): 2.000 UI/m&#178; ao dia, por 10 dias, com in&#237;cio no 220 dia do per&#237;odo de tratamento com predinisona e vincristina.</p>\r\n<p class=\"MsoNormal\">- Infus&#227;o intravenosa (consolida&#231;&#227;o): 6.000 a 10.000 UI/m&#178; ao dia, por 14 dias; ou</p>\r\n<p class=\"MsoNormal\">- Inje&#231;&#227;o intramuscular profunda: 6.000 UI/m&#178;, nos dias 4, 7, 10, 13, 16, 19, 22, 25 e 28, em conjunto com predinisona e vincristina.</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1257,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Indicado para o tratamento de pacientes com leucemia linfoc&#237;tica aguda. Este agente &#233; principalmente &#250;til em combina&#231;&#227;o com outros agentes quimioter&#225;picos para a indu&#231;&#227;o de remiss&#245;es da enfermidade em pacientes pedi&#225;tricos.</p>\r\n<p class=\"MsoNormal\">- N&#227;o deve ser usado como &#250;nico agente de indu&#231;&#227;o, a n&#227;o ser que a terapia combinada seja considerada inapropriada.</p>\r\n<p class=\"MsoNormal\">- N&#227;o &#233; recomendado para tratamento de manuten&#231;&#227;o.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 165,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 01:46:32",
        "name": "Elspar",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong><span style=\"line-height: 107%;\">Solu&#231;&#227;o injet&#225;vel</span></strong><span style=\"line-height: 107%;\">:&#160;</span>10.000 UI (10 ml)</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "elspar",
        "substance": "Asparaginase",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Erup&#231;&#245;es cut&#226;neas, urtic&#225;ria</p>\r\n<p class=\"MsoNormal\">- Febre, calafrios, n&#225;usea, crise de ansiedade, tosse, broncoespasmo, edema lar&#237;ngeo</p>\r\n<p class=\"MsoNormal\">- Artralgia, dispneia, anafilaxia aguda, pancreatite aguda</p>\r\n<p class=\"MsoNormal\">- C&#243;licas abdominais, rash cut&#226;neo, crises convulsivas</p>\r\n<p class=\"MsoNormal\">- Cefaleia, depress&#227;o, sonol&#234;ncia, fadiga, confus&#227;o, alucina&#231;&#245;es, coma</p>\r\n<p class=\"MsoNormal\">- Coagulopatia, hiperglicemia n&#227;o cet&#243;tica, aumento de transaminases e bilirrubina</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal aguda</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 4608,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>",
        "dosage_adults": "<div>\r\n<p><strong>Pacientes sem tratamento pr&#233;vio:</strong> 300 mg VO 1x/dia + ritonavir 100 mg VO 1x/dia; ou 400 mg VO 1x/dia concomitante com alimentos.</p>\r\n<p><strong>Paciente com tratamento pr&#233;vio:</strong> 300 mg VO 1x/dia + ritonavir 100 mg VO 1x/dia concomitante com alimentos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\">O tratamento sem ritonavir n&#227;o &#233; recomendado para pacientes com tratamento pr&#233;vio com falha virol&#243;gica anterior.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p>A dose di&#225;ria recomendada para pacientes pedi&#225;tricos (6 a 18 anos) &#233; baseada no peso corporal:</p>\r\n<p class=\"MsoNormal\"><strong>- 15 a 20 kg:</strong> 150 mg + ritonavir 100 mg;</p>\r\n<p class=\"MsoNormal\"><strong>- 20 a 40 kg:</strong> 200 mg + ritonavir 100 mg;</p>\r\n<p class=\"MsoNormal\"><strong>- acima de 40 kg:</strong> 300 mg + ritonavir 100 mg;</p>\r\n<p class=\"MsoNormal\">A dose de atazanavir e ritonavir devem ser ingeridas ao mesmo tempo, uma vez ao dia, com alimentos.</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela (outros esquemas antirretrovirais s&#227;o mais indicados).</p>",
        "id": 1258,
        "indications": "<p class=\"MsoNormal\">- Indicado em combina&#231;&#227;o com outros agentes antirretrovirais para o tratamento da infec&#231;&#227;o pelo HIV. A efic&#225;cia &#233; baseada na an&#225;lise do n&#237;vel de replica&#231;&#227;o do HIV no sangue e na contagem de linf&#243;citos CD4+ de estudos em pacientes sem e com tratamento anterior com antirretrovirais.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 50,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 02:41:57",
        "name": "Reyataz",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>C&#225;psula gelatinosa dura:</strong>&#160;150mg, 200 mg e 300 mg</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>- R<span style=\"line-height: 107%;\">eceita de controle especial (C4- anti-retrovirais - Formul&#225;rio pr&#243;prio/DST/AIDS).</span></p>",
        "record_status": 1,
        "slug": "reyataz",
        "substance": "Atazanavir",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia, tontura, del&#237;rio, ins&#244;nia, febre</p>\r\n<p class=\"MsoNormal\">- Icter&#237;cia as custas de indireta (Gilbert like)</p>\r\n<p class=\"MsoNormal\">- Dor abdominal, v&#244;mito, diarreia, indigest&#227;o, n&#225;usea</p>\r\n<p class=\"MsoNormal\">- Rash</p>\r\n<p class=\"MsoNormal\">- Astenia, fadiga, artralgia</p>\r\n<p class=\"MsoNormal\">- Pode precipitar diabetes</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbio de condu&#231;&#227;o card&#237;aca</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"text-decoration: underline;\">Insufici&#234;ncia renal:</span></p>\r\n<p class=\"MsoNormal\"><span style=\"text-indent: 35.4pt;\">- Insufici&#234;ncia renal severa em hemodi&#225;lise: n&#227;o h&#225; ajuste</span></p>\r\n<p class=\"MsoNormal\"><span style=\"text-indent: 35.4pt;\">- Pacientes sem tratamento pr&#233;vio que sofrem hemodi&#225;lise: 300 mg com 100 mg de ritonavir. Esses pacientes n&#227;o devem administrar atazanavir sem ritonavir.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"text-indent: 35.4pt;\">- Pacientes com tratamento pr&#233;vio para HIV com insufici&#234;ncia renal severa sob hemodi&#225;lise: n&#227;o recomendado.</span></p>\r\n<p class=\"MsoNormal\"><span style=\"text-decoration: underline;\">Insufici&#234;ncia hep&#225;tica:</span></p>\r\n<p class=\"MsoNormal\">- Leve a moderada: Deve ser administrado com cautela.</p>\r\n<p class=\"MsoNormal\">- Pacientes com insufici&#234;ncia hep&#225;tica moderada que n&#227;o apresentaram falha anterior ao tratamento: 300 mg, 1x/dia.</p>\r\n<p class=\"MsoNormal\">- Grave: N&#227;o recomendado</p>\r\n</div>"
    },
    {
        "content_length": 4033,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula</p>\r\n<p class=\"MsoNormal\">- Bradicardia</p>\r\n<p class=\"MsoNormal\">- Choque cardiog&#234;nico</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- Acidose metab&#243;lica</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios graves da circula&#231;&#227;o arterial perif&#233;rica</p>\r\n<p class=\"MsoNormal\">- Bloqueio card&#237;aco de segundo ou terceiro grau</p>\r\n<p class=\"MsoNormal\">- S&#237;ndrome do nodo sinusal</p>\r\n<p class=\"MsoNormal\">- Feocromocitoma n&#227;o tratado</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca descompensada</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong> 50 a 100 mg/dia, VO</p>\r\n<p><strong>Angina:</strong> 50 ou 100 mg, VO, 2x/dia</p>\r\n<p><strong>Arritmias card&#237;acas:</strong> 50 a 100 mg, VO, 1x/dia</p>\r\n<p><strong>Infarto do mioc&#225;rdio:</strong> 100 mg/dia, VO</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Dose m&#225;xima:</strong> 200 mg/dia</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1277,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o arterial</p>\r\n<p class=\"MsoNormal\">- Angina pectoris</p>\r\n<p class=\"MsoNormal\">- Arritmias card&#237;acas</p>\r\n<p class=\"MsoNormal\">- Infarto do mioc&#225;rdio</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 47,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 03:47:08",
        "name": "Tenolon",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Comprimido:</strong> 25mg; 50mg e 100 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Tenolon",
        "substance": "Atenolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Bradicardia</p>\r\n<p class=\"MsoNormal\">- Extremidades frias</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios gastrointestinais</p>\r\n<p class=\"MsoNormal\">- Cefaleia, ins&#244;nia, sonol&#234;ncia, fraqueza, dificuldade de concentra&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mitos, azia, diarreia ou constipa&#231;&#227;o</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>ClCr&gt; 50-90</strong>: Sem ajuste</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>ClCr 10-50</strong>: Avaliar necessidade, 50 mg/dia.</p>\r\n<p class=\"MsoNormal\">-<strong>&#160;ClCr&lt; 10</strong>: Dose em dias alternados.</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Hemodi&#225;lise</strong>: Avaliar necessidade.</p>\r\n</div>"
    },
    {
        "content_length": 3295,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma de &#226;ngulo fechado</p>\r\n<p class=\"MsoNormal\">- Uso concomitante de IMAO</p>\r\n<p class=\"MsoNormal\">- Feocromocitoma</p>\r\n<p class=\"MsoNormal\">- Doen&#231;a cardiovascular severa</p>\r\n</div>",
        "dosage_adults": "<p><strong>Dose inicial:</strong> 40 mg, VO, 1x/dia. Ap&#243;s 3 ou mais dias, progredir para 80 mg/dia (1-2 doses). Ap&#243;s 2-4 semanas, pode-se aumentar a dose para 100 mg/dia. Deve-se aguardar 8 semanas para avaliar a efetividade do tratamento.</p>",
        "dosage_children": "<div>\r\n<p><strong>&lt; 70 kg&#160;</strong></p>\r\n<ul>\r\n<li><strong>Dose inicial:</strong> 0,5 mg/kg/dia, VO, com aumentos de 0,5 mg a cada 3 ou mais dias.</li>\r\n<li><strong>Dose usual:</strong> 1,2 mg/kg/dia</li>\r\n<li><strong>Dose m&#225;xima:</strong> 1,4 mg/kg/dia (100 mg/dia)</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1278,
        "indications": "<p class=\"MsoNormal\">- Transtorno de d&#233;ficit de aten&#231;&#227;o e hiperatividade</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 51,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-09 17:19:22",
        "name": "Strattera",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>C&#225;psula:</strong> 10 mg, 18 mg, 25 mg, 40 mg e 60 mg</span></li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Amarela (A3).</p>",
        "record_status": 1,
        "slug": "strattera",
        "substance": "Atomoxetina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Dispepsia, n&#225;usea, v&#244;mitos, boca seca, hiporexia, perda de peso</p>\r\n<p class=\"MsoNormal\">- Constipa&#231;&#227;o, fadiga, indisposi&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- Cefaleia, tonteira, labilidade emocional, depress&#227;o, idea&#231;&#227;o suicida em crian&#231;as e adolescentes</p>\r\n<p class=\"MsoNormal\">- Piora dos sintomas no dist&#250;rbio bipolar</p>\r\n<p class=\"MsoNormal\">- Reten&#231;&#227;o urin&#225;ria, dis&#250;ria, disfun&#231;&#227;o er&#233;til, prostatite</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal: n&#227;o estabelecido.</p>\r\n<p class=\"MsoNormal\">- Em hepatopatas, n&#227;o exceder 50-75% da dose habitual.</p>\r\n</div>"
    },
    {
        "content_length": 4098,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Disfun&#231;&#227;o hep&#225;tica</p>\r\n<p class=\"MsoNormal\">- Gravidez</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose habitual:</strong> 10 a 80 mg, VO, 1x/dia</p>\r\n<p><strong>Dose m&#225;xima:</strong> 80 mg/dia</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Dose habitual:</strong> 10 mg/dia, VO, 1x/dia</p>\r\n<p><strong>Dose m&#225;xima:</strong> 20 mg/dia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 10 anos.</span></p>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1295,
        "indications": "<div>\r\n<p class=\"MsoNormal\"><strong>Tratamento:</strong></p>\r\n<p class=\"MsoNormal\">- Pacientes com n&#237;veis elevados de colesterol total, LDL, apolipoprote&#237;na B e triglic&#233;rides, para aumentar os n&#237;veis de HDL.</p>\r\n<p class=\"MsoNormal\">- Pacientes com disbetalipoproteinemia</p>\r\n<p class=\"MsoNormal\">- Hipercolesterolemia familiar homozig&#243;tica</p>\r\n<p class=\"MsoNormal\">- Preven&#231;&#227;o secund&#225;ria de s&#237;ndrome coron&#225;ria aguda</p>\r\n<p class=\"MsoNormal\">- Preven&#231;&#227;o de complica&#231;&#245;es cardiovasculares</p>\r\n<p class=\"MsoNormal\">- Redu&#231;&#227;o dos n&#237;veis de colesterol total, LDL e apolipoprote&#237;na B em meninas p&#243;s-menarca e meninos entre 10 e 17 anos, com hipercolesterolemia familiar heterozig&#243;tica.</p>\r\n<p class=\"MsoNormal\"><strong>Reduzir o risco de:</strong></p>\r\n<p class=\"MsoNormal\">- Infarto do mioc&#225;rdio n&#227;o-fatal</p>\r\n<p class=\"MsoNormal\">- Acidente vascular cerebral fatal e n&#227;o-fatal</p>\r\n<p class=\"MsoNormal\">- Procedimentos de revasculariza&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- Hospitaliza&#231;&#227;o por insufici&#234;ncia card&#237;aca congestiva e de angina</p>\r\n<p class=\"MsoNormal\">- Doen&#231;a card&#237;aca coronariana clinicamente evidente</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 74,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 14:51:15",
        "name": "Zarator",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Comprimido:</strong> 10mg, 20 mg, 40mg e 80mg</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Zarator",
        "substance": "Atorvastatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Nasofaringite, dor faringolar&#237;ngea, epistaxe</p>\r\n<p class=\"MsoNormal\">- N&#225;useas, diarreia, dispepsia, flatul&#234;ncia</p>\r\n<p class=\"MsoNormal\">- Artralgia, dor nas extremidades, dor musculoesquel&#233;tica, espasmos musculares, mialgia, edema articular</p>\r\n<p class=\"MsoNormal\">- Altera&#231;&#245;es nas fun&#231;&#245;es hep&#225;ticas, hepatite, colestase</p>\r\n<p class=\"MsoNormal\">- Aumento da creatina fosfoquinase sangu&#237;nea, hiperglicemia</p>\r\n<p class=\"MsoNormal\">- Cefaleia, fraqueza, ins&#244;nia, tonteira</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3382,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Descolamento prematuro de placenta</p>\r\n<p class=\"MsoNormal\">- Ecl&#226;mpsia e pr&#233;-ecl&#226;mpsia graves</p>\r\n<p class=\"MsoNormal\">- Idade gestacional abaixo de 24 ou acima de 33 semanas completas</p>\r\n<p class=\"MsoNormal\">- Hemorragia uterina pr&#233;-parto, requerendo parto imediato</p>\r\n<p class=\"MsoNormal\">- Morte fetal intra-uterina</p>\r\n<p class=\"MsoNormal\">- Placenta pr&#233;via</p>\r\n<p class=\"MsoNormal\">- Retardo do crescimento intra-uterino e frequ&#234;ncia card&#237;aca fetal anormal</p>\r\n<p class=\"MsoNormal\">- Ruptura prematura das membranas com idade gestacional superior a 30 semanas</p>\r\n<p class=\"MsoNormal\">- Suspeita de infec&#231;&#227;o intra-uterina</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose inicial:</strong> 1 ampola (0,9 ml), em bolus, IV, infundida em 1 minuto</p>\r\n<p><strong>Dose de manuten&#231;&#227;o:</strong> 18 mg/h (24 ml/h), infus&#227;o, IV, por 3 horas; ap&#243;s, reduzir para 6 mg/h (8 ml/h);</p>\r\n<p><strong>Dose m&#225;xima:</strong> 330 mg por ciclo terap&#234;utico.</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 1296,
        "indications": "<p class=\"MsoNormal\">- Retardar o trabalho de parto prematuro</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 113,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:15:11",
        "name": "Tractocile",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;7,5 mg/ml frasco-ampola (6,75 mg/0,9 ml) e (37,5 mg/5 ml)</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar)</p>",
        "record_status": 1,
        "slug": "tractocile",
        "substance": "Atosibano",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia, hipotens&#227;o, tonteira, ins&#244;nia</p>\r\n<p class=\"MsoNormal\">- N&#225;useas, v&#244;mito</p>\r\n<p class=\"MsoNormal\">- Taquicardia</p>\r\n<p class=\"MsoNormal\">- Fogacho, rea&#231;&#227;o no local da inje&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- Hiperglicemia</p>\r\n<p class=\"MsoNormal\">- Febre, rash cut&#226;neo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2328,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as menores de 1 m&#234;s de idade</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><a href=\"https://www.appsosplantao.com.br/dashboard/calculadoras/detalhe/atracurio/\" target=\"_blank\" rel=\"noopener\">Calcule a dose aqui</a></p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Dose usual:</strong> 0,3-0,6 mg/kg, IV</p>\r\n<p><strong>Dose inicial para crian&#231;as entre 1 m&#234;s e 2 anos de idade, sob anestesia com halotano:</strong> 0,3-0,4 mg/kg.</p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1300,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Adjuvante em anestesia geral</p>\r\n<p class=\"MsoNormal\">- Para facilitar intuba&#231;&#227;o e ventila&#231;&#227;o mec&#226;nica em pacientes em UTI.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:15:23",
        "name": "Tracur",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 10 mg/ml, ampola de 25 mg e 50 mg</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "Tracur",
        "substance": "Atracúrio",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Hiperemia</p>\r\n<p class=\"MsoNormal\">- Bradicardia</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o arterial</p>\r\n<p class=\"MsoNormal\">- Prurido, anafilaxia</p>\r\n<p class=\"MsoNormal\">- Dispneia, broncoespasmo, laringosespasmo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 6678,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Glaucoma, ades&#227;o entre a &#237;ris e o cristalino</p>\r\n<p class=\"MsoNormal\">- Asma</p>\r\n<p class=\"MsoNormal\">- Taquicardia, estado cardiovascular inst&#225;vel em hemorragia aguda</p>\r\n<p class=\"MsoNormal\">- Isquemia do mioc&#225;rdio</p>\r\n<p class=\"MsoNormal\">- Enfermidades obstrutivas gastrointestinais e geniturin&#225;rias, &#237;leo paral&#237;tico, atonia intestinal, em pacientes geri&#225;tricos ou debilitados, colite ulcerativa severa, megacolon t&#243;xico associado &#224; colite ulcerativa.</p>\r\n<p class=\"MsoNormal\">- Enfermidades hep&#225;ticas e renais severas</p>\r\n<p class=\"MsoNormal\">- Miastenia gravis</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Antimuscar&#237;nico:</strong>&#160;0,4 a 0,6 mg (via intramuscular, intravenosa ou subcut&#226;nea), a cada 4 a 6 horas.</p>\r\n<p><strong>Arritmias:</strong>&#160;0,4 a 1 mg (via intravenosa), a cada 1 a 2 horas, at&#233; no m&#225;ximo 2 mg.</p>\r\n<p><strong>Radiografia gastrintestinal:</strong>&#160;1 mg (via intramuscular)</p>\r\n<p><strong>Pr&#233;-medica&#231;&#227;o anest&#233;sica:</strong>&#160;0,2 a 0,6 mg (via intramuscular), entre meia a uma hora antes da cirurgia.</p>\r\n<p><strong>Coadjuvante colin&#233;rgico (bloqueio curariforme):&#160;</strong>0,6 a 1,2 mg (via intravenosa), antes ou concomitante &#224; administra&#231;&#227;o de neostigmina (seringas separadas).</p>\r\n<p><strong>Ant&#237;doto de inibidores da colinesterase:</strong>&#160;inicialmente 2 a 4 mg (via intravenosa) seguidos de 2 mg repetidos a intervalos de 5 a 10 minutos at&#233; que desapare&#231;am os sintomas muscar&#237;nicos.</p>\r\n<p><strong>Ant&#237;doto de organofosforados e muscarina (intoxica&#231;&#245;es f&#250;ngicas):</strong>&#160;1 a 2 mg cada hora, por via intravenosa ou intramuscular at&#233; remiss&#227;o dos efeitos respirat&#243;rios ou at&#233; desaparecimento da cianose. Nas intoxica&#231;&#245;es por inseticidas fosforados, repetir a dose a cada 20 a 30 minutos at&#233; o desaparecimento da cianose. Prosseguir at&#233; melhora definitiva, o que pode suceder, em certos casos, em dois ou mais dias.</p>\r\n<hr>\r\n<p>A inje&#231;&#227;o intravenosa deve ser feita lentamente.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Antimuscar&#237;nico:</strong>&#160;&#160;0,01 mg/kg (via subcut&#226;nea), sem ultrapassar 0,4 ou 0,3 mg, por m&#178; de superf&#237;cie corporal, em intervalos de 4 a 6 horas..</p>\r\n<p><strong>Arritmias:</strong>&#160;0,01 a 0,03 mg/kg (via intravenosa).</p>\r\n<p><strong>Pr&#233;-medica&#231;&#227;o anest&#233;sica</strong>&#160;<strong>(via subcut&#226;nea):</strong> at&#233; 3 kg: 0,1 mg; de 7 a 9 kg: 0,2 mg; de 12 a 16 kg: 0,3 mg; de 20 a 27 kg: 0,4 mg; com 32 kg: 0,5 mg; com 41 kg: 0,6 mg. Para pesos intermedi&#225;rios n&#227;o especificados use a dosagem intermedi&#225;ria correspondente.</p>\r\n<p><strong>Ant&#237;doto de inibidores da colinesterase:</strong>&#160;inicialmente 1 mg (via intravenosa ou intramuscular), seguidos de 0,5 a 1 mg a cada 5 ou 10 minutos, at&#233; que desapare&#231;am os sintomas muscar&#237;nicos. Recomenda-se n&#227;o ultrapassar a dose de aproximadamente 10 mg, pode ser letal em crian&#231;as.</p>\r\n<hr>\r\n<p>A inje&#231;&#227;o intravenosa deve ser feita lentamente.&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1309,
        "indications": "<div>\r\n<p>- Tratamento de arritmias ou bradicardia sinusal severa e s&#237;ncope devido &#224; hiperatividade do reflexo sino-carot&#237;deo, no controle do bloqueio card&#237;aco atrioventricular decorrente de um aumento da atividade vagal (por exemplo, em alguns casos ap&#243;s a administra&#231;&#227;o de digit&#225;licos);</p>\r\n<p>- Coadjuvante no tratamento de &#250;lcera p&#233;ptica, doen&#231;as do trato gastrintestinal e biliar, no tratamento de c&#243;licas durante a menstrua&#231;&#227;o, no tratamento sintom&#225;tico de doen&#231;as do aparelho geniturin&#225;rio (por exemplo: no al&#237;vio de c&#243;licas ureterais e renais, na incontin&#234;ncia urin&#225;ria, no espasmo da musculatura uterina);</p>\r\n<p>- Como medica&#231;&#227;o pr&#233;-anest&#233;sica para diminuir a saliva&#231;&#227;o e a secre&#231;&#227;o do trato respirat&#243;rio e para bloquear o reflexo inibit&#243;rio vagal no cora&#231;&#227;o durante a indu&#231;&#227;o da anestesia e intuba&#231;&#227;o;</p>\r\n<p>- Coadjuvante em radiografias gastrintestinais, no tratamento de parkinsonismo, na profilaxia e tratamento de intoxica&#231;&#245;es por inibidores da colinesterase (por exemplo: inseticidas organofosforados), drogas colin&#233;rgicas e muscar&#237;nicas.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 141,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-09 03:18:13",
        "name": "Santropina",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 0,25 mg/ml e 0,50 mg/2ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Santropina",
        "substance": "Atropina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Taquicardia e arritmias atriais</p>\r\n<p class=\"MsoNormal\">- Hipertermia</p>\r\n<p class=\"MsoNormal\">- Miopatia</p>\r\n<p class=\"MsoNormal\">- Reten&#231;&#227;o urin&#225;ria</p>\r\n<p class=\"MsoNormal\">- Turva&#231;&#227;o visual</p>\r\n<p class=\"MsoNormal\">- Xerostomia</p>\r\n<p class=\"MsoNormal\">- Rea&#231;&#245;es al&#233;rgicas severas</p>\r\n<p class=\"MsoNormal\">- Cefaleia, sonol&#234;ncia, desorienta&#231;&#227;o, nervosismos, ins&#244;nia</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<p class=\"MsoNormal\">- Perda tempor&#225;ria da mem&#243;ria, confus&#227;o mental e excita&#231;&#227;o</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecidos.</p>\r\n</div>"
    },
    {
        "content_length": 3576,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Pacientes com tumores hep&#225;ticos malignos avan&#231;ados</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Primeiro ciclo de tratamento:</strong> 75 mg/m&#178;, SC, diariamente, durante 7 dias.</p>\r\n<p><strong>Ciclos subsequentes&#160;(a cada 4 semanas):</strong> a dose pode ser aumentada para 100 mg/m&#178;, SC.</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1310,
        "indications": "<div>\r\n<p class=\"MsoNormal\"><strong>- </strong>S&#237;ndrome Mielodispl&#225;sica dos subtipos: anemia refrat&#225;ria com excesso de blastos (AREB) de acordo com a classifica&#231;&#227;o FAB;</p>\r\n<p class=\"MsoNormal\">- Leucemia miel&#243;ide aguda com 20-30% de blastos na medula &#243;ssea com displasia multilinhagem de acordo com a classifica&#231;&#227;o OMS;</p>\r\n<p class=\"MsoNormal\">- Leucemia mielomonoc&#237;tica cr&#244;nica (classifica&#231;&#227;o FAB modificada).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 192,
        "lactation_text": "<p>- Nao estabelecido.</p>",
        "last_update": "2019-03-10 14:21:56",
        "name": "Vidaza",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>P&#243; li&#243;filo para inje&#231;&#227;o:</strong> 100 mg/frasco</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "vidaza",
        "substance": "Azacitidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal</p>\r\n<p class=\"MsoNormal\">- Acidose tubular renal</p>\r\n<p class=\"MsoNormal\">- Coma hep&#225;tico</p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito, diarreia, constipa&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- Eritema no local de inje&#231;&#227;o</p>\r\n<p class=\"MsoNormal\">- Equimose</p>\r\n<p class=\"MsoNormal\">- Anemia, neutropenia, trombocitopenia, hipocalemia, creatinina s&#233;rica elevada.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Redu&#231;&#245;es inexplicadas nos n&#237;veis de bicarbonato s&#233;rico para menos de 20 mEq/L: 50% da dose no pr&#243;ximo ciclo.</p>\r\n<p class=\"MsoNormal\">- Eleva&#231;&#245;es inexplicadas de BUN ou creatinina s&#233;rica: 50% da dose no pr&#243;ximo ciclo.</p>\r\n</div>"
    },
    {
        "content_length": 4664,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>",
        "dosage_adults": "<div>\r\n<p><strong>Transplante</strong></p>\r\n<ul>\r\n<li><strong>Dose inicial:</strong>&#160;at&#233; 5 mg/kg no primeiro dia, VO</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong>&#160;1 a 4mg/kg por dia, VO, e deve ser ajustada de acordo com as necessidades cl&#237;nicas e com a toler&#226;ncia hematol&#243;gica.</li>\r\n</ul>\r\n<p><strong>Outras indica&#231;&#245;es&#160;</strong></p>\r\n<ul>\r\n<li><strong>Dose habitual:</strong> 1 a 3 mg/kg/dia, VO</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong> 1 a 3 mg/kg/dia, VO</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Transplante</strong></p>\r\n<ul>\r\n<li><strong>Dose inicial:</strong>&#160;at&#233; 5 mg/kg no primeiro dia, VO</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong>&#160;1 a 4mg/kg por dia, VO, e deve ser ajustada de acordo com as necessidades cl&#237;nicas e com a toler&#226;ncia hematol&#243;gica.</li>\r\n</ul>\r\n<p><strong>Outras indica&#231;&#245;es&#160;</strong></p>\r\n<ul>\r\n<li><strong>Dose habitual:</strong>&#160;1 a 3 mg/kg/dia, VO</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong>&#160;1 a 3 mg/kg/dia, VO</li>\r\n</ul>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1313,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Transplantes de &#243;rg&#227;os, como transplante renal, card&#237;aco ou hep&#225;tico, e na redu&#231;&#227;o da quantidade de corticosteroides necess&#225;ria aos pacientes que receberam transplante renal</p>\r\n<p class=\"MsoNormal\">- Artrite reumatoide grave</p>\r\n<p class=\"MsoNormal\">- Lupus eritematoso sist&#234;mico</p>\r\n<p class=\"MsoNormal\">- Dermatomiosite/polimiosite</p>\r\n<p class=\"MsoNormal\">- Hepatite cr&#244;nica ativa auto-imune</p>\r\n<p class=\"MsoNormal\">- P&#234;nfigo vulgar</p>\r\n<p class=\"MsoNormal\">- Poliarterite nodosa</p>\r\n<p class=\"MsoNormal\">- Anemia hemol&#237;tica autoimune</p>\r\n<p class=\"MsoNormal\">- P&#250;rpura trombocitop&#234;nica idiop&#225;tica (PTI) refrat&#225;ria cr&#244;nica</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 22,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 20:53:22",
        "name": "Imussuprex",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Comprimido:</strong> 50 mg</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Imussuprex",
        "substance": "Azatioprina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Infec&#231;&#245;es virais, f&#250;ngicas e bacterianas</p>\r\n<p class=\"MsoNormal\">- Depress&#227;o medular &#243;ssea</p>\r\n<p class=\"MsoNormal\">- Leucopenia, trombocitopenia</p>\r\n<p class=\"MsoNormal\">- Estomatite, n&#225;usea, V&#244;mitos, diarreia</p>\r\n<p class=\"MsoNormal\">- Hepatotoxicidade</p>\r\n<p class=\"MsoNormal\">- Febre, calafrios, retinopatia, mialgia</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>ClCr &gt; 50-90</strong>: Avaliar necessidade</p>\r\n<p class=\"MsoNormal\">-<strong>&#160;ClCr 10-50</strong>: Utilizar dose m&#237;nima</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>ClCr &lt; 10</strong>: Utilizar dose m&#237;nima</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Hemodi&#225;lise</strong>: Avaliar necessidade</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Insufici&#234;ncia hep&#225;tica</strong>: dose m&#237;nima</p>\r\n</div>"
    },
    {
        "content_length": 2987,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as menores de 5 anos</p>\r\n<p class=\"MsoNormal\">- Primeiro trimestre de gravidez</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose usual:</strong>&#160;uma aplica&#231;&#227;o (0,14 ml= 0,14 mg cloridrato de azelastina) em cada narina 2x/dia (equivalente a uma dose di&#225;ria de 0,56 mg)</p>\r\n<p><strong>Dose aumentada:</strong> de acordo com o caso, podem ser indicadas duas aplica&#231;&#245;es em cada narina 2x/dia.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Crian&#231;as de 5 anos ou mais:</strong>&#160;uma aplica&#231;&#227;o em casa narina 2x/dia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\">N&#227;o fazer uso cont&#237;nuo por mais que 6 meses.</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1317,
        "indications": "<p class=\"MsoNormal\">- Indicado para o tratamento de rinite al&#233;rgica</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 01:45:57",
        "name": "Aznite",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Spray nasal:</strong> 1 mg/ml com 10ml</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Rino-Lastin",
        "substance": "Azelastina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Tosse, asma</p>\r\n<p class=\"MsoNormal\">- Faringite</p>\r\n<p class=\"MsoNormal\">- Conjuntivite</p>\r\n<p class=\"MsoNormal\">- Dor de cabe&#231;a, tontura, sonol&#234;ncia</p>\r\n<p class=\"MsoNormal\">- V&#244;mito, n&#225;useas, desconforto abdominal</p>\r\n<p class=\"MsoNormal\">- Altera&#231;&#227;o no apetite</p>\r\n<p class=\"MsoNormal\">- Coceira e vermelhid&#227;o na pele</p>\r\n<p class=\"MsoNormal\">- Ganho de peso</p>\r\n<p class=\"MsoNormal\">- Epistaxe, espirros repetidos</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2949,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Crian&#231;as menores de 12 anos</p>\r\n<p class=\"MsoNormal\">- Primeiro trimestre de gravidez</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose usual:</strong>&#160;1 aplica&#231;&#227;o em cada narina, 12/12 horas.&#160;</p>\r\n<p><strong>Dose aumentada:</strong> de acordo com o caso, podem ser indicadas 2 aplica&#231;&#245;es em cada narina, 12/12 horas.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Crian&#231;as de 12 anos ou mais</strong>: 1 aplica&#231;&#227;o em casa narina, 12/12 horas.</p>\r\n<hr>\r\n<p class=\"MsoNormal\">N&#227;o fazer uso cont&#237;nuo por mais que 6 meses.</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "id": 1318,
        "indications": "<p class=\"MsoNormal\">-&#160; Al&#237;vio de sintomas moderados a severos de rinite al&#233;rgica sazonal ou cr&#244;nica quando a monoterapia com anti-histam&#237;nicos ou glicocorticoides nasais sozinhos n&#227;o &#233; considerada suficiente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 59,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 02:15:26",
        "name": "Dymista",
        "presentation": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Spray nasal:</strong> 1 mg/g + 0,365 mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dymista",
        "substance": "Azelastina + Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Tosse, asma</p>\r\n<p class=\"MsoNormal\">- Faringite</p>\r\n<p class=\"MsoNormal\">- Conjuntivite</p>\r\n<p class=\"MsoNormal\">- Dor de cabe&#231;a, tontura, sonol&#234;ncia</p>\r\n<p class=\"MsoNormal\">- V&#244;mito, n&#225;useas, desconforto abdominal</p>\r\n<p class=\"MsoNormal\">- Altera&#231;&#227;o no apetite</p>\r\n<p class=\"MsoNormal\">- Coceira e vermelhid&#227;o na pele</p>\r\n<p class=\"MsoNormal\">- Ganho de peso</p>\r\n<p class=\"MsoNormal\">- Epistaxe, espirros repetidos</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2215,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- An&#250;ria</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia hep&#225;tica ou renal grave</p>\r\n<p class=\"MsoNormal\">- Lupus</p>\r\n<p class=\"MsoNormal\">- Hipopotassemia, hipomagnesemia e hiponatremia.</p>\r\n<p class=\"MsoNormal\">- Gesta&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose inicial:</strong> 20 mgVO, 1x/dia</p>\r\n<p><strong>Dose m&#225;xima:</strong> 80 mg VO 1x/dia</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong>- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1319,
        "indications": "<p class=\"MsoNormal\">- Hipertens&#227;o arterial sist&#234;mica</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 02:01:19",
        "name": "Edarbi",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimido revestido:</strong> 40 mg e 80 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "edarbi",
        "substance": "Azilsartana",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Tontura</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Na insufici&#234;ncia renal com ClCr&lt; 30 ml/min: seguran&#231;a e efic&#225;cia n&#227;o estabelecidas.</p>\r\n</div>"
    },
    {
        "content_length": 3256,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o</p>\r\n<p class=\"MsoNormal\">- An&#250;ria</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia hep&#225;tica ou renal grave</p>\r\n<p class=\"MsoNormal\">- Lupus eritematoso sist&#234;mico</p>\r\n<p class=\"MsoNormal\">- Hipopotassemia, hipomagnesemia e hiponatremia</p>\r\n<p class=\"MsoNormal\">- Gesta&#231;&#227;o</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose usual:</strong></p>\r\n<ul>\r\n<li>Iniciar com 40mg+12,5mg VO 1x ao dia;</li>\r\n<li>Pode-se ajustar para 40mg+25mg ap&#243;s 2 a 4 semanas.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong>- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1320,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o arterial essencial, nefrog&#234;nica ou sist&#243;lica isolada; como terapia prim&#225;ria ou em combina&#231;&#227;o com outros agentes anti-hipertensivos.</p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia card&#237;aca congestiva est&#225;vel de grau leve a moderado (classe funcional II ou III da New York Heart Association, NYHA).</p>\r\n<p class=\"MsoNormal\">- Edema de origem espec&#237;fica: decorrente de insufici&#234;ncia venosa perif&#233;rica cr&#244;nica; terapia de curto prazo, se medidas f&#237;sicas provarem ser insuficientes; ascite decorrente de cirrose hep&#225;tica em pacientes est&#225;veis sob controle rigoroso; edema decorrente de s&#237;ndrome nefr&#243;tica.</p>\r\n<p class=\"MsoNormal\">- Tratamento profil&#225;tico de c&#225;lculo de oxalato de c&#225;lcio recorrente, em pacientes com hipercalci&#250;ria normocalc&#234;mica idiop&#225;tica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 02:00:57",
        "name": "Edarbiclor",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimido revestido:</strong> 20 mg ou 40 mg de&#160;azilsartana + 12,5 mg de clortalidona</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "edarbiclor",
        "substance": "Azilsartana + Clortalidona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Tontura</p>\r\n<p class=\"MsoNormal\">- Fadiga</p>\r\n<p class=\"MsoNormal\">- Hipotens&#227;o</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Na insufici&#234;ncia renal com ClCr&lt; 30 ml/min: seguran&#231;a e efic&#225;cia n&#227;o estabelecidas.</p>\r\n</div>"
    },
    {
        "content_length": 2526,
        "contraindications": "<p>- Tratamento de epis&#243;dios agudos de asma e para indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>",
        "dosage_adults": "<div>\r\n<p><strong>Uso inalat&#243;rio por via oral</strong></p>\r\n<ul>\r\n<li><strong>Asma leve:&#160;</strong>100 mcg a 250 mcg, 12/12 horas.</li>\r\n<li><strong>Asma moderada:</strong> 250 mcg a 500 mcg, 12/12 horas.</li>\r\n<li>Asma grave: 500 mcg a 1.000 mcg, 12/12 horas.</li>\r\n<li><strong>DPOC:</strong> 500 mcg, 12/12 horas.</li>\r\n<li>O tratamento dever&#225; ser mantido por 3 a 6 meses.&#160;</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Uso inalat&#243;rio por via oral</strong></p>\r\n<ul>\r\n<li><strong>&gt; 4 anos:</strong> doses de 50 mcg a 100 mcg, 12/12 horas.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1322,
        "indications": "<p>- Tratamento de manuten&#231;&#227;o da asma e DPOC.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:13:50",
        "name": "Fluticaps",
        "presentation": "<ul>\r\n<li><strong>C&#225;psula com p&#243; para inala&#231;&#227;o:</strong> 50 mcg e 250 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2389,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Menores de 4 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Uso intranasal:&#160;</strong>2 doses em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2x/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 4 doses em cada narina.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Uso intranasal</strong></p>\r\n<ul>\r\n<li><strong>&gt; 4 anos:</strong> 1&#160;dose em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2x/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 2 doses em cada narina.&#160;</li>\r\n<li><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1323,
        "indications": "<p>- Profilaxia e tratamento da rinite al&#233;rgica sazonal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 17:39:36",
        "name": "Plurair",
        "presentation": "<ul>\r\n<li><strong>Spray nasal:</strong> 50 mcg (60 ou 120 doses).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2561,
        "contraindications": "<div>\r\n<p>- Infec&#231;&#245;es cut&#226;neas sem tratamento, ros&#225;cea, acne vulgar, dermatite perioral, prurido sem inflama&#231;&#227;o.</p>\r\n<p>- Prurido perianal e genital.</p>\r\n<p>- Dermatoses em crian&#231;as com menos de 1 ano de idade, incluindo dermatite e assaduras pelo uso de fralda.</p>\r\n<p>- Menores de 1 ano de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Uso t&#243;pico:&#160;</strong>Aplicar 1 camada fina, 1 ou 2x/dia por at&#233; 4 semanas, reduzindo a frequencia da aplica&#231;&#227;o at&#233; cessar o uso.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Uso t&#243;pico</strong></p>\r\n<ul>\r\n<li><strong>&gt; 1 ano:</strong> Aplicar 1 camada fina, 1x/dia. Mantendo pelo menor tempo poss&#237;vel.</li>\r\n<li><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 1 ano.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1324,
        "indications": "<p>- Al&#237;vio de manifesta&#231;&#245;es inflamat&#243;rias e pruriginosas como: Dermatite at&#243;pica; Psor&#237;ase; Dermatite de contato al&#233;rgica ou irritativa.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:13:58",
        "name": "Flutivate",
        "presentation": "<ul>\r\n<li><strong>Creme:</strong> 0,5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2374,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Menores de 4 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Uso intranasal:&#160;</strong>2 doses em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2x/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 4 doses em cada narina.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Uso intranasal</strong></p>\r\n<ul>\r\n<li><strong>&gt; 4 anos:</strong> 1&#160;dose em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2x/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 2 doses em cada narina.&#160;</li>\r\n<li><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1325,
        "indications": "<p>- Profilaxia e tratamento da rinite al&#233;rgica sazonal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 92,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:13:41",
        "name": "Flutican",
        "presentation": "<ul>\r\n<li><strong>Spray nasal:</strong> 50 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3032,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes, insufici&#234;ncia renal grave, les&#245;es preexistentes no aparelho auditivo ou no sistema labir&#237;ntico. beb&#234;s prematuros, rec&#233;m-nascidos e lactentes.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><strong>Dose habitual:</strong> Aplicar sobrea a regi&#227;o afetada, 2 a 5x/dia at&#233; 3 dias ap&#243;s os sintomas desaparecerem.</li>\r\n<li class=\"MsoNormal\"><strong>Queimaduras ou grandes &#225;reas:</strong> Usar no m&#225;ximo por 8 a 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><strong>Dose usual:&#160;</strong>Aplicar sobre a regi&#227;o afetada uma fina camada do produto, 2 a 5x/dia, com o aux&#237;lio de uma gaze. Em &#225;reas extensas, usar no m&#225;ximo 8 a 10 dias.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1326,
        "indications": "<p class=\"MsoNormal\">- Tratamento de infec&#231;&#245;es bacterianas da pele e de mucosas: piodermites, impetigo, eczemas infectados, otite externa, infec&#231;&#245;es da mucosa nasal, fur&#250;nculos, antraz, ectima, abcessos, acne infectada, intertrigo, &#250;lceras cut&#226;neas e queimaduras infectadas. Profilaxia de infec&#231;&#245;es cut&#226;neo-mucosas decorrentes de ferimentos cortantes (inclusive cir&#250;rgicos), abras&#245;es, queimaduras pouco extensas.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 01:51:17",
        "name": "Bacitracina + Neomicina",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Pomada:</strong> 5mg/g de Sulfato de Neomicina + 250 UI/g de Bacitracina.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bacitracina-neomicina",
        "substance": "Bacitracina + Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Rea&#231;&#245;es al&#233;rgicas locais.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2382,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Menores de 4 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Uso intranasal:&#160;</strong>2 doses em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2x/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 4 doses em cada narina.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Uso intranasal</strong></p>\r\n<ul>\r\n<li><strong>&gt; 4 anos:</strong> 1&#160;dose em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2x/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 2 doses em cada narina.</li>\r\n<li><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1343,
        "indications": "<p>- Profilaxia e tratamento da rinite al&#233;rgica sazonal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 18:08:22",
        "name": "Flixonase",
        "presentation": "<ul>\r\n<li><strong>Spray nasal:</strong> 50 mcg (60 ou 120 doses).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2384,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Menores de 2 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Uso intranasal:&#160;</strong>2 jatos em cada narina, 1x/dia pela manh&#227;. Podendo-se diminuir para 1 jato em cada narina ap&#243;s o controle dos sintomas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Uso intranasal</strong></p>\r\n<ul>\r\n<li><strong>&gt; 2 anos:</strong> 1&#160;jato em cada narina, 1x/dia pela manh&#227;. Podendo-se estender para 2 jatos em cada narina na aus&#234;ncia de resposta. Ap&#243;s controle: 1 jato em cada narina, 1x/dia.</li>\r\n<li><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1348,
        "indications": "<p>- Profilaxia e tratamento da rinite al&#233;rgica sazonal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:21:03",
        "name": "Avamys",
        "presentation": "<ul>\r\n<li><strong>Spray nasal:</strong> 0,0275 mg/dose (120 doses).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3112,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><strong>Dose inicial:</strong> 5mg/dose, VO, 3x/dia, durante as refei&#231;&#245;es. Aumentar a dose gradualmente.</li>\r\n<li class=\"MsoNormal\"><strong>Dose m&#225;xima:</strong> 80mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-79ac3831-7fff-b0db-ec18-414a405d2aba\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1350,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Espasticidade dos m&#250;sculos esquel&#233;ticos na esclerose m&#250;ltipla, estados esp&#225;sticos nas mielopatias de origem infecciosa, degenerativa, traum&#225;tica, neopl&#225;sica ou desconhecida, espasmo muscular de origem cerebral.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 01:51:38",
        "name": "Baclofeno",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Comprimido:</strong> 10mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Baclofeno",
        "substance": "Baclofeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Seda&#231;&#227;o, sonol&#234;ncia, depress&#227;o respirat&#243;ria e del&#237;rios, dist&#250;rbios de acomoda&#231;&#227;o e dist&#250;rbios visuais, hipotens&#227;o, disfun&#231;&#227;o card&#237;aca, er&#233;til e hep&#225;tica, dist&#250;rbios gastrintestinais, v&#244;mito seco, v&#244;mito, constipa&#231;&#227;o, n&#225;useas, dor abdominal e diarreia, polaqui&#250;ria, enurese, dis&#250;ria e reten&#231;&#227;o urin&#225;ria, erup&#231;&#227;o cut&#226;nea, hiperidrose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3968,
        "contraindications": "<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>",
        "dosage_adults": "<div>\r\n<p><strong>Uso inalat&#243;rio por via oral (</strong><strong>Flixotide Diskus&#174; ou&#160;</strong><strong>Flixotide Spray<strong><strong>&#174;</strong></strong></strong><strong>):</strong></p>\r\n<ul>\r\n<li><strong>Asma leve:&#160;</strong>100 mcg a 250 mcg, 12/12 horas.</li>\r\n<li><strong>Asma moderada:</strong> 250 mcg a 500 mcg, 12/12 horas.</li>\r\n<li><strong>Asma grave:</strong> 500 mcg a 1.000 mcg, 12/12 horas.</li>\r\n<li><strong>DPOC:</strong> 500 mcg, 12/12 horas.</li>\r\n<li>O tratamento dever&#225; ser mantido por 3 a 6 meses.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Uso inalat&#243;rio por via oral (</strong><strong>Flixotide Nebules<strong>&#174;)</strong></strong><strong>:</strong></p>\r\n<ul>\r\n<li>0,5mg a 2mg, 12/12 horas.&#160;Diluir com Cloreto de S&#243;dio, se necess&#225;rio.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Uso inalat&#243;rio por via oral (</strong><strong>Flixotide Diskus&#174;):</strong></p>\r\n<ul>\r\n<li><strong>&gt; 4 anos:</strong> doses de 50 mcg a 200 mcg, 12/12 horas.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.&#160;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Uso inalat&#243;rio por via oral (</strong><strong>Flixotide Spray<strong><strong>&#174;):</strong></strong></strong></p>\r\n<ul>\r\n<li><strong>1 a 4 anos:</strong>&#160;100mcg, 12/12 horas, com uso do espa&#231;ador.</li>\r\n<li><strong>&gt; 4 anos:</strong>&#160;doses de 50 mcg a 200 mcg, 12/12 horas.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 1 ano.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Uso inalat&#243;rio por via oral (</strong><strong>Flixotide Nebules<strong>&#174;):</strong></strong></p>\r\n<ul>\r\n<li><strong>&gt; 4 anos:</strong>&#160;1mg, 12/12 horas. Diluir com Cloreto de S&#243;dio, se necess&#225;rio.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1354,
        "indications": "<p>- Tratamento de manuten&#231;&#227;o da asma e DPOC.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 18:08:30",
        "name": "Flixotide",
        "presentation": "<ul>\r\n<li><strong>Diskus com p&#243; para inala&#231;&#227;o (Flixotide Diskus&#174;):</strong> 50 mcg e 250 mcg.</li>\r\n<li><strong>Suspens&#227;o para nebuliza&#231;&#227;o (Flixotide Nebules<strong>&#174;</strong>):</strong>&#160;0,25 mg/ml e 1,0 mg/ml.</li>\r\n<li><strong>Suspens&#227;o aerossol (Flixotide Spray<strong><strong>&#174;</strong></strong>):</strong>&#160;50 mcg e 250 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2727,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes, intoxica&#231;&#245;es agudas com subst&#226;ncias que deprimem o SNC (&#225;lcool, tranquilizantes, analg&#233;sicos, etc.), porfirias hep&#225;ticas, cardiopatias, nefropatias, e hepatopatia graves, tireotoxicoses, feocromocitoma. glaucoma agudo, adenoma de pr&#243;stata com reten&#231;&#227;o urin&#225;ria residual, arritmias card&#237;acas, angina pectoris grave, psicose com agita&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\"><strong>Dose habitual:</strong> 200 a 400mg/dia.</li>\r\n<li class=\"MsoNormal\"><strong>Dose m&#225;xima:</strong> 800mg.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><strong>Dose habitual:</strong> 5 a 8mg/kg/dia.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p>- N&#227;o estabelecido.</p>",
        "id": 1355,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Tratamento e preven&#231;&#227;o de crises convulsivas t&#244;nico-cl&#244;nicas, parciais ou generalizadas, grande mal epil&#233;tico, pequeno mal miocl&#244;nico.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 79,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:17:17",
        "name": "Maliasin",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Comprimidos:</strong> 100mg.</span></li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p><span id=\"docs-internal-guid-67eb73a0-7fff-3f2f-a4a2-c192334e03f9\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Receita Azul (B1- psicotr&#243;picos).</span></span></p>",
        "record_status": 1,
        "slug": "maliasin",
        "substance": "Barbexaclona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Irrita&#231;&#227;o, inquieta&#231;&#227;o, astenia, perda de peso, alucina&#231;&#245;es visuais, inapet&#234;ncia, doen&#231;a consumptiva, obnubila&#231;&#227;o, ataxia, nistagmo, vertigem, v&#244;mito.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3489,
        "contraindications": "<p class=\"MsoNormal\">- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose padr&#227;o:</strong> 20 mg por infus&#227;o, IV durante 20-30 minutos ou como inje&#231;&#227;o em bolus, no per&#237;odo de 2 horas antes da cirurgia de transplante e 20mg 4 dias ap&#243;s o transplante.</li>\r\n<li><strong>Dilui&#231;&#227;o:</strong> (4mg/ml) 5 ml + (at&#233; 50ml) SF 0,9%/SG 5%.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><strong>Peso &lt; 40 kg:</strong> 20mg, administrados em duas doses de 10mg, IV durante 20-30 minutos ou como inje&#231;&#227;o em bolus.</li>\r\n<li class=\"MsoNormal\"><strong>Peso &#8805; 40 kg: </strong>posologia idem adultos.</li>\r\n<li><strong>Dilui&#231;&#227;o</strong>: (4mg/ml) 5 ml + (at&#233; 50 ml) SF 0,9%/SG 5%.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1356,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Administrado a adultos, adolescentes e crian&#231;as que v&#227;o realizar um transplante de rim, ajuda a prevenir a rejei&#231;&#227;o do rim transplantado durante as primeiras 4 a 6 semanas ap&#243;s a opera&#231;&#227;o. Outros medicamentos ser&#227;o administrados durante este per&#237;odo (por exemplo, ciclosporina para microemuls&#227;o).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-09 16:37:52",
        "name": "Simulect",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>P&#243; liofilizado:</strong> 20mg com diluente 5ml.</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p><span id=\"docs-internal-guid-1b8a672b-7fff-5253-91f0-4a37ae3f1767\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Uso hospitalar.</span></span></p>",
        "record_status": 1,
        "slug": "simulect",
        "substance": "Basiliximabe",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Constipa&#231;&#227;o, n&#225;useas, diarreia, aumento de peso, dor de cabe&#231;a, incha&#231;o das m&#227;os, tornozelos ou p&#233;s, press&#227;o alta, anemia, complica&#231;&#245;es da ferida cir&#250;rgica, diferentes tipos de infec&#231;&#245;es, altera&#231;&#245;es nos n&#237;veis de pot&#225;ssio, colesterol, fosfato e creatinina, crescimento excessivo de cabelo, coriza ou nariz entupido, febre, press&#227;o arterial elevada, diferentes tipos de infec&#231;&#227;o, constipa&#231;&#227;o intestinal, sepse.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2524,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula e menores de 4 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Asma:</strong> 1 inala&#231;&#227;o, 12/12 horas.</li>\r\n<li><strong>DPOC:</strong> dose m&#225;xima recomendada &#233; de 1 inala&#231;&#227;o de 50 mcg/250 mcg ou 50 mcg/500 mcg, 12/12 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as maiores de 4 anos:</strong>&#160;1 inala&#231;&#227;o 50mcg, 12/12 horas.</li>\r\n<li><strong>Crian&#231;as menores de 4 anos:</strong>&#160;n&#227;o recomendado.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1357,
        "indications": "<div>\r\n<p>- Pacientes em tratamento de manuten&#231;&#227;o com E2-agonistas de longa dura&#231;&#227;o e corticoides por via inalat&#243;ria, sintom&#225;ticos sob monoterapia com corticoides por via inalat&#243;ria e pacientes em tratamento regular com broncodilatadores que requerem o uso de corticoides por via inalat&#243;ria.&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-09 16:26:04",
        "name": "Seretide Diskus",
        "presentation": "<ul>\r\n<li><strong>Diskus com p&#243; para inala&#231;&#227;o:</strong> 50mcg/100mcg, 50mcg/250mcg e 50mcg/500mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Salmeterol + Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 2503,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes, casos de tuberculose (ativa ou inativa) e herpes simples.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> dois jatos, 12/12h. De acordo com a necessidade podem ser prescritas doses de at&#233; 8 jatos por dia.</li>\r\n<li><strong>Dose m&#225;xima recomendada:</strong> 400 mcg.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Posologia idem adultos.</li>\r\n<li><span id=\"docs-internal-guid-669b6b88-7fff-2064-57b9-2b4358f801fe\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1359,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- &#201; destinado ao tratamento e preven&#231;&#227;o de rinite al&#233;rgica perene ou sazonal e rinite vasomotora.&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 38,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 17:47:17",
        "name": "Alerfin",
        "presentation": "<div>\r\n<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 100<span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">mc</span>g/jato.</li>\r\n</ul>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Alerfin",
        "substance": "Beclometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Candid&#237;ase na boca e garganta, irrita&#231;&#227;o da garganta e rouquid&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes</strong><strong>:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2446,
        "contraindications": "<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Asma:</strong>&#160;1 inala&#231;&#227;o, 12/12 horas.</li>\r\n<li><strong>DPOC:</strong>&#160;dose m&#225;xima recomendada &#233; de 1 inala&#231;&#227;o de 50 mcg/250 mcg ou 50 mcg/500 mcg, 12/12 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as maiores de 4 anos:</strong>&#160;1 inala&#231;&#227;o 50mcg, 12/12 horas.</li>\r\n<li><strong>Crian&#231;as menores de 4 anos:</strong>&#160;n&#227;o recomendado.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1362,
        "indications": "<p>- Pacientes em tratamento de manuten&#231;&#227;o com E2-agonistas de longa dura&#231;&#227;o e corticoides por via inalat&#243;ria, sintom&#225;ticos sob monoterapia com corticoides por via inalat&#243;ria e pacientes em tratamento regular com broncodilatadores que requerem o uso de corticoides por via inalat&#243;ria.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-09 16:26:30",
        "name": "Seretide Spray",
        "presentation": "<ul>\r\n<li><strong>Aerossol:</strong> 25mcg/50mcg, 25mcg/125mcg e 25mcg/250mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Salmeterol + Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajustes.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2805,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Menores de 12 anos.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Uso inalat&#243;rio por via oral</strong></p>\r\n<ul>\r\n<li><strong>Asma:</strong> 1 inala&#231;&#227;o, 1x/dia; Independente da apresenta&#231;&#227;o.</li>\r\n<li><strong>DPOC:</strong> dose m&#225;xima recomendada &#233; de 1 inala&#231;&#227;o de 100 mcg/25 mcg, 1x/dia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>&gt; 12 anos:</strong> posologia idem adultos.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.&#160;</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1368,
        "indications": "<div>\r\n<p>- Indicado para o tratamento regular da asma em adultos e adolescentes com 12 anos ou mais.</p>\r\n<p>- Pacientes n&#227;o adequadamente controlados com corticosteroide inalat&#243;rio e quando necess&#225;rio agonista seletivo do receptor beta2 adren&#233;rgico de curta a&#231;&#227;o.</p>\r\n<p>- Tratamento sintom&#225;tico de pacientes com doen&#231;a pulmonar obstrutiva cr&#244;nica (DPOC) com VEF1 &#8249; 70% do normal previsto (p&#243;s-broncodilatador) e em pacientes com hist&#243;rico de exacerba&#231;&#227;o.&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-09 02:32:30",
        "name": "Relvar Ellipta",
        "presentation": "<ul>\r\n<li><strong>P&#243; para inala&#231;&#227;o oral:</strong> 100 mcg/25 mcg e 200 mcg/25 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Fluticasona + Vilanterol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2481,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Menores de 12 anos.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Uso inalat&#243;rio por via oral:&#160;</strong>1 c&#225;psula, 12/12 horas.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>&gt; 12 anos:</strong> posologia idem adultos.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1369,
        "indications": "<div>\r\n<p>- Indicado para o tratamento regular da asma em adultos e adolescentes com 12 anos ou mais.</p>\r\n<p>- Pacientes n&#227;o adequadamente controlados com corticosteroide inalat&#243;rio e quando necess&#225;rio agonista seletivo do receptor beta2 adren&#233;rgico de curta a&#231;&#227;o.</p>\r\n<p>- Pacientes j&#225; controlados adequadamente com ambos, corticosteroide inalat&#243;rio e beta2-agonista de longa dura&#231;&#227;o.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:11:39",
        "name": "Lugano",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o:</strong> 12 mcg/250 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Formoterol + Fluticasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2945,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\"><span style=\"color: black; background: white;\">- Hipersensibilidade aos componentes,&#160;</span><span style=\"color: black; background: white;\">hist&#243;ria pr&#233;via de angioedema. </span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong> 10mg VO 1x/dia, sendo ajustado conforme resposta da press&#227;o arterial, at&#233; a dose m&#225;xima de 40mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Maiores de 6 anos:</strong> 2,5mg a 5mg VO 1x/dia.</li>\r\n<li>N&#227;o &#233; recomendado para crian&#231;as com menos de 25 Kg ou menores de 6 anos.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1370,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\">- Tratamento da hipertens&#227;o arterial. Tratamento adjuvante da insufici&#234;ncia card&#237;aca congestiva. (pacientes classe II-IV da NYHA)</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:08:13",
        "name": "Lotensin",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\"><strong>Comprimidos Revestidos:&#160;</strong>5mg e 10mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lotensin",
        "substance": "Benazepril",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\">- Palpita&#231;&#245;es, hipotens&#227;o ortost&#225;tica, angina pectoris, arritmias, tosse, constipa&#231;&#227;o, n&#225;usea, v&#244;mito, dores abdominais, polaci&#250;ria e fadiga.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido. Recomenda-se doses menores em portadores de insufici&#234;ncia hep&#225;tica ou renal.</p>\r\n</div>"
    },
    {
        "content_length": 2373,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\">- Insufici&#234;ncia&#160;renal de m&#233;dia ou grave intensidade (filtra&#231;&#227;o glomerular &lt; 20ml/min), gr&#225;vidas.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> 1 comprimido 100mg VO 1x/dia pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><span id=\"docs-internal-guid-2a8efc44-7fff-f668-5b31-fbe9eef84fb6\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Categoria X:</span><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></span></p>",
        "id": 1371,
        "indications": "<p class=\"MsoNormal\"><span style=\"background: white;\">- Hiperuricemia prim&#225;ria, secund&#225;ria e gota de todas as etiologias.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 85,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:51:02",
        "name": "Narcaricina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "narcaricina",
        "substance": "Benzobromarona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\">- Diarreia e n&#225;useas.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2933,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\"><span style=\"color: black; background: white;\">- Hipersensibilidade aos componentes, i</span><span style=\"color: black; background: white;\">nsufici&#234;ncia hep&#225;tica, renal e afec&#231;&#245;es neurol&#243;gicas ser&#227;o consideradas contraindica&#231;&#245;es relativas.<span class=\"apple-converted-space\">&#160;</span></span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\"><strong>Dose usual:</strong> 5 a 7 mg/kg VO, devendo ser dividida em duas tomadas, de 12/12 horas . O tratamento deve ser mantido durante 30 a 60 dias consecutivos. </span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\"><strong>Menores de doze anos de idade:</strong> na fase aguda da doen&#231;a, doses de 10 mg/kg durante os primeiros dez a vinte dias do tratamento.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\"><strong>Maiores de doze anos:</strong> Posologia idem adultos.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1374,
        "indications": "<p>- Infec&#231;&#245;es devidas ao Trypanosoma cruzi (doen&#231;a de Chagas).</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:15:43",
        "name": "Benzonidazol",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Benzonidazol",
        "substance": "Benzonidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;<span style=\"color: black; background: white;\">- Rea&#231;&#245;es cut&#226;neas, n&#225;useas, parestesias, sintomas de polineurites perif&#233;ricas, cefaleia, vertigem, fadiga.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido. Recomenda-se doses menores em portadores de insufici&#234;ncia hep&#225;tica ou renal.</p>\r\n</div>"
    },
    {
        "content_length": 2755,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\"><span style=\"color: black; background: white;\">- Hipersensibilidade aos componentes, m</span><span style=\"color: black; background: white;\">enores de 18 anos, &#250;</span><span style=\"color: black; background: white;\">lcera gastrointestinal ativa, f</span><span style=\"color: black; background: white;\">eocromocitoma.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> 8mg VO 8/8 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span id=\"docs-internal-guid-6ffad09a-7fff-c9a5-beef-f5765d12c446\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1375,
        "indications": "<div>\r\n<p class=\"MsoNormal\"><span style=\"color: black; background: white;\">- Tratamento sintom&#225;tico da vertigem interativa com ou sem sinais cocleares, v</span><span style=\"color: black;\"><span style=\"background: white;\">ertigens devidas a dist&#250;rbios circulat&#243;rios do ouvido interno, z</span></span><span style=\"color: black;\"><span style=\"background: white;\">umbidos no ouvido e vertigens do tipo S&#237;ndrome de Meni&#233;re.</span></span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:23:52",
        "name": "Betaistina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 8mg, 16mg e 24mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "betaistina",
        "substance": "Betaistina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;- N&#225;useas, v&#244;mitos e cefal&#233;ia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2972,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes, infec&#231;&#227;o f&#250;ngica.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> de 0,25mg/dia a 8mg/dia, independente da via (VO ou IM) e dependendo da indica&#231;&#227;o e gravidade da doen&#231;a.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong> Varia de 0,017mg a 0,25mg por kg de peso por dia,&#160;independente da via (VO ou IM), ou 0,5mg a 7,5mg por metro quadrado de superf&#237;cie corporal.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1383,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\">- Indicado em v&#225;rios dist&#250;rbios end&#243;crinos, osteomusculares, do col&#225;geno, dermatol&#243;gicos, al&#233;rgicos, oft&#225;lmicos, respirat&#243;rios, hematol&#243;gicos, neopl&#225;sicos<span style=\"mso-spacerun: yes;\">&#160; </span>sens&#237;veis &#224; corticoterapia.<span class=\"apple-converted-space\">&#160;</span></span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:24:27",
        "name": "Betametasona",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\"><strong>Comprimido:</strong> 0,5mg e&#160;</span>2mg.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Gotas:&#160;</strong>0,5mg/ml.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ampola para uso IM:</strong> 4mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "betametasona",
        "substance": "Betametasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Dor de est&#244;mago, ins&#244;nia, ansiedade, reten&#231;&#227;o de s&#243;dio, perda de pot&#225;ssio, reten&#231;&#227;o de l&#237;quido, dermatite al&#233;rgica, urtic&#225;ria e retardo de cicatriza&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3210,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes, infec&#231;&#227;o f&#250;ngica.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> 1ml a 2ml na maioria das condi&#231;&#245;es, repetindo-se a terapia, quando necess&#225;rio. A administra&#231;&#227;o &#233; atrav&#233;s de inje&#231;&#227;o intramuscular (IM) profunda na regi&#227;o gl&#250;tea.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong>&#160;Varia de 0,017mg a 0,25mg por kg de peso por dia,&#160;independente da via, ou 0,5mg a 7,5mg por metro quadrado de superf&#237;cie corporal.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1384,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: black; background: white;\">- Indicado em v&#225;rios dist&#250;rbios end&#243;crinos, osteomusculares, do col&#225;geno, dermatol&#243;gicos, al&#233;rgicos, oft&#225;lmicos, respirat&#243;rios, hematol&#243;gicos, neopl&#225;sicos<span style=\"mso-spacerun: yes;\">&#160; </span>sens&#237;veis &#224; corticoterapia, i</span><span style=\"color: black; background: white;\"><span class=\"apple-converted-space\">ndicado para a terapia de doen&#231;as de intensidade moderada a grave, doen&#231;as agudas e cr&#244;nicas autolimitadas, responsivas aos corticosteroides sist&#234;micos, sendo especialmente &#250;til em pacientes que n&#227;o podem usar este tipo de medicamento por via oral.</span></span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:59:49",
        "name": "Beclonato",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o injet&#225;vel:</strong> 5mg/ml de&#160;Dipropionato de Betametasona + 2 mg/ml de&#160;Fosfato Diss&#243;dico de Betametasona.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Beclonato",
        "substance": "Betametasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Dor de est&#244;mago, ins&#244;nia, ansiedade, reten&#231;&#227;o de s&#243;dio, perda de pot&#225;ssio, reten&#231;&#227;o de l&#237;quido, dermatite al&#233;rgica, urtic&#225;ria e retardo de cicatriza&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 7211,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Administra&#231;&#227;o conjunta com inibidores da MAO;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arritmias graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Crise asm&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o ou insufici&#234;ncia respirat&#243;ria;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o grave do sistema nervoso central;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- DPOC&#160;descompensada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo cr&#244;nico, delirium tremens e desordens convulsivas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipertens&#227;o intracraniana;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- P&#243;s-operat&#243;rio de cirurgia de trato biliar, abd&#244;men e anastomoses;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Sensibilidade a morfina ou a algum componente da formula;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Analgesia: </strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"text-decoration: underline;\">VO</span>: 10 a 30 mg/dose, at&#233; 6x/dia (dose m&#225;xima: 75 mg/dose);</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"text-decoration: underline;\">IV</span>: 2,5 a 5 mg/dose em 4-5 minutos, de 4/4 horas ( dose m&#225;xima: 10 &#8211; 80 mg/h);Vent. mec&#226;nica: 1 a 10 mg/dose a cada 1-2 horas, ou infus&#227;o continua de 5-35 mg/h.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Epidural:</strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de ataque: 1 a 6 mg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de manuten&#231;&#227;o: 0,1 a 1 mg/hora (dose m&#225;xima: 10 mg/dia).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><strong>Infarto:</strong> 2 a 5 mg/dose (repetir 1x se necess&#225;rio).</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Analgesia para procedimentos:</strong> 5 a 10 mcg/kg/hora;</li>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>P&#243;s-operat&#243;rio:</strong> 10 a 40 mcg/kg/hora.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1396,
        "indications": "<div>\r\n<p>- Analgesia para dor moderada ou intensa;</p>\r\n<p>- Adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Alivio da dispneia no infarto e no edema agudo de pulm&#227;o;</p>\r\n<p>- Pacientes terminais.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-01-13 20:35:56",
        "name": "Dimorf",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas</strong> de 30mg, 60mg ou 100mg;</li>\r\n<li><strong>Comprimidos</strong> de 10mg ou 30mg;</li>\r\n<li><strong>Ampolas para uso injet&#225;vel</strong> com 0,1mg/1mL, 0,2mg/1mL e 10mg/1mL;</li>\r\n<li><strong>Solu&#231;&#227;o oral</strong> 10mg/mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receitu&#225;rio amarelo (exceto ampolas de 0,1 e 0,2mg - receitu&#225;rio controlado em 2 vias).</p>",
        "record_status": 1,
        "slug": "dimorf",
        "substance": "Morfina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Aumento da press&#227;o intracraniana e bradicardia, confus&#227;o mental e depress&#227;o respirat&#243;ria, constipa&#231;&#227;o, espasmo biliar, miose, n&#225;useas e v&#244;mitos, redu&#231;&#227;o da motilidade intestinal, reten&#231;&#227;o urinaria, toler&#226;ncia e depend&#234;ncia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-<strong>&#160;</strong><strong>CICr &gt; 50 &#8211; 90:</strong> sem ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50:</strong> fazer 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10:</strong> fazer 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> avaliar necessidade.</p>\r\n</div>"
    },
    {
        "content_length": 7157,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Administra&#231;&#227;o conjunta com inibidores da MAO;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arritmias graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Crise asm&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o ou insufici&#234;ncia respirat&#243;ria;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o grave do sistema nervoso central;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- DPOC&#160;descompensada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo cr&#244;nico, delirium tremens e desordens convulsivas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipertens&#227;o intracraniana;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- P&#243;s-operat&#243;rio de cirurgia de trato biliar, abd&#244;men e anastomoses;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Sensibilidade a morfina ou a algum componente da formula;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Analgesia: </strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"text-decoration: underline;\">VO</span>: 10 a 30 mg/dose, at&#233; 6x/dia (dose m&#225;xima: 75 mg/dose);</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"text-decoration: underline;\">IV</span>: 2,5 a 5 mg/dose em 4-5 minutos, de 4/4 horas ( dose m&#225;xima: 10 &#8211; 80 mg/h);Vent. mec&#226;nica: 1 a 10 mg/dose a cada 1-2 horas, ou infus&#227;o continua de 5-35 mg/h.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Epidural:</strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de ataque: 1 a 6 mg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de manuten&#231;&#227;o: 0,1 a 1 mg/hora (dose m&#225;xima: 10 mg/dia).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><strong>Infarto:</strong> 2 a 5 mg/dose (repetir 1x se necess&#225;rio).</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Analgesia para procedimentos:</strong> 5 a 10 mcg/kg/hora;</li>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>P&#243;s-operat&#243;rio:</strong> 10 a 40 mcg/kg/hora.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1398,
        "indications": "<div>\r\n<p>- Analgesia para dor moderada ou intensa;</p>\r\n<p>- Adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Alivio da dispneia no infarto e no edema agudo de pulm&#227;o;</p>\r\n<p>- Pacientes terminais.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-01-13 20:35:57",
        "name": "Dolo Moff",
        "presentation": "<ul>\r\n<li><strong>Comprimidos</strong> de 10mg ou 30mg;</li>\r\n<li><strong>Ampolas para uso injet&#225;vel</strong> com 0,2mg/1mL, 2mg/2mL e 10mg/1mL;</li>\r\n<li><strong>Solu&#231;&#227;o oral</strong> 10mg/mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receitu&#225;rio amarelo (exceto ampolas de 0,1 e 0,2mg - receitu&#225;rio controlado em 2 vias).</p>",
        "record_status": 1,
        "slug": "dolo-moff",
        "substance": "Morfina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Aumento da press&#227;o intracraniana e bradicardia, confus&#227;o mental e depress&#227;o respirat&#243;ria, constipa&#231;&#227;o, espasmo biliar, miose, n&#225;useas e v&#244;mitos, redu&#231;&#227;o da motilidade intestinal, reten&#231;&#227;o urinaria, toler&#226;ncia e depend&#234;ncia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-<strong>&#160;</strong><strong>CICr &gt; 50 &#8211; 90:</strong> sem ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50:</strong> fazer 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10:</strong> fazer 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> avaliar necessidade.</p>\r\n</div>"
    },
    {
        "content_length": 7001,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Administra&#231;&#227;o conjunta com inibidores da MAO;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Arritmias graves;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Crise asm&#225;tica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o ou insufici&#234;ncia respirat&#243;ria;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Depress&#227;o grave do sistema nervoso central;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- DPOC&#160;descompensada;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Alcoolismo cr&#244;nico, delirium tremens e desordens convulsivas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipertens&#227;o intracraniana;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- P&#243;s-operat&#243;rio de cirurgia de trato biliar, abd&#244;men e anastomoses;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Sensibilidade a morfina ou a algum componente da formula;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Analgesia: </strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"text-decoration: underline;\">VO</span>: 10 a 30 mg/dose, at&#233; 6x/dia (dose m&#225;xima: 75 mg/dose);</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><span style=\"text-decoration: underline;\">IV</span>: 2,5 a 5 mg/dose em 4-5 minutos, de 4/4 horas ( dose m&#225;xima: 10 &#8211; 80 mg/h);Vent. mec&#226;nica: 1 a 10 mg/dose a cada 1-2 horas, ou infus&#227;o continua de 5-35 mg/h.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Epidural:</strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de ataque: 1 a 6 mg;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Dose de manuten&#231;&#227;o: 0,1 a 1 mg/hora (dose m&#225;xima: 10 mg/dia).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><strong>Infarto:</strong> 2 a 5 mg/dose (repetir 1x se necess&#225;rio).</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Analgesia para procedimentos:</strong> 5 a 10 mcg/kg/hora;</li>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>P&#243;s-operat&#243;rio:</strong> 10 a 40 mcg/kg/hora.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1399,
        "indications": "<div>\r\n<p>- Analgesia para dor moderada ou intensa;</p>\r\n<p>- Adapta&#231;&#227;o a ventila&#231;&#227;o mec&#226;nica;</p>\r\n<p>- Alivio da dispneia no infarto e no edema agudo de pulm&#227;o;</p>\r\n<p>- Pacientes terminais.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></span></p>",
        "last_update": "2019-03-05 00:37:28",
        "name": "Morfina",
        "presentation": "<ul>\r\n<li><strong>Ampolas para uso injet&#225;vel</strong> com 2mg/2mL e 10mg/1mL;</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receitu&#225;rio amarelo (exceto ampolas de 0,1 e 0,2mg - receitu&#225;rio controlado em 2 vias).</p>",
        "record_status": 1,
        "slug": "morfina",
        "substance": "Morfina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Aumento da press&#227;o intracraniana e bradicardia, confus&#227;o mental e depress&#227;o respirat&#243;ria, constipa&#231;&#227;o, espasmo biliar, miose, n&#225;useas e v&#244;mitos, redu&#231;&#227;o da motilidade intestinal, reten&#231;&#227;o urinaria, toler&#226;ncia e depend&#234;ncia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-<strong>&#160;</strong><strong>CICr &gt; 50 &#8211; 90:</strong> sem ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50:</strong> fazer 75% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10:</strong> fazer 50% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> avaliar necessidade.</p>\r\n</div>"
    },
    {
        "content_length": 2670,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1401,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es bacterianas de pele como: impetigo, foliculite e furuncolose;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Profilaxia pr&#233;-operat&#243;ria (cirurgia orovalvar).</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-04 01:54:03",
        "name": "Bactroban",
        "presentation": "<ul>\r\n<li><strong>Pomada</strong> a 2%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em 2 vias.</span></p>",
        "record_status": 1,
        "slug": "bactroban",
        "substance": "Mupirocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Ard&#234;ncia localizada na &#225;rea da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2664,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1402,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es bacterianas de pele como: impetigo, foliculite e furuncolose;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Profilaxia pr&#233;-operat&#243;ria (cirurgia orovalvar).</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 139,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-04 01:52:14",
        "name": "Bacrocin",
        "presentation": "<ul>\r\n<li><strong>Pomada</strong> a 2%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em duas vias.</span></p>",
        "record_status": 1,
        "slug": "bacrocin",
        "substance": "Mupirocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Ard&#234;ncia localizada na &#225;rea da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2658,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1403,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es bacterianas de pele como: impetigo, foliculite e furuncolose;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Profilaxia pr&#233;-operat&#243;ria (cirurgia orovalvar).</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-05 00:43:56",
        "name": "Mupirocina",
        "presentation": "<ul>\r\n<li><strong>Pomada</strong> a 2%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em 2 vias.</span></p>",
        "record_status": 1,
        "slug": "mupirocina",
        "substance": "Mupirocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Ard&#234;ncia localizada na &#225;rea da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2670,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1405,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es bacterianas de pele como: impetigo, foliculite e furuncolose;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Profilaxia pr&#233;-operat&#243;ria (cirurgia orovalvar).</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-04 01:54:16",
        "name": "Bactroneo",
        "presentation": "<ul>\r\n<li><strong>Pomada</strong> a 2%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em 2 vias.</span></p>",
        "record_status": 1,
        "slug": "bctroneo",
        "substance": "Mupirocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Ard&#234;ncia localizada na &#225;rea da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2657,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1406,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es bacterianas de pele como: impetigo, foliculite e furuncolose;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Profilaxia pr&#233;-operat&#243;ria (cirurgia orovalvar).</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 73,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-01-13 20:36:40",
        "name": "Dermoban",
        "presentation": "<ul>\r\n<li><strong>Pomada</strong> a 2%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em 2 vias.</span></p>",
        "record_status": 1,
        "slug": "dermoban",
        "substance": "Mupirocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Ard&#234;ncia localizada na &#225;rea da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2663,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Aplicar na &#225;rea afetada ate 3x/dia e por no m&#225;ximo 10 dias.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1407,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es bacterianas de pele como: impetigo, foliculite e furuncolose;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Profilaxia pr&#233;-operat&#243;ria (cirurgia orovalvar).</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 92,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-10 03:19:03",
        "name": "Supirocin",
        "presentation": "<ul>\r\n<li><strong>Pomada</strong> a 2%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples, em 2 vias.</span></p>",
        "record_status": 1,
        "slug": "supirocin",
        "substance": "Mupirocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Ard&#234;ncia localizada na &#225;rea da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3314,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Paciente com anticorpos anti-murinos maior ou igual a 1:1000;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Insufici&#234;ncia card&#237;aca descompensada.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia:</strong> 5 mg 1x/dia por 14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Tratamento:</strong> 5 mg 1x/dia por 10 a 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1408,
        "indications": "<p>- Profilaxia e tratamento da rejei&#231;&#227;o celular aguda do &#243;rg&#227;o transplantado.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 16:45:14",
        "name": "Orthoclone OKT",
        "presentation": "<ul>\r\n<li><strong>Ampolas</strong> de 5mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita de controle especial - uso hospitalar.</span></p>",
        "record_status": 1,
        "slug": "orthoclone-okt",
        "substance": "Muromonabe CD3",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">Rea&#231;&#245;es anafil&#225;ticas, colapso cardiovascular, parada cardiorrespirat&#243;ria, perda de consci&#234;ncia, hipotens&#227;o, edema pulmonar, taquicardia, prurido, urticaria, angioedema, dispneia, broncoespasmo e obstru&#231;&#227;o das vias a&#233;reas.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3477,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Gel:</strong> &#189; colher de ch&#225; (2,5 ml) 4x/dia ap&#243;s as refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Gel:</strong> 1,25 ml de gel (6 a 24 meses) a 2,5 ml de gel (&gt; 2 anos), 4x/dia ap&#243;s as refei&#231;&#245;es.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1409,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:28:29",
        "name": "Daktarin",
        "presentation": "<ul>\r\n<li><strong>Gel oral</strong> 20mg/g;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> 20mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "daktarin",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3208,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1410,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:22:19",
        "name": "Micozen",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> 20mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "micozen",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3043,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1411,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 15,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:28:23",
        "name": "Ciconazol",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> 20mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "ciconazol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2936,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1412,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-03 19:43:35",
        "name": "Gino Mizonol",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "gino-mizonol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3043,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1413,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 121,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-03 19:43:59",
        "name": "Ginotarin",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> a 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> 20mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "ginotarin",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3323,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme:</strong> aplicar na &#225;rea afetada 2x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme</strong>&#160;<strong>vaginal:</strong> utilizar um aplicador cheio, antes de dormir, por 14 dias.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1414,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:28:46",
        "name": "Miconazol",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> a 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> 20mg/mL;</li>\r\n<li><strong>Creme vaginal</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "miconazol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3126,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme / P&#243;:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o / Creme / P&#243;:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1415,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-10 14:37:36",
        "name": "Vodol",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> a 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> 20mg/mL;</li>\r\n<li><strong>P&#243; dermatol&#243;gico</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "vodol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2973,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1416,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-03 23:55:03",
        "name": "Amicozol",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "amicozol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2867,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> usar 1 aplicador cheio, ao dormir, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1417,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de <em>Tinea pedis</em>, <em>Tinea cruris</em>, <em>Tinea corposis</em> e onicomicoses causadas pelo <em>Trychophyton</em>, <em>Epidermophyton</em> e <em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea, <em>Tinea versicolor</em> e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 58,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-04 00:33:43",
        "name": "Anfugitarin",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "anfugitarin",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3353,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme / Lo&#231;&#227;o / P&#243;:</strong> aplicar na &#225;rea afetada 2x/dia</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> usar 1 aplicador cheio, ao dormir, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme / Lo&#231;&#227;o / P&#243;:</strong>&#160;aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1418,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 52,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:28:25",
        "name": "Colpadak",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> a 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> a 2%;</li>\r\n<li><strong>P&#243;</strong> a 2%;</li>\r\n<li><strong>Creme dermatol&#243;gico</strong> 20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "colpadak",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2967,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong>&#160;aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1419,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 69,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:28:27",
        "name": "Daknax",
        "presentation": "<ul>\r\n<li><strong>Lo&#231;&#227;o</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "daknax",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3043,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme / Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme / Lo&#231;&#227;o:</strong>&#160;aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1420,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:28:34",
        "name": "Daktazol",
        "presentation": "<ul>\r\n<li><strong>Lo&#231;&#227;o</strong> a 2%;</li>\r\n<li><strong>Creme</strong> com 20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "daktazol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2939,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1421,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 16,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-03 19:43:52",
        "name": "Gino-Daczol",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "gino-daczol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2939,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1422,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 69,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-03 20:21:35",
        "name": "Gyno Daknax",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "gino-daknax",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2930,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1423,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:19:59",
        "name": "Micofim",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "micofim",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2930,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 14 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1424,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:20:08",
        "name": "Micogyn",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal</strong> 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "micogyn",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2975,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Lo&#231;&#227;o:</strong>&#160;aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1425,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 84,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:21:07",
        "name": "Miconil",
        "presentation": "<ul>\r\n<li><strong>Lo&#231;&#227;o</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "miconil",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2946,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme:</strong>&#160;aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1426,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-05 00:33:12",
        "name": "Mizonol",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "mizonol",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3040,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme / lo&#231;&#227;o:</strong> aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme / lo&#231;&#227;o:</strong>&#160;aplicar na &#225;rea afetada 2x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 1427,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es vulvoginais e perianais causadas por C&#226;ndida;</p>\r\n<p>- Tratamento de&#160;<em>Tinea pedis</em>,&#160;<em>Tinea cruris</em>,&#160;<em>Tinea corposis</em>&#160;e onicomicoses causadas pelo&#160;<em>Trychophyton</em>,&#160;<em>Epidermophyton</em>&#160;e&#160;<em>Microspoum;</em></p>\r\n<p>- Tratamento de candid&#237;ase cut&#226;nea,&#160;<em>Tinea versicolor</em>&#160;e cromofitose;</p>\r\n<p>- Tratamento terap&#234;utico e profil&#225;tico da candid&#237;ase da cavidade bucofar&#237;ngea.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 73,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-10 14:38:14",
        "name": "Volnac",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico</strong> a 2%;</li>\r\n<li><strong>Lo&#231;&#227;o</strong> a 2%.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "volnac",
        "substance": "Miconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>Cefaleia, prurido genital feminino, sensa&#231;&#227;o de ard&#234;ncia genital, irrita&#231;&#227;o vaginal, corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4260,
        "contraindications": "<p><span id=\"docs-internal-guid-3487e3ec-7fff-4fcf-e3f3-ddc5da525c2a\"><span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Hipersensibilidade aos componentes, hipertireoidismo, &#250;lcera p&#233;ptica latente ou ativa, asma br&#244;nquica, bradicardia pronunciada ou hipotens&#227;o, instabilidade vasomotora, coronariopatias, epilepsia e parkinsonismo, presen&#231;a de obstru&#231;&#227;o mec&#226;nica da bexiga, peritonite ou marcada vagotonia.</span></span></p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 115%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Dose usual:</strong> 10mg a 50mg VO tr&#234;s a quatro vezes ao dia, dependendo do tipo e gravidade da condi&#231;&#227;o tratada.&#160; </span></li>\r\n<li><span style=\"line-height: 115%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>S</strong><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>olu&#231;&#227;o Injet&#225;vel:</strong> 1 ml SC (5mg) repetindo a mesma dose a cada 15 ou 30 minutos, atingindo um m&#225;ximo de 4 doses, at&#233; obter o efeito desejado.</span></span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1428,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- No tratamento da reten&#231;&#227;o urin&#225;ria (funcional) aguda p&#243;s-operat&#243;ria e p&#243;s-parto e, da reten&#231;&#227;o urin&#225;ria causada pela atonia neurog&#234;nica da bexiga.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 7,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 00:49:25",
        "name": "Liberan",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:&#160;</strong>5mg, 10mg e 25mg.</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel subcut&#226;nea:</strong> 5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "liberan",
        "substance": "Betanecol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">-&#160;</span><span style=\"white-space: pre-wrap;\">Hipotens&#227;o com taquicardia reflexa, resposta vasomotora, broncoconstri&#231;&#227;o, cefal&#233;ia, sudorese, hipotermia e tremores, contra&#231;&#245;es ou desconforto abdominal, c&#243;licas dolorosas, n&#225;useas, diarr&#233;ia,saliva&#231;&#227;o, urg&#234;ncia urin&#225;ria.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3156,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes,&#160;</span>bradicardia sinusal, maior do que o bloqueio atrioventricular de primeiro grau, choque cardiog&#234;nico ou pacientes com insufici&#234;ncia card&#237;aca comprovada.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 1 ou 2 gotas no olho afetado 2x/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 1 ou 2 gotas no olho afetado 2x/dia.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1429,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipertens&#227;o ocular e glaucoma de &#226;ngulo aberto.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-09-29 18:57:08",
        "name": "Betaxolol",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Col&#237;rio:</strong> 5mg/ml e 2,5mg/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "betaxolol",
        "substance": "Betaxolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Lacrimejamento, vis&#227;o borrada, secre&#231;&#227;o, dor ocular e secura nos olhos.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">&#160;- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 4997,
        "contraindications": "<p class=\"MsoNormal\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes da f&#243;rmula e produtos de c&#233;lulas de ov&#225;rio de hamster chin&#234;s ou a outros anticorpos recombinantes humanos ou humanizados. </span></p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>C&#226;ncer colorretal metast&#225;tico:&#160;</strong>Na terapia de primeira linha &#233; de 5mg/kg IV, administrada uma vez a cada 14 dias, ou 7,5mg/kg IV, administrada uma vez a cada 21 dias. A dose recomendada em terapia de segunda linha &#233; 10mg/kg IV, administrada uma vez a cada 14 dias, ou 15mg/kg IV, administrada uma vez a cada 21 dias.</li>\r\n<li><strong>C&#226;ncer de mama metast&#225;tico:&#160;</strong>10mg/kg IV, administrada a cada duas semanas, ou 15mg/kg IV, administrada a cada tr&#234;s semanas.</li>\r\n<li><strong>C&#226;ncer de pulm&#227;o de n&#227;o pequenas c&#233;lulas avan&#231;ado, metast&#225;tico ou recorrente:&#160;</strong>Deve ser administrado em associa&#231;&#227;o com quimioterapia &#224; base de platina, em at&#233; seis ciclos de tratamento, seguidos de Bevacizumabe em monoterapia at&#233; progress&#227;o da doen&#231;a. A dose recomendada quando usado em associa&#231;&#227;o com quimioterapia &#224; base de cisplatina, &#233; de 7,5mg/kg IV, administrada uma vez a cada tr&#234;s semanas. A dose recomendada quando usado em associa&#231;&#227;o com quimioterapia &#224; base de carboplatina, &#233; de 15mg/kg IV, administrada uma vez a cada tr&#234;s semanas.</li>\r\n<li><strong>C&#226;ncer de c&#233;lulas renais metast&#225;tico e/ou avan&#231;ado:&#160;</strong>10mg/kg IV, administrada a cada duas semanas, quando em monoterapia deve ser mantido at&#233; a progress&#227;o da doen&#231;a de base.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1434,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; mso-fareast-language: PT-BR;\">- C&#226;ncer de c&#243;lon e reto (tratamento) (em combina&#231;&#227;o com quimioterapia com 5-fluorouracila), c&#226;ncer de mama (metast&#225;tico) (HER2 negativo - primeira linha de terapia em combina&#231;&#227;o com paclitaxel), c&#226;ncer de pulm&#227;o de c&#233;lulas n&#227;o pequenas e n&#227;o escamosas (avan&#231;ado/metast&#225;tico).</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-09-29 19:06:22",
        "name": "Avastin",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel</strong>: 4mg/ml, 16mg/ml e 25mg/ml.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p><span id=\"docs-internal-guid-9675a882-7fff-acdd-0e08-fad6839a1031\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Uso hospitalar.</span></span></p>",
        "record_status": 1,
        "slug": "avastin",
        "substance": "Bevacizumabe",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Aumento da<span class=\"apple-converted-space\">&#160;</span><span class=\"posttip\">press&#227;o arterial</span>, problemas de cicatriza&#231;&#227;o de feridas e de cortes cir&#250;rgicos,<span class=\"apple-converted-space\">&#160;hemorragias,</span><span class=\"posttip\">infarto agudo&#160;</span></span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">do<span class=\"apple-converted-space\">&#160;</span><span class=\"posttip\">mioc&#225;rdio</span> (principalmente em indiv&#237;duos com idade acima de 65 anos), d</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\"><span class=\"posttip\">errame</span><span class=\"apple-converted-space\">&#160;</span>cerebral.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3885,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes, i</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">nsufici&#234;ncia hep&#225;tica grave, i</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">nsufici&#234;ncia renal grave,&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">doen&#231;as biliares.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 1 comprimido 200mg VO de 8/8 horas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-176a6ea3-7fff-a8b0-d59f-fb8731a8cfdb\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1435,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipercolesterolemia, hipertrigliceridemia, hiperlipidemia mista.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:27:11",
        "name": "Bezafibrato",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido:</strong> 200mg.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido de a&#231;&#227;o prolongada:</strong> 400mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bezafibrato",
        "substance": "Bezafibrato",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><span id=\"docs-internal-guid-5af604c4-7fff-da6a-98c2-2739b06bd1bd\"><span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Mialgia, vertigem, tontura, cefal&#233;ia, fadiga, n&#225;usea, v&#244;mito, diarreia, alopecia, urtic&#225;ria, prurido, e disfun&#231;&#227;o er&#233;til.</span></span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">&#160;- N&#227;o estabelecido. Recomenda-se doses menores em portadores de hep&#225;tica ou insufici&#234;ncia renal.</p>\r\n</div>"
    },
    {
        "content_length": 3868,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-ansi-language: PT-BR;\">- Hipersensibilidade aos componentes;</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Portadores de doen&#231;as inflamat&#243;rias intestinais ativas graves, colite t&#243;xica, obstru&#231;&#227;o ou perfura&#231;&#227;o do trato gastrintestinal e na presen&#231;a de dor abdominal de etiologia desconhecida;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 122%;\"><span style=\"mso-ansi-language: PT-BR;\"><strong>Constipa&#231;&#227;o intestinal:</strong> 1-2 sach&#234;s, VO, ao dia;</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 122%;\"><strong>Impacta&#231;&#227;o fecal:</strong> 8 sach&#234;s/dia dissolvidos em 1 litro de &#225;gua, tomando-se a solu&#231;&#227;o VO em 4-6 horas;</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 122%;\"><strong>Preparo para colonoscopia:</strong> dissolver 8 sach&#234;s em 1 litro de &#225;gua e administrar um copo de 250 ml, VO, a cada 10 minutos at&#233; que o efluente retal seja claro e livre de part&#237;culas s&#243;lidas, ou at&#233; que tenham sido consumidos 4 litros da solu&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 122%;\"><span style=\"mso-ansi-language: PT-BR;\"><strong>Constipa&#231;&#227;o intestinal (&gt;2 anos):</strong> 0,3 a 1,4 g/kg/dia, VO;&#160;</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 122%;\"><strong>Impacta&#231;&#227;o fecal (&gt;2 anos):</strong> 1,5 g/kg/dia, at&#233; o m&#225;ximo de 100 g, VO.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1438,
        "indications": "<div>\r\n<p><span style=\"mso-ansi-language: PT-BR;\">- Tratamento da constipa&#231;&#227;o intestinal;&#160;</span></p>\r\n<p>- Tratamento da impacta&#231;&#227;o fecal;</p>\r\n<p>- Preparo intestinal antes de cirurgias e exames endosc&#243;picos ou radiol&#243;gicos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-05 00:45:16",
        "name": "Muvinlax",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-ansi-language: PT-BR;\"><strong>P&#243; para prepara&#231;&#227;o extempor&#226;nea:</strong> 13,125 g de Macrogol 3350; 0,1775 g de bicarbonato de s&#243;dio; 0,3507 g de cloreto de s&#243;dio e 0,0466 g de cloreto de pot&#225;ssio.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "muvinlax",
        "substance": "Macrogol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>N&#225;useas, incha&#231;o.</p>\r\n<hr>\r\n<p><strong>Ajustesna Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 7135,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Menores de 2 anos, a</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">lcalose, h</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">ipocalcemia.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li style=\"text-align: justify; line-height: 107%; background: white; vertical-align: baseline; margin: 0cm 0cm 8.0pt 0cm;\"><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\"><strong>Acidose Metab&#243;lica:&#160;</strong></span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\">Infus&#227;o intravenosa, 2 a 5mEq por kg de peso, no per&#237;odo de 4 a 8 horas.</span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;\">&#160;</span></li>\r\n<li style=\"text-align: justify; line-height: 107%; background: white; vertical-align: baseline; margin: 0cm 0cm 8.0pt 0cm;\"><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\"><strong>Parada Card&#237;aca:&#160;</strong></span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\">Via intravenosa, iniciando com 1mEq por kg de peso corporal e depois 0,5mEq por kg de peso corporal cada 10 minutos se a parada continuar.</span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;\">&#160;</span></li>\r\n<li style=\"text-align: justify; line-height: 107%; background: white; vertical-align: baseline; margin: 0cm 0cm 8.0pt 0cm;\"><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\"><strong>Alcaliniza&#231;&#227;o Urin&#225;ria:&#160;</strong></span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\">Infus&#227;o intravenosa, 2 a 5mEq por kg de peso corporal, em um per&#237;odo de 4 a 8 horas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify; line-height: 107%; background: white; vertical-align: baseline; margin: 0cm 0cm 8.0pt 0cm;\"><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\"><strong>Parada Card&#237;aca:&#160;</strong></span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: windowtext; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; font-weight: normal; mso-bidi-font-weight: bold; font-style: normal; mso-bidi-font-style: italic;\">Via intravenosa (1mEq por kg de peso corporal inicialmente e a seguir 0,5mEq por kg de peso corporal para cada 10 minutos se a parada continuar).</span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;\">&#160;</span></li>\r\n<li style=\"text-align: justify; line-height: 107%; background: white; vertical-align: baseline; margin: 0cm 0cm 8.0pt 0cm;\">Posologia idem adultos para as demais indica&#231;&#245;es.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1439,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Acidoses graves, acidose tubular renal, cetoacidose diab&#233;tica e insufici&#234;ncia renal.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:29:00",
        "name": "Bicarbonato de Sódio 8,4%",
        "presentation": "<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Solu&#231;&#227;o Injet&#225;vel:</strong> 5% e 8,4%.</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p><span id=\"docs-internal-guid-e7780944-7fff-b5e3-ef08-d7c41e87ffdd\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Uso hospitalar.</span></span></p>",
        "record_status": 1,
        "slug": "bicarbonato-de-sodio-84",
        "substance": "Bicarbonato de Sódio 8,4%",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Alcalose, convuls&#245;es, tetania, hipernatremia e congest&#227;o pulmonar.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3110,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Hipersensibilidade aos componentes da f&#243;rmula;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Hist&#243;rico de convuls&#245;es ou dist&#250;rbios neuro-psiqui&#225;tricos graves;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Rea&#231;&#245;es adversos &#224; antimal&#225;ricos quinol&#237;nicos;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Insufici&#234;ncia hep&#225;tica grave.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 250 mg/semana;</li>\r\n<li><strong>Para profilaxia:</strong> iniciar 1 semana antes da viagem e manter at&#233; 4 semanas ap&#243;s o retorno (em virtude dos eventos adversos graves ocorrerem habitualmente at&#233; a terceira dose, sugere-se iniciar tr&#234;s semanas antes da viagem a fim de monitor&#225;-los);</li>\r\n<li><strong>Alternativa:</strong> 750 mg em dose de ataque e depois iniciar 250 mg/semana.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as a partir de 5 kg:</strong> 5 mg/kg/semana VO (m&#225;ximo = 250mg/semana).</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1442,
        "indications": "<p><span style=\"line-height: 107%;\">- Profilaxia e tratamento da mal&#225;ria.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-01-13 19:24:40",
        "name": "Mefloquina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio comum.</p>",
        "record_status": 1,
        "slug": "mefloquina",
        "substance": "Mefloquina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Tonturas;</p>\r\n<p>- Vertigem;</p>\r\n<p>- Perda de equil&#237;brio.</p>\r\n<hr>\r\n<p><strong>Ajustes em Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4380,
        "contraindications": "<div>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com hipersensibilidade aos componentes da f&#243;rmula;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com depend&#234;ncia de opi&#243;ides; </span></p>\r\n<p><span style=\"line-height: 107%;\">- Amamenta&#231;&#227;o;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Concomitantemente &#224; inibidores da MAO;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Insufici&#234;ncia respirat&#243;ria grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>IM:</strong> 25 a 150 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>EV:</strong> 25 a 100 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 500mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Analgesia:</strong> 1 a 1,5 mg/kg/dose, EV ou IM, de 3/3h ou 4/4h;</li>\r\n<li><strong>Controle de tremores:</strong> 0,25 a 0,5 mg/kg/dose;</li>\r\n<li><strong>Dose usual:</strong> 6 a 9 mg/kg/dia (m&#225;ximo = 100mg/dia)</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1443,
        "indications": "<div>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Analgesia de dores moderadas &#224; graves;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Pr&#233;-anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Terapia de apoio ao procedimento anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Controle de tremores.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-01-13 19:30:30",
        "name": "Dolantina",
        "presentation": "<ul>\r\n<li><strong>Ampolas: </strong>100mg/2mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "dolantina",
        "substance": "Meperidina / Petidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Bradicardia, taquicardia, hipotens&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Broncoespasmo;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Miose, solu&#231;o, n&#225;usea, tontura, confus&#227;o, v&#244;mito, dor e eritema no local da aplica&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Dificuldade de mic&#231;&#227;o e constipa&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Seda&#231;&#227;o, euforia e depress&#227;o respirat&#243;ria, convuls&#245;es.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4444,
        "contraindications": "<div>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com hipersensibilidade aos componentes da f&#243;rmula;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com depend&#234;ncia de opi&#243;ides; </span></p>\r\n<p><span style=\"line-height: 107%;\">- Amamenta&#231;&#227;o;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Concomitantemente &#224; inibidores da MAO;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Insufici&#234;ncia respirat&#243;ria grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>IM:</strong> 25 a 150 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>EV:</strong> 25 a 100 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 500mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Analgesia:</strong> 1 a 1,5 mg/kg/dose, EV ou IM, de 3/3h ou 4/4h;</li>\r\n<li><strong>Controle de tremores:</strong> 0,25 a 0,5 mg/kg/dose;</li>\r\n<li><strong>Dose usual:</strong> 6 a 9 mg/kg/dia (m&#225;ximo = 100mg/dia)</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1444,
        "indications": "<div>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Analgesia de dores moderadas &#224; graves;</span></span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Pr&#233;-anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Terapia de apoio ao procedimento anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Controle de tremores.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-06 17:19:07",
        "name": "Petidina",
        "presentation": "<ul>\r\n<li><strong>Ampolas:</strong> 100mg/2mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "petidina",
        "substance": "Meperidina / Petidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Bradicardia, taquicardia, hipotens&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Broncoespasmo;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Miose, solu&#231;o, n&#225;usea, tontura, confus&#227;o, v&#244;mito, dor e eritema no local da aplica&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Dificuldade de mic&#231;&#227;o e constipa&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Seda&#231;&#227;o, euforia e depress&#227;o respirat&#243;ria, convuls&#245;es.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4376,
        "contraindications": "<div>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com hipersensibilidade aos componentes da f&#243;rmula;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com depend&#234;ncia de opi&#243;ides; </span></p>\r\n<p><span style=\"line-height: 107%;\">- Amamenta&#231;&#227;o;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Concomitantemente &#224; inibidores da MAO;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Insufici&#234;ncia respirat&#243;ria grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>IM:</strong> 25 a 150 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>EV:</strong> 25 a 100 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 500mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Analgesia:</strong> 1 a 1,5 mg/kg/dose, EV ou IM, de 3/3h ou 4/4h;</li>\r\n<li><strong>Controle de tremores:</strong> 0,25 a 0,5 mg/kg/dose;</li>\r\n<li><strong>Dose usual:</strong> 6 a 9 mg/kg/dia (m&#225;ximo = 100mg/dia)</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1445,
        "indications": "<div>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Analgesia de dores moderadas &#224; graves;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Pr&#233;-anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Terapia de apoio ao procedimento anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Controle de tremores.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-01-13 19:30:34",
        "name": "Dolosal",
        "presentation": "<ul>\r\n<li><strong>Ampolas:</strong> 100mg/2mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "dolosal",
        "substance": "Meperidina / Petidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Bradicardia, taquicardia, hipotens&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Broncoespasmo;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Miose, solu&#231;o, n&#225;usea, tontura, confus&#227;o, v&#244;mito, dor e eritema no local da aplica&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Dificuldade de mic&#231;&#227;o e constipa&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Seda&#231;&#227;o, euforia e depress&#227;o respirat&#243;ria, convuls&#245;es.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4462,
        "contraindications": "<div>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com hipersensibilidade aos componentes da f&#243;rmula;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com depend&#234;ncia de opi&#243;ides; </span></p>\r\n<p><span style=\"line-height: 107%;\">- Amamenta&#231;&#227;o;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Concomitantemente &#224; inibidores da MAO;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Insufici&#234;ncia respirat&#243;ria grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>IM:</strong> 25 a 150 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>EV:</strong> 25 a 100 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 500mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Analgesia:</strong> 1 a 1,5 mg/kg/dose, EV ou IM, de 3/3h ou 4/4h;</li>\r\n<li><strong>Controle de tremores:</strong> 0,25 a 0,5 mg/kg/dose;</li>\r\n<li><strong>Dose usual:</strong> 6 a 9 mg/kg/dia (m&#225;ximo = 100mg/dia)</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1446,
        "indications": "<div>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Analgesia de dores moderadas &#224; graves;</span></span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Pr&#233;-anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Terapia de apoio ao procedimento anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Controle de tremores.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-01-13 19:30:37",
        "name": "Dornot",
        "presentation": "<ul>\r\n<li><strong>Ampolas:</strong> 100mg/2mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "dornot",
        "substance": "Meperidina / Petidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Bradicardia, taquicardia, hipotens&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Broncoespasmo;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Miose, solu&#231;o, n&#225;usea, tontura, confus&#227;o, v&#244;mito, dor e eritema no local da aplica&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Dificuldade de mic&#231;&#227;o e constipa&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Seda&#231;&#227;o, euforia e depress&#227;o respirat&#243;ria, convuls&#245;es.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4452,
        "contraindications": "<div>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com hipersensibilidade aos componentes da f&#243;rmula;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Pacientes com depend&#234;ncia de opi&#243;ides; </span></p>\r\n<p><span style=\"line-height: 107%;\">- Amamenta&#231;&#227;o;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Concomitantemente &#224; inibidores da MAO;</span></p>\r\n<p><span style=\"line-height: 107%;\">- Insufici&#234;ncia respirat&#243;ria grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>IM:</strong> 25 a 150 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>EV:</strong> 25 a 100 mg, dose &#250;nica, podendo ser repetida ap&#243;s 3h;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 500mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Analgesia:</strong> 1 a 1,5 mg/kg/dose, EV ou IM, de 3/3h ou 4/4h;</li>\r\n<li><strong>Controle de tremores:</strong> 0,25 a 0,5 mg/kg/dose;</li>\r\n<li><strong>Dose usual:</strong> 6 a 9 mg/kg/dia (m&#225;ximo = 100mg/dia)</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1447,
        "indications": "<div>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\"><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Analgesia de dores moderadas &#224; graves;</span></span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Pr&#233;-anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Terapia de apoio ao procedimento anest&#233;sico;</span></p>\r\n<p><span style=\"mso-fareast- color: black; mso-fareast-language: PT-BR;\">- Controle de tremores.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 111,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-06 17:19:15",
        "name": "Petinan",
        "presentation": "<ul>\r\n<li><strong>Ampolas:</strong> 100mg/2mL.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "petinan",
        "substance": "Meperidina / Petidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Bradicardia, taquicardia, hipotens&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Broncoespasmo;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Miose, solu&#231;o, n&#225;usea, tontura, confus&#227;o, v&#244;mito, dor e eritema no local da aplica&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Dificuldade de mic&#231;&#227;o e constipa&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"mso-fareast- color: black; background: white; mso-fareast-language: PT-BR;\">- Seda&#231;&#227;o, euforia e depress&#227;o respirat&#243;ria, convuls&#245;es.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4452,
        "contraindications": "<div>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- Hipersensibilidade &#224; metadona ou a algum componente da f&#243;rmula;</p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- Casos de insufici&#234;ncia respirat&#243;ria grave e asma br&#244;nquica aguda ou hipercarbia;</p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- Pacientes com &#237;leo paral&#237;tico.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Para dor:</strong> 2,5-10 mg 3/3 ou 4/4 horas e em caso de uso cr&#244;nico ajuste pela resposta do paciente;</li>\r\n<li><strong>Para depend&#234;ncia de narc&#243;ticos:</strong>\r\n<ul>\r\n<li><span style=\"text-decoration: underline;\">Desintoxica&#231;&#227;o inicial</span>: 15 a 40 mg 1x/dia com redu&#231;&#227;o gradual at&#233; retirada e manuten&#231;&#227;o determinada pelas necessidades de cada paciente.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Dose m&#225;xima di&#225;ria:</strong> 120mg.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">Dose individualizada pelo m&#233;dico considerando idade e peso da crian&#231;a.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1448,
        "indications": "<div>\r\n<p>- Al&#237;vio da dor aguda e cr&#244;nica;</p>\r\n<p>- Tratamento de desintoxica&#231;&#227;o de adictos em narc&#243;ticos (hero&#237;na ou outras similares &#224; morfina).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:47:08",
        "name": "Mytedom",
        "presentation": "<ul>\r\n<li><strong>Ampolas:</strong> 10mg/1mL;</li>\r\n<li><strong>C&#225;psulas:</strong> 5mg ou 10mg.</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "mytedom",
        "substance": "Metadona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- Del&#237;rio, tontura, seda&#231;&#227;o, euforia, disforia, fraqueza, dor de cabe&#231;a, ins&#244;nia, agita&#231;&#227;o, desorienta&#231;&#227;o e dist&#250;rbios visuais;</p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- N&#225;useas, v&#244;mitos, boca seca, glossite, anorexia, constipa&#231;&#227;o e espasmo do trato biliar e dor abdominal;</p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\"><span style=\"background: white;\">- Rubor da face, arritmias, cardiomiopatia, ECG anormal, extra-s&#237;stole, hipotens&#227;o, flebite, prolongamento do intervalo QT, taquicardia, bradicardia, palpita&#231;&#227;o, desmaio e s&#237;ncope;</span></p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\"><span style=\"background: white;\"><span style=\"color: #333333;\">- Reten&#231;&#227;o urin&#225;ria, efeito anti-diur&#233;tico, redu&#231;&#227;o da libido e/ou pot&#234;ncia e amenorreia;</span></span></p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- Transpira&#231;&#227;o, prurido, urtic&#225;ria, edema, outras erup&#231;&#245;es na pele e, raramente, urtic&#225;ria hemorr&#225;gica;</p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">- Hipocalemia, hipomagnesemia, ganho de peso, edema pulmonar, trombocitopenia revers&#237;vel em viciado em narc&#243;tico com hepatite cr&#244;nica, depress&#227;o respirat&#243;ria, depress&#227;o circulat&#243;ria, parada respirat&#243;ria, choque, parada card&#237;aca, entre outros.</p>\r\n<hr>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNoSpacing\" style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5164,
        "contraindications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- O uso do mataraminol com ciclopropano ou halotano deve ser evitado, a n&#227;o ser que circunst&#226;ncias cl&#237;nicas indiquem este uso;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Est&#225; tamb&#233;m contraindicado a pacientes com hipersensibilidade a qualquer componente da f&#243;rmula.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><strong>Administra&#231;&#227;o atrav&#233;s de infus&#227;o intravenosa:</strong> A dose recomendada &#233; de 15 a 100 mg (1,5 a 10 mL) em 500 mL de cloreto de s&#243;dio 0,9% ou glicose 5%, ajustando a velocidade de infus&#227;o, de acordo com a resposta press&#243;rica, para manter a press&#227;o no n&#237;vel desejado. T&#234;m sido utilizadas altas doses de metaraminol de 150 a 500 mg em 500 ml de infus&#227;o, em situa&#231;&#245;es especiais; &#224;&#160;medida em que os efeitos m&#225;ximos n&#227;o aparecem imediatamente, pelo menos 10 minutos devem transcorrer antes do aumento da dose, e a possibilidade de um efeito cumulativo deve ser levada em conta.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\"><strong>Administra&#231;&#227;o intravenosa direta:</strong> Em choque grave, quando o tempo &#233; de grande import&#226;ncia, este agente dever&#225; ser administrado diretamente. A dose sugerida &#233; de 0,5 a 5 mg (0,05 a 0,5 mL) seguida de uma infus&#227;o de 15 a 100 mg (1,5 a 10 mL) em 500 mL de cloreto de s&#243;dio 0,9% ou glicose 5%.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\">Pode ser administrado por via intramuscular ou intravenosa, sendo que a via de administra&#231;&#227;o depende da natureza e gravidade de cada caso. A inje&#231;&#227;o subcut&#226;nea aumenta o risco de necrose tecidual local e descama&#231;&#227;o.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>N&#227;o foram ainda estabelecidos seguran&#231;a e efetividade em pacientes pedi&#225;tricos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1449,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Indicado para a preven&#231;&#227;o e tratamento dos estados hipotensivos que ocorram associados &#224; raquianestesia;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- No tratamento da hipotens&#227;o devida &#224; hemorragia, rea&#231;&#245;es medicamentosas, complica&#231;&#245;es cir&#250;rgicas e choque associado com dano cerebral devido a trauma e tumor. </span></p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-04 00:45:54",
        "name": "Aramin",
        "presentation": "<ul>\r\n<li><strong>Ampolas: </strong>10mg/1mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio comum.</p>",
        "record_status": 1,
        "slug": "aramin",
        "substance": "Metaraminol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">Efeitos adversos:</span></strong></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Cefal&#233;ia, &#226;nsia de v&#244;mito, hipertens&#227;o arterial, hipotens&#227;o de rebote; </span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Bradicardia, arritmias ventriculares, taquicardia, palpita&#231;&#227;o, tremor, dispneia, tontura, palidez, v&#244;mitos, nervosismo, ansiedade;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Angina grave, forma&#231;&#227;o de abscessos, necrose tecidual severa, extravasamento da medica&#231;&#227;o para os tecidos circunjacentes ou descama&#231;&#227;o.</span></p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 5099,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1450,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 18:04:52",
        "name": "Flagyl",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg;</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;500mg/100mL;</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 40mg/mL;</li>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flagyl",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 5018,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1451,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 02:15:25",
        "name": "Benzoilmetronidazol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg;</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 40mg/mL;</li>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flagyl",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 5005,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1452,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:16:47",
        "name": "Metronidazol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg;</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 40mg/mL;</li>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "metronidazol",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 5036,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1453,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:03:54",
        "name": "Neo Metrodazol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg;</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 40mg/mL;</li>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 125mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neo-metrodazol",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4868,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1454,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 20:25:12",
        "name": "Canderm",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "canderm",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 5019,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1455,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 71,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 20:25:14",
        "name": "Candifen",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg;</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 40mg/mL;</li>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "candifen",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4526,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong>&#160;500 mg IV 3x/dia durante 7-14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1456,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 39,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 01:20:23",
        "name": "Endonidazol",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 500mg/100mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "endonidazol",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 5010,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Giardiase:</strong> 250 mg VO 3x/dia por 5 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Ameb&#237;ase:</strong> 500 mg VO 4x/dia por 7 a 10 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong> 400 mg VO 3x/dia durante 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1457,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 20:25:15",
        "name": "Helmizol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 400mg;</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 40mg/mL;</li>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "helmizol",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4521,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong>&#160;500 mg IV 3x/dia durante 7-14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1458,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 185,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 20:31:21",
        "name": "Hidazol",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 500mg/100mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "hidazol",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4526,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong>&#160;500 mg IV 3x/dia durante 7-14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1459,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 177,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:16:15",
        "name": "Metrobacter",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 500mg/100mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "metrobacter",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4515,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong>&#160;500 mg IV 3x/dia durante 7-14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1460,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:16:31",
        "name": "Metronack",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 500mg/100mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "metronack",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4522,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong>&#160;500 mg IV 3x/dia durante 7-14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1461,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 9,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:17:00",
        "name": "Metroniflex",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 500mg/100mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "metroniflex",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 4525,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 1,5 a 2 g/dia, 6/6 ou 8/8 horas VO ou IV;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Bact&#233;rias anaer&#243;bias:</strong>&#160;500 mg IV 3x/dia durante 7-14 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Profilaxia em cirurgias:</strong> 1500 mg em perfus&#227;o IV 1 hora antes da cirurgia &#8211; 5 ml/min.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 30 a 50 mg/kg/dia divididos em 6/6 ou 8/8 horas VO ou IV.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1462,
        "indications": "<div>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Giard&#237;ase e ameb&#237;ase;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis;</span></p>\r\n<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Infec&#231;&#245;es por bact&#233;rias anaer&#243;bias.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 180,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:44:27",
        "name": "Nidazofarma",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 500mg/100mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nidazofarma",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 3641,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Contraindicado em crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Administrar 1 aplicador inravaginal cheio &#224; noite, antes de dormir, por 10-20 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1463,
        "indications": "<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 75,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 20:25:16",
        "name": "Colplen",
        "presentation": "<ul>\r\n<li>&#160;<strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "colplen",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 3644,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Contraindicado em crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Administrar 1 aplicador intravaginal cheio &#224; noite, antes de dormir, por 10-20 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1464,
        "indications": "<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 52,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 18:04:40",
        "name": "Flagimax Gel",
        "presentation": "<ul>\r\n<li><strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flagimax-gel",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 3640,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Contraindicado em crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Administrar 1 aplicador inravaginal cheio &#228; noite, antes de dormir, por 10-20 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1465,
        "indications": "<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 96,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:16:03",
        "name": "Metrizol",
        "presentation": "<ul>\r\n<li>&#160;<strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "metrizol",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 3632,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos seus componentes;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o associar com bebidas alco&#243;licas;&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez, consultar m&#233;dico do pr&#233;-natal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Contraindicado em crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<p>- Administrar 1 aplicador inravaginal cheio &#224; noite, antes de dormir, por 10-20 dias.</p>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">N&#227;o indicado para crian&#231;as.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1466,
        "indications": "<p><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tricomoniase e vaginites por gardnerella vaginalis.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:25:24",
        "name": "Minegyl",
        "presentation": "<ul>\r\n<li>&#160;<strong>Gel&#233;ia ginecol&#243;gica:</strong> 100mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "minegyl",
        "substance": "Metronidazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cefaleia, tonteira, ataxia, confus&#227;o mental, convuls&#245;es, ins&#244;nia, parestesia e neuropatia;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#225;useas, v&#244;mitos, anorexia, estomatite, xerostomia, diarreia e pancreatite;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Urina vermelho escura e dis&#250;ria, leucopenia e neutropenia, efeito dissulfiram-like.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>-</strong> <strong>CICr &gt; 50 &#8211; 90mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr 10 &#8211; 50mL/min:</strong> 500 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- CICr &lt; 10mL/min:</strong> 250 mg em 8/8 horas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>- Hemodi&#225;lise:</strong> sem doses adicionais.</p>\r\n</div>"
    },
    {
        "content_length": 2805,
        "contraindications": "<div>\r\n<p>- Hist&#243;rico de hipersensibilidade a derivados imidaz&#243;licos e aos compostos da f&#243;rmula.&#160;</p>\r\n<p>- Crian&#231;as menores de 10 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> Aplicar o produto 1x/dia na &#225;rea afetada, fazendo uma leve massagem.</li>\r\n<li><strong>Dura&#231;&#227;o do tratamento:</strong>&#160;4 semanas para tinea pedis, 2-3 semanas para tinea corporis, 1-2 semanas para pitir&#237;ase versicolor e 2-4 semanas para candid&#237;ase cut&#226;nea.</li>\r\n<li>O limite m&#225;ximo di&#225;rio &#233; de 2 aplica&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>&gt; 10 anos:</strong> posologia idem adultos.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 10 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1467,
        "indications": "<p>- Tratamento t&#243;pico de micoses cut&#226;neas superficiais produzidas por fungos, tais como infec&#231;&#245;es produzidas por dermat&#243;fitos como a tinea e suas variedades, infec&#231;&#245;es produzidas por leveduras, principalmente a candid&#237;ase cut&#226;nea e pitir&#237;ase versicolor.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:19:13",
        "name": "Micetal",
        "presentation": "<ul>\r\n<li><strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Uso t&#243;pico (creme):</span></strong>&#160;0,01 g/g.</li>\r\n<li><strong>Solu&#231;&#227;o t&#243;pica (spray):</strong> 0,01 g/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "micetal",
        "substance": "Flutrimazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Vermelhid&#227;o, sensa&#231;&#227;o de queima&#231;&#227;o ou irrita&#231;&#227;o no local de aplica&#231;&#227;o nos primeiros dias de tratamento.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia&#160;</strong><strong style=\"mso-bidi-font-weight: normal;\">Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3095,
        "contraindications": "<div>\r\n<p>- Em pacientes com hipersensibilidade conhecida &#224; Fluvastatina ou a qualquer dos componentes das f&#243;rmulas.</p>\r\n<p>- Em pacientes com doen&#231;a hep&#225;tica ativa, ou n&#227;o esclarecida, com eleva&#231;&#245;es persistentes das transaminases s&#233;ricas.</p>\r\n<p>- Durante a gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Lescol&#174;:</strong></p>\r\n<ul>\r\n<li><strong>Dose inicial: </strong>1 cp (20-40 mg), VO, ao deitar. Ajustar a dose, em intervalos de 4-8 semanas, at&#233; atingir os n&#237;veis alvos para os lip&#237;deos s&#233;ricos.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 80 mg di&#225;rios.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Lescol XL&#174;:</strong></p>\r\n<ul>\r\n<li><strong>Dose usual:</strong>&#160;1 cp, 1x/dia, sendo a dose m&#225;xima recomendada.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Lescol XL&#174;:</strong></p>\r\n<ul>\r\n<li><strong>&gt; 9 anos:</strong>&#160;1 cp, 1x/dia, sendo a dose m&#225;xima recomendada.</li>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para menores de 9 anos.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Lescol&#174;:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>\r\n</div>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1469,
        "indications": "<p>- Dislipidemia, preven&#231;&#227;o prim&#225;ria e secund&#225;ria da cardiopatia isqu&#234;mica.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 22:34:30",
        "name": "Lescol",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong> 20 e 40 mg.</li>\r\n<li><strong>Comprimidos de libera&#231;&#227;o prolongada:</strong> 80 mg (Lescol XL&#174;).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "lescol-xl",
        "substance": "Fluvastatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: left;\" align=\"center\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: left;\" align=\"center\">- Cefaleia, constipa&#231;&#227;o, diarreia; raramente eleva&#231;&#227;o das transaminases, rabdomi&#243;lise, miopatia, trombocitopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n<p class=\"MsoNormal\">- N&#227;o utilizar em doen&#231;a hep&#225;tica ativa.</p>\r\n</div>"
    },
    {
        "content_length": 3904,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade conhecida ao maleato de fluvoxamina ou a qualquer excipiente da f&#243;rmula.</p>\r\n<p>- Tratamento de depress&#227;o em pacientes com menos de 18 anos.</p>\r\n<p>- Tratamento do transtorno obsessivo-compulsivo em pacientes com menos de 8 anos.</p>\r\n<p>- Administra&#231;&#227;o concomitantemente de fluvoxamina com tizanidina e inibidores da monoamino-oxidase (iMAOs).&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Depress&#227;o:</strong>&#160;</p>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 50 mg ou 100 mg, em dose &#250;nica, ao anoitecer.</li>\r\n<li>Doses totais di&#225;rias acima de 150 mg sejam administradas em doses divididas.&#160;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 300 mg/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Transtorno obsessivo compulsivo:</strong></p>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;50 mg ao anoitecer, por 3-4 dias, aumentando-se a dose gradualmente at&#233; que se torne eficaz (100 a 300 mg).</li>\r\n<li>Doses totais di&#225;rias acima de 150 mg sejam administradas em doses divididas.&#160;</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;300 mg/dia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Depress&#227;o:</strong></p>\r\n<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para o tratamento de depress&#227;o em menores de 18 anos.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Transtorno obsessivo compulsivo:</strong></p>\r\n<ul>\r\n<li><strong>Uso em &gt; 8 anos.</strong></li>\r\n<li><strong>Dose recomendada:</strong> 50 mg ao anoitecer, por 3-4 dias, aumentando a dose gradualmente at&#233; se tornar eficaz.</li>\r\n<li>Doses totais di&#225;rias acima de 150 mg sejam administradas em doses divididas.&#160;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 200 mg/dia.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1473,
        "indications": "<p>- Tratamento da depress&#227;o maior, dos sintomas do transtorno depressivo e dos sintomas do transtorno obsessivo-compulsivo (TOC).</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- Contraindicado</p>",
        "last_update": "2019-03-03 19:14:13",
        "name": "Fluvoxamina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 50mg e 100mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receita de controle especial, em duas vias (C1).</span></p>",
        "record_status": 1,
        "slug": "revoc",
        "substance": "Fluvoxamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong><strong>&#160;</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia, sonol&#234;ncia, ins&#244;nia, nervosismo, tontura, tremores, n&#225;usea, diarreia, xerostomia, fraqueza.<br> Menos comumente: palpita&#231;&#227;o, taquicardia, hipomania, agita&#231;&#227;o, ansiedade, amn&#233;sia, hipertonia, dor abdominal, dispepsia, constipa&#231;&#227;o, ganho de peso, retardo da ejacula&#231;&#227;o, diminui&#231;&#227;o da libido, impot&#234;ncia, anorgasmia, reten&#231;&#227;o urin&#225;ria, vis&#227;o borrada, dispneia, artralgia, confus&#227;o mental, convuls&#227;o, galactorreia, hepatotoxicidade, hipotens&#227;o, rash, sudorese, vertigens.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Pacientes com insufici&#234;ncia hep&#225;tica ou renal devem iniciar o tratamento com doses baixas e ser cuidadosamente monitorados.</p>\r\n</div>"
    },
    {
        "content_length": 6526,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade conhecida ao fondaparinux ou a qualquer um dos excipientes.</p>\r\n<p>- Sangramento ativo clinicamente significativo.</p>\r\n<p>- Endocardite bacteriana aguda.&#160;</p>\r\n<p>- Comprometimento renal grave definido pelo clearance de creatinina &lt; 20 mL/min.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p>Uso <strong>SC&#160;</strong>(apresenta&#231;&#227;o de 2,5 mg e 7,5 mg) ou <strong>IV&#160;</strong>(somente apresenta&#231;&#227;o de 2,5 mg):</p>\r\n<ul>\r\n<li>Os locais de administra&#231;&#227;o subcut&#226;nea devem ser alternados entre a parede abdominal &#226;ntero-lateral esquerda e direita e p&#243;stero-lateral esquerda e direita.</li>\r\n<li>Via de administra&#231;&#227;o intravenosa: usada somente na primeira dose em pacientes com infarto do mioc&#225;rdio com eleva&#231;&#227;o do segmento ST.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Cirurgia ortop&#233;dica e abdominal:</strong>&#160;</p>\r\n<ul>\r\n<li><strong>Dose recomedada:</strong> 2,5 mg, SC, 1x/dia.</li>\r\n<li>Primeira dose n&#227;o deve ser antes de seis horas ap&#243;s o t&#233;rmino da cirurgia e somente ap&#243;s o estabelecimento da hemostasia.</li>\r\n<li><strong>Dura&#231;&#227;o:</strong> Tratamento mantido at&#233; que o paciente esteja deambulando, pelo menos 5 a 9 dias ap&#243;s a cirurgia.&#160;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Risco de complica&#231;&#245;es tromboemb&#243;licas:</strong>&#160;</p>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> 2,5 mg, SC, 1x/dia.</li>\r\n<li><strong>Dura&#231;&#227;o:</strong> 6 a 14 dias.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Trombose venosa profunda (TVP) e tromboembolismo pulmonar agudo (TEP):</strong></p>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong> &lt; 50kg: 5 mg; 50 a 100 kg: 7,5 mg; &gt; 100 kg:10 mg, SC, 1x/dia.</li>\r\n<li><strong>Dura&#231;&#227;o:</strong> 5&#160;a 9 dias e at&#233; que a anticoagula&#231;&#227;o oral adequada esteja estabelecida .</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Tratamento de angina inst&#225;vel/infarto do mioc&#225;rdio sem eleva&#231;&#227;o do segmento ST:</strong></p>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;2,5 mg, SC, 1x/dia.&#160;</li>\r\n<li><strong>Dura&#231;&#227;o:</strong> 8 dias ou at&#233; a alta hospitalar, caso esta ocorra antes.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Tratamento de infarto&#160;do mioc&#225;rdio com eleva&#231;&#227;o do segmento ST:</strong></p>\r\n<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;2,5 mg, 1x/dia.</li>\r\n<li>A primeira dose deve ser administrada via intravenosa - Deve ser feita somente atrav&#233;s de cateter intravenoso, diretamente ou atrav&#233;s de um pequeno volume de solu&#231;&#227;o salina 0,9% (25 ou 50 mL). No caso de administrar atrav&#233;s de solu&#231;&#227;o salina, a infus&#227;o deve ocorrer entre um e dois minutos. <br>As doses subsequentesdever&#227;o ser administradas via SC.</li>\r\n<li><strong>Dura&#231;&#227;o:</strong> 8 dias ou at&#233; a alta hospitalar, caso esta ocorra antes.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para menores de 17 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1474,
        "indications": "<div>\r\n<p>- Tratamento de Trombose Venosa Profunda (TVP).</p>\r\n<p>- Tratamento de Tromboembolismo Pulmonar agudo (TEP).</p>\r\n<p>- Tratamento da angina inst&#225;vel e da s&#237;ndrome coronariana aguda, caracterizada por infarto do mioc&#225;rdio com ou sem eleva&#231;&#227;o do segmento ST.</p>\r\n<p>- Preven&#231;&#227;o de Eventos Tromboemb&#243;licos Venosos em pacientes submetidos &#224; cirurgia ortop&#233;dica de grande porte dos membros inferiores; Submetidos &#224; cirurgia abdominal sob o risco de complica&#231;&#245;es tromboemb&#243;licas; Ou que est&#227;o sob o risco de complica&#231;&#245;es tromboemb&#243;licas pela mobilidade restringida durante doen&#231;a aguda.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 96,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 17:27:10",
        "name": "Arixtra",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel</strong>: 2,5mg/0,5mL e 7,5mg/0,6mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "arixtra",
        "substance": "Fondaparinux",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Anemia, sangramento, p&#250;rpura, edema, trombocitopenia, trombocitemia, cefaleia, nausea e v&#244;mitos, testes anormais da fun&#231;&#227;o hep&#225;tica, enzimas hep&#225;ticas aumentadas, febre, rash, prurido, secre&#231;&#227;o na ferida.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Insufici&#234;ncia renal:&#160;&#160;</p>\r\n<p class=\"MsoNormal\"><strong>Preven&#231;&#227;o de Eventos Tromboemb&#243;licos Venosos:</strong> Clearance de creatinina &gt; 30mL/min: n&#227;o h&#225; ajuste;&#160;20 a 30 mL/min: 2,5 mg em dias alternados; &lt; 20 mL/min: uso n&#227;o recomendado.</p>\r\n<p class=\"MsoNormal\"><strong>Tratamento de Eventos Tromboemb&#243;licos Venosos:</strong> Clearance de creatinina &gt;&#160;30mL/min: n&#227;o h&#225; ajuste; &lt;&#160;30 mL/min: uso n&#227;o recomendado.</p>\r\n<p class=\"MsoNormal\"><strong>Tratamento de angina inst&#225;vel ou infarto do mioc&#225;rdio com ou sem eleva&#231;&#227;o do segmento</strong></p>\r\n<p class=\"MsoNormal\"><strong>ST:</strong> Clearance de creatinina &gt; 20mL/min: n&#227;o h&#225; ajuste; &lt;&#160;20 mL/min: uso n&#227;o recomendado.</p>\r\n<p class=\"MsoNormal\">- Idosos: Usar com cautela devido a diminui&#231;&#227;o da fun&#231;&#227;o renal.</p>\r\n<p class=\"MsoNormal\">- Pacientes &lt; 50 kg est&#227;o sob risco aumentado de sangramento.</p>\r\n<p class=\"MsoNormal\">- Uso com cautela em insuficiencia hep&#225;tica grave.</p>\r\n</div>"
    },
    {
        "content_length": 2621,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade conhecida aos componentes da f&#243;rmula.</p>\r\n<p>- Apendicite, obstru&#231;&#227;o intestinal, sangramento retal, colite ulcerativa, insufici&#234;ncia card&#237;aca congestiva, hipertens&#227;o arterial.</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal.</p>\r\n<p>- Crian&#231;as menores de 12 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> Aplicar o conteudo de 1 frasco, em dose &#250;nica, via retal.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>&gt; 12 anos:</strong> posologia idem adultos.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1476,
        "indications": "<p>- Indicado como laxante no tratamento da constipa&#231;&#227;o e no esvaziamento do c&#243;lon no pr&#233; e p&#243;s-parto, no pr&#233; e p&#243;s-operat&#243;rio e na prepara&#231;&#227;o para exames proctol&#243;gicos e radiol&#243;gicos.&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 200,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 18:07:53",
        "name": "Fleet Enema",
        "presentation": "<div>\r\n<ul>\r\n<li><strong>Solu&#231;&#227;o Retal:</strong> Fosfato de S&#243;dio Dib&#225;sico 0,06 g/mL + Fosfato de S&#243;dio Monob&#225;sico 0,16 g/mL.</li>\r\n</ul>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "fleet-enema",
        "substance": "Fosfato de sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160; Irrita&#231;&#227;o da pele pr&#243;xima &#224; regi&#227;o do reto, queima&#231;&#227;o, coceira, dor ou sangramento retal.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\">- Contraindicado na Insufici&#234;ncia Hep&#225;tica ou Renal.</p>\r\n<p class=\"MsoNormal\">- Uso cauteloso em idosos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2631,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade conhecida aos componentes da f&#243;rmula.</p>\r\n<p>- Apendicite, obstru&#231;&#227;o intestinal, sangramento retal, colite ulcerativa, insufici&#234;ncia card&#237;aca congestiva, hipertens&#227;o arterial.</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal.</p>\r\n<p>- Crian&#231;as menores de 12 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> Aplicar o conteudo de 1 frasco, em dose &#250;nica, via retal.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>&gt; 12 anos:</strong> posologia idem adultos.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1477,
        "indications": "<p>- Indicado como laxante no tratamento da constipa&#231;&#227;o e no esvaziamento do c&#243;lon no pr&#233; e p&#243;s-parto, no pr&#233; e p&#243;s-operat&#243;rio e na prepara&#231;&#227;o para exames proctol&#243;gicos e radiol&#243;gicos.&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 17:20:05",
        "name": "Phosfoenema",
        "presentation": "<div>\r\n<ul>\r\n<li><strong>Solu&#231;&#227;o Retal:</strong> Fosfato de S&#243;dio Monob&#225;sico 160 mg/mL + Fosfato de S&#243;dio Dib&#225;sico 60mg/mL.</li>\r\n</ul>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "fleet-enema",
        "substance": "Fosfato de sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160; Irrita&#231;&#227;o da pele pr&#243;xima &#224; regi&#227;o do reto, queima&#231;&#227;o, coceira, dor ou sangramento retal.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\">- Contraindicado na Insufici&#234;ncia Hep&#225;tica ou Renal.</p>\r\n<p class=\"MsoNormal\">- Uso cauteloso em idosos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3003,
        "contraindications": "<p>- Hipersensibilidade ao fosinopril, a qualquer outro inibidor da enzima conversora de angiotensina ou qualquer outro componente da f&#243;rmula.&#160;</p>",
        "dosage_adults": "<ul>\r\n<li><strong>HAS:</strong> 10-40 mg, VO, 1x/dia.</li>\r\n<li><strong>ICC:</strong> dose inicial de 10 mg/dia, aumentar se necess&#225;rio.</li>\r\n<li><strong> Dose m&#225;xima:</strong> 40 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- 1&#186; trimestre - Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- 2&#186; e 3&#186; trimestres - Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>\r\n</div>",
        "id": 1478,
        "indications": "<p>- Hipertens&#227;o arterial, Insufici&#234;ncia card&#237;aca, Disfun&#231;&#227;o de ventr&#237;culo esquerdo ap&#243;s IAM.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 19:19:41",
        "name": "Fosinopril",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 10 e 20 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "fosinopril",
        "substance": "Fosinopril",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipotens&#227;o ortost&#225;tica, palpita&#231;&#227;o, tontura, cefaleia, fraqueza, fadiga, hipercalemia, diarreia, n&#225;useas, v&#244;mitos, dor musculoesquel&#233;tica, dor no peito, aumento da creatinina s&#233;rica, deteriora&#231;&#227;o da fun&#231;&#227;o renal (pacientes com estenose de art&#233;ria renal bilateral ou hipovolemia), tosse, infec&#231;&#227;o de trato respirat&#243;rio superior.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\">- Uso cauteloso em Insufici&#234;ncia Renal e hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3687,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li><span class=\"apple-converted-space\"><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>Dose usual:</strong> aplicar&#160;</span></span><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">creme ou solu&#231;&#227;o spray 1x/dia antes de dormir, e no caso do creme, friccionar uma fina camada na &#225;rea afetada.&#160;</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.&#160;</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1482,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span id=\"docs-internal-guid-3024ea97-7fff-0827-4ab6-d4181a260d02\"><span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Micoses do p&#233; e da m&#227;o (Tinea pedum, Tinea manuum), micoses da pele e das pregas da pele (Tinea corporis, Tinea inguinalis), pitir&#237;ase versicolor, balanite por C&#226;ndida.</span></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:45:51",
        "name": "Mycospor",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\"><strong>Creme:&#160;</strong>10mg/g.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Solu&#231;&#227;o spray:</strong> 10mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mycospor",
        "substance": "Bifonazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Dermatite de contato, eczema, prurido, erup&#231;&#227;o cut&#226;nea, pele seca e rea&#231;&#245;es d&#233;rmicas.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3010,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 1 gota em cada olho afetado 1x/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">N&#227;o estabelecido.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1483,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Preven&#231;&#227;o e tratamento do aumento de press&#227;o intraocular, glaucoma de &#226;ngulo aberto e glaucoma de &#226;ngulo fechado.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:29:49",
        "name": "Bimatoprosta",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Col&#237;rio:</strong> 0,1 mg/ml e 0,3 mg/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bimatoprosta",
        "substance": "Bimatoprosta",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Vis&#227;o borrada, conjuntivite al&#233;rgica, lacrimejamento, dor ocular, irrita&#231;&#227;o ocular, coceira nos olhos e vermelhid&#227;o nos olhos.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3322,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose inicial:</strong> 1mg VO de 12/12 horas.</span></li>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:&#160;</strong>3mg a 16mg VO de 8/8 horas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">N&#227;o estabelecido.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1491,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dist&#250;rbios extrapiramidais e parkinsonismo idiop&#225;tico.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 79,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 17:07:45",
        "name": "Akineton",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimidos:</strong> 2mg e 4mg.</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p><span id=\"docs-internal-guid-cbc14966-7fff-41fd-5c60-a2755e7af9b8\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Receita de controle especial.</span></span></p>",
        "record_status": 1,
        "slug": "akineton",
        "substance": "Biperideno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Sonol&#234;ncia, torpor, hipotens&#227;o, agita&#231;&#227;o, ansiedade, euforia, n</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">&#225;useas, v&#244;mitos e constipa&#231;&#227;o.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3945,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Hipersensibilidade aos componentes, d</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">esidrata&#231;&#227;o, o</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">bstru&#231;&#227;o intestinal e outros quadros de abdome ag&#250;do.</span></p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 5mg a 10mg, VO 1x/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Crian&#231;as de 4 a 10 anos:</strong> 5mg, VO 1x/dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Crian&#231;as maiores de 10 anos:</strong><span style=\"mso-spacerun: yes;\">&#160; </span>5mg a 10mg, VO 1x/dia.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1496,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento da constipa&#231;&#227;o intestinal e preparo para procedimentos diagn&#243;sticos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 02:34:17",
        "name": "Bisalax",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido:</strong> 5mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bisalax",
        "substance": "Bisacodil",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- C&#243;licas, diarreia e n&#225;usea.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3724,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes, i</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">nsufici&#234;ncia renal grave, c</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">rian&#231;as com gripe ou catapora.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> Suspens&#227;o oral 30 ml VO 1x/dia.</span><u></u></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Crian&#231;as de 3 a 6 anos:</strong> Suspens&#227;o oral 5ml VO 1x/dia.&#160;</span></p>\r\n</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Crian&#231;as de 6 a 9 anos:</strong> Suspens&#227;o oral 10ml VO 1x/dia.&#160;</p>\r\n</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Crian&#231;as de 9 a 12 anos:</strong> Suspens&#227;o oral 15ml VO 1x/dia.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1506,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Controle da diarreia aliviando c&#243;licas abdominais, al&#237;vio da m&#225; digest&#227;o, n&#225;useas, refluxo gastro- esof&#225;gico, gastrites e inflama&#231;&#227;o do duodeno.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 17:16:21",
        "name": "Peptozil",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;262mg/15 ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Peptozil",
        "substance": "Bismuto",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Tontura, cefaleia, n&#225;useas, v&#244;mitos, diarreia, escurecimento de dentes e escurecimento de fezes.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Insufici&#234;ncia renal grave (ClCr &lt; 30) est&#225; contra-indicado.</p>\r\n</div>"
    },
    {
        "content_length": 4512,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Hipersensibilidade aos componentes, insufici&#234;ncia card&#237;aca aguda ou durante epis&#243;dios de descompensa&#231;&#227;o da insufici&#234;ncia card&#237;aca que requeiram terap&#234;utica inotr&#243;pica IV, choque cardiog&#234;nico, bloqueio atrioventricular de segundo ou terceiro grau (sem marca-passo), s&#237;ndrome do n&#243; sinusal, bloqueio sinoatrial, bradicardia sintom&#225;tica, hipotens&#227;o sintom&#225;tica, asma br&#244;nquica grave ou doen&#231;a pulmonar obstrutiva cr&#244;nica grave, feocromocitoma n&#227;o tratado e acidose metab&#243;lica.<br style=\"mso-special-character: line-break;\"> <!--[endif]--></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong style=\"white-space: pre-wrap; text-align: justify;\">Hipertens&#227;o ou Angina pectoris:</strong><span style=\"white-space: pre-wrap; text-align: justify;\"> 5mg VO 1x/dia, podendo ajustar conforme resposta, sendo a dose m&#225;xima recomendada de 20mg 1x/dia.</span></li>\r\n<li dir=\"ltr\" style=\"list-style-type: disc; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre;\">\r\n<p dir=\"ltr\" style=\"line-height: 1.284; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;\"><span style=\"color: #000000; background-color: #ffffff; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\"><strong>Insufici&#234;ncia card&#237;aca cr&#244;nica est&#225;vel:</strong> Paciente deve estar est&#225;vel (sem insufici&#234;ncia aguda) quando for iniciado o tratamento. A dose inicial recomendada &#233; 1,25mg VO 1x/dia, dependendo da toler&#226;ncia individual, a dose &#233; gradualmente aumentada para 2,5mg VO 1x/dia, 3,75mg VO 1x/dia, 5mg VO 1x/dia, 7,5mg VO 1x/dia e 10mg VO 1x/dia.<br></span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1508,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento da hipertens&#227;o, angina pectoris e insufici&#234;ncia card&#237;aca cr&#244;nica est&#225;vel com fun&#231;&#227;o ventricular reduzida.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:36:10",
        "name": "Bisoprolol",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimidos:&#160;</strong>2,5mg, 5mg e 10mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bisoprolol",
        "substance": "Bisoprolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Bradicardia, t</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">ontura, cefaleia, broncoespasmo,c&#227;ibras e disfun&#231;&#227;o er&#233;til, n</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">&#225;useas, v&#244;mitos, diarreia, constipa&#231;&#227;o, alopecia, astenia.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">&#160;- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3821,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose Inicial:</strong> 0,25U a 0,5U por kg de peso IM 1 ou 2x/semana.</li>\r\n<li><strong>Dose de Manuten&#231;&#227;o:</strong> 1U por dia ou 5 U IM por semana.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1517,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de carcinomas e linfomas.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 50,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:38:01",
        "name": "Blenoxane",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>P&#243; liofiliz&#225;vel:</strong> 15U.</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p><span id=\"docs-internal-guid-ecbcbb0a-7fff-8120-d5cd-ae93b316a68a\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Uso hospitalar.</span></span></p>",
        "record_status": 1,
        "slug": "Blenoxane",
        "substance": "Bleomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; mso-fareast-language: PT-BR;\">- Pneumonite, f</span><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; mso-fareast-language: PT-BR;\">alta de apetite, n&#225;usea, v&#244;mito, i</span><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; mso-fareast-language: PT-BR;\">nflama&#231;&#227;o na boca, vermelhid&#227;o da pele, aumento da pigmenta&#231;&#227;o na pele, espinhas, erup&#231;&#227;o, estria, sensibilidade na pele, coceira, perda de cabelos revers&#237;vel, e calafrio.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#227;o estabelecido. Recomenda-se doses menores em portadores de insufici&#234;ncia renal.</p>\r\n</div>"
    },
    {
        "content_length": 6341,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\">- Hipersensibilidade significativa clinicamente demonstrada anteriormente ao&#160;princ&#237;pio ativo ou a qualquer um de seus excipientes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\">- Hepatite auto-imune;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\">- Fun&#231;&#227;o hep&#225;tica n&#227;o-compensada [escore Child-Pugh &gt;6 (classes B e C)];</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\">- Coadministra&#231;&#227;o com medicamentos com depura&#231;&#227;o altamente dependentes da CYP3A4/5 e&#160;para os quais concentra&#231;&#245;es plasm&#225;ticas elevadas est&#227;o associadas a eventos graves e/ou&#160;potencialmente fatais, como midazolam, amiodarona, astemizol, bepridil, pimozida,flecainida,&#160;propafenona, quinidina, sinvastatina, lovastatina e derivados do ergot (diidroergotamina, ergonovina, ergotamina, metilergonovina) administrados por via oral;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\">- Gestantes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 800 mg VO de 8/8 horas.&#160;</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">A dura&#231;&#227;o do tratamento &#233; avaliada utilizando o esquema de terapia orientada pela resposta.</span></li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><strong>Observa&#231;&#227;o: </strong>pacientes que iniciam o tratamento devem receber o esquema de ribavirina e alfapeginterferona por quatro semanas e na quinta semana iniciar as doses de boceprevir</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1519,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento da hepatite cr&#244;nica C, usado em esquema combinado com ribavirina e alfapeginterferona</span>, em pacientes adultos (18 anos ou mais) com doen&#231;a hep&#225;tica compensada previamente n&#227;o-tratada ou que n&#227;o tenham respondido ao tratamento anterior.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 191,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 14:21:21",
        "name": "Victrelis",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>C&#225;psula:</strong>&#160;200 mg em embalagem com 336 c&#225;psulas</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "victrelis",
        "substance": "Boceprevir",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dispneia, tosse.<u></u></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Cefaleia, tontura.<u></u></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Diarreia, n&#225;usea, v&#244;mito,&#160;boca seca, disgeusia, hiporexia e perda de peso.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Alopecia, pele seca, prurido, erup&#231;&#227;o cut&#226;nea.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Artralgia, mialgia.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Astenia, calafrios, fadiga, doen&#231;a tipo influenza, pirexia.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Ansiedade, depress&#227;o, ins&#244;nia, irritabilidade.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 12.0pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Anemia, neutropenia.</span></p>\r\n</div>"
    },
    {
        "content_length": 11836,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"text-decoration: underline;\"><span style=\"color: black; background: white; text-decoration: underline;\"><strong>Monoterapia</strong></span></span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\"><strong>Mieloma M&#250;ltiplo Recidivado: </strong>dose recomendada de bortezomibe &#233; de 1,3 mg/m2/dose administrada 2 vezes por semana durante 2 semanas (Dias 1, 4, 8 e 11), seguido por um per&#237;odo de repouso de 10 dias (Dias 12 a 21). Este per&#237;odo de 3 semanas &#233; considerado como um ciclo de tratamento. Para extens&#227;o do tratamento al&#233;m de 8 ciclos, o bortezomibe pode ser administrado no esquema padr&#227;o ou no esquema de manuten&#231;&#227;o de uma vez por semana por 4 semanas (Dias 1, 8, 15 e 22), seguido por um per&#237;odo de repouso de 13 dias (Dias 23 a 35).</span></li>\r\n</ul>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Modifica&#231;&#227;o da Dose e Rein&#237;cio do Tratamento:</strong> o&#160;tratamento<span class=\"apple-converted-space\">&#160;</span>deve ser interrompido ao in&#237;cio de qualquer evid&#234;ncia de toxicidade n&#227;o hematol&#243;gica de Grau 3 ou hematol&#243;gica de Grau 4, excluindo neuropatia. Ap&#243;s a remiss&#227;o dos sintomas de toxicidade, o tratamento pode ser reiniciado com dose 25% menor (1,3 mg/m2 /dose reduzida para 1,0 mg/m2/dose; 1,0 mg/m2/dose reduzida para 0,7 mg/m2/dose).</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><strong><span style=\"text-decoration: underline;\">Terapia combinada</span></strong></li>\r\n<li><strong> Mieloma m&#250;ltiplo n&#227;o tratado previamente em pacientes n&#227;o eleg&#237;veis a transplante de c&#233;lulas-tronco: </strong>dose recomendada na combina&#231;&#227;o de bortezomibe com melfalana e prednisona [bortezomibe (1,3 mg/m2 ); Melfalana (9 mg/m2) e Prednisona (60 mg/m2)], por 9 ciclos de 6 semanas de tratamento. Nos Ciclos 1 a 4, bortezomibe &#233; administrado 2 (duas) vezes por semana (Dias 1, 4, 8, 11, 22, 25, 29 e 32). Nos Ciclos 5 a 9, bortezomibe &#233; administrado uma vez por semana (Dias 1, 8, 22 e 29).</li>\r\n<li><strong>Mieloma m&#250;ltiplo n&#227;o tratado previamente e que s&#227;o eleg&#237;veis a transplante de c&#233;lulas-tronco hematopoi&#233;ticas:</strong></li>\r\n</ul>\r\n<p style=\"padding-left: 30px;\"><span style=\"text-decoration: underline;\">- Terapia combinada com dexametasona:</span>&#160;a dexametasona &#233; administrada por via oral na dose de 40mg nos dias 1, 2, 3, 4 e dias 8, 9, 10, 11 do ciclo de tratamento com bortezomibe.</p>\r\n<p style=\"padding-left: 30px;\"><span style=\"text-decoration: underline;\">- Terapia combinada com dexametasona e talidomida:</span>&#160;a dexametasona &#233; administrada por via oral na dose de 40mg nos dias 1, 2, 3, 4 e dias 8, 9, 10, 11 dos ciclos de tratamento com bortezomibe. A talidomida &#233; administrada por via oral na dose de 50mg por dia nos dias 1 a 14 e, se tolerado, a dose &#233; aumentada para 100mg nos dias 15 a 28, e posteriormente pode ser aumentada para 200mg por dia.</p>\r\n<hr>\r\n<ul>\r\n<li><span style=\"text-decoration: underline;\"><strong>Dilui&#231;&#227;o:</strong></span></li>\r\n<li><strong>IV:</strong> diluir em 3,5 mL de SF0,9% se for aplica&#231;&#227;o IV<strong>&#160;</strong>(concentra&#231;&#227;o 1,0 mg/mL)&#160;<em>in bolus&#160;</em>seguido por lavagem com solu&#231;&#227;o de cloreto de s&#243;dio 0,9%;</li>\r\n<li><strong>SC:</strong>&#160;diluir em 1,4mL de SF0,9% para administra&#231;&#227;o subcut&#226;nea (concentra&#231;&#227;o 2,5 mg/mL) injetada na coxa (direita ou esquerda) ou abd&#244;men (esquerdo ou direito) - os locais de inje&#231;&#227;o devem ser alternados para inje&#231;&#245;es sucessivas e&#160; devem ser administradas a, pelo menos, 2,5 cm do local anterior, e nunca em &#225;reas em que o local esteja sens&#237;vel, ferido, vermelho ou r&#237;gido.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>Devem decorrer pelo menos 72 horas entre as administra&#231;&#245;es consecutivas de bortezomibe.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p><strong style=\"mso-bidi-font-weight: normal;\">-&#160;</strong><span class=\"TextRun SCXW7938239\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW7938239\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Categoria D:</span></span><span class=\"TextRun SCXW7938239\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW7938239\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></span></p>",
        "id": 1524,
        "indications": "<div>\r\n<p><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de mieloma m&#250;ltiplo:</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; text-align: justify; line-height: 107%; padding-left: 30px;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- que n&#227;o receberam tratamento pr&#233;vio e impossibilitados de receberem tratamento com alta dose de quimioterapia e transplante de medula &#243;ssea. Nesses pacientes, o bortezomibe &#233; utilizado em combina&#231;&#227;o com melfalana e prednisona</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; text-align: justify; line-height: 107%; padding-left: 30px;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- que n&#227;o receberam tratamento pr&#233;vio e que s&#227;o eleg&#237;veis a receberem tratamento de indu&#231;&#227;o com alta dose de quimioterapia com transplante de c&#233;lulas-tronco hematopoi&#233;ticas. Nesses pacientes, o bortezomibe &#233; utilizado em combina&#231;&#227;o com dexametasona, ou com dexametasona e talidomida.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; text-align: justify; line-height: 107%; padding-left: 30px;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- que receberam pelo menos um tratamento anterior. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; text-align: justify; line-height: 107%; padding-left: 30px;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- retratamento com bortezomibe pode ser considerado para pacientes com mieloma m&#250;ltiplo que haviam respondido previamente ao tratamento com bortezomibe . O per&#237;odo m&#237;nimo entre o tratamento anterior e o in&#237;cio do retratamento &#233; de 6 meses.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 287,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2018-11-07 23:05:18",
        "name": "Bortezomibe",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>P&#243; liofilizado:</strong>&#160;1 frasco-ampola de 3,5 mg.</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "bortezomibe",
        "substance": "Bortezomibe",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span>- N&#227;o estabelecido. Recomenda-se doses menores em portadores de insufici&#234;ncia hep&#225;tica.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">-&#160;Constipa&#231;&#227;o, n&#225;usea, diarreia, v&#244;mito</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Neuropatia perif&#233;rica, parestesia, neuropatia perif&#233;rica sensorial, cefaleia</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Fadiga, pirexia, astenia</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Trombocitopenia, anemia, leucopenia</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Herpes Zoster</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Hiperglicemia, hiponatremia</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Ins&#244;nia</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; background: white;\">- Obstru&#231;&#227;o intestinal;&#160;</span>colite isqu&#234;mica, pancreatite aguda; coagula&#231;&#227;o intravascular disseminada; bloqueio completo atrioventricular, tamponamento card&#237;aco; surdez bilateral; herpes oft&#225;lmica, neuropatia &#243;ptica, cegueira, cal&#225;zio/blefarite; meningoencefalite herp&#233;tica, choque s&#233;ptico; angioedema; encefalopatia, neuropatia auton&#244;mica, s&#237;ndrome de encefalopatia posterior revers&#237;vel; doen&#231;a pulmonar infiltrativa difusa aguda, hipertens&#227;o pulmonar; dermatose neutrof&#237;lica febril aguda (S&#237;ndrome de Sweet), s&#237;ndrome de Stevens-Johnson e necr&#243;lise epid&#233;rmica t&#243;xica; leucoencefalopatia multifocal progressiva; rea&#231;&#227;o anafil&#225;tica; microangiopatia tromb&#243;tica.</p></div>"
    },
    {
        "content_length": 7753,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Insufici&#234;ncia hep&#225;tica moderada e grave.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Uso concomitante de ciclosporina A</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Uso concomitante de glibenclamida (gliburida)</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Gravidez, mulheres em idade f&#233;rtil e que n&#227;o estejam praticando m&#233;todos anticoncepcionais seguros.</span></p>\r\n</div>",
        "dosage_adults": "<div><ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><strong>Hipertens&#227;o arterial pulmonar:</strong>&#160;iniciar com 62,5 mg 2x/dia por 4 semanas, e aumentada para a dose de manuten&#231;&#227;o de 125 mg 2x/dia.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- Pacientes que n&#227;o estejam respondendo bem &#224; dose de 125 mg de bosentana , duas vezes ao dia, podem ter sua capacidade de se exercitar levemente melhorada com o aumento da dose para 250 mg, 2x/dia. Uma avalia&#231;&#227;o criteriosa do risco/benef&#237;cio deve ser realizada, levando-se em considera&#231;&#227;o que a toxicidade hep&#225;tica &#233; dosedependente.</p>\r\n<hr>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Esclerose sist&#234;mica com doen&#231;a de &#250;lceras digitais em andamento:</strong>&#160;iniciar com 62,5 mg 2x/dia, durante 4 semanas, e, em seguida, aumentar para 125 mg 2x/dia.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Descontinua&#231;&#227;o do tratamento:</strong>&#160;experi&#234;ncias com a descontinua&#231;&#227;o abrupta da bosentana &#233; limitada. N&#227;o foram observadas evid&#234;ncias de efeito rebote agudo. No entanto, indica-se a redu&#231;&#227;o gradual da dose (atrav&#233;s da administra&#231;&#227;o de metade da dose ao longo de 3 a 7 dias)</li>\r\n</ul></div>",
        "dosage_children": "<div><ul>\r\n<li><strong style=\"text-align: justify;\">Hipertens&#227;o arterial pulmonar:</strong>&#160;dose alvo recomendada de bosentana em pacientes pedi&#225;tricos &#233; de 2 mg/kg, de manh&#227; e &#224; noite.</li>\r\n</ul>\r\n<table style=\"margin-left: auto; margin-right: auto;\">\r\n<tbody>\r\n<tr>\r\n<td style=\"text-align: center;\"><strong>Peso corporal (Kg)&#160;</strong></td>\r\n<td style=\"text-align: center;\"><strong>Dose basal (4 semanas)&#160;</strong></td>\r\n<td style=\"text-align: center;\"><strong>Dose de manuten&#231;&#227;o</strong>&#160;</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">10 &#8804; x &#8804;20&#160;</td>\r\n<td style=\"text-align: center;\">31,25 mg (1x/dia)</td>\r\n<td style=\"text-align: center;\">31,25 mg (2x/dia)</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">20 &lt; x &#8804; 40</td>\r\n<td style=\"text-align: center;\">31,25 mg (2x/dia)</td>\r\n<td style=\"text-align: center;\">62,5 mg (2x/dia)</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">&#160;&gt; 40</td>\r\n<td style=\"text-align: center;\">&#160;62,5 mg (2x/dia)&#160;</td>\r\n<td style=\"text-align: center;\">125 mg (2x/dia)</td>\r\n</tr>\r\n</tbody>\r\n</table></div>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1525,
        "indications": "<div><p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Tratamento da Hipertens&#227;o Arterial Pulmonar (WHO - Grupo I) em pacientes de classe funcional III e IV, segundo classifica&#231;&#227;o da Organiza&#231;&#227;o Mundial da Sa&#250;de (WHO) para aumentar a capacidade f&#237;sica e diminuir os &#237;ndices de piora cl&#237;nica.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Redu&#231;&#227;o do n&#250;mero de novas &#250;lceras digitais em pacientes com esclerose sist&#234;mica e &#250;lceras digitais ativas. </span></p></div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2018-11-09 22:32:28",
        "name": "Bosentana",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido:</strong>&#160;62,5 mg e 125 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bosentana",
        "substance": "Bosentana",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o recomendado para pacientes com insufici&#234;ncia hep&#225;tica moderada e grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span>Anemia, trombocitopenia, neutropenia, leucopenia</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Eritema, dermatite, prurido, erup&#231;&#227;o cut&#226;nea, anafilaxia e/ou angioedema</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Cefaleia, s&#237;ncope, palpita&#231;&#245;es, rubor, hipotens&#227;o</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Congest&#227;o nasal</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Doen&#231;a do refluxo gastroesof&#225;gico, diarreia, fun&#231;&#227;o hep&#225;tica anormal, eleva&#231;&#227;o das aminotransferases associada com hepatite e/ou icter&#237;cia, cirrose hep&#225;tica, insufici&#234;ncia hep&#225;tica</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Edema</p></div>"
    },
    {
        "content_length": 5752,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Uso concomitante com IMAO.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong>&#160;01 gota no(s) olho(s) afetado(s) de 8/8 horas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span class=\"NormalTextRun SCXW245880646\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\"><span class=\"NormalTextRun SCXW191696709\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para menores de</span>&#160;2 anos. </span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span class=\"NormalTextRun SCXW245880646\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\"><strong>Crian&#231;as maiores de 2 anos:</strong> 01 gota no(s) olho(s) afetado(s) de 8/8 horas (crian&#231;as com 2 anos de idade ou mais, especialmente aquelas com peso menor ou igual a 20kg, devem ser tratadas com cautela e monitoradas de perto devido &#224; alta incid&#234;ncia e severidade de sonol&#234;ncia).</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">-&#160;</strong><span class=\"TextRun SCXW208039844\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW208039844\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Categoria B:</span></span><span class=\"TextRun SCXW208039844\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW208039844\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com cautela.</span></span><span class=\"EOP SCXW208039844\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></p>",
        "id": 1533,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de hipertens&#227;o ocular e glaucoma de &#226;ngulo aberto.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 23:45:17",
        "name": "Alphabrin",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oft&#225;lmica:</strong> 2mg/mL (0,2%) e 1,5mg/mL (0,15%)</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Accera",
        "substance": "Tartarato de brimonidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hiperemia conjuntival, cefaleia, rinite, xerostomia, astenia, hiperemia conjuntival, sensa&#231;&#227;o de corpo estranho nos olhos, fol&#237;culos conjuntivais, prurido nos olhos, conjuntivite al&#233;rgica, fotofobia, eritema nas p&#225;lpebras, dor nos olhos, olhos secos, edema das p&#225;lpebras, edema conjuntival, blefarite, irrita&#231;&#227;o nos olhos, secre&#231;&#227;o nos olhos, dist&#250;rbios visuais, ep&#237;fora, piora na acuidade visual, conjuntivite folicular, ceratite puntacta superficial. </span></p>\r\n</div>"
    },
    {
        "content_length": 4656,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes;</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Insufici&#234;ncia renal grave ou acidose hiperclor&#234;mica.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 1 gota no(s) olho(s) afetado(s) de 8/8 horas.</span></li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><span class=\"NormalTextRun SCXW14989294\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span><span class=\"EOP SCXW14989294\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1536,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipertens&#227;o intraocular e glaucoma de &#226;ngulo aberto.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-11-16 21:11:57",
        "name": "Azopt",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Suspens&#227;o oft&#225;lmica:</strong>&#160;10 mg/mL em frasco com 5mL</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "azopt",
        "substance": "Brinzolamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o utilizar na insufici&#234;ncia renal grave (ClCr &lt; 30) pelo risco de acidose grave.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Depress&#227;o, ins&#244;nia, tontura, parestesia, dor de cabe&#231;a, perda de mem&#243;ria, sonol&#234;ncia</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Vis&#227;o turva, irrita&#231;&#227;o ocular, dor ocular, desconforto ocular, hiperemia ocular, eros&#227;o da c&#243;rnea, ceratite ponteada, ceratite, conjuntivite, conjuntivite al&#233;rgica, blefarite, fotosensibilidade, olho seco, astenopia, prurido ocular, aumento de l&#225;grimas, secre&#231;&#227;o nos olhos, crosta na margem da p&#225;lpebra, edema da c&#243;rnea, diplopia, acuidade visual reduzida, fotopsia, hipoestesia ocular, edema periorbital</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Zumbido</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Angina pectoris, frequ&#234;ncia card&#237;aca irregular</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Dispneia, epistaxe, rinorreia, dor na regi&#227;o orofar&#237;ngea, tosse, irrita&#231;&#227;o na garganta, hiperreatividade dos br&#244;nquios, congest&#227;o do trato respirat&#243;rio superior, congest&#227;o sinusal, congest&#227;o nasal, ressecamento nasal&#160;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Disgeusia, n&#225;usea, diarreia, dispepsia, desconforto abdominal, boca seca</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Rash, urtic&#225;ria, alopecia, prurido generalizado</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Fadiga, astenia, irritabilidade, diminui&#231;&#227;o do apetite, hipoestesia, queda da press&#227;o sangu&#237;nea, artralgia.</p>\r\n</div>"
    },
    {
        "content_length": 4940,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">Uso concomitante com IMAO ou&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">antidepressivos que afetam a transmiss&#227;o noradren&#233;rgica (antidepressivos tric&#237;clicos)</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Pacientes com insufici&#234;ncia renal grave (precau&#231;&#227;o devido ao risco de acidose metab&#243;lica)</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose usual:</strong>&#160;<span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">1 gota no(s) olho(s) afetado(s) de 12/12 a 8/8 horas.</span></li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><span class=\"TextRun SCXW24126308\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW24126308\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1537,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipertens&#227;o intraocular e glaucoma de &#226;ngulo aberto.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>-&#160;<span class=\"TextRun SCXW48131291\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW48131291\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">N&#227;o recomendado.</span></span></p>",
        "last_update": "2019-03-09 16:34:20",
        "name": "Simbrinza",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Suspens&#227;o oft&#225;lmica:</strong>&#160;10mg/mL de Brinzolamida + 2mg/mL de Brimonidina em 5ml ou 8ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Simbrinza",
        "substance": "Brinzolamida + Brimonidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o utilizar em insufici&#234;ncia renal grave (ClCr &lt; 30) pelo risco de acidose grave.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Sonol&#234;ncia, disgeusia, tontura, dor de cabe&#231;a;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Conjuntivite, conjuntivite al&#233;rgica, alergia ocular, vis&#227;o turva, dor ocular, olho irritado, olho seco, prurido ocular, hiperemia ocular, blefarite, desconforto ocular, eros&#227;o na c&#243;rnea, ceratite, ceratite puntata, blefarite al&#233;rgica, fotofobia, secre&#231;&#227;o ocular, aumento do lacrimejamento, astenopia, eritema da p&#225;lpebra, acuidade visual reduzida, diminui&#231;&#227;o do lacrimejamento;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Vertigens, hipotens&#227;o, diminui&#231;&#227;o da press&#227;o sangu&#237;nea, secura nasal, congest&#227;o nasal, dor de garganta, boca seca, n&#225;usea, dispepsia, desconforto abdominal, dermatite al&#233;rgica, astenia, fadiga.</p>\r\n</div>"
    },
    {
        "content_length": 10198,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Hipersensibilidade conhecida aos benzodiazep&#237;nicos ou a qualquer excipiente do produto</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Insufici&#234;ncia respirat&#243;ria grave</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Insufici&#234;ncia hep&#225;tica grave, uma vez que benzodiazep&#237;nicos podem desencadear encefalopatia hep&#225;tica</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- S&#237;ndrome de apneia do sono</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual&#160;de pacientes ambulatoriais:</strong> 1,5 a 3 mg, at&#233; 3 vezes ao dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose em casos graves, especialmente em hospital:</strong> 6 a 12 mg, 2 ou 3 vezes ao dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose m&#225;xima di&#225;ria:</strong>&#160;36 mg</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dura&#231;&#227;o do tratamento:</strong> geralmente n&#227;o deve exceder o per&#237;odo de 8 a 12 semanas, incluindo a fase de descontinua&#231;&#227;o gradual do medicamento.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">U</span><span class=\"TextRun SCXW235550258\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW235550258\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">sualmente n&#227;o &#233; indicado a crian&#231;as, mas se julgar que o tratamento com bromazepam &#233; apropriado, a dose deve ser ajustada ao peso corporal da crian&#231;a (cerca de 0,1 &#8211; 0,3 mg/kg de peso corporal).</span></span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1538,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Ansiedade, tens&#227;o e outras queixas som&#225;ticas ou psicol&#243;gicas associadas &#224; s&#237;ndrome de ansiedade. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Adjuvante no tratamento de ansiedade e agita&#231;&#227;o associadas a transtornos psiqui&#225;tricos, como transtornos do humor e esquizofrenia. </span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-16 21:44:40",
        "name": "Bromazepam",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimidos:</strong>&#160;3 mg e 6 mg.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Solu&#231;&#227;o oral:&#160;</strong>2,5 mg/mL (1 gota = 0,1 mg)</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p>- Receitu&#225;rio azul (B1).</p>",
        "record_status": 1,
        "slug": "bromazepam",
        "substance": "Bromazepam",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Nao estabelecido. Recomenda-se doses menores em portadores de insufici&#234;ncia renal.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Contraindicado em insufici&#234;ncia hep&#225;tica grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span>Perturba&#231;&#245;es psiqui&#225;tricas: confus&#227;o mental, desorienta&#231;&#227;o, dist&#250;rbios emocionais e humor. Esses fen&#244;menos ocorrem predominantemente no in&#237;cio da terapia e normalmente desaparecem ap&#243;s a repeti&#231;&#227;o das doses. Altera&#231;&#245;es na libido foram relatadas ocasionalmente.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Depress&#227;o: depress&#227;o preexistente pode ser desmascarada durante a utiliza&#231;&#227;o de benzodiazep&#237;nicos.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Rea&#231;&#245;es paradoxais: como inquieta&#231;&#227;o, agita&#231;&#227;o, irritabilidade, agressividade, ilus&#245;es, raiva, pesadelos, alucina&#231;&#245;es, psicose, comportamentos inadequados, nervosismo, ansiedade, sonhos anormais, hiperatividade e outros efeitos adversos comportamentais, podem ocorrer. A ocorr&#234;ncia &#233; mais prov&#225;vel em crian&#231;as e idosos e, se isso ocorrer, o uso do medicamento deve ser interrompido.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Depend&#234;ncia: uso cr&#244;nico (mesmo em doses terap&#234;uticas) pode conduzir ao desenvolvimento de depend&#234;ncia f&#237;sica e psicol&#243;gica. A descontinua&#231;&#227;o da terapia pode resultar em abstin&#234;ncia ou efeito rebote. O abuso de benzodiazep&#237;nicos &#233; mais comum em toxicodependentes de mais de uma droga.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios do sistema nervoso: sonol&#234;ncia, dores de cabe&#231;a, tontura, diminui&#231;&#227;o da prontid&#227;o, ataxia. Esses fen&#244;menos ocorrem predominantemente no in&#237;cio da terap&#234;utica e geralmente desaparecem ap&#243;s a repeti&#231;&#227;o das doses. Amn&#233;sia anter&#243;grada pode ocorrer em doses terap&#234;uticas, e o risco aumenta se houver a administra&#231;&#227;o de doses mais elevadas. Efeitos amn&#233;sicos podem estar associados a comportamentos inapropriados.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios oculares: diplopia. Esse fen&#244;meno ocorre predominantemente no in&#237;cio da terapia e, geralmente, desaparece ap&#243;s a repeti&#231;&#227;o das doses.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios gastrintestinais: dist&#250;rbios gastrintestinais t&#234;m sido relatados ocasionalmente.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios da pele e tecido subcut&#226;neo: rea&#231;&#245;es cut&#226;neas t&#234;m sido relatadas ocasionalmente.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios musculoesquel&#233;ticos e do tecido conectivo: fraqueza muscular. Esse fen&#244;meno ocorre predominantemente no in&#237;cio da terap&#234;utica e, geralmente, desaparece com doses repetidas.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios gerais e condi&#231;&#245;es de administra&#231;&#227;o: fadiga. Esse fen&#244;meno ocorre predominantemente no in&#237;cio da terap&#234;utica e, geralmente, desaparece ap&#243;s a repeti&#231;&#227;o das doses.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Les&#245;es, intoxica&#231;&#245;es e complica&#231;&#245;es de procedimentos: existem relatos de quedas e fraturas em pacientes sob uso de benzodiazep&#237;nicos. O risco &#233; maior em pacientes que recebem, concomitantemente, sedativos (incluindo bebidas alco&#243;licas) e em pacientes idosos.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;rbios respirat&#243;rios: depress&#227;o respirat&#243;ria.</p>\r\n</div>"
    },
    {
        "content_length": 3763,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes, n</span>utrizes, insufici&#234;ncia respirat&#243;ria grave, insufici&#234;ncia hep&#225;tica grave, s&#237;ndrome de apneia do sono.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 3-4 c&#225;psulas di&#225;rias podendo atingir 6 c&#225;psulas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">N&#227;o estabelecido.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1550,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Transtorno de ansiedade generalizado, fobia social, s&#237;ndrome do p&#226;nico, agita&#231;&#227;o e ins&#244;nia.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 03:18:14",
        "name": "Sulpan",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>C&#225;psula gelatinosa:&#160;</strong>25 mg de Sulpirida + 1 mg de Bromazepam.</span></li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p>-&#160;<span style=\"background-color: transparent; white-space: pre-wrap;\">Receita Azul (B1- psicotr&#243;picos).</span></p>",
        "record_status": 1,
        "slug": "Sulpan",
        "substance": "Sulpirida + Bromazepan",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 14.98px; text-align: left;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: left;\">&#160;- Depress&#227;o, seda&#231;&#227;o, sonol&#234;ncia, amn&#233;sia, tremor, fraqueza muscular, confus&#227;o, ansiedade, ins&#244;nia, nervosismo, hipomania, mania, alucina&#231;&#245;es, abuso e depend&#234;ncia,&#160;constipa&#231;&#227;o, boca seca.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: left;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: left;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Recomenda-se doses menores em portadores de insufici&#234;ncia renal e c</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">ontraindicado em insufici&#234;ncia hep&#225;tica grave.</span></p>\r\n</div>"
    },
    {
        "content_length": 4082,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Paciente com intoler&#226;ncia a frutose.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong>&#160;8mg VO de 8/8 horas.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose m&#225;xima:</strong>&#160;24mg/dia</span></li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Dose usual: </strong>crian&#231;as de 2 a &#8804; 6 anos: 2mg VO 3 vezes ao dia; acima de 6 anos a &#8804; 12 anos: 4mg VO 3 vezes ao dia; adolescentes acima de 12 anos: 8mg VO 3 vezes ao dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> crian&#231;as de 2 a &#8804; 6 anos: 6mg/dia; crian&#231;as acima de 6 a &#8804; 12 anos: 12mg/dia; adolescentes acima de 12 anos: 24mg/dia</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1556,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Atua como secretol&#237;tico e expectorante em doen&#231;as broncopulmonares agudas e&#160;cr&#244;nicas associadas a secre&#231;&#227;o mucosa anormal e transtornos do transporte mucoso.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-16 22:43:25",
        "name": "Bromexina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong><span class=\"NormalTextRun SCXW226537995\" style=\"background-color: inherit;\">Solu&#231;&#227;o oral (xarope):</span></strong>&#160;4 mg/5mL e&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">8 mg/5mL</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Bequidex",
        "substance": "Bromexina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dor abdominal, n&#225;useas, v&#244;mitos, diarreia, hipersensibilidade, erup&#231;&#227;o cut&#226;nea, rea&#231;&#227;o anafil&#225;tica, choque anafil&#225;tico, broncoespasmo, edema angioneur&#243;tico, urtic&#225;ria, prurido.</span></p>\r\n</div>"
    },
    {
        "content_length": 12165,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipertens&#227;o n&#227;o-controlada</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Dist&#250;rbios hipertensivos da gravidez (inclusive ecl&#226;mpsia, pr&#233;-ecl&#226;mpsia ou hipertens&#227;o induzida pela gravidez), hipertens&#227;o p&#243;s-parto e no puerp&#233;rio.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Toxemia grav&#237;dica<span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black;\"><br style=\"mso-special-character: line-break;\"></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Inibi&#231;&#227;o da lacta&#231;&#227;o fisiol&#243;gica;<span class=\"apple-converted-space\">&#160;</span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Disfun&#231;&#227;o do ciclo menstrual (s&#237;ndrome pr&#233;-menstrual);<span class=\"apple-converted-space\">&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black;\"><br style=\"mso-special-character: line-break;\"></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Galactorr&#233;ia com ou sem amenorr&#233;ia: no p&#243;s-parto; idiop&#225;tica; tumoral; por f&#225;rmacos;<span class=\"apple-converted-space\">&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Ingurgitamento mam&#225;rio puerperal;<span class=\"apple-converted-space\">&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Fase l&#250;tea curta;<span class=\"apple-converted-space\">&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Em per&#237;odo p&#243;s-parto, em mulheres com hist&#243;ria de doen&#231;a cardiovascular;<span class=\"apple-converted-space\">&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Crian&#231;as menores de 15 anos;<span class=\"apple-converted-space\">&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\">- Sintomas e/ou hist&#243;ria de dist&#250;rbios ps&#237;quicos s&#233;rios;<span class=\"apple-converted-space\">&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%;\"><span style=\"text-align: justify;\">- Doen&#231;a da art&#233;ria coron&#225;ria e outras condi&#231;&#245;es cardiovasculares graves.</span><span class=\"apple-converted-space\" style=\"text-align: justify;\">&#160;</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Doen&#231;a de Parkinson:</strong>&#160;iniciar com 1,25 mg (meio comprimido) a 2,5 mg/dia, em duas tomadas com as refei&#231;&#245;es (a dosagem de levodopa, durante o per&#237;odo introdut&#243;rio deste medicamento, deve ser mantida, se poss&#237;vel). Avalia&#231;&#245;es a cada 2 semanas s&#227;o aconselh&#225;veis para assegurar que doses mais baixas possam produzir o efeito terap&#234;utico desejado. Se necess&#225;rio, a dose pode ser aumentada a cada 14 - 28 dias com 2,5 mg/dia, administradas com as refei&#231;&#245;es. Neste momento, &#233; aconselh&#225;vel reduzir as doses de levodopa devido aos efeitos adversos.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Estados hiperprolactin&#234;micos: </strong>iniciar com&#160;1,25 mg (meio comprimido) a 2,5 mg/dia. Doses adicionais de 2,5 mg/dia podem ser administradas a cada 3 a 7 dias at&#233; que uma resposta terap&#234;utica adequada seja alcan&#231;ada. A dose terap&#234;utica usual &#233; de 5 mg a 7,5 mg.</span></li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Adenomas:</strong> 1,25 mg (meio comprimido) a 2,5 mg por dia, aumentando gradativamente a dose at&#233; que se consiga manter os n&#237;veis plasm&#225;ticos de prolactina adequadamente suprimidos.</span></li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Acromegalia:</strong>&#160;iniciar com 1,25 mg (meio comprimido) a 2,5 mg/dia. Doses adicionais de 1,25 mg a 2,5 mg a cada 3 a 7 dias podem ser administradas at&#233; que uma resposta terap&#234;utica adequada seja alcan&#231;ada -&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">reavalia&#231;&#227;o mensal e a dose ajustada, baseada na redu&#231;&#227;o do horm&#244;nio de crescimento ou da resposta cl&#237;nica. </span></li>\r\n</ul>\r\n<p style=\"padding-left: 30px;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- A dose usual varia de 20 a 30 mg/dia na maioria dos pacientes. </span></p>\r\n<p style=\"padding-left: 30px;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Pacientes submetidos &#224; irradia&#231;&#227;o da hip&#243;fise devem descontinuar Parlodel&#174; para uma avalia&#231;&#227;o, tanto dos efeitos cl&#237;nicos da irradia&#231;&#227;o sobre o desenvolvimento da doen&#231;a como do uso do Parlodel&#174;. O per&#237;odo adequado para tal retirada &#233; de 4 a 8 semanas. A recorr&#234;ncia dos sinais ou sintomas ou aumento do horm&#244;nio do crescimento indicam que a doen&#231;a ainda est&#225; ativa e novo tratamento com Parlodel&#174; deve ser considerado.</span></p>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Contraindicado para menores de 15 anos.</span></li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><span style=\"text-decoration: underline;\"><strong>Entre 15 e 17 anos:</strong> </span></li>\r\n<li><strong>Adenomas:</strong>&#160;1,25 mg (meio comprimido) duas ou tr&#234;s vezes por dia, aumentar gradativamente a quantidade di&#225;ria de comprimidos requeridas para manter a prolactina plasm&#225;tica adequadamente suprimida. A dose m&#225;xima di&#225;ria recomendada para indiv&#237;duos entre 15 e 17 anos &#233; 20 mg.</li>\r\n<li><strong> Acromegalia:</strong>&#160;inicialmente 1,25 mg (meio comprimido) duas ou tr&#234;s vezes por dia, aumentar gradativamente a quantidade di&#225;ria de comprimidos dependendo da resposta cl&#237;nica e das rea&#231;&#245;es adversas. A dose m&#225;xima di&#225;ria recomendada para indiv&#237;duos com idade entre 15 e 17 anos &#233; 20 mg.&#160;</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1564,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento da doen&#231;a de Parkinson</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de estados hiperprolactin&#234;micos patol&#243;gicos incluindo amenorreia, infertilidade feminina e hipogonadismo; </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de pacientes com adenomas que secretam prolactina; </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Acromegalia.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-06 17:08:16",
        "name": "Parlodel",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimidos:</strong>&#160;2,5 mg</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "parlodel",
        "substance": "Bromocriptina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido. Recomenda-se doses menores em portadores de insufici&#234;ncia renal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Estado confusional, hiperatividade psicomotora, alucina&#231;&#245;es, dist&#250;rbios psic&#243;ticos, ins&#244;nia, transtorno do controle dos impulsos</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dor de cabe&#231;a, sonol&#234;ncia, vertigem, discinesia, parestesia, in&#237;cio s&#250;bito de sono</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dist&#250;bios visuais, vis&#227;o borrada</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Tinnitus (zumbido)</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Efus&#227;o peric&#225;rdica, pericardite constrictiva, taquicardia, bradicardia, arritmia, fibrose da v&#225;lvula card&#237;aca, hipotens&#227;o, hipotens&#227;o ortost&#225;tica (muito raramente levando a s&#237;ncope)</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">-&#160;Palidez revers&#237;vel dos dedos da m&#227;o e dos p&#233;s induzido pelo frio (especialmente em pacientes com hist&#243;ria do fen&#244;meno de Raynaud)</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Congest&#227;o nasal, efus&#227;o pleural, fibrose pleural, pleurisia, fibrose pulmonar, dispneia</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#225;usea, constipa&#231;&#227;o, v&#244;mitos, boca seca, diarreia, dor abdominal, fibrose retroperitoneal, &#250;lcera gastrintestinal, hemorragia gastrintestinal</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dermatite al&#233;rgica, alopecia</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Espasmos musculares</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Fadiga, edema perif&#233;rico, s&#237;ndrome semelhante &#224; S&#237;ndrome Maligna Neurol&#233;ptica com a retirada abrupta de Parlodel&#174;</p>\r\n</div>"
    },
    {
        "content_length": 6438,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Hemorragia, obstru&#231;&#227;o mec&#226;nica ou perfura&#231;&#227;o gastrintestinal;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Em pacientes epil&#233;pticos ou que estejam recebendo outras drogas que possam causar rea&#231;&#245;es extrapiramidais, uma vez que a frequ&#234;ncia e intensidade destas rea&#231;&#245;es podem ser aumentadas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Em crian&#231;as menores de 1 ano de idade, devido ao risco aumentado da ocorr&#234;ncia de agita&#231;&#227;o, irritabilidade e convuls&#245;es;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Feocromocitoma; tal crise hipertensiva pode ser controlada com fentolamina.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 10 mg IV de 8/8 horas, sendo no m&#225;ximo 60 mg/dia.<u></u></span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Orienta&#231;&#245;es:&#160;</strong>deve ser feita de forma lenta (superior a 3 minutos) ap&#243;s dilui&#231;&#227;o com solu&#231;&#227;o fisiol&#243;gica (cloreto de s&#243;dio 0,9% ou glicose 5%) para evitar rea&#231;&#245;es adversas como agita&#231;&#227;o, ansiedade, sonol&#234;ncia e hipotens&#227;o.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 115%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Dose usual:</strong> 0,5 a 1 mg/kg/dia IV dividido em tr&#234;s doses, cada dose de 8/8.</span></li>\r\n<li><span style=\"line-height: 115%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#201; contraindicado para crian&#231;as menores de 1 ano.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1572,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dist&#250;rbios da motilidade gastrintestinal; </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Refluxo gastroesof&#225;gico; </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#225;useas e v&#244;mitos de origem central e perif&#233;rica (cirurgias, metab&#243;licas, infecciosas e problemas secund&#225;rios ao uso de medicamentos);</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Para facilitar os procedimentos radiol&#243;gicos do trato gastrintestinal. </span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 204,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-02-20 00:50:16",
        "name": "Bromogex",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;10mg/2mL</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Bromogex",
        "substance": "Bromoprida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Inquieta&#231;&#227;o, sonol&#234;ncia, fadiga, hipotens&#227;o e sintomas extrapiramidais.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Ins&#244;nia, cefaleia, tontura, n&#225;useas, sintomas extrapiramidais, galactorreia, ginecomastia, erup&#231;&#245;es cut&#226;neas, incluindo urtic&#225;ria ou dist&#250;rbios intestinais. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">C&#243;licas intestinais, diarreia.<u></u></span></p>\r\n</div>"
    },
    {
        "content_length": 3033,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a componentes da f&#243;rmula</p>\r\n<p>- Hipertens&#227;o arterial grave, coronariopatias severas, arritmias</p>\r\n<p>- Glaucoma</p>\r\n<p>- Hipertireoidismo e/ou hipertrofia prost&#225;tica</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Comprimidos:</strong> 1 comprimido, 3 a 4 vezes ao dia</li>\r\n<li><strong>Elixir:</strong>&#160;5ml at&#233; 4 vezes ao dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Solu&#231;&#227;o Oral:</strong>&#160;Crian&#231;as acima de 2 anos: Duas gotas por kg de peso (como dose di&#225;ria total), dividida em tr&#234;s vezes ao dia (1 ml = 20 gotas). Dose m&#225;xima di&#225;ria limitada a 60 gotas.</li>\r\n<li><strong>Elixir:</strong>&#160;em crian&#231;as maiores de 12 anos: 5ml at&#233; 4 vezes ao dia; crian&#231;as de 6 a 12 anos: 5ml at&#233; 3 vezes ao dia e crian&#231;as de 3 a 6 anos: 2,5ml at&#233; 3 vezes ao dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1580,
        "indications": "<p><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Tratamento sintom&#225;tico das manifesta&#231;&#245;es al&#233;rgicas do aparelho respirat&#243;rio, tais como gripes e resfriados, rinites e rinofaringites.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 02:27:23",
        "name": "Bialerge",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 4mg de Bronfeniramina + 5mg de Fenilefrina</li>\r\n<li><strong>Solu&#231;&#227;o oral:</strong>&#160;2mg de Bronfeniramina + 1,5mg de&#160;Fenilefrina a cada&#160;mL em frasco de 20mL</li>\r\n<li><strong>Elixir: </strong>0,8mg<strong>&#160;</strong>de<strong>&#160;</strong>Bronfeniramina + 1mg de Fenilefrina a cada mL em frasco de 100mL</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bialerge",
        "substance": "Bronfeniramina + Fenilefrina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o, arritmia card&#237;aca, n&#225;useas, v&#244;mitos, cefaleia, vertigem, xerostomia, sonol&#234;ncia, diminui&#231;&#227;o dos reflexos, ins&#244;nia, irritabilidade, turva&#231;&#227;o visual, espessamento das secre&#231;&#245;es br&#244;nquicas.</p>\r\n</div>"
    },
    {
        "content_length": 2555,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:</strong> 200 mg, VO, de 12/12h h, por 7-10 dias ou 20 mL da suspens&#227;o, 12/12 horas, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>1 m&#234;s a 6 anos:</strong>&#160;5mL da suspens&#227;o, 12/12 horas por 7 dias.</li>\r\n<li><strong>6 a 12 anos:</strong> 1/2 cp, 12/12 horas por 7 dias ou 10mL da suspens&#227;o, 12/12 horas por 7 dias.</li>\r\n<li>Pode ser necess&#225;ria a redu&#231;&#227;o da dose, se ocorrerem efeitos como n&#225;useas e v&#244;mitos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1585,
        "indications": "<p>&#160;- Tratamento da giard&#237;ase, da enterite e disenteria causadas por microorganismos sens&#237;veis &#224; furazolidona.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 90,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 19:41:59",
        "name": "Giarlam",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 200 mg</li>\r\n<li><strong>Suspens&#227;o oral (xarope):</strong> 10 mg/ml em 70 ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "giarlam",
        "substance": "Furazolidona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;N&#225;useas, v&#244;mitos, diarreia, rea&#231;&#245;es al&#233;rgicas (hipotens&#227;o, urtic&#225;ria, infiltrado pulmonar, febre e exantema cut&#226;neo), hipoglicemia, cefaleia e, raramente, anemia hemol&#237;tica (em pacientes com defici&#234;ncia de G6PD e em neonatos), rea&#231;&#227;o dissulfiram-s&#237;mile e poli neuropatia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5387,
        "contraindications": "<div>\r\n<p>- Insufici&#234;ncia renal com an&#250;ria.</p>\r\n<p>- Pr&#233;-coma e coma associado &#224; encefalopatia hep&#225;tica.</p>\r\n<p>- Hipopotassemia severa.</p>\r\n<p>- Hiponatremia severa.&#160;</p>\r\n<p>- Hipovolemia (com ou sem hipotens&#227;o) ou desidrata&#231;&#227;o.</p>\r\n<p>- Hipersensibilidade &#224; furosemida, &#224;s sulfonamidas ou a qualquer componente da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>VO:</strong></p>\r\n<ul>\r\n<li><strong>Dose inicial:</strong>&#160;20 a 80 mg/dia, VO, de prefer&#234;ncia pela manh&#227;.</li>\r\n<li><strong>Dose manuten&#231;&#227;o:</strong> 20 a 40 mg/dia.&#160;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Injet&#225;vel:</strong></p>\r\n<ul>\r\n<li><strong>Dose usual:&#160;</strong>20-40 mg/dose IV.</li>\r\n<li>A dose pode ser gradualmente aumentada, em intervalos de 2 horas, de 20mg (1 ampola) a cada vez, at&#233; que seja obtida diurese satisfat&#243;ria.</li>\r\n<li>A administra&#231;&#227;o intravenosa de furosemida solu&#231;&#227;o injet&#225;vel deve ser realizada lentamente, n&#227;o</li>\r\n<li>excedendo a velocidade de infus&#227;o de 4mg/min.</li>\r\n<li>A administra&#231;&#227;o IM deve ser restrita a casos excepcionais nos quais a administra&#231;&#227;o oral ou intravenosa n&#227;o forem dispon&#237;veis.</li>\r\n<li><strong>Edema pulmonar agudo:</strong> Administrar uma dose inicial de 40mg (2 ampolas), IV. Se a condi&#231;&#227;o do paciente requerer, injetar uma dose adicional de 20 a 40mg de furosemida (1 a 2 ampolas) ap&#243;s 20 minutos.&#160; A posologia indicada para o tratamento &#233; de 100mg a 300mg ao dia, por um per&#237;odo m&#225;ximo de 48 horas.</li>\r\n<li><strong>Diurese for&#231;ada:</strong> Administrar 20 a 40mg (1 a 2 ampolas) em adi&#231;&#227;o &#224; infus&#227;o de solu&#231;&#227;o de eletr&#243;litos. No envenenamento com subst&#226;ncias &#225;cidas ou b&#225;sicas, a taxa de elimina&#231;&#227;o pode ser aumentada ainda mais pela alcaliniza&#231;&#227;o ou acidifica&#231;&#227;o da urina, respectivamente. A posologia indicada para o tratamento &#233; de 100mg a 300mg ao dia, por um per&#237;odo m&#225;ximo de 48 horas.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>VO:</strong> Se poss&#237;vel, deve ser administrada por via oral para lactentes e crian&#231;as abaixo de 15 anos de idade.&#160;<strong>Dose recomendada:</strong>&#160;2mg/kg, at&#233; um m&#225;ximo de 40mg por dia.&#160;</li>\r\n<li><strong>Dose injet&#225;vel:&#160;</strong>1mg/kg, at&#233; um m&#225;ximo di&#225;rio de 20mg (1 ampola).<br>Indicada a administra&#231;&#227;o parenteral (se necess&#225;rio, infus&#227;o gota a gota) somente em condi&#231;&#245;es de risco de vida.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1586,
        "indications": "<div>\r\n<p>- Hipertens&#227;o arterial leve a moderada.</p>\r\n<p>- Edemas devido a doen&#231;as card&#237;acas e doen&#231;as hep&#225;ticas (ascite), doen&#231;as renais (na s&#237;ndrome nefr&#243;tica, a terapia da doen&#231;a causal tem prioridade).</p>\r\n<p>- Insufici&#234;ncia card&#237;aca aguda, especialmente no edema pulmonar (administra&#231;&#227;o conjunta com outras medidas terap&#234;uticas).</p>\r\n<p>- Elimina&#231;&#227;o urin&#225;ria reduzida devido &#224; gestose (ap&#243;s restaura&#231;&#227;o do volume de l&#237;quidos ao normal).</p>\r\n<p>- Edemas cerebrais como medida de suporte.</p>\r\n<p>- Edemas devido a queimaduras.</p>\r\n<p>- Crises hipertensivas (em adi&#231;&#227;o a outras medidas anti-hipertensivas).</p>\r\n<p>- Indu&#231;&#227;o de diurese for&#231;ada em envenenamentos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 1,
        "laboratory_id": null,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 19:26:34",
        "name": "Furosemida",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 40 mg.</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 10mg/ml em 2 ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "furosemida",
        "substance": "Furosemida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Dist&#250;rbios do equil&#237;brio hidreletrol&#237;tico (principalmente hipocalemia), hipovolemia, dist&#250;rbios circulat&#243;rios, hiperuricemia (raramente sintom&#225;tica), dist&#250;rbios gastrintestinais, exantemas, redu&#231;&#227;o dos elementos figurados do sangue, parestesias, nefrite intersticial al&#233;rgica, ototoxicidade.<br> Doses muito altas, principalmente em pacientes com IR, podem causar necrose hep&#225;tica.</p>\r\n<hr>\r\n<p>&#160;<strong>Ajustes:</strong></p>\r\n<p>- Em pacientes com insufici&#234;ncia renal severa (creatinina s&#233;rica &gt; 5mg/dL), recomenda-se n&#227;o exceder a velocidade de infus&#227;o de 2,5mg/min.</p>\r\n</div>"
    },
    {
        "content_length": 4796,
        "contraindications": "<div>\r\n<p>- Insufici&#234;ncia renal com an&#250;ria.</p>\r\n<p>- Pr&#233;-coma e coma associado &#224; encefalopatia hep&#225;tica.</p>\r\n<p>- Hipopotassemia severa.</p>\r\n<p>- Hiponatremia severa.&#160;</p>\r\n<p>- Hipovolemia (com ou sem hipotens&#227;o) ou desidrata&#231;&#227;o.</p>\r\n<p>- Hipersensibilidade &#224; furosemida, &#224;s sulfonamidas ou a qualquer componente da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:&#160;</strong>20-40 mg/dose IV.</li>\r\n<li>A dose pode ser gradualmente aumentada, em intervalos de 2 horas, de 20mg (1 ampola) a cada vez, at&#233; que seja obtida diurese satisfat&#243;ria.</li>\r\n<li>A administra&#231;&#227;o intravenosa de furosemida solu&#231;&#227;o injet&#225;vel deve ser realizada lentamente, n&#227;o</li>\r\n<li>excedendo a velocidade de infus&#227;o de 4mg/min.</li>\r\n<li>A administra&#231;&#227;o IM deve ser restrita a casos excepcionais nos quais a administra&#231;&#227;o oral ou intravenosa n&#227;o forem dispon&#237;veis.</li>\r\n<li><strong>Edema pulmonar agudo:</strong>&#160;Administrar uma dose inicial de 40mg (2 ampolas), IV. Se a condi&#231;&#227;o do paciente requerer, injetar uma dose adicional de 20 a 40mg de furosemida (1 a 2 ampolas) ap&#243;s 20 minutos.&#160; A posologia indicada para o tratamento &#233; de 100mg a 300mg ao dia, por um per&#237;odo m&#225;ximo de 48 horas.</li>\r\n<li><strong>Diurese for&#231;ada:</strong>&#160;Administrar 20 a 40mg (1 a 2 ampolas) em adi&#231;&#227;o &#224; infus&#227;o de solu&#231;&#227;o de eletr&#243;litos. No envenenamento com subst&#226;ncias &#225;cidas ou b&#225;sicas, a taxa de elimina&#231;&#227;o pode ser aumentada ainda mais pela alcaliniza&#231;&#227;o ou acidifica&#231;&#227;o da urina, respectivamente. A posologia indicada para o tratamento &#233; de 100mg a 300mg ao dia, por um per&#237;odo m&#225;ximo de 48 horas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;1mg/kg IV, at&#233; um m&#225;ximo di&#225;rio de 20mg (1 ampola).</li>\r\n<li>Indicada a administra&#231;&#227;o parenteral (se necess&#225;rio, infus&#227;o gota a gota) somente em condi&#231;&#245;es de risco de vida.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1588,
        "indications": "<div>\r\n<p>- Hipertens&#227;o arterial leve a moderada.</p>\r\n<p>- Edemas devido a doen&#231;as card&#237;acas e doen&#231;as hep&#225;ticas (ascite), doen&#231;as renais (na s&#237;ndrome nefr&#243;tica, a terapia da doen&#231;a causal tem prioridade).</p>\r\n<p>- Insufici&#234;ncia card&#237;aca aguda, especialmente no edema pulmonar (administra&#231;&#227;o conjunta com outras medidas terap&#234;uticas).</p>\r\n<p>- Elimina&#231;&#227;o urin&#225;ria reduzida devido &#224; gestose (ap&#243;s restaura&#231;&#227;o do volume de l&#237;quidos ao normal).</p>\r\n<p>- Edemas cerebrais como medida de suporte.</p>\r\n<p>- Edemas devido a queimaduras.</p>\r\n<p>- Crises hipertensivas (em adi&#231;&#227;o a outras medidas anti-hipertensivas).</p>\r\n<p>- Indu&#231;&#227;o de diurese for&#231;ada em envenenamentos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 180,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 19:26:17",
        "name": "Furosefarma",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 10mg/ml em 2 ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "furosemida",
        "substance": "Furosemida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Dist&#250;rbios do equil&#237;brio hidreletrol&#237;tico (principalmente hipocalemia), hipovolemia, dist&#250;rbios circulat&#243;rios, hiperuricemia (raramente sintom&#225;tica), dist&#250;rbios gastrintestinais, exantemas, redu&#231;&#227;o dos elementos figurados do sangue, parestesias, nefrite intersticial al&#233;rgica, ototoxicidade.<br> Doses muito altas, principalmente em pacientes com IR, podem causar necrose hep&#225;tica.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Em pacientes com insufici&#234;ncia renal severa (creatinina s&#233;rica &gt; 5mg/dL), recomenda-se n&#227;o exceder a velocidade de infus&#227;o de 2,5mg/min.</p>\r\n</div>"
    },
    {
        "content_length": 2645,
        "contraindications": "<div>\r\n<p>- Insufici&#234;ncia renal com an&#250;ria.</p>\r\n<p>- Pr&#233;-coma e coma associado &#224; encefalopatia hep&#225;tica.</p>\r\n<p>- Hipopotassemia severa.</p>\r\n<p>- Hiponatremia severa.&#160;</p>\r\n<p>- Hipovolemia (com ou sem hipotens&#227;o) ou desidrata&#231;&#227;o.</p>\r\n<p>- Hipersensibilidade &#224; furosemida, &#224;s sulfonamidas ou a qualquer componente da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong>&#160;20 a 80 mg/dia, VO, de prefer&#234;ncia pela manh&#227;.</li>\r\n<li><strong>Dose manuten&#231;&#227;o:</strong> 20 a 40 mg/dia.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;2mg/kg VO, at&#233; um m&#225;ximo de 40mg por dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1593,
        "indications": "<div>\r\n<p>- Hipertens&#227;o arterial leve a moderada.</p>\r\n<p>- Edemas devido a doen&#231;as card&#237;acas e doen&#231;as hep&#225;ticas (ascite), doen&#231;as renais (na s&#237;ndrome nefr&#243;tica, a terapia da doen&#231;a causal tem prioridade).</p>\r\n<p>- Edemas devido a queimaduras.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-01-13 17:28:43",
        "name": "Diflumid",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 40 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "furosemida",
        "substance": "Furosemida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Dist&#250;rbios do equil&#237;brio hidreletrol&#237;tico (principalmente hipocalemia), hipovolemia, dist&#250;rbios circulat&#243;rios, hiperuricemia (raramente sintom&#225;tica), dist&#250;rbios gastrintestinais, exantemas, redu&#231;&#227;o dos elementos figurados do sangue, parestesias, nefrite intersticial al&#233;rgica, ototoxicidade.<br> Doses muito altas, principalmente em pacientes com IR, podem causar necrose hep&#225;tica.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 2707,
        "contraindications": "<div>\r\n<p>- Insufici&#234;ncia renal com an&#250;ria, pr&#233;-coma e coma associado &#224; encefalopatia hep&#225;tica, hipopotassemia severa, hiponatremia severa, hipovolemia (com ou sem hipotens&#227;o) ou desidrata&#231;&#227;o, hipersensibilidade &#224; furosemida, &#224;s sulfonamidas ou a qualquer componente da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;1 a 2 cp, VO, de prefer&#234;ncia pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1603,
        "indications": "<div>\r\n<p>- Hipertens&#227;o arterial leve a moderada, edemas devido a doen&#231;as card&#237;acas e doen&#231;as hep&#225;ticas (ascite), doen&#231;as renais (na s&#237;ndrome nefr&#243;tica, a terapia da doen&#231;a causal tem prioridade), edemas devido a queimaduras.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 114,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 20:31:54",
        "name": "Hidrion",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 40mg Furosemida + 100mg Cloreto Pot&#225;ssio.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "furosemida",
        "substance": "Furosemida + Cloreto de Potássio",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Dist&#250;rbios do equil&#237;brio hidreletrol&#237;tico (principalmente hipocalemia), hipovolemia, dist&#250;rbios circulat&#243;rios, hiperuricemia (raramente sintom&#225;tica), dist&#250;rbios gastrintestinais, exantemas, redu&#231;&#227;o dos elementos figurados do sangue, parestesias, nefrite intersticial al&#233;rgica, ototoxicidade. Doses muito altas, principalmente em pacientes com IR, podem causar necrose hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3053,
        "contraindications": "<div>\r\n<p>- Insufici&#234;ncia renal com an&#250;ria; Pr&#233;-coma e coma associado &#224; encefalopatia hep&#225;tica; Hiperpotassemia e Hipopotassemia severa; Hiponatremia severa; Hipovolemia (com ou sem hipotens&#227;o) ou desidrata&#231;&#227;o.; Hipersensibilidade &#224; espironolactona, furosemida, sulfonamidas ou a qualquer componente da f&#243;rmula.; Pacientes com comprometimento da fun&#231;&#227;o renal com clearance de creatinina menor que 30 mL/min; Pacientes com insufici&#234;ncia hep&#225;tica acompanhada de comprometimento do n&#237;vel de consci&#234;ncia (coma ou pr&#233;- coma hep&#225;tico risco de deteriora&#231;&#227;o do n&#237;vel da consci&#234;ncia).&#160;</p>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong>&#160;1 caps at&#233; 6/6 horas, durante 3 a 6 dias.</li>\r\n<li><strong>Dose manuten&#231;&#227;o:&#160;</strong>1 caps at&#233; 8/8 horas, em dias alternados ou a cada 3 dias, a crit&#233;rio m&#233;dico.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">N&#227;o estabelecido.</p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1604,
        "indications": "<p>- Hipertens&#227;o arterial leve a moderada. Edemas devido a doen&#231;as card&#237;acas e doen&#231;as hep&#225;ticas (ascite), doen&#231;as renais (na s&#237;ndrome nefr&#243;tica, a terapia da doen&#231;a de base tem prioridade).<br><br></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 22:29:32",
        "name": "Lasilactona",
        "presentation": "<ul>\r\n<li><strong>Comprimido: </strong>100 mg de Espironolactona + 20mg de Furosemida.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "furosemida",
        "substance": "Espironolactona + Furosemida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Dist&#250;rbios do equil&#237;brio hidreletrol&#237;tico (principalmente hipocalemia), hipovolemia, dist&#250;rbios circulat&#243;rios, hiperuricemia (raramente sintom&#225;tica), dist&#250;rbios gastrintestinais, exantemas, redu&#231;&#227;o dos elementos figurados do sangue, parestesias, nefrite intersticial al&#233;rgica, ototoxicidade.<br> Doses muito altas, principalmente em pacientes com IR, podem causar necrose hep&#225;tica.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Contraindicado: <br>Pacientes com clearance de creatinina &lt; 30 mL/min.<br>Insufici&#234;ncia hep&#225;tica com comprometimento do n&#237;vel de consci&#234;ncia.</p>\r\n</div>"
    },
    {
        "content_length": 1951,
        "contraindications": "<div>\r\n<p>- Hiperssensibilidade ao medicamento</p>\r\n<p>- Insufici&#234;ncia renal grave</p>\r\n<p>- Neutropenia</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Artrite reumatoide:</strong></p>\r\n<p>- dose recomendada de Kineret &#233; de 100 mg administrados, uma vez por dia, atrav&#233;s de uma inje&#231;&#227;o subcut&#226;nea. A dose dever&#225; ser administrada aproximadamente &#224; mesma hora todos os dias.</p>\r\n</div>",
        "dosage_children": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 6,
        "gestation_text": "<p>- N&#227;o estabelecido.</p>",
        "id": 1605,
        "indications": "<p>- O Kineret est&#225; indicado em adultos no tratamento dos sinais e sintomas da artrite reumatoide (AR) em combina&#231;&#227;o com metotrexato, com uma resposta inadequada ao metotrexato administrado isoladamente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 22:14:23",
        "name": "Kineret",
        "presentation": "<ul>\r\n<li><strong>Seringa para uso SC:</strong>&#160;100mg de anakinra</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "kineret",
        "substance": "Anakinra",
        "trade_names": "",
        "warnings": "<div>\r\n<p>&#160;</p>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- alergias</p>\r\n<p>- hepatite</p>\r\n<p>- neutropenia</p>\r\n<p>- infec&#231;&#245;es graves</p>\r\n<p>- trombocitopenia</p>\r\n<p>- dislipidemia</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o utilizar em insufici&#234;ncia renal grave (ClCr &lt; 30)</p>\r\n</div>"
    },
    {
        "content_length": 3914,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes</span></p>\r\n<p>- Gestantes e lactantes</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:&#160;</strong>1 comprimido meia hora antes do almo&#231;o e 1 comprimido meia hora antes do jantar.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as de 6 a 12 anos:</strong>&#160;meio comprimido meia hora antes do almo&#231;o e meio comprimido meia hora antes do jantar.</li>\r\n<li>Deve haver acompanhamento m&#233;dico regular durante o tempo de uso do medicamento nessa faixa et&#225;ria.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><span class=\"TextRun SCXW90877522\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 21px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW90877522\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">- Categoria X:</span></span><span class=\"TextRun SCXW90877522\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 21px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW90877522\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></span></p>",
        "id": 1608,
        "indications": "<div>\r\n<p><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Estimulador de apetite</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 121,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-02-20 00:50:42",
        "name": "Buclina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido:&#160;</strong>25 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Apetil",
        "substance": "Buclizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Sonol&#234;ncia, cefaleia, nervosismo, ins&#244;nia, t</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">ontura, v&#244;mito, n&#225;usea, dispneia, ins&#244;nia, diarreia e rash macular.</span></p>\r\n</div>"
    },
    {
        "content_length": 3762,
        "contraindications": "<div>\r\n<p>- Infec&#231;&#245;es locais ou sist&#234;micas de origem bacteriana, viral ou f&#250;ngica;</p>\r\n<p>- Hipersensibilidade &#224; budesonida ou aos outros componentes da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong>&#160;na doen&#231;a de leve a moderada &#233; de 9 mg uma vez ao dia (pela manh&#227;), ou 4,5 mg duas vezes ao dia (manh&#227; e noite), por at&#233; 8 semanas.&#160;Para prolongar a remiss&#227;o da doen&#231;a, recomenda-se uma dose de 6 mg, administrada uma vez ao dia, pela manh&#227;. Em geral, o efeito completo &#233; obtido dentro de 2 a 4 semanas.</li>\r\n<li style=\"text-align: justify;\">Para substituir a prednisolona em pacientes que desenvolveram depend&#234;ncia aos medicamentos esteroides, a dose recomendada &#233; de 6 mg, administrada uma vez ao dia pela manh&#227;.&#160;Quando o tratamento, a dose de prednisolona deve ser ajustada.</li>\r\n<li style=\"text-align: justify;\"><strong>Preven&#231;&#227;o de recorr&#234;ncia ap&#243;s cirurgia em pacientes com doen&#231;a ativa:</strong>&#160;6 mg, administrada uma vez ao dia pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<p>-&#160;<span class=\"TextRun SCXW163378218\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW163378218\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span><span class=\"EOP SCXW163378218\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></p>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C</strong>: Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.&#160;</p>",
        "id": 1614,
        "indications": "<p>- Indicado para o tratamento da Doen&#231;a de Crohn presente no &#237;leo e/ou no c&#243;lon ascendente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 00:48:32",
        "name": "Entocort",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas gelatinosas duras com microgr&#226;nulos:</strong>&#160;3mg de budesonida em embalagem com 45 c&#225;psulas.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "entocort",
        "substance": "Budesonida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Caracter&#237;sticas cushingoides;</p>\r\n<p>- Hipocalemia;</p>\r\n<p>- Altera&#231;&#245;es de comportamento;</p>\r\n<p>- Vis&#227;o emba&#231;ada;</p>\r\n<p>- Palpita&#231;&#245;es;</p>\r\n<p>- Dispepsia&#160;</p>\r\n<p>- Rea&#231;&#245;es na pele;</p>\r\n<p>- C&#226;imbras musculares;</p>\r\n<p>- Dist&#250;rbios menstruais;</p>\r\n<p>- Tremor;</p>\r\n<p>-&#160;Rea&#231;&#245;es anafil&#225;ticas;</p>\r\n<p>-&#160;Velocidade de crescimento reduzida.</p>\r\n</div>"
    },
    {
        "content_length": 3989,
        "contraindications": "<p>- Intoler&#226;ncia conhecida a qualquer um dos seus componentes ou a outros morfiomim&#233;ticos.</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dica:</strong> 50 mcg = 0,05 mg = 1 ml.</li>\r\n<li><strong>Pr&#233;-medica&#231;&#227;o:&#160;</strong>50 a 100 mcg (1 a 2 ml), IM, 30 a 60 minutos antes da cirurgia.</li>\r\n<li><strong>Componente de anestesia geral</strong>\r\n<ul>\r\n<li><strong>Dose baixa:</strong> 2 mcg/kg (0,04 ml/kg) -procedimentos com dor de baixa intensidade-. N&#227;o &#233; necess&#225;rio dose de manuten&#231;&#227;o.</li>\r\n<li><strong>Dose moderada:</strong> 2 a 20 mcg/kg (0,04 a 0,4 ml/kg)-procedimentos com dor de intensidade intermedi&#225;ria-. Pode-se utilizar dose de manuten&#231;&#227;o de 25 a 100 mcg/kg (0,5 a 2 ml), IV ou IM, caso haja movimenta&#231;&#227;o ou altera&#231;&#245;es dos sinais vitais que indicam resposta reflexa ao trauma cir&#250;rgico ou superficializa&#231;&#227;o da analgesia.</li>\r\n<li><strong>Dose elevada:</strong> 20 a 50 mcg/kg (0,4 a 1 ml/kg) -cirurgias mais prolongadas-. A dose de manuten&#231;&#227;o deve ser individualizada, variando de 20 mcg/kg (0,5 ml) at&#233; a metade da dose utilizada inicialmente.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Anest&#233;sico geral:&#160;</strong>50 a 100 mcg/kg (1 a 2 ml/kg).</li>\r\n<li><strong>Anestesia regional:&#160;</strong>1,5 mcg/kg por via epidural. Quando necessita-se de complementa&#231;&#227;o de anestesia regional, doses de 50 a 100 mcg (1 a 2 ml) podem ser administradas por via IM ou IV lento.</li>\r\n<li><strong>P&#243;s operat&#243;rio (sala de recupera&#231;&#227;o):</strong>\r\n<ul>\r\n<li>50 a 100 mcg (1 a 2 ml) por via IM podem ser administrados para controle da dor. A dose pode ser repetida ap&#243;s 1 a 2 horas se necess&#225;rio.</li>\r\n<li>100 mcg (2 ml) por via espinhal.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>Dose usual:</strong> 20 a 30 mcg (0,4 a 0,6 ml) para cada 10 a 12 kg de peso corporal.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1622,
        "indications": "<p>- Analgesia de curta dura&#231;&#227;o durante o per&#237;odo anest&#233;sico ou p&#243;s operat&#243;rio imediato. Componente analg&#233;sico da anestesia geral e suplemento da anestesia regional. Pode ser agente anest&#233;sico &#250;nico com oxig&#234;nio em determinados pacientes de alto risco.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 17:59:12",
        "name": "Fentanest",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> ampolas de 2, 5 e 10 ml a 50 mcg/ml (0,05 mg/ml).</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "fentanest",
        "substance": "Fentanila",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- Rigidez muscular, movimentos miocl&#244;nicos, vertigem, hipotens&#227;o, bradicardia, apneia, depress&#227;o respirat&#243;ria, n&#225;usea, v&#244;mito, rea&#231;&#245;es al&#233;rgicas.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- N&#227;o estabelecido.</span></p>\r\n</div>"
    },
    {
        "content_length": 4038,
        "contraindications": "<p>- Intoler&#226;ncia conhecida a qualquer um dos seus componentes ou a outros morfiomim&#233;ticos.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dica:</strong>&#160;50 mcg = 0,05 mg = 1 ml.</li>\r\n<li><strong>Pr&#233;-medica&#231;&#227;o:&#160;</strong>50 a 100 mcg (1 a 2 ml), IM, 30 a 60 minutos antes da cirurgia.</li>\r\n<li><strong>Componente de anestesia geral</strong>\r\n<ul>\r\n<li><strong>Dose baixa:</strong>&#160;2 mcg/kg (0,04 ml/kg) -procedimentos com dor de baixa intensidade-. N&#227;o &#233; necess&#225;rio dose de manuten&#231;&#227;o.</li>\r\n<li><strong>Dose moderada:</strong>&#160;2 a 20 mcg/kg (0,04 a 0,4 ml/kg)-procedimentos com dor de intensidade intermedi&#225;ria-. Pode-se utilizar dose de manuten&#231;&#227;o de 25 a 100 mcg/kg (0,5 a 2 ml), IV ou IM, caso haja movimenta&#231;&#227;o ou altera&#231;&#245;es dos sinais vitais que indicam resposta reflexa ao trauma cir&#250;rgico ou superficializa&#231;&#227;o da analgesia.</li>\r\n<li><strong>Dose elevada:</strong>&#160;20 a 50 mcg/kg (0,4 a 1 ml/kg) -cirurgias mais prolongadas-. A dose de manuten&#231;&#227;o deve ser individualizada, variando de 20 mcg/kg (0,5 ml) at&#233; a metade da dose utilizada inicialmente.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Anest&#233;sico geral:&#160;</strong>50 a 100 mcg/kg (1 a 2 ml/kg).</li>\r\n<li><strong>Anestesia regional:&#160;</strong>1,5 mcg/kg por via epidural. Quando necessita-se de complementa&#231;&#227;o de anestesia regional, doses de 50 a 100 mcg (1 a 2 ml) podem ser administradas por via IM ou IV lento.</li>\r\n<li><strong>P&#243;s operat&#243;rio (sala de recupera&#231;&#227;o):</strong>\r\n<ul>\r\n<li>50 a 100 mcg (1 a 2 ml) por via IM podem ser administrados para controle da dor. A dose pode ser repetida ap&#243;s 1 a 2 horas se necess&#225;rio.</li>\r\n<li>100 mcg (2 ml) por via espinhal.</li>\r\n</ul>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose usual:</strong> 20 a 30 mcg (0,4 a 0,6 mL) para cada 10 a 12 kg de peso corporal.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1623,
        "indications": "<p>Analgesia de curta dura&#231;&#227;o durante o per&#237;odo anest&#233;sico ou p&#243;s operat&#243;rio imediato. Componente analg&#233;sico da anestesia geral e suplemento da anestesia regional. Pode ser agente anest&#233;sico &#250;nico com oxig&#234;nio em determinados pacientes de alto risco.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 04:43:08",
        "name": "Unifental",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> ampolas de 2 e 5 ml a 78,5 mcg/ml, equivalente &#224; 50 mcg/ml de Fentanila (0,05 mg/ml).</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "fentanest",
        "substance": "Fentanila",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- Rigidez muscular, movimentos miocl&#244;nicos, vertigem, hipotens&#227;o, bradicardia, apneia, depress&#227;o respirat&#243;ria, n&#225;usea, v&#244;mito, rea&#231;&#245;es al&#233;rgicas.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- N&#227;o estabelecido.</span></p>\r\n</div>"
    },
    {
        "content_length": 3983,
        "contraindications": "<p>- Intoler&#226;ncia conhecida a qualquer um dos seus componentes ou a outros morfiomim&#233;ticos.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dica:</strong>&#160;50 mcg = 0,05 mg = 1 ml.</li>\r\n<li><strong>Pr&#233;-medica&#231;&#227;o:&#160;</strong>50 a 100 mcg (1 a 2 ml), IM, 30 a 60 minutos antes da cirurgia.</li>\r\n<li><strong>Componente de anestesia geral</strong>\r\n<ul>\r\n<li><strong>Dose baixa:</strong>&#160;2 mcg/kg (0,04 ml/kg) -procedimentos com dor de baixa intensidade-. N&#227;o &#233; necess&#225;rio dose de manuten&#231;&#227;o.</li>\r\n<li><strong>Dose moderada:</strong>&#160;2 a 20 mcg/kg (0,04 a 0,4 ml/kg)-procedimentos com dor de intensidade intermedi&#225;ria-. Pode-se utilizar dose de manuten&#231;&#227;o de 25 a 100 mcg/kg (0,5 a 2 ml), IV ou IM, caso haja movimenta&#231;&#227;o ou altera&#231;&#245;es dos sinais vitais que indicam resposta reflexa ao trauma cir&#250;rgico ou superficializa&#231;&#227;o da analgesia.</li>\r\n<li><strong>Dose elevada:</strong>&#160;20 a 50 mcg/kg (0,4 a 1 ml/kg) -cirurgias mais prolongadas-. A dose de manuten&#231;&#227;o deve ser individualizada, variando de 20 mcg/kg (0,5 ml) at&#233; a metade da dose utilizada inicialmente.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Anest&#233;sico geral:&#160;</strong>50 a 100 mcg/kg (1 a 2 ml/kg).</li>\r\n<li><strong>Anestesia regional:&#160;</strong>1,5 mcg/kg por via epidural. Quando necessita-se de complementa&#231;&#227;o de anestesia regional, doses de 50 a 100 mcg (1 a 2 ml) podem ser administradas por via IM ou IV lento.</li>\r\n<li><strong>P&#243;s operat&#243;rio (sala de recupera&#231;&#227;o):</strong>\r\n<ul>\r\n<li>50 a 100 mcg (1 a 2 ml) por via IM podem ser administrados para controle da dor. A dose pode ser repetida ap&#243;s 1 a 2 horas se necess&#225;rio.</li>\r\n<li>100 mcg (2 ml) por via espinhal.</li>\r\n</ul>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose usual:</strong> 20 a 30 mcg (0,4 a 0,6 mL) para cada 10 a 12 kg de peso corporal.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1624,
        "indications": "<p>- Analgesia de curta dura&#231;&#227;o durante o per&#237;odo anest&#233;sico ou p&#243;s operat&#243;rio imediato. Componente analg&#233;sico da anestesia geral e suplemento da anestesia regional. Pode ser agente anest&#233;sico &#250;nico com oxig&#234;nio em determinados pacientes de alto risco.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 120,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 04:17:09",
        "name": "Tranil",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> ampolas de 2, 5 e 10 mL a 50 mcg/ml (0,05 mg/ml).</li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Amarela.</p>",
        "record_status": 1,
        "slug": "fentanest",
        "substance": "Fentanila",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- Rigidez muscular, movimentos miocl&#244;nicos, vertigem, hipotens&#227;o, bradicardia, apneia, depress&#227;o respirat&#243;ria, n&#225;usea, v&#244;mito, rea&#231;&#245;es al&#233;rgicas.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- N&#227;o estabelecido.</span></p>\r\n</div>"
    },
    {
        "content_length": 5883,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Insufici&#234;ncia renal severa.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Pacientes epil&#233;pticos.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Menores de 18 anos.</span></p>\r\n<p>- Primeiro trimestre de gesta&#231;&#227;o</p>\r\n<p>- Nutrizes</p>\r\n<p>- Insufici&#234;ncia renal severa (definida pelo clearence de creatinina &lt; 30 ml/min).</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\"><strong>Dose usual:</strong><span style=\"mso-spacerun: yes;\">&#160; </span>150 mg VO de 8/8 horas, ou 300 mg VO de 12/12 horas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span class=\"NormalTextRun SCXW189198860\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span><span class=\"EOP SCXW189198860\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>\r\n<p><strong>- Contraindicado no primeiro trimestre.</strong></p>\r\n</div>",
        "id": 1625,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dist&#250;rbios circulat&#243;rios a n&#237;vel de microcircula&#231;&#227;o.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 79,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-02-20 00:51:04",
        "name": "Bufedil",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimido revestido:</strong> 150 mg e 300 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bufedil",
        "substance": "Buflomedil",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Recomenda-se reduzir a dose pela metade quando o &#237;ndice de protrombina &#233; de cerca de 50% associado a uma baixa concentra&#231;&#227;o de albumina. </span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- As fun&#231;&#245;es renais e hep&#225;ticas devem ser monitoradas. </span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Em pacientes com insufici&#234;ncia renal leve ou moderada (definida pelo clearance de creatinina entre 30 e 80 ml/min) e com insufici&#234;ncia hep&#225;tica, a dose deve ser ajustada e n&#227;o deve exceder 300 mg/dia. </span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Vasodilata&#231;&#227;o, prurido, v</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">ertigem, cefal&#233;ia, d</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">ist&#250;rbios gastrintestinais, n&#225;useas, tonturas.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Rash, psor&#237;ase, rea&#231;&#245;es al&#233;rgicas (ex: rash, taquicardia, hipotens&#227;o/choque), fibrila&#231;&#227;o atrial, taquicardia, poli&#250;ria, hipotens&#227;o e rubor, sonol&#234;ncia, rea&#231;&#245;es do tipo mioclonia e convuls&#245;es, epistaxis, menorragia, aumento de creatina. </span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Pacientes com complica&#231;&#245;es renais podem ser mais suscet&#237;veis a rea&#231;&#245;es adversas mais s&#233;rias tal como mioclonia, convuls&#245;es e taquicardia. Por isto &#233; importante fazer, quando necess&#225;rio o ajuste de doses nesses pacientes. </span></p>\r\n</div>"
    },
    {
        "content_length": 4576,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Hipersensibilidade conhecida &#224; bumetanida ou aos excipientes presentes em sua formula&#231;&#227;o.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- An&#250;ria completa, em coma hep&#225;tico e com deple&#231;&#227;o eletrol&#237;tica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong> 0,5 mg (meio comprimido) a 1,0 mg (um comprimido) VO/dia. </span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Posologia n&#227;o estabelecida</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1626,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de edemas de origem renal, card&#237;aco ou hep&#225;tica.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipertens&#227;o arterial.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 79,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-02-20 00:51:44",
        "name": "Burinax",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimidos:</strong>&#160;1 mg em embalagem com 20 comprimidos. </span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "burinax",
        "substance": "Bumetanida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Rea&#231;&#245;es comuns (&gt; 1/100 e &lt; 1/10): hiperglicemia, hiperuricemia, hipocloremia, hipocalemia, c&#227;ibras, tontura. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Rea&#231;&#245;es incomuns (&gt; 1/1.000 e &lt; 1/100): v&#244;mitos, altera&#231;&#227;o de eletrocardiograma, hipotens&#227;o, sensibilidade dos mamilos, n&#225;useas, altera&#231;&#245;es dos n&#237;veis de hemoglobina, altera&#231;&#227;o do tempo de protrombina, trombocitopenia, fraqueza muscular, mialgia, encefalopatia, cefaleia. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Rea&#231;&#245;es raras (&gt; 1/10.000 e &lt; 1/1.000): prurido, fraqueza abdominal e erup&#231;&#245;es na pele, insufici&#234;ncia renal, disfun&#231;&#227;o sexual (ejacula&#231;&#227;o precoce e dificuldades em manter a ere&#231;&#227;o). </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Rea&#231;&#245;es muito raras (&lt;1/10.000): diarreia, sudorese.</span></p>\r\n</div>"
    },
    {
        "content_length": 6756,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipotens&#227;o acentuada.</span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Bloqueios obst&#233;tricos paracervicais que possam causar bradicardia fetal.</span></span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><strong>Infiltra&#231;&#227;o local:</strong> solu&#231;&#227;o a 0,5% utilizando-se 5mL-30mL</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><strong> Anestesia peridural cont&#237;nua:</strong>&#160;solu&#231;&#227;o a 0,5% utilizando-se&#160;10mL inicialmente, seguindo por 3mL-8mL a cada 4-6 horas</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><strong>Bloqueio intercostal:&#160;</strong>solu&#231;&#227;o a 0,5% utilizando-se&#160;2mL-3mL por nervo para um total de 10 nervos</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><strong>Bloqueios maiores (Peridural, caudal e plexo braquial):&#160;</strong>solu&#231;&#227;o a 0,5% utilizando-se 15mL-30 mL</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; text-align: justify;\"><strong>Anestesia obst&#233;trica:</strong>&#160;as doses iniciais podem ser repetidas a cada 2-3 horas, se necess&#225;rio:\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Anestesia peridural e caudal (para parto vaginal):</strong>&#160;solu&#231;&#227;o a 0,5% utilizando-se&#160;6mL-10mL</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong>Bloqueio peridural (ces&#225;rea):</strong>&#160;solu&#231;&#227;o a 0,5% utilizando-se&#160;15mL-30mL</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose m&#225;xima recomendada:</strong>&#160;em um per&#237;odo de 4 horas &#233; de 2 mg/kg de peso at&#233; 150 mg em adultos. Experi&#234;ncias at&#233; o momento indicam que a administra&#231;&#227;o de 400 mg durante 24 horas &#233; bem tolerada em adultos normais.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para a faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1628,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento e profilaxia de dores causadas por processos cir&#250;rgicos.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Anestesia por infiltra&#231;&#227;o, quando se deseja longa dura&#231;&#227;o, por exemplo, para analgesia p&#243;soperat&#243;ria. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Bloqueios de longa dura&#231;&#227;o ou anestesia peridural onde a epinefrina &#233; contra-indicada e o relaxamento muscular potente n&#227;o &#233; necess&#225;rio ou desej&#225;vel. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Anestesia em obstetr&#237;cia.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 178,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-02-20 00:51:14",
        "name": "Bupican",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5 mg/mL</span></li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "Bupican",
        "substance": "Bupivacaína",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- H</span>ipotens&#227;o, n&#225;usea, parestesia e tontura, bradicardia, hipertens&#227;o, v&#244;mito, reten&#231;&#227;o urin&#225;ria, sinais e sintomas de toxicidade do SNC (convuls&#245;es, parestesia circumoral, dorm&#234;ncia da l&#237;ngua, hiperacusia, dist&#250;rbios visuais, perda da consci&#234;ncia, tremor, tontura (sensa&#231;&#227;o de aus&#234;ncia), tinido e disartria), rea&#231;&#245;es al&#233;rgicas, choque/rea&#231;&#227;o anafil&#225;tico, neuropatia, dano do nervo perif&#233;rico e aracnoidite, diplopia, parada card&#237;aca e arritmia card&#237;aca, depress&#227;o respirat&#243;ria.</p>\r\n</div>"
    },
    {
        "content_length": 7232,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Insufici&#234;ncia respirat&#243;ria grave.</span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Insufici&#234;ncia renal grave.</span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Uso concomitante com IMAOs.</span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- N&#227;o deve ser usado para tratamento de depend&#234;ncia de narc&#243;ticos.</span></span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">Dose usual: </span></strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">iniciar com&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">5 mg e realizar a titula&#231;&#227;o da dose a cada 3-7 dias, at&#233; que se alcance a analgesia adequada.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span class=\"NormalTextRun SCXW219646875\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span><span class=\"EOP SCXW219646875\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1633,
        "indications": "<p><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de dor moderada a forte intensidade (quando &#233; necess&#225;rio terapia cont&#237;nua com opioide para obter analgesia adequada). </span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 208,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 02:39:03",
        "name": "Restiva",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Adesivo transd&#233;rmico:</strong> 5 mg, 10 mg e 20 mg.</span></li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p>- Receitu&#225;rio amarelo (A1).</p>",
        "record_status": 1,
        "slug": "restiva",
        "substance": "Buprenorfina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">&#160;</span></strong><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o &#233; necess&#225;rio ajuste de dose em pacientes com insufici&#234;ncia renal. </span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Rea&#231;&#245;es al&#233;rgicas, respostas anafil&#225;ticas, anorexia, desidrata&#231;&#227;o, confus&#227;o, depress&#227;o, ins&#244;nia, nervosismo, ansiedade, labilidade emocional, agita&#231;&#227;o, humor&#160;euf&#243;rico, alucina&#231;&#227;o, diminui&#231;&#227;o da libido, pesadelos, agress&#227;o, dist&#250;rbio psic&#243;tico, despersonaliza&#231;&#227;o;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tontura, cefaleia, sonol&#234;ncia, tremor, comprometimento da concentra&#231;&#227;o, coordena&#231;&#227;o anormal, disartria, disgeusia, hipoestesia, comprometimento da mem&#243;ria, enxaqueca, s&#237;ncope, parestesia, convuls&#245;es, olho seco, vis&#227;o emba&#231;ada, miose, tinido e vertigem, palpita&#231;&#245;es, taquicardia, angina pectoris, vermelhid&#227;o, hipertens&#227;o, hipotens&#227;o, vasodilata&#231;&#227;o, hipotens&#227;o ortost&#225;tica;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dispneia, tosse, solu&#231;os, sibilos, insufici&#234;ncia respirat&#243;ria, depress&#227;o respirat&#243;ria, asma agravada, hiperventila&#231;&#227;o, rinite, constipa&#231;&#227;o, n&#225;usea, v&#244;mito, dor abdominal, diarreia, dispepsia, boca seca, flatul&#234;ncia, disfagia, &#237;leo paral&#237;tico, diverticulite,&#160;c&#243;lica biliar;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Prurido, eritema, sudorese, pele seca, urtic&#225;ria, dermatite de contato, edema facial, espasmos musculares, mialgia, incontin&#234;ncia urin&#225;ria, reten&#231;&#227;o urin&#225;ria, hesita&#231;&#227;o urin&#225;ria, disfun&#231;&#227;o sexual, rea&#231;&#227;o no local da aplica&#231;&#227;o, condi&#231;&#245;es de astenia (incluindo fraqueza muscular), edema perif&#233;rico, edema, pirexia, tremores, s&#237;ndrome de retirada, dermatite no local da aplica&#231;&#227;o, dor no peito, sintomas tipo gripe, s&#237;ndrome de retirada neonatal, aumento da alanina aminotransferase, diminui&#231;&#227;o de peso, les&#227;o acidental (incluindo queda).</span></p>\r\n</div>"
    },
    {
        "content_length": 7024,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes</p>\r\n<p>- Epilepsia ou outros dist&#250;rbios convulsivos</p>\r\n<p>- Se diagn&#243;stico atual ou pr&#233;vio de bulimia ou anorexia nervosa</p>\r\n<p>- Administra&#231;&#227;o concomitante de inibidores da monoaminoxidase (IMAOs) ou o uso associado de bupropiona dentro de at&#233; 14 dias ap&#243;s a interrup&#231;&#227;o do tratamento com IMAOs</p>\r\n<p>- Processo de descontinua&#231;&#227;o abrupta do uso de sedativos ou &#225;lcool</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Depress&#227;o: </strong>tratamento inicial: 150mg qx/dia; pacientes que n&#227;o respondem adequadamente &#224; dose podem se beneficiar com o aumento para 300 mg/dia, administrada como 150 mg 2x/dia; <span style=\"text-decoration: underline;\">terap&#234;utica de manuten&#231;&#227;o:</span>&#160;300 mg/dia tem demonstrado efic&#225;cia durante tratamentos prolongados (estudos com at&#233; um ano de dura&#231;&#227;o).</li>\r\n<li><strong>Tabagismo:</strong> tomar 150 mg VO 1x/dia nos 3 primeiros dias e ap&#243;s tomar 150 mg VO de 12/12 horas.</li>\r\n<li><strong>Dose di&#225;ria m&#225;xima:</strong>&#160;300mg.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span class=\"TextRun SCXW235970859\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW235970859\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span><span class=\"EOP SCXW235970859\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1647,
        "indications": "<div>\r\n<p>- Tratamento de doen&#231;as depressivas ou na preven&#231;&#227;o de reca&#237;das e recorr&#234;ncias de epis&#243;dios depressivos ap&#243;s resposta inicial satisfat&#243;ria.</p>\r\n<p>- Para ajudar a parar de fumar (dosagens e outras instru&#231;&#245;es s&#227;o diferentes para pacientes em tratamento para deixar de fumar).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 14:41:27",
        "name": "Wellbutrin SR",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Comprimidos de libera&#231;&#227;o lenta:</strong> 150 mg.</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "WellbutrinR",
        "substance": "Bupropiona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Recomenda-se doses menores em portadores de insufici&#234;ncia hep&#225;tica ou renal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span>Rea&#231;&#245;es muito comuns (&#8805;1/10): ins&#244;nia, cefaleia, boca seca, transtornos gastrintestinais como n&#225;usea e v&#244;mito.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Rea&#231;&#245;es comuns (&gt;1/100 e 1&lt;10): rea&#231;&#245;es de hipersensibilidade, como urtic&#225;ria; anorexia, agita&#231;&#227;o, ansiedade; tremor, vertigem, transtornos no paladar; transtornos na vis&#227;o; tinido; hipertens&#227;o (em alguns casos, grave), calor e rubor; dor abdominal, constipa&#231;&#227;o; Rash, prurido, sudorese; febre, dor no peito, astenia.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Rea&#231;&#245;es incomuns (&gt;1/1000 e &lt;1/100): perda de peso; depress&#227;o, confus&#227;o mental; taquicardia; dist&#250;rbios de concentra&#231;&#227;o.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Rea&#231;&#227;o rara (&gt;1/10.000 e &lt;1/1.000): convuls&#245;es</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Rea&#231;&#245;es muito raras (&lt;1/10.000): rea&#231;&#245;es de hipersensibilidade mais graves, incluindo angioedema, dispneia, broncoespasmo e choque anafil&#225;tico; artralgia, mialgia e febre tamb&#233;m foram relatadas em associa&#231;&#227;o com rash e outros sintomas sugestivos de hipersensibilidade tardia. Esses sintomas podem lembrar a Doen&#231;a do soro. Agress&#227;o, hostilidade, irritabilidade, inquieta&#231;&#227;o, alucina&#231;&#245;es, sonhos anormais, despersonaliza&#231;&#227;o, del&#237;rio, idea&#231;&#227;o paran&#243;ide; altera&#231;&#245;es da glicemia, hiponatremia; distonia, ataxia, parkinsonismo, altera&#231;&#245;es na coordena&#231;&#227;o motora, altera&#231;&#245;es de mem&#243;ria, parestesias, s&#237;ncopes; palpita&#231;&#245;es; vasodilata&#231;&#227;o, hipotens&#227;o postural; eleva&#231;&#227;o no n&#237;vel de enzimas hep&#225;ticas, icter&#237;cia, hepatite; eritema multiforme, s&#237;ndrome de Stevens-Johnson; movimentos involunt&#225;rios; aumento da frequ&#234;ncia urin&#225;ria ou reten&#231;&#227;o urin&#225;ria; incontin&#234;ncia urin&#225;ria.</p>\r\n</div>"
    },
    {
        "content_length": 6315,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes</span></p>\r\n<p>- Pacientes menores de 18 anos de idade</p>\r\n<p>- Epilepsia</p>\r\n<p>- Intoxica&#231;&#227;o aguda por &#225;lcool, hipn&#243;ticos, analg&#233;sicos ou drogas antipsic&#243;ticas</p>\r\n<p>- Insufici&#234;ncia renal e hep&#225;tica graves</p>\r\n<p>- Hist&#243;ria de crises convulsivas</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong>&#160;dosagem inicial de 15 mg di&#225;rios (5 mg 3x/dia, de prefer&#234;ncia nos intervalos das refei&#231;&#245;es), a cada dois ou tr&#234;s dias a dosagem poder&#225; ser aumentada em 5 mg por dia, a resposta &#243;tima terap&#234;utica &#233; obtida, para a maioria dos pacientes, incluindo idosos, com pequenos aumentos na dose at&#233; uma dosagem di&#225;ria de 20 a 30 mg divididas em duas ou tr&#234;s tomadas.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose m&#225;xima di&#225;ria:</strong>&#160;60 mg</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span class=\"TextRun SCXW235970859\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW235970859\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span><span class=\"EOP SCXW235970859\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1649,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dist&#250;rbios de ansiedade, como o transtorno de ansiedade generalizada e no al&#237;vio em curto prazo dos sintomas de ansiedade, acompanhados ou n&#227;o de depress&#227;o.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 00:37:04",
        "name": "Ansitec",
        "presentation": "<div>\r\n<ul>\r\n<li><span style=\"text-align: justify;\"><strong>Comprimidos:</strong>&#160;5 mg e 10 mg.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\">&#160;</span></p>\r\n</div>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 em duas vias).</p>",
        "record_status": 1,
        "slug": "ansitec",
        "substance": "Buspirona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Insufici&#234;ncia renal: ClCr 20-49mL/min administrar duas doses ao dia e ClCr&lt; 20mL/min &#233; contraindicado</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Contraindicado em insufici&#234;ncia hep&#225;tica grave</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">-&#160;Nervosismo, ins&#244;nia, dist&#250;rbios de aten&#231;&#227;o, depress&#227;o, estado confusional, desordens do sono, raiva. desordens psic&#243;ticas, alucina&#231;&#227;o, despersonaliza&#231;&#227;o, labilidade emocional, tontura (incluindo vertigem), cefaleia, sonol&#234;ncia, parestesia, vis&#227;o turva, coordena&#231;&#227;o anormal, tremor, tinido, s&#237;ndrome da serotonina, convuls&#227;o, vis&#227;o estreita (em t&#250;nel), desordens extrapiramidais, rea&#231;&#245;es dist&#244;nicas e rigidez em roda denteada, discinesia, distonia, desmaios, amn&#233;sia, ataxia, parkinsonismo, acatisia, sindrome das pernas inquietas, inquieta&#231;&#227;o.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Taquicardia, dor tor&#225;cica, congest&#227;o nasal, dor faringolar&#237;ngea, n&#225;usea, dor abdominal, boca seca, diarreia, constipa&#231;&#227;o, v&#244;mito.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Suor frio, erup&#231;&#227;o cut&#226;nea, edema angioneur&#243;tico (angioedema), equimose, urtic&#225;ria, dor musculoesquel&#233;tica, reten&#231;&#227;o urin&#225;ria, galactorreia, fadiga, astenia (fraqueza).</span></p>\r\n</div>"
    },
    {
        "content_length": 2894,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia: </strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar: </strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania: </strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1650,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo; transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 02:17:17",
        "name": "Olanzapina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 2,5mg; 5mg e 10mg.</li>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<div>\r\n<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>\r\n<p>&#160;</p>\r\n</div>",
        "record_status": 1,
        "slug": "olanzapina",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- <strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong> 5 mg, cautela no aumento da dose.</p>\r\n<p>- <strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong> 5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2719,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1652,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-04 01:23:40",
        "name": "Axonium",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "axonium",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2716,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1653,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 162,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 14:51:07",
        "name": "Zap",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "zap",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 6252,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\"><strong>Dose usual:&#160;</strong>um implante &#233; injetado por via subcut&#226;nea a cada 2 meses na parede abdominal. O intervalo de dose pode ser diminu&#237;do ou estendido por poucos dias. </span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\"><strong>Orienta&#231;&#245;es:&#160;</strong>5 dias antes do primeiro implante, deve ser administrado um antiandrog&#234;nico (acetato de ciproterona (150 mg/dia), a flutamida (750 mg/dia) e a nilutamida (300 mg/dia) mostraram-se eficazes). Esta medica&#231;&#227;o adicional deve ser mantida durante as primeiras 3 a 4 semanas do tratamento. </span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">Pode ser usado um anest&#233;sico local antes da aplica&#231;&#227;o. </span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">A resposta ao tratamento pode ser monitorada pela avalia&#231;&#227;o dos n&#237;veis de testosterona, fosfatase &#225;cida e ant&#237;geno pr&#243;st&#225;tico-espec&#237;fico no soro (PSA).</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span class=\"NormalTextRun SCXW235970859\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span><span class=\"EOP SCXW235970859\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p>- N&#227;o estabelecido.</p>",
        "id": 1654,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Tratamento end&#243;crino de carcinoma da pr&#243;stata horm&#244;nio-dependente avan&#231;ado.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 03:19:28",
        "name": "Suprefact Depot",
        "presentation": "<ul>\r\n<li><strong>Implante subcut&#226;neo:</strong> 6,6 mg/implante</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "suprefact-depot",
        "substance": "Buserrelina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Palpita&#231;&#245;es,&#160;trombocitopenia e leucopenia, cefaleia, dist&#250;rbios do sono, sonol&#234;ncia, dist&#250;rbios de mem&#243;ria e concentra&#231;&#227;o, vertigem, vis&#227;o prejudicada (por exemplo: vis&#227;o turva), sensa&#231;&#227;o de press&#227;o retrocular, tinido, dist&#250;rbios na audi&#231;&#227;o.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- N&#225;usea, v&#244;mito, diarreia, constipa&#231;&#227;o, altera&#231;&#245;es no couro cabeludo e nos p&#234;los do corpo (aumento ou diminui&#231;&#227;o), desconforto musculoesquel&#233;tico e dor.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- O uso de agonistas-LHRH pode estar associado com redu&#231;&#227;o da densidade &#243;ssea e pode causar osteoporose e um aumento do risco de fratura &#243;ssea. O risco de fratura esquel&#233;tica aumenta com a dura&#231;&#227;o do tratamento.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Aumento da sede, altera&#231;&#245;es no apetite, redu&#231;&#227;o na toler&#226;ncia da glicose. Isto pode, nos pacientes diab&#233;ticos, causar a uma deteriora&#231;&#227;o do controle metab&#243;lico; foram relatados casos muito raros de adenoma pituit&#225;rio, deteriora&#231;&#227;o nos n&#237;veis da press&#227;o sangu&#237;nea em pacientes com hipertens&#227;o, fadiga, rea&#231;&#245;es de hipersensibilidade: rubor cut&#226;neo, prurido, rash cut&#226;neo (incluindo urtic&#225;ria) e asma al&#233;rgica com dispneia, assim como, em casos isolados, causar choque anafil&#225;tico/anafilactoide, nervosismo, instabilidade emocional, sensa&#231;&#227;o de ansiedade. Em casos raros, pode-se desenvolver depress&#227;o ou quando j&#225; existe, pode ocorrer o seu agravamento.</p>\r\n</div>"
    },
    {
        "content_length": 4627,
        "contraindications": "<div>\r\n<p>- Menores de 12 anos;</p>\r\n<p>- Hipersensibilidade ao medicamento.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Dose usual:</strong>&#160;aplicar uma camada fina de creme na les&#227;o 1x/dia durante 2-4 semanas.<u></u></span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span class=\"TextRun SCXW53447203\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW53447203\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></span><span class=\"EOP SCXW53447203\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n<li><span class=\"EOP SCXW53447203\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>Para crian&#231;as maiores de 12 anos a dose &#233; a mesma dos adultos.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">-&#160;</strong><span class=\"TextRun SCXW235471518\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW235471518\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Categoria B:</span></span><span class=\"TextRun SCXW235471518\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW235471518\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1655,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de micoses superficiais da pele, como: pitir&#237;ase versicolor (micose de praia), tinea pedis (p&#233;-de-atleta), tinea corporis (micose do corpo) e tinea cruris (micose da virilha).</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 03:34:03",
        "name": "Tefin",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico:</strong> 1% contendo 10g ou 20g</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tefin",
        "substance": "Butenafina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\">- Dermatite de contato, eritema, irrita&#231;&#227;o e prurido.</p>\r\n</div>"
    },
    {
        "content_length": 2726,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1656,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 15:08:28",
        "name": "Zopix",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "zopix",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 4139,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; background: white;\">- Hipersensibilidade aos componentes.</span></p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> um aplicador pr&#233;-envasado (aproximadamente 5 gramas do creme), por via intravaginal, em dose &#250;nica. Esta quantidade de creme cont&#233;m 100 mg de nitrato de butoconazol. A higieniza&#231;&#227;o das m&#227;os &#233; necess&#225;ria antes e ap&#243;s a aplica&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<p><span class=\"TextRun SCXW152807418\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent;   line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW152807418\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">- Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span><span class=\"EOP SCXW152807418\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent;  line-height: 18.3458px; \" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1657,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Infec&#231;&#227;o vulvovaginal causado por <em style=\"mso-bidi-font-style: normal;\">Candida albicans.</em></span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-12-06 00:23:26",
        "name": "Butoconazol",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\"><strong>Creme vaginal:</strong> 20 mg/g</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "butoconazol",
        "substance": "Butoconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;C&#243;licas, prurido vaginal, irrita&#231;&#227;o vaginal e corrimento vaginal;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Rea&#231;&#245;es al&#233;rgicas, dermatite de contato, dor de cabe&#231;a, inquieta&#231;&#227;o, prurido de pele, rash cut&#226;neo, urtic&#225;ria.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2887,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1658,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 211,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 15:12:21",
        "name": "Zyprexa",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel intra-muscular:</strong> 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "zyprexa",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2745,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1663,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-01-13 23:35:41",
        "name": "Crisapina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "crisapina",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2741,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1664,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 17:40:39",
        "name": "Expolid",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "expolid",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2737,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1665,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 91,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 22:18:36",
        "name": "Kotico",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "kotico",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2733,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1667,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 00:07:53",
        "name": "Lyzapil",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "lyzapil",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2719,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1669,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 212,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 01:20:35",
        "name": "Neupine",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong> 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "neupine",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2730,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1670,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 02:17:09",
        "name": "Olanexyn",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "olanexyn",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2738,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1671,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 61,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 02:17:32",
        "name": "Olazofren",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;2,5mg; 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "olazofren",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2724,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Esquizofrenia:</strong></p>\r\n<ul>\r\n<li>5mg a 10mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Transtorno bipolar:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia.</li>\r\n</ul>\r\n<p><strong>Mania:</strong></p>\r\n<ul>\r\n<li>10mg a 15mg, VO, 1x/dia com progress&#227;o para 20 mg.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1673,
        "indications": "<p>- Esquizofrenia e transtorno esquizoafetivo, transtorno bipolar e mania.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 34,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-10 15:08:19",
        "name": "Zopina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 Branca 2 vias).</p>",
        "record_status": 1,
        "slug": "zopina",
        "substance": "Olanzapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Ganho de peso, hiperglicemia, aumento&#160; do colesterol total, LDL e triglicer&#237;deos em jejum,aumento da prolactina, eosinofilia, sonol&#234;ncia, vertigem, astenia, pirexia, fadiga, constipa&#231;&#227;o, xerostomia, incontin&#234;ncia urinaria, pneumonia, eleva&#231;&#227;o das transaminases, psicose induzida por drogas, aumento do apetite, edema perif&#233;rico, artralgia, glicos&#250;ria, aumento do &#225;cido &#250;rico,&#160; leucopenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Disfun&#231;&#227;o renal grave (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n<p>-&#160;<strong>Disfun&#231;&#227;o hep&#225;tica modera (dose inicial):</strong>&#160;5 mg, cautela no aumento da dose.</p>\r\n</div>"
    },
    {
        "content_length": 6355,
        "contraindications": "<div><p>- Hist&#243;rico de rea&#231;&#245;es severas de hipersensibilidade ao cabazitaxel ou outras drogas formuladas com polissorbato 80;</p>\r\n<p>- Contagem neutrof&#237;lica &lt;1.500/mm3;&#160;</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica severa (bilirrubina total &gt; 3 LSN);</p>\r\n<p>- Uso concomitante com vacina contra febre amarela.</p></div>",
        "dosage_adults": "<div><ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><strong>Dose recomendada:</strong> 25 mg/m&#178; infus&#227;o IV de 1 hora de 3/3 semanas, em associa&#231;&#227;o com 10 mg prednisona (ou prednisolona) oral administrada diariamente durante todo o tratamento</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li><strong>Pr&#233;-medica&#231;&#227;o:</strong>\r\n<ul>\r\n<li>Anti-histam&#237;nico (dexclorfeniramina 5 mg ou difenidramina 25 mg ou equivalente)</li>\r\n<li>Corticosteroide (dexametasona 8 mg ou equivalente)</li>\r\n<li>Antagonista H2 (ranitidina ou equivalente)</li>\r\n<li>Profilaxia antiem&#233;tica &#233; recomendada e pode ser dada por via oral ou por via intravenosa, como necess&#225;rio.</li>\r\n<li>Durante todo o tratamento, a hidrata&#231;&#227;o adequada do paciente precisa ser assegurada, a fim de evitar complica&#231;&#245;es como insufici&#234;ncia renal.</li>\r\n</ul>\r\n</li>\r\n</ul></div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1676,
        "indications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\">- Tratamento de c&#226;ncer de pr&#243;stata com met&#225;stase resistente ao tratamento hormonal, previamente tratados com um regime contendo docetaxel, sendo feito em associa&#231;&#227;o com prednisona ou prednisolona.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 163,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-12-06 22:59:19",
        "name": "Cabazred",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 60mg/1,5mL</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "Cabazred",
        "substance": "Cabazitaxel",
        "trade_names": "",
        "warnings": "<div><p><strong>Ajustes:</strong></p>\r\n<p><strong>-&#160;</strong>Pacientes com insufici&#234;ncia hep&#225;tica leve (bilirrubina total &gt; 1 a &#8804; 1,5 x LSN ou AST &gt; 1,5 x LSN), devem ter a dose reduzida para 20 mg/m2 .&#160;</p>\r\n<p>- Dados limitados de efic&#225;cia est&#227;o dispon&#237;veis para recomendar cabazitaxel a 15 mg/m2 , dose m&#225;xima tolerada em pacientes com insufici&#234;ncia hep&#225;tica moderada (bilirrubina total &gt; 1,5 a &#8804; 3,0 x LSN)</p>\r\n<p>-&#160;N&#227;o &#233; necess&#225;rio ajuste de dose em pacientes com insufici&#234;ncia renal que n&#227;o necessitam de hemodi&#225;lise.</p>\r\n<table style=\"margin-left: auto; margin-right: auto;\" border=\"1\">\r\n<tbody>\r\n<tr>\r\n<td style=\"text-align: center;\"><strong>Rea&#231;&#245;es adversas&#160;</strong></td>\r\n<td style=\"text-align: center;\"><strong>Modifica&#231;&#245;es na dose&#160;</strong></td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">Neutropenia prolongada (mais de 1 semana) grau &#8805; 3, apesar de medica&#231;&#227;o apropriada incluindo G-CSF&#160;</td>\r\n<td style=\"text-align: center;\">Retarde o tratamento at&#233; que a contagem neutrof&#237;lica seja &gt;1500 c&#233;lulas/mm3 , ent&#227;o reduza a dose de cabazitaxel de 25 mg/m2 para 20 mg/m2&#160;</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">Neutropenia febril ou infec&#231;&#227;o neutrop&#234;nica&#160;</td>\r\n<td style=\"text-align: center;\">Retarde o tratamento at&#233; melhora ou resolu&#231;&#227;o e at&#233; que a contagem neutrof&#237;lica seja &gt; 1500 c&#233;lulas/mm3 , ent&#227;o reduza a dose de cabazitaxel de 25 mg/m2 para 20 mg/m2</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">&#160;Diarreia grau &#8805; 3 ou diarreia persistente, apesar de medica&#231;&#227;o apropriada, reposi&#231;&#227;o de fluidos e eletr&#243;litos&#160;</td>\r\n<td style=\"text-align: center;\">Retarde o tratamento at&#233; melhora ou resolu&#231;&#227;o, ent&#227;o reduza a dose de cabazitaxel de 25 mg/m2 para 20 mg/m2</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">&#160;Neuropatia perif&#233;rica grau &gt; 2&#160;</td>\r\n<td style=\"text-align: center;\">Retarde o tratamento at&#233; melhora, ent&#227;o considere a redu&#231;&#227;o da dose.</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Anemia, leucopenia, neutropenia, trombocitopenia, neutropenia febril, diarreia, cansa&#231;o, n&#225;usea, v&#244;mito, constipa&#231;&#227;o, Dispepsia, Dor abdominal superior, Hemorroida, Refluxo gastroesof&#225;gico, Hemorragia retal, Boca seca, Distens&#227;o abdominal, Fadiga, Astenia, Pirexia, Inflama&#231;&#227;o de mucosa, Dor no peito, Edema, Calafrios, Mal-estar, Dor nas costas, fraqueza, dor abdominal, sangue na urina,&#160;Artralgia, Dor nas extremidades, Espasmos musculares, Mialgia, Dor tor&#225;cica musculoesquel&#233;tica, Desidrata&#231;&#227;o, anorexia, neuropatia perif&#233;rica (incluindo neuropatia perif&#233;rica sensorial e motora), febre, falta de ar, altera&#231;&#227;o ou diminui&#231;&#227;o do paladar, tosse, dor nas articula&#231;&#245;es e perda de cabelo,&#160;Ansiedade,&#160;Hemat&#250;ria,&#160;Dis&#250;ria, Incontin&#234;ncia urin&#225;ria,&#160;Insufici&#234;ncia renal aguda,&#160;C&#243;lica renal, Infec&#231;&#227;o do trato urin&#225;rio,&#160;Hipotens&#227;o,&#160;Perda de peso</p></div>"
    },
    {
        "content_length": 0,
        "contraindications": "<div><p>- Menores de 16 anos.</p>\r\n<p>- Hipersensibilidade a qualquer componente ou qualquer alcaloide do ergot.</p>\r\n<p>- Hist&#243;rico de dist&#250;rbios fibr&#243;ticos retroperitoneal, pulmonar e card&#237;aco, incluindo evid&#234;ncias de valvulopatias.</p></div>",
        "dosage_adults": "<div><p>- Tratamento de dist&#250;rbios hiperprolactin&#234;micos: 0,5 mg VO em 1 ou 2 doses por semana podendo variar de 0,25 mg a 2 mg por semana e alguns casos podendo chegar at&#233; 4,5 mg por semana.</p>\r\n<p>- Inibi&#231;&#227;o da lacta&#231;&#227;o: 1 mg VO dose &#250;nica no primeiro dia p&#243;s-parto.</p>\r\n<p>- Supress&#227;o da lacta&#231;&#227;o: 0,25 mg de 12/12 horas por dias.</p></div>",
        "dosage_children": "<p>N&#227;o estabelecido.</p>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1679,
        "indications": "<p>- Tratamento de aumento de prolactina e disfun&#231;&#245;es associadas &#224; hiperprolactinemia (amenorreia, oligomenorreia, anovula&#231;&#227;o, galactorreia), inibi&#231;&#227;o da lacta&#231;&#227;o fisiol&#243;gica imediatamento ap&#243;s o parto e supress&#227;o da lacta&#231;&#227;o j&#225; estabelecida.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p>N&#227;o recomendado (exceto se interrup&#231;&#227;o da lacta&#231;&#227;o intencional).</p>",
        "last_update": "2018-07-04 03:08:39",
        "name": "Caberedux",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\">Comprimidos: 0,5 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Caberedux",
        "substance": "Cabergolina",
        "trade_names": "",
        "warnings": "<div><p><strong>Ajustes:</strong></p>\r\n<p>- Pacientes com insufici&#234;ncia hep&#225;tica recomenda-se usar as menores doses, usar com cautela em paciente diab&#233;ticos por conter a&#231;&#250;car na composi&#231;&#227;o</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Tontura/vertigem, cefaleia, n&#225;usea, dor abdominal, palpita&#231;&#245;es, dor epig&#225;strica, sonol&#234;ncia, epistaxe, hemianopsia, hipotens&#227;o assintom&#225;tica durante os primeiros 3-4 dias p&#243;s-parto, v&#244;mitos, s&#237;ncope, rubores, astenia/fadiga, constipa&#231;&#227;o, dor no peito, depress&#227;o, parestesia.</p>\r\n<p>&#160;</p></div>"
    },
    {
        "content_length": 6334,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula</p>\r\n<p>- N&#227;o deve ser administrado a pacientes com hipercalcemia ou evid&#234;ncia de toxicidade por vitamina D</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong>&#160;a dose inicial &#233; 1,0 mcg (0,02 mcg/kg) a 2,0 mcg 3x/semana, em dias alternados. A dose pode ser aumentada em 0,5 a 1,0 mcg, a intervalos de duas a quatro semanas at&#233; doses m&#225;ximas de 8,0 mcg (8 ampolas), tr&#234;s vezes por semana.</li>\r\n<li style=\"text-align: justify;\"><strong>Observa&#231;&#227;o: </strong>durante esse per&#237;odo de titula&#231;&#227;o de dose, os n&#237;veis s&#233;ricos de c&#225;lcio e f&#243;sforo devem ser obtidos pelo menos duas vezes por semana e, caso seja observada hipercalcemia ou um produto c&#225;lcio x fosfato s&#233;ricos maior que 70, o medicamento dever&#225; ser imediatamente descontinuado, at&#233; que os n&#237;veis s&#233;ricos destes par&#226;metros retornem aos n&#237;veis da normalidade. A administra&#231;&#227;o de calcitriol deve, ent&#227;o, ser reiniciada com uma dose mais baixa.</li>\r\n<li style=\"text-align: justify;\"><strong>Titula&#231;&#227;o da dose:&#160;</strong>em resposta &#224; terapia, &#224; medida que os n&#237;veis de PTH v&#227;o diminuindo, pode haver a necessidade de redu&#231;&#227;o da dose e, da mesma forma, aumentos de dose devem ser individualizados e proporcionais aos n&#237;veis de PTH, n&#237;veis s&#233;ricos de c&#225;lcio e f&#243;sforo. A dose &#243;tima de calcitriol deve ser cuidadosamente determinada para cada paciente.&#160;\r\n<table style=\"margin-left: auto; margin-right: auto;\" border=\"1\">\r\n<tbody>\r\n<tr>\r\n<td style=\"text-align: center;\"><strong>N&#205;VEIS DE PTH&#160;&#160;</strong></td>\r\n<td style=\"text-align: center;\"><strong>DOSE DE CALCITRIOL&#160;</strong></td>\r\n</tr>\r\n<tr style=\"text-align: center;\">\r\n<td>mantidos ou aumentados&#160;</td>\r\n<td>aumentar&#160;</td>\r\n</tr>\r\n<tr style=\"text-align: center;\">\r\n<td>diminui&#231;&#227;o &lt; 30%</td>\r\n<td>aumentar&#160;</td>\r\n</tr>\r\n<tr style=\"text-align: center;\">\r\n<td>diminui&#231;&#227;o &gt; 30% e &lt; 60%&#160;</td>\r\n<td>manter&#160;&#160;</td>\r\n</tr>\r\n<tr style=\"text-align: center;\">\r\n<td>diminui&#231;&#227;o &gt; 60%&#160;&#160;</td>\r\n<td>diminuir&#160;</td>\r\n</tr>\r\n<tr>\r\n<td style=\"text-align: center;\">uma e meia a tr&#234;s vezes a taxa normal&#160;</td>\r\n<td style=\"text-align: center;\">manter&#160;&#160;</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para a faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><span class=\"TextRun SCXW180285352\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold;   line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW180285352\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">- Categoria C:</span></span><span class=\"TextRun SCXW180285352\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent;   line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW180285352\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span><span class=\"EOP SCXW180285352\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent;  line-height: 18.3458px; \" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></p>",
        "id": 1682,
        "indications": "<p>- Hipocalcemia em pacientes submetidos &#224; di&#225;lise renal cr&#244;nica, para reduzir significativamente os n&#237;veis elevados de paratorm&#244;nio (PTH), resultando em melhora da osteodistrofia renal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 257,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-12-08 23:53:26",
        "name": "Calcijex",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 1 mcg/ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "calcijex",
        "substance": "Calcitriol",
        "trade_names": "",
        "warnings": "<div><p style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o estabelecido. Aten&#231;&#227;o com PTH e doen&#231;a &#243;ssea adin&#226;mica.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Astenia, cefaleia, sonol&#234;ncia, n&#225;usea, v&#244;mito, secura na boca, constipa&#231;&#227;o, mialgia, dor &#243;ssea, disgeusia, falta de apetite, dor abdominal e dispepsia, infec&#231;&#227;o no trato urin&#225;rio.</p>\r\n<p style=\"text-align: justify;\">- Poli&#250;ria, polidipsia, falta de apetite, perda de peso, noct&#250;ria, dep&#243;sitos de c&#225;lcio nas conjuntivas, pancreatite, fotofobia, rinorreia, prurido, hipertermia, diminui&#231;&#227;o da libido, eleva&#231;&#227;o da ureia sangu&#237;nea, albumin&#250;ria, hipercolesterolemia, eleva&#231;&#227;o da aspartato aminotransferase e alanina aminotransferase, calcinose , hipertens&#227;o, arritmias card&#237;acas, fraqueza muscular, parestesia, desidrata&#231;&#227;o, apatia, infec&#231;&#245;es do trato urin&#225;rio e, raramente, psicose manifesta</p></div>"
    },
    {
        "content_length": 6588,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula.</p>\r\n<p>- Todas as doen&#231;as associadas com hipercalcemia &#8211; sarcoidose, hipervitaminose D, estados de m&#225; absor&#231;&#227;o, arteriosclerose obliterante, nefrolit&#237;ase, calcifica&#231;&#227;o metast&#225;tica.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Osteoporose:</strong> 0,25mcg 2x/dia</li>\r\n<li style=\"text-align: justify;\"><strong>Osteodistrofia renal:</strong> iniciar com 0,25mcg nos casos leves a cada dois dias e nos demais de forma di&#225;ria em intervalos de 2 a 4 semanas.</li>\r\n<li style=\"text-align: justify;\"><strong>Hipoparatireoidismo e raquitismo:</strong> iniciar com 0,25mcg pela manh&#227; e se n&#227;o resolver pode-se aumentar dose a cada 2 a 4 semanas.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Observa&#231;&#227;o:</strong>&#160;as doses di&#225;rias de calcitriol s&#227;o baseadas em fun&#231;&#227;o do n&#237;vel s&#233;rico de c&#225;lcio de cada paciente. Deve-se iniciar sempre com as doses mais baixas poss&#237;veis, aumentando-as somente com rigoroso controle do c&#225;lcio s&#233;rico. Uma vez determinada a dose ideal de calcitriol, dever&#227;o ser controlados mensalmente os n&#237;veis s&#233;ricos de c&#225;lcio.&#160; As coletas de sangue para dosagem do c&#225;lcio devem ser feitas sem o uso de torniquete.</li>\r\n<li style=\"text-align: justify;\">O aporte de c&#225;lcio no in&#237;cio do tratamento (cerca de 800 mg/dia) &#233; importante para melhorar a efic&#225;cia do calcitriol. Caso haja necessidade, deve-se prescrever c&#225;lcio suplementar.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><span class=\"NormalTextRun SCXW29227047\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span><span class=\"EOP SCXW29227047\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"TextRun SCXW113467920\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW113467920\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">-&#160;</span></span><span class=\"TextRun SCXW255909810\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW255909810\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Categoria B:</span></span><span class=\"TextRun SCXW255909810\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW255909810\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com cautela.</span></span></p>",
        "id": 1685,
        "indications": "<p style=\"text-align: justify;\">- Osteoporose; hipoparatireoidismo idiop&#225;tico e p&#243;s-operat&#243;rio; pseudo hipoparatireoidismo; osteodistrofia renal em pacientes com insufici&#234;ncia renal cr&#244;nica, em especial aqueles submetidos &#224; hemodi&#225;lise; raquitismo dependente de vitamina D; raquitismo hipofosfat&#234;mico resistente &#224; vitamina D.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 96,
        "lactation_text": "<p>-&#160;<span class=\"TextRun SCXW216929782\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 18.3458px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW216929782\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">Contraindicado.</span></span></p>",
        "last_update": "2019-03-06 16:49:25",
        "name": "Ostriol",
        "presentation": "<ul>\r\n<li><strong>C&#225;psula de gelatina mole:</strong> 0,25 mcg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Ostriol",
        "substance": "Calcitriol",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o estabelecido. Aten&#231;&#227;o com PTH e doen&#231;a &#243;ssea adin&#226;mica.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Astenia, cefaleia, sonol&#234;ncia, n&#225;usea, v&#244;mito, secura na boca, constipa&#231;&#227;o, mialgia, dor &#243;ssea, disgeusia, falta de apetite, dor abdominal e dispepsia, infec&#231;&#227;o no trato urin&#225;rio.</p>\r\n<p style=\"text-align: justify;\">- Poli&#250;ria, polidipsia, falta de apetite, perda de peso, noct&#250;ria, dep&#243;sitos de c&#225;lcio nas conjuntivas, pancreatite, fotofobia, rinorreia, prurido, hipertermia, diminui&#231;&#227;o da libido, eleva&#231;&#227;o da ureia sangu&#237;nea, albumin&#250;ria, hipercolesterolemia, eleva&#231;&#227;o da aspartato aminotransferase e alanina aminotransferase, calcinose , hipertens&#227;o, arritmias card&#237;acas, fraqueza muscular, parestesia, desidrata&#231;&#227;o, apatia, infec&#231;&#245;es do trato urin&#225;rio e, raramente, psicose manifesta.</p>\r\n</div>"
    },
    {
        "content_length": 3731,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula</p>\r\n<p>- Hipervitaminose A e/ou D</p>\r\n<p>- Hipercalcemia</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Osteoporose:</strong> 200UI/dia (acompanhado de ingest&#227;o adequada de c&#225;lcio e vitamina D);</li>\r\n<li style=\"text-align: justify;\"><strong>Dor &#243;ssea associada com oste&#243;lise e/ou osteopenia:</strong> 200-400UI/dia (pode-se administrar at&#233; 200 UI como dose &#250;nica; quando for necess&#225;ria posologia mais alta, esta deve ser dada em doses divididas);</li>\r\n<li style=\"text-align: justify;\"><strong>Doen&#231;a de Paget:</strong> 200UI/dia, em doses &#250;nicas ou em doses divididas. Em alguns casos, podem ser necess&#225;rias 400 UI em doses divididas no in&#237;cio da terapia;</li>\r\n<li style=\"text-align: justify;\"><strong>Distrofia Sintom&#225;tica Reflexa:&#160;</strong>200UI/dia em dose &#250;nica, por um per&#237;odo de 2 - 4 semanas e 200 UI a cada dois dias podem ser administrados a seguir, durante at&#233; 6 semanas, dependendo do progresso cl&#237;nico.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para a faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1688,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">- Osteoporose p&#243;s-menop&#225;usica em pacientes para os quais tratamentos alternativos n&#227;o s&#227;o adequados;</p>\r\n<p style=\"text-align: justify;\">- Dor &#243;ssea associada com oste&#243;lise e/ou osteopenia;</p>\r\n<p style=\"text-align: justify;\">- Doen&#231;a &#243;ssea de Paget (oste&#237;te deformante) apenas em pacientes que n&#227;o respondem a tratamentos alternativos ou para aqueles que esses tratamentos n&#227;o s&#227;o adequados;</p>\r\n<p style=\"text-align: justify;\">- Distrofia Sintom&#225;tica Reflexa (sin&#244;nimo: algodistrofia ou doen&#231;a de Sudeck): decorrentes de diversos fatores etiol&#243;gicos e predisponentes, tais como, osteoporose p&#243;s-traum&#225;tica dolorosa, distrofia reflexa, s&#237;ndrome ombro-bra&#231;o, causalgia, dist&#250;rbios neurodistr&#243;ficos induzidos por medicamentos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 135,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 03:24:43",
        "name": "Seacalcit",
        "presentation": "<div>\r\n<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 200 UI/dose</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Seacalcit",
        "substance": "Calcitonina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;usea, v&#244;mito, tontura, leve rubor facial com sensa&#231;&#227;o de calor, poli&#250;ria, calafrios, anafilaxia, cefaleia, disgeusia, hipertens&#227;o, altera&#231;&#245;es nasais se uso de solu&#231;&#227;o nasal, diarreia, dor abdominal, artralgia, prurido, rash cut&#226;neo.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2930,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula, c&#225;lculos renais de c&#225;lcio, hipercalci&#250;ria, hipercalcemia prim&#225;ria ou secund&#225;ria, intoxica&#231;&#227;o por digit&#225;licos, hipersensibilidade a qualquer componente da f&#243;rmula, sarcoidose.</p>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:&#160;</strong>1 comprimido VO por dia, durante a refei&#231;&#227;o.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Dose usual:</strong>&#160;1 comprimido VO por dia, durante a refei&#231;&#227;o.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1692,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">- Tratamento e preven&#231;&#227;o da osteoporose;</p>\r\n<p style=\"text-align: justify;\">- Complementa&#231;&#227;o das necessidades de c&#225;lcio no organismo, em estados deficientes;&#160; suplemento mineral em dietas restritivas e inadequadas.</p>\r\n<p style=\"text-align: justify;\">- Tratamento de hipocalcemia.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-06 16:45:31",
        "name": "Os-Cal 500",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "OsCal",
        "substance": "Carbonato de Cálcio",
        "trade_names": "",
        "warnings": "<div>\r\n<p>-&#160;<strong>Ajuste na i</strong><strong>nsufici&#234;ncia Renal:&#160;</strong>na&#160;insufici&#234;ncia renal cr&#244;nica ou na presen&#231;a de qualquer outra doen&#231;a renal, ou quando h&#225; propens&#227;o &#224; forma&#231;&#227;o de c&#225;lculos renais, &#233; necess&#225;ria a monitora&#231;&#227;o da excre&#231;&#227;o de c&#225;lcio na urina e, se preciso, a dose deve ser reduzida ou a terap&#234;utica com c&#225;lcio deve ser interrompida.&#160;</p>\r\n<p>-<strong> Ajuste na i</strong><strong>nsufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Hipercalcemia, constipa&#231;&#227;o, n&#225;usea, v&#244;mito, diarreia, dor abdominal.</p>\r\n</div>"
    },
    {
        "content_length": 1842,
        "contraindications": "<p>- Hipersensibilidade a qualquer um dos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> Aplicar 1 a 2 gotas nos olhos, tantas vezes quantas necess&#225;rias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "id": 1697,
        "indications": "<p>- Lubrificante e protetor ocular para al&#237;vio de ard&#234;ncia, irrita&#231;&#227;o, secura e desconforto ocular.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 6,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 00:53:04",
        "name": "Endura",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o t&#243;pica (col&#237;rio):&#160;</strong>Glicerina + Polissorbato 80 + Carb&#244;mer + &#211;leo de r&#237;cino + Manitol + Hidr&#243;xido de s&#243;dio + &#193;gua purificada.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "endura-lubrificante-ocular",
        "substance": "Glicerina + Soluções",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Turva&#231;&#227;o visual tempor&#225;ria ap&#243;s a instila&#231;&#227;o, devido &#224; sua viscosidade. Outros eventos adversos que podem ocorrer s&#227;o: sensa&#231;&#227;o de pontadas nos olhos, ardor, irrita&#231;&#227;o e vermelhid&#227;o ocular, vis&#227;o turva ou sensibilidade &#224; luz.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2094,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Obstru&#231;&#227;o do TGI,&#160; n&#225;useas, v&#244;mitos e dor abdominal sem causa definida, pacientes acamados, crian&#231;as menores que 6 anos.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li>15-45 ml, VO, divididos em at&#233; 2 doses (dose m&#225;xima: 150 mL/dia).</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Crian&#231;as &gt;6 anos:</strong></p>\r\n<ul>\r\n<li>5-20 ml, VO, divididos em at&#233; 2 doses.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1700,
        "indications": "<p>- Constipa&#231;&#227;o intestinal, prepara&#231;&#227;o para exames diagn&#243;sticos e pr&#233;-operat&#243;rios.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 15,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-05 02:17:50",
        "name": "Óleo mineral",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (oleo):</strong> 100ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "oleo-mineral",
        "substance": "Óleo mineral",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Pneumonite lip&#237;dica (aspira&#231;&#227;o), incontin&#234;ncia anal, prurido anal, v&#244;mitos, diarreia, dor abdominal, n&#225;useas.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 10300,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos sais de ferro ou a qualquer um dos componentes do produto;</p>\r\n<p>- Todas as anemias n&#227;o ferrop&#234;nicas, particularmente aquelas causadas por ac&#250;mulo de ferro ou incapacidade de sua utiliza&#231;&#227;o, tais como hemocromatose, hemosiderose, anemia falciforme, anemia hemol&#237;tica ou anemia megalobl&#225;stica devida a defici&#234;ncia de vitamina B12, anemia provocada pelo chumbo, anemia s&#237;dero-acr&#233;stica, talassemia, anemia por tumores ou infec&#231;&#245;es (sem defici&#234;ncia de ferro), anemias associadas &#224; leucemia aguda ou cr&#244;nica e hepatopatia aguda;</p>\r\n<p>- Processos que impedem a absor&#231;&#227;o de ferro por via oral, como diarreias cr&#244;nicas e retocolite ulcerativa.&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Observa&#231;&#245;es iniciais:</strong></p>\r\n<ul>\r\n<li>1 comprimido = 100 mg de ferro elementar</li>\r\n<li>10 ml do xarope = 100 mg de ferro elementar&#160;</li>\r\n<li>A dose e a dura&#231;&#227;o da terapia dependem da extens&#227;o da defici&#234;ncia de ferro.</li>\r\n<li>Deve ser administrado durante ou imediatamente ap&#243;s as refei&#231;&#245;es.</li>\r\n<li>Para facilitar a administra&#231;&#227;o, a dose pode ser misturada com mingau, sucos de fruta ou verduras ou leite.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Tratamento da anemia:</strong></p>\r\n<ul>\r\n<li>10 a 30 ml de xarope/dia divididos 1 a 3x/dia, ou 1 comprimido mastig&#225;vel 1 a 3x/dia, ou 40 a 120 gotas/dia divididos 1 a 3x/dia.</li>\r\n<li>Tratamento por 3 a 5 meses, at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 1 comprimido 1x/dia&#160;por v&#225;rias semanas (2 a 3 meses) a fim de restaurar a reserva de ferro.</li>\r\n</ul>\r\n<p><strong>Profilaxia da anemia:</strong></p>\r\n<ul>\r\n<li>5 a 10 ml do xarope 1x/dia, ou 1 comprimido mastig&#225;vel 1x/dia, ou 20 a 40 gotas 1x/dia, por 1 a 2 meses.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Mulheres gr&#225;vidas:</strong></p>\r\n<ul>\r\n<li><strong>Tratamento:</strong> 20 a 30 ml do xarope/dia 2 a 3x/dia, ou 1 comprimido mastig&#225;vel 2 a 3x/dia, ou 80 a 120 gotas/dia divididos&#160;2 a 3x/dia,&#160;&#160;at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 1 comprimido 1x/dia&#160;pelo menos at&#233; o final da gravidez a fim de restaurar a reserva de ferro.</li>\r\n<li><strong>Profilaxia:</strong> 10 ml do xarope 1x/dia, ou 1 comprimido mastig&#225;vel 1x/dia, ou 40 gotas 1x/dia.&#160;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Uso parenteral:</strong></p>\r\n<p>Em casos de anemia ferrop&#234;nica grave ou de necessidade elevada de ferro, as doses podem ser aumentadas a crit&#233;rio m&#233;dico, ou haver necessidade de Noripurum&#174; parenteral (IM ou EV) como tratamento inicial.</p>\r\n<p>Fique atento pois existem medica&#231;&#245;es e posologias diferentes para apresenta&#231;&#245;es IV e IM.</p>\r\n<ul>\r\n<li><strong>Posologia m&#233;dia recomendada:</strong> 1 ampola/dia&#160;</li>\r\n</ul>\r\n<p><span style=\"text-decoration: underline;\">C&#225;lculo da dose:</span></p>\r\n<p>A posologia do Noripurum&#174; IM dever&#225; ser determinada individualmente, conforme a necessidade total de ferro, levando-se em conta tr&#234;s fatores:</p>\r\n<p><strong>1)</strong> grau de defici&#234;ncia de ferro, d&#233;ficit total de ferro em mg;</p>\r\n<p><strong>2)</strong> peso do paciente em kg;</p>\r\n<p><strong>3)</strong> reserva de ferro necess&#225;ria.</p>\r\n<p>Pode-se encontrar a dose total (em mg) para um tratamento completo por meio da seguinte f&#243;rmula:</p>\r\n<p><strong>Defici&#234;ncia total em ferro (mg) =</strong> [peso (kg) x DHb (g/ dl) x 2,4] + reservas de Fe (mg)</p>\r\n<p>onde DHb = diferen&#231;a entre a hemoglobina ideal para o sexo e a idade do paciente e a hemoglobina encontrada no exame laboratorial do paciente (em g/dl).</p>\r\n<table style=\"height: 74px; margin-left: auto; margin-right: auto;\" border=\"3\" width=\"605\">\r\n<tbody>\r\n<tr>\r\n<td style=\"width: 194px;\">&#160;</td>\r\n<td style=\"width: 194px;\"><strong>Valores m&#233;dios de hemoglobina desejados</strong></td>\r\n<td style=\"width: 195px;\"><strong>Reservas de ferro desejadas</strong></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 194px;\"><strong>&lt; 35 kg de peso corporal</strong></td>\r\n<td style=\"width: 194px;\">13,0 g/ dl</td>\r\n<td style=\"width: 195px;\">15 mg/kg</td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 194px;\"><strong>&#8805;&#160;35 kg de peso corporal</strong></td>\r\n<td style=\"width: 194px;\">15,0 g/ dl&#160;</td>\r\n<td style=\"width: 195px;\">500 mg</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p style=\"text-align: center;\">dada a resposta...</p>\r\n<p><strong>N&#186; total de ampolas administradas (apresenta&#231;&#227;o IM) =</strong> Defici&#234;ncia Total em Ferro (mg) / 100 mg</p>\r\n<p><strong>N&#186; total de mL administrados (apresenta&#231;&#227;o IV) =&#160;</strong>Defici&#234;ncia Total em Ferro (mg) /&#160;20 mg/ml</p>\r\n<p style=\"text-align: center;\">Posologia <strong>MACETEADA&#160;</strong>para apresenta&#231;&#227;o <strong>IM</strong></p>\r\n<p><img style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"https://appsosplantao.com.br/media/noripurum-min.jpg\" alt=\"\" width=\"654\" height=\"298\"></p>\r\n<p style=\"text-align: center;\"><span style=\"text-align: center;\">Posologia&#160;</span><strong style=\"text-align: center;\">MACETEADA&#160;</strong><span style=\"text-align: center;\">para apresenta&#231;&#227;o&#160;</span><strong style=\"text-align: center;\">IV</strong></p>\r\n<p style=\"text-align: center;\"><strong style=\"text-align: center;\"><img src=\"https://appsosplantao.com.br/media/noripurum_iv-min.jpg\" alt=\"\" width=\"657\" height=\"298\"></strong></p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Prematuros, lactentes e crian&#231;as de at&#233; um ano:</strong></p>\r\n<ul>\r\n<li>Dose m&#233;dia de 2,5 a 5,0 mg por kg de peso.</li>\r\n<li>Para defici&#234;ncia de ferro manifesta sugere-se a dose de 2,5 a 5 ml de xarope ao dia ou 1-2 gotas / kg peso corporal, por 3 a 5 meses.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Crian&#231;as de 1 a 12 anos:</strong></p>\r\n<ul>\r\n<li><strong>Profilaxia:</strong>&#160; 2,5 a 5 ml&#160;do xarope 1x/dia, ou 10-20&#160;gotas 1x/dia.</li>\r\n<li><strong>Tratamento:</strong>&#160;5 a 10&#160;ml de xarope 1x/dia, ou 20-40&#160;gotas 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Crian&#231;as &gt; 12 anos:</strong></p>\r\n<ul>\r\n<li>Posologia idem adultos.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Comprimidos mastig&#225;veis:</strong></p>\r\n<ul>\r\n<li>1 comprimido mastig&#225;vel 1x/dia.</li>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 14.98px;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</span></li>\r\n</ul>\r\n<hr>\r\n<p><strong>Uso parenteral:</strong></p>\r\n<p>Dose di&#225;ria m&#225;xima tolerada:</p>\r\n<ul>\r\n<li>&lt; 5 kg: 1/4 de ampola IM (0,5 ml = 25 mg de ferro)</li>\r\n<li>5 a 10 kg: 1/2 ampola IM (1,0 ml = 50 mg de ferro)</li>\r\n<li>10 a 45 kg: 1 ampola IM (2,0 ml = 100 mg de ferro)</li>\r\n</ul>\r\n<p style=\"text-align: center;\"><span style=\"text-align: center;\">Posologia&#160;</span><strong style=\"text-align: center;\">MACETEADA </strong>para apresenta&#231;&#227;o <strong>IM</strong></p>\r\n<p style=\"text-align: center;\"><strong style=\"text-align: center;\"><img src=\"https://appsosplantao.com.br/media/noripurum-min.jpg\" alt=\"\" width=\"654\" height=\"298\"></strong></p>\r\n<p style=\"text-align: center;\">Posologia&#160;<strong>MACETEADA&#160;</strong>para apresenta&#231;&#227;o&#160;<strong>IV</strong></p>\r\n<p style=\"text-align: center;\"><strong><img src=\"https://appsosplantao.com.br/media/noripurum_iv-min.jpg\" alt=\"\" width=\"657\" height=\"298\"></strong></p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1718,
        "indications": "<div>\r\n<p>- S&#237;ndromes ferrop&#234;nicas latentes e moderadas;</p>\r\n<p>- Anemias ferroprivas devidas a subnutri&#231;&#227;o e/ou car&#234;ncias alimentares qualitativas e quantitativas;</p>\r\n<p>- Anemias das s&#237;ndromes disabsortivas intestinais;</p>\r\n<p>- Anemia ferropriva da gravidez e da lacta&#231;&#227;o;</p>\r\n<p>- Anemia por hemorragias agudas ou cr&#244;nicas e em condi&#231;&#245;es nas quais seja conveniente uma suplementa&#231;&#227;o dos fatores hematog&#234;nicos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:55:39",
        "name": "Noripurum",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 10 mg/ml.</li>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 50 mg/ml.</li>\r\n<li><strong>Comprimido mastig&#225;vel:</strong> 100 mg.</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel IM:</strong> 100 mg/2ml.</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel IV:</strong>&#160;100 mg/5ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Ferripolimaltose",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Rea&#231;&#227;o muito comum: fezes escurecidas;</p>\r\n<p>- Rea&#231;&#227;o comum: diarreia, n&#225;useas, dor abdominal , constipa&#231;&#227;o;</p>\r\n<p>- Rea&#231;&#227;o incomum: v&#244;mitos , escurecimento de dente, gastrite, rash (exantema, erup&#231;&#227;o cut&#226;nea, rash cut&#226;neo), urtic&#225;ria, prurido, eritema, cefaleia;</p>\r\n<p>- Rea&#231;&#227;o rara: espasmos musculares, mialgia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3650,
        "contraindications": "<div>\r\n<p>- Sensibilidade a qualquer componente da f&#243;rmula ou a outros medicamentos derivados da sulfonamida;</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o;</p>\r\n<p>- Coadministra&#231;&#227;o do alisquireno em pacientes com diabetes.</p>\r\n<p>- Pacientes com insufici&#234;ncia renal grave (ClCr &lt;30 mL/min) ou com an&#250;ria.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> Olmesartana 20mg + Hidroclorotiazida 12,5mg/dia em dose &#250;nica di&#225;ria;</li>\r\n<li>Ajustes a cada duas a quatro semanas;</li>\r\n<li><strong>Dose m&#225;xima:</strong> Olmesartana 40mg + Hidroclorotiazida 50mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\"><span style=\"text-decoration: underline;\">1&#186; trimestre</span> -&#160;<strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>\r\n<p><span style=\"text-decoration: underline;\">2&#186; e 3&#186; trimestres</span> -&#160;<strong>Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "id": 1724,
        "indications": "<p>- Hipertens&#227;o arterial essencial (prim&#225;ria) inadequadamente controlada em monoterapia.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">-&#160;</strong>Contraindicado.</p>",
        "last_update": "2019-03-06 16:25:50",
        "name": "Olmesartana + Hidroclorotiazida",
        "presentation": "<ul>\r\n<li><strong>Comprimido</strong>: Olmesartana/Hidroclorotiazida 20mg/12,5mg; 40mg/12,5mg; 40mg/25mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "olmesartana-medoxomila",
        "substance": "Olmesartana + Hidroclorotiazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Tontura, hiperuricemia, s&#237;ncope, palpita&#231;&#245;es, fadiga, fraqueza, hipotens&#227;o postural, hipotens&#227;o, erup&#231;&#227;o cut&#226;nea, eczema, cefaleia, hiperglicemia, hipertrigliceridemia, hiperlipidemia, diarreia, dorsalgia, aumento da CPK, hemat&#250;ria, bronquite, faringite, rinite, sinusite, s&#237;ndrome gripal, tosse, altera&#231;&#245;es dos n&#237;veis s&#233;ricos de pot&#225;ssio e c&#225;lcio, edema angioneur&#243;tico, insufici&#234;ncia renal aguda, aumento dos n&#237;veis de creatinina s&#233;rica, fotossensibilidade, urtic&#225;ria.</p>\r\n<p>&#160;</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Insufici&#234;ncia renal (ClCr&gt;30ml/min):&#160;N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica:&#160;N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2444,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula</p>\r\n<p>- Menores de 2 anos</p>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 2 comprimidos VO, repetindo a dose 10 dias depois.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose usual (7 a 12 anos):</strong> 1 comprimido VO ou 20mL da suspens&#227;o oral, repetir 10 dias ap&#243;s a primeira dose</li>\r\n<li><strong>Dose usual (2 a 6 anos):</strong> 10 mL VO, repetir 10 dias ap&#243;s a primeira dose</li>\r\n<li><strong>Dose usual (&gt; 12 anos):</strong>&#160;2 comprimidos VO, repetindo a dose 10 dias depois</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1730,
        "indications": "<div><p>- Tratamento da estrongiloid&#237;ase, tanto as formas cr&#244;nica, disseminada ou refrat&#225;ria a tratamento com tiabendazol.</p>\r\n<p>- A&#231;&#227;o anti-helm&#237;ntica de amplo espectro, atingindo as parasitoses causadas por <em>Ancylostoma brasiliense </em>(Larva migrans), <em>Ancylostoma caninum, Toxocara canis, Toxocara cati </em>e principalmente o<em> Strongyloides stercoralis. </em></p></div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 90,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-12-09 00:18:28",
        "name": "Cambem",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 180 mg</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 6 mg/mL&#160;</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cambem",
        "substance": "Cambendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Dor abdominal, dor epig&#225;strica, n&#225;useas, diarr&#233;ia, v&#244;mitos, obstru&#231;&#227;o intestinal, flatul&#234;ncia, anorexia, tontura, cefal&#233;ia, astenia, sonol&#234;ncia.</p>\r\n</div>"
    },
    {
        "content_length": 3738,
        "contraindications": "<div>\r\n<p>- Sensibilidade a qualquer componente da f&#243;rmula ou a outros medicamentos derivados da sulfonamida.</p>\r\n<p>- Gesta&#231;&#227;o.</p>\r\n<p>- Coadministra&#231;&#227;o do alisquireno em pacientes com diabetes.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> Olmesartana 20mg + Anlodipino 5mg/dia em dose &#250;nica di&#225;ria.</li>\r\n<li>Ajustes a cada duas semanas.</li>\r\n<li><strong>Dose m&#225;xima:</strong> Olmesartana 40mg + Anlodipino 10mg/dia em dose &#250;nica di&#225;ria.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><span style=\"text-decoration: underline;\">1&#186; trimestre</span> -&#160;<strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</li>\r\n<li><span style=\"text-decoration: underline;\">2o e 3o trimestres</span> -&#160;<strong>Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</li>\r\n</ul>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "id": 1731,
        "indications": "<p>- Hipertens&#227;o arterial essencial (prim&#225;ria) inadequadamente controlada em monoterapia.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<ul>\r\n<li class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Alto risco:</span></strong><span style=\"line-height: 107%;\"> Uso inseguro. Avaliar alternativas mais seguras.</span></li>\r\n</ul>",
        "last_update": "2019-03-05 02:18:53",
        "name": "Olmesartana + Anlodipino",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> Olmesartana/Anlodipino 20mg/5mg; 40mg/5mg; 40mg/10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "olmesartana-medoxomila",
        "substance": "Olmesartana + Anlodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, tontura, fadiga, edema,&#160;hipotens&#227;o, hipotens&#227;o ortost&#225;tica, rash, palpita&#231;&#227;o, aumento da frequ&#234;ncia urin&#225;ria, noct&#250;ria, rubor facial, icter&#237;cia, eleva&#231;&#227;o das enzimas hep&#225;ticas, ginecomastia,&#160;dor abdominal, n&#225;useas, v&#244;mitos, diarreia, aumento das enzimas hep&#225;ticas, enteropatia semelhante &#224; doen&#231;a cel&#237;aca, tosse, insufici&#234;ncia renal aguda, aumento dos n&#237;veis de creatinina s&#233;rica, exantema, prurido, edema angioneur&#243;tico, edema perif&#233;rico, cefaleia, hiperpotassemia, mialgia, astenia, letargia, indisposi&#231;&#227;o e rea&#231;&#227;o anafil&#225;tica.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Insufici&#234;ncia renal grave (ClCr &lt;30 ml/min): Iniciar com dose inferior.</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica grave: N&#227;o &#233; recomendado.</p>\r\n</div>"
    },
    {
        "content_length": 3164,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade ao cambendazol, mebendazol ou a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Crian&#231;as menores de 2 anos de idade.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 1 comprimido VO de 12/12h ou 15mL da suspens&#227;o oral VO de 12/12h</li>\r\n<li>Ap&#243;s tr&#234;s semanas do t&#233;rmino do tratamento, o paciente deve realizar exame laboratorial de fezes. Se houver resultado positivo, o tratamento deve ser repetido.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose usual (2 a 6 anos):</strong> 5mL da suspens&#227;o oral VO de 12/12h</li>\r\n<li><strong>Dose usual (7 a 12 anos):</strong>&#160;01 comprimido VO ao dia ou 7,5mL da suspens&#227;o oral de 12/12h</li>\r\n<li>Ap&#243;s tr&#234;s semanas do t&#233;rmino do tratamento, o paciente deve realizar exame laboratorial de fezes. Se houver resultado positivo, o tratamento deve ser repetido.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1734,
        "indications": "<p>- Tratamento de v&#225;rias parasitoses intestinais, como ancilostom&#237;ase, necator&#237;ase, oxiur&#237;ase, tricur&#237;ase, ascar&#237;ase, ten&#237;ase e estrongiloid&#237;ase incluindo as formas cr&#244;nicas e disseminadas.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 90,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 17:37:50",
        "name": "Exelmin",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 75 mg de cambendazol + 200mg de mebendazol</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 5 mg/mL de cambendazol + 13,33 mg/mL de mebendazol</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Exelmin",
        "substance": "Cambendazol + Mebendazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Dor abdominal, dor epig&#225;strica, n&#225;useas, diarr&#233;ia, v&#244;mitos, obstru&#231;&#227;o intestinal, flatul&#234;ncia, anorexia, solu&#231;os, tontura, cefaleia, convuls&#245;es, astenia, febre, sonol&#234;ncia, letargia, neutropenia, agranulocitose,&#160;eleva&#231;&#227;o das transaminases hep&#225;ticas (TGO e TGP), aumento da fosfatase alcalina, aumento da bilirrubina, hepatite, hipotens&#227;o, cilindr&#250;ria, tontura, eritema, prurido, n&#243;dulo cut&#226;neo, urtic&#225;ria, bolhas na pele, diarreia, n&#225;usea, v&#244;mitos, dor abdominal, tosse.</p>\r\n</div>"
    },
    {
        "content_length": 2874,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong> 100 mg ou 300 mg VO 1x ao dia de prefer&#234;ncia antes da primeira refei&#231;&#227;o do dia</li>\r\n<li style=\"text-align: justify;\">Somente considerar 300 mg como dose inicial se paciente com ClCr &#8805;60 ml/min. No caso de paciente fazendo uso de diur&#233;tico de al&#231;a ou &#8805;75 anos administrar 100 mg como dose inicial</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para a faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1737,
        "indications": "<p style=\"text-align: justify;\">- Monoterapia ou terapia combinada como um adjuvante &#224; dieta e ao exerc&#237;cio para melhorar o controle glic&#234;mico em adultos com diabetes mellitus tipo 2</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 20:59:09",
        "name": "Invokana",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 100 mg e 300 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "invokana",
        "substance": "Canagliflozina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Recomenda-se monitoramento mais frequente da fun&#231;&#227;o renal em pacientes com uma ClCr &lt; 60 mL/min</p>\r\n<p>- N&#227;o deve ser usado em pacientes com um ClCr &lt; 45 mL/min.</p>\r\n<p>-&#160;Deve-se realizar o monitoramento de LDL-C</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Constipa&#231;&#227;o,&#160;N&#225;usea,&#160;Sede,&#160;Poli&#250;ria ou polaci&#250;ria,&#160;Infec&#231;&#227;o do trato urin&#225;rio,&#160;Balanite ou balanopostite,&#160;Candid&#237;ase vulvovaginal,&#160;Amputa&#231;&#227;o de membros inferiores em pacientes com pelo menos dois fatores para doen&#231;a cardiovascular,&#160;Rea&#231;&#245;es Anafil&#225;ticas,&#160;Angioedema,&#160;Pielonefrite,&#160;Insufici&#234;ncia renal (relacionada &#224; diminui&#231;&#227;o de volume), sepse urin&#225;ria.</p>\r\n<p>-&#160;Existe um risco aumentado de cetoacidose diab&#233;tica em pacientes com diabetes mellitus tipo 1</p>\r\n</div>"
    },
    {
        "content_length": 5304,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade confirmada &#224; subst&#226;ncia ativa ou a qualquer um dos excipientes</p>\r\n<p style=\"text-align: justify;\">- Menores de 2 anos de idade</p>\r\n<p style=\"text-align: justify;\">- O tratamento n&#227;o deve ser iniciado ou continuado em pacientes com infec&#231;&#227;o ativa</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>CAPS:</strong> iniciar com 150mg SC a cada 8 semanas -&gt; sem resposta ap&#243;s 7 dias (resolu&#231;&#227;o da erup&#231;&#227;o cut&#226;nea e outros sintomas de inflama&#231;&#227;o generalizada) -&gt; dose adicional de 150 mg ou 2 mg/kg -&gt; se uma resposta completa ao tratamento for alcan&#231;ada, o regime de manuten&#231;&#227;o da dose &#233; 300 mg ou 4 mg/kg a cada 8 semanas, por&#233;m, se n&#227;o houver resposta cl&#237;nica satisfat&#243;ria em 7 dias -&gt; dose adicional de 300 mg ou 4 mg/kg -&gt; se uma resposta completa ao tratamento for alcan&#231;ada, o regime de manuten&#231;&#227;o &#233; com uma dose de&#160;600 mg ou 8 mg/kg a cada 8 semanas.</li>\r\n<li style=\"text-align: justify;\"><strong>TRAPS/HIDS/MKD/FMF:</strong>&#160;dose inicial de 150mg SC&#160; de quatro em quatro semanas -&gt; sem resposta ap&#243;s 7 dias -&gt; dose adicional de&#160;150mg ou 2 mg/kg -&gt; resposta adequada ao tratamento -&gt; manuten&#231;&#227;o com 300mg ou 4mg/kg a cada 4 semanas deve ser mantido.</li>\r\n<li style=\"text-align: justify;\"><strong>AIJS:&#160;</strong>4mg/kg SC (at&#233; o m&#225;ximo de 300 mg) administrado a cada quatro semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong>CAPS: </strong>dose inicial em&#160;crian&#231;as de 4 anos de idade ou mais: 150mg para pacientes com peso corporal -&gt; 40 kg; 2 mg/kg com peso corporal &#8805; 15 kg e &#8804; 40 kg; 4 mg/kg com peso corporal &#8805; 7,5 kg e &lt; 15 kg.</li>\r\n<li style=\"text-align: justify;\"><strong>TRAPS/HIDS/MKD/FMF:</strong>&#160;dose inicial de 2 mg/kg SC&#160;com peso corporal &#8804; 40kg de quatro em quatro semanas -&gt; sem resposta ap&#243;s 7 dias -&gt; dose adicional 2mg/kg -&gt; resposta adequada ao tratamento -&gt; manuten&#231;&#227;o com 300mg ou 4mg/kg a cada 4 semanas deve ser mantido.</li>\r\n<li style=\"text-align: justify;\"><strong>AIJS:&#160;</strong>4mg/kg SC se peso cop&#243;reo &#8805; 7,5 kg (at&#233; o m&#225;ximo de 300 mg) administrado a cada quatro semanas.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1738,
        "indications": "<div>\r\n<p>- S&#237;ndromes Peri&#243;dicas Associadas &#224; Criopirina (CAPS): s&#237;ndrome Autoinflamat&#243;ria Familiar desencadeada pelo Frio (FCAS) / Urtic&#225;ria Familiar ao Frio (FCU); S&#237;ndrome de Muckle-Wells (MWS); Doen&#231;a Inflamat&#243;ria Multissist&#234;mica de In&#237;cio Neonatal (NOMID) / S&#237;ndrome cr&#244;nico-infantil-neurol&#243;gica-cut&#226;neoarticular (CINCA).</p>\r\n<p>- S&#237;ndrome Peri&#243;dica Associada ao Receptor do Fator de Necrose Tumoral (TRAPS)&#160;</p>\r\n<p>- S&#237;ndrome da Hiperimunoglobulinemia D (HIDS)/ Defici&#234;ncia da Mevalonato Quinase (MKD)</p>\r\n<p>- Febre Familiar do Mediterr&#226;neo (FMF) (nos quais a colchicina &#233; contraindicada, n&#227;o &#233; tolerada, ou n&#227;o apresenta uma resposta adequada, apesar da maior dose toler&#225;vel de colchicina).</p>\r\n<p>- Artrite Idiop&#225;tica Juvenil Sist&#234;mica (AIJS)</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 20:48:58",
        "name": "Ilaris",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>150 mg</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receitu&#225;rio simples (uso hospitalar).</p>",
        "record_status": 1,
        "slug": "ilaris",
        "substance": "Canaquinumabe",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Infec&#231;&#245;es e infesta&#231;&#245;es Infec&#231;&#227;o (e.x. nasofaringite, sinusite, infec&#231;&#227;o do trato respirat&#243;rio superior, amigdalite, rinite, bronquite, infec&#231;&#227;o no trato urin&#225;rio, infec&#231;&#227;o no ouvido, gastroenterite, faringite, pneumonia, candid&#237;ase vulvovaginal, etc.),&#160;Rea&#231;&#227;o no local da inje&#231;&#227;o,&#160;Tontura/vertigem, Dor abdominal (superior),&#160;Artralgia, Dor musculoesquel&#233;tica, Diminui&#231;&#227;o do clearance (depura&#231;&#227;o) renal de creatinina, Protein&#250;ria, Leucopenia, neutropenia e plaquetopenia.</p>\r\n</div>"
    },
    {
        "content_length": 2015,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose usual:</strong> 1 gota no(s) olho(s) afetado(s), 2x/dia por 6 semanas.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;4 gotas/dia = 0,16 mg olopatadina.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>&gt;3 anos:</strong> Idem a de adultos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<ul>\r\n<li class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</li>\r\n</ul>",
        "id": 1739,
        "indications": "<p>- Conjutivite al&#233;rgica.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 5,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-06 17:09:54",
        "name": "Patanol",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oftalmol&#243;gica:</strong> 1 mg/ml</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "patanol",
        "substance": "Olopatadina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, disgeusia, tontura, ressecamento nasal, ceratite, dor nos olhos, xeroftalmia, edema palpebral, prurido nos olhos, secre&#231;&#227;o ocular, hiperemia e desconforto nos olhos, fotofobia, turva&#231;&#227;o visual, dermatite de contato e fadiga, xerostomia, n&#225;useas.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3358,
        "contraindications": "<p>- Hipersensibilidade a qualquer componente da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>IgE &#8805; 30-100 UI/ml:</strong>&#160;20-40 kg: 75 mg; 40-90 kg: 150 mg; &gt; 90-150 kg: 300 mg, a cada 4 semanas.</li>\r\n<li><strong>IgE &#8805; 100-200 UI/ml:</strong>&#160;20-40 kg:150 mg; 40-90 kg: 300 mg, &gt; 90-125 kg: 450 mg; 125-150 kg: 600 mg a cada 4 semanas.</li>\r\n<li><strong>IgE &#8805; 200-300 UI/ml:</strong>&#160;20-30 kg: 150 mg; 30-40 kg: 225 mg; 40-60 kg: 300 mg; 60-90 kg: 450 mg, a cada 4 semanas; 125-150 kg: 375 mg, a cada 2 semanas.</li>\r\n<li><strong>IgE &#8805; 300-400 UI/ml:</strong>&#160;20-30 kg: 225 mg; 30-40 kg: 300 mg; 40-70 kg: 450 mg; 70-90: 600 mg, a cada 4 semanas; &gt; 90-125 kg: 400 mg; 125-150 kg:525 mg, a cada 2 semanas.</li>\r\n<li><strong>IgE &#8805; 400-500 UI/ml:</strong>&#160;20-25 kg: 225 mg; 25-30 kg: 300 mg; 30-50 kg: 450 mg; 50-70 kg: 600 mg,&#160;a cada 4 semanas;&#160; 70-90 kg: 375 mg; 90-125 kg:525 mg; 125-150 kg: 600mg, a cada 2 semanas;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos no tratamento de asma al&#233;rgica.</li>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos no tratamento de urtic&#225;ria cr&#244;nica espont&#226;nea.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1742,
        "indications": "<div>\r\n<p>- Tratamento da asma al&#233;rgica persistente , moderada a grave, n&#227;o controlada com corticoides inalat&#243;rios, para pacientes &gt;6 anos de idade;</p>\r\n<p>- Terapia adicional para uso adulto e pedi&#225;trico (acima de 12 anos de idade) em pacientes com urtic&#225;ria cr&#244;nica espont&#226;nea refrat&#225;ria ao tratamento com anti-histam&#237;nicos H1.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-10 14:48:18",
        "name": "Xolair",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 150 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples (restrito a hospitais).</p>",
        "record_status": 1,
        "slug": "xolair",
        "substance": "Omalizumabe",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, rea&#231;&#227;o no local da inje&#231;&#227;o, infec&#231;&#227;o do trato respirat&#243;rio superior, sinusite, faringite e infec&#231;&#227;o viral, fadiga, tontura, dermatite, prurido e artralgia, alopecia, anafilaxia, forma&#231;&#227;o de anticorpos contra o omalizumabe, trombocitopenia, edema de l&#237;ngua e urtic&#225;ria, infec&#231;&#245;es parasit&#225;rias, hipotens&#227;o postural, rubor, n&#225;usea, diarreia, ganho de peso.</p>\r\n<hr>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3659,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade &#224; candesartana ou a qualquer componente da f&#243;rmula;</p>\r\n<p style=\"text-align: justify;\">- Durante a gravidez e lacta&#231;&#227;o;</p>\r\n<p style=\"text-align: justify;\">- Altera&#231;&#245;es hep&#225;ticas graves e/ou colestase;</p>\r\n<p style=\"text-align: justify;\">- Pacientes com diabetes mellitus (tipo I ou II)</p>\r\n<p style=\"text-align: justify;\">- Insufici&#234;ncia renal moderada a grave (ClCr &lt; 60mL/min) e que fazem uso de medicamentos contendo alisquireno.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose inicial: </strong>8 mg, 1 vez ao dia.</li>\r\n<li style=\"text-align: justify;\"><strong> Dose de manuten&#231;&#227;o: </strong>8 mg, 1 vez ao dia, podendo ser aumentada para 16 mg, 1 vez ao dia. Pacientes que requerem uma maior redu&#231;&#227;o da press&#227;o sangu&#237;nea, a dose pode ser aumentada para 32 mg, 1 vez ao dia.</li>\r\n<li style=\"text-align: justify;\">O efeito anti-hipertensivo m&#225;ximo &#233; atingido dentro de 4 semanas ap&#243;s o in&#237;cio do tratamento.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para a faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1744,
        "indications": "<p><span style=\"mso-bidi- line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Insufici&#234;ncia card&#237;aca e hipertens&#227;o arterial leve, moderada e grave.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2018-12-09 20:13:49",
        "name": "Atacand",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 8 mg e 16 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Atacand",
        "substance": "Candesartana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- <strong>Insufici&#234;ncia renal:</strong>&#160;ClCr &lt;30mL/min deve-se considerar uma dose inicial de 4 mg.</p>\r\n<p>- <strong>Insufici&#234;ncia hep&#225;tica:</strong>&#160;doen&#231;a hep&#225;tica cr&#244;nica de leve a moderada iniciar com dose de 4 mg.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Aumentos nos n&#237;veis de creatinina, ureia ou pot&#225;ssio e diminui&#231;&#227;o nos n&#237;veis de s&#243;dio; hipotens&#227;o, hipercalemia, insufici&#234;ncia renal,&#160; leucopenia, neutropenia e agranulocitose,&#160;tontura,&#160;tosse,&#160;aumento das enzimas hep&#225;ticas, fun&#231;&#227;o hep&#225;tica alterada ou hepatite,&#160;angioedema, exantema, urtic&#225;ria e prurido,&#160;dor lombar.</p>\r\n</div>"
    },
    {
        "content_length": 2075,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a macitentana;</p>\r\n<p>- Gravidez;</p>\r\n<p>- Amamenta&#231;&#227;o;</p>\r\n<p>- Doentes com doen&#231;a hep&#225;tica moderada ou grave;</p>\r\n<p>- Valores basais das aminotransferases hep&#225;ticas - aspartato aminotransferase (AST) e/ou alanina</p>\r\n<p>aminotransferase (ALT) &gt; 3 &#215; o normal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mg VO 1x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Contraindicado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1753,
        "indications": "<ul>\r\n<li>Hipertens&#227;o arterial pulmonar em adultos, classe funcional II e III; tratamento de longo prazo.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 188,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-06 16:38:28",
        "name": "Opsumit",
        "presentation": "<ul>\r\n<li>Comprimidos de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "opsumit",
        "substance": "Macitentana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Aumento de transaminases hep&#225;ticas;</p>\r\n<p>- Redu&#231;&#227;o da hemoglobina;</p>\r\n<p>- Hipotens&#227;o arterial;</p>\r\n<p>- Cuidado em pacientes com intoler&#226;ncia a lactose (presente na formula&#231;&#227;o).</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2026,
        "contraindications": "<div>\r\n<p>- Insufici&#234;ncia renal grave (ClCr &lt; 30mL/min);</p>\r\n<p>- Menores de 12 anos de idade;</p>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>10mL 4-6 vezes ao dia, em caso de sintomas;</li>\r\n<li>Dose m&#225;xima = 80mL/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o deve ser administrado a menores de 12 anos;</li>\r\n<li>Maiores de 12 anos podem usar 10mL 4-6x/dia, guiado por sintomas.</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 1754,
        "indications": "<ul>\r\n<li>Hiperacidez g&#225;strica, azia, esofagite de refluxo, gastrite, &#250;lcera g&#225;strica.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-09 02:47:54",
        "name": "Riopan",
        "presentation": "<ul>\r\n<li>Suspens&#227;o oral - 80mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "riopan",
        "substance": "Magaldrato",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Aumento da incid&#234;ncia de pneumonia.</p>\r\n<hr>\r\n<p><strong>Ajustes em Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o se recomenda o uso em pacientes com insufici&#234;ncia renal.</p>\r\n</div>"
    },
    {
        "content_length": 4295,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>DRGE/esofagite:</strong> 20mg 1x/dia, pela manh&#227;, por 4-8 semanas.</li>\r\n<li><strong>&#218;lcera duodenal:</strong> 20 mg 1x/dia pela manh&#227;, por 2-4 semanas.</li>\r\n<li><strong>&#218;lcera g&#225;strica:</strong> 20 mg/dia, por 4-8 semanas.</li>\r\n<li><strong>Erradica&#231;&#227;o do H. pylori:</strong> esquemas com 20-40 mg/dia em associa&#231;&#245;es com antibioticos espec&#237;ficos</li>\r\n<li><strong>Estados hipersecretores:</strong> dose inicial de 60 mg/dia (caso doses di&#225;rias maiores que 80 mg, deve-se administrar em doses divididas).</li>\r\n<li><strong>Preven&#231;&#227;o de &#250;lcera de estresse:</strong> 10-20 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Crian&#231;as com mais de 1 ano de idade:</strong> 10 mg/dia pela manh&#227; com o aux&#237;lio de l&#237;quido (&#225;gua ou suco de&#160;frutas; mas n&#227;o leite).</li>\r\n<li><strong>Crian&#231;as acima de 20 kg:</strong> 20 mg. Caso a crian&#231;a tenha dificuldade para engolir, as c&#225;psulas podem ser abertas e o seu conte&#250;do&#160;pode ser misturado com l&#237;quido e ingerido imediatamente. Se necess&#225;rio, a dose poder&#225; ser aumentada, at&#233;, no&#160;m&#225;ximo, 40 mg/dia.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1755,
        "indications": "<div>\r\n<p>- &#218;lcera g&#225;strica/duodenal.</p>\r\n<p>- DRGE, esofagite.</p>\r\n<p>- S&#237;ndrome de Zollinger-Ellison ou outros estados hipersecretores.</p>\r\n<p>- Profilaxia de &#250;lcera de estresse.</p>\r\n<p>- Parte do regime de drogas para erradica&#231;&#227;o do<em> H. pylori.</em></p>\r\n<p>- Les&#245;es g&#225;stricas por AINES.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 1,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-06 16:27:38",
        "name": "Omeprazol",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "omeprazol",
        "substance": "Omeprazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, diarreia, constipa&#231;&#227;o, dor abdominal, n&#225;usea, flatul&#234;ncia, v&#244;mito, regurgita&#231;&#227;o, infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, rash, astenia, dor nas costas e tosse,&#160;parestesia, sonol&#234;ncia, ins&#244;nia, vertigem. Aumento das enzimas hep&#225;ticas (alanina, aminotransferase, transaminase-glut&#226;mico-oxalac&#233;tica-s&#233;rica, transpeptidase-gamaglutamil, fosfatase alcalina e bilirrubina), erup&#231;&#227;o ou prurido, urtic&#225;ria, mal-estar,&#160;confus&#227;o mental revers&#237;vel, agita&#231;&#227;o, agressividade, depress&#227;o, alucina&#231;&#245;es (especialmente em estado grave), ginecomastia, xerostomia, trombocitopenia, agranulocitose, pancitopenia,&#160;encefalopatia hep&#225;tica (em pacientes com insufici&#234;ncia hep&#225;tica grave pr&#233;-existente), hepatite com ou sem icter&#237;cia, insufici&#234;ncia hep&#225;tica, artralgia, fraqueza muscular, mialgia, fotossensibilidade, eritema multiforme, s&#237;ndrome de Stevens-Johnson, necr&#243;lise epid&#233;rmica t&#243;xica, alopecia, rea&#231;&#245;es de hipersensibilidade (angioedema, febre, broncoespasmo, nefrite intersticial, choque anafil&#225;tico), aumento da transpira&#231;&#227;o, edema perif&#233;rico, turva&#231;&#227;o da vis&#227;o, altera&#231;&#227;o do paladar, hiponatremia</p>\r\n<hr>\r\n<p><strong>Ajustes:&#160;</strong>N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2059,
        "contraindications": "<div>\r\n<p>- Uso em homens;</p>\r\n<p>- Uso antes da menarca;</p>\r\n<p>- Uso em gestantes ou em mulheres;</p>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Pacientes com suspeita ou diagn&#243;stico de neoplasia de mama;</p>\r\n<p>- Pacientes com hist&#243;ria de dist&#250;rbios tromboemb&#243;licos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>150mg IM em intervalos de 12-13 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1756,
        "indications": "<ul>\r\n<li>Contraceptivo.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-01-13 19:24:05",
        "name": "Depo Provera",
        "presentation": "<ul>\r\n<li>Suspens&#227;o injet&#225;vel com 50mg/1m ou 150mg/1mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "depo-provera",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Reten&#231;&#227;o h&#237;drica;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 3099,
        "contraindications": "<div>\r\n<p>- Presen&#231;a ou hist&#243;rico de tromboflebite, dist&#250;rbios tromboemb&#243;licos e cerebrovasculares;</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica grave;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de &#243;rg&#227;os genitais;</p>\r\n<p>- Sangramento vaginal de causa n&#227;o diagnosticada;</p>\r\n<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de mama;</p>\r\n<p>- Abortamento retido;</p>\r\n<p>- Gesta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Amenorr&#233;ia secund&#225;ria e hemorragia uterina disfuncional:</strong> 10mg/dia VO por 5-10 dias, por 2-3 ciclos consecutivos;</li>\r\n<li><strong>Menopausadas n&#227;o-histerectomizadas (associadas a estr&#243;genos):</strong> 10mg/dia VO por 10-14 dias, a cada 28 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1764,
        "indications": "<ul>\r\n<li>Amenorreia secund&#225;ria;</li>\r\n<li>Sangramento uterino disfuncional devido ao desequil&#237;brio hormonal, na aus&#234;ncia de patologias org&#226;nicas, como mioma ou&#160;carcinoma uterino;</li>\r\n<li>Terapia hormonal em oposi&#231;&#227;o aos efeitos endometriais do estrog&#234;nio em mulheres namenopausa n&#227;o histerectomizadas, como complemento &#224; terapia estrog&#234;nica.&#160;</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-06 18:50:48",
        "name": "Provera",
        "presentation": "<ul>\r\n<li>Comprimidos de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "provera",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefal&#233;ia, n&#225;useas, depress&#227;o, ins&#244;nia, nervosismo, tonteiras;</p>\r\n<p>- Alop&#233;cia, acne, urtic&#225;ria, prurido;</p>\r\n<p>- Aumento de peso, pirexia, fadiga;</p>\r\n<p>- Reten&#231;&#227;o h&#237;drica, hirsutismo, galactorr&#233;ia;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino disfuncional;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 2050,
        "contraindications": "<div>\r\n<p>- Uso em homens;</p>\r\n<p>- Uso antes da menarca;</p>\r\n<p>- Uso em gestantes ou em mulheres;</p>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Pacientes com suspeita ou diagn&#243;stico de neoplasia de mama;</p>\r\n<p>- Pacientes com hist&#243;ria de dist&#250;rbios tromboemb&#243;licos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>150mg IM em intervalos de 12-13 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1766,
        "indications": "<ul>\r\n<li>Contraceptivo.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-01-13 19:24:02",
        "name": "Contracep",
        "presentation": "<ul>\r\n<li>Suspens&#227;o injet&#225;vel com 50mg/1m ou 150mg/1mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "contracep",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Reten&#231;&#227;o h&#237;drica;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 3100,
        "contraindications": "<div>\r\n<p>- Presen&#231;a ou hist&#243;rico de tromboflebite, dist&#250;rbios tromboemb&#243;licos e cerebrovasculares;</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica grave;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de &#243;rg&#227;os genitais;</p>\r\n<p>- Sangramento vaginal de causa n&#227;o diagnosticada;</p>\r\n<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de mama;</p>\r\n<p>- Abortamento retido;</p>\r\n<p>- Gesta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Amenorr&#233;ia secund&#225;ria e hemorragia uterina disfuncional:</strong> 10mg/dia VO por 5-10 dias, por 2-3 ciclos consecutivos;</li>\r\n<li><strong>Menopausadas n&#227;o-histerectomizadas (associadas a estr&#243;genos):</strong> 10mg/dia VO por 10-14 dias, a cada 28 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1768,
        "indications": "<ul>\r\n<li>Amenorreia secund&#225;ria;</li>\r\n<li>Sangramento uterino disfuncional devido ao desequil&#237;brio hormonal, na aus&#234;ncia de patologias org&#226;nicas, como mioma ou&#160;carcinoma uterino;</li>\r\n<li>Terapia hormonal em oposi&#231;&#227;o aos efeitos endometriais do estrog&#234;nio em mulheres namenopausa n&#227;o histerectomizadas, como complemento &#224; terapia estrog&#234;nica.&#160;</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 16:12:21",
        "name": "Acetoflux",
        "presentation": "<ul>\r\n<li>Comprimidos de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "acetoflux",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefal&#233;ia, n&#225;useas, depress&#227;o, ins&#244;nia, nervosismo, tonteiras;</p>\r\n<p>- Alop&#233;cia, acne, urtic&#225;ria, prurido;</p>\r\n<p>- Aumento de peso, pirexia, fadiga;</p>\r\n<p>- Reten&#231;&#227;o h&#237;drica, hirsutismo, galactorr&#233;ia;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino disfuncional;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 2069,
        "contraindications": "<div>\r\n<p>- Uso em homens;</p>\r\n<p>- Uso antes da menarca;</p>\r\n<p>- Uso em gestantes ou em mulheres;</p>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Pacientes com suspeita ou diagn&#243;stico de neoplasia de mama;</p>\r\n<p>- Pacientes com hist&#243;ria de dist&#250;rbios tromboemb&#243;licos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>150mg IM em intervalos de 12-13 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1770,
        "indications": "<ul>\r\n<li>Contraceptivo.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-01-13 19:24:08",
        "name": "Dermerox",
        "presentation": "<ul>\r\n<li>Suspens&#227;o injet&#225;vel com 50mg/1m ou 150mg/1mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dermedrox",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Reten&#231;&#227;o h&#237;drica;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 3101,
        "contraindications": "<div>\r\n<p>- Presen&#231;a ou hist&#243;rico de tromboflebite, dist&#250;rbios tromboemb&#243;licos e cerebrovasculares;</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica grave;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de &#243;rg&#227;os genitais;</p>\r\n<p>- Sangramento vaginal de causa n&#227;o diagnosticada;</p>\r\n<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de mama;</p>\r\n<p>- Abortamento retido;</p>\r\n<p>- Gesta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Amenorr&#233;ia secund&#225;ria e hemorragia uterina disfuncional:</strong> 10mg/dia VO por 5-10 dias, por 2-3 ciclos consecutivos;</li>\r\n<li><strong>Menopausadas n&#227;o-histerectomizadas (associadas a estr&#243;genos):</strong> 10mg/dia VO por 10-14 dias, a cada 28 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1772,
        "indications": "<ul>\r\n<li>Amenorreia secund&#225;ria;</li>\r\n<li>Sangramento uterino disfuncional devido ao desequil&#237;brio hormonal, na aus&#234;ncia de patologias org&#226;nicas, como mioma ou&#160;carcinoma uterino;</li>\r\n<li>Terapia hormonal em oposi&#231;&#227;o aos efeitos endometriais do estrog&#234;nio em mulheres namenopausa n&#227;o histerectomizadas, como complemento &#224; terapia estrog&#234;nica.&#160;</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 17:44:04",
        "name": "Farlutal",
        "presentation": "<ul>\r\n<li>Comprimidos de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "farlutal",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefal&#233;ia, n&#225;useas, depress&#227;o, ins&#244;nia, nervosismo, tonteiras;</p>\r\n<p>- Alop&#233;cia, acne, urtic&#225;ria, prurido;</p>\r\n<p>- Aumento de peso, pirexia, fadiga;</p>\r\n<p>- Reten&#231;&#227;o h&#237;drica, hirsutismo, galactorr&#233;ia;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino disfuncional;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 3108,
        "contraindications": "<div>\r\n<p>- Presen&#231;a ou hist&#243;rico de tromboflebite, dist&#250;rbios tromboemb&#243;licos e cerebrovasculares;</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica grave;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de &#243;rg&#227;os genitais;</p>\r\n<p>- Sangramento vaginal de causa n&#227;o diagnosticada;</p>\r\n<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula;</p>\r\n<p>- Presen&#231;a ou suspeita de doen&#231;a maligna de mama;</p>\r\n<p>- Abortamento retido;</p>\r\n<p>- Gesta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Amenorr&#233;ia secund&#225;ria e hemorragia uterina disfuncional:</strong> 10mg/dia VO por 5-10 dias, por 2-3 ciclos consecutivos;</li>\r\n<li><strong>Menopausadas n&#227;o-histerectomizadas (associadas a estr&#243;genos):</strong> 10mg/dia VO por 10-14 dias, a cada 28 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1773,
        "indications": "<ul>\r\n<li>Amenorreia secund&#225;ria;</li>\r\n<li>Sangramento uterino disfuncional devido ao desequil&#237;brio hormonal, na aus&#234;ncia de patologias org&#226;nicas, como mioma ou&#160;carcinoma uterino;</li>\r\n<li>Terapia hormonal em oposi&#231;&#227;o aos efeitos endometriais do estrog&#234;nio em mulheres namenopausa n&#227;o histerectomizadas, como complemento &#224; terapia estrog&#234;nica.&#160;</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 121,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 16:09:28",
        "name": "Acemedrox",
        "presentation": "<ul>\r\n<li>Comprimidos de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "acemederox",
        "substance": "Medroxiprogesterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefal&#233;ia, n&#225;useas, depress&#227;o, ins&#244;nia, nervosismo, tonteiras;</p>\r\n<p>- Alop&#233;cia, acne, urtic&#225;ria, prurido;</p>\r\n<p>- Aumento de peso, pirexia, fadiga;</p>\r\n<p>- Reten&#231;&#227;o h&#237;drica, hirsutismo, galactorr&#233;ia;</p>\r\n<p>- Diminui&#231;&#227;o da toler&#226;ncia a glicose;</p>\r\n<p>- Aumento do risco de problemas cardiovasculares;</p>\r\n<p>- Sangramento uterino disfuncional;</p>\r\n<p>- Diminui&#231;&#227;o da densidade &#243;ssea.</p>\r\n</div>"
    },
    {
        "content_length": 3029,
        "contraindications": "<div>\r\n<p>- C&#226;ncer de mama, diagnosticado ou suspeito;</p>\r\n<p>- Neoplasia estr&#243;geno-dependente, diagnosticada ou suspeita;</p>\r\n<p>- Gravidez diagnosticada ou suspeita;</p>\r\n<p>- Sangramento genital anormal de causa indeterminada;</p>\r\n<p>- Hist&#243;ria ou presen&#231;a de tromboflebite ou dist&#250;rbios tromboemb&#243;licos ou apoplexia cerebral;</p>\r\n<p>- Doen&#231;a ou disfun&#231;&#227;o hep&#225;tica;</p>\r\n<p>- Hipersensibilidade aos componentes da formula&#231;&#227;o.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>1cp ao dia, sem interrup&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1791,
        "indications": "<ul>\r\n<li>Sintomas vasomotores do climat&#233;rio;</li>\r\n<li>Vaginite atr&#243;fica e uretrite atr&#243;fica;</li>\r\n<li>Osteoporose;</li>\r\n<li>Hipoestrogenismo.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-09 16:24:17",
        "name": "Selecta",
        "presentation": "<ul>\r\n<li>Comprimidos com 1,5mg demedroxiprogesterona + 0,45mg de estr&#243;genos conjugados.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "selecta",
        "substance": "Medroxiprogesterona + Estrógenos",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Tromboflebite, embolia pulmonar, trombose cerebral, trombose retiniana;</p>\r\n<p>- Altera&#231;&#245;es do fluxo menstrual, sangramento intermenstrual, dismenorreia, amenorreia, aumento do tamanho de fibromas uterinos, eros&#245;es cervicais, candid&#237;ase vaginal;</p>\r\n<p>- Hipersensibilidade das mamas, secre&#231;&#227;o mam&#225;ria;</p>\r\n<p>- N&#225;usea, v&#244;mitos, c&#243;licas abdominais, distens&#227;o abdominal, icter&#237;cia;</p>\r\n<p>- Urtic&#225;ria, eritema multiforme, cloasma, eritema nodoso, alopecia, hirsutismo;</p>\r\n<p>- Intoler&#226;ncia a lentes de contato, tontura, enxaqueca, cefaleias, depress&#227;o;</p>\r\n<p>- Edema, altera&#231;&#227;o da libido, altera&#231;&#227;o de peso, fadiga e hipertens&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 1343,
        "contraindications": "<ul>\r\n<li>N&#227;o h&#225; contraindica&#231;&#245;es formais at&#233; o momento.</li>\r\n</ul>",
        "dosage_adults": "<ul>\r\n<li>1cp 1-2h antes da hora de deitar, por no m&#225;ximo 13 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><strong>Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1792,
        "indications": "<ul>\r\n<li>Ins&#244;nia prim&#225;ria.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 19:24:54",
        "name": "Circadin",
        "presentation": "<ul>\r\n<li>Comprimidos de 2mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "circadin",
        "substance": "Melatonina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#227;o h&#225; registro at&#233; o momento.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2464,
        "contraindications": "<div>\r\n<p>- Tumores na gl&#226;ndula hip&#243;fise ou no hipot&#225;lamo;</p>\r\n<p>- Tumores no &#250;tero, ov&#225;rios e mamas;</p>\r\n<p>- Gravidez e lacta&#231;&#227;o;</p>\r\n<p>- Sangramento ginecol&#243;gico de etiologia desconhecida;</p>\r\n<p>- Hipersensibilidade &#224; subst&#226;ncia ativa ou a qualquer um dos excipientes utilizados na formula&#231;&#227;o;</p>\r\n<p>- Aumento dos ov&#225;rios ou cistos que n&#227;o tenham sido causados por s&#237;ndrome de ov&#225;rio polic&#237;stico;</p>\r\n<p>- Fal&#234;ncia prim&#225;ria ovariana;</p>\r\n<p>- Malforma&#231;&#227;o de &#243;rg&#227;os sexuais incompat&#237;veis com a gravidez;</p>\r\n<p>- Tumor fibroide do &#250;tero incompat&#237;vel com a gravidez .</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Mulheres com anovula&#231;&#227;o:</strong> 75-225UI via SC ou IM diariamente, dentro dos primeiros 7 dias do ciclo menstrual, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Contraindicado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><strong>Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1793,
        "indications": "<ul>\r\n<li>Infertilidade em mulheres com insufici&#234;ncia ovariana.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 113,
        "lactation_text": "<p>N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 19:30:27",
        "name": "Menopur",
        "presentation": "<ul>\r\n<li>Solu&#231;&#227;o injet&#225;vel: 75UI, 600UI e 1200UI.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "menopur",
        "substance": "Menotropina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Dor e distens&#227;o abdominal;</p>\r\n<p>- Aumento ovariano;</p>\r\n<p>- Aumento de peso, dispneia, olig&#250;ria;</p>\r\n<p>- Sintomas gastrintestinais incluindo n&#225;usea, v&#244;mito e diarreia;</p>\r\n<p>- Hipovolemia, hemoconcentra&#231;&#227;o, desequil&#237;brio eletrol&#237;tico, ascite, hemoperit&#244;nio, efus&#227;o pleural, hidrot&#243;rax, dor pulmonar aguda e eventos tromboemb&#243;licos.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1729,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes;</p>\r\n<p>- Carcinoma de pr[ostata;</p>\r\n<p>- Hist&#243;ria de tumor hep&#225;tico;</p>\r\n<p>- Mulheres e crian&#231;as.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> 1cp 3x/dia;</li>\r\n<li><strong>Manuten&#231;&#227;o:</strong> 1cp 1-2x/dia;</li>\r\n<li><strong>Hipogonadismo:</strong> 1-2cp VO 3x/dia;</li>\r\n<li><strong>Infertilidade:</strong> 1cp VO 2-3x/dia, por 90 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Contraindicado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><strong>Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1794,
        "indications": "<ul>\r\n<li>Hipogonadismo masculino;</li>\r\n<li>Infertilidade masculina;</li>\r\n<li>Dist&#250;rbios de pot&#234;ncia;</li>\r\n<li>Oligospermia;</li>\r\n<li>Defici&#234;ncia androg&#234;nica.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 18:50:58",
        "name": "Proviron",
        "presentation": "<ul>\r\n<li>Comprimidos de 25mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "proviron",
        "substance": "Mesterolona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Ere&#231;&#227;o frequente ou persistente.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 1952,
        "contraindications": "<p>- Pacientes com hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li>1cp ao dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p><strong>Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.&#160;</p>",
        "id": 1796,
        "indications": "<ul>\r\n<li>Tratamento paliativo do c&#226;ncer de mama avan&#231;ado.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 50,
        "lactation_text": "<p>N&#227;o reomendado.</p>",
        "last_update": "2019-01-13 19:24:47",
        "name": "Megestat",
        "presentation": "<ul>\r\n<li>Comprimidos de 160mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "megestat",
        "substance": "Megestrol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Aumento da trombog&#234;nese;</p>\r\n<p>- Exacerba&#231;&#227;o de diabetes;</p>\r\n<p>- N&#225;useas, v&#244;mitos, diarr&#233;ia;</p>\r\n<p>- Dispn&#233;ia, dor, letargia, erup&#231;&#245;es cut&#226;neas;</p>\r\n<p>- Fogachos, altera&#231;&#227;o do humor, f&#225;cies cushing&#243;ide;</p>\r\n<p>- Exacerba&#231;&#227;o tumoral;</p>\r\n<p>- S&#237;ndrome do t&#250;nel do carpo.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 1954,
        "contraindications": "<p>- Pacientes com hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li>1cp ao dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado em crian&#231;as.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p><strong>Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.&#160;</p>",
        "id": 1797,
        "indications": "<ul>\r\n<li>Tratamento paliativo do c&#226;ncer de mama avan&#231;ado.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 176,
        "lactation_text": "<p>N&#227;o reomendado.</p>",
        "last_update": "2019-03-03 17:51:42",
        "name": "Femigestrol",
        "presentation": "<ul>\r\n<li>Comprimidos de 160mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "megestat",
        "substance": "Megestrol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Aumento da trombog&#234;nese;</p>\r\n<p>- Exacerba&#231;&#227;o de diabetes;</p>\r\n<p>- N&#225;useas, v&#244;mitos, diarr&#233;ia;</p>\r\n<p>- Dispn&#233;ia, dor, letargia, erup&#231;&#245;es cut&#226;neas;</p>\r\n<p>- Fogachos, altera&#231;&#227;o do humor, f&#225;cies cushing&#243;ide;</p>\r\n<p>- Exacerba&#231;&#227;o tumoral;</p>\r\n<p>- S&#237;ndrome do t&#250;nel do carpo.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 1554,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Crian&#231;as ou adolescentes.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>25-50mg VO 1x/dia, pela manh&#227;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudos de seguran&#231;a nesta popula&#231;&#227;o.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1798,
        "indications": "<p>- Tratamento da incontin&#234;ncia urin&#225;ria de urg&#234;ncia / bexiga hiperativa.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 187,
        "lactation_text": "<p>- N&#227;o determinado.</p>",
        "last_update": "2019-03-05 00:47:01",
        "name": "Myrbetric",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;25mg ou 50mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "myrbetric",
        "substance": "Mirabegrona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Infec&#231;&#227;o urin&#225;ria;</p>\r\n<p>- Taquicardia;</p>\r\n<p>- N&#225;usea, diarr&#233;ia, constipa&#231;&#227;o;</p>\r\n<p>- Tonteiras, cefal&#233;ia.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2101,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes;</p>\r\n<p>- Pacientes com hist&#243;ria de melanoma ou carcinoma invasivo de c&#233;luals escamosas;</p>\r\n<p>- Pacientes com afaquia (aus&#234;ncia de cristalino).</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Vitiligo:</strong> 1-2 c&#225;psulas, 1-1,5 horas antes da exposi&#231;&#227;o a UVA; usar em dias alternados.</li>\r\n<li><strong>Psor&#237;ase:</strong> 1,5-2 horas antes da exposi&#231;&#227;o a UVA, 2-3x/semana; dose de acordo com o peso: &lt;30kg = 10mg; 30-50kg = 20mg; 51-65kg = 30mg; 66-80kg = 40mg; 81-90kg = 50mg; 91-115kg = 60mg; &gt;115mg = 70mg.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o h&#225; estudosde seguran&#231;a nesta popula&#231;&#227;o.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><strong>Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1799,
        "indications": "<ul>\r\n<li>Tratamento repigmentante de psor&#237;ase e vitiligo por fotoquimioterapia sist&#234;mica.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 139,
        "lactation_text": "<p>N&#227;o recomendado.</p>",
        "last_update": "2019-03-06 16:57:50",
        "name": "Oxsoralen",
        "presentation": "<ul>\r\n<li>C&#225;psulas de 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "oxsoralen",
        "substance": "Metoxisaleno",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;useas, nervosismo, ins&#244;nia, depress&#227;o;</p>\r\n<p>- Incha&#231;o, cefal&#233;ia, mal-estar, diminui&#231;&#227;o de pigmenta&#231;&#227;o, forma&#231;&#227;o de bolhas;</p>\r\n<p>- Herpes simples, urtic&#225;ria, c&#227;imbras, hipotens&#225;o arterial, dist&#250;rbios gastrointestinais.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>N&#227;o definido.</p>\r\n</div>"
    },
    {
        "content_length": 2596,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer um dos componentes do produto.</p>\r\n<p>- Contraindicado em pacientes com depura&#231;&#227;o da creatinina &lt; 9 mL/min.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose Inicial:</strong>&#160; 8 mg, VO, pela manh&#227;, de prefer&#234;ncia com alimentos.</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong>&#160;16 mg, VO, pela manh&#227;, de prefer&#234;ncia com alimentos,&#160;durante pelo menos 4 semanas.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 24 mg/dia.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1806,
        "indications": "<p>- Tratamento sintom&#225;tico da dem&#234;ncia do tipo Alzheimer, de intensidade leve a moderada, associado ou n&#227;o a doen&#231;a vascular cerebral relevante.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:31:12",
        "name": "Galantamina",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas de libera&#231;&#227;o prolongada:</strong> 8 mg, 16 mg e 24 mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial, em duas vidas (C1).</p>",
        "record_status": 1,
        "slug": "galantamina",
        "substance": "Galantamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- N&#225;usea, v&#244;mito, diarreia, anorexia, perda de peso, dor abdominal, dispepsia, flatul&#234;ncia, tontura, cefaleia, depress&#227;o, fadiga, ins&#244;nia, sonol&#234;ncia. Menos comuns s&#227;o: infec&#231;&#227;o do trato urin&#225;rio, hemat&#250;ria, incontin&#234;ncia, anemia, tremor, rinite, aumento da fosfatase alcalina.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Fun&#231;&#227;o hep&#225;tica moderadamente comprometida: A dose de manuten&#231;&#227;o ser&#225; de 8 mg/dia durante pelo menos 4 semanas. Dose m&#225;xima: 16 mg/dia.</p>\r\n</div>"
    },
    {
        "content_length": 2721,
        "contraindications": "<div>\r\n<p>-&#160;Hipersensibilidade a qualquer componente da f&#243;rmula ou a outros antibi&#243;ticos da fam&#237;lia das quinolonas.</p>\r\n<p>- Iinfec&#231;&#245;es oculares purulentas agudas e infec&#231;&#245;es micobacterianas dos olhos.</p>\r\n<p>- Doen&#231;as virais da c&#243;rnea e conjuntiva.</p>\r\n<p>- Tuberculose ocular e doen&#231;as f&#250;ngicas do olho.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Infec&#231;&#245;es oculares</strong>: 1 gota aplicada no olho afetado, 6/6 horas, por at&#233; 7 dias.</li>\r\n<li><strong>Preven&#231;&#227;o e tratamento de infec&#231;&#227;o e inflama&#231;&#227;o no uso p&#243;s-cir&#250;rgico ocular:</strong>&#160;1 gota aplicada no olho afetado, 6/6 horas, por at&#233; 15 dias.</li>\r\n<li>De acordo com a severidade e evolu&#231;&#227;o cl&#237;nica a dura&#231;&#227;o do tratamento poder&#225; ser aumentada a crit&#233;rio m&#233;dico.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1810,
        "indications": "<p>- Tratamento e preven&#231;&#227;o das infec&#231;&#245;es e inflama&#231;&#245;es oculares em pacientes submetidos a cirurgias oculares.&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 6,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 15:12:15",
        "name": "Zypred",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oft&#225;lmica:</strong> Gatifloxacino 0,3% + Prednisolona 1%.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "tequin",
        "substance": "Gatifloxacina + Prednisolona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Ardor, irrita&#231;&#227;o ocular, prurido e dor ocular, emba&#231;amento / vis&#227;o turva, desconforto ocular, lacrimejamento, sensa&#231;&#227;o de corpo estranho, olho seco, cefaleia, irrita&#231;&#227;o conjuntival.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3300,
        "contraindications": "<p>&#160;- Hipersensibilidade grave ao gefitinibe ou aos outros componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:&#160;</strong>250 mg 1x/dia, VO, podendo ser administrado com ou sem a ingest&#227;o de alimentos, de prefer&#234;ncia no mesmo hor&#225;rio todos os dias.</li>\r\n<li>Este medicamento n&#227;o deve ser partido ou mastigado.</li>\r\n<li>Se a administra&#231;&#227;o de comprimidos inteiros n&#227;o for poss&#237;vel, como pacientes que s&#243; conseguem engolir l&#237;quidos, os comprimidos podem ser administrados como uma dispers&#227;o em &#225;gua. O comprimido deve ser colocado em meio copo de &#225;gua pot&#225;vel (sem g&#225;s), sem quebrar ou esmagar, e o copo agitado at&#233; que o comprimido seja disperso (aproximadamente 15 minutos) e deve-se tomar o liquido imediatamente. Adicionar mais meio copo de &#225;gua, mexer e tomar a &#225;gua adicionada.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1812,
        "indications": "<div>\r\n<p>- Tratamento do c&#226;ncer de pulm&#227;o de n&#227;o-pequenas c&#233;lulas (CPNPC) localmente avan&#231;ado ou metast&#225;tico, que t&#234;m muta&#231;&#245;es de ativa&#231;&#227;o do receptor de fator de crescimento epid&#233;rmico tirosina quinase (EGFR).</p>\r\n<p>- Tratamento de pacientes com c&#226;ncer de pulm&#227;o de n&#227;o-pequenas c&#233;lulas (CPNPC) localmente avan&#231;ado ou metast&#225;tico, que receberam previamente quimioterapia ou que n&#227;o s&#227;o eleg&#237;veis para quimioterapia.&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 21:03:01",
        "name": "Iressa",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 250 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "iressa",
        "substance": "Gefitinibe",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Diarreia e altera&#231;&#245;es na pele, incluindo erup&#231;&#227;o na pele, acne, pele seca e prurido (coceira no corpo), anorexia leve ou moderada, eleva&#231;&#245;es na alanina aminotransferase, astenia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2650,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade pr&#233;via a quinolonas ou a qualquer um de seus componentes.&#160;</p>\r\n<p>- Pacientes com insufici&#234;ncia renal grave (clearance de creatinina menor que 40 ml/min).&#160;</p>\r\n<p>- Menores de 18 anos.&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Exacerba&#231;&#227;o bacteriana aguda de bronquite cr&#244;nica:&#160;</strong>1cp, VO, 1x/dia em jejum, por 5 dias.</li>\r\n<li><strong>Sinusite aguda bacteriana:</strong> 1cp, VO, 1x/dia em jejum, por 5 a 7 dias.</li>\r\n<li><strong>Pneumonia adquirida na comunidade:</strong> 1cp, VO, 1x/dia em jejum, por 5 dias ou a crit&#233;rio m&#233;dico.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para menores de 18 anos.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1813,
        "indications": "<p>- Tratamento da exacerba&#231;&#227;o da bronquite cr&#244;nica e pneumonia adquirida na comunidade.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p>- N&#227;o estabelecido.&#160;</p>",
        "last_update": "2019-03-03 17:42:22",
        "name": "Factive",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 320 mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "factive",
        "substance": "Gemifloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Diarreia, n&#225;usea, v&#244;mito, dor abdominal, cefaleia, tontura, rea&#231;&#245;es de hipersensibilidade cut&#226;nea (&#8220;rash&#8221; cut&#226;neo) ou qualquer outra manifesta&#231;&#227;o de hipersensibilidade, eleva&#231;&#245;es das enzimas hep&#225;ticas, rea&#231;&#227;o anafil&#225;tica, rupturas de tend&#245;es.&#160;</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- Clearance de creatinina &#8805;40ml/min: n&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\">- Clearance &lt; 40ml/min: medica&#231;&#227;o n&#227;o recomendada.</p>\r\n</div>"
    },
    {
        "content_length": 4743,
        "contraindications": "<p>- Hipersensibilidade conhecida a qualquer um dos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Uso Intravenoso (IV):</strong></p>\r\n<ul>\r\n<li><strong>Reconstitui&#231;&#227;o:</strong> 5 mL de SF 0,9% + 200 mg ou 25 mL de SF 0,9% + 1 g. Estas dilui&#231;&#245;es atingem uma concentra&#231;&#227;o de 38 mg/mL.</li>\r\n<li><strong>C&#226;ncer de bexiga:</strong>&#160;Uso isolado: 1.250 mg/m2, IV em 30 minutos, nos dias 1, 8 e 15 de cada ciclo de 28 dias. Uso combinado com cisplatina: 1.000 mg/m2 , IV em 30 minutos, nos dias 1, 8 e 15 de cada ciclo de 28 dias.</li>\r\n<li><strong>C&#226;ncer pancre&#225;tico:</strong>&#160;1.000 mg/m2, IV em 30 minutos, 1x/semana, at&#233; 7 semanas, seguido por um per&#237;odo de descanso de 1 semana. Ciclos subsequentes: inje&#231;&#245;es semanais por 3 semanas consecutivas.</li>\r\n<li><strong>C&#226;ncer de Pulm&#227;o de C&#233;lulas N&#227;o Pequenas:</strong> Uso isolado: 1.000 mg/m2, IV em 30 minutos, 1x/semana por 3 semanas, seguido por um per&#237;odo de descanso de 1 semana. Uso combinado com cisplatina: 1.250 mg/m2 , IV em 30 minutos, nos dias 1 e 8 de cada ciclo de 21 dias ou&#160;&#160;1.000 mg/m2, IV em 30 minutos, nos dias 1, 8 e 15 cada ciclo de 28 dias.</li>\r\n<li><strong>C&#226;ncer de mama:&#160;</strong>Uso combinado com paclitaxel: 1.250 mg/m2 , IV em 30 minutos, nos dias 1 e 8 de cada ciclo de 21 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<p>- N&#227;o estabelecido</p>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1814,
        "indications": "<p>- Tratamento do c&#226;ncer de bexiga e adenocarcinoma do p&#226;ncreas localmente avan&#231;ado ou metast&#225;tico; C&#226;ncer pancre&#225;tico refrat&#225;rio ao 5-FU (5- Fluorouracil); C&#226;ncer de pulm&#227;o de c&#233;lulas n&#227;o pequenas localmente avan&#231;ado ou metast&#225;tico;&#160;C&#226;ncer de mama irressec&#225;vel, metast&#225;tico ou localmente recorrente, que recidivou ap&#243;s quimioterapia adjuvante/neoadjuvante.&#160;</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">- Alto risco:</span></strong><span style=\"line-height: 107%;\"> Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2019-03-03 19:39:07",
        "name": "Gencitabina",
        "presentation": "<ul>\r\n<li><strong>P&#243; para solu&#231;&#227;o injet&#225;vel:</strong> 200 mg e 1 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "gencitabina",
        "substance": "Gencitabina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Mielossupress&#227;o, n&#225;useas e v&#244;mitos, diarr&#233;ia, estomatites, hemat&#250;ria, protein&#250;ria discreta, s&#237;ndrome ur&#234;mica hemol&#237;tica, febre, erup&#231;&#227;o macular pruriginosa no tronco e nas extremidades, prurido, dispn&#233;ia, pneumonite, edema perif&#233;rico e edema generalizado, astenia, anorexia, cefaleia, tosse, calafrios, mialgia, ins&#244;nia, rinite, sudora&#231;&#227;o, aumento da incid&#234;ncia de infec&#231;&#245;es, queda de cabelos, parestesias leves ou severas, infarto do mioc&#225;rdio, acidente vascular cerebral, arritimia e hipotens&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Uso cauteloso na Insufici&#234;ncia Renal Grave.&#160;</p>\r\n<p class=\"MsoNormal\">-&#160;Contagem absoluta de granul&#243;citos (x 106 /L): &gt; 1.000 e Contagem de plaquetas: (x 106 /L)&#160;&gt; 100.000: N&#227;o h&#225; ajuste.&#160;</p>\r\n<p class=\"MsoNormal\">-&#160;Contagem absoluta de granul&#243;citos (x 106 /L): 500 - 1.000 ou Contagem de plaquetas (x 106 /L): 50.000 a 100.000: 75% da dose.</p>\r\n<p class=\"MsoNormal\">-&#160;Contagem absoluta de granul&#243;citos (x 106 /L): &lt; 500 ou Contagem de plaquetas (x 106 /L): &lt; 50.000: Suspender.</p>\r\n</div>"
    },
    {
        "content_length": 7272,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Hist&#243;rico de trombocitopenia com nadroparina; Sangramento ativo ou risco aumentado de hemorragia em rela&#231;&#227;o a hemostasias, exceto por CIVD n&#227;o induzida por heparina; Les&#227;o org&#226;nica com tend&#234;ncia a sangrament; Acidente vascular cerebral hemorr&#225;gico; Infec&#231;&#227;o endoc&#225;rdica aguda; Insufici&#234;ncia renal grave em pacientes recebendo tratamento para doen&#231;as tromboemb&#243;licas, angina inst&#225;vel e infarto do mioc&#225;rdico n&#227;o-Q;</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Cirurgia em geral:</strong></li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- 0,3 ml SC de 2 a 4 horas antes da cirurgia e depois 1x/dia nos dias subsequentes;</p>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Cirurgia ortop&#233;dica:</strong>&#160;</li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- <strong>&lt;50 kg:</strong> 0,2ml 12 horas antes e depois da cirurgia e ap&#243;s 1x/dia at&#233; o terceiro dia do p&#243;s-operat&#243;rio. 2850 UI do quarto dia do p&#243;s-operat&#243;rio em diante;</p>\r\n<p style=\"text-align: justify;\"><strong>-</strong> <strong>Entre 50&#8211;69 kg:</strong> 0,2mL 12 horas antes e depois da cirurgia e ap&#243;s 1x/dia ate o terceiro dia do p&#243;s-operat&#243;rio 3800 UI do quarto dia do p&#243;s-operat&#243;rio em diante;</p>\r\n<p style=\"text-align: justify;\"><strong>- &gt;70 kg:</strong> 0,4mL 12 horas antes e depois da cirurgia e ap&#243;s 1x/dia at&#233; o terceiro dia do p&#243;s-operat&#243;rio.&#160; 5700 UI do quarto dia do p&#243;s-operat&#243;rio em diante;</p>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Pacientes cl&#237;nicos de alto risco em tratamento intensivo:</strong></li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- <strong>&lt;70 kg:</strong> 0,4mL SC 1x/dia.</p>\r\n<p style=\"text-align: justify;\">- <strong>&gt;70 kg:</strong> 0,6mL SC 1x/dia;</p>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Tratamento de doen&#231;as troembomb&#243;licas:</strong></li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- <strong>&lt;50 kg:</strong> 0,4mL SC 12/12h por 10 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 50-59 kg:</strong> 0,5mL SC 12/12h por 10 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 60-69 kg:</strong> 0,6mL SC 12/12h por 10 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 70-79 kg:</strong> 0,7mL SC 12/12h por 10 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 80-89 kg:</strong> 0,8mL SC 12/12h por 10 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>&gt;90 kg:</strong> 0,9mL SC 12/12h por 10 dias;</p>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Preven&#231;&#227;o de forma&#231;&#227;o de coagulo durante a hemodi&#225;lise:</strong></li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- <strong>&lt;50 kg</strong>: 0,3mL injetado na linha arterial no inicio da di&#225;lise.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 50-69 kg:</strong> 0,4mL injetado na linha arterial no inicio da di&#225;lise.</p>\r\n<p style=\"text-align: justify;\">- <strong>&gt;70 kg:</strong> 0,6mL injetado na linha arterial no inicio da di&#225;lise.</p>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Angina inst&#225;vel e infarto do mioc&#225;rdio sem supra de ST:</strong></li>\r\n</ul>\r\n<p style=\"text-align: justify;\">- <strong>&lt;50 kg:</strong> 0,4mL IV inicial e 0,4mL SC 12/12h por 6 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 50&#8211;59 kg:</strong> 0,5mL IV inicial e 0,5mL SC 12/12h por 6 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 60&#8211;69 kg:</strong> 0,6mL IV inicial e 0,6mL SC 12/12h por 6 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 70&#8211;79 kg:</strong> 0,7mL IV inicial e 0,7mL SC 12/12h por 6 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 80&#8211;89 kg:</strong> 0,8mL IV inicial e 0,8mL SC 12/12h por 6 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>Entre 90&#8211;99 kg:</strong> 0,9mL IV inicial e 0,9mL SC 12/12h por 6 dias.</p>\r\n<p style=\"text-align: justify;\">- <strong>&gt;100 kg:</strong> 1mL IV inicial e 1mL SC 12/12h por 6 dias.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>&#160;N&#227;o h&#225; estudos de seguran&#231;a na popula&#231;&#227;o pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1824,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Profilaxia de doen&#231;as tromboemb&#243;licas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Tratamento de doen&#231;as tromboemb&#243;licas;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Preven&#231;&#227;o de coagula&#231;&#227;o durante a hemodi&#225;lise;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Tratamento de angina inst&#225;vel e infarto do mioc&#225;rdio n&#227;o-Q.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 96,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 19:20:54",
        "name": "Fraxiparina",
        "presentation": "<ul>\r\n<li><strong><span style=\"line-height: 107%;\">Solu&#231;&#227;o injet&#225;vel</span></strong><span style=\"line-height: 107%;\">:</span>&#160;0,3ml(2850 UI) e 0,6ml(5700 UI).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "fraxiparina",
        "substance": "Nadroparina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Manifesta&#231;&#245;es hemorr&#225;gicas em v&#225;rios locais, transaminases aumentadas, pequeno hematoma no local da inje&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>- </strong>Insufici&#234;ncia renal grave na profilaxia de doen&#231;as tromboemb&#243;licas<strong>:</strong> 25% da dose;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Insufici&#234;ncia renal leve a moderada no tratamento de doen&#231;as tromboemb&#243;licas, angina inst&#225;vel e infarto do mioc&#225;rdio sem supra de ST: 25% da dose.</p>\r\n</div>"
    },
    {
        "content_length": 2377,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1825,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 25,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 00:52:56",
        "name": "Nasalflux",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nasalflux",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2904,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n<li><strong>Solu&#231;&#227;o oft&#225;lmica: </strong>instilar 1 ou 2 gotas no olho afetado at&#233; 4x/dia, por at&#233; 3 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1826,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>\r\n<p>- Hiperemia devido a irrita&#231;&#245;es oculares.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 00:48:01",
        "name": "Nafazolina",
        "presentation": "<ul>\r\n<li><strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Solu&#231;&#227;o oft&#225;lmica:&#160;</span></strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">0,12mg/ml</span></li>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong>&#160;0,1mg/ml, 0,5mg/ml, 1mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nafazolina",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2610,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li><strong>0,5 mg/ml:</strong> 2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>0,1mg/ml:</strong> 2 a 4 gotas em cada narina a cada 4 a 6horas.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1827,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 15,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 00:52:25",
        "name": "Narix",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,1mg/ml e 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "narix",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2369,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1828,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 16,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 00:53:45",
        "name": "Nasofluid",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nasofluid",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2369,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1829,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 119,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 01:10:37",
        "name": "Neonazol",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neonazol",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2851,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade a qualquer componente da f&#243;rmula.</p>\r\n<p style=\"text-align: justify;\">- Pele irritada ou com feridas abertas.</p>\r\n<p style=\"text-align: justify;\">- Menores de 12 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong>&#160;aplicar uma fina camada do produto na &#225;rea afetada de 8/8h ou no m&#225;ximo de 6/6h</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong>&#160;aplicar uma fina camada do produto na &#225;rea afetada de 8/8h ou no m&#225;ximo de 6/6h</li>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o contraindicada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1830,
        "indications": "<p style=\"text-align: justify;\">- Dor associada &#224; neuralgia que acompanha o Herpes Zoster, &#224; neuropatia diab&#233;tica dolorosa, &#224; artrose, &#224; artrite reumatoide e a outras condi&#231;&#245;es que acometem os nervos.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 7,
        "lactation_text": "<p>- N&#227;o recomendado</p>",
        "last_update": "2019-03-05 00:35:11",
        "name": "Moment",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><strong>Creme dermatol&#243;gico t&#243;pico:</strong> 0,025% e 0,075%</li>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><strong>Lo&#231;&#227;o t&#243;pica:</strong> 0,025% - Frasco com 60 mL</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "moment-creme",
        "substance": "Capsaicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Eritema, dor e queima&#231;&#227;o no local da aplica&#231;&#227;o, prurido, p&#225;pulas, edema ou pele seca no local da aplica&#231;&#227;o; hipertens&#227;o; nasofaringite, bronquite, sinusite; n&#225;usea; urtic&#225;ria, parestesia, dermatite de contato, hiperestesia, escoria&#231;&#227;o, anestesia, inflama&#231;&#227;o ou exfolia&#231;&#227;o no local da aplica&#231;&#227;o; bloqueio &#225;trio-ventricular de primeiro grau, taquicardia; tosse e irrita&#231;&#227;o na garganta; dor nas extremidades; espasmos musculares.</p>\r\n</div>"
    },
    {
        "content_length": 2499,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li><strong>0,5mg/ml:</strong> 2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n<li><strong>1mg/ml:&#160;</strong>aplicar uma gota em cada narina at&#233; 4x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1832,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 121,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 02:01:28",
        "name": "Novo Rino",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml e 1mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "novo-rino",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2380,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1836,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 00:52:07",
        "name": "Narinef",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "narinef",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2369,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1837,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas);&#160;Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 205,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-09 17:10:27",
        "name": "Sorisma N",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "sorisma-n",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2921,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Glaucoma de &#226;ngulo estreito;&#160;</span><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Hipersensibilidade aos componentes da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li>1 a 2 gotas no saco conjuntival do olho afetado at&#233; a cada 6 horas, por at&#233; 3 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\">-&#160;<strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1849,
        "indications": "<p>- Hiperemia por irrita&#231;&#245;es oculares.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 5,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:36:49",
        "name": "Claroft",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oft&#225;lmica:</strong> 0,12mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "claroft",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- HAS (principalmente em pacientes em uso de IMAO); Uso prolongado pode causar vasodilata&#231;&#227;o ou congest&#227;o ocular de rebote; Use com precau&#231;&#227;o em idosos, em pacientes com doen&#231;as cardiovasculares ou em pacientes com denerva&#231;&#227;o simp&#225;tica (por exemplo, pacientes diab&#233;ticos insulino-dependentes, com hipotens&#227;o ortost&#225;tica, hipertens&#227;o, hipertireoidismo) devido ao risco de poss&#237;veis efeitos sist&#234;micos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2359,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1855,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas); Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-09 17:09:53",
        "name": "Sorine",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "sorine",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2329,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>1 gota em cada narina at&#233; 4x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1856,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas); Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-06 18:39:16",
        "name": "Privina",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 1mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "privina",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2363,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1857,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas); Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-05 01:12:35",
        "name": "Neosoro",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neosoro",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2393,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Disfun&#231;&#227;o hep&#225;tica e renal (contraindica&#231;&#227;o relativa);&#160;Uso cuidadoso em pacientes em uso de inibidores de MAO;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Em caso de gravidez consultar o medico do pr&#233;-natal.</span></p>",
        "dosage_adults": "<ul>\r\n<li>2 a 4 gotas em cada narina a cada 4 a 6 horas (Dose m&#225;xima: 24 gotas).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado para crian&#231;as menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1858,
        "indications": "<p style=\"text-align: justify;\">- Vasoconstritor e descongestionante nasal de inicio r&#225;pido (10 minutos) e dura&#231;&#227;o prolongada (6 horas); Fludificador de secre&#231;&#227;o nasal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p><strong>- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-09 16:41:41",
        "name": "Sinustrat Vasoconstritor",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o nasal:</strong> 0,5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "sinustrat-vasoconstritor",
        "substance": "Nafazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, bradicardia reflexa, excitabilidade, ins&#244;nia e raramente arritmias.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3823,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade ao cloridrato de nalbufina ou a qualquer outro componente do produto; Abd&#244;men agudo, obstru&#231;&#227;o gastrointestinal suspeita ou conhecida, incluindo &#237;leo paral&#237;tico. Tratamento com inibidores da monoaminoxidase (IMAO) ou cuja suspens&#227;o destes f&#225;rmacos for inferior a 14 dias. Depress&#227;o respirat&#243;ria significativa. Asma br&#244;nquica aguda ou severa em ambiente n&#227;o monitorado ou na aus&#234;ncia de equipamentos de ressuscita&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Analgesia:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">10 mg, SC, IM ou IV, a cada 3 a 6 horas, se necess&#225;rio; (Dose &#250;nica m&#225;xima: 20 mg. Dose di&#225;ria m&#225;xima: 160 mg)</li>\r\n</ul>\r\n<p><strong>Complemento da anestesia:</strong></p>\r\n<ul>\r\n<li><strong>Dose de indu&#231;&#227;o:&#160;</strong>0,3 mg/kg a 3 mg/kg IV por 10 a 15 min</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong>&#160;0,25 a 0,5 mg/kg IV dose &#250;nica quando necess&#225;rio.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1860,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Analgesia pr&#233; e p&#243;s-operat&#243;ria;&#160;Analgesia obst&#233;trica durante trabalho de parto;&#160;Alivio da dor ap&#243;s infarto agudo do mioc&#225;rdio.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p><strong>- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-05 02:05:06",
        "name": "Nubain",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;10mg/1ml.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receita de controle especial - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "nubain",
        "substance": "Nalbufina",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Seda&#231;&#227;o, sudorese, n&#225;useas, v&#244;mitos, tontura/vertigem, boca seca, cefaleia.</p>\r\n<p style=\"text-align: justify;\">- Uso com cautela em idosos por serem mais propensos a efeitos adversos, especialmente depress&#227;o respirat&#243;ria.</p>\r\n<p style=\"text-align: justify;\">-&#160;Pacientes em uso de analg&#233;sico narc&#243;tico, anest&#233;sicos em geral, fenotiazinas ou outros tranquilizantes, sedativos, hipn&#243;ticos ou outros depressores do SNC (incluindo &#225;lcool), concomitantemente ao cloridrato de nalbufina, podem apresentar efeitos aditivos, devendo-se, portanto, reduzir a dose de um ou de ambos os medicamentos.</p>\r\n<p style=\"text-align: justify;\">-&#160;A nalbufina, assim como outros opioides, pode causar depend&#234;ncia, al&#233;m de expor ao risco de abuso ou uso inapropriado.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Recomenda-se reduzir a dose em insufici&#234;ncia renal e/ou hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3811,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade ao cloridrato de nalbufina ou a qualquer outro componente do produto; Abd&#244;men agudo, obstru&#231;&#227;o gastrointestinal suspeita ou conhecida, incluindo &#237;leo paral&#237;tico. Tratamento com inibidores da monoaminoxidase (IMAO) ou cuja suspens&#227;o destes f&#225;rmacos for inferior a 14 dias. Depress&#227;o respirat&#243;ria significativa. Asma br&#244;nquica aguda ou severa em ambiente n&#227;o monitorado ou na aus&#234;ncia de equipamentos de ressuscita&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Analgesia:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">10 mg, SC, IM ou IV, a cada 3 a 6 horas, se necess&#225;rio; (Dose &#250;nica m&#225;xima: 20 mg. Dose di&#225;ria m&#225;xima: 160 mg)</li>\r\n</ul>\r\n<p><strong>Complemento da anestesia:</strong></p>\r\n<ul>\r\n<li><strong>Dose de indu&#231;&#227;o:&#160;</strong>0,3 mg/kg a 3 mg/kg IV por 10 a 15 min</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong> 0,25 a 0,5 mg/kg IV dose &#250;nica quando necess&#225;rio.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1861,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Analgesia pr&#233; e p&#243;s-operat&#243;ria;&#160;Analgesia obst&#233;trica durante trabalho de parto;&#160;Alivio da dor ap&#243;s infarto agudo do mioc&#225;rdio.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-05 00:48:25",
        "name": "Nalbufina",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;10mg/1ml.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receita de controle especial - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "nalbufina",
        "substance": "Nalbufina",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Seda&#231;&#227;o, sudorese, n&#225;useas, v&#244;mitos, tontura/vertigem, boca seca, cefaleia.</p>\r\n<p style=\"text-align: justify;\">- Uso com cautela em idosos por serem mais propensos a efeitos adversos, especialmente depress&#227;o respirat&#243;ria.</p>\r\n<p style=\"text-align: justify;\">-&#160;Pacientes em uso de analg&#233;sico narc&#243;tico, anest&#233;sicos em geral, fenotiazinas ou outros tranquilizantes, sedativos, hipn&#243;ticos ou outros depressores do SNC (incluindo &#225;lcool), concomitantemente ao cloridrato de nalbufina, podem apresentar efeitos aditivos, devendo-se, portanto, reduzir a dose de um ou de ambos os medicamentos.</p>\r\n<p style=\"text-align: justify;\">-&#160;A nalbufina, assim como outros opioides, pode causar depend&#234;ncia, al&#233;m de expor ao risco de abuso ou uso inapropriado.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Recomenda-se reduzir a dose em insufici&#234;ncia renal e/ou hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3516,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>",
        "dosage_adults": "<div>\r\n<p style=\"text-align: justify;\"><strong>Superdosagem de opi&#243;ide:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li><strong>Dose de ataque:</strong>&#160;0,4mg a 2mg, IV, repetir a cada 2 a 3 minutos ate obter o efeito desejado (Dose m&#225;xima culmulativa: 10 mg). Caso n&#227;o seja poss&#237;vel a infus&#227;o venosa, pode ser aplicado via SC ou IM.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\"><strong>Depress&#227;o narc&#243;tica p&#243;s-operat&#243;ria:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose de ataque:</strong>&#160;0,1mg a 0,2mg, IV,&#160;com 2 ou 3 minutos de intervalo, para se alcan&#231;ar um n&#237;vel desej&#225;vel de revers&#227;o.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p style=\"text-align: justify;\"><strong>Superdosagem de opi&#243;ide:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li>0,1 mg/kg/peso para crian&#231;as at&#233; 20 Kg ou menores que 5 anos, aplicada via IV(prefer&#237;vel), SC ou IM.</li>\r\n<li>2 mg para crian&#231;as com mais de 20 Kg ou maiores que 5 anos, aplicada via IV(prefer&#237;vel), SC ou IM.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\"><strong>Depress&#227;o narc&#243;tica p&#243;s-operat&#243;ria:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li>0,005mg a 0,01mg, IV, com 2 a 3 minutos de intervalo entre as doses, para se alcan&#231;ar um n&#237;vel desej&#225;vel de revers&#227;o.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\"><strong>Depress&#227;o induzida por narc&#243;tico:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">0,01mg/kg/peso, IV ou SC ou IM,&#160;com 2 ou 3 minutos de intervalo, para se alcan&#231;ar um n&#237;vel desej&#225;vel de revers&#227;o.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1868,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">- Revers&#227;o completa ou parcial da depress&#227;o causada por opioide, inclusive depress&#227;o respirat&#243;ria, induzida por ingest&#227;o de narc&#243;ticos opioides naturais ou sint&#233;ticos, como propoxifeno, metadona e certos analg&#233;sicos agonistas-antagonistas como nalbufina, pentazocina, butorfanol e ciclazocina.</p>\r\n<p>- Teste diagn&#243;stico de superdosagem aguda suspeita ou conhecida por opioides.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p><strong>-&#160;</strong>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:50:53",
        "name": "Narcan",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;0,4mg/1ml.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receita de controle especial - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "narcan",
        "substance": "Naloxona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Agita&#231;&#227;o, alucina&#231;&#227;o, tremores, arritmias, hipertens&#227;o, rubor, n&#225;useas e v&#244;mitos, dispneia, depress&#227;o respirat&#243;ria, hipoxemia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3330,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>",
        "dosage_adults": "<div>\r\n<p><strong>Superdosagem de opi&#243;ide:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose de ataque:</strong> 0,4mg a 2mg, IV, repetir a cada 2 a 3 minutos ate obter o efeito desejado (Dose m&#225;xima culmulativa: 10 mg). Caso n&#227;o seja poss&#237;vel a infus&#227;o venosa, pode ser aplicado via SC ou IM.</li>\r\n</ul>\r\n<p><strong>Depress&#227;o narc&#243;tica p&#243;s-operat&#243;ria:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose de ataque:</strong> 0,1mg a 0,2mg, IV,&#160;com 2 ou 3 minutos de intervalo, para se alcan&#231;ar um n&#237;vel desej&#225;vel de revers&#227;o.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p style=\"text-align: justify;\"><strong>Superdosagem de opi&#243;ide:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li>0,01mg/kg/peso, IV; se n&#227;o houver resposta:&#160;0,1 mg/kg/peso; Pode ser aplicado por via SC ou IM em doses divididas.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\"><strong>Depress&#227;o narc&#243;tica p&#243;s-operat&#243;ria:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li>0,005mg a 0,01mg, IV, com 2 a 3 minutos de intervalo entre as doses, para se alcan&#231;ar um n&#237;vel desej&#225;vel de revers&#227;o.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\"><strong>Depress&#227;o induzida por narc&#243;tico:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">0,01mg/kg/peso, IV ou SC ou IM,&#160;com 2 ou 3 minutos de intervalo, para se alcan&#231;ar um n&#237;vel desej&#225;vel de revers&#227;o.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1869,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">- Revers&#227;o completa ou parcial da depress&#227;o causada por opioide, inclusive depress&#227;o respirat&#243;ria, induzida por ingest&#227;o de narc&#243;ticos opioides naturais ou sint&#233;ticos, como propoxifeno, metadona e certos analg&#233;sicos agonistas-antagonistas como nalbufina, pentazocina, butorfanol e ciclazocina.</p>\r\n<p style=\"text-align: justify;\">- Teste diagn&#243;stico de superdosagem aguda suspeita ou conhecida por opioides.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:48:58",
        "name": "Naloxona",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 0,4mg/1ml.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>- Receita de controle especial - uso hospitalar.</p>",
        "record_status": 1,
        "slug": "naloxona",
        "substance": "Naloxona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Agita&#231;&#227;o, alucina&#231;&#227;o, tremores, arritmias, hipertens&#227;o, rubor, n&#225;useas e v&#244;mitos, dispneia, depress&#227;o respirat&#243;ria, hipoxemia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajustes.</p>\r\n</div>"
    },
    {
        "content_length": 3114,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Mulheres gravidas; Homens com carcinoma prost&#225;tico ou mam&#225;rio conhecido ou suspeito.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Osteoporose:</strong></p>\r\n<ul>\r\n<li>50mg, IM, a cada 3 semanas.</li>\r\n</ul>\r\n<p><strong>Adjuvante a tratamentos:</strong></p>\r\n<ul>\r\n<li>25mg a 50mg, IM, a cada 2 semanas.</li>\r\n</ul>\r\n<p><strong>Anemia por insufici&#234;ncia renal cr&#244;nica:</strong></p>\r\n<ul>\r\n<li>100mg a 200mg, IM, 1 vez por semana.</li>\r\n</ul>\r\n<p><strong>Anemia apl&#225;sica:</strong></p>\r\n<ul>\r\n<li>50mg a 150mg, IM, 1 vez por semana.</li>\r\n</ul>\r\n<p><strong>Anemia devido a tratamento citot&#243;xico:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">200mg, IM, 1 vez por semana, inicio 2 semanas antes do ciclo de tratamento citot&#243;xico. Utilizar durante todo o tratamento.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><strong>- Categoria X:</strong> Prescri&#231;&#227;o proibitiva (contraindicado).</p>",
        "id": 1870,
        "indications": "<p style=\"text-align: justify;\">- Tratamento de osteoporose; Tratamento da anemia da insufici&#234;ncia renal cr&#244;nica, anemia apl&#225;sica e anemia devido a tratamentos citot&#243;xicos; Adjuvante a tratamentos espec&#237;ficos e medidas diet&#233;ticas em condi&#231;&#245;es patol&#243;gicas caracterizadas por balan&#231;o negativo de nitrog&#234;nio.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 65,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 20:39:43",
        "name": "Deca-Durabolin",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/1ml e 50mg/1ml.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "deca-durabolin",
        "substance": "Nandrolona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Virilismo, hiperlipidemia, libido aumentado, hipertens&#227;o, disfonia, n&#225;useas, acne, exantema, prurido, hirsutismo, edema, hiperplasia prost&#225;tica benigna, priapismo, p&#234;nis aumentado, clit&#243;ris aumentado, amenorreia, oligomenorreia, contagem de esperma diminu&#237;da.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4023,
        "contraindications": "<p>- Rea&#231;&#245;es intensas ao medicamento ou outras hidanto&#237;nas, S&#237;ndrome de Adam-Stokes, Bloqueio AV de 2&#186; e 3&#186; graus, Bloqueio sinoatrial, Bradicardia sinusal.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Modo de dilui&#231;&#227;o:</strong>&#160;4 ampolas de 5 ml + 80 ml de SF 0,9% (Solu&#231;&#227;o: 10 mg/ml);</li>\r\n<li><strong>Ataque:</strong> 15 mg/kg em 30 minutos IV;</li>\r\n<li><strong>Manuten&#231;&#227;o</strong>: 10 ml da solu&#231;&#227;o (100mg) de 8/8 horas ou 2 ml da ampola sem diluir.</li>\r\n<li><strong>VO:</strong> 2 a 5 comprimidos divididos em 2 a 3 tomadas di&#225;rias (5 a 10 mg/Kg).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Modo de dilui&#231;&#227;o:</strong>&#160;4 ampolas de 5 ml + 80 ml de SF 0,9% (Solu&#231;&#227;o: 10 mg/ml);</li>\r\n<li><strong><strong>Ataque:</strong><span style=\"font-weight: 400;\">&#160;10 a 15 mg/kg em 30 minutos IV.</span></strong></li>\r\n<li><strong>VO: &lt; 30 Kg:</strong> 1 a 2 comprimidos divididos em 2 a 3 tomadas di&#225;rias (10 a 15 mg/Kg).&#160;<strong>&gt; 30 Kg:</strong> mesma posologia do adulto.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1871,
        "indications": "<p>- Crises convulsivas epil&#233;pticas e parciais, por traumatismo cranioencef&#225;lico, secund&#225;rias e neurocirurgia.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 20:31:13",
        "name": "Hidantal",
        "presentation": "<ul>\r\n<li><strong>Comprimido</strong>: 100 mg</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel</strong>: 50 mg/ml com 5 ml.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 - branca em duas vias).</p>",
        "record_status": 1,
        "slug": "hidantal",
        "substance": "Fenitoína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p>- Sistema nervoso central: Nistagmo, ataxia, dificuldade na fala, altera&#231;&#245;es na coordena&#231;&#227;o, confus&#227;o mental, vertigem, ins&#244;nia, nervosismo transit&#243;rio, contra&#231;&#227;o motora, cefaleia. Relato de raros casos de discinesia induzida por fenito&#237;na. Observado polineuropatia perif&#233;rica em pacientes sob tratamento a longo prazo</p>\r\n<p>- Sistema gastrointestinal: n&#225;usea, v&#244;mitos, constipa&#231;&#227;o, hepatite t&#243;xica e preju&#237;zo hep&#225;tico</p>\r\n<p>- Sistema tegumentar: rash morbiliforme e escarlatiniforme</p>\r\n<p>- Sistema hematopoi&#233;tico: trombocitopenia, leucopenia, granulocitopenia, agranulocitose e pancitopenia</p>\r\n<p>- Sistema do tecido conjuntivo: engrossamento das caracter&#237;sticas faciais, aumento dos l&#225;bios, hiperplasia gengival, hipertricose, doen&#231;a de Peyronie</p>\r\n<p>- Sistema cardiovascular: periarterite nodosa</p>\r\n<p>- Sistema imunol&#243;gico: s&#237;ndrome de hipersensibilidade, lupus eritematoso sist&#234;mico, anormalidade de imunoglobulinas</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 10068,
        "contraindications": "<div><p>- Hipersensibilidade conhecida &#224; carbamazepina ou a f&#225;rmacos estruturalmente relacionados (por ex.: antidepressivos tric&#237;clicos) ou a qualquer outro componente da formula&#231;&#227;o.</p>\r\n<p>- Pacientes com bloqueio atrioventricular.</p>\r\n<p>- Pacientes com hist&#243;rico de depress&#227;o da medula &#243;ssea.</p>\r\n<p>- Pacientes com hist&#243;rico de porfirias hep&#225;ticas (por ex.: porfiria intermitentemente aguda, porfiria variegada, porfiria cut&#226;nea tardia)</p></div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Epilepsia:</strong> In&#237;cio com 100-200mg de 24/24h ou 12/12h, at&#233; atingir 400mg VO de 12/12h ou 8/8h. - Dose m&#225;xima: 2000mg/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Mania aguda e manuten&#231;&#227;o em dist&#250;rbios afetivos bipolares:</strong> O intervalo de dose &#233; de 400 a 1.600 mg/dia, sendo que a posologia usual &#233; de 400 a 600 mg/dia divididos em 2 a 3 doses.</li>\r\n<li style=\"text-align: justify;\"><strong>S&#237;ndrome de abstin&#234;ncia alco&#243;lica:</strong> 200-400mg VO de 8/8h.</li>\r\n<li style=\"text-align: justify;\"><strong>Neuralgia do trig&#234;meo:</strong>&#160;In&#237;cio com 200mg/dia VO, podendo atingir at&#233; 200mg VO de 8/8h ou 6/6h. A dose m&#225;xima recomendada &#233; de 1.200 mg/dia</li>\r\n<li style=\"text-align: justify;\"><strong>Neuropatia diab&#233;tica dolorosa:</strong> 200mg VO de 12/12h, 8/8h ou 6/6h.</li>\r\n<li style=\"text-align: justify;\"><strong>Diabetes ins&#237;pida central:</strong> 200mg VO de 8/8h ou 12/12h.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Epilepsia:&#160;</strong>crian&#231;as de 4 anos ou menos: dose inicial de 20 a 60 mg/dia, aumentada de 20 a 60 mg a cada dois dias. Para crian&#231;as acima de 4 anos, come&#231;ar com 100 mg/dia, aumentada de 100 mg em intervalos semanais.\r\n<ul>\r\n<li>At&#233; 1 ano de idade: 100 a 200 mg por dia&#160;</li>\r\n<li>1 a 5 anos de idade: 200 a 400 mg por dia</li>\r\n<li>6 a 10 anos de idade: 400 a 600 mg por dia</li>\r\n<li>11 a 15 anos de idade: 600 a 1.000 mg por dia</li>\r\n<li>&gt; 15 anos de idade: 800 a 1.200 mg por dia (mesma dose de adultos)</li>\r\n</ul>\r\n</li>\r\n<li><strong>Dose m&#225;xima recomendada:</strong> at&#233; 6 anos de idade: 35 mg/kg/dia; 6-15 anos de idade: 1.000 mg/dia; &gt;15 anos de idade: 1.200 mg/dia</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria D</strong>: Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1872,
        "indications": "<p style=\"text-align: justify;\">- Mania aguda e manuten&#231;&#227;o em dist&#250;rbios afetivos bipolares, s&#237;ndrome de abstin&#234;ncia alco&#243;lica, neuralgia trigeminal idiop&#225;tica ou por esclerose m&#250;ltipla, neuropatia diab&#233;tica doloroso, neuralgia glossofar&#237;ngea idiop&#225;tica, diabetes ins&#237;pida central, poli&#250;ria e polidipsia de origem neuro-hormonal, crises parciais complexas ou cimples com ou sem generaliza&#231;&#227;o secund&#225;ria, crises t&#244;nico-cl&#244;nicas generalizadas e formas mistas desses crises de epilepsia.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 1,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Baixo risco</strong>: Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2018-12-09 22:36:45",
        "name": "Carbamazepina",
        "presentation": "<div>\r\n<ul>\r\n<li><strong>Comprimido:</strong> 200mg e 400mg</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 20mg/mL</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 branca em duas vias).</p>",
        "record_status": 1,
        "slug": "carbamazepina",
        "substance": "Carbamazepina",
        "trade_names": "",
        "warnings": "<div><p><strong>Ajustes</strong></p>\r\n<p>-<strong>&#160;Insufici&#234;ncia Renal:&#160;</strong>N&#227;o estabelecido.</p>\r\n<p style=\"text-align: justify;\">-<strong>&#160;Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o estabelecido.&#160;</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Leucopenia, trombocitopenia, eosinofilia, leucocitose, linfadenopatia, agranulocitose, anemia apl&#225;stica, pancitopenia, aplasia de eritr&#243;cito pura, anemia, anemia megalobl&#225;stica, reticulose e anemia hemol&#237;tica,&#160;</p>\r\n<p style=\"text-align: justify;\">- Dist&#250;rbio de hipersensibilidade retardada em m&#250;ltiplos &#243;rg&#227;os com febre, erup&#231;&#245;es de pele, vasculite, linfadenopatia, pseudolinfoma, artralgia, leucopenia, eosinofilia, hepatoesplenomegalia, teste da fun&#231;&#227;o hep&#225;tica anormal e s&#237;ndrome do desaparecimento do ducto biliar (destrui&#231;&#227;o e desaparecimento dos ductos biliares intra-hep&#225;ticos), ocorrendo em v&#225;rias combina&#231;&#245;es. Outros &#243;rg&#227;os tamb&#233;m podem ser afetados (por ex.: pulm&#245;es, rins, p&#226;ncreas, mioc&#225;rdio e c&#243;lon), rea&#231;&#227;o anafil&#225;tica, angioedema, hipogamaglobulinemia.</p>\r\n<p style=\"text-align: justify;\">- Edema, reten&#231;&#227;o de l&#237;quido, aumento de peso, hiponatremia, e redu&#231;&#227;o de osmolaridade do sangue causada por um efeito semelhante ao do horm&#244;nio antidiur&#233;tico (ADH), conduzindo em casos raros, &#224; intoxica&#231;&#227;o h&#237;drica acompanhada de letargia, v&#244;mito, cefaleia, confus&#227;o e dist&#250;rbios neurol&#243;gicos, galactorreia e ginecomastia.</p>\r\n<p style=\"text-align: justify;\">- Defici&#234;ncia de folato e diminui&#231;&#227;o do apetite, porfiria aguda (porfiria aguda intermitente e porfiria variegada), porfiria n&#227;o aguda (porfiria cut&#226;nea tardia)</p>\r\n<p style=\"text-align: justify;\">- Alucina&#231;&#245;es (visuais ou auditivas), depress&#227;o, agress&#227;o, agita&#231;&#227;o, inquieta&#231;&#227;o, e estado de confus&#227;o, ativa&#231;&#227;o de psicose, ataxia, vertigem, sonol&#234;ncia, diplopia e cefaleia, movimentos involunt&#225;rios anormais (por ex.: tremor, asterixis, distonia, tiques) e nistagmo, discinesia, dist&#250;rbios de movimentos dos olhos, dist&#250;rbios da fala (por ex.: disartria ou pron&#250;ncia desarticulada da fala), coreoatetose, neuropatia perif&#233;rica, parestesia, paresia, s&#237;ndrome neurol&#233;ptica maligna, meningite ass&#233;ptica com mioclonia e eosinofilia perif&#233;rica, disgeusia.</p>\r\n<p style=\"text-align: justify;\">- Dist&#250;rbio de acomoda&#231;&#227;o (por ex.: vis&#227;o borrada), opacidade lenticular, conjuntivite, press&#227;o intraocular aumentada, dist&#250;rbios auditivos, por ex.: zumbido, hiperacusia, hipoacusia e mudan&#231;a na percep&#231;&#227;o do espa&#231;o.</p>\r\n<p style=\"text-align: justify;\">- Dist&#250;rbios de condu&#231;&#227;o card&#237;aca, arritmia, bloqueio atrioventricular com s&#237;ncope, bradicardia, insufici&#234;ncia card&#237;aca congestiva, agravamento da doen&#231;a coronariana.</p>\r\n<p style=\"text-align: justify;\">- Hipertens&#227;o ou hipotens&#227;o, colapso circulat&#243;rio, embolismo (por ex.: embolismo pulmonar), tromboflebite.</p>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade pulmonar caracterizada, por ex.: por febre, dispneia, pneumonite ou pneumonia.</p>\r\n<p style=\"text-align: justify;\">- V&#244;mito, n&#225;usea, boca seca, diarreia, constipa&#231;&#227;o, dor abdominal, pancreatite, glossite, estomatite, hepatite colest&#225;tica e parenquimatosa (hepatocelular) ou de tipo mista, s&#237;ndrome do desaparecimento do ducto biliar, icter&#237;cia, insufici&#234;ncia hep&#225;tica, doen&#231;a do f&#237;gado granulomatosa.</p>\r\n<p style=\"text-align: justify;\">- Urtic&#225;ria que em alguns casos pode ser grave, dermatite al&#233;rgica, dermatite esfoliativa, l&#250;pus eritematoso sist&#234;mico, prurido, S&#237;ndrome de Stevens-Johnson, necr&#243;lise epid&#233;rmica t&#243;xica, rea&#231;&#227;o de fotossensibilidade, eritema multiforme, eritema nodoso, dist&#250;rbio de pigmenta&#231;&#227;o, p&#250;rpura, acne, hiperidrose, alopecia, hirsutismo.</p>\r\n<p style=\"text-align: justify;\">- Fraqueza muscular, dist&#250;rbios do metabolismo &#243;sseo (diminui&#231;&#227;o do c&#225;lcio plasm&#225;tico e sangu&#237;neo 25-hidroxi-colecalciferol), levando &#224; osteomalacia / osteoporose, artralgia, mialgia, espasmos musculares.</p>\r\n<p style=\"text-align: justify;\">- Nefrite tubulointersticial, insufici&#234;ncia renal, disfun&#231;&#227;o renal (por ex.: albumin&#250;ria, hemat&#250;ria, olig&#250;ria e ureia sangu&#237;nea aumentada/azotemia elevada), reten&#231;&#227;o urin&#225;ria, frequ&#234;ncia urin&#225;ria alterada, disfun&#231;&#227;o sexual/disfun&#231;&#227;o er&#233;til, espermatog&#234;nese anormal (com contagem diminu&#237;da do esperma e/ou motilidade).</p>\r\n<p style=\"text-align: justify;\">- Fadiga, aumento da gama-glutamil transferase, aumento da fosfatase alcalina do sangue, aumento das transaminases, aumento da press&#227;o intraocular, aumento do colesterol no sangue, aumento da lipoprote&#237;na de alta densidade, aumento dos triglic&#233;rides no sangue. Teste de fun&#231;&#227;o da tireoide anormal: diminui&#231;&#227;o da L-tiroxina (tiroxina livre, tiroxina, triiodotironina) e aumento no sangue do horm&#244;nio estimulante da tireoide, geralmente sem manifesta&#231;&#245;es, aumento na prolactina no sangue.</p></div>"
    },
    {
        "content_length": 3678,
        "contraindications": "<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Historia de ulcera gastroduodenal ou sangramento gastrintestinal; Insufici&#234;ncia card&#237;aca grave, hep&#225;tica ou renal; Asma, rinite, p&#243;lipos nasais ou urtic&#225;ria pelo uso de AAS ou outros AINES; Crian&#231;as abaixo de 2 anos de idade.</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 275mg:</strong> 1 comprimido, VO, 1 a 2 vezes por dia.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 550mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n</ul>\r\n<hr>\r\n<p>N&#227;o se deve utilizar por mais de 10 dias seguidos.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>-&#160;</strong><strong><span style=\"line-height: 107%;\">Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1875,
        "indications": "<p style=\"text-align: justify;\">- Dores agudas causadas por inflama&#231;&#227;o; Dor e febre em adultos; Dores musculares e articulares; Artrite reumatoide, osteoartrite, espondilite anquilosante, gota e artrite reumatoide juvenil; Tratamento e preven&#231;&#227;o de enxaqueca; Ap&#243;s cirurgias; Entorses, distens&#245;es, contus&#245;es e dor decorrente da pratica desportiva.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 18:05:56",
        "name": "Flanax",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong> 275mg e 550mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flanax",
        "substance": "Naproxeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#225;useas, v&#244;mitos, desconforto abdominal, diarreia, hemorragia digestiva, cefaleia, mal estar, tonteira e vertigem, dist&#250;rbios da coagula&#231;&#227;o, erup&#231;&#227;o cut&#226;nea e prurido, disfun&#231;&#227;o hep&#225;tica e renal, trombocitopenia e agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o utilizar se depura&#231;&#227;o de creatinina &lt; 30ml/min.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal e hep&#225;tica, considerar doses menores.</p>\r\n</div>"
    },
    {
        "content_length": 3539,
        "contraindications": "<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Historia de ulcera gastroduodenal ou sangramento gastrintestinal; Insufici&#234;ncia card&#237;aca grave, hep&#225;tica ou renal; Asma, rinite, p&#243;lipos nasais ou urtic&#225;ria pelo uso de AAS ou outros AINES; Crian&#231;as abaixo de 2 anos de idade.</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 550mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n</ul>\r\n<hr>\r\n<p>N&#227;o se deve utilizar por mais de 10 dias seguidos.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>-&#160;</strong><strong><span style=\"line-height: 107%;\">Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1877,
        "indications": "<p style=\"text-align: justify;\">- Dores agudas causadas por inflama&#231;&#227;o; Dor e febre em adultos; Dores musculares e articulares; Artrite reumatoide, osteoartrite, espondilite anquilosante, gota e artrite reumatoide juvenil; Tratamento e preven&#231;&#227;o de enxaqueca; Ap&#243;s cirurgias; Entorses, distens&#245;es, contus&#245;es e dor decorrente da pratica desportiva.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:49:46",
        "name": "Napronax",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong> 550mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "napronax",
        "substance": "Naproxeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#225;useas, v&#244;mitos, desconforto abdominal, diarreia, hemorragia digestiva, cefaleia, mal estar, tonteira e vertigem, dist&#250;rbios da coagula&#231;&#227;o, erup&#231;&#227;o cut&#226;nea e prurido, disfun&#231;&#227;o hep&#225;tica e renal, trombocitopenia e agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o utilizar se depura&#231;&#227;o de creatinina &lt; 30ml/min.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal e hep&#225;tica, considerar doses menores.</p>\r\n</div>"
    },
    {
        "content_length": 3812,
        "contraindications": "<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Historia de ulcera gastroduodenal ou sangramento gastrintestinal; Insufici&#234;ncia card&#237;aca grave, hep&#225;tica ou renal; Asma, rinite, p&#243;lipos nasais ou urtic&#225;ria pelo uso de AAS ou outros AINES; Crian&#231;as abaixo de 2 anos de idade.</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 250mg:</strong>&#160;1 comprimido, VO, 1 a 2 vezes por dia.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 500mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n</ul>\r\n<hr>\r\n<p>N&#227;o se deve utilizar por mais de 10 dias seguidos.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong style=\"text-align: justify;\">-&#160;</strong><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1880,
        "indications": "<p style=\"text-align: justify;\">- Dores agudas causadas por inflama&#231;&#227;o; Dor e febre em adultos; Dores musculares e articulares; Artrite reumatoide, osteoartrite, espondilite anquilosante, gota e artrite reumatoide juvenil; Tratamento e preven&#231;&#227;o de enxaqueca; Ap&#243;s cirurgias; Entorses, distens&#245;es, contus&#245;es e dor decorrente da pratica desportiva.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:50:04",
        "name": "Naprox",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naprox",
        "substance": "Naproxeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#225;useas, v&#244;mitos, desconforto abdominal, diarreia, hemorragia digestiva, cefaleia, mal estar, tonteira e vertigem, dist&#250;rbios da coagula&#231;&#227;o, erup&#231;&#227;o cut&#226;nea e prurido, disfun&#231;&#227;o hep&#225;tica e renal, trombocitopenia e agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o utilizar se depura&#231;&#227;o de creatinina &lt; 30ml/min.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal e hep&#225;tica, considerar doses menores.</p>\r\n</div>"
    },
    {
        "content_length": 4136,
        "contraindications": "<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Historia de ulcera gastroduodenal ou sangramento gastrintestinal; Insufici&#234;ncia card&#237;aca grave, hep&#225;tica ou renal; Asma, rinite, p&#243;lipos nasais ou urtic&#225;ria pelo uso de AAS ou outros AINES; Crian&#231;as abaixo de 2 anos de idade.</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 250mg:</strong> 1 comprimido, VO, 1 a 2 vezes por dia.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 500mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 550mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n</ul>\r\n<hr>\r\n<p>N&#227;o se deve utilizar por mais de 10 dias seguidos.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>-&#160;</strong><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria D:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1882,
        "indications": "<p style=\"text-align: justify;\">- Dores agudas causadas por inflama&#231;&#227;o; Dor e febre em adultos; Dores musculares e articulares; Artrite reumatoide, osteoartrite, espondilite anquilosante, gota e artrite reumatoide juvenil; Tratamento e preven&#231;&#227;o de enxaqueca; Ap&#243;s cirurgias; Entorses, distens&#245;es, contus&#245;es e dor decorrente da pratica desportiva.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:50:13",
        "name": "Naproxeno",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 500mg.</li>\r\n<li><strong>Comprimido&#160;</strong><strong>revestido:</strong>&#160;550mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naproxeno",
        "substance": "Naproxeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#225;useas, v&#244;mitos, desconforto abdominal, diarreia, hemorragia digestiva, cefaleia, mal estar, tonteira e vertigem, dist&#250;rbios da coagula&#231;&#227;o, erup&#231;&#227;o cut&#226;nea e prurido, disfun&#231;&#227;o hep&#225;tica e renal, trombocitopenia e agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o utilizar se depura&#231;&#227;o de creatinina &lt; 30ml/min.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal e hep&#225;tica, considerar doses menores.</p>\r\n</div>"
    },
    {
        "content_length": 3528,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Historia de ulcera gastroduodenal ou sangramento gastrintestinal; Insufici&#234;ncia card&#237;aca grave, hep&#225;tica ou renal; Asma, rinite, p&#243;lipos nasais ou urtic&#225;ria pelo uso de AAS ou outros AINES; Crian&#231;as abaixo de 2 anos de idade.</span></p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 250mg:</strong>&#160;1 comprimido, VO, 1 a 2 vezes por dia.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 500mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n</ul>\r\n<hr>\r\n<p>N&#227;o se deve utilizar por mais de 10 dias seguidos.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1883,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Dores agudas causadas por inflama&#231;&#227;o; Dor e febre em adultos; Dores musculares e articulares; Artrite reumatoide, osteoartrite, espondilite anquilosante, gota e artrite reumatoide juvenil; Tratamento e preven&#231;&#227;o de enxaqueca; Ap&#243;s cirurgias; Entorses, distens&#245;es, contus&#245;es e dor decorrente da pratica desportiva.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:56:32",
        "name": "Naxotec",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naxotec",
        "substance": "Naproxeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#225;useas, v&#244;mitos, desconforto abdominal, diarreia, hemorragia digestiva, cefaleia, mal estar, tonteira e vertigem, dist&#250;rbios da coagula&#231;&#227;o, erup&#231;&#227;o cut&#226;nea e prurido, disfun&#231;&#227;o hep&#225;tica e renal, trombocitopenia e agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o utilizar se depura&#231;&#227;o de creatinina &lt; 30ml/min.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal e hep&#225;tica, considerar doses menores.</p>\r\n</div>"
    },
    {
        "content_length": 3904,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Historia de ulcera gastroduodenal ou sangramento gastrintestinal; Insufici&#234;ncia card&#237;aca grave, hep&#225;tica ou renal; Asma, rinite, p&#243;lipos nasais ou urtic&#225;ria pelo uso de AAS ou outros AINES; Crian&#231;as abaixo de 2 anos de idade.</span></p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 250mg:</strong>&#160;1 comprimido, VO, 1 a 2 vezes por dia.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Comprimido 500mg:&#160;</strong>1 comprimido, VO, 1 vez por dia.</li>\r\n</ul>\r\n<hr>\r\n<p>N&#227;o se deve utilizar por mais de 10 dias seguidos.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong style=\"text-align: justify;\">-&#160;</strong><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 1885,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Dores agudas causadas por inflama&#231;&#227;o; Dor e febre em adultos; Dores musculares e articulares; Artrite reumatoide, osteoartrite, espondilite anquilosante, gota e artrite reumatoide juvenil; Tratamento e preven&#231;&#227;o de enxaqueca; Ap&#243;s cirurgias; Entorses, distens&#245;es, contus&#245;es e dor decorrente da pratica desportiva.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 00:49:56",
        "name": "Naprosyn",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;250mg e 500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naprosyn",
        "substance": "Naproxeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#225;useas, v&#244;mitos, desconforto abdominal, diarreia, hemorragia digestiva, cefaleia, mal estar, tonteira e vertigem, dist&#250;rbios da coagula&#231;&#227;o, erup&#231;&#227;o cut&#226;nea e prurido, disfun&#231;&#227;o hep&#225;tica e renal, trombocitopenia e agranulocitose.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o utilizar se depura&#231;&#227;o de creatinina &lt; 30ml/min.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Insufici&#234;ncia renal e hep&#225;tica, considerar doses menores.</p>\r\n</div>"
    },
    {
        "content_length": 5021,
        "contraindications": "<p>- Rea&#231;&#245;es intensas ao medicamento ou outras hidanto&#237;nas, S&#237;ndrome de Adam-Stokes, Bloqueio AV de 2&#186; e 3&#186; graus, Bloqueio sinoatrial, Bradicardia sinusal</p>",
        "dosage_adults": "<div>\r\n<p>&#160;<strong>Dose ambulatorial</strong></p>\r\n<ul>\r\n<li>Pacientes que n&#227;o receberam tratamento pr&#233;vio podem iniciar com 100 mg da suspens&#227;o oral (5 mL), 3 vezes ao dia.</li>\r\n<li>Em seguida, a dose deve ser ajustada de acordo com as necessidades individuais.</li>\r\n<li>Se necess&#225;rio, pode ser realizado um aumento na dose para at&#233; 500 mg (25 mL) diariamente.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose inicial de ataque n&#227;o emergencial</strong></p>\r\n<ul>\r\n<li>Uma dose de ataque pode ser utilizada para in&#237;cio n&#227;o emergencial da terapia em adultos que necessitam de r&#225;pido estado de equil&#237;brio dos n&#237;veis s&#233;ricos e quando n&#227;o &#233; desej&#225;vel a administra&#231;&#227;o intravenosa. Este esquema posol&#243;gico deve ser reservado para pacientes internados em cl&#237;nicas e hospitais; ou seja, locais onde os n&#237;veis s&#233;ricos de fenito&#237;na podem ser rigorosamente monitorados. Pacientes com hist&#243;ria de disfun&#231;&#227;o renal ou hep&#225;tica n&#227;o devem receber esta dose inicial de ataque por via oral.</li>\r\n<li><strong>Dose de ataque:</strong> 1 grama, dividida em 3 doses (400 mg, 300 mg, 300 mg) e administrada em intervalos de duas horas. A dose de manuten&#231;&#227;o normal &#233;, ent&#227;o, institu&#237;da 24 horas ap&#243;s a dose inicial de ataque, com determina&#231;&#245;es frequentes dos n&#237;veis s&#233;ricos.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>Inicialmente:</strong> 5 mg/kg/dia em 2 ou 3 doses igualmente divididas, com doses subsequentes individualizadas de no m&#225;ximo 300 mg/dia.</li>\r\n<li><strong>Dose de manuten&#231;&#227;o:</strong> 4 a 8 mg/kg.</li>\r\n<li>Crian&#231;as acima de 6 anos e adolescentes podem necessitar da dose m&#237;nima de adultos (300 mg/dia).</li>\r\n<li>Se a dose di&#225;ria n&#227;o puder ser dividida por igual, a dose maior deve ser administrada na hora de dormir.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1887,
        "indications": "<p>- Crises convulsivas epil&#233;pticas e parciais, por traumatismo cranioencef&#225;lico, secund&#225;rias e neurocirurgia.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:44:39",
        "name": "Epelin",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral (xarope)</strong>: 20 mg/mL.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial (C1 - branca em duas vias).</p>",
        "record_status": 1,
        "slug": "hidantal",
        "substance": "Fenitoína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p>- Sistema nervoso central: Nistagmo, ataxia, dificuldade na fala, altera&#231;&#245;es na coordena&#231;&#227;o, confus&#227;o mental, vertigem, ins&#244;nia, nervosismo transit&#243;rio, contra&#231;&#227;o motora, cefaleia. Relato de raros casos de discinesia induzida por fenito&#237;na. Observado polineuropatia perif&#233;rica em pacientes sob tratamento a longo prazo</p>\r\n<p>- Sistema gastrointestinal: n&#225;usea, v&#244;mitos, constipa&#231;&#227;o, hepatite t&#243;xica e preju&#237;zo hep&#225;tico</p>\r\n<p>- Sistema tegumentar: rash morbiliforme e escarlatiniforme</p>\r\n<p>- Sistema hematopoi&#233;tico: trombocitopenia, leucopenia, granulocitopenia, agranulocitose e pancitopenia</p>\r\n<p>- Sistema do tecido conjuntivo: engrossamento das caracter&#237;sticas faciais, aumento dos l&#225;bios, hiperplasia gengival, hipertricose, doen&#231;a de Peyronie</p>\r\n<p>- Sistema cardiovascular: periarterite nodosa</p>\r\n<p>- Sistema imunol&#243;gico: s&#237;ndrome de hipersensibilidade, lupus eritematoso sist&#234;mico, anormalidade de imunoglobulinas</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5762,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes, uso concomitante de cloridrato de apomorfina.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito em geral:</strong> 8mg IV de 12/12h&#160;</li>\r\n<li><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mitos no p&#243;s-operat&#243;rio:&#160;</strong>8 mg, IV, 1 hora antes da anestesia, seguida de outras duas doses de 8 mg de 8/8 horas.</li>\r\n<li><strong>Quimioterapia altamente emetog&#234;nica:</strong> dose &#250;nica de 24 mg, IV, administrado 30 minutos antes do inicio da quimioterapia do dia.</li>\r\n<li><strong>Quimioterapia moderadamente emetog&#234;nica:</strong> 8mg, IV, 2x/dia, 30 minutos antes do inicio da quimioterapia emetog&#234;nica, com dose subsequente 8h depois. 8 mg de ondansetrona, 2x/dia, durante 1 a 2 dias ap&#243;s t&#233;rmino da quimioterapia.</li>\r\n<li><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito associado a radioterapia:</strong> 8mg, IV, 3x/dia. Para irradia&#231;&#227;o total do corpo: 8 mg, IV, 1 a 2 horas antes de cada fra&#231;&#227;o de radioterapia. Para radioterapia do abdome em dose &#250;nica elevada: 8mg, IV, 1 a 2 horas antes da radioterapia, com doses subsequentes por VO&#160;a cada 8h ap&#243;s a primeira dose, durante 1 a 2 dias ap&#243;s o t&#233;rmino da radioterapia. Para radioterapia do abdome em doses fracionadas di&#225;rias: 8mg, IV, 1 a 2 horas antes da radioterapia, com doses subsequentes por VO a cada 8 horas ap&#243;s a primeira dose.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito em geral: </strong>&gt;11 anos: 4 a 8 mg. Para crian&#231;as de 2-11 anos: 4 mg.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Quimioterapia altamente emetog&#234;nica:&#160;</strong>dose &#250;nica intravenosa de 0,15 mg/kg, n&#227;o excedendo 8mg, antes da quimioterapia. No 1&#186; dia, duas doses adicionais por via intravenosa podem ser dadas com intervalos de 4 horas. A administra&#231;&#227;o por via oral pode come&#231;ar 12h mais tarde e continuar por at&#233; 5 dias. N&#227;o deve ser excedida a dose de adultos.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Quimioterapia moderadamente emetog&#234;nica:</strong> &gt;11anos: Idem a de adultos. Para crian&#231;as com 2-11 anos: 4 mg, 3x/dia durante 1 a 2 dias ap&#243;s o t&#233;rmino da quimioterapia.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito associado a radioterapia:</strong> para crian&#231;as com 2-11 anos: 4 mg, 3x/dia. A primeira dose deve ser administrada 1 a 2 horas antes do in&#237;cio da radioterapia, com doses subsequentes a cada 8h. 4 mg de ondansetrona, 3x/dia durante 1 a 2 dias ap&#243;s t&#233;rmino da radioterapia. &gt;11 anos: Idem a de adultos.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1890,
        "indications": "<ul>\r\n<li>Controle da n&#225;usea e do v&#244;mito induzidos por quimioterapia citot&#243;xica e radioterapia.</li>\r\n<li>Preven&#231;&#227;o e tratamento de n&#225;useas e v&#244;mitos do p&#243;s-operat&#243;rio.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Baixo risco:</span></strong><span style=\"line-height: 107%;\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-04 00:36:38",
        "name": "Ansentron",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 4 mg e 8 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ondansetrona",
        "substance": "Ondansetrona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"text-align: justify;\">- Cefaleia, sensa&#231;&#227;o de calor ou rubor, constipa&#231;&#227;o intestinal, eleva&#231;&#245;es nos n&#237;veis de transaminase, rea&#231;&#245;es no local da inje&#231;&#227;o intravenosa,&#160;convuls&#227;o, transtornos do movimento (inclusive dist&#250;rbios extrapiramidais, tais como crises ocul&#243;giras, rea&#231;&#245;es dist&#244;nicas e discinesia, observados sem evid&#234;ncias definitivas de persist&#234;ncia de sequelas cl&#237;nicas), arritmias, dor tor&#225;cica, com ou sem depress&#227;o do segmento ST,&#160; bradicardia, hipotens&#227;o, solu&#231;os, aumento P&#225;gina 8 de 10 assintom&#225;tico de testes funcionais hep&#225;ticos (essas rea&#231;&#245;es foram observadas em pacientes submetidos a quimioterapia com cisplatina),&#160;rea&#231;&#245;es de hipersensibilidade imediata, &#224;s vezes graves, inclusive anafilaxia, tontura predominantemente durante a administra&#231;&#227;o intravenosa r&#225;pida, dist&#250;rbios visuais passageiros (como vis&#227;o turva), predominantemente durante a administra&#231;&#227;o intravenosa; prolongamento do intervalo QT (incluindo Torsade de Pointes).</span></p>\r\n<hr>\r\n<p><strong>Ajustes na Insufuci&#234;ncia hep&#225;tica:&#160;</strong>Dose m&#225;xima de 8 mg.</p>\r\n<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 107%;\">N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 6157,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos sais de ferro ou a qualquer um dos componentes do produto;</p>\r\n<p>- Todas as anemias n&#227;o ferrop&#234;nicas, particularmente aquelas causadas por ac&#250;mulo de ferro ou incapacidade de sua utiliza&#231;&#227;o, tais como hemocromatose, hemosiderose, anemia falciforme, anemia hemol&#237;tica ou anemia megalobl&#225;stica devida a defici&#234;ncia de vitamina B12, anemia provocada pelo chumbo, anemia s&#237;dero-acr&#233;stica, talassemia, anemia por tumores ou infec&#231;&#245;es (sem defici&#234;ncia de ferro), anemias associadas &#224; leucemia aguda ou cr&#244;nica e hepatopatia aguda;</p>\r\n<p>- Processos que impedem a absor&#231;&#227;o de ferro por via oral, como diarreias cr&#244;nicas e retocolite ulcerativa.&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Uso parenteral IV:</strong></p>\r\n<ul>\r\n<li><strong>Posologia m&#233;dia recomendada:</strong> 5 a 10 mL de hidr&#243;xido f&#233;rrico (100 a 200 mg de ferro) 1 a 3x/semana, dependendo do n&#237;vel de hemoglobina</li>\r\n</ul>\r\n<hr>\r\n<p><strong><span style=\"text-decoration: underline;\">C&#225;lculo da dose:</span></strong></p>\r\n<p>A posologia dever&#225; ser determinada individualmente, conforme a necessidade total de ferro, levando-se em conta tr&#234;s fatores:</p>\r\n<p><strong>1)</strong> grau de defici&#234;ncia de ferro, d&#233;ficit total de ferro em mg;</p>\r\n<p><strong>2)</strong> peso do paciente em kg;</p>\r\n<p><strong>3)</strong> reserva de ferro necess&#225;ria.</p>\r\n<p>Pode-se encontrar a dose total (em mg) para um tratamento completo por meio da seguinte f&#243;rmula:</p>\r\n<p><strong>Defici&#234;ncia total em ferro (mg) =</strong> [peso (kg) x DHb (g/ dl) x 2,4] + reservas de Fe (mg)</p>\r\n<p>onde DHb = diferen&#231;a entre a hemoglobina ideal para o sexo e a idade do paciente e a hemoglobina encontrada no exame laboratorial do paciente (em g/dl).</p>\r\n<table style=\"height: 74px; margin-left: auto; margin-right: auto;\" border=\"3\" width=\"605\">\r\n<tbody>\r\n<tr>\r\n<td style=\"width: 194px;\">&#160;</td>\r\n<td style=\"width: 194px;\"><strong>Valores m&#233;dios de hemoglobina desejados</strong></td>\r\n<td style=\"width: 195px;\"><strong>Reservas de ferro desejadas</strong></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 194px;\"><strong>&lt; 35 kg de peso corporal</strong></td>\r\n<td style=\"width: 194px;\">13,0 g/ dl</td>\r\n<td style=\"width: 195px;\">15 mg/kg</td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 194px;\"><strong>&#8805;&#160;35 kg de peso corporal</strong></td>\r\n<td style=\"width: 194px;\">15,0 g/ dl&#160;</td>\r\n<td style=\"width: 195px;\">500 mg</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p style=\"text-align: center;\">dada a resposta...</p>\r\n<p><strong>N&#186; total de mL administrados (apresenta&#231;&#227;o IV) =&#160;</strong>Defici&#234;ncia Total em Ferro (mg) /&#160;20 mg/ml</p>\r\n<p style=\"text-align: center;\"><span style=\"text-align: center;\">Posologia&#160;</span><strong style=\"text-align: center;\">MACETEADA&#160;</strong><span style=\"text-align: center;\">para apresenta&#231;&#227;o&#160;</span><strong style=\"text-align: center;\">IV</strong></p>\r\n<p style=\"text-align: center;\"><strong style=\"text-align: center;\"><img src=\"https://appsosplantao.com.br/media/noripurum_iv-min.jpg\" alt=\"\" width=\"657\" height=\"298\"></strong></p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Uso parenteral IV:</strong></p>\r\n<p>Dose di&#225;ria m&#225;xima tolerada:</p>\r\n<ul>\r\n<li>N&#227;o exceder a dose de 0,15 mL/kg de hidr&#243;xido f&#233;rrico (3 mg de ferro/kg), 1 a 3x/semana, dependendo do n&#237;vel de hemoglobina.&#160;</li>\r\n</ul>\r\n<p style=\"text-align: center;\">&#160;</p>\r\n<p style=\"text-align: center;\">Posologia&#160;<strong>MACETEADA&#160;</strong>para apresenta&#231;&#227;o&#160;<strong>IV</strong></p>\r\n<p style=\"text-align: center;\"><strong><img src=\"https://appsosplantao.com.br/media/noripurum_iv-min.jpg\" alt=\"\" width=\"657\" height=\"298\"></strong></p>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1906,
        "indications": "<div>\r\n<p>- S&#237;ndromes ferrop&#234;nicas latentes e moderadas;</p>\r\n<p>- Anemias ferroprivas devidas a subnutri&#231;&#227;o e/ou car&#234;ncias alimentares qualitativas e quantitativas;</p>\r\n<p>- Anemias das s&#237;ndromes disabsortivas intestinais;</p>\r\n<p>- Anemia ferropriva da gravidez e da lacta&#231;&#227;o;</p>\r\n<p>- Anemia por hemorragias agudas ou cr&#244;nicas e em condi&#231;&#245;es nas quais seja conveniente uma suplementa&#231;&#227;o dos fatores hematog&#234;nicos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 58,
        "lactation_text": "<p class=\"MsoNormal\">N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 18:00:50",
        "name": "Ferropurum",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel IV:</strong>&#160;100 mg/5ml (20 mg/ml)</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ferropurum",
        "substance": "Hidróxido de Ferro",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Rea&#231;&#227;o muito comum: fezes escurecidas;</p>\r\n<p>- Rea&#231;&#227;o comum: diarreia, n&#225;useas, dor abdominal , constipa&#231;&#227;o;</p>\r\n<p>- Rea&#231;&#227;o incomum: v&#244;mitos , escurecimento de dente, gastrite, rash (exantema, erup&#231;&#227;o cut&#226;nea, rash cut&#226;neo), urtic&#225;ria, prurido, eritema, cefaleia;</p>\r\n<p>- Rea&#231;&#227;o rara: espasmos musculares, mialgia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2702,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade conhecida &#224; Zopiclona e aos demais componentes do produto, miastenia grave, insufici&#234;ncia respirat&#243;ria, s&#237;ndrome de apneia do sono severa, insufici&#234;ncia hep&#225;tica severa.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose habitual:&#160;</strong>7,5mg, VO, ao deitar-se.</li>\r\n<li>O tempo de tratamento n&#227;o deve exceder 4 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1907,
        "indications": "<p>- Indicado para o tratamento de curta dura&#231;&#227;o da ins&#244;nia em adultos.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 20:52:39",
        "name": "Imovane",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong> 7,5mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples em duas vias.</p>",
        "record_status": 1,
        "slug": "zopiclona",
        "substance": "Zopiclona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">-&#160;</strong>Tontura, cefaleia, sonol&#234;ncia residual, dispepsia, n&#225;usea, boca seca, alergia ou rea&#231;&#245;es cut&#226;neas como prurido e rash, amn&#233;sia anter&#243;grada, irritabilidade, confus&#227;o, alucina&#231;&#245;es, agressividade, ins&#244;nia rebote, ansiedade, tremor, suor, agita&#231;&#227;o, confus&#227;o, cefal&#233;ia, palpita&#231;&#227;o, taquicardia, del&#237;rio, pesadelos, alucina&#231;&#245;es, irritabilidade.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">-&#160;</strong>Em pacientes com insufici&#234;ncia hep&#225;tica e renal, recomenda-se a dose inicial de 3,75 mg, recomenda-se uma dose inicial menor para pacientes com insufici&#234;ncia respirat&#243;ria cr&#244;nica. Pacientes idosos devem utilizar dose reduzida (3,75mg iniciais).</p>\r\n</div>"
    },
    {
        "content_length": 1892,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula, &#250;lceras g&#225;stricas e duodenais.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong>&#160;5-10 ml VO de 8/8h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>&lt;12 anos:</strong>&#160;0,25 ml/kg VO de 8/8h.</li>\r\n<li><strong>&gt;12 anos:&#160;</strong>Idem a de adultos.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1911,
        "indications": "<p>- Mucol&#237;tico e fluidificante das secre&#231;&#245;es nas afec&#231;&#245;es agudas ou cr&#244;nicas do trato respirat&#243;rio.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-12-09 23:44:57",
        "name": "Carbocisteína",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 50mg/ml e 20mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "carbocisteina",
        "substance": "Carbocisteína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;useas, diarreia, desconforto g&#225;strico, ins&#244;nia, cefaleia, tontura, erup&#231;&#245;es cut&#226;neas.</p>\r\n<hr>\r\n<p><strong>- Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p><strong>- Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5207,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos sais de ferro ou a qualquer um dos componentes do produto;</p>\r\n<p>- Todas as anemias n&#227;o ferrop&#234;nicas, particularmente aquelas causadas por ac&#250;mulo de ferro ou incapacidade de sua utiliza&#231;&#227;o, tais como hemocromatose, hemosiderose, anemia falciforme, anemia hemol&#237;tica ou anemia megalobl&#225;stica devida a defici&#234;ncia de vitamina B12, anemia provocada pelo chumbo, anemia s&#237;dero-acr&#233;stica, talassemia, anemia por tumores ou infec&#231;&#245;es (sem defici&#234;ncia de ferro), anemias associadas &#224; leucemia aguda ou cr&#244;nica e hepatopatia aguda;</p>\r\n<p>- Processos que impedem a absor&#231;&#227;o de ferro por via oral, como diarreias cr&#244;nicas e retocolite ulcerativa.&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Observa&#231;&#245;es iniciais:</strong></p>\r\n<ul>\r\n<li>1 comprimido = 100 mg de ferro elementar</li>\r\n<li>10 ml do xarope = 100 mg de ferro elementar&#160;</li>\r\n<li>A dose e a dura&#231;&#227;o da terapia dependem da extens&#227;o da defici&#234;ncia de ferro.</li>\r\n<li>Deve ser administrado durante ou imediatamente ap&#243;s as refei&#231;&#245;es.</li>\r\n<li>Para facilitar a administra&#231;&#227;o, a dose pode ser misturada com mingau, sucos de fruta ou verduras ou leite.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Tratamento da anemia (adultos e lactantes):</strong></p>\r\n<ul>\r\n<li>10 a 20 ml de xarope 1x/dia, ou 20 a 40 gotas 1x/dia.</li>\r\n<li>Tratamento por 3 a 5 meses, at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 10 ml 1x/dia ou 20 gotas 1x/dia por v&#225;rias semanas (2 a 3 meses) a fim de restaurar a reserva de ferro.</li>\r\n</ul>\r\n<p><strong>Profilaxia da anemia (adultos e lactantes):</strong></p>\r\n<ul>\r\n<li>10 ml do xarope 1x/dia, ou 20 gotas 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Mulheres gr&#225;vidas:</strong></p>\r\n<ul>\r\n<li><strong>Tratamento:</strong> 20 a 30 ml do xarope/dia 2 a 3x/dia, ou 40 gotas 1x/dia,&#160;&#160;at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 20 gotas 1x/dia&#160;pelo menos at&#233; o final da gravidez a fim de restaurar a reserva de ferro.</li>\r\n<li><strong>Profilaxia:</strong> 10 ml do xarope 1x/dia, ou 20 gotas 1x/dia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Crian&#231;as de at&#233; um ano:</strong></p>\r\n<ul>\r\n<li>N&#227;o citado na bula.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Crian&#231;as de 1 a 12 anos:</strong></p>\r\n<ul>\r\n<li><strong>Profilaxia:</strong>&#160;2,5 a 6 ml do xarope 1x/dia, ou 5 a 12 gotas 1x/dia.</li>\r\n<li><strong>Tratamento:</strong>&#160;at&#233; 6 ml do xarope 1x/dia, ou 1 gota/kg/dia para crian&#231;as at&#233; 12 kg. Acima de 12 kg, ingerir 12 gotas 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Crian&#231;as &gt; 12 anos:</strong></p>\r\n<ul>\r\n<li>Posologia idem adultos.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1919,
        "indications": "<div>\r\n<p>- S&#237;ndromes ferrop&#234;nicas latentes e moderadas;</p>\r\n<p>- Anemias ferroprivas devidas a subnutri&#231;&#227;o e/ou car&#234;ncias alimentares qualitativas e quantitativas;</p>\r\n<p>- Anemias das s&#237;ndromes disabsortivas intestinais;</p>\r\n<p>- Anemia ferropriva da gravidez e da lacta&#231;&#227;o;</p>\r\n<p>- Anemia por hemorragias agudas ou cr&#244;nicas e em condi&#231;&#245;es nas quais seja conveniente uma suplementa&#231;&#227;o dos fatores hematog&#234;nicos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 72,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:46:53",
        "name": "Myrafer",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 400 mg/ml (100 mg de ferro elementar).</li>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 400 mg/10ml (100 mg de ferro elementar).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Ferripolimaltose",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Rea&#231;&#227;o muito comum: fezes escurecidas;</p>\r\n<p>- Rea&#231;&#227;o comum: diarreia, n&#225;useas, dor abdominal , constipa&#231;&#227;o;</p>\r\n<p>- Rea&#231;&#227;o incomum: v&#244;mitos , escurecimento de dente, gastrite, rash (exantema, erup&#231;&#227;o cut&#226;nea, rash cut&#226;neo), urtic&#225;ria, prurido, eritema, cefaleia;</p>\r\n<p>- Rea&#231;&#227;o rara: espasmos musculares, mialgia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5209,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos sais de ferro ou a qualquer um dos componentes do produto;</p>\r\n<p>- Todas as anemias n&#227;o ferrop&#234;nicas, particularmente aquelas causadas por ac&#250;mulo de ferro ou incapacidade de sua utiliza&#231;&#227;o, tais como hemocromatose, hemosiderose, anemia falciforme, anemia hemol&#237;tica ou anemia megalobl&#225;stica devida a defici&#234;ncia de vitamina B12, anemia provocada pelo chumbo, anemia s&#237;dero-acr&#233;stica, talassemia, anemia por tumores ou infec&#231;&#245;es (sem defici&#234;ncia de ferro), anemias associadas &#224; leucemia aguda ou cr&#244;nica e hepatopatia aguda;</p>\r\n<p>- Processos que impedem a absor&#231;&#227;o de ferro por via oral, como diarreias cr&#244;nicas e retocolite ulcerativa.&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Observa&#231;&#245;es iniciais:</strong></p>\r\n<ul>\r\n<li>1 comprimido = 100 mg de ferro elementar</li>\r\n<li>10 ml do xarope = 100 mg de ferro elementar&#160;</li>\r\n<li>A dose e a dura&#231;&#227;o da terapia dependem da extens&#227;o da defici&#234;ncia de ferro.</li>\r\n<li>Deve ser administrado durante ou imediatamente ap&#243;s as refei&#231;&#245;es.</li>\r\n<li>Para facilitar a administra&#231;&#227;o, a dose pode ser misturada com mingau, sucos de fruta ou verduras ou leite.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Tratamento da anemia (adultos e lactantes):</strong></p>\r\n<ul>\r\n<li>10 a 20 ml de xarope 1x/dia, ou 20 a 40 gotas 1x/dia.</li>\r\n<li>Tratamento por 3 a 5 meses, at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 10 ml 1x/dia ou 20 gotas 1x/dia por v&#225;rias semanas (2 a 3 meses) a fim de restaurar a reserva de ferro.</li>\r\n</ul>\r\n<p><strong>Profilaxia da anemia (adultos e lactantes):</strong></p>\r\n<ul>\r\n<li>10 ml do xarope 1x/dia, ou 20 gotas 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Mulheres gr&#225;vidas:</strong></p>\r\n<ul>\r\n<li><strong>Tratamento:</strong> 20 a 30 ml do xarope/dia 2 a 3x/dia, ou 40 gotas 1x/dia,&#160;&#160;at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 20 gotas 1x/dia&#160;pelo menos at&#233; o final da gravidez a fim de restaurar a reserva de ferro.</li>\r\n<li><strong>Profilaxia:</strong> 10 ml do xarope 1x/dia, ou 20 gotas 1x/dia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Crian&#231;as de at&#233; um ano:</strong></p>\r\n<ul>\r\n<li>N&#227;o citado na bula.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Crian&#231;as de 1 a 12 anos:</strong></p>\r\n<ul>\r\n<li><strong>Profilaxia:</strong>&#160;2,5 a 6 ml do xarope 1x/dia, ou 5 a 12 gotas 1x/dia.</li>\r\n<li><strong>Tratamento:</strong>&#160;at&#233; 6 ml do xarope 1x/dia, ou 1 gota/kg/dia para crian&#231;as at&#233; 12 kg. Acima de 12 kg, ingerir 12 gotas 1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Crian&#231;as &gt; 12 anos:</strong></p>\r\n<ul>\r\n<li>Posologia idem adultos.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1930,
        "indications": "<div>\r\n<p>- S&#237;ndromes ferrop&#234;nicas latentes e moderadas;</p>\r\n<p>- Anemias ferroprivas devidas a subnutri&#231;&#227;o e/ou car&#234;ncias alimentares qualitativas e quantitativas;</p>\r\n<p>- Anemias das s&#237;ndromes disabsortivas intestinais;</p>\r\n<p>- Anemia ferropriva da gravidez e da lacta&#231;&#227;o;</p>\r\n<p>- Anemia por hemorragias agudas ou cr&#244;nicas e em condi&#231;&#245;es nas quais seja conveniente uma suplementa&#231;&#227;o dos fatores hematog&#234;nicos.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 17:13:03",
        "name": "Dexfer",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 400 mg/ml (100 mg de ferro elementar).</li>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 400 mg/10ml (100 mg de ferro elementar).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Ferripolimaltose",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Rea&#231;&#227;o muito comum: fezes escurecidas;</p>\r\n<p>- Rea&#231;&#227;o comum: diarreia, n&#225;useas, dor abdominal , constipa&#231;&#227;o;</p>\r\n<p>- Rea&#231;&#227;o incomum: v&#244;mitos , escurecimento de dente, gastrite, rash (exantema, erup&#231;&#227;o cut&#226;nea, rash cut&#226;neo), urtic&#225;ria, prurido, eritema, cefaleia;</p>\r\n<p>- Rea&#231;&#227;o rara: espasmos musculares, mialgia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2756,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; droga.</p>\r\n<p>- Hist&#243;ria de arritmias.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Trombocitopenia (profilaxia):</strong> 50 mcg/kg de peso corporal, 1x/dia, SC, 24 a 48 horas ap&#243;s o t&#233;rmino da quimioterapia ou ap&#243;s a ocorr&#234;ncia de trombocitopenia, uma vez ao dia por 7 a 14 dias;</li>\r\n<li>Interromper o tratamento caso a contagem de plaquetas retorne ao normal e, pelo menos, dois dias antes do in&#237;cio do pr&#243;ximo ciclo de quimioterapia.</li>\r\n</ul>",
        "dosage_children": "<p>-&#160;<span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>",
        "gestation": 3,
        "gestation_text": "<ul>\r\n<li class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</li>\r\n</ul>",
        "id": 1932,
        "indications": "<p>- Preven&#231;&#227;o de trombocitopenia grave ap&#243;s quimioterapia mielossupressiva em pacientes com tumores malignos n&#227;o-miel&#243;ides.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 127,
        "lactation_text": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Alto risco:</span></strong><span style=\"line-height: 107%;\"> Uso inseguro. Avaliar alternativas mais seguras.</span></p>\r\n</li>\r\n</ul>",
        "last_update": "2019-03-05 01:20:13",
        "name": "Neumega",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "plaquemax",
        "substance": "Oprelvecina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Edema, neutropenia febril, cefaleia, febre, taquicardia, vasodilata&#231;&#227;o, palpita&#231;&#245;es, desmaios e fibrila&#231;&#227;o/flutter atrial, n&#225;usea/v&#244;mitos, mucosite, diarreia, candid&#237;ase oral, tontura, ins&#244;nia, dispneia, rinite, aumento da tosse, faringite, derrame pleural, erup&#231;&#227;o cut&#226;nea, congest&#227;o conjuntival, turva&#231;&#227;o visual, desidrata&#231;&#227;o, descolora&#231;&#227;o da pele, dermatite esfoliativa e hemorragia ocular.</p>\r\n<hr>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5557,
        "contraindications": "<div>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Insufici&#234;ncia hep&#225;tica significativa ou n&#227;o explicada</span></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"text-indent: 0cm;\">- Disfun&#231;&#227;o hep&#225;tica</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- &#218;lcera p&#233;ptica ativa </span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Sangramento arterial</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"text-indent: 0cm;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Dose inicial:</span></strong><span class=\"apple-converted-space\" style=\"text-indent: 0cm;\"><span style=\"mso-bidi- line-height: 150%; background: white; mso-bidi-font-weight: bold;\">&#160;</span></span><span style=\"mso-bidi- line-height: 150%; background: white;\">10 mg/kg/dia VO para tomar de 8/8 horas, aumentar dose em 100 mg/dia a cada 2 - 3 semanas.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"text-indent: 0cm;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Dose m&#225;xima:</span></strong><span class=\"apple-converted-space\" style=\"text-indent: 0cm;\"><span style=\"mso-bidi- line-height: 150%; background: white;\">&#160;</span></span><span style=\"mso-bidi- line-height: 150%; background: white;\">2000 mg/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">Medica&#231;&#227;o n&#227;o recomendada para a faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1936,
        "indications": "<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Hipertrigliceridemia e hipercolesterolemia.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 16:22:55",
        "name": "Acinic",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\"><strong>Comprimido de libera&#231;&#227;o prolongada:</strong> 500 mg e 750 mg&#160;</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Acinic",
        "substance": "Ácido Nicotínico",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 150%;\">Ajustes na insufici&#234;ncia renal:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 150%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Rea&#231;&#227;o mais comum: flush (pele vermelha, sensa&#231;&#227;o de calor e coceira), que pode ser acompanhado de tonturas, palpita&#231;&#227;o, dispneia, sudorese, calafrios e/ou incha&#231;o. Outros efeitos adversos poss&#237;veis s&#227;o cefaleia, dor abdominal, dispepsia, diarreia, n&#225;usea, eleva&#231;&#227;o das transaminases, hiperglicemia, v&#244;mito, rinite e exantema, principalmente em doses mais elevadas. H&#225; aumento dos n&#237;veis de &#225;cido &#250;rico e pode ocasionar crises de gota. O uso de 325 mg de &#225;cido acetilsalic&#237;lico, 30 min antes do &#225;cido nicot&#237;nico, reduz o flush.</span></p>\r\n</div>"
    },
    {
        "content_length": 4139,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Cardiomiopatia hipertr&#243;fica;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipotens&#227;o arterial grave;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Infarto ventricular direito;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Em caso de gravidez consultar o medico do pr&#233;-natal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Angina cr&#244;nica:</strong> 10 a 40 mg VO 2-3x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Na emerg&#234;ncia:&#160;</strong>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">10 ampolas (100mg/10mL) + SF 0,9% 90mL; fazer 0,8mg/kg IV por 2-3h a cada 8-12h.</li>\r\n</ul>\r\n</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Recomenda-se intervalo m&#237;nimo de 12 horas entre a &#250;ltima dose de um dia e a primeira dose do dia seguinte do comprimido.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">N&#227;o recomendado para popula&#231;&#227;o pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1938,
        "indications": "<div>\r\n<p>- Angina de repouso, de esfor&#231;o, p&#243;s infarto;</p>\r\n<p>- Edema pulmonar cardiog&#234;nico;</p>\r\n<p>- Insufici&#234;ncia card&#237;aca associada a infarto;</p>\r\n<p>- Isquemia coronariana.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-01-13 20:34:48",
        "name": "Coronar",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong>&#160;20mg;</li>\r\n<li><strong>Ampolas para uso injet&#225;vel:&#160;</strong>10mg/1mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "coronar",
        "substance": "Mononitrato de Isossorbida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Bradicardia, dor tor&#225;cica, hipotens&#227;o, n&#225;useas e v&#244;mitos, rea&#231;&#245;es al&#233;rgicas, sudorese.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2249,
        "contraindications": "<div>\r\n<p>- Presen&#231;a ou hist&#243;rico de tromboflebite, dist&#250;rbios tromboemb&#243;licos ou cerebrovasculares;</p>\r\n<p>- Presen&#231;a ou hist&#243;ria de pancreatite;</p>\r\n<p>- Presen&#231;a de hipertens&#227;o arterial sist&#234;mica moderada ou grave;</p>\r\n<p>- Angina pectoris;</p>\r\n<p>- Hist&#243;ria de c&#226;ncer de mama, &#250;tero ou vagina;</p>\r\n<p>- Sangramento vaginal de causa n&#227;o diagnosticada;</p>\r\n<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula;</p>\r\n<p>- Presen&#231;a ou hist&#243;ria de tumores hep&#225;ticos benignos ou malignos;</p>\r\n<p>- Gesta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>1 aplica&#231;&#227;o mensal IM entre o 1&#176; e o 5&#176; dia do ciclo menstrual.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o indicado antes da menarca.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 1940,
        "indications": "<ul>\r\n<li>Contraceptivo.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p><strong>Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.&#160;</p>",
        "last_update": "2019-01-13 19:24:17",
        "name": "Depomês",
        "presentation": "<ul>\r\n<li>Suspens&#227;o injet&#225;vel: 25mg de medroxiprogesterona + 5mg de estradiol em 1 mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "depomes",
        "substance": "Medroxiprogesterona + Estradiol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Sangramento intermenstrual;</p>\r\n<p>- Altera&#231;&#227;o do padr&#227;o normal de sangramento.</p>\r\n<hr>\r\n<p><strong>Ajustes na Infusici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4006,
        "contraindications": "<div>\r\n<p>- Hist&#243;ria de hipersensibilidade a qualquer um dos componentes da prepara&#231;&#227;o.</p>\r\n<p>- Atrofia de pele preexistente, que pode ser exacerbada pela a&#231;&#227;o do corticoster&#243;ide.</p>\r\n<p>- Infec&#231;&#227;o no local da tratamento, que pode ser exacerbada caso n&#227;o esteja sendo utilizado um antimicrobiano adequado.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Creme:&#160;</strong>Les&#245;es &#250;midas: uma pequena quantidade deve ser friccionada cuidadosamente sobre a &#225;rea afetada, 2 a 3x/dia.</li>\r\n<li><strong>Pomada:&#160;</strong>Les&#245;es secas e escamosas: deve ser aplicado em finas camadas nas &#225;reas afetadas, 2 a 3x/dia.</li>\r\n<li><strong>Lo&#231;&#227;o capilar:&#160;</strong>Direcionado para o uso no couro cabeludo ou outras &#225;reas pilosas, al&#233;m de extensas &#225;reas de aplica&#231;&#227;o, quando necess&#225;rio. Deve ser friccionada cuidadosamente sobre a &#225;rea afetada, 2 a 3x/dia.</li>\r\n<li><strong>Curativo:&#160;</strong>Controle de psor&#237;ase ou outras condi&#231;&#245;es resistentes: Colocar uma fita por dia no local afetado, podendo tambem ser trocada de 12/12 horas.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li>Uso permitido, por&#233;m usar uma posologia um pouco menor do que nos adultos.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1941,
        "indications": "<p>- Al&#237;vio de manifesta&#231;&#245;es inflamat&#243;rias e pruriginosas de dermatoses que respondem a corticoster&#243;ides.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-01-13 17:20:42",
        "name": "Drenison",
        "presentation": "<ul>\r\n<li><strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Uso t&#243;pico (creme):&#160;</span></strong>0,125 mg/g.</li>\r\n<li><strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Uso t&#243;pico (pomada):</span></strong>&#160;0,125 mg/g.</li>\r\n<li><strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Uso t&#243;pico (lo&#231;&#227;o):&#160;</span></strong>frasco com 30 mL a 0,5 mg/mL.</li>\r\n<li><strong>Curativo oclusivo:</strong> 4mcg/cm&#178;.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "drenison",
        "substance": "Fludroxicortida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Queimadura, prurido, irrita&#231;&#227;o, secura da pele, foliculite, hipertricose, erup&#231;&#245;es acneiformes, hipopigmenta&#231;&#227;o ou outras altera&#231;&#245;es na pigmenta&#231;&#227;o da pele, dermatite perioral, dermatite de contato al&#233;rgica, macera&#231;&#227;o da pele, infec&#231;&#227;o secund&#225;ria, atrofia da pele, estrias, mili&#225;ria, furunculose, p&#250;stulas, piodermatite, vesicula&#231;&#227;o, hiperestesia, p&#250;rpura, entorpecimento dos dedos, telangiectasia, S&#237;ndrome de Cushing, edema, &#250;lcera g&#225;strica, glaucoma secund&#225;rio, hipertensao, S&#237;ndrome hipocal&#234;mica, deple&#231;&#227;o proteica, atrofia do tecido subcut&#226;neo, perda de cabelo incomum, erup&#231;&#227;o da pele.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3163,
        "contraindications": "<div>\r\n<p>- Hist&#243;ria de hipersensibilidade a qualquer um dos componentes da prepara&#231;&#227;o.</p>\r\n<p>- Atrofia de pele preexistente, que pode ser exacerbada pela a&#231;&#227;o do corticoster&#243;ide.</p>\r\n<p>- Infec&#231;&#227;o no local da tratamento, que pode ser exacerbada caso n&#227;o esteja sendo utilizado um antimicrobiano adequado.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose usual:</strong> Uma pequena quantidade deve ser friccionada cuidadosamente sobre a &#225;rea afetada, 2 a 3x/dia.</li>\r\n</ul>\r\n<p style=\"text-align: justify;\">&#160;</p>\r\n<p style=\"text-align: justify;\">&#160;</p>\r\n<p style=\"text-align: justify;\">&#160;</p>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li>Mesma posologia dos adultos, por&#233;m usar pelo menor tempo poss&#237;vel.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1942,
        "indications": "<p>- Tratamento de inflama&#231;&#245;es e alergias na pele associadas a infec&#231;&#245;es.&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-01-13 17:20:46",
        "name": "Drenison N",
        "presentation": "<ul>\r\n<li><strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Uso t&#243;pico (creme):</span></strong>&#160;Fludroxicortida 0,125 mg/g + Neomicina 3,5 mg/g.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "drenison",
        "substance": "Fludroxicortida + Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Queimadura, prurido, irrita&#231;&#227;o, secura da pele, foliculite, hipertricose, erup&#231;&#245;es acneiformes, hipopigmenta&#231;&#227;o ou outras altera&#231;&#245;es na pigmenta&#231;&#227;o da pele, dermatite perioral, dermatite de contato al&#233;rgica, macera&#231;&#227;o da pele, infec&#231;&#227;o secund&#225;ria, atrofia da pele, estrias, mili&#225;ria, furunculose, p&#250;stulas, piodermatite, vesicula&#231;&#227;o, hiperestesia, p&#250;rpura, entorpecimento dos dedos, telangiectasia, S&#237;ndrome de Cushing, edema, &#250;lcera g&#225;strica, glaucoma secund&#225;rio, hipertensao, S&#237;ndrome hipocal&#234;mica, deple&#231;&#227;o proteica, atrofia do tecido subcut&#226;neo, perda de cabelo incomum, erup&#231;&#227;o da pele.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 14667,
        "contraindications": "<div>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Hipersensibilidade aos componentes</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- &#218;lceras p&#233;pticas ativas</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Di&#225;tese hemorr&#225;gica</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Hist&#243;ria de asma induzida pela administra&#231;&#227;o de salicilatos ou subst&#226;ncias com a&#231;&#227;o similar</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Pacientes com varicela</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Combina&#231;&#227;o com metotrexato em dose de 15 mg/semana ou mais, </span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- &#218;lltimo trimestre de gravidez</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Insufici&#234;ncia renal grave</span></p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Insufici&#234;ncia hep&#225;tica grave</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Insufici&#234;ncia card&#237;aca grave</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Analg&#233;sico e antipir&#233;tico</strong>: 500 - 1000 mg VO de 4/4 horas a 6/6 horas (m&#225;ximo 4g/dia)</p>\r\n<p><strong>Cefaleia</strong>: 250 a 1000 mg/dose</p>\r\n<p><strong>Artrite reumatoide</strong>: 3,2/dia a 6 g/dia</p>\r\n<p><strong>S&#237;ndromes coronarianas agudas</strong>: 160-325 mg, mastigados.&#160;</p>\r\n<p><strong>Angioplastia</strong>: 80-325 mg/dia, iniciando 2 h antes do procedimento.</p>\r\n<p><strong>Angina est&#225;vel</strong>: 75-100 mg 1 x/dia.</p>\r\n<p><strong>Fase aguda do AVE isqu&#234;mico</strong>: 160-325 mg em at&#233; 48 horas ap&#243;s o in&#237;cio dos sintomas.</p>\r\n<p><strong>Preven&#231;&#227;o do AVC isqu&#234;mico</strong>: 75-100 mg 1x/dia.</p>\r\n<p><strong>Estenose de art&#233;ria car&#243;tida</strong>: 75-100 mg 1 x/dia.</p>\r\n<p><strong>Doen&#231;a arterial perif&#233;rica</strong>: 75-100 mg 1x/dia.</p>\r\n<p><strong>Pericardite p&#243;s-infarto</strong>: 650 mg de 6/6 horas</p>\r\n<p><strong>Preven&#231;&#227;o da pr&#233;-ecl&#226;mpsia</strong>: 75-100 mg 1 x/dia</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong>Analg&#233;sico e antit&#233;rmico:</strong><span class=\"apple-converted-space\">&#160;</span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; background: white;\">10 a 15 mg/kg VO 1x/dia at&#233; 6/6 horas</span></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Dosagem simplificada para apresenta&#231;&#227;o infantil (100 mg):</p>\r\n<ul>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><strong><span style=\"mso-bidi- line-height: 150%; background: white; font-weight: normal; mso-bidi-font-weight: bold;\">6 meses a 1 ano:</span></strong><span class=\"apple-converted-space\">&#160;</span><span style=\"mso-bidi- line-height: 150%; background: white;\">&#189; a 1 comprimido</span></li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><strong style=\"text-indent: 0cm;\"><span style=\"line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-weight: normal;\">1 a 3 anos:</span></strong><span class=\"apple-converted-space\" style=\"text-indent: 0cm;\">&#160;</span><span style=\"text-indent: 0cm; line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">1 comprimido</span></li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: normal;\">&#160;</span><strong style=\"text-indent: 0cm;\"><span style=\"line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-weight: normal;\">4 a 6 anos:</span></strong><span class=\"apple-converted-space\" style=\"text-indent: 0cm;\">&#160;</span><span style=\"text-indent: 0cm; line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">2 comprimidos</span></li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><strong style=\"text-indent: 0cm;\"><span style=\"line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-weight: normal;\">7 a 9 anos:</span></strong><span class=\"apple-converted-space\" style=\"text-indent: 0cm;\">&#160;</span><span style=\"text-indent: 0cm; line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">3 comprimidos</span></li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l0 level1 lfo1; tab-stops: 7.1pt;\"><strong style=\"text-indent: 0cm;\"><span style=\"line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-weight: normal;\">Acima de 9 anos:</span></strong><span class=\"apple-converted-space\" style=\"text-indent: 0cm;\">&#160;</span><span style=\"text-indent: 0cm; line-height: 150%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">4 comprimidos</span></li>\r\n</ul>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"mso-add-space: auto; line-height: 150%; tab-stops: 7.1pt; margin: 0cm 7.1pt 8.0pt 0cm;\"><span style=\"mso-bidi- line-height: 150%; background: white;\">Estas doses podem ser repetidas em intervalos de 4 a 8 horas, se necess&#225;rio, at&#233; um m&#225;ximo de 3 doses por dia</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong>Antiinflamat&#243;rio:</strong><span class=\"apple-converted-space\">&#160;</span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%; background: white;\">60 a 130 mg/kg/dia de 6/6 horas a 4/4 horas</span></li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong>Doen&#231;a de Kawasaki:</strong><span class=\"apple-converted-space\"><span style=\"mso-bidi- line-height: 150%; background: white; mso-bidi-font-weight: bold;\"><strong>&#160;</strong></span></span></p>\r\n<ul>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l1 level1 lfo2; tab-stops: 7.1pt;\"><span style=\"font: 7.0pt 'Times New Roman';\">&#160;</span><strong><span style=\"mso-bidi- line-height: 150%; background: white; font-weight: normal; mso-bidi-font-weight: bold;\">Fase febril:</span></strong><span class=\"apple-converted-space\">&#160;</span><span style=\"mso-bidi- line-height: 150%; background: white;\">80 a 100 mg/kg/dia VO de 6/6 horas a 4/4 horas por 14 dias ou 3 dias ap&#243;s tornar-se afebril</span></li>\r\n</ul>\r\n<ul>\r\n<li class=\"MsoListParagraphCxSpLast\" style=\"margin-right: 7.1pt; mso-add-space: auto; text-indent: 0cm; line-height: 150%; mso-list: l1 level1 lfo2; tab-stops: 7.1pt;\"><strong><span style=\"mso-bidi- line-height: 150%; background: white; font-weight: normal; mso-bidi-font-weight: bold;\">Fase afebril (antiplaquet&#225;rio):</span></strong><span class=\"apple-converted-space\">&#160;</span><span style=\"mso-bidi- line-height: 150%; background: white;\">3 a 5 mg/kg/dia VO 1x/dia por 6 a 8 semanas.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1944,
        "indications": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Dor de intensidade leve a moderada</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Febre, inflama&#231;&#227;o;</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Preven&#231;&#227;o e tratamento das s&#237;ndromes coronarianas agudas;</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Terapia adjuvante nos procedimentos de revasculariza&#231;&#227;o ( bypass coronariano, angioplastia, endarterectomia de car&#243;tidas);</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Cardiopatia isqu&#234;mica e AVE;</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Artrite reumatoide, osteoartrite, gota e febre reum&#225;tica; trombose vascular perif&#233;rica;</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Fibrila&#231;&#227;o atrial (alternativa para os pacientes que n&#227;o podem usar anticoagulante oral);</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Portadores de pr&#243;tese valvular card&#237;aca;</li>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\">Preven&#231;&#227;o da pr&#233;-ecl&#226;mpsia em mulheres de alto risco.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-04 02:09:54",
        "name": "Ecasil 81",
        "presentation": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong>Comprimido:</strong> 81mg</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Ecasil",
        "substance": "Ácido Acetilsalicílico",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 150%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- Hemorragia gastrintestinal oculta ou evidente (podendo causar anemia ferropriva), &#250;lcera e perfura&#231;&#227;o gastroduodenal, disfun&#231;&#227;o hep&#225;tica, tontura e zumbido, urtic&#225;ria, rea&#231;&#245;es cut&#226;neas, rea&#231;&#245;es anafil&#225;ticas, asma, dor abdominal, azia, n&#225;useas e v&#244;mitos.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><strong><span style=\"mso-bidi- line-height: 150%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; line-height: 150%; tab-stops: 7.1pt;\"><span style=\"mso-bidi- line-height: 150%;\">- N&#227;o estabelecido.</span></p>\r\n</div>"
    },
    {
        "content_length": 8120,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Dist&#250;rbios do ciclo da ureia. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Doen&#231;as hep&#225;ticas. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Gesta&#231;&#227;o e amamenta&#231;&#227;o.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\"><strong>Crises epil&#233;pticas:</strong> Iniciar com 250 mg VO de 1x/dia. Pode aumentar para 250 mg de 8/8 horas, no curso de 3-6 dias. </span></li>\r\n</ul>\r\n<p><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">Dose m&#225;xima: 60 mg/kg/dia. </span></p>\r\n<p><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">A retirada deve ser gradual para evitar s&#237;ndrome de abstin&#234;ncia ou a ocorr&#234;ncia de crises epil&#233;ticas.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p>\r\n<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\"><strong>Profilaxia da enxaqueca:</strong> 250 mg de 8/8 horas. A dose deve ser ajustada de acordo com a dor do paciente. Dose usual de 500-1.000 mg/dia. Neuropatia diab&#233;tica: 500-1.200 mg/dia.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">Crian&#231;as acima de 10 anos: </span></strong><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">Dose inicial:</span><span class=\"apple-converted-space\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">&#160;</span></span><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">15 mg/kg/dia de 12/12 horas at&#233; 8/8 horas. Aumentar de 5 a 10 mg/kg/dia, at&#233; o controle das convuls&#245;es.&#160;Dose m&#225;xima:&#160;60&#160;mg/kg/dia.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1946,
        "indications": "<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Crises epil&#233;pticas parciais simples, crises parciais complexas, crises secundariamente generalizadas e crises generalizadas. Mania aguda. Profilaxia da enxaqueca. Neuropatia diab&#233;tica.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\">N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 00:39:30",
        "name": "Epilenil",
        "presentation": "<ul>\r\n<li>Comprimidos: 250mg e 500mg</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">Receita de controle especial (C1 branca em duas vias).</p>",
        "record_status": 1,
        "slug": "epilenil",
        "substance": "Ácido Valpróico",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Hipertens&#227;o, palpita&#231;&#227;o, edema, taquicardia, trombocitopenia.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Infec&#231;&#245;es do trato respirat&#243;rio superior.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Alucina&#231;&#245;es,sonol&#234;ncia, ins&#244;nia, nervosismo, depress&#227;o.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Tontura,tremor, fraqueza, amn&#233;sia.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">N&#225;usea, v&#244;mito, diarreia, dor abdominal, dispepsia, anorexia,ganho de peso.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">-&#160;Alopecia, vis&#227;o borrada,agranulocitose, altera&#231;&#227;o no tempo de coagula&#231;&#227;o, altera&#231;&#227;o da fun&#231;&#227;o hep&#225;tica, hepatotoxicidade, pancreatite, anemia apl&#225;sica, s&#237;ndrome dos ov&#225;rios polic&#237;sticos, ataxia, altera&#231;&#245;es cognitivas, hiperglicemia, amenorreia, dismenorreia, incontin&#234;ncia urin&#225;ria, reten&#231;&#227;o urin&#225;ria.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\"><strong>Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-right: 7.1pt; text-align: justify; tab-stops: 7.1pt;\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 5615,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade ao iodo, &#224; amiodarona ou a qualquer um dos excipientes da f&#243;rmula;</p>\r\n<p class=\"MsoNormal\">- Bradicardia sinusal, bloqueio sino-atrial e doen&#231;a do n&#243; sinusal (sem que um marcapasso artificial esteja implantado - risco de parada sinusal);</p>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios graves de condu&#231;&#227;o atrioventricular (bloqueios atrioventriculares de alto grau, bloqueios bi outrifasciculares);</p>\r\n<p class=\"MsoNormal\">- Doen&#231;a tireoidiana presente ou anterior. Em caso de d&#250;vida (antecedentes incertos, hist&#243;ria tireoidiana familiar) avaliar a fun&#231;&#227;o glandular antes de iniciar o tratamento;</p>\r\n<p class=\"MsoNormal\">- Associa&#231;&#227;o com medicamentos que possam induzir \"torsade de pointes\", inclusive outros antiarr&#237;tmicos.</p>\r\n<p class=\"MsoNormal\">- A administra&#231;&#227;o intravenosa &#233; contra-indicada em caso de hipotens&#227;o, insufici&#234;ncia respirat&#243;ria grave, miocardiopatia ou insufici&#234;ncia card&#237;aca.</p>\r\n<p class=\"MsoNormal\">- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Via oral (comprimido ou gotas)</strong>:</p>\r\n<p>- Deve ocorrer em duas etapas, fase de ataque e fase de manuten&#231;&#227;o.</p>\r\n<p>- Dose de ataque: 800 a 1200 mg/dia por 8 a 10 dias ou at&#233; resposta terap&#234;utica inicial e/ou impregna&#231;&#227;o eletrocardiogr&#225;fica ou rea&#231;&#245;es adversas.</p>\r\n<p>- Dose de manuten&#231;&#227;o: 200 a 400mg/dia, dependendo do resultado terap&#234;utico do paciente.</p>\r\n<p><strong>Via intravenosa (evitar infus&#227;o em acesso perif&#233;rico devido rea&#231;&#245;es adversas locais): </strong></p>\r\n<p class=\"MsoNormal\">- Inje&#231;&#227;o&#160;<em>in bolus</em>&#160;lento (para supress&#227;o r&#225;pida da arritmia): m&#225;x. 5 mg/kg durante 5 min, podendo fazer uma repeti&#231;&#227;o ap&#243;s 15 minutos.</p>\r\n<p class=\"MsoNormal\">- Infus&#227;o endovenosa intermitente (dose de ataque): 5 mg/kg em 250 ml de solu&#231;&#227;o de glicose 5%, administrados por um per&#237;odo de 20 min a 2 h. Isto pode ser repetido de 2 a 4x em um per&#237;odo de 24 h. N&#227;o ultrapassar 1200 mg/dia.</p>\r\n<p class=\"MsoNormal\">- Infus&#227;o endovenosa cont&#237;nua (dose de manuten&#231;&#227;o): usualmente 300 mg de amiodarona em 250 ml de SG 5% com ou sem bomba de infus&#227;o cont&#237;nua 10 a 20 mg/kg/dia, com m&#225;x. de 1200 mg/dia.</p>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Via oral:</strong></p>\r\n<p class=\"MsoNormal\">- Dose de ataque: 10 mg/kg/dia ou 800 mg/1,72 m&#178; de superf&#237;cie corporal/dia, por 10 diasou at&#233; resposta terap&#234;utica inicial e/ou impregna&#231;&#227;o eletrocardiogr&#225;fica ou rea&#231;&#245;es adversas. Quando for atingido um controle adequado, reduzir a dose pela metade e manter por algumas semanas.</p>\r\n<p class=\"MsoNormal\">- Dose de manuten&#231;&#227;o: 2-4 mg/kg/dia ou 200 mg/1,72m&#178;/dia.</p>\r\n<p class=\"MsoNormal\"><strong>Via intravenosa:</strong></p>\r\n<p class=\"MsoNormal\">- Inje&#231;&#227;o <em>in bolus</em> lento (para supress&#227;o r&#225;pida da arritmia): 3-6 mg/kg em 5 min.</p>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1953,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Dist&#250;rbios graves do ritmo card&#237;aco, inclusive aqueles resistentes a outras terap&#234;uticas;</p>\r\n<p class=\"MsoNormal\">- Taquicardia ventricular sintom&#225;tica;</p>\r\n<p class=\"MsoNormal\">- Taquicardia supraventricular sintom&#225;tica;</p>\r\n<p class=\"MsoNormal\">- Altera&#231;&#245;es do ritmo associadas &#224; s&#237;ndrome de Wolff-Parkinson-White.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:28:23",
        "name": "Miodon",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimido:</strong> 100 mg e 200 mg</li>\r\n<li class=\"MsoNormal\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50mg/ml, ampola de 3 ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Miodon",
        "substance": "Amiodarona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Exacerba&#231;&#227;o de arritmias, Toxicidade pulmonar, Broncoespasmo, Tremor extrapiramidal, Dist&#250;rbios do sono, Neuropatia perif&#233;rica e/ou miopatia, Hepatite, Icter&#237;cia, Insufici&#234;ncia hep&#225;tica, N&#225;useas e v&#244;mitos, Micro dep&#243;sitos corneanos, Hipertireoidismo e hipotireoidismo</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Uso cauteloso em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 6217,
        "contraindications": "<p>- Hipersensibilidade aos seus componentes, uso concomitante de cloridrato de apomorfina.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito em geral:</strong> 2 comprimidos VO de 8 mg de 12/12h.&#160;</li>\r\n<li><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mitos no p&#243;s-operat&#243;rio:</strong>&#160;8 mg, VO, 1 hora antes da anestesia, seguida de outras duas doses de 8 mg de 8/8h.</li>\r\n<li><strong>Quimioterapia altamente emetog&#234;nica:</strong> dose &#250;nica de 24 mg, administrado 30 minutos antes do inicio da quimioterapia do dia.</li>\r\n<li><strong>Quimioterapia moderadamente emetog&#234;nica:</strong>&#160;1 comprimido VO de 8 mg, 2x/dia. A primeira dose deve ser administrada 30 minutos antes do inicio da quimioterapia emetog&#234;nica, com dose subsequente 8 horas ap&#243;s a primeira dose. 8 mg , 2x/dia, durante 1 a 2 dias ap&#243;s t&#233;rmino da quimioterapia.</li>\r\n<li><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito associado a radioterapia:</strong>&#160;1 comprimido de 8 mg, VO, 3x/dia. Para irradia&#231;&#227;o total do corpo: 1 comprimido de 8 mg, VO, 1 a 2 horas antes de cada fra&#231;&#227;o de radioterapia aplicada em cada dia. Para radioterapia do abdome em dose &#250;nica elevada: 1 comprimido de 8 mg, VO, 1 a 2 horas antes da radioterapia, com doses subsequentes a cada 8h, durante 1 a 2 dias ap&#243;s o t&#233;rmino da radioterapia. Para radioterapia do abdome em doses fracionadas di&#225;rias: 1 comprimido de 8mg, VO, 1 a 2 horas antes da radioterapia, com doses a cada 8h.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito em geral:</strong> &gt; 11 anos: 4 a 8 mg de ondansetrona (1 a 2 comprimidos de 4 mg). Para crian&#231;as de 2-11 anos: 4 mg.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Quimioterapia altamente emetog&#234;nica:&#160;</strong>dose &#250;nica intravenosa de 0,15 mg/kg, n&#227;o excedendo 8mg, antes da quimioterapia. No 1&#186; dia, duas doses adicionais por via intravenosa podem ser dadas com intervalos de 4 horas. A administra&#231;&#227;o por via oral pode come&#231;ar 12h mais tarde e continuar por at&#233; 5 dias. N&#227;o deve ser excedida a dose de adultos.</span></li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Quimioterapia moderadamente emetog&#234;nica:</strong>&#160;&gt;</span><span style=\"mso-bidi- line-height: 107%;\">11 anos: Idem a de adultos. P</span><span style=\"mso-bidi- line-height: 107%;\">ara crian&#231;as com 2 a 11 anos de idade:4 mg, 3x/dia durante 1 a 2 dias ap&#243;s o t&#233;rmino da quimioterapia.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Preven&#231;&#227;o de n&#225;usea e v&#244;mito associado a radioterapia:&#160;</strong></span><span style=\"mso-bidi- line-height: 107%;\">2-11 anos de idade: 4 mg de ondansetrona, 3x/dia, 1 a 2 horas antes do in&#237;cio da radioterapia, com doses subsequentes a cada 8h. 4 mg de ondansetrona, 3x/dia durante 1 a 2 dias ap&#243;s t&#233;rmino da radioterapia. &gt;11 anos: Idem a de adultos.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1954,
        "indications": "<ul>\r\n<li>Controle da n&#225;usea e do v&#244;mito induzidos por quimioterapia citot&#243;xica e radioterapia.</li>\r\n<li>Preven&#231;&#227;o e tratamento de n&#225;useas e v&#244;mitos do p&#243;s-operat&#243;rio.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-06 16:32:13",
        "name": "Ondansetrona",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 4 mg e 8 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ondansetrona",
        "substance": "Ondansetrona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Cefaleia, sensa&#231;&#227;o de calor ou rubor, constipa&#231;&#227;o intestinal, eleva&#231;&#245;es nos n&#237;veis de transaminase, rea&#231;&#245;es no local da inje&#231;&#227;o intravenosa,&#160;convuls&#227;o, transtornos do movimento (inclusive dist&#250;rbios extrapiramidais, tais como crises ocul&#243;giras, rea&#231;&#245;es dist&#244;nicas e discinesia, observados sem evid&#234;ncias definitivas de persist&#234;ncia de sequelas cl&#237;nicas), arritmias, dor tor&#225;cica, com ou sem depress&#227;o do segmento ST,&#160; bradicardia, hipotens&#227;o, solu&#231;os, aumento P&#225;gina 8 de 10 assintom&#225;tico de testes funcionais hep&#225;ticos (essas rea&#231;&#245;es foram observadas em pacientes submetidos a quimioterapia com cisplatina),&#160;rea&#231;&#245;es de hipersensibilidade imediata, &#224;s vezes graves, inclusive anafilaxia, tontura predominantemente durante a administra&#231;&#227;o intravenosa r&#225;pida, dist&#250;rbios visuais passageiros (como vis&#227;o turva), predominantemente durante a administra&#231;&#227;o intravenosa; prolongamento do intervalo QT (incluindo Torsade de Pointes).</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufuci&#234;ncia hep&#225;tica:&#160;</strong>Dose m&#225;xima de 8 mg.</p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 107%;\">N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 2316,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes, miastenia gravis, depress&#227;o respirat&#243;ria, glaucoma.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 10mg VO &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o recomendado.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C</strong>: Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 1956,
        "indications": "<div>\r\n<p>- Indutor do sono, agonista espec&#237;fico de receptor benzodiazep&#237;nico tipo 1 central, ins&#244;nia, ansiol&#237;tico (pr&#233;-operat&#243;rio), transtorno de sono relacionados a abstin&#234;ncia &#224; maconha.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 15:06:05",
        "name": "Zolpidem",
        "presentation": "<ul>\r\n<li><strong>Comprimidos Revestidos:</strong> 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\">- Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "Zolpidem",
        "substance": "Zolpidem",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:&#160;</strong></p>\r\n<p class=\"MsoNormal\">- Ins&#244;nia de rebote 24 horas ap&#243;s a suspens&#227;o da droga, sonol&#234;ncia, tontura ,amn&#233;sia&#160;anter&#243;grada, confus&#227;o mental, cefal&#233;ia, colestase, n&#225;useas , v&#244;mitos, xerostomia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"> -&#160;</strong>Adultos com idade acima de 65 anos ou com insufici&#234;ncia hep&#225;tica: Recomenda-se a administra&#231;&#227;o de &#189; comprimido (5mg) por dia. A dose somente deve ser aumentada para um comprimido (10mg) em casos excepcionais. A dosagem n&#227;o deve exceder 10mg por dia.</p>\r\n</div>"
    },
    {
        "content_length": 3218,
        "contraindications": "<p style=\"text-align: justify;\">- Gravidez, glaucoma, hipertrofia da pr&#243;stata, estenose de colo vesical, obstru&#231;&#227;o pil&#243;rica ou duodenal, &#250;lcera p&#233;ptica estenosante, miastenia grave, casos de hipersensibilidade aos componentes, fun&#231;&#227;o da medula &#243;ssea insufuciente ou doen&#231;as do sistema hematopoi&#233;tico, defici&#234;ncia cong&#234;nita da glicose-6-fosfato-desidrogenase(G6PD).</p>",
        "dosage_adults": "<ul>\r\n<li>30 a 60 gotas, 3-4x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 1958,
        "indications": "<p>- Al&#237;vio da dor associada a contraturas musculares decorrentes de processos traum&#225;ticos ou inflamat&#243;rios e em cefaleias tensionais.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<ul>\r\n<li class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso moderadamente seguro. Monitorar tratamento.</span></li>\r\n<li>A lacta&#231;&#227;o deve ser evitada at&#233; 48 horas ap&#243;s o uso deste medicamento.</li>\r\n</ul>",
        "last_update": "2019-03-06 16:43:22",
        "name": "Orfenadrina + Dipirona + Cafeína Anidra",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral:</strong> Orfenadrina + Dipirona + Cafe&#237;na anidra (35 + 300 + 50)mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "orfenadrina-dipirona-cafeina-anidra",
        "substance": "Orfenadrina + Dipirona + Cafeína Anidra",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Vis&#227;o turva, xerostomia, sensa&#231;&#227;o de cabe&#231;a leve, s&#237;ncope, taquicardia, palpita&#231;&#227;o, reten&#231;&#227;o urin&#225;ria, midr&#237;ase, aumento da press&#227;o intra-ocular, n&#225;useas e v&#244;mitos, cefal&#233;ias, constipa&#231;&#227;o, tonteiras, urtic&#225;ria, S&#237;ndrome de kounis, choque anafil&#225;tico, anemia aplastica, agranulocitose, pancitopenia, leucopenia, trombocitopenia.</p>\r\n<hr>\r\n<p><strong>Ajustes na insufici&#234;ncia renal:&#160;</strong>N&#227;o h&#225; ajuste.&#160;</p>\r\n<p><strong>Ajustes na insufici&#234;ncia hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3242,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>\r\n<p>- Mulheres amamentando.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Hipertireoidismo leve:&#160;</strong>15 a 30mg por dia</li>\r\n<li><strong>Hipertireoidismo moderadamente grave: </strong>30 a 40mg por dia</li>\r\n<li><strong>Hipertireoidismo grave: </strong>60mg por dia</li>\r\n<li><strong>Dose de manuten&#231;&#227;o: </strong>5 a 15 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose recomendada:</strong> 0,4 mg/kg VO 1x/dia;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose de manuten&#231;&#227;o:</strong> 0,2 mg/kg VO.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p><span id=\"docs-internal-guid-b53bf4d4-7c82-362a-ec10-97659a1a14a7\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Categoria D:</span><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></span></p>",
        "id": 1960,
        "indications": "<p>- Hipertireoidismo. Controlar o hipertireoidismo na prepara&#231;&#227;o da tireoidectomia subtotal ou terapia com iodo radioativo. Metimazol &#233; usado tamb&#233;m quando a tireoidectomia &#233; contraindicada ou desaconselhada.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 03:28:46",
        "name": "Tapazol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 5mg e 10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tapazol",
        "substance": "Tiamazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>-&#160;</strong>Erup&#231;&#227;o cut&#226;nea, urtic&#225;ria, n&#225;usea, v&#244;mito, dor de cabe&#231;a, dor epig&#225;strica, artralgia, parestesia, perda do paladar, perda anormal do cabelo, mialgia, prurido, sonol&#234;ncia, neurite, edema, vertigem, pigmenta&#231;&#227;o da pele, icter&#237;cia, sialadenopatia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2243,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade ao fenoprofeno.</p>\r\n<p>- Hist&#243;ria de &#250;lcera gastrointestinal e sangramento intestinal ou g&#225;strico.</p>\r\n<p>- Pacientes com antecedentes de insufici&#234;ncia hep&#225;tica ou renal significativa.</p>\r\n<p>- Pacientes nos quais os AINEs produzem sintomas de asma, rinite ou urtic&#225;rias.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 1 cp VO, at&#233; 6/6 horas.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 3200 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1961,
        "indications": "<p>- Tratamento da dor leve a moderada, al&#237;vio dos sinais e sintomas da gripe, afec&#231;&#245;es da via a&#233;rea superior, dores localizadas e fraturas, feridas cir&#250;rgicas, episiotomias e c&#243;licas uterinas.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:17:00",
        "name": "Trandor",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 200 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "trandor",
        "substance": "Fenoprofeno",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi-font-weight: normal;\">- Dispepsia, constipa&#231;&#227;o, n&#225;useas, v&#244;mitos</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3470,
        "contraindications": "<div>\r\n<p>- Gravidez, glaucoma, hipertrofia da pr&#243;stata, estenose de colo vesical, obstru&#231;&#227;o pil&#243;rica ou duodenal, &#250;lcera p&#233;ptica estenosante, miastenia grave, casos de hipersensibilidade aos componentes, insufici&#234;ncia renal e insufici&#234;ncia hep&#225;tica.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 1 a 2 comprimidos, 3-4/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 8 comprimidos/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 1996,
        "indications": "<p>- Al&#237;vio da dor associada a contraturas musculares decorrentes de processos traum&#225;ticos ou inflamat&#243;rios e em cefaleias tensionais.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></li>\r\n</ul>",
        "last_update": "2019-03-04 02:12:25",
        "name": "Benoflex P",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> Orfenadrina + Paracetamol + Cafe&#237;na anidra (35 + 450 + 50)mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "orfenadrina-dipirona-cafeina-anidra",
        "substance": "Orfenadrina + Paracetamol + Cafeína Anidra",
        "trade_names": "",
        "warnings": "<div><p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Ataxia, dist&#250;rbio da fala, disfagia, agita&#231;&#227;o, pele seca e quente, taquicardia, palpita&#231;&#227;o, dis&#250;ria ou reten&#231;&#227;o urin&#225;ria, tontura, alucina&#231;&#245;es, aumento da press&#227;o intraocular, n&#225;useas e v&#244;mitos, cefaleia, constipa&#231;&#227;o, diminui&#231;&#227;o dos movimentos perist&#225;lticos intestinais, del&#237;rio e sonol&#234;ncia,&#160;erup&#231;&#245;es cut&#226;neas, urtic&#225;ria, eritema e eritema pigmentar fixo, febre, hipoglicemia, icter&#237;cia,&#160;leucopenia, trombocitopenia, neutropenia, pancitopenia, agranulocitose, anemia hemol&#237;tica em pacientes com defici&#234;ncia de glicose 6-fosfato desidrogenase, necr&#243;lise epid&#233;rmica t&#243;xica, s&#237;ndrome de Stevens-Johnson, pustulose exantematosa aguda generalizada, erup&#231;&#227;o medicamentosa fixa,&#160;angioedema, choque anafil&#225;tico.hepatite citol&#237;tica, que pode levar &#224; insufici&#234;ncia hep&#225;tica aguda, e s&#237;ndrome de Kounis, broncoespasmo,&#160;bradicardia ou taquicardia, arritmias card&#237;acas, secura da boca, sede, diminui&#231;&#227;o da sudorese, midr&#237;ase, dificuldade de acomoda&#231;&#227;o visual.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p style=\"text-align: justify;\">- N&#227;o h&#225; ajustes</p></div>"
    },
    {
        "content_length": 2675,
        "contraindications": "<div>\r\n<p>- S&#237;ndrome de m&#225;-absor&#231;&#227;o intestinal, doen&#231;as graves do f&#237;gado ou das vias biliares, colestase.&#160;</p>\r\n<p>- Hipersensibilidade conhecida ao orlistate ou a qualquer um dos componentes de sua formula&#231;&#227;o.</p>\r\n<p>&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 120 mg VO 3x/dia, durante ou logo ap&#243;s as refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 1997,
        "indications": "<p>- Tratamento de pacientes com sobrepeso ou obesidade, incluindo fatores de risco associados &#224; obesidade, em conjunto com uma dieta de baixa caloria.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<div>\r\n<p class=\"MsoNormal\"><strong>-&#160;</strong>N&#227;o recomendado.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "last_update": "2019-03-06 16:44:39",
        "name": "Orlistate",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 120 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "orlistate",
        "substance": "Orlistate",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Esteatorreia, flatul&#234;ncia com perdas oleosas, urg&#234;ncia para evacuar, aumento das evacua&#231;&#245;es, desconforto/dor abdominal, flatul&#234;ncia, fezes l&#237;quidas, infec&#231;&#245;es do trato respirat&#243;rio superior, gripe, cefaleia e hipoglicemia,&#160; incontin&#234;ncia fecal, fezes amolecidas, desconforto/dor retal, dist&#250;rbios dentais ou gengivais, infec&#231;&#245;es do trato respirat&#243;rio inferior, irregularidades menstruais, ansiedade, fadiga, infec&#231;&#227;o urin&#225;ria e distens&#227;o abdominal,&#160;prurido, rash, urtic&#225;ria, angioedema, broncoespasmo e anafilaxia.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\"><strong><span style=\"line-height: 107%;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3735,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes, supress&#227;o medular antes do 1&#186; ciclo, sangramento severo ou insufici&#234;ncia renal grave antes 1&#186; ciclo do tratamento, gravidez e lacta&#231;&#227;o.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose usual:</strong> 130 mg/m&#178; a cada 3 semanas quando em associa&#231;&#227;o com bevacizumabe e capecitabina e a cada 2 semanas quando em associa&#231;&#227;o com 5-fluouracil/Leucovorin. C&#226;ncer de col&#243;n retal metast&#225;tico/avan&#231;ado: 85 mg/m&#178; IV a cada 2 semanas em associa&#231;&#227;o com fluoropirimidinas por 12 ciclos (6 meses).</li>\r\n<li>Administrada em infus&#227;o venosa de curta dura&#231;&#227;o (2 a 6 horas), dilu&#237;da em 250 a 500 ml de glicose a 5%.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2010,
        "indications": "<p>- Tratamento de pacientes com c&#226;ncer col&#243;n retal metast&#225;tico e como adjuvante no tratamento de c&#226;ncer col&#243;n retal est&#225;gio III ap&#243;s completa ressec&#231;&#227;o do tumor prim&#225;rio usado em combina&#231;&#227;o com 5-fluouracil.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-06 16:56:18",
        "name": "Oxaliplatina",
        "presentation": "<div>\r\n<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50 mg e 100 mg.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "recipient": 7,
        "recipient_type": "<p class=\"MsoNormal\">-&#160;Uso hospitalar.</p>",
        "record_status": 1,
        "slug": "oxaliplatina",
        "substance": "Oxaliplatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Edema, taquicardia, s&#237;ndrome de Kounis, alop&#233;cia, anemia, leucopenia, granulocitopenia, trombocitopenia, neutropenia febril, anemia hemol&#237;tica, mucosite, dor abdominal, constipa&#231;&#227;o, estomatite, anorexia, n&#225;useas, v&#244;mitos e diarreia, algumas vezes graves podendo gerar desidrata&#231;&#227;o, &#237;leo intestinal, hipocalemia, acidose metab&#243;lica, comprometimento renal ou hep&#225;tico, neuropatias perif&#233;ricas sensitivas, c&#227;ibras, disestesias da regi&#227;o peri-oral e laringe, disartria, neurite &#243;ptica, surdez, febre, erup&#231;&#227;o cut&#226;nea e mal estar geral, tosse n&#227;o produtiva, dispneia, estertores ou presen&#231;a radiol&#243;gica de infiltrado pulmonar, S&#237;ndrome m&#227;o-p&#233;, bilirrubina anormal, ALT e AST anormais, hepatite, hipertens&#227;o porta, doen&#231;a veno-oclusiva hep&#225;tica, dorsalgia, fadiga, febre e vis&#227;o turva,&#160; pneumonite grave, fibrose pulmonar, dispneia, IRA, SHU, NIA, acidose tubular renal.</p>\r\n<hr>\r\n<p><strong>Ajustes na insufici&#234;ncia renal leve a moderada:</strong> 85 mg/m&#178;.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2910,
        "contraindications": "<div>\r\n<p>- Disfun&#231;&#227;o hep&#225;tica e renal graves.</p>\r\n<p>- Problemas na ves&#237;cula biliar pr&#233;-existentes.</p>\r\n<p>- Hipersensibilidade &#224; Genfibrozila ou a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Uso concomitante com repaglinida e outros reguladores de l&#237;pides.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:</strong>&#160;900 mg, VO, 1x/dia meia hora antes do jantar ou&#160;1200 mg, VO, 12/12 horas, meia hora antes do caf&#233; e do jantar.</li>\r\n<li><strong> Dose m&#225;xima:</strong>&#160;1500 mg/dia (2,5 comprimidos de 600 mg ou 1,5 comprimidos 900 mg).</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2019,
        "indications": "<div>\r\n<p>- Preven&#231;&#227;o prim&#225;ria da doen&#231;a arterial coron&#225;ria e infarto do mioc&#225;rdio em pacientes com hipercolesterolemia, dislipidemia mista e hipertrigliceridemia.</p>\r\n<p>- Tratamento de outras dislipidemias, tais como: Fredrickson tipos III e V; dislipidemia associada a diabetes e dislipidemia associada a xantoma.&#160;</p>\r\n<p>- Tratamento de pacientes adultos com n&#237;veis s&#233;rico elevados de triglic&#233;rides (hiperlipidemia tipos IV e V) que apresentam risco de pancreatite e n&#227;o respondam adequadamente a um determinado esfor&#231;o diet&#233;tico para control&#225;-los.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 19:39:21",
        "name": "Genfibrozila",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 600 e 900 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples</p>",
        "record_status": 1,
        "slug": "genfibrozila",
        "substance": "Genfibrozila",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Dor abdominal, dispepsia, diarreia, n&#225;useas, eczema de hipersensibilidade, eosinofilia, dor muscular, vis&#227;o borrada, leucopenia, anemia, aumento das transaminases, aumento da glicemia e incid&#234;ncia de c&#225;lculos biliares.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- Contraindicado na&#160;Disfun&#231;&#227;o Hep&#225;tica e Renal graves.</p>\r\n</div>"
    },
    {
        "content_length": 1886,
        "contraindications": "<p>&#160;- Hipersensibilidade conhecida ao acetato de glatir&#226;mer ou ao manitol.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:</strong> 20 mg, SC, 1x/dia.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 2022,
        "indications": "<div>\r\n<p>- Pacientes com alto risco de desenvolver esclerose m&#250;ltipla clinicamente definida.</p>\r\n<p>- Esclerose m&#250;ltipla remissiva recidivante.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 151,
        "lactation_text": "<p>- N&#227;o estabelecido.&#160;</p>",
        "last_update": "2019-01-13 17:36:40",
        "name": "Copaxone",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 20 mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "copaxone",
        "substance": "Glatirâmer",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Rea&#231;&#245;es no local da inje&#231;&#227;o: eritema, algia, n&#243;dulo, prurido, edema, inflama&#231;&#227;o, hipersensibilidade e raras ocorr&#234;ncias de lipoatrofia e necrose de pele. Dispneia,&#160;vasodilata&#231;&#227;o, gravidez n&#227;o programada, depress&#227;o, taquicardia,&#160;vertigem e tremor.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2874,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2023,
        "indications": "<p>- Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 1,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:45:58",
        "name": "Glibenclamida",
        "presentation": "<ul>\r\n<li><strong>Comprimido</strong>: 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.</p>\r\n</div>"
    },
    {
        "content_length": 2978,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2024,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:50:54",
        "name": "Glionil",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2969,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2025,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 80,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:46:30",
        "name": "Glibexil",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2968,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2026,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:46:06",
        "name": "Glibendiab",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2902,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2027,
        "indications": "<p>- Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-01-13 17:36:45",
        "name": "Clamiben",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2969,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2028,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 35,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-01-13 17:36:48",
        "name": "Daonil",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.</p>\r\n</div>"
    },
    {
        "content_length": 2978,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2029,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 25,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:48:26",
        "name": "Gliconil",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2969,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2030,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:46:41",
        "name": "Glicamin",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2856,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2031,
        "indications": "<p>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 15,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-03-03 19:46:15",
        "name": "Glibeneck",
        "presentation": "<ul>\r\n<li>Comprimido: 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2971,
        "contraindications": "<div>\r\n<p>- DM tipo 1.</p>\r\n<p>- Situa&#231;&#245;es de estresse importantes (infec&#231;&#245;es, cirurgia e infarto).</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica ou renal grave.</p>\r\n<p>- Gesta&#231;&#227;o e lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial:</strong> &#189; a 1 cp, VO, 1x/dia. Pacientes idosos ou &lt; 50 Kg devem iniciar com a menor dose eficaz poss&#237;vel. Pode&#160;ser aumentada em incrementos de &#189; comprimido em intervalos de 1 a 2 semanas.</li>\r\n<li><strong>Dose usual:&#160;</strong> &#189; a 2 cp, VO, antes do caf&#233;.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;15 mg/dia (3cp). Doses maiores que 2cp devem ser dividas em 12/12 horas, antes das refei&#231;&#245;es.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2032,
        "indications": "<p><strong>-&#160;</strong>Diabetes mellitus n&#227;o insulinodependente.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 133,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><strong>-&#160;</strong>Alto risco:</strong> Uso inseguro. Avaliar alternativas mais seguras.</p>",
        "last_update": "2019-01-13 17:36:52",
        "name": "Diabinil",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><strong>-&#160;</strong>Receitu&#225;rio simples.&#160;</p>",
        "record_status": 1,
        "slug": "glibenclamida",
        "substance": "Glibenclamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Hipoglicemia &#233; a complica&#231;&#227;o mais comum. Outras: n&#225;useas, v&#244;mitos, dor abdominal, sensa&#231;&#227;o de plenitude g&#225;strica ou peso na regi&#227;o epig&#225;strica, diarreia, rea&#231;&#245;es al&#233;rgicas com prurido, erup&#231;&#245;es, urtic&#225;ria, incluindo choque e vasculite, trombocitopenia, anemia, leucopenia, agranulocitose, anemia hemol&#237;tica ou pancitopenia, altera&#231;&#245;es hep&#225;ticas, como eleva&#231;&#227;o dos n&#237;veis de enzimas hep&#225;ticas, hepatite e colestase.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Uso cauteloso em idosos.</p>\r\n<p>- Contraindicado na Insufici&#234;ncia Renal e Hep&#225;tica graves.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2522,
        "contraindications": "<div>\r\n<p>- Apendicite, hemorragia retal n&#227;o diagnosticada e obstru&#231;&#227;o intestinal.&#160;</p>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula.</p>\r\n<p>- P&#243;s operat&#243;rio de cirurgia retal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:&#160;</strong>1 suposit&#243;rio adulto via retal, 1x/dia (dose &#250;nica e espor&#225;dica).</li>\r\n<li>Introduzir o suposit&#243;rio no reto e procurar ret&#234;-lo at&#233; que advenha a vontade de evacuar.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Dose usual:&#160;</strong>1 suposit&#243;rio pedi&#225;trico via retal, 1x/dia (dose &#250;nica e espor&#225;dica).</li>\r\n<li>Introduzir o suposit&#243;rio no reto e segur&#225;-lo at&#233; que se obtenha fluxo fetal.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2037,
        "indications": "<p>- Tratamento e/ou preven&#231;&#227;o da pris&#227;o de ventre. Finalidade de provocar a evacua&#231;&#227;o.&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 85,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 19:46:58",
        "name": "Glicel",
        "presentation": "<ul>\r\n<li><strong>Suposit&#243;rio pedi&#225;trico:</strong> 0,831 g.</li>\r\n<li><strong>Suposit&#243;rio adulto:</strong> 2,254 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicerin-supositorio",
        "substance": "Glicerol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Diarreia, flatul&#234;ncia, c&#243;licas, n&#225;useas, v&#244;mitos, irrita&#231;&#227;o retal, hiperglicemia, cefaleia, tontura.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 2998,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Menores de 18 anos;&#160;Historia previa de AVC e AIT;&#160;Hipertens&#227;o descompensada e doen&#231;a coronariana;&#160;Insufici&#234;ncia renal grave;&#160;</span><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Uso concomitante com IMAO e ergotam&#237;nicos.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">1 comprimido, VO, repetir ap&#243;s 4 horas se necess&#225;rio (d<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">ose m&#225;xima: 5 mg/dia).</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2042,
        "indications": "<p>- Tratamento agudo de crises de enxaqueca, com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-13 12:23:34",
        "name": "Naramig",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naramig",
        "substance": "Naratriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Sensa&#231;&#227;o de calor, parestesia, seda&#231;&#227;o, vertigem, tonteira, fraqueza, fadiga, sudorese, c&#226;imbras, rubor, precordialgia, hipertens&#227;o e taquicardia, eleva&#231;&#227;o das transaminases.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal leve a moderada: dose oral n&#227;o deve exceder 2,5 mg;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal grave: contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 2988,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Menores de 18 anos;&#160;Historia previa de AVC e AIT;&#160;Hipertens&#227;o descompensada e doen&#231;a coronariana;&#160;Insufici&#234;ncia renal grave;&#160;</span><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Uso concomitante com IMAO e ergotam&#237;nicos.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">1 comprimido, VO, repetir ap&#243;s 4 horas se necess&#225;rio (d<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">ose m&#225;xima: 5 mg/dia).</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2045,
        "indications": "<p>- Tratamento agudo de crises de enxaqueca, com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-13 12:23:43",
        "name": "Naratano",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naratano",
        "substance": "Naratriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Sensa&#231;&#227;o de calor, parestesia, seda&#231;&#227;o, vertigem, tonteira, fraqueza, fadiga, sudorese, c&#226;imbras, rubor, precordialgia, hipertens&#227;o e taquicardia, eleva&#231;&#227;o das transaminases.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal leve a moderada: dose oral n&#227;o deve exceder 2,5 mg;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal grave: contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 2988,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Menores de 18 anos;&#160;Historia previa de AVC e AIT;&#160;Hipertens&#227;o descompensada e doen&#231;a coronariana;&#160;Insufici&#234;ncia renal grave;&#160;</span><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Uso concomitante com IMAO e ergotam&#237;nicos.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">1 comprimido, VO, repetir ap&#243;s 4 horas se necess&#225;rio (d<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">ose m&#225;xima: 5 mg/dia).</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2046,
        "indications": "<p>- Tratamento agudo de crises de enxaqueca, com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-13 12:23:51",
        "name": "Naratrin",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naratrin",
        "substance": "Naratriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Sensa&#231;&#227;o de calor, parestesia, seda&#231;&#227;o, vertigem, tonteira, fraqueza, fadiga, sudorese, c&#226;imbras, rubor, precordialgia, hipertens&#227;o e taquicardia, eleva&#231;&#227;o das transaminases.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal leve a moderada: dose oral n&#227;o deve exceder 2,5 mg;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal grave: contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 2987,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Menores de 18 anos;&#160;Historia previa de AVC e AIT;&#160;Hipertens&#227;o descompensada e doen&#231;a coronariana;&#160;Insufici&#234;ncia renal grave;&#160;</span><span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Uso concomitante com IMAO e ergotam&#237;nicos.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">1 comprimido, VO, repetir ap&#243;s 4 horas se necess&#225;rio (d<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">ose m&#225;xima: 5 mg/dia).</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2047,
        "indications": "<p>- Tratamento agudo de crises de enxaqueca, com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 22,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-13 12:24:14",
        "name": "Narcef",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "narcef",
        "substance": "Naratriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Sensa&#231;&#227;o de calor, parestesia, seda&#231;&#227;o, vertigem, tonteira, fraqueza, fadiga, sudorese, c&#226;imbras, rubor, precordialgia, hipertens&#227;o e taquicardia, eleva&#231;&#227;o das transaminases.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal leve a moderada: dose oral n&#227;o deve exceder 2,5 mg;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal grave: contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 3041,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Menores de 18 anos;&#160;Historia previa de AVC e AIT;&#160;Hipertens&#227;o descompensada e doen&#231;a coronariana;&#160;Insufici&#234;ncia renal grave;&#160;<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Uso concomitante com IMAO e ergotam&#237;nicos.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">1 comprimido, VO, repetir ap&#243;s 4 horas se necess&#225;rio (d<span style=\"line-height: 115%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">ose m&#225;xima: 5 mg/dia).</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2048,
        "indications": "<p>- Tratamento agudo de crises de enxaqueca, com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-13 12:23:59",
        "name": "Naratriptana",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong> 2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "naratriptana",
        "substance": "Naratriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Sensa&#231;&#227;o de calor, parestesia, seda&#231;&#227;o, vertigem, tonteira, fraqueza, fadiga, sudorese, c&#226;imbras, rubor, precordialgia, hipertens&#227;o e taquicardia, eleva&#231;&#227;o das transaminases.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal leve a moderada: dose oral n&#227;o deve exceder 2,5 mg;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Insufici&#234;ncia renal grave: contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 2174,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes; Diabetes tipo 1; Crian&#231;as; Cetoacidose diab&#233;tica.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">120mg, VO, antes das refei&#231;&#245;es, 3x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2049,
        "indications": "<p>- Diabetes tipo 2.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-09 17:15:27",
        "name": "Starlix",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong> 120mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "starlix",
        "substance": "Nateglinida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipoglicemia; Dor abdominal; Diarr&#233;ia; Cefal&#233;ia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2807,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Diabetes tipo 1;&#160;Crian&#231;as;&#160;Cetoacidose diab&#233;tica, pr&#233;-coma diab&#233;tico;&#160;Insufici&#234;ncia renal org&#226;nica ou funcional; Insufici&#234;ncia card&#237;aca congestiva; Insufici&#234;ncia hepatocelular aguda ou cr&#244;nica; Administra&#231;&#227;o de meios de contraste iodados intravasculares.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Dose inicial:</strong></p>\r\n<ul>\r\n<li>120mg Nateglinida + 500mg Metformina, VO, antes das refei&#231;&#245;es, 2x/dia, por 1 semana.</li>\r\n</ul>\r\n<p><strong>Dose de manuten&#231;&#227;o:</strong></p>\r\n<ul>\r\n<li>120mg Nateglinida + 500mg Metformina, VO, antes das refei&#231;&#245;es, 3x/dia, por 1 semana.</li>\r\n</ul>\r\n<p><strong>Dose m&#225;xima:</strong> 720 mg/dia de nateglinida e 2.550 mg/dia de metformina.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria X:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 2050,
        "indications": "<p>- Diabetes tipo 2.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-09 17:15:17",
        "name": "Starform",
        "presentation": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Comprimidos revestidos:&#160;</strong>120mg Nateglinida + 500mg Metformina; 120mg Nateglinida + 850mg Metformina.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "starform",
        "substance": "Nateglinida + Metformina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipoglicemia,&#160;Dor abdominal,&#160;Diarr&#233;ia,&#160;Cefal&#233;ia, Astenia, Fadiga, Tremor, N&#225;usea.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3422,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Insufici&#234;ncia hep&#225;tica ou fun&#231;&#227;o hep&#225;tica diminu&#237;da; Insufici&#234;ncia card&#237;aca aguda, choque cardiog&#234;nico; Doen&#231;a do n&#243;dulo sinusal, incluindo o bloqueio sino-auricular; Bloqueio card&#237;aco do segundo e terceiro grau (sem marca-passo); Hist&#243;ria de broncoespasmo e asma br&#244;nquica; Feocromocitoma n&#227;o tratado; Acidose metab&#243;lica; Bradicardia; Hipotens&#227;o arterial (press&#227;o arterial sist&#243;lica &lt; 90 mmHg); Perturba&#231;&#245;es circulat&#243;rias perif&#233;ricas graves.</span></p>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong></p>\r\n<ul>\r\n<li><strong>Adultos:</strong>&#160;5mg, VO, 1x/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Pacientes &gt;65 anos:&#160;</strong>iniciar o tratamento com 2,5mg, VO, 1x/dia. Se necess&#225;rio aumentar para 5mg/dia.</li>\r\n</ul>\r\n<p><strong>Insufici&#234;ncia Card&#237;aca:</strong></p>\r\n<ul>\r\n<li>Ajuste gradual at&#233; que a dose &#243;tima individual seja alcan&#231;ada.</li>\r\n<li style=\"text-align: justify;\">Iniciar com 1,25mg, VO, 1x/dia; depois 2,5mg, VO, 1x/dia; depois 5 mg, VO, 1x/dia (Dose m&#225;xima 10 mg/dia).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2052,
        "indications": "<p>-&#160;Hipertens&#227;o arterial; Insufici&#234;ncia card&#237;aca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 116,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:57:50",
        "name": "Neblock",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neblock",
        "substance": "Nebivolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Dor de cabe&#231;a, vertigem, cansa&#231;o, prurido, diarreia, constipa&#231;&#227;o, n&#225;usea, dificuldade respirat&#243;ria, m&#227;os e p&#233;s inchados.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Na insufici&#234;ncia renal a dose inicial recomendada para o tratamento de hipertens&#227;o &#233; 2,5mg.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajustes para a insufici&#234;ncia renal leve a moderada no tratamento da insufici&#234;ncia card&#237;aca.</p>\r\n</div>"
    },
    {
        "content_length": 3420,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Insufici&#234;ncia hep&#225;tica ou fun&#231;&#227;o hep&#225;tica diminu&#237;da; Insufici&#234;ncia card&#237;aca aguda, choque cardiog&#234;nico; Doen&#231;a do n&#243;dulo sinusal, incluindo o bloqueio sino-auricular; Bloqueio card&#237;aco do segundo e terceiro grau (sem marca-passo); Hist&#243;ria de broncoespasmo e asma br&#244;nquica; Feocromocitoma n&#227;o tratado; Acidose metab&#243;lica; Bradicardia; Hipotens&#227;o arterial (press&#227;o arterial sist&#243;lica &lt; 90 mmHg); Perturba&#231;&#245;es circulat&#243;rias perif&#233;ricas graves.</span></p>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong></p>\r\n<ul>\r\n<li><strong>Adultos:</strong>&#160;5mg, VO, 1x/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Pacientes &gt;65 anos:&#160;</strong>iniciar o tratamento com 2,5mg, VO, 1x/dia. Se necess&#225;rio aumentar para 5mg/dia.</li>\r\n</ul>\r\n<p><strong>Insufici&#234;ncia Card&#237;aca:</strong></p>\r\n<ul>\r\n<li>Ajuste gradual at&#233; que a dose &#243;tima individual seja alcan&#231;ada.</li>\r\n<li style=\"text-align: justify;\">Iniciar com 1,25mg, VO, 1x/dia; depois 2,5mg, VO, 1x/dia; depois 5 mg, VO, 1x/dia (Dose m&#225;xima 10 mg/dia).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2053,
        "indications": "<p>-&#160;Hipertens&#227;o arterial; Insufici&#234;ncia card&#237;aca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:57:31",
        "name": "Nebilet",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nebilet",
        "substance": "Nebivolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Dor de cabe&#231;a, vertigem, cansa&#231;o, prurido, diarreia, constipa&#231;&#227;o, n&#225;usea, dificuldade respirat&#243;ria, m&#227;os e p&#233;s inchados.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Na insufici&#234;ncia renal a dose inicial recomendada para o tratamento de hipertens&#227;o &#233; 2,5mg.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajustes para a insufici&#234;ncia renal leve a moderada no tratamento da insufici&#234;ncia card&#237;aca.</p>\r\n</div>"
    },
    {
        "content_length": 3559,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">&#160;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Insufici&#234;ncia hep&#225;tica ou fun&#231;&#227;o hep&#225;tica diminu&#237;da; Insufici&#234;ncia card&#237;aca aguda, choque cardiog&#234;nico; Doen&#231;a do n&#243;dulo sinusal, incluindo o bloqueio sino-auricular; Bloqueio card&#237;aco do segundo e terceiro grau (sem marca-passo); Hist&#243;ria de broncoespasmo e asma br&#244;nquica; Feocromocitoma n&#227;o tratado; Acidose metab&#243;lica; Bradicardia; Hipotens&#227;o arterial (press&#227;o arterial sist&#243;lica &lt; 90 mmHg); Perturba&#231;&#245;es circulat&#243;rias perif&#233;ricas graves.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong></p>\r\n<ul>\r\n<li><strong>Adultos:</strong>&#160;5mg, VO, 1x/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Pacientes &gt;65 anos:&#160;</strong>iniciar o tratamento com 2,5mg, VO, 1x/dia. Se necess&#225;rio aumentar para 5mg/dia.</li>\r\n</ul>\r\n<p><strong>Insufici&#234;ncia Card&#237;aca:</strong></p>\r\n<ul>\r\n<li>Ajuste gradual at&#233; que a dose &#243;tima individual seja alcan&#231;ada.</li>\r\n<li style=\"text-align: justify;\">Iniciar com 1,25mg, VO, 1x/dia; depois 2,5mg, VO, 1x/dia; depois 5 mg, VO, 1x/dia (Dose m&#225;xima 10 mg/dia).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2054,
        "indications": "<p>-&#160;Hipertens&#227;o arterial; Insufici&#234;ncia card&#237;aca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 81,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 02:36:41",
        "name": "Bivolet",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bivolet",
        "substance": "Nebivolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Dor de cabe&#231;a, vertigem, cansa&#231;o, prurido, diarreia, constipa&#231;&#227;o, n&#225;usea, dificuldade respirat&#243;ria, m&#227;os e p&#233;s inchados.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Na insufici&#234;ncia renal a dose inicial recomendada para o tratamento de hipertens&#227;o &#233; 2,5mg.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajustes para a insufici&#234;ncia renal leve a moderada no tratamento da insufici&#234;ncia card&#237;aca.</p>\r\n</div>"
    },
    {
        "content_length": 3421,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Insufici&#234;ncia hep&#225;tica ou fun&#231;&#227;o hep&#225;tica diminu&#237;da; Insufici&#234;ncia card&#237;aca aguda, choque cardiog&#234;nico; Doen&#231;a do n&#243;dulo sinusal, incluindo o bloqueio sino-auricular; Bloqueio card&#237;aco do segundo e terceiro grau (sem marca-passo); Hist&#243;ria de broncoespasmo e asma br&#244;nquica; Feocromocitoma n&#227;o tratado; Acidose metab&#243;lica; Bradicardia; Hipotens&#227;o arterial (press&#227;o arterial sist&#243;lica &lt; 90 mmHg); Perturba&#231;&#245;es circulat&#243;rias perif&#233;ricas graves.</span></p>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong></p>\r\n<ul>\r\n<li><strong>Adultos:</strong>&#160;5mg, VO, 1x/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Pacientes &gt;65 anos:&#160;</strong>iniciar o tratamento com 2,5mg, VO, 1x/dia. Se necess&#225;rio aumentar para 5mg/dia.</li>\r\n</ul>\r\n<p><strong>Insufici&#234;ncia Card&#237;aca:</strong></p>\r\n<ul>\r\n<li>Ajuste gradual at&#233; que a dose &#243;tima individual seja alcan&#231;ada.</li>\r\n<li style=\"text-align: justify;\">Iniciar com 1,25mg, VO, 1x/dia; depois 2,5mg, VO, 1x/dia; depois 5 mg, VO, 1x/dia (Dose m&#225;xima 10 mg/dia).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2056,
        "indications": "<p>-&#160;Hipertens&#227;o arterial; Insufici&#234;ncia card&#237;aca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 03:54:31",
        "name": "Teubiliv",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "teubiliv",
        "substance": "Nebivolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Dor de cabe&#231;a, vertigem, cansa&#231;o, prurido, diarreia, constipa&#231;&#227;o, n&#225;usea, dificuldade respirat&#243;ria, m&#227;os e p&#233;s inchados.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Na insufici&#234;ncia renal a dose inicial recomendada para o tratamento de hipertens&#227;o &#233; 2,5mg.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajustes para a insufici&#234;ncia renal leve a moderada no tratamento da insufici&#234;ncia card&#237;aca.</p>\r\n</div>"
    },
    {
        "content_length": 3418,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Insufici&#234;ncia hep&#225;tica ou fun&#231;&#227;o hep&#225;tica diminu&#237;da; Insufici&#234;ncia card&#237;aca aguda, choque cardiog&#234;nico; Doen&#231;a do n&#243;dulo sinusal, incluindo o bloqueio sino-auricular; Bloqueio card&#237;aco do segundo e terceiro grau (sem marca-passo); Hist&#243;ria de broncoespasmo e asma br&#244;nquica; Feocromocitoma n&#227;o tratado; Acidose metab&#243;lica; Bradicardia; Hipotens&#227;o arterial (press&#227;o arterial sist&#243;lica &lt; 90 mmHg); Perturba&#231;&#245;es circulat&#243;rias perif&#233;ricas graves.</span></p>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong></p>\r\n<ul>\r\n<li><strong>Adultos:</strong>&#160;5mg, VO, 1x/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Pacientes &gt;65 anos:&#160;</strong>iniciar o tratamento com 2,5mg, VO, 1x/dia. Se necess&#225;rio aumentar para 5mg/dia.</li>\r\n</ul>\r\n<p><strong>Insufici&#234;ncia Card&#237;aca:</strong></p>\r\n<ul>\r\n<li>Ajuste gradual at&#233; que a dose &#243;tima individual seja alcan&#231;ada.</li>\r\n<li style=\"text-align: justify;\">Iniciar com 1,25mg, VO, 1x/dia; depois 2,5mg, VO, 1x/dia; depois 5 mg, VO, 1x/dia (Dose m&#225;xima 10 mg/dia).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2057,
        "indications": "<p>-&#160;Hipertens&#227;o arterial; Insufici&#234;ncia card&#237;aca.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 79,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-04 00:59:32",
        "name": "Lobeat",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lobeat",
        "substance": "Nebivolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Dor de cabe&#231;a, vertigem, cansa&#231;o, prurido, diarreia, constipa&#231;&#227;o, n&#225;usea, dificuldade respirat&#243;ria, m&#227;os e p&#233;s inchados.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Na insufici&#234;ncia renal a dose inicial recomendada para o tratamento de hipertens&#227;o &#233; 2,5mg.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajustes para a insufici&#234;ncia renal leve a moderada no tratamento da insufici&#234;ncia card&#237;aca.</p>\r\n</div>"
    },
    {
        "content_length": 3485,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Insufici&#234;ncia hep&#225;tica ou fun&#231;&#227;o hep&#225;tica diminu&#237;da; Insufici&#234;ncia card&#237;aca aguda, choque cardiog&#234;nico; Doen&#231;a do n&#243;dulo sinusal, incluindo o bloqueio sino-auricular; Bloqueio card&#237;aco do segundo e terceiro grau (sem marca-passo); Hist&#243;ria de broncoespasmo e asma br&#244;nquica; Feocromocitoma n&#227;o tratado; Acidose metab&#243;lica; Bradicardia; Hipotens&#227;o arterial (press&#227;o arterial sist&#243;lica &lt; 90 mmHg); Perturba&#231;&#245;es circulat&#243;rias perif&#233;ricas graves.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Hipertens&#227;o:</strong></p>\r\n<ul>\r\n<li><strong>Adultos:</strong> 5mg, VO, 1x/dia.</li>\r\n<li style=\"text-align: justify;\"><strong>Pacientes &gt;65 anos:&#160;</strong>iniciar o tratamento com 2,5mg, VO, 1x/dia. Se necess&#225;rio aumentar para 5mg/dia.</li>\r\n</ul>\r\n<p><strong>Insufici&#234;ncia Card&#237;aca:</strong></p>\r\n<ul>\r\n<li>Ajuste gradual at&#233; que a dose &#243;tima individual seja alcan&#231;ada.</li>\r\n<li style=\"text-align: justify;\">Iniciar com 1,25mg, VO, 1x/dia; depois 2,5mg, VO, 1x/dia; depois 5 mg, VO, 1x/dia (Dose m&#225;xima 10 mg/dia).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2058,
        "indications": "<div>\r\n<p>-&#160;Hipertens&#227;o arterial; Insufici&#234;ncia card&#237;aca.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:57:41",
        "name": "Nebivolol",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nebivolol",
        "substance": "Nebivolol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Dor de cabe&#231;a, vertigem, cansa&#231;o, prurido, diarreia, constipa&#231;&#227;o, n&#225;usea, dificuldade respirat&#243;ria, m&#227;os e p&#233;s inchados.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Na insufici&#234;ncia renal a dose inicial recomendada para o tratamento de hipertens&#227;o &#233; 2,5mg.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajustes para a insufici&#234;ncia renal leve a moderada no tratamento da insufici&#234;ncia card&#237;aca.</p>\r\n</div>"
    },
    {
        "content_length": 2048,
        "contraindications": "<div>\r\n<p>- Apendicite, hemorragia retal n&#227;o diagnosticada e obstru&#231;&#227;o intestinal.&#160;</p>\r\n<p>- Hipersensibilidade a qualquer componente da f&#243;rmula.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose m&#237;mima recomendada: </strong>250mL/dia, via retal.</li>\r\n<li><strong>Dose m&#225;xima: </strong>1000mL/dia, via retal.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Posologia idem adultos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2062,
        "indications": "<p>- Auxiliar na lavagem intestinal, pr&#233;-parto, pr&#233;-operat&#243;rio, prepara&#231;&#227;o para exames radiol&#243;gicos.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 19:47:47",
        "name": "Glicerol",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o retal:</strong> 120 mg/mL (12%).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicerin-supositorio",
        "substance": "Glicerol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;Diarreia, flatul&#234;ncia, c&#243;licas, irrita&#231;&#227;o retal.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste</p>\r\n</div>"
    },
    {
        "content_length": 3018,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Hipersensibilidade aos componentes;&#160;Altera&#231;&#227;o do labirinto; Insufici&#234;ncia renal grave; Beb&#234;s prematuros, rec&#233;m-nascidos, lactentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>Aplica&#231;&#227;o t&#243;pica:</strong>&#160;1 a 3x/dia&#160;sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Aplica&#231;&#227;o t&#243;pica:</strong>&#160;1 a 3x/dia&#160;<span style=\"text-align: justify;\">sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria D:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2064,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;Dermatoses infectadas;&#160;Queimaduras infectadas;&#160;Cortes e ulceras cut&#226;neas;&#160;Impetigo e fur&#250;nculos;&#160;Otite externa.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 158,
        "lactation_text": "<p><strong>- Muito baixo risco: </strong>Uso liberado na lacta&#231;&#227;o.&#160;</p>",
        "last_update": "2019-03-05 00:58:16",
        "name": "Nemicina",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong> 5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nemicina",
        "substance": "Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Eritema, rash cut&#226;neo, prurido, incha&#231;o no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3135,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Hipersensibilidade aos componentes;&#160;Altera&#231;&#227;o do labirinto; Insufici&#234;ncia renal grave; Beb&#234;s prematuros, rec&#233;m-nascidos, lactentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong style=\"text-align: justify;\">Aplica&#231;&#227;o t&#243;pica:</strong><span style=\"text-align: justify;\">&#160;1 a 3x/dia&#160;sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong style=\"text-align: justify;\">Aplica&#231;&#227;o t&#243;pica:</strong><span style=\"text-align: justify;\">&#160;1 a 3x/dia&#160;sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2066,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Dermatoses infectadas;&#160;Queimaduras infectadas;&#160;Cortes e ulceras cut&#226;neas;&#160;Impetigo e fur&#250;nculos;&#160;Otite externa.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 16,
        "lactation_text": "<p><strong>- Muito baixo risco: </strong>Uso liberado na lacta&#231;&#227;o.&#160;</p>",
        "last_update": "2019-03-05 01:10:29",
        "name": "Neomicon",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neomicon",
        "substance": "Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Eritema, rash cut&#226;neo, prurido, incha&#231;o no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2510,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Hipersensibilidade aos componentes;&#160;Altera&#231;&#227;o do labirinto; Uso oft&#225;lmico; Uso em beb&#234;s prematuros, rec&#233;m-nascidos e lactantes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Aplica&#231;&#227;o t&#243;pica:</strong> 3x/dia sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Aplica&#231;&#227;o t&#243;pica:</strong>&#160;3x/dia sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2067,
        "indications": "<div>\r\n<p>- Infec&#231;&#245;es de pele como eczema, piodermite, fur&#250;nculo, abcessos e &#250;lceras cut&#226;neas.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Muito baixo risco: </strong>Uso liberado na lacta&#231;&#227;o.&#160;</p>",
        "last_update": "2019-03-05 01:10:11",
        "name": "Neomicina",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong> 3,5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neomicina",
        "substance": "Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Eritema, rash cut&#226;neo, prurido, incha&#231;o no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3099,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Hipersensibilidade aos componentes;&#160;Altera&#231;&#227;o do labirinto; Insufici&#234;ncia renal grave.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong style=\"text-align: justify;\">Aplica&#231;&#227;o t&#243;pica:</strong><span style=\"text-align: justify;\">&#160;1 a 3x/dia&#160;sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong style=\"text-align: justify;\">Aplica&#231;&#227;o t&#243;pica:</strong><span style=\"text-align: justify;\">&#160;1 a 3x/dia&#160;sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2069,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Dermatoses infectadas;&#160;Queimaduras infectadas;&#160;Cortes e ulceras cut&#226;neas;&#160;Impetigo e fur&#250;nculos;&#160;Otite externa.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 83,
        "lactation_text": "<p><strong>- Muito baixo risco: </strong>Uso liberado na lacta&#231;&#227;o.&#160;</p>",
        "last_update": "2019-03-04 01:00:53",
        "name": "Lomicina",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lomicina",
        "substance": "Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Eritema, rash cut&#226;neo, prurido, incha&#231;o no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2875,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">-&#160;Hipersensibilidade aos componentes;&#160;Altera&#231;&#227;o do labirinto; Insufici&#234;ncia renal grave; Beb&#234;s prematuros, rec&#233;m-nascidos, lactentes.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Aplica&#231;&#227;o t&#243;pica:</strong>&#160;1 a 3x/dia&#160;<span style=\"text-align: justify;\">sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Aplica&#231;&#227;o t&#243;pica:</strong>&#160;1 a 3x/dia&#160;<span style=\"text-align: justify;\">sobre a &#225;rea lesada. Lavar o local com &#225;gua e sab&#227;o, e secar, previamente.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria D:</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2074,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Dermatoses infectadas;&#160;Queimaduras infectadas;&#160;Cortes e ulceras cut&#226;neas;&#160;Impetigo e fur&#250;nculos;&#160;Otite externa.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 52,
        "lactation_text": "<p><strong>- Muito baixo risco: </strong>Uso liberado na lacta&#231;&#227;o.&#160;</p>",
        "last_update": "2019-03-06 17:43:20",
        "name": "Pomicina",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "pomicina",
        "substance": "Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Eritema, rash cut&#226;neo, prurido, incha&#231;o no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2576,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">Pingar 1 a 2 gotas sobre o local afetado da boca, 3 a 6 vezes/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Pingar 1 a 2 gotas sobre o local afetado da boca, 3 a 6 vezes/dia.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>-&#160;</strong><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria D:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2076,
        "indications": "<p>- Auxiliar no tratamento das afec&#231;&#245;es bucais.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 61,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-04 02:34:28",
        "name": "Bismu-jet",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;25mg/mL Neomicina&#160;+ 25mg/mL Bismuto&#160;+ 15mg/mL Proca&#237;na.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bismujet",
        "substance": "Neomicina + Bismuto + Procaína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Rea&#231;&#245;es al&#233;rgicas.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2517,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">-&#160;Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Dose usual:</strong> Aplicar uma fina camada sobre a &#225;rea afetada 1-2x/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Posologia idem adultos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2084,
        "indications": "<p>- Indicado nas afec&#231;&#245;es de pele, onde se exigem a&#231;&#245;es anti-inflamat&#243;ria, antibacteriana e antimic&#243;tica, causadas por germes sens&#237;veis, como: dermatites de contato, dermatite at&#243;pica, dermatite seborreica, intertrigo, disidrose, neurodermatite.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Muito baixo risco: </strong>Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 02:25:02",
        "name": "Betametasona + Cetoconazol + Neomicina",
        "presentation": "<ul>\r\n<li><strong>Pomada dermatol&#243;gica:</strong>&#160;Betametasona 0,64mg/g + Cetoconazol 20mg/g + Neomicina 2,5mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cetoconazol-betametasona-neomicina",
        "substance": "Betametasona + Cetoconazol + Neomicina",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- Ard&#234;ncia, irrita&#231;&#227;o, prurido, ressecamento.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal; text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2602,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes, infec&#231;&#227;o f&#250;ngica.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> Aplicar sobre a &#225;rea afetada, 2-3x/dia, at&#233; que haja melhora; em seguida, pode-se fazer uma aplica&#231;&#227;o ao dia ou em dias alternados. A partir da resposta as doses tamb&#233;m podem ser aumentadas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">Posologia idem adultos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2090,
        "indications": "<div>\r\n<p>- Eczema, inclusive at&#243;pico, infantil e disc&#243;ide, psor&#237;ase, exceto a psor&#237;ase em placa disseminada, neurodermatoses, incluindo l&#237;quen simples e l&#237;quen plano, dermatite seborreica e dermatites de contato, l&#250;pus eritematoso discoide, eritroderma generalizado, util para o controle de picadas de inseto, queimadura solar e mili&#225;ria rubra.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-09-29 18:12:28",
        "name": "Betnovate N",
        "presentation": "<ul>\r\n<li><strong>Pomada e Creme dermatol&#243;gicos:</strong> 0,1% de Betametasona + 0,5% de Neomicina.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "betnovate-n",
        "substance": "Betametasona + Neomicina",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Dor de est&#244;mago, ins&#244;nia, ansiedade, reten&#231;&#227;o de s&#243;dio, perda de pot&#225;ssio, reten&#231;&#227;o de l&#237;quido, dermatite al&#233;rgica, urtic&#225;ria e retardo de cicatriza&#231;&#227;o.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o estabelecido.</p></div>"
    },
    {
        "content_length": 3578,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Obstru&#231;&#227;o intestinal mec&#226;nica ou obstru&#231;&#227;o urin&#225;ria; Uso em associa&#231;&#227;o com miorrelaxantes despolarizantes como o suxamet&#244;nio.</span></p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Constipa&#231;&#227;o at&#244;nica, meteorismo</strong>:</p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">0,25mg a 0,5mg, SC ou IM;</li>\r\n</ul>\r\n<p><strong>Atonia intestinal p&#243;s-operat&#243;ria e reten&#231;&#227;o urinaria:</strong>&#160;</p>\r\n<ul>\r\n<li>Profilaxia: 0,25mg, SC ou IM ap&#243;s a cirurgia, repetir dose 4 a 6 horas se necess&#225;rio;</li>\r\n<li>Tratamento: 0,5mg, SC ou IM ap&#243;s a cirurgia, repetir dose 4 a 5 horas se necess&#225;rio;</li>\r\n</ul>\r\n<p><strong>Antagonista dos curarizantes:</strong></p>\r\n<ul>\r\n<li>1mg a 5 mg, IM ou IV.</li>\r\n</ul>\r\n<p><strong>Miastenia gravis pseudoparal&#237;tica:</strong></p>\r\n<ul>\r\n<li>A dose deve ser ajustada de acordo com o grau de paralisia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Constipa&#231;&#227;o at&#244;nica, meteorismo</strong>:</p>\r\n<ul>\r\n<li>0,125mg a 0,25mg, SC ou IM;</li>\r\n</ul>\r\n<p><strong>Atonia intestinal p&#243;s-operat&#243;ria e reten&#231;&#227;o urinaria:&#160;</strong></p>\r\n<ul>\r\n<li>0,125mg a 0,25mg, SC ou IM.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2091,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Constipa&#231;&#227;o at&#244;nica; Meteorismo; Atonia intestinal p&#243;s-operat&#243;ria; Reten&#231;&#227;o urinaria; Miastenia gravis pseudoparal&#237;tica; Antagonista dos curarizantes.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 139,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 18:49:07",
        "name": "Prostigmine",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;0,5mg/1ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "prostigmne",
        "substance": "Neostigmina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Aumento do peristaltismo, diarreia, n&#225;useas, v&#244;mitos; Bradicardia; Hipersecre&#231;&#227;o br&#244;nquica, hipersaliva&#231;&#227;o e lacrimenjamento; Contra&#231;&#227;o e espasmo muscular, fraqueza.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Disfun&#231;&#227;o renal: intervalos de dosagem prolongados ou diminui&#231;&#227;o da dosagem.</p>\r\n</div>"
    },
    {
        "content_length": 3865,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Obstru&#231;&#227;o intestinal mec&#226;nica ou obstru&#231;&#227;o urin&#225;ria; Uso em associa&#231;&#227;o com miorrelaxantes despolarizantes como o suxamet&#244;nio.</p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Constipa&#231;&#227;o at&#244;nica, meteorismo</strong>:</p>\r\n<ul style=\"text-align: start;\">\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">0,25mg a 0,5mg, SC ou IM;</li>\r\n</ul>\r\n<p style=\"text-align: start;\"><strong>Atonia intestinal p&#243;s-operat&#243;ria e reten&#231;&#227;o urinaria:</strong>&#160;</p>\r\n<ul style=\"text-align: start;\">\r\n<li>Profilaxia: 0,25mg, SC ou IM ap&#243;s a cirurgia, repetir dose 4 a 6 horas se necess&#225;rio;</li>\r\n<li>Tratamento: 0,5mg, SC ou IM ap&#243;s a cirurgia, repetir dose 4 a 5 horas se necess&#225;rio;</li>\r\n</ul>\r\n<p style=\"text-align: start;\"><strong>Antagonista dos curarizantes:</strong></p>\r\n<ul style=\"text-align: start;\">\r\n<li>1mg a 5 mg, IM ou IV.</li>\r\n</ul>\r\n<p style=\"text-align: start;\"><strong>Miastenia gravis pseudoparal&#237;tica:</strong></p>\r\n<ul style=\"text-align: start;\">\r\n<li>A dose deve ser ajustada de acordo com o grau de paralisia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p style=\"text-align: start;\"><strong>Constipa&#231;&#227;o at&#244;nica, meteorismo</strong>:</p>\r\n<ul style=\"text-align: start;\">\r\n<li>0,125mg a 0,25mg, SC ou IM;</li>\r\n</ul>\r\n<p style=\"text-align: start;\"><strong>Atonia intestinal p&#243;s-operat&#243;ria e reten&#231;&#227;o urinaria:&#160;</strong></p>\r\n<ul style=\"text-align: start;\">\r\n<li>0,125mg a 0,25mg, SC ou IM.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2092,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;Constipa&#231;&#227;o at&#244;nica; Meteorismo; Atonia intestinal p&#243;s-operat&#243;ria; Reten&#231;&#227;o urinaria; Miastenia gravis pseudoparal&#237;tica; Antagonista dos curarizantes.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:56:08",
        "name": "Normastig",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;0,5mg/1ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "normastig",
        "substance": "Neostigmina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Aumento do peristaltismo, diarreia, n&#225;useas, v&#244;mitos; Bradicardia; Hipersecre&#231;&#227;o br&#244;nquica, hipersaliva&#231;&#227;o e lacrimenjamento; Contra&#231;&#227;o e espasmo muscular, fraqueza.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Disfun&#231;&#227;o renal: intervalos de dosagem prolongados ou diminui&#231;&#227;o da dosagem.</p>\r\n</div>"
    },
    {
        "content_length": 3547,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes; Obstru&#231;&#227;o intestinal mec&#226;nica ou obstru&#231;&#227;o urin&#225;ria; Uso em associa&#231;&#227;o com miorrelaxantes despolarizantes como o suxamet&#244;nio.</p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Constipa&#231;&#227;o at&#244;nica, meteorismo</strong>:</p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">0,25mg a 0,5mg, SC ou IM;</li>\r\n</ul>\r\n<p><strong>Atonia intestinal p&#243;s-operat&#243;ria e reten&#231;&#227;o urinaria:</strong>&#160;</p>\r\n<ul>\r\n<li>Profilaxia: 0,25mg, SC ou IM ap&#243;s a cirurgia, repetir dose 4 a 6 horas se necess&#225;rio;</li>\r\n<li>Tratamento: 0,5mg, SC ou IM ap&#243;s a cirurgia, repetir dose 4 a 5 horas se necess&#225;rio;</li>\r\n</ul>\r\n<p><strong>Antagonista dos curarizantes:</strong></p>\r\n<ul>\r\n<li>1mg a 5 mg, IM ou IV.</li>\r\n</ul>\r\n<p><strong>Miastenia gravis pseudoparal&#237;tica:</strong></p>\r\n<ul>\r\n<li>A dose deve ser ajustada de acordo com o grau de paralisia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Constipa&#231;&#227;o at&#244;nica, meteorismo</strong>:</p>\r\n<ul>\r\n<li>0,125mg a 0,25mg, SC ou IM;</li>\r\n</ul>\r\n<p><strong style=\"text-align: left;\">Atonia intestinal p&#243;s-operat&#243;ria e reten&#231;&#227;o urinaria:&#160;</strong></p>\r\n<ul>\r\n<li>0,125mg a 0,25mg, SC ou IM.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2093,
        "indications": "<p style=\"text-align: justify;\">-&#160;Constipa&#231;&#227;o at&#244;nica; Meteorismo; Atonia intestinal p&#243;s-operat&#243;ria; Reten&#231;&#227;o urinaria; Miastenia gravis pseudoparal&#237;tica; Antagonista dos curarizantes.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:13:04",
        "name": "Neostigmina",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 0,5mg/1ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neostigmina",
        "substance": "Neostigmina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Aumento do peristaltismo, diarreia, n&#225;useas, v&#244;mitos; Bradicardia; Hipersecre&#231;&#227;o br&#244;nquica, hipersaliva&#231;&#227;o e lacrimenjamento; Contra&#231;&#227;o e espasmo muscular, fraqueza.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Disfun&#231;&#227;o renal: intervalos de dosagem prolongados ou diminui&#231;&#227;o da dosagem.</p>\r\n</div>"
    },
    {
        "content_length": 5024,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade aos componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Grave disfun&#231;&#227;o hep&#225;tica ou n&#237;veis de ALT e AST 5 vezes maiores do que o limite superior de refer&#234;ncia.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong><span style=\"mso-bidi- line-height: 107%;\">Tratamento HIV:</span></strong></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">200 mg, VO, uma vez ao dia nos primeiros 14 dias e ent&#227;o 200 mg 2x/dia, em associa&#231;&#227;o com mais 2 agentes antirretrovirais.</span></p>\r\n</li>\r\n</ul>\r\n<hr>\r\n<p style=\"text-align: justify;\">Os pacientes&#160;que interromperem o tratamento por mais de 7 dias devem realizar novamente a fase de introdu&#231;&#227;o reiniciando o per&#237;odo de introdu&#231;&#227;o de 2 semanas.</p>\r\n<p style=\"text-align: justify;\"><strong>Profilaxia materno-infantil:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">Dose materna: 200mg, VO, assim que poss&#237;vel ap&#243;s o in&#237;cio do trabalho de parto. Dose &#250;nica.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong><span style=\"mso-bidi- line-height: 107%;\">Tratamento do HIV:</span></strong></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">150mg/m&#178;, 1x/dia, por 2 semanas e depois 150mg/m&#178;, 2x/dia; (</span><span style=\"mso-bidi- line-height: 107%;\">Dose m&#225;xima: 400mg/dia)</span></p>\r\n</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%;\"><strong style=\"text-align: justify;\">Profilaxia materno-infantil:</strong></span></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">Dose neonato: 2mg/kg, at&#233; 72 horas ap&#243;s o nascimento.&#160;Se a m&#227;e tiver recebido sua dose de nevirapina menos de 2 horas antes do nascimento, deve-se administrar ao rec&#233;m-nascido uma dose oral &#250;nica de 2mg/kg de nevirapina suspens&#227;o imediatamente ap&#243;s o nascimento e a segunda dose de 2mg/kg deve ser administrada dentro de 24-72 horas ap&#243;s a primeira dose.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 2095,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Tratamento de pacientes infectados com HIV;</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Preven&#231;&#227;o da transmiss&#227;o materno-infantil do HIV-1 no caso de mulheres gr&#225;vidas que n&#227;o estiverem recebendo tratamento antirretroviral durante o trabalho de parto.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 230,
        "lactation_text": "<div>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p style=\"text-align: justify;\">Recomenda-se que mulheres infectadas com HIV n&#227;o amamentem seus filhos a fim de previnir a transmiss&#227;o p&#243;s-natal.&#160;</p>\r\n</div>",
        "last_update": "2019-03-03 17:45:06",
        "name": "Farmanguinhos Nevirapina",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;200mg;</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receita de controle especial (C4- anti-retrovirais - Formul&#225;rio pr&#243;prio/DST/AIDS).</span></p>",
        "record_status": 1,
        "slug": "nevirapina",
        "substance": "Nevirapina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Erup&#231;&#227;o cut&#226;nea, hipersensibilidade;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Cefaleia, n&#225;useas, v&#244;mitos, dor abdominal, diarreia, hepatite;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Fadiga, febre, granulocitopenia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Exame das fun&#231;&#245;es do f&#237;gado anormais e casos raros de anemia e neutropenia.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- <strong>Di&#225;lise em pacientes pedi&#225;tricos</strong>: dose adicional de 50% da dose di&#225;ria ap&#243;s a di&#225;lise.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- <strong>Di&#225;lise em adultos:</strong> dose adicional de 200 mg ap&#243;s a di&#225;lise.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- <strong>Disfun&#231;&#227;o hep&#225;tica moderada:</strong> cautela na administra&#231;&#227;o.</p>\r\n</div>"
    },
    {
        "content_length": 2573,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade aos componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">H</span>emorragia aguda; Bradicardia acentuada; Infarto do mioc&#225;rdio recente; Hipotens&#227;o ortost&#225;tica; Menores de 18 anos.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">30mg a 60mg/dia em 1 ou 2 doses.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2096,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Tratamento para transtornos metab&#243;lico-vasculares cerebrais e perif&#233;ricos;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Doen&#231;a de Raynoud;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Arteriopatias org&#226;nicas e funcionais dos membros.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 31,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 16:27:25",
        "name": "Sermion",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong> 30mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nicergolina",
        "substance": "Nicergolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Desconforto abdominal.<br></span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- <strong>Creatinina s&#233;rica &gt; 2mg/dL</strong>: reduzir a dose.</p>\r\n</div>"
    },
    {
        "content_length": 4510,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade aos componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Pacientes que estejam no per&#237;odo p&#243;s-infarto do mioc&#225;rdio, que sofreram AVE recente, com arritmias card&#237;acas graves;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Portadores de angina pectoris;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Indiv&#237;duos com afec&#231;&#245;es ativas da articula&#231;&#227;o temporomandibular;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hipertens&#227;o descontrolada.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Gomas mastig&#225;veis:</strong></span><span style=\"mso-bidi- line-height: 107%;\">&#160;mascar 2 mg toda vez que sentir o desejo de fumar; em pacientes que fumam mais de 20 cigarros/dia, mascar 4mg. Dose m&#225;xima: 96mg/dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Adesivos transd&#233;rmicos:</strong> se o paciente fuma at&#233; 10 cigarros/dia, adesivo de 16,6mg por 6 semanas e de 8,3mg por 2 semanas, trocando a cada 24h; se fuma mais de 10 cigarros/dia, adesivo de 24,9mg por 6 semanas, de 16,6mg por 2 semanas e de 8,3mg por mais 2 semanas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2098,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Tratamento de indiv&#237;duos tabaco-dependentes; aliviar os sintomas da s&#237;ndrome de abstin&#234;ncia de nicotina.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 82,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:44:01",
        "name": "Nicorette",
        "presentation": "<ul>\r\n<li><strong>Gomas mastig&#225;veis:</strong> 2mg e 4mg;</li>\r\n<li><strong>Adesivos transd&#233;rmicos:</strong> 8,3mg, 16,6mg e 24,9mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nicorette",
        "substance": "Nicotina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;N&#225;useas, v&#244;mitos, dor de cabe&#231;a, tontura;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Rea&#231;&#245;es no local de aplica&#231;&#227;o;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Ins&#244;nia, tremores, palpita&#231;&#245;es, falta de ar, faringite;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Tosse, nervosismo, desconforto digestivo, dor abdominal alta, diarr&#233;ia, boca seca, pris&#227;o de ventre;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Aumento da transpira&#231;&#227;o, dores nas articula&#231;&#245;es e musculares;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Dor tor&#225;cica, dor nos membros, astenia, fadiga, taquicardia, mal estar;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Sintomas semelhantes aos da gripe, hipersensibilidade, rea&#231;&#245;es anafil&#225;ticas, dermatite al&#233;rgica, dermatite de contato, fotossensibilidade.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3163,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Pacientes que estejam no per&#237;odo p&#243;s-infarto do mioc&#225;rdio, que sofreram AVE recente, com arritmias card&#237;acas graves;&#160;Portadores de angina pectoris;&#160;Indiv&#237;duos com afec&#231;&#245;es ativas da articula&#231;&#227;o temporomandibular;&#160;Hipertens&#227;o descontrolada.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">mascar 2 mg toda vez que sentir o desejo de fumar; em pacientes que fumam mais de 20 cigarros/dia, mascar 4mg. Dose m&#225;xima: 96mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2099,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Tratamento de indiv&#237;duos tabaco-dependentes; aliviar os sintomas da s&#237;ndrome de abstin&#234;ncia de nicotina.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 82,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:44:12",
        "name": "Nicorette Freshfuit",
        "presentation": "<ul>\r\n<li><strong>Gomas mastig&#225;veis:</strong>&#160;2mg e 4mg;</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nicorette-freshfruit",
        "substance": "Nicotina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas, v&#244;mitos, dor de cabe&#231;a, tontura;&#160;Rea&#231;&#245;es no local de aplica&#231;&#227;o;&#160;Ins&#244;nia, tremores, palpita&#231;&#245;es, falta de ar, faringite;&#160;Tosse, nervosismo, desconforto digestivo, dor abdominal alta, diarr&#233;ia, boca seca, pris&#227;o de ventre;&#160;Aumento da transpira&#231;&#227;o, dores nas articula&#231;&#245;es e musculares;&#160;Dor tor&#225;cica, dor nos membros, astenia, fadiga, taquicardia, mal estar;&#160;Sintomas semelhantes aos da gripe, hipersensibilidade, rea&#231;&#245;es anafil&#225;ticas, dermatite al&#233;rgica, dermatite de contato, fotossensibilidade.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3355,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Pacientes que estejam no per&#237;odo p&#243;s-infarto do mioc&#225;rdio, que sofreram AVE recente, com arritmias card&#237;acas graves;&#160;Portadores de angina pectoris;&#160;Indiv&#237;duos com afec&#231;&#245;es ativas da articula&#231;&#227;o temporomandibular;&#160;Hipertens&#227;o descontrolada.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Adesivos transd&#233;rmicos:</strong> se o paciente fuma at&#233; 10 cigarros/dia, adesivo de 14mg por 6 semanas e de 7mg por 2 semanas, trocando a cada 24h; se fuma mais de 10 cigarros/dia, adesivo de 21mg por 6 semanas, de 14mg por 2 semanas e de 7mg por mais 2 semanas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2100,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Tratamento de indiv&#237;duos tabaco-dependentes; aliviar os sintomas da s&#237;ndrome de abstin&#234;ncia de nicotina.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 23,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:44:19",
        "name": "Nicotinell",
        "presentation": "<ul>\r\n<li><strong>Adesivos transd&#233;rmicos:</strong>&#160;7mg, 14mg e 21mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nicotinell",
        "substance": "Nicotina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas, v&#244;mitos, dor de cabe&#231;a, tontura;&#160;Rea&#231;&#245;es no local de aplica&#231;&#227;o;&#160;Ins&#244;nia, tremores, palpita&#231;&#245;es, falta de ar, faringite;&#160;Tosse, nervosismo, desconforto digestivo, dor abdominal alta, diarr&#233;ia, boca seca, pris&#227;o de ventre;&#160;Aumento da transpira&#231;&#227;o, dores nas articula&#231;&#245;es e musculares;&#160;Dor tor&#225;cica, dor nos membros, astenia, fadiga, taquicardia, mal estar;&#160;Sintomas semelhantes aos da gripe, hipersensibilidade, rea&#231;&#245;es anafil&#225;ticas, dermatite al&#233;rgica, dermatite de contato, fotossensibilidade.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3739,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Pacientes que estejam no per&#237;odo p&#243;s-infarto do mioc&#225;rdio, que sofreram AVE recente, com arritmias card&#237;acas graves;&#160;Portadores de angina pectoris;&#160;Indiv&#237;duos com afec&#231;&#245;es ativas da articula&#231;&#227;o temporomandibular;&#160;Hipertens&#227;o descontrolada.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Gomas mastig&#225;veis:</strong></span><span style=\"mso-bidi- line-height: 107%;\">&#160;mascar 2 mg toda vez que sentir o desejo de fumar; em pacientes que fumam mais de 20 cigarros/dia, mascar 4mg. Dose m&#225;xima: 96mg/dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Adesivos transd&#233;rmicos:</strong> se o paciente fuma at&#233; 10 cigarros/dia, adesivo de 14mg por 6 semanas e de 7mg por 2 semanas, trocando a cada 24h; se fuma mais de 10 cigarros/dia, adesivo de 21mg por 6 semanas, de 14mg por 2 semanas e de 7mg por mais 2 semanas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2101,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Tratamento de indiv&#237;duos tabaco-dependentes; aliviar os sintomas da s&#237;ndrome de abstin&#234;ncia de nicotina.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 212,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:47:27",
        "name": "Niquitin",
        "presentation": "<ul>\r\n<li><strong>Pastilhas:</strong> 2mg e 4mg;</li>\r\n<li><strong>Adesivos transd&#233;rmicos:</strong> 7mg, 14mg e 21mg .</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "niquitin",
        "substance": "Nicotina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas, v&#244;mitos, dor de cabe&#231;a, tontura;&#160;Rea&#231;&#245;es no local de aplica&#231;&#227;o;&#160;Ins&#244;nia, tremores, palpita&#231;&#245;es, falta de ar, faringite;&#160;Tosse, nervosismo, desconforto digestivo, dor abdominal alta, diarr&#233;ia, boca seca, pris&#227;o de ventre;&#160;Aumento da transpira&#231;&#227;o, dores nas articula&#231;&#245;es e musculares;&#160;Dor tor&#225;cica, dor nos membros, astenia, fadiga, taquicardia, mal estar;&#160;Sintomas semelhantes aos da gripe, hipersensibilidade, rea&#231;&#245;es anafil&#225;ticas, dermatite al&#233;rgica, dermatite de contato, fotossensibilidade.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2542,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span>Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Crise Hipertensiva:</strong></p>\r\n<ul>\r\n<li>10 mg VO dose &#250;nica;</li>\r\n</ul>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong> 60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2106,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica; Crise hipertensiva.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 16:31:46",
        "name": "Adalat",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong>&#160;10mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "adalat",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- E</span>dema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2257,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>20mg, VO de 12/12 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>20mg, VO de 12/12 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2107,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 24,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-01-13 23:23:28",
        "name": "Dilaflux Retard",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:</strong>&#160;20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dilaflux-retard",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Edema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2252,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>20mg, VO de 12/12 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>20mg, VO de 12/12 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2108,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 193,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-04 01:01:27",
        "name": "Loncord",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong> 20mg e 40mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "loncord",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Edema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2370,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Crise Hipertensiva:</strong></p>\r\n<ul>\r\n<li>10 mg VO dose &#250;nica;</li>\r\n</ul>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2109,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica; Crise hipertensiva.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:00:20",
        "name": "Neo Fedipina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 10mg e 20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neo-fedipina",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Edema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2364,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Crise Hipertensiva:</strong></p>\r\n<ul>\r\n<li>10 mg VO dose &#250;nica;</li>\r\n</ul>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2110,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica; Crise hipertensiva.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 25,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:44:52",
        "name": "Nifedipress",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nifedipress",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Edema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2348,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Crise Hipertensiva:</strong></p>\r\n<ul>\r\n<li>10 mg VO dose &#250;nica;</li>\r\n</ul>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2111,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica; Crise hipertensiva.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:47:08",
        "name": "Nioxil",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 10mg e 20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nioxil",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Edema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2343,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Crise Hipertensiva:</strong></p>\r\n<ul>\r\n<li>10 mg VO dose &#250;nica;</li>\r\n</ul>\r\n<p><strong>Coronariopatia:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>10 mg VO de 8/8 horas;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;60 mg/dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2112,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 10,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-03 16:32:08",
        "name": "Adalat Oros",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 20mg, 30mg e 60mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "adalat-oros",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Edema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; Sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2402,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span>Infarto do mioc&#225;rdio recente; Angina inst&#225;vel; Choque cardiovascular; Hipersensibilidade aos seus componentes; Em associa&#231;&#227;o com a rifampicina; Na gravidez antes da 20&#170; semana e durante a amamenta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Coronariopatia:</strong>&#160;</p>\r\n<ul>\r\n<li>20 mg VO de 12/12 horas;</li>\r\n</ul>\r\n<p><strong>Hipertens&#227;o arterial:</strong></p>\r\n<ul>\r\n<li>20 mg VO de 12/12 horas; (Dose m&#225;xima: 80 mg/dia)</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2113,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Angina est&#225;vel ou vasoesp&#225;stica; Hipertens&#227;o arterial cr&#244;nica.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 01:44:43",
        "name": "Nifedipina",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong> 20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nifedipina",
        "substance": "Nifedipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- E</span>dema, vasodilata&#231;&#227;o; Constipa&#231;&#227;o; Cefal&#233;ia; sensa&#231;&#227;o de mal estar.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3478,
        "contraindications": "<div>\r\n<p><span style=\"color: #000000;\">- Usado cuidadosamente por pacientes portadores de doen&#231;as cr&#244;nicas, evitar o uso prolongado de bicarbonato de s&#243;dio a fim de evitar o risco de hipernatremia, deve ser cuidadoso em pacientes com constipa&#231;&#227;o&#160;pr&#233;-existente ou com hist&#243;rico de impacta&#231;&#227;o fecal , hemorroidas, obstru&#231;&#227;o gastrintestinal ou diminui&#231;&#227;o da motilidade g&#225;strica, devem ser utilizados cuidadosamente em pacientes com dano renal leve a moderado (devido ao risco elevado de desenvolver hipermagnesemia, al&#233;m de pacientes com dieta restrita de s&#243;dio, pacientes com insufici&#234;ncia card&#237;aca, edema&#160;ou doen&#231;a hep&#225;tica grave.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\"><strong>Dose usual:</strong> Tomar uma colher das de ch&#225; (5g) do p&#243;, dispersos em meio copo de &#225;gua, 3 vezes ao dia, de prefer&#234;ncia ap&#243;s as principais refei&#231;&#245;es (caf&#233; da manh&#227;, almo&#231;o e jantar) e &#224; noite, ao deitar, at&#233; a melhora dos sintomas ou a crit&#233;rio m&#233;dico </span></li>\r\n<li><span style=\"color: #000000;\"><strong>Dose m&#225;xima di&#225;ria:&#160;</strong>20g.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"color: #000000;\">N&#227;o estabelecido.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><span style=\"color: #000000;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 2114,
        "indications": "<p><span style=\"color: #000000;\">- No tratamento das gastrites e suas manifesta&#231;&#245;es.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:36:20",
        "name": "Bisuisan",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>P&#243; de uso oral:</strong> 5g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p><span style=\"color: #000000;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "bisuisan",
        "substance": "Bicarbonato de Sódio + Carbonato de Cálcio + Carbonato Básico de Bismuto + Carbonato de Magnésio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><span style=\"color: #000000;\"><strong>Efeitos adversos:</strong></span></p>\r\n<p><span style=\"color: #000000;\">- Reten&#231;&#227;o de l&#237;quidos ou diurese e desidrata&#231;&#227;o, reten&#231;&#227;o de s&#243;dio, hipersecre&#231;&#227;o g&#225;strica, rebote &#225;cido, flatul&#234;ncia, distens&#227;o g&#225;strica (solu&#231;o, refluxo), dor abdominal, n&#225;useas, v&#244;mitos, constipa&#231;&#227;o ou diarreia, hemorroidas ou fissuras anais (em pacientes com hist&#243;rico de constipa&#231;&#227;o), eructa&#231;&#227;o, hipercalcemia, c&#225;lculo renal e/ou alcalose metab&#243;lica&#160; em pacientes pr&#233;-dispostos, hipofosfatemia.</span></p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>&#160;- N&#227;o estabelecido.&#160;Utilizados cuidadosamente em pacientes com dano renal leve a moderado e doen&#231;a hep&#225;tica grave.</p>\r\n</div>"
    },
    {
        "content_length": 3755,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos seus componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Pacientes com diagn&#243;stico recente de LMC:</strong></p>\r\n<ul>\r\n<li>300mg VO 12/12h;</li>\r\n</ul>\r\n<p style=\"text-align: justify;\"><strong>Pacientes com LMC&#160;ap&#243;s resist&#234;ncia ou intoler&#226;ncia a pelo menos uma terapia pr&#233;via, incluindo imatinibe: </strong></p>\r\n<ul>\r\n<li>400mg VO 12/12h.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2122,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Tratamento de adultos com leucemia miel&#243;ide cr&#244;nica, (LMC) nas fases cr&#244;nica, acelerada ou bl&#225;stica miel&#243;ide/linf&#243;ide com resist&#234;ncia ou intoler&#226;ncia &#224; terapia anterior incluindo imatinibe. </span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-13 01:15:12",
        "name": "Tasigna",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong>&#160;150mg e 200mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tasigna",
        "substance": "Nilotinibe",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span>Diarreia, reten&#231;&#227;o de l&#237;quidos; Cefal&#233;ia, dor muscoloesquel&#233;tica; Hemorragia, febre, fadiga e infec&#231;&#227;o; Derrame pleural, neutropenia febril, pneumonia, infec&#231;&#227;o, sangramento gastrintestinal.&#160;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>-&#160;</strong><span style=\"mso-bidi- line-height: 107%;\"><strong>LMC fase cr&#244;nica:</strong> CNA (contagem de neutr&#243;filos absolutos) &lt; 1 x 10^9 ou plaquetas &lt; 50 x 10^9/L: suspender e monitorar contagens sangu&#237;neas e retormar o tratamento dentro de duas semanas com a dose inicial. Caso a contagem permane&#231;a baixa, pode ser necess&#225;ria a redu&#231;&#227;o da dose para 400 mg 1x/dia;</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>- LMC fase acelerada:</strong> CNA &lt; 0,5 x 10^9/L ou plaquetas &lt; 10 x 10^9/L: suspender e monitorar contagens sangu&#237;neas e retomar o tratamento dentro de duas semanas com a dose inicial se CAN &gt; 1,0 x 10^9/L e/ou plaquetas &gt; 20 x 10^9/L. Caso a contagem permane&#231;a baixa, pode ser necess&#225;rio reduzir a dose para 400 mg 1x/dia.</span></p>\r\n</div>"
    },
    {
        "content_length": 3591,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido dispers&#237;vel:</strong></p>\r\n<ul>\r\n<li>100mg, VO, 2x/dia. Dissolver o comprimido em meio copo de &#225;gua (100 mL), agitar com aux&#237;lio de uma colher e tomar. Se necess&#225;rio voc&#234; pode colocar mais um pouco de &#225;gua no copo, mexer com a colher e tomar em seguida.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<p><strong>Suposit&#243;rio:</strong></p>\r\n<ul>\r\n<li>100mg, VR, 2x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2135,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:48:35",
        "name": "Nisulid",
        "presentation": "<ul>\r\n<li><strong>Comprimido dispers&#237;vel:</strong> 100mg.</li>\r\n<li><strong>Solu&#231;&#227;o oral:</strong> 50mg/ml.</li>\r\n<li><strong>Suposit&#243;rio:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nisulid",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2971,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">&#160;200mg, VO, 1x/dia, ap&#243;s a refei&#231;&#227;o (</span>Dose m&#225;xima: 400mg/dia em dose &#250;nica).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2136,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 193,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 23:26:07",
        "name": "Arflex Retard",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong> 200mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "arflex-retard",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3588,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<p><strong>Gel:</strong></p>\r\n<ul>\r\n<li>Aplicar sobre a pele 2x/dia. Espalhar uniformemente sobre a zona afetada at&#233; que a cor do medicamento desapare&#231;a. Dura&#231;&#227;o: 7 a 15 dias.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2137,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos;</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Auxiliar no tratamento de osteoartrite e artrite reumat&#243;ide.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 15,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 23:26:10",
        "name": "Cimelide",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;50mg/ml.</li>\r\n<li><strong>Gel:&#160;</strong>20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cimelide",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3137,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2138,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 61,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 20:55:31",
        "name": "Inflalide",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "inflalide",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3140,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2139,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:13:14",
        "name": "Neosulida",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neosulida",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3136,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2140,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 125,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:45:49",
        "name": "Nimelit",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimelit",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3133,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2141,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:45:57",
        "name": "Nimesilam",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimesilam",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2866,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2142,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 160,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:46:05",
        "name": "Nimesubal",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimesubal",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3968,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi- line-height: 107%;\">Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Disfun&#231;&#227;o hep&#225;tica;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Crian&#231;as menores de 12 anos.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<p><strong>Gel:</strong></p>\r\n<ul>\r\n<li>Aplicar sobre a pele 2x/dia. Espalhar uniformemente sobre a zona afetada at&#233; que a cor do medicamento desapare&#231;a. Dura&#231;&#227;o: 7 a 15 dias.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong> 400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2143,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:46:13",
        "name": "Nimesulida",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n<li><strong>Gel:&#160;</strong>20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimesulida",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span>N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><span style=\"mso-bidi- line-height: 107%;\"><strong>:</strong> N&#227;o h&#225; ajuste;</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>- ClCr &lt; 30mL/min:</strong> Contraindicado.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica. </span></p>\r\n</div>"
    },
    {
        "content_length": 3153,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral 50mg/ml:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2144,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:46:29",
        "name": "Nimesulix",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 10mg/ml e 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimesulix",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3134,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2145,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:47:44",
        "name": "Nisoflan",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nispflan",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3123,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Gel:</strong></p>\r\n<ul>\r\n<li>Aplicar sobre a pele 2x/dia. Espalhar uniformemente sobre a zona afetada at&#233; que a cor do medicamento desapare&#231;a. Dura&#231;&#227;o: 7 a 15 dias.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2146,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:48:27",
        "name": "Nisufar",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Gel:&#160;</strong>20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nisufar",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3324,
        "contraindications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade a qualquer componente da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose usual:</strong> 1-2 gotas nos olhos afetados quantas vezes forem necess&#225;rias.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2147,
        "indications": "<div>\r\n<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Melhora da irrita&#231;&#227;o, ardor e secura dos olhos, que podem ser causadas pela exposi&#231;&#227;o ao vento, sol, calor, ar seco, e tamb&#233;m como protetor contra irrita&#231;&#245;es oculares.</span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Lubrificante e reumidificante durante o uso de lentes de contato para aliviar o ressecamento, irrita&#231;&#227;o, desconforto e coceira.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 109,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 02:05:32",
        "name": "Ecofilm",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Solu&#231;&#227;o oft&#225;lmica:</strong> 5 mg/mL</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ecofilm",
        "substance": "Carmelose",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</span></strong></p>\r\n<hr>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Irrita&#231;&#227;o, queima&#231;&#227;o e desconforto ocular, dist&#250;rbios visuais, secre&#231;&#227;o nos olhos, dor nos olhos, prurido ocular e hiperemia palpebral. </span></p>\r\n</div>"
    },
    {
        "content_length": 3133,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2150,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 55,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-06 16:38:37",
        "name": "Optaflan",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "optaflan",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3134,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2152,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 55,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 03:20:37",
        "name": "Scaflogin",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong> 50mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "scalogin",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2879,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2153,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 03:24:16",
        "name": "Scalid",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "scalid",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2762,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<ul>\r\n<li>50mg a 100mg, VO, 2x/dia (dose m&#225;xima:&#160;400mg por dia).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2154,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 90,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 04:38:07",
        "name": "Uciton",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "uciton",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3422,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Comprimido:</strong></p>\r\n<ul>\r\n<li>50mg a 100mg, VO, 2x/dia.</li>\r\n</ul>\r\n<p><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li>Pingar uma gota (2,5 mg) por kg de peso, 2x/dia, diretamente na boca ou se preferir dilua em um pouco de &#225;gua com a&#231;&#250;car.</li>\r\n</ul>\r\n<p><strong>Gel:</strong></p>\r\n<ul>\r\n<li>Aplicar sobre a pele 2x/dia. Espalhar uniformemente sobre a zona afetada at&#233; que a cor do medicamento desapare&#231;a. Dura&#231;&#227;o: 7 a 15 dias.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Dose m&#225;xima:</strong>&#160;400mg por dia.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2155,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 286,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 23:26:12",
        "name": "Deltaflan",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;100mg.</li>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;10mg/ml e 50mg/ml.</li>\r\n<li><strong>Gel:&#160;</strong>20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "deltaflan",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 4365,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- &#218;lcera p&#233;ptica (ou hist&#243;ria pregressa de &#250;lcera p&#233;ptica), discrasias sang&#252;&#237;neas (ou hist&#243;ria pregressa de discrasias sang&#252;&#237;neas), di&#225;teses hemorr&#225;gicas (trombocitopenia, dist&#250;rbios da coagula&#231;&#227;o sang&#252;&#237;nea), insufici&#234;ncia card&#237;aca, hep&#225;tica ou renal graves, hipertens&#227;o arterial grave, mol&#233;stias da tire&#243;ide e hipersensibilidade aos derivados do pirazol, s&#237;ndrome de Sj&#245;gren, quando&#160;</span><span style=\"text-align: justify;\">acessos de asma, urtic&#225;ria, ou rinite aguda s&#227;o desencadeados pelo &#225;cido acetilsalicilico ou por outros medicamentos inibidores da prostaglandina-sintetase e</span><span style=\"text-align: justify;\">&#160;em casos de porfiria aguda intermitente.</span></p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Doen&#231;as reum&#225;ticas:&#160;</strong>2 comprimidos VO de 6/6h ou 8/8h, seguido de 2-3 comprimidos VO por dia.</li>\r\n<li><span style=\"text-align: justify;\"><strong>Analg&#233;sico e relaxamente muscular:</strong>&#160;2 comprimidos VO de 8/8h.</span></li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<p style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong><span style=\"text-align: justify;\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2158,
        "indications": "<div>\r\n<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Epis&#243;dios agudos de espondilite anquilosante, e</span><span style=\"text-align: justify;\">pis&#243;dios agudos de artrite reumat&#243;ide e osteartrose e formas agudas de reumatismo extra-articular, quando n&#227;o houver resposta ao tratamento com outras subst&#226;ncias antiinflamat&#243;rias n&#227;o ester&#243;ides, to</span><span style=\"text-align: justify;\">das as situa&#231;&#245;es em que seja necess&#225;rio aliviar a dor e obter relaxamento da musculatura esquel&#233;tica.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-04-15 22:33:10",
        "name": "Mioflex",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong>&#160;Carisoprodol 150mg + Paracetamol&#160;300mg + Fenilbutazona&#160;75mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mioflex",
        "substance": "Carisoprodol + Fenilbutazona + Paracetamol",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- R<span style=\"text-align: justify;\">ea&#231;&#245;es al&#233;rgicas e dist&#250;rbios gastrintestinais (dispepsia, dor epig&#225;strica, recorr&#234;ncia de &#250;lcera p&#233;ptica), dor de cabe&#231;a, confus&#227;o, n&#225;usea, v&#244;mito, edema por reten&#231;&#227;o de eletr&#243;litos, estomatites, sialadenites, dist&#250;rbios da vis&#227;o, b&#243;cio, hepatite, pancreatite e nefrite, s&#237;ndrome de Stevens-Johnson, s&#237;ndrome de Lyell, leucopenia, trombocitopenia, agranulocitose, anemia apl&#225;stica, metahemoglobinemia e anemia hemol&#237;tica.</span></p>\r\n<hr>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>Contraindicado em insufici&#234;ncia grave.</p>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>Contraindicado em insufici&#234;ncia grave.</p>\r\n</div>"
    },
    {
        "content_length": 3165,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hiperssensibilidade a qualquer componentes da f&#243;rmula, miastenia gravis, discrasias sangu&#237;neas, porfiria aguda intermitente, gastrites, duodenites, &#250;lceras g&#225;stricas ou duodenais, hipertens&#227;o, cardiopatias, nefropatias e hepatopatias.&#160;</span></p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:&#160;</strong>1-2 comprimidos VO de 12/12h ou 6/6h.</li>\r\n<li style=\"text-align: justify;\"><strong>Dose m&#225;xima:&#160;</strong>8 comprimidos/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\" line-height: 107%; \">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2163,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Analg&#233;sico e miorrelaxante destinado ao tratamento de todos os estados dolorosos, reum&#225;ticos ou traum&#225;ticos, tais como: dores musculares, espasmos e distens&#227;o muscular, traumatismo de regi&#227;o n&#227;o especificada do corpo, torcicolos, luxa&#231;&#227;o, entorse e distens&#227;o de regi&#227;o n&#227;o especificada do corpo.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-24 13:49:35",
        "name": "Dorilax",
        "presentation": "<div>\r\n<ul>\r\n<li><span style=\"text-align: justify;\"><strong>Comprimido:</strong>&#160;C</span><span style=\"text-align: justify;\">arisoprodol 150mg</span><span style=\"text-align: justify;\">&#160;+ C</span><span style=\"text-align: justify;\">afe&#237;na 50mg</span><span style=\"text-align: justify;\">&#160;+ P</span><span style=\"text-align: justify;\">aracetamol 350mg</span><span style=\"text-align: justify;\">.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\">&#160;</span></p>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dorilax",
        "substance": "Carisoprodol + Cafeína + Paracetamol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"text-align: justify;\">- cefaleia, tonturas, rea&#231;&#227;o al&#233;rgica tipo exantema.&#160;</span></p>\r\n<hr>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>Contraindicado em insufici&#234;ncia grave.</p>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>Contraindicado em insufici&#234;ncia grave.</p>\r\n</div>"
    },
    {
        "content_length": 3387,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- &#218;lcera p&#233;ptica em atividade, hipersensibilidade a quaisquer dos componentes de sua f&#243;rmula, discrasias sangu&#237;neas, di&#225;teses hemorr&#225;gicas (trombocitopenia, dist&#250;rbios da coagula&#231;&#227;o), porfiria, insufici&#234;ncia card&#237;aca, hep&#225;tica ou renal grave, hipertens&#227;o grave, asm&#225;ticos nos quais s&#227;o precipitados crises de asma, urtic&#225;ria ou rinite aguda pelos anti-inflamat&#243;rios n&#227;o esteroidais, uso de isocarboxazida e/ou de fenelzina e/ou tranilcipromina. </span></p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:&#160;</strong>1 comprimido VO de 12/12h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2164,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;</span><span style=\"text-align: justify;\">Reumatismo nas suas formas inflamat&#243;rio-degenerativas agudas e cr&#244;nicas, crises agudas de gota, estados inflamat&#243;rios agudos, p&#243;s-traum&#225;ticos e p&#243;s-cir&#250;rgicos, exacerba&#231;&#245;es agudas de artrite reumatoide e osteoartrose e estados agudos de reumatismo nos tecidos extra-articulares, coadjuvante em processos inflamat&#243;rios graves decorrentes de quadros infecciosos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:28:50",
        "name": "Mioflex A",
        "presentation": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\"><strong>Comprimido:</strong> 50mg de diclofenaco s&#243;dico + 125mg de carisoprodol + 300mg de paracetamol + 30mg de cafe&#237;na.</li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\">&#160;</span></p>\r\n</div>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "MioflexA",
        "substance": "Carisoprodol + Cafeína + Diclofenaco de Sódio + Paracetamol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"text-align: justify;\">- Cefaleia, tonturas, rea&#231;&#227;o al&#233;rgica tipo exantema.&#160;</span></p>\r\n<hr>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>Contraindicado em insufici&#234;ncia grave.</p>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>Contraindicado em insufici&#234;ncia grave.</p>\r\n</div>"
    },
    {
        "content_length": 3423,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade a quaisquer dos componentes de sua f&#243;rmula; nos casos de miastenia gravis, discrasias sangu&#237;neas e porfiria aguda intermitente. Contraindicado na gesta&#231;&#227;o e lacta&#231;&#227;o.</span></p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"text-align: justify;\"><strong>Dose usual:</strong> 1 comprimido VO de 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong>&#160;8 comprimidos/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-9f725e11-a434-7960-6c0d-43cd1df48401\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><span id=\"docs-internal-guid-38024a71-a437-d4fe-13f1-ac08928e7578\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Categoria X:</span><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></span></p>",
        "id": 2165,
        "indications": "<p><span style=\"text-align: justify;\">- Miorrelaxante, antineur&#237;tico e anti&#225;lgico.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 00:28:59",
        "name": "Mionevrix",
        "presentation": "<ul>\r\n<li style=\"text-align: justify;\"><strong><span style=\"text-align: justify;\">Comprimido</span></strong><span style=\"text-align: justify;\">: P</span><span style=\"text-align: justify;\">iridoxina 100mg&#160;+&#160;</span><span style=\"text-align: justify;\">Tiamina 50mg&#160;+ C</span><span style=\"text-align: justify;\">ianocobalamina 1000mcg&#160; + D</span><span style=\"text-align: justify;\">ipirona 250mg&#160; + C</span><span style=\"text-align: justify;\">arisoprodol 250mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mionevrix",
        "substance": "Carisoprodol + Cianocobalamina + Dipirona Sódica + Piridoxina + Tiamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N<span style=\"text-align: justify;\">&#225;useas, v&#244;mitos, aumento da motilidade intestinal e solu&#231;os,&#160;</span><span style=\"text-align: justify;\">sonol&#234;ncia, ataxia, tremor, irritabilidade, cefaleia, inquieta&#231;&#227;o ou ins&#244;nia, taquicardia, hipotens&#227;o postural e rubor facial.</span><span style=\"text-align: justify;\">&#160;</span></p>\r\n<hr>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Renal: </strong>N&#227;o h&#225; ajuste.</p>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2945,
        "contraindications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade a qualquer componente da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose recomendada:</strong> 1 a 2 gotas nos olhos afetados conforme a necessidade.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2172,
        "indications": "<div>\r\n<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Sintomas de secura ocular leve, moderada ou intensa </span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Doen&#231;a do olho seco</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 6,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-08 19:22:48",
        "name": "Refresh Advanced",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oftalmol&#243;gica:</strong>&#160;Carmelose s&#243;dica 5 mg/mL + Glicerol 10 mg/mL + Polissorbato80 5 mg/mL</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "RefreshAdvanced",
        "substance": "Carmelose + Glicerol + Polissorbato80",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><strong>-&#160;</strong><strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Irrita&#231;&#227;o, queima&#231;&#227;o, desconforto ocular, vis&#227;o borrada, redu&#231;&#227;o da acuidade visual, sensa&#231;&#227;o de corpo estranho, hiperemia, hipersensibilidade.</span></p></div>"
    },
    {
        "content_length": 2865,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Rea&#231;&#245;es de hipersensibilidade em resposta ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;Dist&#250;rbios de coagula&#231;&#227;o graves;&#160;Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;Disfun&#231;&#227;o hep&#225;tica;&#160;Crian&#231;as menores de 12 anos.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Uso t&#243;pico:</strong> aplicar na &#225;rea afetada 2x/dia por at&#233; 15 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2175,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Auxiliar no tratamento de osteoartrite e artrite reumat&#243;ide.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 75,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:50:26",
        "name": "Nizuil",
        "presentation": "<ul>\r\n<li><strong>Gel:</strong> 20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Nizuil",
        "substance": "Nimesulida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas; Sonol&#234;ncia; Vertigem; Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><strong>:</strong>&#160;N&#227;o h&#225; ajuste;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr &lt; 30mL/min:</strong>&#160;Contraindicado.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;O uso &#233; contraindicado em pacientes com insufici&#234;ncia hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3604,
        "contraindications": "<div>\r\n<p>- Pacientes que apresentam hipersensibilidade a qualquer componente da formula&#231;&#227;o.</p>\r\n<p>- Para as formas farmac&#234;uticas: Solu&#231;&#227;o oral: Este medicamento &#233; contraindicado para menores de 1 ano. Comprimidos revestidos: Este medicamento &#233; contraindicado para menores de 12 anos</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Tratamento da anemia:</strong></p>\r\n<ul>\r\n<li>10 a 20 ml de xarope 1x/dia, ou 1 a 2 comprimidos 1x/dia.</li>\r\n<li>Tratamento por 3 a 5 meses, at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 1 comprimido 1x/dia&#160;por v&#225;rias semanas (2 a 3 meses) a fim de restaurar a reserva de ferro.</li>\r\n</ul>\r\n<p><strong>Profilaxia da anemia:</strong></p>\r\n<ul>\r\n<li>10 a 20 ml do xarope 1x/semana, ou 1 a 2 comprimidos por semana.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Mulheres lactentes:</strong></p>\r\n<ul>\r\n<li><strong>Tratamento:</strong>&#160;5 gotas/kg/dia 1x/dia (m&#225;ximo de 50 gotas),&#160;&#160;at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina.</li>\r\n<li><strong>Profilaxia:</strong>&#160;5 gotas/kg 1x/semana (m&#225;ximo de 50 gotas).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>Tratamento da anemia:&#160;</strong>deve ser utilizado, por via oral, na dose de 0,5 ml/kg por dia at&#233; o limite de 50 mg (16,6 mL). N&#227;o ultrapassar a dose m&#225;xima de 50mg (16,6 ml) ao dia.</li>\r\n<li><strong>Profilaxia da anemia:</strong>&#160;deve ser utilizado, por via oral, na dose de 0,5 ml/kg 1x/semana. N&#227;o ultrapassar a dose m&#225;xima de 50mg (16,6 ml) ao dia.&#160;</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 2176,
        "indications": "<p>- Indicado como suplemento mineral auxiliar nas anemias carenciais.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 72,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 18:00:22",
        "name": "Ferrini",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 15 mg/ml (3 mg de ferro elementar).</li>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 30 mg/ml (6 mg de ferro elementar).</li>\r\n<li><strong>Comprimido:</strong> 150 mg (30 mg de ferro elementar).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Glicinato ferroso",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Rea&#231;&#227;o muito comum: fezes escurecidas;</p>\r\n<p>- Rea&#231;&#227;o comum: diarreia, n&#225;useas, dor abdominal , constipa&#231;&#227;o;</p>\r\n<p>- Rea&#231;&#227;o incomum: v&#244;mitos , escurecimento de dente, gastrite, rash (exantema, erup&#231;&#227;o cut&#226;nea, rash cut&#226;neo), urtic&#225;ria, prurido, eritema, cefaleia;</p>\r\n<p>- Rea&#231;&#227;o rara: espasmos musculares, mialgia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3410,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi- line-height: 107%;\">Rea&#231;&#245;es de hipersensibilidade aos componentes, ao &#225;cido acetilsalic&#237;lico ou a outros f&#225;rmacos anti-inflamat&#243;rios n&#227;o-esteroidais;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">&#218;lcera p&#233;ptica em fase ativa, hemorragia gastrintestinal;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Dist&#250;rbios de coagula&#231;&#227;o graves (hemofilia);&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Disfun&#231;&#227;o renal grave (clearance de creatinina abaixo de 30 mL/min);&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Disfun&#231;&#227;o hep&#225;tica;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Crian&#231;as menores de 12 anos.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>400mg, VO, 12/12h. (Esta &#233; a dose m&#225;xima di&#225;ria)</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2177,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Antiinflamat&#243;rio, analg&#233;sico e antipir&#233;tico em estados flog&#237;sticos dolorosos e n&#227;o dolorosos.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 23:27:03",
        "name": "Maxsulid",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 400mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "maxsulid",
        "substance": "Nimesulida + Betaciclodextrina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span>N&#225;useas; Epigastralgia; Diarr&#233;ia; V&#244;mitos; Erup&#231;&#245;es cut&#226;neas;&#160;Sonol&#234;ncia;&#160;Vertigem;&#160;Cefal&#233;ia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- ClCr entre 30-80mL/min</strong><span style=\"mso-bidi- line-height: 107%;\"><strong>:</strong> N&#227;o h&#225; ajuste.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>- ClCr &lt; 30mL/min:</strong> Contraindicado.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>- Insufici&#234;ncia hep&#225;tica:</strong> contraindicado.</span></p>\r\n</div>"
    },
    {
        "content_length": 3345,
        "contraindications": "<div>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade a qualquer componente da f&#243;rmula, casos de i</span><span style=\"mso-bidi- line-height: 107%;\">ntoxica&#231;&#227;o aguda.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose usual:&#160;</strong>2-3 comprimidos, VO, de 12/12h, no intervalo das refei&#231;&#245;es.&#160;</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\"><strong>Dose usual:&#160;</strong>1-1,5 comprimido, VO, 12/12h, nos intervalos das refei&#231;&#245;es.</span></li>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.<br></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2178,
        "indications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Casos que se necessite da absor&#231;&#227;o de gases e toxinas, bem como auxiliar no tratamento de enterites, colites, enterocolites, aerofagias e meteorismos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<div>\r\n<p>-&#160;<strong><span style=\"line-height: 107%;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso liberado na lacta&#231;&#227;o.</span></p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "last_update": "2018-11-21 11:37:28",
        "name": "Carverol",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido:</strong> 250 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "carverol",
        "substance": "Carvão Ativado",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><strong><span style=\"mso-bidi- line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Constipa&#231;&#227;o intestinal.</span></p>\r\n<hr>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p>-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p><strong>&#160;</strong></p>\r\n</div>"
    },
    {
        "content_length": 4815,
        "contraindications": "<div><p class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade a qualquer componente da f&#243;rmula, i</span><span style=\"mso-bidi- line-height: 107%;\">nsufici&#234;ncia card&#237;aca descompensada/inst&#225;vel, i</span><span style=\"mso-bidi- line-height: 107%;\">nsufici&#234;ncia hep&#225;tica clinicamente manifesta, a</span><span style=\"mso-bidi- line-height: 107%;\">sma br&#244;nquica ou DPOC, b</span><span style=\"mso-bidi- line-height: 107%;\">loqueio atrioventricular de segundo ou terceiro grau, b</span><span style=\"mso-bidi- line-height: 107%;\">radicardia grave, s</span><span style=\"mso-bidi- line-height: 107%;\">&#237;ndrome do n&#243; sinusal, c</span><span style=\"mso-bidi- line-height: 107%;\">hoque cardiog&#234;nico, h</span><span style=\"mso-bidi- line-height: 107%;\">ipotens&#227;o grave.</span></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">&#160;</p></div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Hipertens&#227;o essencial:&#160;</strong>12,5 mg VO 1x/dia nos 2 primeiros dias seguido de 25 mg 1x/dia - Dose m&#225;xima: 50mg/dia.</span></li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Angina do peito:</strong>&#160;12,5 mg VO 2x/dia nos 2 primeiros dias seguido de 25 mg 2x/dia - Dose m&#225;xima: 50mg VO 12/12h. - Dose m&#225;xima no idoso: 25mg VO 12/12h.</li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Insufici&#234;ncia card&#237;aca congestiva:</strong>&#160; 3,125 mg VO 2x/dia por duas semanas, podendo aumentar gradativamente at&#233; o m&#225;ximo de 25 mg 12/12h (at&#233; 85 kg) ou 50mg 12/12h (acima de 85 kg).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\" line-height: 107%; \">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2179,
        "indications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipertens&#227;o arterial, angina do peito e insufici&#234;ncia card&#237;aca congestiva.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-21 11:56:30",
        "name": "Carvedilol",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido:</strong> 3,125 mg, 6,25 mg, 12,5 mg, 25 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "carvedilol",
        "substance": "Carvedilol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Anemia, bradicardia, hipervolemia, sobrecarga h&#237;drica, altera&#231;&#245;es visuais, redu&#231;&#227;o do lacrimejamento, irrita&#231;&#227;o ocular, n&#225;usea, diarreia, v&#244;mito, dispepsia, dor abdominal, astenia, edema, dor, pneumonia, bronquite, infec&#231;&#227;o do trato urin&#225;rio e respirat&#243;rio superior, piora do controle da glicemia em diab&#233;ticos, tontura, cefaleia, s&#237;ncope, depress&#227;o, insufici&#234;ncia renal ou anormalidades renais, dispeneia, edema pulmonar, asma em predispostos, hipotens&#227;o ortost&#225;stica, dist&#250;rbios da circula&#231;&#227;o perif&#233;rica, hipertens&#227;o, aumento de transaminases, hiperssensibilidade.</span></p>\r\n<hr>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>Contraindicado na insufici&#234;ncia hep&#225;tica manifestada clinicamente.</p>\r\n</div>"
    },
    {
        "content_length": 2384,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Angina de peito inst&#225;vel ou durante as primeiras 4 semanas posteriores a um infarto do mioc&#225;rdio; Insufici&#234;ncia card&#237;aca congestiva n&#227;o tratada; Insufici&#234;ncia renal severa; Insufici&#234;ncia hep&#225;tica de intensidade moderada a severa; Crian&#231;as; Uso prolongado de anticonvulsivantes.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">30mg, VO, 8/8h (dose m&#225;xima: 360mg VO/dia).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "id": 2190,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Espasmo vascular secund&#225;rio a hemorragia subaracnoide ou ruptura de aneurisma cerebral;&#160;Dist&#250;rbio cognitivo do idoso.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 193,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:46:46",
        "name": "Nimovas",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;30mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimovas",
        "substance": "Nimodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Cautela com os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Desconforto gastrointestinal, tontura, cefaleia; Ins&#244;nia, agita&#231;&#227;o motora, excita&#231;&#227;o, agressividade; Sudorese, hipercinesia, depress&#227;o; Hipotens&#227;o arterial, sensa&#231;&#227;o de calor, avermelhado da pele e edema perif&#233;rico.</p>\r\n</div>"
    },
    {
        "content_length": 2426,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Angina de peito inst&#225;vel ou durante as primeiras 4 semanas posteriores a um infarto do mioc&#225;rdio; Insufici&#234;ncia card&#237;aca congestiva n&#227;o tratada; Insufici&#234;ncia renal severa; Insufici&#234;ncia hep&#225;tica de intensidade moderada a severa; Crian&#231;as; Uso prolongado de anticonvulsivantes.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">30mg, VO, 8/8h (dose m&#225;xima: 360mg VO/dia).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "id": 2191,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Espasmo vascular secund&#225;rio a hemorragia subaracnoide ou ruptura de aneurisma cerebral;&#160;</span>Dist&#250;rbio cognitivo do idoso.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 125,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 00:28:03",
        "name": "Miocardil",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;30mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "miocardil",
        "substance": "Nimodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Cautela com os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Desconforto gastrointestinal, tontura, cefaleia; Ins&#244;nia, agita&#231;&#227;o motora, excita&#231;&#227;o, agressividade; Sudorese, hipercinesia, depress&#227;o; Hipotens&#227;o arterial, sensa&#231;&#227;o de calor, avermelhado da pele e edema perif&#233;rico.</p>\r\n</div>"
    },
    {
        "content_length": 2632,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Angina de peito inst&#225;vel ou durante as primeiras 4 semanas posteriores a um infarto do mioc&#225;rdio; Insufici&#234;ncia card&#237;aca congestiva n&#227;o tratada; Insufici&#234;ncia renal severa; Insufici&#234;ncia hep&#225;tica de intensidade moderada a severa; Crian&#231;as; Uso prolongado de anticonvulsivantes.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">30mg, VO, 8/8h (dose m&#225;xima: 360mg VO/dia).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o estabelecido.</span></p>",
        "id": 2192,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Espasmo vascular secund&#225;rio a hemorragia subaracnoide ou ruptura de aneurisma cerebral;&#160;</span>Dist&#250;rbio cognitivo do idoso.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"text-align: justify;\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-05 01:46:37",
        "name": "Nimodipino",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong> 30mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nimodipino",
        "substance": "Nimodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Cautela com os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Desconforto gastrointestinal, tontura, cefaleia; Ins&#244;nia, agita&#231;&#227;o motora, excita&#231;&#227;o, agressividade; Sudorese, hipercinesia, depress&#227;o; Hipotens&#227;o arterial, sensa&#231;&#227;o de calor, avermelhado da pele e edema perif&#233;rico.</p>\r\n</div>"
    },
    {
        "content_length": 4569,
        "contraindications": "<p>- Pacientes que apresentam hipersensibilidade a qualquer componente da formula&#231;&#227;o, pacientes com defici&#234;ncia da vitamina B12, nas anemias n&#227;o ferroprivas, particularmente aquelas caracterizadas por ac&#250;mulo ou incapacidade de utiliza&#231;&#227;o do ferro, tais como hemocromatose, anemia falciforme, anemia hemol&#237;tica, anemias siderobl&#225;sticas, anemias do chumbo, talassemia, anemias por tumores ou infec&#231;&#245;es (sem defici&#234;ncia de ferro), anemias associadas &#224; leucemia. N&#227;o se recomenda o &#225;cido f&#243;lico no tratamento da anemia perniciosa, nem de outras anemias megalobl&#225;sticas secund&#225;rias a uma defici&#234;ncia de vitamina B12, pois pode produzir uma remiss&#227;o hematol&#243;gica, sem interferir sobre as manifesta&#231;&#245;es neurol&#243;gicas que continuam evoluindo.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Observa&#231;&#245;es iniciais:</strong></p>\r\n<ul>\r\n<li>N&#227;o tem sua absor&#231;&#227;o prejudicada pela presen&#231;a de alimentos, sendo inclusive recomendada sua administra&#231;&#227;o pr&#243;xima &#224;s refei&#231;&#245;es.&#160;</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Tratamento da anemia:</strong></p>\r\n<ul>\r\n<li>10 ml de xarope 1x/dia, ou 1 comprimido 1x/dia.</li>\r\n<li>Tratamento por 3 a 5 meses, at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina. Posteriormente a terapia deve prosseguir com 10 ml ou 1 comprimido 1x/dia&#160;por v&#225;rias semanas (2 a 3 meses) a fim de restaurar a reserva de ferro.</li>\r\n</ul>\r\n<p><strong>Profilaxia da anemia:</strong></p>\r\n<ul>\r\n<li>10 a 20 ml do xarope 1x/semana, ou 1 a 2 comprimidos 1x/semana.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Mulheres lactentes:</strong></p>\r\n<ul>\r\n<li><strong>Tratamento:</strong>&#160;5 gotas/kg/dia 1x/dia (m&#225;ximo de 50 gotas),&#160;&#160;at&#233; a normaliza&#231;&#227;o dos valores de hemoglobina.</li>\r\n<li><strong>Profilaxia:</strong>&#160;5 gotas/kg 1x/semana (m&#225;ximo de 50 gotas).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>Tratamento da anemia:&#160;</strong>deve ser utilizado, por via oral, na dose de 0,5 ml/kg por dia at&#233; o limite de 50 mg (16,6 ml). N&#227;o ultrapassar a dose m&#225;xima de 50mg (16,6 ml) ao dia.</li>\r\n<li><strong>Profilaxia da anemia:</strong>&#160;deve ser utilizado, por via oral, na dose de 0,5 ml/kg 1x/semana. N&#227;o ultrapassar a dose m&#225;xima de 50mg (16,6 ml) ao dia.&#160;</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 2196,
        "indications": "<p>- Indicado como suplemento mineral auxiliar nas anemias carenciais.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 72,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 18:00:33",
        "name": "Ferrini Fólico",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 15 mg/ml&#160;+ 0,5mg de &#225;cido f&#243;lico (3 mg de ferro elementar).</li>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 30 mg/ml&#160;+ 0,2mg de &#225;cido f&#243;lico (6 mg de ferro elementar).</li>\r\n<li><strong>Comprimido:</strong> 150 mg +&#160; 5 mg de &#225;cido f&#243;lico (30 mg de ferro elementar).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Ferro aminoácido quelato + Ácido fólico",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Rea&#231;&#227;o muito comum: fezes escurecidas;</p>\r\n<p>- Rea&#231;&#227;o comum: diarreia, n&#225;useas, dor abdominal , constipa&#231;&#227;o;</p>\r\n<p>- Rea&#231;&#227;o incomum: v&#244;mitos , escurecimento de dente, gastrite, rash (exantema, erup&#231;&#227;o cut&#226;nea, rash cut&#226;neo), urtic&#225;ria, prurido, eritema, cefaleia;</p>\r\n<p>- Rea&#231;&#227;o rara: espasmos musculares, mialgia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2382,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Angina de peito inst&#225;vel ou durante as primeiras 4 semanas posteriores a um infarto do mioc&#225;rdio; Insufici&#234;ncia card&#237;aca congestiva n&#227;o tratada; Insufici&#234;ncia renal severa; Insufici&#234;ncia hep&#225;tica de intensidade moderada a severa; Crian&#231;as; Uso prolongado de anticonvulsivantes.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">30mg, VO, 8/8h (dose m&#225;xima: 360mg VO/dia).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "id": 2198,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Espasmo vascular secund&#225;rio a hemorragia subaracnoide ou ruptura de aneurisma cerebral;&#160;Dist&#250;rbio cognitivo do idoso.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 04:54:43",
        "name": "Vasodipina",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;30mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "vasodipina",
        "substance": "Nimodipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Cautela com os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Desconforto gastrointestinal, tontura, cefaleia; Ins&#244;nia, agita&#231;&#227;o motora, excita&#231;&#227;o, agressividade; Sudorese, hipercinesia, depress&#227;o; Hipotens&#227;o arterial, sensa&#231;&#227;o de calor, avermelhado da pele e edema perif&#233;rico.</p>\r\n</div>"
    },
    {
        "content_length": 3470,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes; Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria adulta.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li style=\"text-align: justify;\">150mg/m&#178;, IV, 1x/semana, durante 6 semanas (per&#237;odo de indu&#231;&#227;o), e posteriormente, uma dose de manuten&#231;&#227;o a cada 15 dias.</li>\r\n</ul>\r\n<hr>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.</span></p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2200,
        "indications": "<p style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Tratamento de astrocitomas de alto grau recorrentes e/ou refrat&#225;rios ao tratamento cir&#250;rgico, radioter&#225;pico e quimioter&#225;pico em crian&#231;as.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-01-13 23:27:19",
        "name": "Cimaher",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50mg/10ml.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Uso hospitalar.</p>",
        "record_status": 1,
        "slug": "cimaher",
        "substance": "Nimotuzumabe",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi- line-height: 107%;\">N&#225;useas, v&#244;mitos, dor abdominal, constipa&#231;&#227;o;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Vertigem,<span style=\"mso-spacerun: yes;\">&#160; </span>cefal&#233;ia, dispn&#233;ia, eritrema, prurido;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hiporexia, astenia, anemia, leucopenia, trombocitopenia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Aumento de AST e ALT, eleva&#231;&#227;o do pot&#225;ssio e do magn&#233;sio;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hipertens&#227;o, hipertermia, febre, fotossensibilidade, acne, ins&#244;nia.</span></p>\r\n</div>"
    },
    {
        "content_length": 2960,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2201,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 23:27:40",
        "name": "Canditrat",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong>&#160;25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "canditrat",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 2965,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2202,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 75,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 00:21:53",
        "name": "Micostalab",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong>&#160;25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "micostalab",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 2977,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2203,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:04:03",
        "name": "Neo Mistatin",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong>&#160;25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neo-mistatin",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 3078,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong> </span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2204,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 1,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:48:02",
        "name": "Nistatina",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong> 100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong> 25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nistatina",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, e<span style=\"mso-bidi- line-height: 107%;\">rup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</span></p>\r\n</div>"
    },
    {
        "content_length": 2056,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p>&#160;</p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p>&#160;</p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2205,
        "indications": "<p>- Candid&#237;ase genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:48:20",
        "name": "Nistrazin",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal:</strong> 25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nistrazin",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi- line-height: 107%;\">- Erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade.</span></p>\r\n</div>"
    },
    {
        "content_length": 3120,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n<p><strong>Dr&#225;gea:</strong></p>\r\n<ul>\r\n<li>1 a 2 drageas, VO, 6/6 horas.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal e Dr&#225;gea:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2208,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 73,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 17:10:56",
        "name": "Albistin",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong> 100.000UI/ml.</li>\r\n<li><strong>Dr&#225;gea:</strong> 500.000UI.</li>\r\n<li><strong>Creme vaginal:</strong> 25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "albistin",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 1984,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2211,
        "indications": "<p>- Candid&#237;ase genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 69,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 00:20:57",
        "name": "Miconastin",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal:</strong> 25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "miconastin",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\"><span style=\"mso-bidi- line-height: 107%;\">- Erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</span></p>\r\n</div>"
    },
    {
        "content_length": 2964,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2212,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 00:22:01",
        "name": "Micostatin",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong>&#160;25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "micostatin",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 2965,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2215,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 121,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:44:36",
        "name": "Nidazolin",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong>&#160;25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nidazolin",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 2383,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2216,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 105,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:47:54",
        "name": "Nistamax",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong> 100.000UI/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nistamax",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, e<span style=\"mso-bidi- line-height: 107%;\">rup&#231;&#245;es cut&#226;neas.</span></p>\r\n</div>"
    },
    {
        "content_length": 2965,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Suspens&#227;o oral:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">1ml a 6ml, VO, 6/6h, por 10 a 14 dias. Deve-se bochechar e manter na boca o maior tempo poss&#237;vel antes de engolir.</li>\r\n</ul>\r\n<p><strong>Creme vaginal:</strong></p>\r\n<ul>\r\n<li>administrar com aplicador intravaginal cheio, 1x/dia, por 14 dias.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong style=\"text-align: justify;\">Suspens&#227;o oral:</strong><span style=\"text-align: justify;\">&#160;</span></p>\r\n<ul>\r\n<li><span style=\"text-align: justify;\">Prematuros e baixo peso: 1ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Lactentes: 1ml a 2ml, VO, 6/6h.</span></li>\r\n<li><span style=\"text-align: justify;\">Crian&#231;as: 1ml a 6ml, VO, 6/6h.</span></li>\r\n</ul>\r\n<p><span style=\"text-align: justify;\"><strong>Creme vaginal:</strong></span></p>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2220,
        "indications": "<p>- Candid&#237;ase orofar&#237;ngea e genital.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 52,
        "lactation_text": "<p class=\"MsoNormal\"><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:47:09",
        "name": "Vagistatina",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:</strong>&#160;100.000UI/ml.</li>\r\n<li><strong>Creme vaginal:</strong>&#160;25.000UI/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "vagistatina",
        "substance": "Nistatina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Diarr&#233;ia, dist&#250;rbios gastrointestinais, n&#225;useas e v&#244;mitos, erup&#231;&#245;es cut&#226;neas, irrita&#231;&#227;o e sensibilidade cut&#226;nea.</p>\r\n</div>"
    },
    {
        "content_length": 1870,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2222,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 01:48:08",
        "name": "Babyneo",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "babyneo",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 3763,
        "contraindications": "<div>\r\n<p>- Pacientes com anemia n&#227;o causada por defici&#234;ncia de ferro ou que recebem transfus&#245;es de sangue repetidas.</p>\r\n<p>- Este medicamento &#233; contraindicado em casos de hipersensibilidade a qualquer um dos componentes da f&#243;rmula.&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Comprimido:&#160;</strong>1 comprimido, 2x/dia, preferencialmente antes das refei&#231;&#245;es. Os comprimidos devem ser tomados inteiros com &#225;gua. Este medicamento n&#227;o deve ser partido, aberto ou mastigado.</li>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):&#160;</strong>15 mL, 2x/dia, preferencialmente antes das refei&#231;&#245;es.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>Solu&#231;&#227;o oral (xarope):</strong></p>\r\n<ul>\r\n<li><strong>&lt; 20 kg:</strong> 5 mL, 2x/dia, preferencialmente antes das refei&#231;&#245;es.</li>\r\n<li><strong>&gt; 20 kg:</strong> 15 mL 1x/dia, preferencialmente antes da principal refei&#231;&#227;o.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Solu&#231;&#227;o oral (gotas):</strong></p>\r\n<ul>\r\n<li><strong>&lt; 20 kg:</strong> 10 gotas (0,5 mL), 2x/dia, preferencialmente antes das refei&#231;&#245;es.</li>\r\n<li><strong>&gt; 20 kg:</strong> 20 gotas (1,0 mL), 2x/dia, preferencialmente antes das refei&#231;&#245;es.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2223,
        "indications": "<p>- Tratamento de anemias por defici&#234;ncia de ferro, estados de desnutri&#231;&#227;o e convalescen&#231;a.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 05:09:57",
        "name": "Vi-Ferrin",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o Oral (Gotas):</strong> 150 mg/ml de quelato de ferro (21 mg de ferro elementar) + 0,25 mg/ml de &#225;cido f&#243;lico + 7,5 mcg/ml de cianocobalamina.</li>\r\n<li><strong>Solu&#231;&#227;o Oral (xarope):</strong> 20 mg/ml de quelato de ferro (41,66 mg de ferro elementar para cada 15 ml) + 0,333 mg/ml de &#225;cido f&#243;lico + 1,0 mcg/ml de cianocobalamina.</li>\r\n<li><strong>Comprimido:</strong> 300 mg de quelato de ferro (41,66 mg de ferro elementar) + 5 mg de &#225;cido f&#243;lico + 15 mcg de cianocobalamina.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "vi-ferrin",
        "substance": "Ferro + Ácido fólico + Cianocobalamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Rea&#231;&#245;es adversas:</strong></p>\r\n<p>- Colora&#231;&#227;o amarela na urina, o que ocorre em doses elevadas e n&#227;o tem significado cl&#237;nico.</p>\r\n<p>- Rea&#231;&#227;o muito comum: dor abdominal, constipa&#231;&#227;o, n&#225;usea, v&#244;mito, fezes escuras.</p>\r\n<p>- Rea&#231;&#227;o comum: pirose, diarreia, a solu&#231;&#227;o oral pode ocasionar mancha nos dentes.</p>\r\n<p>- Rea&#231;&#227;o incomum: rea&#231;&#227;o al&#233;rgica, podendo apresentar rubor leve, mal-estar generalizado, prurido, erup&#231;&#227;o cut&#226;nea, broncoespasmo.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1866,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2224,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 21,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 01:58:57",
        "name": "Bebex N",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "bebex-n",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1899,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2225,
        "indications": "<p style=\"text-align: justify;\">- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 44,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 02:13:23",
        "name": "Benzevit",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "benzevit",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1869,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2226,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 23:28:14",
        "name": "Dermodex",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dermodex",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1875,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2227,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 61,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 23:28:20",
        "name": "Dermostatin",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dermostatin",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1869,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2228,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 16,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-06 16:58:15",
        "name": "Oxyderme",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "oxyderme",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1880,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2229,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 32,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-06 17:48:48",
        "name": "Pratiderm",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "pratiderm",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1868,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2230,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 24,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 23:28:12",
        "name": "Confiare",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "confiare",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1869,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2231,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 55,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-01-13 23:28:18",
        "name": "Dermonase",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dermonase",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1873,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2232,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 20:37:14",
        "name": "Hipodertrat",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "hipodertrat",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 1903,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia, nas regi&#245;es afetadas.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Assaduras em beb&#234;s:</strong></p>\r\n<ul>\r\n<li>Aplicar depois do banho e a cada troca de fraldas, ap&#243;s lavagem e secagem da pele.</li>\r\n</ul>\r\n<p><strong>Demais indica&#231;&#245;es:</strong></p>\r\n<ul>\r\n<li>Aplicar 2 ou mais vezes ao dia nas regi&#245;es afetadas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2233,
        "indications": "<p>- Assaduras em beb&#234;s; Irrita&#231;&#227;o na pele dos &#243;rg&#227;os genitais e n&#225;degas, entre os dedos, axilas, seios e outras &#225;reas de atrito.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:48:12",
        "name": "Nistatina + Óxido de Zinco",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong>&#160;100.000UI/g Nistatina&#160;+ 200mg/g &#211;xido de Zinco.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nistatina-oxido-de-zinco",
        "substance": "Nistatina + Óxido de Zinco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Irrita&#231;&#227;o da pele.</p>\r\n</div>"
    },
    {
        "content_length": 3915,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Diabetes mellitus; Doen&#231;a hep&#225;tica ou renal. Menores de 1 ano de idade.</p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>Comprimidos revestidos:</strong>&#160;500mg, VO, de 12/12h, por 3 dias.</p>\r\n</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Criptospor&#237;ase:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos revestidos:</strong>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>CD4&gt;50 c&#233;lulas/mm&#179;:</strong>&#160;500mg a 1000mg, VO, de 12/12 horas, por 14 dias.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>500mg a 1000mg, VO, de 12/12 horas, por no m&#237;nimo 8 semanas.</p>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Comprimidos revestidos:</span></strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></li>\r\n</ul>\r\n<p><strong><span style=\"line-height: 107%;\">Suspens&#227;o oral:</span></strong></p>\r\n<ul>\r\n<li><span style=\"line-height: 107%;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></span>\r\n<ul>\r\n<li>0,375ml (7,5mg) por kg, VO, 2x/dia, por 3 dias.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Criptospor&#237;ase:</strong>\r\n<ul>\r\n<li><strong>CD4&gt;50 c&#233;lulas/mm&#179;:&#160;</strong>0,375ml (7,5mg) por kg, VO, 2x/dia, por 14 dias.</li>\r\n<li><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>0,375ml (7,5mg) por kg, VO, 2x/dia, por no m&#237;nimo 8 semanas.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong>- Categoria B: </strong>Prescri&#231;&#227;o com cautela.&#160;</p>",
        "id": 2234,
        "indications": "<p style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Gastroenterites virais (Rotav&#237;rus e Norov&#237;rus);&#160;</span><span style=\"text-align: justify;\">Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistos; Criptosporid&#237;ase.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 20,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 00:36:21",
        "name": "Annita",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;500mg.</li>\r\n<li><strong>Suspens&#227;o oral:&#160;</strong>20mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "annita",
        "substance": "Nitazoxanida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Avaliar os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefal&#233;ia, dor abdominal, diarr&#233;ia, n&#225;useas, v&#244;mitos, constipa&#231;&#227;o, flatul&#234;ncia.</p>\r\n</div>"
    },
    {
        "content_length": 2898,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Diabetes mellitus; Doen&#231;a hep&#225;tica ou renal. Menores de 1 ano de idade.</span></p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\">500mg, VO, de 12/12h, por 3 dias.</p>\r\n</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Criptospor&#237;ase:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>CD4&gt;50 c&#233;lulas/mm&#179;:</strong>&#160;500mg a 1000mg, VO, de 12/12 horas, por 14 dias.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>500mg a 1000mg, VO, de 12/12 horas, por no m&#237;nimo 8 semanas.</p>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong>- Categoria B: </strong>Prescri&#231;&#227;o com cautela.&#160;</p>",
        "id": 2235,
        "indications": "<p style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Gastroenterites virais (Rotav&#237;rus e Norov&#237;rus);&#160;</span><span style=\"text-align: justify;\">Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistos; Criptosporid&#237;ase.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 04:29:31",
        "name": "Trinida",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;500mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "trinida",
        "substance": "Nitazoxanida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Avaliar os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefal&#233;ia, dor abdominal, diarr&#233;ia, n&#225;useas, v&#244;mitos, constipa&#231;&#227;o, flatul&#234;ncia.</p>\r\n</div>"
    },
    {
        "content_length": 3930,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Diabetes mellitus; Doen&#231;a hep&#225;tica ou renal. Menores de 1 ano de idade.</p>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></p>\r\n<ul style=\"text-align: justify;\">\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>Comprimidos revestidos:</strong>&#160;500mg, VO, de 12/12h, por 3 dias.</p>\r\n</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Criptospor&#237;ase:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos revestidos:</strong>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>CD4&gt;50 c&#233;lulas/mm&#179;:</strong>&#160;500mg a 1000mg, VO, de 12/12 horas, por 14 dias.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>500mg a 1000mg, VO, de 12/12 horas, por no m&#237;nimo 8 semanas.</p>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Comprimidos revestidos:</span></strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></li>\r\n</ul>\r\n<p><strong><span style=\"line-height: 107%;\">Suspens&#227;o oral:</span></strong></p>\r\n<ul>\r\n<li><span style=\"line-height: 107%;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></span>\r\n<ul>\r\n<li>0,375ml (7,5mg) por kg, VO, 2x/dia, por 3 dias.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Criptospor&#237;ase:</strong>\r\n<ul>\r\n<li><strong>CD4&gt;50 c&#233;lulas/mm&#179;:&#160;</strong>0,375ml (7,5mg) por kg, VO, 2x/dia, por 14 dias.</li>\r\n<li><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>0,375ml (7,5mg) por kg, VO, 2x/dia, por no m&#237;nimo 8 semanas.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong>- Categoria B: </strong>Prescri&#231;&#227;o com cautela.&#160;</p>",
        "id": 2236,
        "indications": "<p style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Gastroenterites virais (Rotav&#237;rus e Norov&#237;rus);&#160;</span><span style=\"text-align: justify;\">Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistos; Criptosporid&#237;ase.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"MsoNormal\"><strong>-&#160;</strong>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 03:28:10",
        "name": "Tanisea",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;500mg.</li>\r\n<li><strong>Suspens&#227;o oral:&#160;</strong>20mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tanisea",
        "substance": "Nitazoxanida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Avaliar os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefal&#233;ia, dor abdominal, diarr&#233;ia, n&#225;useas, v&#244;mitos, constipa&#231;&#227;o, flatul&#234;ncia.</p>\r\n</div>"
    },
    {
        "content_length": 4153,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Diabetes mellitus; Doen&#231;a hep&#225;tica ou renal. Menores de 1 ano de idade.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></span></p>\r\n<ul style=\"text-align: justify;\">\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimidos revestidos:</strong> 500mg, VO, de 12/12h, por 3 dias.</span></p>\r\n</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Criptospor&#237;ase:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos revestidos:</strong>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>CD4&gt;50 c&#233;lulas/mm&#179;:</strong> 500mg a 1000mg, VO, de 12/12 horas, por 14 dias.</p>\r\n</li>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>500mg a 1000mg, VO, de 12/12 horas, por no m&#237;nimo 8 semanas.</p>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Comprimidos revestidos:</span></strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></li>\r\n</ul>\r\n<p><strong><span style=\"line-height: 107%;\">Suspens&#227;o oral:</span></strong></p>\r\n<ul>\r\n<li><span style=\"line-height: 107%;\"><strong>Gastroenterites virais, Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistose:</strong></span>\r\n<ul>\r\n<li>0,375ml (7,5mg) por kg, VO, 2x/dia, por 3 dias.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Criptospor&#237;ase:</strong>\r\n<ul>\r\n<li><strong>CD4&gt;50 c&#233;lulas/mm&#179;:&#160;</strong>0,375ml (7,5mg) por kg, VO, 2x/dia, por 14 dias.</li>\r\n<li><strong>CD4&lt;50 c&#233;ls/mm&#179;:&#160;</strong>0,375ml (7,5mg) por kg, VO, 2x/dia, por no m&#237;nimo 8 semanas.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong>- Categoria B: </strong>Prescri&#231;&#227;o com cautela.&#160;</p>",
        "id": 2237,
        "indications": "<p style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Gastroenterites virais (Rotav&#237;rus e Norov&#237;rus);&#160;</span>Helmint&#237;ase, ameb&#237;ase, giard&#237;ase, isospor&#237;ase, balantid&#237;ase, blastocistos; Criptosporid&#237;ase.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:48:45",
        "name": "Nitazoxanida",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:</strong>&#160;500mg.</li>\r\n<li><strong>Suspens&#227;o oral:&#160;</strong>20mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\" style=\"line-height: normal;\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nitazoxanida",
        "substance": "Nitazoxanida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<span style=\"text-align: justify;\">N&#227;o estabelecido. Avaliar os casos de Insufici&#234;ncia Renal Grave.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefal&#233;ia, dor abdominal, diarr&#233;ia, n&#225;useas, v&#244;mitos, constipa&#231;&#227;o, flatul&#234;ncia.</p>\r\n</div>"
    },
    {
        "content_length": 2941,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>&#211;vulo:</strong> introduzir 1 &#243;vulo profundamente na vagina, com o aplicador, 1x/dia, ao deitar, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2239,
        "indications": "<p>- Candid&#237;ase vaginal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 72,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 17:59:38",
        "name": "Fentinax",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal:</strong> 20mg/g;</li>\r\n<li><strong>&#211;vulo vaginal:</strong> 600mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "fentinax",
        "substance": "Fenticonazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia;</p>\r\n<p>- Prurido genital feminino;</p>\r\n<p>- Sensa&#231;&#227;o de ard&#234;ncia genital;</p>\r\n<p>- Irrita&#231;&#227;o vaginal;</p>\r\n<p>- Corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2938,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>&#211;vulo:</strong> introduzir 1 &#243;vulo profundamente na vagina, com o aplicador, 1x/dia, ao deitar, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2242,
        "indications": "<p>- Candid&#237;ase vaginal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 19:42:48",
        "name": "Ginna",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal:</strong> 20mg/g;</li>\r\n<li><strong>&#211;vulo vaginal:</strong> 600mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "ginna",
        "substance": "Fenticonazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia;</p>\r\n<p>- Prurido genital feminino;</p>\r\n<p>- Sensa&#231;&#227;o de ard&#234;ncia genital;</p>\r\n<p>- Irrita&#231;&#227;o vaginal;</p>\r\n<p>- Corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2954,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong>&#160;1 aplicador cheio 1x/dia, ao deitar, por 7 dias;</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>&#211;vulo:</strong>&#160;introduzir 1 &#243;vulo profundamente na vagina, com o aplicador, 1x/dia, ao deitar, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2243,
        "indications": "<p>- Candid&#237;ase vaginal.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 17:59:29",
        "name": "Fenticonazol",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal:</strong> 20mg/g.</li>\r\n<li><strong>&#211;vulo vaginal:</strong> 600mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "fenticonazol",
        "substance": "Fenticonazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia;</p>\r\n<p>- Prurido genital feminino;</p>\r\n<p>- Sensa&#231;&#227;o de ard&#234;ncia genital;</p>\r\n<p>- Irrita&#231;&#227;o vaginal;</p>\r\n<p>- Corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2648,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Dose usual:</strong> 1 aplicador cheio 1x/dia, ao deitar, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2244,
        "indications": "<p>- Candid&#237;ase vaginal.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 91,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-10 04:47:01",
        "name": "Vagicand",
        "presentation": "<ul>\r\n<li><strong>Creme vaginal:</strong> 20mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "vagicand",
        "substance": "Fenticonazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia;</p>\r\n<p>- Prurido genital feminino;</p>\r\n<p>- Sensa&#231;&#227;o de ard&#234;ncia genital;</p>\r\n<p>- Irrita&#231;&#227;o vaginal;</p>\r\n<p>- Corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3717,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme dermatol&#243;gico:&#160;</strong>aplicar na &#225;rea afetada1-2x/dia, ap&#243;s limpeza e secagem do local.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Spray dermatol&#243;gico:&#160;</strong>aplicar na &#225;rea afetada1-2x/dia, ap&#243;s limpeza e secagem do local.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>Creme vaginal:</strong>&#160;1 aplicador cheio 1x/dia, ao deitar, por 7 dias.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\"><strong>&#211;vulo:</strong>&#160;introduzir 1 &#243;vulo profundamente na vagina, com o aplicador, 1x/dia, ao deitar, por 7 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2245,
        "indications": "<p>- Tratamento de micoses de pele e mucosas, causadas por fungos, incluindo candid&#237;ases, dermatomicoses e ptir&#237;ase versicolor, al&#233;m de outros tipos de micoses.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Muito baixo risco:</strong></span><span class=\"normaltextrun\">&#160;Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 17:59:46",
        "name": "Fentizol",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico:</strong> 20mg/g.</li>\r\n<li><strong>Spray dermatol&#243;gico:</strong> 20mg/g.</li>\r\n<li><strong>Creme vaginal:</strong> 20mg/g.</li>\r\n<li><strong>&#211;vulo vaginal:</strong> 600mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simpes.</span></p>",
        "record_status": 1,
        "slug": "fentizol-creme-dermatologico",
        "substance": "Fenticonazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia;</p>\r\n<p>- Prurido genital feminino;</p>\r\n<p>- Sensa&#231;&#227;o de ard&#234;ncia genital;</p>\r\n<p>- Irrita&#231;&#227;o vaginal;</p>\r\n<p>- Corrimento vaginal.</p>\r\n<hr>\r\n<p><strong>Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2447,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hipersensibilidade aos seus componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Glaucoma de &#226;ngulo fechado;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Insufici&#234;ncia respirat&#243;ria;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Miastenia gravis;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hepatopatia grave;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Depend&#234;ncia de drogas, inclusive &#225;lcool.</span></p>",
        "dosage_adults": "<ul>\r\n<li>5mg a 10mg, VO, &#224; noite.</li>\r\n<li><strong>Idosos:</strong>&#160;2,5mg a 5mg, VO, &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria D: </strong>Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2247,
        "indications": "<p><span style=\"text-align: justify;\">- Ins&#244;nia e ansiedade.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 17:08:51",
        "name": "Sonebon",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5mg.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Azul (B1 - psicotr&#243;picos).</p>",
        "record_status": 1,
        "slug": "sonebon",
        "substance": "Nitrazepam",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Depend&#234;ncia; Sonol&#234;ncia; Tonteiras.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Usar doses menores em doen&#231;a renal e/ou hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2460,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hipersensibilidade aos seus componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Glaucoma de &#226;ngulo fechado;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Insufici&#234;ncia respirat&#243;ria;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Miastenia gravis;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hepatopatia grave;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Depend&#234;ncia de drogas, inclusive &#225;lcool.</span></p>",
        "dosage_adults": "<ul>\r\n<li>5mg a 10mg, VO, &#224; noite.</li>\r\n<li><strong>Idosos:</strong>&#160;2,5mg a 5mg, VO, &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria D: </strong>Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2248,
        "indications": "<p><span style=\"text-align: justify;\">- Ins&#244;nia e ansiedade.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:49:00",
        "name": "Nitrapan",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5mg.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Azul (B1 - psicotr&#243;picos).</p>",
        "record_status": 1,
        "slug": "nitrapan",
        "substance": "Nitrazepam",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Depend&#234;ncia; Sonol&#234;ncia; Tonteiras.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Usar doses menores em doen&#231;a renal e/ou hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 2413,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi- line-height: 107%;\">Hipersensibilidade aos seus componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Glaucoma de &#226;ngulo fechado;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Insufici&#234;ncia respirat&#243;ria;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Miastenia gravis;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Hepatopatia grave;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Depend&#234;ncia de drogas, inclusive &#225;lcool.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>5mg a 10mg, VO, &#224; noite.</li>\r\n<li><strong>Idosos:</strong>&#160;2,5mg a 5mg, VO, &#224; noite.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>- Categoria D: </strong>Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>",
        "id": 2249,
        "indications": "<p style=\"text-align: justify;\">- Ins&#244;nia e ansiedade.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:49:16",
        "name": "Nitrazepam",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5mg.</li>\r\n</ul>",
        "recipient": 4,
        "recipient_type": "<p class=\"MsoNormal\">- Receita Azul (B1 - psicotr&#243;picos).</p>",
        "record_status": 1,
        "slug": "nitrazepam",
        "substance": "Nitrazepam",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p>- Depend&#234;ncia; Sonol&#234;ncia; Tonteiras.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Usar doses menores em doen&#231;a renal e/ou hep&#225;tica.</p>\r\n</div>"
    },
    {
        "content_length": 3525,
        "contraindications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade a qualquer componente da f&#243;rmula.</span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><strong><span style=\"mso-bidi- line-height: 107%;\">Dose usual:&#160;</span></strong><span style=\"mso-bidi- line-height: 107%;\">70mg IV no 1&#186; dia, seguido de 50mg/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>3 meses a 17 anos:&#160;</strong>70mg/m&#178; IV no 1&#186; dia, seguido de 50mg/m&#178; diariamente, em infus&#227;o IV lenta.</li>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\" line-height: 107%; \">Medica&#231;&#227;o n&#227;o recomendada para menores de 3 meses.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2250,
        "indications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;Infec&#231;&#227;o f&#250;ngica presumida em pacientes neutrop&#234;nicos febris, candid&#237;ase invasiva, incluindo candidemia em pacientes neutrop&#234;nicos e n&#227;o neutrop&#234;nicos, candid&#237;ase esof&#225;gica, candid&#237;ase orofar&#237;ngea, aspergilose invasiva em pacientes refrat&#225;rios ou intolerantes a outros tratamentos antif&#250;ngicos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 26,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-21 12:21:02",
        "name": "Cancidas",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50 mg e 70 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cancidas",
        "substance": "Caspofungina",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoListParagraphCxSpMiddle\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Febre, irrita&#231;&#227;o na veia de infus&#227;o, cefaleia, dor, calafrios, taquicardia, sudorese, n&#225;usea, diarreia, v&#244;mito, rubor da face e pesco&#231;o, erup&#231;&#227;o cut&#226;nea, coceira, dispneia, incha&#231;o de extremidades, preju&#237;zo da fun&#231;&#227;o hep&#225;tica e altera&#231;&#245;es laboratoriais, flebite, tromboflebite.</span></p>\r\n<hr>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>35mg/dia em insufici&#234;ncia moderada (Child-Pugh 7-9).</p></div>"
    },
    {
        "content_length": 4292,
        "contraindications": "<p class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade a qualquer componente da f&#243;rmula ou sulfonamidas, p</span>aciente que apresentou asma, urtic&#225;ria ou rea&#231;&#245;es al&#233;rgicas ap&#243;s uso de AAS ou AINES, doen&#231;as hep&#225;ticas, insufici&#234;ncia renal grave, tratamento da dor perioperat&#243;ria em cirurgia de revasculariza&#231;&#227;o do mioc&#225;rdio.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Analgesia aguda:</strong> 400mg VO, seguido de 200mg VO de 12/12h.</span></li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Dismenorreia prim&#225;ria:</strong> 400mg VO, seguido de 200mg VO de 12/12h.</li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Osteoartrite:</strong> 200mg/dia VO ou 100mg VO de 12/12h.</li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Artrite reumatoide:</strong>&#160;100-200mg VO de 12/12h.</li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Espondilite anquilosante:</strong>&#160;200mg/dia VO ou 100mg VO de 12/12h.</li>\r\n<li class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong>Lombalgia:</strong>&#160;100-200mg VO de 12/12h.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2251,
        "indications": "<p class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Al&#237;vio dos sinais e sintomas da osteoartrite, artrite reumatoide, espondilite anquilosante, dor aguda, dismenorreia prim&#225;ria, lombalgia.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-13 03:26:12",
        "name": "Celecoxibe",
        "presentation": "<ul>\r\n<li class=\"MsoListParagraph\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido:</strong> 100mg e 200mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "celecoxibe",
        "substance": "Celecoxibe",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Bronquite, sinusite, infec&#231;&#227;o do trato respirat&#243;rio superior e urin&#225;rio, faringite, rinite, anemia, hipersensibilidade, ins&#244;nia, ansiedade, vertigem, hipertonia e sonol&#234;ncia, vis&#227;o borrada, zumbido, palpita&#231;&#227;o, hipertens&#227;o, tosse, v&#244;mito, dor abdominal, diarreia, dispepsia, flatul&#234;ncia, &#250;lcera g&#225;strica, doen&#231;as dent&#225;rias, aumento transaminases, prurido, urtic&#225;ria, equimose, edema perif&#233;rico, edema facial e quadro similar ao gripal.</span></p>\r\n<hr>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.&#160;</p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>Iniciar com menor dose em caso de insufici&#234;ncia hep&#225;tica moderada.</p>\r\n</div>"
    },
    {
        "content_length": 2044,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes; Estenose a&#243;rtica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">10mg a 20mg, VO, pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2253,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o arterial sist&#234;mica; Doen&#231;a arterial coronariana.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 100,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 23:31:25",
        "name": "Caltren",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimidos:</strong>&#160;10 mg e 20 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "caltren",
        "substance": "Nitrendipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Insufici&#234;ncia renal cr&#244;nica:</strong>&#160;Utilizar com cautela.</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Insufici&#234;ncia hep&#225;tica:</strong>&#160;iniciar com a menor dose poss&#237;vel.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia; Rubor facial; Edema perif&#233;rico; Taquicardia.</p>\r\n</div>"
    },
    {
        "content_length": 2072,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes; Estenose a&#243;rtica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">10mg a 20mg, VO, pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2254,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o arterial sist&#234;mica; Doen&#231;a arterial coronariana.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:49:24",
        "name": "Nitrencord",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimidos revestidos:</strong>&#160;10 mg e 20 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nitrencord",
        "substance": "Nitrendipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Insufici&#234;ncia renal cr&#244;nica:</strong>&#160;Utilizar com cautela.</p>\r\n<p class=\"MsoNormal\">-&#160;<strong>Insufici&#234;ncia hep&#225;tica:</strong>&#160;iniciar com a menor dose poss&#237;vel.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia; Rubor facial; Edema perif&#233;rico; Taquicardia.</p>\r\n</div>"
    },
    {
        "content_length": 2186,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\">- Hipersensibilidade aos componentes; Estenose a&#243;rtica grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\">10mg a 20mg, VO, pela manh&#227;.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2256,
        "indications": "<div>\r\n<p class=\"MsoNormal\">- Hipertens&#227;o arterial sist&#234;mica; Doen&#231;a arterial coronariana.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:49:32",
        "name": "Nitrendipino",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\"><strong>Comprimidos:</strong>&#160;10 mg e 20 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nitrendipino",
        "substance": "Nitrendipino",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\">- <strong>Insufici&#234;ncia renal cr&#244;nica:</strong> Utilizar com cautela.</p>\r\n<p class=\"MsoNormal\">- <strong>Insufici&#234;ncia hep&#225;tica:</strong> iniciar com a menor dose poss&#237;vel.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia; Rubor facial; Edema perif&#233;rico; Taquicardia.</p>\r\n</div>"
    },
    {
        "content_length": 2780,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes; Crian&#231;as menores de 1 ano;&#160;Insufici&#234;ncia renal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Acima de 1 ano:</strong> Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2260,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Pacientes com queimaduras de segundo e terceiro graus;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Transplantes de pele em que h&#225; contamina&#231;&#227;o por bact&#233;rias.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:25:44",
        "name": "Furacin",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong> 2mg/g;</li>\r\n<li><strong>Solu&#231;&#227;o dermatol&#243;gica:&#160;</strong>2mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "furacin",
        "substance": "Nitrofural",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Dermatite t&#243;pica no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2767,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes; Crian&#231;as menores de 1 ano; Insufici&#234;ncia renal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Acima de 1 ano:</strong> Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2261,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Pacientes com queimaduras de segundo e terceiro graus;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Transplantes de pele em que h&#225; contamina&#231;&#227;o por bact&#233;rias.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 73,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 23:31:32",
        "name": "Caziderm",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong> 2mg/g;</li>\r\n<li><strong>Solu&#231;&#227;o dermatol&#243;gica:&#160;</strong>2mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "caziderm",
        "substance": "Nitrofural",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Dermatite t&#243;pica no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2717,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes; Crian&#231;as menores de 1 ano; Insufici&#234;ncia renal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Acima de 1 ano:</strong> Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2263,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Pacientes com queimaduras de segundo e terceiro graus;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Transplantes de pele em que h&#225; contamina&#231;&#227;o por bact&#233;rias.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><strong>-&#160;</strong>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:49:53",
        "name": "Nitrofural",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong> 2mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "nitrofural",
        "substance": "Nitrofural",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Dermatite t&#243;pica no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3463,
        "contraindications": "<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes, tuberculose ativa, sepse, abcessos, infec&#231;&#245;es oportunistas, insufici&#234;ncia card&#237;aca moderada a grave.&#160;</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose de indu&#231;&#227;o:&#160;</strong>400mg SC nas semanas 0, 2 e 4.&#160;</li>\r\n<li><strong>Doen&#231;a de Chron:&#160;</strong>400mg SC a cada 4 semanas.</li>\r\n<li><strong>Artrite reumatoide:&#160;</strong>200mg SC a cada 2 semanas.&#160;</li>\r\n<li><strong>Artrite psori&#225;sica:&#160;</strong>200mg SC a cada duas semanas ou 400mg SC a cada 4 semanas.&#160;</li>\r\n<li><strong>Espondiloartrite axial: </strong>200mg SC a cada duas semanas ou 400mg SC a cada 4 semanas.&#160;<strong>&#160;</strong></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\" line-height: 107%; \">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong>-&#160;</strong><strong style=\"mso-bidi-font-weight: normal;\"><span style=\" line-height: 107%; \">Categoria B:</span></strong><span style=\" line-height: 107%; \"> Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 2264,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Formas moderadas e graves de artrite reumatoide refrat&#225;ria ao tratamento de escolha, doen&#231;a de Crohn refrat&#225;ria ao tratamento de escolha, artrite psori&#225;sica refrat&#225;ria ao tratamento com DMARDs anterior, espondiloartrite axial grave.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 130,
        "lactation_text": "<p>-&#160;<strong style=\"mso-bidi-font-weight: normal;\"><span style=\" line-height: 107%; \">Alto risco:</span></strong><span style=\" line-height: 107%; \"> Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2018-11-22 01:30:05",
        "name": "Cimzia",
        "presentation": "<ul>\r\n<li><strong><span style=\"line-height: 107%;\">Solu&#231;&#227;o injet&#225;vel</span></strong><span style=\"line-height: 107%;\">:&#160;</span>200mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cimzia",
        "substance": "Certolizumabe Pegol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Cefaleia, sonol&#234;ncia, n&#225;usea, v&#244;mitos, febre, fadiga, dor abdominal, hipertens&#227;o, risco de infec&#231;&#245;es bacterianas e infec&#231;&#245;es oportunistas, reativa&#231;&#227;o de hepatite B, risco aumentado de neoplasias secund&#225;rias, eritema nodoso, urtic&#225;ria, tromboflebite, vasculite, ansiedade, transtorno bipolar, insufici&#234;ncia renal.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o estabelecido.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2714,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt;\">- Hipersensibilidade aos componentes;&#160;Crian&#231;as menores de 1 ano;&#160;Insufici&#234;ncia renal.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: center 212.6pt left 356.25pt;\"><strong>Acima de 1 ano:</strong> Aplicar uma fina camada do produto sobre a regi&#227;o afetada at&#233; 8/8 horas durante 7 a 10 dias.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2265,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Pacientes com queimaduras de segundo e terceiro graus;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Transplantes de pele em que h&#225; contamina&#231;&#227;o por bact&#233;rias.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\">- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-09 16:25:26",
        "name": "Sensiderme",
        "presentation": "<ul>\r\n<li><strong>Pomada:</strong> 2mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "sensiderme",
        "substance": "Nitrofural",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Dermatite t&#243;pica no local da aplica&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5481,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Press&#227;o arterial elevada que possa constituir grave risco ao paciente e rea&#231;&#245;es pr&#233;vias de hipersensibilidade &#224; droga.</p>",
        "dosage_adults": "<div><ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dilui&#231;&#227;o:</strong> 01 ampola de cetamina de 10mL com 50mg/mL deve ser dilu&#237;da em 500mL de soro glicosado a 5% ou solu&#231;&#227;o fisiol&#243;gica a 0,9%, resultando em uma solu&#231;&#227;o com 1mg de cetamina por mL.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Indu&#231;&#227;o:</strong>&#160;Dose IV varia de 1mg/kg a 4,5mg/kg, com a dose de 2 mg/kg de peso produzindo anestesia cir&#250;rgica dentro de 30segundos com efeito anest&#233;sico de 5 a 10 minutos, pode-se ainda, optar por infus&#227;o cont&#237;nua de 1mg/kg ou 2mg/kg na dose de 0,5mg/kg/minuto visando indu&#231;&#227;o anest&#233;sica. Em dose IM pode variar a posologia de 6,5mg/kg a 13mg/kg com a dose de 10 mg/kg produzindo anestesia cir&#250;rgica dentro de 3 a 4 minutos, com dura&#231;&#227;o do efeito por 10 a 25 minutos.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal; mso-layout-grid-align: none; text-autospace: none;\"><strong>Manuten&#231;&#227;o:</strong> Obtida pela administra&#231;&#227;o de doses adicionais de Cetamina, independente da via utilizada para indu&#231;&#227;o, a dose de manuten&#231;&#227;o deve ser ajustada de acordo com as necessidades anest&#233;sicas do paciente. A dose indicada deve ser metade daquela utilizada na indu&#231;&#227;o. Se a indu&#231;&#227;o com cetamina for potencializada com doses de 2mg a 5mg de Diazepam, pode-se optar pela manuten&#231;&#227;o em infus&#227;o lenta, por microgotejamento, de 0,1 a 0,5mg/minuto.</li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal; mso-layout-grid-align: none; text-autospace: none;\">&#160;</p>\r\n<p>&#160;</p></div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Dilui&#231;&#227;o:</strong><span style=\"text-align: justify;\">&#160;01 ampola de cetamina de 10mL com 50mg/mL deve ser dilu&#237;da em 500mL de soro glicosado a 5% ou solu&#231;&#227;o fisiol&#243;gica a 0,9%, resultando em uma solu&#231;&#227;o com 1mg de cetamina por mL.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> 9 a 13mg/kg IM produzem anestesia cir&#250;rgica em 3 a 4 minutos com dura&#231;&#227;o de 12 a 25 minutos.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2266,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Anest&#233;sico &#250;nico em interven&#231;&#245;es diagn&#243;sticas e cir&#250;rgicas que n&#227;o necessitem de relaxamento muscular, indu&#231;&#227;o de anestesia, previamente &#224; administra&#231;&#227;o de outros anest&#233;sicos gerais, suplementar outros agentes anest&#233;sicos de baixa pot&#234;ncia, como &#243;xido nitroso.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-11-18 14:11:55",
        "name": "Cetamina",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50mg/ml.</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receita de controle especial (C1 branca em duas vias).</span></p>",
        "record_status": 1,
        "slug": "cetamina",
        "substance": "Cetamina",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: #000000;\">-&#160;Eleva&#231;&#227;o da press&#227;o arterial em 20% a 25% o valor pr&#233;-anest&#233;sico, aumento da frequ&#234;ncia card&#237;aca, arritmias card&#237;acas, depress&#227;o respirat&#243;ria, apneia, laringosespasmo, diplopia, nistagmo e ligeira eleva&#231;&#227;o da press&#227;o intraocular, del&#237;rio, sonhos v&#237;vidos, aumento do t&#244;nus muscular, movimentos t&#244;nico-cl&#244;nicos, anorexia, n&#225;useas e v&#244;mitos, sialorreia, dor e exantema no local da aplica&#231;&#227;o, eritema e/ou erup&#231;&#227;o morbiliforme.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: #000000;\"><strong>Ajustes:</strong></span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: #000000;\">- N&#227;o estabelecido.</span></p></div>"
    },
    {
        "content_length": 1856,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos seus componentes;&#160;&#218;ltimas semanas da gesta&#231;&#227;o (38-42 semanas);&#160;Crian&#231;as com menos de um m&#234;s de idade;&#160;Insufici&#234;ncia renal.</p>",
        "dosage_adults": "<ul>\r\n<li>100mg, VO, 6/6h, por 7 a 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 2268,
        "indications": "<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Tratamento de infec&#231;&#245;es do trato urin&#225;rio.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-04 01:15:27",
        "name": "Macrodantina",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>-&#160;Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "macrodantina",
        "substance": "Nitrofurantoína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Cefaleia;&#160;Pneumonia intersticial;&#160;Anorexia, diarreia, n&#225;useas, v&#244;mitos e desconforto gastrointestinal.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-&#160;<strong>ClCr &lt; 60mL/min:</strong>&#160;contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 1846,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos seus componentes;&#160;&#218;ltimas semanas da gesta&#231;&#227;o (38-42 semanas);&#160;Crian&#231;as com menos de um m&#234;s de idade;&#160;Insufici&#234;ncia renal.</p>",
        "dosage_adults": "<ul>\r\n<li>100mg, VO, 6/6h, por 7 a 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 2269,
        "indications": "<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Tratamento de infec&#231;&#245;es do trato urin&#225;rio.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:49:46",
        "name": "Nitrofen",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>-&#160;Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "nitrofen",
        "substance": "Nitrofurantoína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Cefaleia;&#160;Pneumonia intersticial;&#160;Anorexia, diarreia, n&#225;useas, v&#244;mitos e desconforto gastrointestinal.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-&#160;<strong>ClCr &lt; 60mL/min:</strong>&#160;contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 2289,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade aos seus componentes;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">&#218;ltimas semanas da gesta&#231;&#227;o (38-42 semanas);&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Crian&#231;as com menos de um m&#234;s de idade;</span><span style=\"mso-bidi- line-height: 107%;\">&#160;Insufici&#234;ncia renal.</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>100mg, VO, 6/6h, por 7 a 10 dias.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p><strong>- Categoria B:</strong> Prescri&#231;&#227;o com cautela.</p>",
        "id": 2271,
        "indications": "<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- mso-ansi-language: PT-BR; mso-fareast-language: PT-BR; mso-bidi-language: AR-SA;\">- Tratamento de infec&#231;&#245;es do trato urin&#225;rio.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:47:36",
        "name": "Nirofurantoína",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas:</strong> 100mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<div>\r\n<p>-&#160;Receitu&#225;rio simples, em duas vias.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n</div>",
        "record_status": 1,
        "slug": "nitrofurantoina",
        "substance": "Nitrofurantoína",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;<span style=\"mso-bidi- line-height: 107%;\">Cefaleia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Pneumonia intersticial;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Anorexia, diarreia, n&#225;useas, v&#244;mitos e desconforto gastrointestinal.</span></p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- <strong>ClCr &lt; 60mL/min:</strong> contraindicado.</p>\r\n</div>"
    },
    {
        "content_length": 3102,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula, &#224; hidroxizina e a qualquer derivado piperaz&#237;nico.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"><strong>Dose usual:</strong> 10mg VO uma vez ao dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span id=\"docs-internal-guid-63f94f62-7fff-5cdd-b659-38f05907e0eb\"><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.</span></span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Crian&#231;as de 2 a 6 anos:</strong>&#160;A dose segura n&#227;o est&#225; estabelecida, podendo ser feito 2,5 mg uma ou duas vezes ao dia.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Maiores de 6 anos:</strong>&#160;10mg VO uma vez ao dia ou 5 mg VO de 12/12h.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o recomendado.</span></p>",
        "id": 2272,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Afec&#231;&#245;es al&#233;rgicas (rinite al&#233;rgica, conjuntivite al&#233;rgica, urtic&#225;ria).</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-18 14:16:00",
        "name": "Cetirizina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 10mg.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Solu&#231;&#227;o oral (xarope):</strong> 1mg/mL.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cetirizina",
        "substance": "Cetirizina",
        "trade_names": "",
        "warnings": "<div><p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Sonol&#234;ncia, fadiga, cefaleia, tontura, agita&#231;&#227;o, boca seca, desconforto gastrointestinal.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- A dose deve ser reduzida pela metade em pacientes com insufici&#234;ncia renal.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Deve ser evitado em pacientes com ClCr&lt;10mL/min.</p></div>"
    },
    {
        "content_length": 0,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula, &#224; hidroxizina e a qualquer derivado piperaz&#237;nico.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">10 mg VO uma vez ao dia.</span></li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Buscar formula&#231;&#245;es pedi&#225;tricas (xaropes) se necess&#225;rio</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Menores de 2 anos</strong> &#8211; contraindicado.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>de 2 a 6 anos</strong> &#8211; a dose segura n&#227;o est&#225; estabelecida, podendo ser feito 2,5 mg uma ou duas vezes ao dia.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>de 6 a 12 anos</strong> &#8211; 10 mg VO uma vez ao dia ou 5 mg VO de 12/12h.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "id": 2273,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Afec&#231;&#245;es al&#233;rgicas (rinite al&#233;rgica, conjuntivite al&#233;rgica, urtic&#225;ria).</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 34,
        "lactation_text": "<p>N&#227;o recomendado.</p>",
        "last_update": "2018-07-05 22:33:33",
        "name": "Cetihexal",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 10 mg</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Cetihexal",
        "substance": "Cetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- A dose deve ser reduzida pela metade em pacientes com insufici&#234;ncia renal.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Deve ser evitado em pacientes com ClCr&lt;10mL/min.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Sonol&#234;ncia, fadiga, cefaleia, tontura, agita&#231;&#227;o, boca seca, desconforto gastrointestinal.</p>\r\n</div>"
    },
    {
        "content_length": 2930,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula, &#224; hidroxizina e a qualquer derivado piperaz&#237;nico.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">10 mg VO uma vez ao dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Menores de 2 anos</strong> &#8211; contraindicado.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>de 2 a 6 anos</strong> &#8211; a dose segura n&#227;o est&#225; estabelecida, podendo ser feito 2,5 mg uma ou duas vezes ao dia.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>de 6 a 12 anos</strong> &#8211; 10 mg VO uma vez ao dia ou 5 mg VO de 12/12h.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "id": 2275,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Afec&#231;&#245;es al&#233;rgicas (rinite al&#233;rgica, conjuntivite al&#233;rgica, urtic&#225;ria).</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 121,
        "lactation_text": "<p>N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 17:48:45",
        "name": "Aletir",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Comprimidos:</strong> 10 mg</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Solu&#231;&#227;o oral (xarope):</strong> 1 mg/mL em frasco de 120mL acompanhado de dosador 10mL</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Aletir",
        "substance": "Cetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- A dose deve ser reduzida pela metade em pacientes com insufici&#234;ncia renal.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Deve ser evitado em pacientes com ClCr&lt;10mL/min.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Sonol&#234;ncia, fadiga, cefaleia, tontura, agita&#231;&#227;o, boca seca, desconforto gastrointestinal.</p>\r\n</div>"
    },
    {
        "content_length": 0,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula, &#224; hidroxizina e a qualquer derivado piperaz&#237;nico.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-fareast- mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">10 mg VO uma vez ao dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Menores de 2 anos</strong> &#8211; contraindicado.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>de 2 a 6 anos</strong> &#8211; a dose segura n&#227;o est&#225; estabelecida, podendo ser feito 2,5 mg uma ou duas vezes ao dia.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>de 6 a 12 anos</strong> &#8211; 10 mg VO uma vez ao dia ou 5 mg VO de 12/12h.</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "id": 2276,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Afec&#231;&#245;es al&#233;rgicas (rinite al&#233;rgica, conjuntivite al&#233;rgica, urtic&#225;ria).</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p>N&#227;o recomendado.</p>",
        "last_update": "2018-07-05 22:34:15",
        "name": "Cetirtec",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (xarope):</strong> 1 mg/mL em frasco de 120mL acompanhado de dosador 10mL</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Cetirtec",
        "substance": "Cetirizina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na insufici&#234;ncia renal:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- A dose deve ser reduzida pela metade em pacientes com insufici&#234;ncia renal.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Deve ser evitado em pacientes com ClCr&lt;10mL/min.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Sonol&#234;ncia, fadiga, cefaleia, tontura, agita&#231;&#227;o, boca seca, desconforto gastrointestinal.</p>\r\n</div>"
    },
    {
        "content_length": 3550,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi- line-height: 107%;\">Hipersensibilidade aos componentes; Glaucoma de &#226;ngulo fechado; Traumatismo craniano ou hemorragia cerebral; Anemia severa; Hipotens&#227;o; Hipovolemia n&#227;o corrigida; Circula&#231;&#227;o cerebral inadequada;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">&#160;Tamponamento peric&#225;rdico, cardiomiopatia restritiva ou pericardite constritiva;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Uso de inibidores de fosfodiesterase-5 (sildenafila, tadalafila, verdenafila ou lodenafila) nas &#250;ltimas 24 horas.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">Deve-se diluir 10ml em 240ml de SG 5% ou SF 0,9% (100mcg/ml);</span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose recomendada:</strong> 5-10mcg/min, podendo aumentar em 10mcg/min at&#233; obter o efeito desej&#225;vel (m&#225;ximo 200mcg/min).</p>\r\n</li>\r\n</ul>\r\n<hr>\r\n<p>OBS: 3 ml/h equivalem a 5mcg/min. Caso a dose utilizada seja maior que 40mcg/min, pode-se realizar a dilui&#231;&#227;o de forma a obter uma concentra&#231;&#227;o maior que 100mcg/ml.</p>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2279,
        "indications": "<p>-&#160;<span style=\"mso-bidi- line-height: 107%;\">Angina;&#160;</span><span style=\"text-align: justify;\">Infarto Agudo do Mioc&#225;rdio</span><span style=\"text-align: justify;\">;&#160;</span><span style=\"text-align: justify;\">Indu&#231;&#227;o de hipotens&#227;o intraoperat&#243;ria; Tratamento de hipertens&#227;o perioperat&#243;ria; Controle de insufici&#234;ncia card&#237;aca congestiva.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:28:11",
        "name": "Tridil",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "tridil",
        "substance": "Nitroglicerina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Cefaleia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Vertigem; Rash cut&#226;neo; Rubor; Fen&#244;meno de rebote isqu&#234;mico ap&#243;s descontinua&#231;&#227;o; Hipertens&#227;o de rebote.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4912,
        "contraindications": "<p><span style=\"line-height: 115%;\">- Hipersensibilidade a qualquer dos seus componentes. N&#227;o deve ser usado no caso de haver uma infec&#231;&#227;o nasal n&#227;o-tratada.&#160;</span></p>",
        "dosage_adults": "<ul>\r\n<li style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%;\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; font-weight: normal; mso-bidi-font-weight: bold;\"><strong>Dose usual:</strong> Dois jatos em cada narina uma vez ao dia (50mcg por jato, m&#225;ximo 200 mcg por dia). </span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 15.6933px;\"><span id=\"docs-internal-guid-9f4a3cc8-7fff-5bce-0425-45aace09e678\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</span></span></span></li>\r\n<li><span style=\"line-height: 15.6933px;\"><strong>Maiores de 6 anos:</strong>&#160;</span><span id=\"docs-internal-guid-2c57c09e-7fff-2989-a6c0-1ec34bccfa5c\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Posologia idem adultos.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2284,
        "indications": "<p>- Rinite Alergica intermitente ou persistente, incluindo congest&#227;o nasal, coriza, prurido e espirros.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 112,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 23:48:56",
        "name": "Alvesco",
        "presentation": "<ul>\r\n<li style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; background: white;\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; font-weight: normal; mso-bidi-font-weight: bold;\"><strong>Suspens&#227;o nasal (spray):&#160;</strong>80mcg e 160mcg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Alvesco",
        "substance": "Ciclesonida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white; text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white; text-align: justify;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p style=\"line-height: 107%; background: white; margin: 0cm 0cm 8pt; text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">Efeitos adversos:</span></strong></p>\r\n<p style=\"line-height: 107%; background: white; margin: 0cm 0cm 8pt; text-align: justify;\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">-&#160;Dor de cabe&#231;a,&#160;</span><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">Indigest&#227;o,&#160;</span><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">Sangramento do nariz, irrita&#231;&#227;o da mucosa do nariz e, boca seca, candid&#237;ase, rinite, ressecamento nasal, dor na garganta, secre&#231;&#227;o nasal, irrita&#231;&#227;o na garganta, transtorno do septo nasal, transtorno do paladar e aumento do n&#250;mero de gl&#243;bulos brancos.</span></p>\r\n</div>"
    },
    {
        "content_length": 4220,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade conhecida &#224; nitroglicerina e a nitratos org&#226;nicos relacionados; Insufici&#234;ncia circulat&#243;ria aguda associada &#224; hipotens&#227;o conhecida (choque); Hipertens&#227;o compensat&#243;ria; Uso concomitante a inibidores de fosfodiesterases tipo 5 tal como o sildenafil, porque os inibidores de PDE 5 podem amplificar os efeitos vasodilatadores, resultando em hipotens&#227;o grave.</span></p>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">Diluir 2ml em 1000ml ou 500ml ou 250ml de&#160;<strong>SG 5%</strong>&#160;(50mcg/ml, 100mcg/ml e 200mcg/ml respectivamente).</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong>&#160;0,5 mcg/kg/min e aumentar conforme a press&#227;o arterial, com aumento de 0,5 mcg at&#233; a dose de 2-3 mcg/kg/min.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong>&#160;8 mcg/kg/min.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">Diluir 2ml em 1000ml ou 500ml ou 250ml de&#160;<strong>SG 5%</strong>&#160;(50mcg/ml, 100mcg/ml e 200mcg/ml respectivamente).</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong>&#160;0,5 mcg/kg/min e aumentar conforme a press&#227;o arterial, com a infus&#227;o de 0,5 mcg at&#233; a dose de 2-3 mcg/kg/min.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong>&#160;10&#160;mcg/kg/min.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2285,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Emerg&#234;ncias e urg&#234;ncias hipertensivas;&#160;Estimular o d&#233;bito card&#237;aco e para reduzir as necessidades de oxig&#234;nio do mioc&#225;rdio na insufici&#234;ncia card&#237;aca secund&#225;ria ao infarto agudo do mioc&#225;rdio; Hipotens&#227;o controlada durante interven&#231;&#245;es cir&#250;rgicas; No espasmo arterial grave e para corre&#231;&#227;o da isquemia dos vasos perif&#233;ricos proveniente de envenenamento com drogas contendo ergotamina.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 01:47:19",
        "name": "Nipride(descontinuado)",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160;25mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nipride",
        "substance": "Nitroprusseto de sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Palpita&#231;&#245;es, hipotens&#227;o, bradicardia;&#160;Mudan&#231;as eletrocardiogr&#225;ficas, taquicardia;&#160;Rash cut&#226;neo, diaforese;&#160;Confus&#227;o, press&#227;o intracraniana elevada, miose, vertigem, cefaleia;&#160;N&#225;useas, v&#244;mitos,&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">desconforto retroesternal, dor abdominal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>Insufici&#234;ncia renal:</strong>&#160;n&#227;o exceder a velocidade m&#225;xima de infus&#227;o de 10mcg/kg/min.</p>\r\n</div>"
    },
    {
        "content_length": 4525,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade conhecida &#224; nitroglicerina e a nitratos org&#226;nicos relacionados; Insufici&#234;ncia circulat&#243;ria aguda associada &#224; hipotens&#227;o conhecida (choque); Hipertens&#227;o compensat&#243;ria; Uso concomitante a inibidores de fosfodiesterases tipo 5 tal como o sildenafil, porque os inibidores de PDE 5 podem amplificar os efeitos vasodilatadores, resultando em hipotens&#227;o grave.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">Diluir 2ml em 1000ml ou 500ml ou 250ml de <strong>SG 5%</strong> (50mcg/ml, 100mcg/ml e 200mcg/ml respectivamente).</span></p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong> 0,5 mcg/kg/min e aumentar conforme a press&#227;o arterial, com aumento de 0,5 mcg at&#233; a dose de 2-3 mcg/kg/min.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong> 8 mcg/kg/min.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">Diluir 2ml em 1000ml ou 500ml ou 250ml de&#160;<strong>SG 5%</strong>&#160;(50mcg/ml, 100mcg/ml e 200mcg/ml respectivamente).</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong>&#160;0,5 mcg/kg/min e aumentar conforme a press&#227;o arterial, com a infus&#227;o de 0,5 mcg at&#233; a dose de 2-3 mcg/kg/min.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong>&#160;10&#160;mcg/kg/min.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2286,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Emerg&#234;ncias e urg&#234;ncias hipertensivas;&#160;</span>Estimular o d&#233;bito card&#237;aco e para reduzir as necessidades de oxig&#234;nio do mioc&#225;rdio na insufici&#234;ncia card&#237;aca secund&#225;ria ao infarto agudo do mioc&#225;rdio; Hipotens&#227;o controlada durante interven&#231;&#245;es cir&#250;rgicas; No espasmo arterial grave e para corre&#231;&#227;o da isquemia dos vasos perif&#233;ricos proveniente de envenenamento com drogas contendo ergotamina.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 102,
        "lactation_text": "<p><strong>-&#160;</strong><span style=\"line-height: 107%;\">N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-05 01:50:01",
        "name": "Nitrop",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 25mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nitrop",
        "substance": "Nitroprusseto de sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;Palpita&#231;&#245;es, hipotens&#227;o, bradicardia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Mudan&#231;as eletrocardiogr&#225;ficas, taquicardia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Rash cut&#226;neo, diaforese;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">Confus&#227;o, press&#227;o intracraniana elevada, miose, vertigem, cefaleia;&#160;</span><span style=\"mso-bidi- line-height: 107%;\">N&#225;useas, v&#244;mitos, <span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">desconforto retroesternal, dor abdominal.</span></span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- <strong>Insufici&#234;ncia renal:</strong> n&#227;o exceder a velocidade m&#225;xima de infus&#227;o de 10mcg/kg/min.</p>\r\n</div>"
    },
    {
        "content_length": 4175,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Hipersensibilidade conhecida &#224; nitroglicerina e a nitratos org&#226;nicos relacionados; Insufici&#234;ncia circulat&#243;ria aguda associada &#224; hipotens&#227;o conhecida (choque); Hipertens&#227;o compensat&#243;ria; Uso concomitante a inibidores de fosfodiesterases tipo 5 tal como o sildenafil, porque os inibidores de PDE 5 podem amplificar os efeitos vasodilatadores, resultando em hipotens&#227;o grave.</span></p>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">Diluir 2ml em 1000ml ou 500ml ou 250ml de&#160;<strong>SG 5%</strong>&#160;(50mcg/ml, 100mcg/ml e 200mcg/ml respectivamente).</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong>&#160;0,5 mcg/kg/min e aumentar conforme a press&#227;o arterial, com aumento de 0,5 mcg at&#233; a dose de 2-3 mcg/kg/min.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong>&#160;8 mcg/kg/min.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">Diluir 2ml em 1000ml ou 500ml ou 250ml de&#160;<strong>SG 5%</strong>&#160;(50mcg/ml, 100mcg/ml e 200mcg/ml respectivamente).</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong>&#160;0,5 mcg/kg/min e aumentar conforme a press&#227;o arterial, com a infus&#227;o de 0,5 mcg at&#233; a dose de 2-3 mcg/kg/min.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong>&#160;10&#160;mcg/kg/min.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2287,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Emerg&#234;ncias e urg&#234;ncias hipertensivas;&#160;Estimular o d&#233;bito card&#237;aco e para reduzir as necessidades de oxig&#234;nio do mioc&#225;rdio na insufici&#234;ncia card&#237;aca secund&#225;ria ao infarto agudo do mioc&#225;rdio; Hipotens&#227;o controlada durante interven&#231;&#245;es cir&#250;rgicas; No espasmo arterial grave e para corre&#231;&#227;o da isquemia dos vasos perif&#233;ricos proveniente de envenenamento com drogas contendo ergotamina.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 17,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-05 01:50:09",
        "name": "Nitroprus",
        "presentation": "<ul>\r\n<li><strong>P&#243; liofilizado para soul&#231;&#227;o injet&#225;vel:&#160;</strong>50mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nitroprus",
        "substance": "Nitroprusseto de sódio",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Palpita&#231;&#245;es, hipotens&#227;o, bradicardia;&#160;Mudan&#231;as eletrocardiogr&#225;ficas, taquicardia;&#160;Rash cut&#226;neo, diaforese;&#160;Confus&#227;o, press&#227;o intracraniana elevada, miose, vertigem, cefaleia;&#160;N&#225;useas, v&#244;mitos,&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">desconforto retroesternal, dor abdominal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>Insufici&#234;ncia renal:</strong>&#160;n&#227;o exceder a velocidade m&#225;xima de infus&#227;o de 10mcg/kg/min.</p>\r\n</div>"
    },
    {
        "content_length": 5216,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white; text-align: justify;\"><span id=\"docs-internal-guid-4b6556cb-7fff-99b4-4f9e-d6d6a220c54b\"><span style=\"  font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Hipersensibilidade &#224; Ciclobenzaprina ou a quaisquer dos componentes da f&#243;rmula do produto; Bloqueios card&#237;acos, arritmia card&#237;aca, dist&#250;rbio da condu&#231;&#227;o card&#237;aca, fal&#234;ncia card&#237;aca congestiva, hipertireoidismo e infarto do mioc&#225;rdio; glaucoma ou reten&#231;&#227;o urin&#225;ria; uso simult&#226;neo com inibidores da monoaminoxidase (IMAO), s&#243; devendo ser utilizado o cloridrato de Ciclobenzaprina 14 dias ap&#243;s a suspens&#227;o dos inibidores da monoaminoxidase (IMAO).</span></span></p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Dose usual:</strong> 20 a 40 mg ao dia, dividida em uma, duas, tr&#234;s ou quatro tomadas.&#160;</span>A dose m&#225;xima di&#225;ria &#233; de 60 mg.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria B:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 2289,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Tratamento dos espasmos musculares associados com dor aguda e de etiologia m&#250;sculo-esquel&#233;tica.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-11-18 14:34:41",
        "name": "Ciclobenzaprina",
        "presentation": "<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Comprimido:</strong> 5mg e 10mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ciclobenzaprina",
        "substance": "Ciclobenzaprina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- N&#227;o estabelecido.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white; text-align: left;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\"><span id=\"docs-internal-guid-052881f3-7fff-a5b9-3026-ca9abee4cf77\"><span style=\" font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline;\">-&#160;</span><span style=\"  font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Taquicardia, arritmias, vasodilata&#231;&#227;o, palpita&#231;&#227;o, hipotens&#227;o; Ataxia, vertigem, disartria, tremores, hipertonia, convuls&#245;es, alucina&#231;&#245;es, ins&#244;nia, perda do paladar, sensa&#231;&#227;o de ru&#237;dos &#160;depress&#227;o, ansiedade, agita&#231;&#227;o, parestesia, diplopia; sonol&#234;ncia, fadiga, astenia,cefal&#233;ia, nervosismo e confus&#227;o; Vis&#227;o borrada, n&#225;useas, constipa&#231;&#227;o, v&#244;mitos, anorexia, diarreia, dor gastrintestinal, gastrite, flatul&#234;ncia, edema de l&#237;ngua, altera&#231;&#227;o das fun&#231;&#245;es hep&#225;ticas, raramente hepatite, icter&#237;cia e colestase, dispepsias e sabor desagrad&#225;vel, anafilaxia, angioedema, prurido, edema facial, urtic&#225;ria e &#8220;rash&#8221;, rigidez muscular, secura da boca, sudorese.</span></span><br style=\"mso-special-character: line-break;\"> <!-- [if !supportLineBreakNewLine]--><br style=\"mso-special-character: line-break;\"> <!--[endif]--></span></p>\r\n</div>"
    },
    {
        "content_length": 5148,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose inicial:</strong>&#160;300mg, 2x/dia.&#160;</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose de manuten&#231;&#227;o:</strong> 600-2.400mg/dia.&#160;</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">Ajustes semanais com aumento de 600mg at&#233; efeito desejado</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose de m&#225;xima:</strong> 2.400 mg/dia durante 48 horas em ambiente hospitalar.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose inicial:</strong> 8-10 mg/kg/dia, divididos em duas doses.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong> Dose de manuten&#231;&#227;o:&#160;</strong>30-46 mg/kg/dia e deve ser alcan&#231;ada em mais de duas semanas.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">Ajustes de 10mg/kg/dia com intervalos semanais</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose de m&#225;xima:</strong>&#160;60 mg/kg/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2304,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: #333333; text-align: start;\">- Crises parciais e c</span><span style=\"color: #333333; text-align: start;\">rises t&#244;nico-cl&#244;nicas generalizadas.</span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 197,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Contraindicado.</span></p>",
        "last_update": "2019-03-06 16:56:41",
        "name": "Oxcarbazepina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido:</strong> 300 ou 600 mg.</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Receita de controle especial.</span></p>",
        "record_status": 1,
        "slug": "oxcarbazepina",
        "substance": "Oxcarbazepina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Anemia apl&#225;stica, agranulocitose, pancitopenia, trombocitopenia, neutropenia. rea&#231;&#245;es anafil&#225;ticas, hipersensibilidade, erup&#231;&#227;o cut&#226;nea, febre, eosinofilia, trombocitopenia, leucopenia, linfadenopatia, esplenomegalia, hepatite, altera&#231;&#245;es nos testes de fun&#231;&#227;o hep&#225;tica, mialgia, artralgia, artrite, encefalopatia hep&#225;tica, insufici&#234;ncia renal, nefrite intersticial, protein&#250;ria, edema pulmonar, asma, broncoespasmos, doen&#231;a pulmonar instersticial, dispneia, angioedema, hipotireoidismo, hiponatremia, convuls&#245;es, encefalopatia, n&#237;vel de consci&#234;ncia prejudicado, confus&#227;o, hipotireoidismo, v&#244;mito, n&#225;usea, defici&#234;ncia de &#225;cido f&#243;lico, agita&#231;&#227;o, instabilidade emocional, confus&#227;o, depress&#227;o, apatia, sonol&#234;ncia, cefaleia, tontura, ataxia, tremor, nistagmo, concentra&#231;&#227;o prejudicada, amn&#233;sia, diplopia, turva&#231;&#227;o visual, vertigem, bloqueio atrioventricular, arritmia, hipertens&#227;o, v&#244;mito, n&#225;usea, diarreia, dor abdominal, constipa&#231;&#227;o, pancreatite, rash, alopecia, acne, S&#237;ndrome de Stevens-Johnson, necr&#243;lise epid&#233;rmica t&#243;xica (s&#237;ndrome de Lyell), eritema multiforme, L&#250;pus eritematoso sist&#234;mico, fadiga, astenia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 17.12px;\">ClCr &lt;30 mL/min: dose inicial de 300 mg/dia.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\"><strong><span style=\"line-height: 17.12px;\">Ajustes na Insufici&#234;ncia Hep&#225;tica Grave:&#160;</span></strong><span style=\"line-height: 17.12px;\">N&#227;o estabelecido.</span></span></p>\r\n</div>"
    },
    {
        "content_length": 2762,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes;&#160;Durante anestesia com ciclopropano ou anest&#233;sicos gerais halogenados;&#160;Em associa&#231;&#227;o com anest&#233;sicos locais em extremidades;&#160;Trombose vascular mesent&#233;rica ou perif&#233;rica.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Diluir 20ml em 80ml de SG 5% e administrar em via exclusiva (200mcg/ml).</li>\r\n<li>\r\n<p>0,1-0,3 mcg/kg/min (dose m&#225;xima:&#160;2mcg/kg/min).</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2305,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">Estados hipotensivos agudos;&#160;</span><span style=\"text-align: justify;\">Coadjuvante no tratamento da parada card&#237;aca e hipotens&#227;o profunda; Choque refrat&#225;rio com hipotens&#227;o.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 182,
        "lactation_text": "<p><strong>-&#160;</strong>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:54:54",
        "name": "Norepine",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>2mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "norepine",
        "substance": "Norepinefrina ou Noradrenalina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Les&#245;es isqu&#234;micas;&#160;Bradicardia, arritmias;&#160;Ansiedade, cefaleia transit&#243;ria, dificuldade respirat&#243;ria;&#160;Fotofobia, dor retroesternal pungente, palidez, sudorese intensa e v&#244;mitos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2759,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes;&#160;Durante anestesia com ciclopropano ou anest&#233;sicos gerais halogenados;&#160;Em associa&#231;&#227;o com anest&#233;sicos locais em extremidades;&#160;Trombose vascular mesent&#233;rica ou perif&#233;rica.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Diluir 20ml em 80ml de SG 5% e administrar em via exclusiva (200mcg/ml).</li>\r\n<li>\r\n<p>0,1-0,3 mcg/kg/min (dose m&#225;xima:&#160;2mcg/kg/min).</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2307,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">Estados hipotensivos agudos;&#160;</span><span style=\"text-align: justify;\">Coadjuvante no tratamento da parada card&#237;aca e hipotens&#227;o profunda; Choque refrat&#225;rio com hipotens&#227;o.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 102,
        "lactation_text": "<p><strong>-&#160;</strong>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 20:44:49",
        "name": "Hyponor",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>2mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "hyponor",
        "substance": "Norepinefrina ou Noradrenalina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Les&#245;es isqu&#234;micas;&#160;Bradicardia, arritmias;&#160;Ansiedade, cefaleia transit&#243;ria, dificuldade respirat&#243;ria;&#160;Fotofobia, dor retroesternal pungente, palidez, sudorese intensa e v&#244;mitos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2760,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;Hipersensibilidade aos componentes;&#160;Durante anestesia com ciclopropano ou anest&#233;sicos gerais halogenados;&#160;Em associa&#231;&#227;o com anest&#233;sicos locais em extremidades;&#160;Trombose vascular mesent&#233;rica ou perif&#233;rica.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Diluir 20ml em 80ml de SG 5% e administrar em via exclusiva (200mcg/ml).</li>\r\n<li>\r\n<p>0,1-0,3 mcg/kg/min (dose m&#225;xima:&#160;2mcg/kg/min).</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2308,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">Estados hipotensivos agudos;&#160;</span>Coadjuvante no tratamento da parada card&#237;aca e hipotens&#227;o profunda; Choque refrat&#225;rio com hipotens&#227;o.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>-&#160;</strong>N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:55:03",
        "name": "Norepinefrina",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>2mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "norepinefrina",
        "substance": "Norepinefrina ou Noradrenalina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span>Les&#245;es isqu&#234;micas;&#160;Bradicardia, arritmias;&#160;Ansiedade, cefaleia transit&#243;ria, dificuldade respirat&#243;ria;&#160;Fotofobia, dor retroesternal pungente, palidez, sudorese intensa e v&#244;mitos.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5590,
        "contraindications": "<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2315,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 25,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 18:11:26",
        "name": "Floximed",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "floximed",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5570,
        "contraindications": "<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2316,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:55:21",
        "name": "Norf",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "norf",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5580,
        "contraindications": "<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2317,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-08 19:06:23",
        "name": "Quinoform",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "quinoform",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5696,
        "contraindications": "<div>\r\n<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2318,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 54,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-04 00:27:13",
        "name": "Androfloxin",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "androfloxin",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5705,
        "contraindications": "<div>\r\n<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2319,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 191,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 18:10:51",
        "name": "Floxacin",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "floxacin",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5693,
        "contraindications": "<div>\r\n<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2320,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 75,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 18:10:59",
        "name": "Floxamox",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "floxamox",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5587,
        "contraindications": "<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2322,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 97,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:08:41",
        "name": "Neofloxin",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "neofloxin",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5580,
        "contraindications": "<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2325,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 55,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:57:11",
        "name": "Norxacin",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "norxacin",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 5604,
        "contraindications": "<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>",
        "dosage_adults": "<div>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 7 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Cistite aguda n&#227;o complicada:</strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><strong>Gonorreia:</strong></p>\r\n<ul>\r\n<li>800mg, VO, em dose &#250;nica.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><strong>Sepse decorrente de neutropenia:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</li>\r\n</ul>\r\n<p><strong>Febre Tifoide:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">400mg, VO, de 8/8 horas, por 14 dias.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2327,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Infec&#231;&#245;es urin&#225;rias;&#160;Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-10 04:41:45",
        "name": "Uni Norflox",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "uni-norflox",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;<strong>ClCr &lt; 30mL/min:</strong>&#160;400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 6467,
        "contraindications": "<div>\r\n<p>-&#160;Hipersensibilidade aos componentes ou a antibi&#243;ticos quinol&#244;nicos.</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p class=\"MsoNormal\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><span style=\"mso-bidi- line-height: 107%;\"><strong>Infec&#231;&#227;o do trato urin&#225;rio:</strong> </span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%;\">400mg, VO, de 12/12 horas, durante 7 a 10 dias.</span></li>\r\n</ul>\r\n<p><strong><span style=\"mso-bidi- line-height: 107%;\">Cistite aguda n&#227;o complicada:</span></strong></p>\r\n<ul>\r\n<li>400mg, VO, de 12/12 horas, durante 3 a 10 dias.</li>\r\n</ul>\r\n<p><strong>Infec&#231;&#227;o do trato urin&#225;rio cr&#244;nica recidivante:</strong></p>\r\n<ul>\r\n<li style=\"text-align: justify;\">400mg, VO, de 12/12 horas, por at&#233; 12 semanas. Se nas primeiras 4 semanas for obtida supress&#227;o adequada, reduzir para 400mg/dia.</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%;\"><strong>Gonorreia:</strong> </span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%;\">800mg, VO, em dose &#250;nica.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Inflama&#231;&#227;o do est&#244;mago e intestino:</strong> </span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, de 12/12 horas, durante 5 dias.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%;\"><strong>Sepse decorrente de neutropenia:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">400mg, VO, de 8/8 horas, enquanto a neutropenia se mantiver.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%;\"><strong>Febre Tifoide:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">400mg, VO, de 8/8 horas, por 14 dias.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\"><strong>Profilaxia de gastroenterite bacteriana:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black; background: white;\">400mg, VO, 1x/dia. Iniciar 24 horas antes da chegada e continuar 48 horas ap&#243;s a sa&#237;da de &#225;reas end&#234;micas.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: left;\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p style=\"text-align: justify;\"><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2330,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"text-align: justify;\">Infec&#231;&#245;es urin&#225;rias;&#160;</span>Gastroenterites;&#160;Profilaxia de peritonite bacteriana espont&#226;nea;&#160;Profilaxia de sepse em pacientes neutrop&#234;nicos;&#160;Gonorr&#233;ia;&#160;Febre Tif&#243;ide.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: left;\">&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:55:30",
        "name": "Norfloxacino",
        "presentation": "<ul>\r\n<li><strong>Comprimido revestido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias.</p>",
        "record_status": 1,
        "slug": "norfloxacino",
        "substance": "Norfloxacino",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">-&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">N&#225;useas, cefaleia, tontura;&#160;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">Exantema;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Pirose, dores/c&#243;licas abdominais e diarreia;</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: 107%;\">&#160;Edema da face, dos l&#225;bios, da l&#237;ngua e/ou orofaringe;</span><span style=\"line-height: 107%;\">&#160;E<span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">ritrema, edema ou forma&#231;&#227;o de bolhas na pele;</span></span><span style=\"line-height: 107%;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&#160;E</span></span><span style=\"line-height: 107%;\">leva&#231;&#227;o de ALT e AST.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- <strong>ClCr &lt; 30mL/min:</strong> 400mg VO 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 2835,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose usual:</strong> 1 gota no saco conjuntival do olho afetado.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\"><strong>Dose usual:</strong>&#160;1 gota no saco conjuntival do olho afetado.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2331,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- Anestesia do globo ocular em cirurgias breves, retirada de corpos estranhos corneanos e conjuntivais e procedimentos diagn&#243;sticos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 109,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Alto risco:</span></strong><span style=\"line-height: 107%;\"> Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2019-03-06 16:57:17",
        "name": "Oxinest",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Solu&#231;&#227;o oftalmol&#243;gica:</strong> 4mg/ml.</span></li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receita de controle especial.</span></p>",
        "record_status": 1,
        "slug": "oxinest",
        "substance": "Oxibuprocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- Rea&#231;&#245;es al&#233;rgicas locais.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 17.12px;\">N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 3733,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Pacientes em uso de inibidores da monoaminoxidase;&#160;Per&#237;odo agudo (30 dias) de recupera&#231;&#227;o p&#243;s infarto do mioc&#225;rdio.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\">25mg, VO, 3 a 4x/dia (dose m&#225;xima: 150mg/dia). A dose total di&#225;ria pode ser administrada uma vez ao dia.</li>\r\n<li><strong>Idosos e adolescentes:</strong>&#160;30mg a 50mg, VO, por dia, divididos em 2 a 3 doses.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2332,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Al&#237;vio dos sintomas de depress&#227;o.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 16:59:28",
        "name": "Pamelor",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>C&#225;psulas:</strong> 10mg, 25mg, 50mg e 75mg.</span></p>\r\n</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Solu&#231;&#227;o oral:</strong> 2mg/ml.<br></span></p>\r\n</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>- Receitu&#225;rio especial (C1 branca em duas vias).</p>",
        "record_status": 1,
        "slug": "pamelor",
        "substance": "Nortriptilina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Hipotens&#227;o, taquicardia, infarto do mioc&#225;rdio, arritmias;&#160;Confus&#227;o mental, alucina&#231;&#245;es, desorienta&#231;&#227;o, ansiedade, inquieta&#231;&#227;o, agita&#231;&#227;o, ins&#244;nia, p&#226;nico, pesadelos;&#160;Tremores, convuls&#245;es, vis&#227;o turva, dist&#250;rbios da acomoda&#231;&#227;o visual, midr&#237;ase;&#160;Reten&#231;&#227;o urin&#225;ria, retardo miccional, dilata&#231;&#227;o do trato urin&#225;rio baixo, dis&#250;ria, nict&#250;ria;&#160;Depress&#227;o da medula &#243;ssea, ginecosmatia em homens, ingurgitameto mam&#225;rio, galactorreia, aumento ou diminui&#231;&#227;o do libido, impot&#234;ncia sexual, orquite;&#160;Hipergliceimia ou hipoglicemia, s&#237;ndrome da secre&#231;&#227;o inapropriada do horm&#244;nio antidiur&#233;tico;&#160;Urtic&#225;ria, sensibilidade &#224; luz solar, edema, n&#225;usea, v&#244;mito, diarreia, anorexia, sonol&#234;ncia;&#160;Cefaleia, torpor, parestesia em extremidades, ataxia, tremores, neuropatia perif&#233;rica, sintomas extrapiramidais;&#160;Xerostomia, adenite sublingual, parotidite, alop&#233;cia.</p>\r\n</div>"
    },
    {
        "content_length": 3598,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes;&#160;Pacientes em uso de inibidores da monoaminoxidase;&#160;Per&#237;odo agudo (30 dias) de recupera&#231;&#227;o p&#243;s infarto do mioc&#225;rdio.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\">25mg, VO, 3 a 4x/dia (dose m&#225;xima: 150mg/dia). A dose total di&#225;ria pode ser administrada uma vez ao dia.</li>\r\n<li><strong>Idosos e adolescentes:</strong> 30mg a 50mg, VO, por dia, divididos em 2 a 3 doses.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2334,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Al&#237;vio dos sintomas de depress&#227;o.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 01:56:41",
        "name": "Nortriptilina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>C&#225;psulas:</strong> 10mg, 25mg, 50mg e 75mg.</span></p>\r\n</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>- Receitu&#225;rio especial (C1 branca em duas vias).</p>",
        "record_status": 1,
        "slug": "nortriptilina",
        "substance": "Nortriptilina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- N&#227;o h&#225; ajuste.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">-&#160;Hipotens&#227;o, taquicardia, infarto do mioc&#225;rdio, arritmias;&#160;Confus&#227;o mental, alucina&#231;&#245;es, desorienta&#231;&#227;o, ansiedade, inquieta&#231;&#227;o, agita&#231;&#227;o, ins&#244;nia, p&#226;nico, pesadelos;&#160;Tremores, convuls&#245;es, vis&#227;o turva, dist&#250;rbios da acomoda&#231;&#227;o visual, midr&#237;ase;&#160;Reten&#231;&#227;o urin&#225;ria, retardo miccional, dilata&#231;&#227;o do trato urin&#225;rio baixo, dis&#250;ria, nict&#250;ria;&#160;Depress&#227;o da medula &#243;ssea, ginecosmatia em homens, ingurgitameto mam&#225;rio, galactorreia, aumento ou diminui&#231;&#227;o do libido, impot&#234;ncia sexual, orquite;&#160;Hipergliceimia ou hipoglicemia, s&#237;ndrome da secre&#231;&#227;o inapropriada do horm&#244;nio antidiur&#233;tico;&#160;Urtic&#225;ria, sensibilidade &#224; luz solar, edema, n&#225;usea, v&#244;mito, diarreia, anorexia, sonol&#234;ncia;&#160;Cefaleia, torpor, parestesia em extremidades, ataxia, tremores, neuropatia perif&#233;rica, sintomas extrapiramidais;&#160;Xerostomia, adenite sublingual, parotidite, alop&#233;cia.</p>\r\n</div>"
    },
    {
        "content_length": 4574,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade ao cloridrato de oxibutinina, glaucoma de &#226;ngulo fechado, obstru&#231;&#227;o parcial ou total do trato gastrointestinal, &#237;leo paral&#237;tico, atonia intestinal dos idosos, empacientes debilitados, megacolon, megacolon t&#243;xico com complica&#231;&#227;o de colite ulcerativa, colite severa e miastenia grave, estado cardiovascular inst&#225;vel em hemorragia aguda, miastenia grave, uropatia obstrituva e reten&#231;&#227;o urin&#225;ria.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong>&#160;5mg ou 5ml, 2-3x/dia.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:</strong> 20mg/dia.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\"><strong>Dose usual: </strong>&gt;5 anos:&#160;5mg ou 5mL, VO, 1x/dia ou 12/12h.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:&#160;</strong>15mg/dia, ou seja, 5mg ou 5mL at&#233; de 8/8h.</li>\r\n</ul>\r\n<hr>\r\n<ul>\r\n<li class=\"MsoNormal\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 5 anos.</span></p>\r\n</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2337,
        "indications": "<div>\r\n<p><span style=\"mso-bidi- line-height: 107%;\">- Incontin&#234;ncia urin&#225;ria, u</span>rg&#234;ncia para urinar, noct&#250;ria e incontin&#234;ncia em pacientes com bexiga neurog&#234;nica, coadjuvante no tratamento da cistite de qualquer natureza e na prostatite cr&#244;nica, dist&#250;rbios psicol&#243;gicos relacionados &#224; mic&#231;&#227;o,&#160;redu&#231;&#227;o dos epis&#243;dios de enurese noturna.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 90,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-03 19:21:02",
        "name": "Frenurin",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido:</strong> 5mg.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Solu&#231;&#227;o oral:</strong> 1 mg/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "oxibutinina",
        "substance": "Oxibutinina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- Xerostomia, diminui&#231;&#227;o da transpira&#231;&#227;o, reten&#231;&#227;o urin&#225;ria, vis&#227;o turva, taquicardia, palpita&#231;&#245;es, midr&#237;ase, cicloplegia, aumento da press&#227;o ocular, sonol&#234;ncia, debilidade, vertigens, ins&#244;nia, v&#244;mitos, constipa&#231;&#227;o, impot&#234;ncia, supress&#227;o da lacta&#231;&#227;o, rea&#231;&#245;es al&#233;rgicas (incluindo urtic&#225;ria), hiperglicemia, diarreia, desconforto abdominal, dor abdominal, garganta seca, disfagia, eructa&#231;&#227;o, flatul&#234;ncia, refluxo gastroesof&#225;gico, v&#244;mitos, infec&#231;&#227;o do trato urin&#225;rio, reten&#231;&#227;o urin&#225;ria, cistite, ardor para urinar.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 17.12px;\">N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 3752,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade &#224; oxicodona, depress&#227;o respirat&#243;ria, asma br&#244;nquica, hipercapnia aguda ou severa, &#237;leo paral&#237;tico, doen&#231;a pulmonar obstrutiva cr&#244;nica, cor pulmonale.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose usual:</strong>&#160;10mg VO, 2x/dia.&#160;</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">O aumento das doses pode ocorrer com ajustes de 25% a 50% a cada 12 horas.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:&#160;</strong>80mg/dia (40mg 2x/dia).</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria B:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 2340,
        "indications": "<div>\r\n<p>&#160;<span style=\"mso-bidi- line-height: 107%;\">- Tratamento de dores moderadas a severas, quando &#233; necess&#225;ria a administra&#231;&#227;o cont&#237;nua de um analg&#233;sico, 24 horas por dia, por per&#237;odo de tempo prolongado<strong>.</strong></span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">&#160;</p>\r\n<p>&#160;</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 60,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-06 16:58:08",
        "name": "Oxycontin",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido:</strong> 10 mg, 20 mg e 40 mg.</span></li>\r\n</ul>",
        "recipient": 3,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">-&#160;</span><span style=\"line-height: 107%;\">Receita Amarela.</span></p>",
        "record_status": 1,
        "slug": "oxycontin",
        "substance": "Oxicodona",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- Obstipa&#231;&#227;o intestinal, n&#225;useas, sonol&#234;ncia, vertigem, v&#244;mitos, prurido, cefaleia, xerostomia, hiperidrose, cansa&#231;o, apneia, depress&#227;o respirat&#243;ria e circulat&#243;ria, hipotens&#227;o e choque, ansiedade, confus&#227;o, ins&#244;nia, nervosismo, pensamento anormal, depress&#227;o, tremor, letargia, amn&#233;sia, convuls&#227;o, hipertonia, hipoestesia, contra&#231;&#245;es musculares involunt&#225;rias, parestesia, dist&#250;rbio da fala, s&#237;ncope, disgeusia, rash, anafilaxia.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 107%;\">Iniciar com metade da dose inicial.</span></p>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</span></strong>Iniciar com metade da dose inicial.</p>\r\n</div>"
    },
    {
        "content_length": 4095,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade a qualquer um dos componentes, doen&#231;a card&#237;aca, hipertens&#227;o, doen&#231;as da tire&#243;ide, diabetes, dificuldade em urinar devido&#160;a aumento do tamanho da pr&#243;stata,&#160;tratamento com (IMAO) ou em pacientes que tomaram IMAO nas duas semanas anteriores, glaucoma de &#226;ngulo estreito,&#160;ap&#243;s hipofisectomia transfenoidal e inflama&#231;&#227;o da pele e mucosa do vest&#237;bulo nasal e incrusta&#231;&#227;o (rinite seca).</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Dose recomendada:</strong>&#160;Solu&#231;&#227;o a 0,5mg/ml, 2 ou 3 atomiza&#231;&#245;es da solu&#231;&#227;o em cada narina de 12/12 horas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>&gt;6 anos:</strong>&#160;Solu&#231;&#227;o a 0,5mg/ml, 2 ou 3 atomiza&#231;&#245;es da solu&#231;&#227;o em cada narina de 12/12 horas.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><strong>2-5 anos:</strong>&#160;Solu&#231;&#227;o a 0,25mg/ml,2 ou 3 gotas em cada narina de 12/12 horas.</li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2341,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\">- C</span>ongest&#227;o nasal e nasofar&#237;ngea decorrentes do resfriado comum, sinusite, febre ou outras alergias das vias a&#233;reas superiores.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-06 16:57:11",
        "name": "Oximetazolina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%;\"><strong>Solu&#231;&#227;o nasal:</strong> 0,25mg/ml e 0,5mg/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "oximetazolina",
        "substance": "Oximetazolina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- Rea&#231;&#227;o de hipersensibilidade, nervosismo, agita&#231;&#227;o, ansiedade, tontura ou sensa&#231;&#227;o de cabe&#231;a vazia, dificuldade de dormir, sonol&#234;ncia, tremores, dor de cabe&#231;a, alucina&#231;&#245;es, vis&#227;o emba&#231;ada, taquicardia, palpita&#231;&#245;es, aumento da press&#227;o arterial, hiperemia reativa, sensa&#231;&#227;o de queima&#231;&#227;o nasal e ardor nasal, espirros, aumento da secre&#231;&#227;o nasal, aumento da obstru&#231;&#227;o nasal, ressecamento nasal, boca seca, irrita&#231;&#227;o nasal, irrita&#231;&#227;o da garganta, congest&#227;o nasal recorrente, n&#225;usea, erup&#231;&#227;o cut&#226;nea, convuls&#245;es e fraqueza.&#160;</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes na Insufici&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 17.12px;\">N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 3800,
        "contraindications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong> Aplicar aproximadamente 1 cm da pomada, dentro do saco conjuntival da p&#225;lpebra inferior, 4-6x/dia, at&#233; a cura completa da infec&#231;&#227;o, podendo durar dias at&#233; semanas.</li>\r\n<li style=\"text-align: justify;\">No caso de blefarite, escamas e crostas devem ser removidas antes da aplica&#231;&#227;o da pomada.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong>&#160;Aplicar aproximadamente 1 cm da pomada, dentro do saco conjuntival da p&#225;lpebra inferior, 4-6x/dia, at&#233; a cura completa da infec&#231;&#227;o, podendo durar dias at&#233; semanas.</li>\r\n<li style=\"text-align: justify;\">No caso de blefarite, escamas e crostas devem ser removidas antes da aplica&#231;&#227;o da pomada.</li>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 8 anos.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria D:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2347,
        "indications": "<p>- Tratamento de infec&#231;&#245;es oculares superficiais, envolvendo a conjuntiva e/ou a c&#243;rnea.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 127,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Alto risco:</span></strong><span style=\"line-height: 107%;\"> Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2019-03-10 03:52:28",
        "name": "Terramicina",
        "presentation": "<ul>\r\n<li><strong><span id=\"docs-internal-guid-1f8bee52-7c31-278e-224a-ae186fac4176\" style=\"font-weight: normal;\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Pomada oft&#225;lmica:</span></span>&#160;</strong>Oxitetraciclina 30mg/g + Polimixina B 10000UI/g.</li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receitu&#225;rio simples, em duas vias.</span></p>",
        "record_status": 1,
        "slug": "terramicina",
        "substance": "Oxitetraciclina + Polimixina B",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- Hipersensibilidade, sensa&#231;&#227;o de queima&#231;&#227;o, aumento do lacrimejamento, dermatite de contato, dor, sensa&#231;&#227;o de corpo estranho.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes na Insufi&#234;ncia Renal:&#160;</span></strong><span style=\"line-height: 107%;\">N&#227;o estabelecido.</span></p>\r\n</div>"
    },
    {
        "content_length": 3477,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glimepirida ou a outras sulfonilureias, outras sulfonamidas ou aos demais componentes da formula&#231;&#227;o.</p>\r\n<p>- Gravidez e lacta&#231;&#227;o.</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica severa.</p>\r\n<p>- Diabetes mellitus insulino-dependente, cetoacidose diab&#233;tica.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial usual:</strong> 1 mg, VO, 1x/dia, antes da primeira refei&#231;&#227;o. <br>Se necess&#225;rio, poder&#225; ser aumentada de forma gradual, em intervalos de 1 a 2 semanas, de1 em 1mg.&#160;</li>\r\n<li><strong> Dose inicial usual para pacientes com diabetes bem controlado:</strong> 1 a 4 mg, VO, 1x/dia, antes da primeira refei&#231;&#227;o.&#160;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 6 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2348,
        "indications": "<div>\r\n<p>- Tratamento oral de diabetes mellitus n&#227;o insulino-dependente (Tipo 2 ou diabetes do adulto).</p>\r\n<p>- Pode ser associada a outros antidiab&#233;ticos orais e tamb&#233;m em associa&#231;&#227;o com insulina.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Contraindicado.</span></p>",
        "last_update": "2019-03-03 19:50:31",
        "name": "Glimepirida",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 1 mg, 2 mg, 4 mg e 6 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glimepirida",
        "substance": "Glimepirida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">-&#160;Hipoglicemia leve &#233; a complica&#231;&#227;o mais comum. Podem haver altera&#231;&#245;es visuais tempor&#225;rias no in&#237;cio do tratamento. Ocasionalmente podem ocorrer n&#225;useas, v&#244;mitos, sensa&#231;&#227;o de plenitude g&#225;strica, dor abdominal e diarreia, altera&#231;&#227;o das enzimas hep&#225;ticas, hepatite, colestase, leucopenia, trombocitopenia, anemia hemol&#237;tica, granulocitopenia ou agranulocitose, pancitopenia, prurido, urtic&#225;ria, erup&#231;&#245;es, hiponatremia, vasculite e fotossensibilidade.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste. Os estudos s&#227;o insuficientes.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 3473,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glimepirida ou a outras sulfonilureias, outras sulfonamidas ou aos demais componentes da formula&#231;&#227;o.</p>\r\n<p>- Gravidez e lacta&#231;&#227;o.</p>\r\n<p>- Insufici&#234;ncia hep&#225;tica severa.</p>\r\n<p>- Diabetes mellitus insulino-dependente, cetoacidose diab&#233;tica.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose inicial usual:</strong> 1 mg, VO, 1x/dia, antes da primeira refei&#231;&#227;o. <br>Se necess&#225;rio, poder&#225; ser aumentada de forma gradual, em intervalos de 1 a 2 semanas, de1 em 1mg.&#160;</li>\r\n<li><strong> Dose inicial usual para pacientes com diabetes bem controlado:</strong> 1 a 4 mg, VO, 1x/dia, antes da primeira refei&#231;&#227;o.&#160;</li>\r\n<li><strong>Dose m&#225;xima:</strong> 6 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2351,
        "indications": "<div>\r\n<p>- Tratamento oral de diabetes mellitus n&#227;o insulino-dependente (Tipo 2 ou diabetes do adulto).</p>\r\n<p>- Pode ser associada a outros antidiab&#233;ticos orais e tamb&#233;m em associa&#231;&#227;o com insulina.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Contraindicado.</span></p>",
        "last_update": "2019-01-13 17:41:57",
        "name": "Betes",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 1 mg, 2 mg e 4 mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glimepirida",
        "substance": "Glimepirida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">-&#160;Hipoglicemia leve &#233; a complica&#231;&#227;o mais comum. Podem haver altera&#231;&#245;es visuais tempor&#225;rias no in&#237;cio do tratamento. Ocasionalmente podem ocorrer n&#225;useas, v&#244;mitos, sensa&#231;&#227;o de plenitude g&#225;strica, dor abdominal e diarreia, altera&#231;&#227;o das enzimas hep&#225;ticas, hepatite, colestase, leucopenia, trombocitopenia, anemia hemol&#237;tica, granulocitopenia ou agranulocitose, pancitopenia, prurido, urtic&#225;ria, erup&#231;&#245;es, hiponatremia, vasculite e fotossensibilidade.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste. Os estudos s&#227;o insuficientes.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2930,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2360,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:48:59",
        "name": "Glicosamina",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">P&#243; para solu&#231;&#227;o oral: </span></strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">1,5 g.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2750,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2361,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 88,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 17:39:22",
        "name": "Glucoreumin",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2750,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2362,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 19:48:03",
        "name": "Glicolive",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2747,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2363,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 60,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 17:39:09",
        "name": "Dinaflex",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2746,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2364,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 34,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-03 17:49:15",
        "name": "Faximin",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2745,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2365,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-01-13 17:39:06",
        "name": "Artoglico",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2759,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2366,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 29,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 16:45:22",
        "name": "Ortosamin",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2749,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2367,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 61,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-06 16:48:16",
        "name": "Osteoglic",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2743,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Fenilceton&#250;ria.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual: </strong>1 sach&#234;, VO, 1x/dia.</li>\r\n<li>Diluir o conte&#250;do em um copo com &#225;gua, aguardar entre 2 a 5 minutos e s&#243; ent&#227;o mexer com o aux&#237;lio de uma colher. Ap&#243;s preparo, ingerir em seguida.&#160;&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2368,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-10 03:18:08",
        "name": "Sulglic",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 3232,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glicosamina ou a qualquer outro componente da f&#243;rmula.</p>\r\n<p>- Gravidez e Lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>P&#243; para solu&#231;&#227;o oral: </strong>1&#160;sach&#234;, VO, 1x/dia.&#160;Dissolver em 100 mL de &#225;gua&#160;em temperatura ambiente, agitar vigorosamente com o aux&#237;lio de uma colher at&#233; dissolu&#231;&#227;o completa e ingerir em seguida.</li>\r\n<li><strong>C&#225;psulas:</strong> 1 c&#225;psula, VO, 3x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2371,
        "indications": "<p>- Tratamento de artrose ou osteoartrite prim&#225;ria e secund&#225;ria e suas manifesta&#231;&#245;es.&#160;&#160;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 19,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-04 00:57:09",
        "name": "Artico",
        "presentation": "<ul type=\"disc\">\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>P&#243; para solu&#231;&#227;o oral:&#160;</strong>1,5 g&#160;<span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">de Glicosamina + 1,2 g de Condroitina.</span></li>\r\n<li class=\"MsoNormal\" style=\"color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;\"><strong>C&#225;psulas: </strong>500 mg&#160;de Glicosamina + 400 mg de Condroitina.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glicosamina",
        "substance": "Glicosamina + Condroitina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\">- Desconforto g&#225;strico, diarreia, n&#225;usea, constipa&#231;&#227;o, v&#244;mito,&#160;dispepsia, dor abdominal, azia, anorexia e cefaleia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 3629,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade &#224; glipizida, outras sulfonilureias ou sulfonamidas ou a qualquer componente da f&#243;rmula.</p>\r\n<p>- Diabetes mellitus tipo 1, cetoacidose diab&#233;tica, coma diab&#233;tico.</p>\r\n<p>- Estados de insufici&#234;ncia hep&#225;tica ou renal graves.</p>\r\n<p>- Gravidez e Lacta&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose Inicial:</strong>&#160;1 cp (5 mg), VO, 1x/dia, antes do caf&#233; da manh&#227; ou do almo&#231;o. Pacientes sob risco de hipoglicemia: iniciar com 1/2 cp (2,5 mg), VO, 1x/dia.</li>\r\n<li><strong> Titula&#231;&#227;o:</strong> O ajuste de dose deve ser feito com incrementos de 2,5 mg ou 5 mg.</li>\r\n<li><strong> Manuten&#231;&#227;o:</strong>&#160;Doses acima de 15 mg devem ser divididas (12/12 horas). Pacientes podem estabilizar com dosagens entre 2,5 mg a 30 mg/dia.</li>\r\n<li><strong>Dose m&#225;xima:</strong>&#160;40 mg/dia.&#160;</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2372,
        "indications": "<p>- Tratamento adjuvante do diabetes mellitus tipo 2.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 74,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-05 00:26:03",
        "name": "Minidiab",
        "presentation": "<ul>\r\n<li><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Comprimidos:</span></strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\"> 5 mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "minidiab",
        "substance": "Glipizida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">-&#160;</span>Hipoglicemia, n&#225;useas, v&#244;mitos, diarreia, constipa&#231;&#227;o, rea&#231;&#245;es dermatol&#243;gicas (eritema maculopapular ou morbiliforme, urtic&#225;ria, exantema, prurido e eczema). Confus&#227;o, tontura, sonol&#234;ncia, cefaleia e dist&#250;rbios visuais foram relatados com frequ&#234;ncia, mas s&#227;o tansit&#243;rios e n&#227;o necessitam interrup&#231;&#227;o. Outros: icter&#237;cia colest&#225;tica (descontinuar), leucopenia, trombocitopenia, agranulocitose, anemia hemol&#237;tica, anemia apl&#225;sica, pancitopenia, eosinofilia, porfiria hep&#225;tica ou cut&#226;nea, hiponatremia, rea&#231;&#227;o tipo dissulfiram, artralgias, mialgias e c&#227;ibras.</p>\r\n<hr>\r\n<p>&#160;<strong><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p>- Idosos, pacientes debilitados, malnutridos ou com ingest&#227;o cal&#243;rica irregular e pacientes com insufici&#234;ncia renal ou hep&#225;tica, dever&#227;o iniciar na dose de 1/2 cp (2,5 mg), VO, 1x/dia.</p>\r\n</div>"
    },
    {
        "content_length": 3307,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade ao glucagon, ou a qualquer um dos excipientes da f&#243;rmula.</p>\r\n<p>- Feocromocitoma.&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>&#160;<strong>Dose usual:</strong>&#160;1 ml (1mg) de solu&#231;&#227;o reconstitu&#237;da, em dose &#250;nica, IM ou SC.</li>\r\n<li>O paciente ir&#225; normalmente responder ao tratamento dentro de 10 minutos. Quando o paciente recuperar a consci&#234;ncia, administrar carboidratos por via oral, para restaurar os n&#237;veis de glicog&#234;nio no f&#237;gado e prevenir a reincid&#234;ncia da hipoglicemia.</li>\r\n<li>Se o paciente n&#227;o responder ao tratamento dentro de 10 minutos, deve-se administrar glicose intravenosa.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as &gt; 6 anos ou &gt; 25 kg:</strong>&#160;1 ml (1mg) de solu&#231;&#227;o reconstitu&#237;da, em dose &#250;nica, IM ou SC.</li>\r\n<li><strong>Crian&#231;as &lt; 6 anos ou &lt; 25 kg:</strong>&#160;0,5 ml (0,5mg) de solu&#231;&#227;o reconstitu&#237;da, em dose &#250;nica, IM ou SC.</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria A:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o liberada.</span></p>",
        "id": 2373,
        "indications": "<p>- Tratamento de rea&#231;&#245;es hipoglic&#234;micas graves que podem ocorrer em crian&#231;as e adultos portadores de diabetes mellitus tratados com insulina.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 115,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-03 19:52:02",
        "name": "GlucaGen Hypokit",
        "presentation": "<ul>\r\n<li><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">Solu&#231;&#227;o injet&#225;vel</span></strong><span style=\"mso-fareast- mso-bidi- mso-fareast-language: PT-BR;\">: 1 UI/ml (1mg/ml).</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "glucagen-hypokit",
        "substance": "Glucagon",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">-&#160;</span>As rea&#231;&#245;es adversas graves s&#227;o muito raras. N&#225;usea, v&#244;mito, dor abdominal podem ocorrer ocasionalmente. Rea&#231;&#245;es de hipersensibilidade, incluindo rea&#231;&#227;o anafil&#225;tica, foram relatadas como muito rara.</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 2249,
        "contraindications": "<p>- Hipersensibilidade ao medicamento, insufici&#234;ncia hep&#225;tica, gestantes, nutrizes e crian&#231;as.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\"><strong>Dose usual:</strong> Tomar 1 comprimido de 12 em 12 horas.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-8f39dbce-7fff-c9f1-e009-4b694cf5af63\"><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><span id=\"docs-internal-guid-e01dcb4e-7fff-fc33-200d-817eebe36ecb\"><span style=\"  background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Categoria X:</span><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></span></p>",
        "id": 2374,
        "indications": "<p><span style=\"color: #000000;\">- Indicado para o tratamento da menopausa.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-18 14:56:16",
        "name": "Menopax",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 200mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "menopax",
        "substance": "Ciclofenila",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido. N&#227;o utilizar na doen&#231;a hep&#225;tica grave.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;usea, v&#244;mito, diarr&#233;ia e cefal&#233;ia, dores mam&#225;rias, hepatite, rea&#231;&#245;es al&#233;rgicas e/ou febre.</p>\r\n</div>"
    },
    {
        "content_length": 3647,
        "contraindications": "<p>- Alergia a ciclofosfamida,&#160;<span style=\"color: #333333;\">portadores de problemas da medula &#243;ssea, varicela</span><span style=\"color: #333333;\">&#160;ou&#160;</span>Herpes zoster<em style=\"box-sizing: border-box; -webkit-font-smoothing: antialiased; color: #333333;\">, </em>gr&#225;vidas e nutrizes.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose de ataque:</strong> intravenosa recomendada para pacientes sem defici&#234;ncias hematol&#243;gicas (no sangue) &#233; 40 - 50mg/kg. Esta dose de ataque inicial total &#233; geralmente aplicada em doses divididas por um per&#237;odo de dois a cinco dias.</li>\r\n<li><strong>Dose de Manuten&#231;&#227;o:</strong> Visa eliminar ou retardar o crescimento das c&#233;lulas cancerosas. Uma variedade de posologias tem sido usada: 10 a 15mg/kg intravenoso a cada 7 a 10 dias e 3 a 5mg/kg intravenoso duas vezes por semana.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-fbdf8e6d-7fff-46c3-5f25-9e774e8e379f\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Posologia idem adultos.</span></span></li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p><span id=\"docs-internal-guid-55250088-7fff-92b2-0e78-39444384722c\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Categoria X:</span><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></span></p>",
        "id": 2378,
        "indications": "<p><span style=\"color: #000000;\">- Usado no tratamento de tumores malignos sens&#237;veis &#224; sua a&#231;&#227;o e no tratamento de doen&#231;as do sistema imunol&#243;gico.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 181,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-03 17:34:26",
        "name": "Evociclo",
        "presentation": "<ul>\r\n<li><strong>P&#243; liofilizado para inje&#231;&#227;o:</strong> 1000mg.</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p><span id=\"docs-internal-guid-2240157f-7fff-0329-de99-2d612b2e0c99\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Uso hospitalar.</span></span></p>",
        "record_status": 1,
        "slug": "Evociclo",
        "substance": "Ciclofosfamida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido. Redu&#231;&#245;es podem ser feitas em casos de insufici&#234;ncia renal grave.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"color: #000000;\">-&#160;Diminui&#231;&#227;o do n&#250;mero de gl&#243;bulos brancos do sangue, anemia, n&#225;usea, v&#244;mito, infec&#231;&#227;o da bexiga (cistite) acompanhada, ou n&#227;o, de sangramento; les&#245;es nos rins; pele amarelada (icter&#237;cia), altera&#231;&#245;es card&#237;acas e perda de cabelos.&#160;Supress&#227;o gonadal, resultando em amenorr&#233;ia&#160;(aus&#234;ncia de menstrua&#231;&#227;o) ou azoospermia, infec&#231;&#245;es como varicela e herpes zoster. Aumenta o risco no desenvolvimento de novas neoplasias.</span></p>\r\n</div>"
    },
    {
        "content_length": 5228,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipersensibilidade &#224; subst&#226;ncia ativa ou a qualquer um dos excipientes.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tuberculose (TB) ativa ou outra infe&#231;&#227;o grave como sepse e infe&#231;&#245;es oportunistas.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Insufici&#234;ncia card&#237;aca moderada ou grave (classe III/IV da NYHA).</span></p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Artrite reumatoide,&#160;</span>Artrite psori&#225;tica, Espondilite Anquilosante ou Espondiloartrite Axial N&#227;o-Radiogr&#225;fica:&#160;</strong>50 mg, 1x/m&#234;s, SC, sempre no mesmo dia de cada m&#234;s.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>Colite Ulcerativa:</strong>&#160;\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">Peso corporal &gt; 80 kg: 200 mg na Semana 0, seguidos de 100 mg na Semana 2 e ent&#227;o, 100 mg a cada 4 semanas, consecutivamente.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">Peso corporal &lt;&#160; 80 kg: 200 mg na Semana 0, seguidos de 100 mg na Semana 2 e ent&#227;o, 50 mg a cada 4 semanas, consecutivamente. &#160;A resposta cl&#237;nica ocorre dentro de 12-14 semanas de tratamento.&#160;</li>\r\n</ul>\r\n</li>\r\n<li><strong>Injet&#225;vel IV:&#160;</strong>Dilui&#231;&#227;o:<strong>&#160;</strong>(50 mg/4,0 ml) 8 ml + 92 ml de SF 0,9%.</li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong>Artrite reumatoide:</strong>&#160;2 mg/kg por infus&#227;o IV de 30 min, nas Semanas 0 e 4 e, posteriormente, a cada 8 semanas.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria B:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 2379,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Artrite reumatoide.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Artrite psori&#225;sica.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Espondilite Anquilosante.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Espondiloartrite axial n&#227;o radiogr&#225;fica.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Colite ulcerativa.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-09 16:37:42",
        "name": "Simponi",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong>&#160; 50 mg/0,5ml e 50 mg/4ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "simponi",
        "substance": "Golimumabe",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">-&#160;</span>Infec&#231;&#227;o do trato respirat&#243;rio superior, infec&#231;&#245;es bacterianas, infec&#231;&#227;o do trato respirat&#243;rio inferior, infec&#231;&#245;es virais, bronquite, sinusite, infec&#231;&#245;es f&#250;ngicas superficiais, abscesso, septicemia, infec&#231;&#245;es oportunistas, artrite bacteriana, pielonefrite, reativa&#231;&#227;o de hepatite B, histoplasmose, coccidioidomicose, pneumocistose, tuberculose, bursite infecciosa, neoplasias benignas e malignas.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong><span style=\"line-height: 107%;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"line-height: 107%;\">- N&#227;o h&#225; ajuste. Estudos insuficientes.&#160;</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3527,
        "contraindications": "<p>- Contraindicado para uso por pacientes com insufici&#234;ncia card&#237;aca ou problemas de hemorragia e aqueles que tenham hipersensibilidade ao medicamento.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"color: #000000;\">Dose usual: 1 comprimido VO duas vezes ao dia, no m&#237;nimo meia hora antes ou duas horas ap&#243;s o caf&#233; da manh&#227; ou o jantar.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-37ae45aa-7fff-776a-99c4-0bc6054753d1\"><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><span class=\"TextRun SCXW161996708\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 21px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW161996708\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">- Categoria C:</span></span><span class=\"TextRun SCXW161996708\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 21px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW161996708\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2380,
        "indications": "<p><span style=\"color: #000000;\">- Indicado para tratar problemas de circula&#231;&#227;o em que ocorre diminui&#231;&#227;o do fluxo de sangue para as art&#233;rias perif&#233;ricas do corpo, condi&#231;&#227;o denominada doen&#231;a vascular perif&#233;rica, cujo sintoma principal &#233; a claudica&#231;&#227;o intermitente e para a preven&#231;&#227;o da recorr&#234;ncia de acidente vascular cerebral&#160;(AVC).</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-18 15:52:15",
        "name": "Cilostazol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 50mg e 100mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cilostazol",
        "substance": "Cilostazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Dor de cabe&#231;a; Diarreia e fezes amolecidas; Dor abdominal, dor nas costas e infec&#231;&#227;o; Palpita&#231;&#227;o e taquicardia; Dispepsia (indigest&#227;o), flatul&#234;ncia (gases) e n&#225;usea; Edema perif&#233;rico (incha&#231;o no tornozelo, p&#233; e perna); Mialgia (dor muscular); Tontura e vertigem; Tosse aumentada, faringite e rinite.</p>\r\n</div>"
    },
    {
        "content_length": 9222,
        "contraindications": "<p>- Hiperssensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<div><h4 style=\"box-sizing: border-box; line-height: 1.58; color: #333333; margin-top: 20px; margin-bottom: 20px; -webkit-font-smoothing: antialiased;\"><span style=\"color: #000000;\">Uso por via oral</span></h4>\r\n<ul>\r\n<li><strong>&#218;lcera g&#225;strica benigna ou duodenal:</strong> Dose di&#225;ria &#250;nica de 800 mg ao deitar. Alternativamente, a dose usual &#233; de 400 mg duas vezes ao dia, no caf&#233; da manh&#227; e ao deitar.</li>\r\n<li><strong>Preven&#231;&#227;o de Recorr&#234;ncia na &#250;lcera beningna:</strong> Pelo tratamento continuado, geralmente com 400 mg ao deitar. O esquema de 400 mg pela manh&#227; e ao deitar tamb&#233;m tem sido usado.</li>\r\n<li><strong>Doen&#231;a do Refluxo Gastroesof&#225;gico:</strong> Esquema de 400 mg quatro vezes ao dia (&#224;s refei&#231;&#245;es e ao deitar), por quatro a oito semanas, &#233; recomendado para curar a esofagite e aliviar os sintomas associados.</li>\r\n<li><strong>Em pacientes com secre&#231;&#227;o g&#225;strica muito intensa (por exemplo, na S&#237;ndrome de Zollinger-Ellison):</strong> Pode ser necess&#225;rio aumentar a dose para 400 mg, quatro vezes ao dia, ou ainda mais, em casos ocasionais.</li>\r\n<li><strong>Na profilaxia da hemorragia por &#250;lcera de estresse em pacientes gravemente doentes:</strong>&#160;Doses de 200 a 400mg podem ser administradas a cada quatro a seis horas.</li>\r\n<li><strong>Em pacientes considerados em risco de s&#237;ndrome de aspira&#231;&#227;o &#225;cida:</strong> Dose oral de 400 mg pode ser administrada entre 90 e 120 minutos antes da indu&#231;&#227;o da anestesia geral, ou, na pr&#225;tica obst&#233;trica, no in&#237;cio do trabalho de parto. Enquanto tal risco persistir, uma dose de at&#233; 400 mg pode ser repetida em intervalos de quatro horas, conforme necess&#225;rio, at&#233; a dose di&#225;ria m&#225;xima de 2,4 g. As precau&#231;&#245;es usuais para evitar a aspira&#231;&#227;o &#225;cida devem ser tomadas.</li>\r\n</ul>\r\n<p><strong>&#160;Via intramuscular:</strong></p>\r\n<ul>\r\n<li style=\"box-sizing: border-box; margin: 0px 0px 10px; -webkit-font-smoothing: antialiased; line-height: 1.58; color: #333333;\"><span style=\"color: #000000;\">Administrar 300mg de cimetidina (subst&#226;ncia ativa) (1 ampola), a cada 4 a 6 horas.</span></li>\r\n</ul>\r\n<h4 style=\"box-sizing: border-box; line-height: 1.58; color: #333333; margin-top: 20px; margin-bottom: 20px; -webkit-font-smoothing: antialiased;\"><span style=\"color: #000000;\">Via intravenosa:</span></h4>\r\n<ul>\r\n<li style=\"box-sizing: border-box; margin: 0px 0px 10px; -webkit-font-smoothing: antialiased; line-height: 1.58; color: #333333;\"><span style=\"color: #000000;\"><strong>Infus&#227;o intermitente:</strong> Administrar 300mg do medicamento dilu&#237;do em 100mL de solu&#231;&#227;o intravenosa compat&#237;vel e infundir por um per&#237;odo m&#237;nimo de 30 minutos. A dose di&#225;ria total n&#227;o deve ser maior que 2400mg (8 ampolas).</span></li>\r\n<li style=\"box-sizing: border-box; margin: 0px 0px 10px; -webkit-font-smoothing: antialiased; line-height: 1.58; color: #333333;\"><span style=\"color: #000000;\"><strong>Infus&#227;o cont&#237;nua:</strong> Administrar 300mg do medicamento dilu&#237;do em 100mL de solu&#231;&#227;o de cloreto de s&#243;dio a 0,9%. A velocidade de infus&#227;o n&#227;o deve ser superior a 75mg/h, durante 24 horas. A dose total di&#225;ria n&#227;o deve ser maior que 2400mg.</span></li>\r\n</ul>\r\n<p style=\"box-sizing: border-box; margin: 0px 0px 10px; -webkit-font-smoothing: antialiased; line-height: 1.58; color: #333333;\"><span style=\"color: #000000;\">Para inje&#231;&#227;o simples diluir 300mg do f&#225;rmaco em at&#233; 20mL de uma solu&#231;&#227;o intravenosa compat&#237;vel e administrar lentamente por no m&#237;nimo 2 minutos. A dose di&#225;ria &#233; de 800mg a 1600mg, em doses divididas.</span></p></div>",
        "dosage_children": "<div>\r\n<h4 style=\"box-sizing: border-box; line-height: 1.58; margin-top: 20px; margin-bottom: 20px; -webkit-font-smoothing: antialiased;\">&#160;Uso por via oral</h4>\r\n<ul>\r\n<li><strong>Crian&#231;as maiores de 1 ano:</strong>&#160;Dose de 25 - 30mg/Kg de peso corporal por dia em doses divididas&#160;</li>\r\n<li><span id=\"docs-internal-guid-be34e7b2-7fff-77d4-9327-72d028f88634\"><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">N&#227;o estabelecido para menores de 1 ano.</span></span>&#160;A dose de 20 mg/Kg de peso corporal em doses divididas tem sido usada.</li>\r\n</ul>\r\n<h4 style=\"box-sizing: border-box; line-height: 1.58; color: #333333; margin-top: 20px; margin-bottom: 20px; -webkit-font-smoothing: antialiased;\"><span style=\"color: #000000;\">Injet&#225;vel</span></h4>\r\n<ul>\r\n<li><strong>Rec&#233;m-nascidos:</strong> Administrar 10 a 15mg/kg/dia, divididos a cada 4 a 6 horas.</li>\r\n<li><strong>Menores de 1 ano:</strong> Administrar 20mg/kg/dia, divididos a cada 4 a 6 horas.</li>\r\n<li><strong>De 1 a 12 anos:</strong> Administrar 20 a 25mg/kg/dia, divididos a cada 4 a 6 horas.</li>\r\n</ul>\r\n</div>",
        "gestation": 2,
        "gestation_text": "<p><span class=\"TextRun SCXW168667765\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; font-weight: bold; line-height: 21px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW168667765\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">- Categoria B:</span></span><span class=\"TextRun SCXW168667765\" lang=\"PT-BR\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 21px; font-variant-ligatures: none !important;\" xml:lang=\"PT-BR\"><span class=\"NormalTextRun SCXW168667765\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; background-color: inherit;\">&#160;Prescri&#231;&#227;o com cautela.</span></span><span class=\"EOP SCXW168667765\" style=\"margin: 0px; padding: 0px; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; line-height: 21px;\" data-ccp-props='{\"201341983\":0,\"335559739\":160,\"335559740\":259}'>&#160;</span></p>",
        "id": 2385,
        "indications": "<div>\r\n<p>- Indicado no tratamento dos dist&#250;rbios do trato gastrintestinal superior nos quais a redu&#231;&#227;o da secre&#231;&#227;o &#225;cida, sua remiss&#227;o e a preven&#231;&#227;o da sua recorr&#234;ncia sejam ben&#233;ficas para o al&#237;vio sintom&#225;tico, como no tratamento agudo de &#250;lcera duodenal, &#250;lcera g&#225;strica benigna, &#250;lceras de boca anastom&#243;tica e p&#243;s-cir&#250;rgica, &#250;lcera p&#233;ptica recorrente e esofagite p&#233;ptica, no controle de condi&#231;&#245;es hiperssecret&#243;rias patol&#243;gicas, como S&#237;ndrome de Zollinger-Ellison, mastocitose sist&#234;mica, adenomas end&#243;crinos m&#250;ltiplos, s&#237;ndrome p&#243;s-operat&#243;ria de intestino curto e hiperssecre&#231;&#227;o idiop&#225;tica, na preven&#231;&#227;o das &#250;lceras de estresse em pacientes gravemente enfermos e de alto risco e como medida de apoio no controle de hemorragia devido a &#250;lceras p&#233;pticas ou eros&#245;es do trato gastrintestinal superior, nos pacientes sob anestesia geral e em mulheres submetidas a cesarianas, este medicamento reduz a acidez e o volume das secre&#231;&#245;es g&#225;stricas, diminuindo o risco de dano pulmonar causado pela aspira&#231;&#227;o de conte&#250;do g&#225;strico (S&#237;ndrome de Mendelson).</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-19 17:05:49",
        "name": "Cimetidina",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> 200mg e 400mg.</li>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 150mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cimetidina",
        "substance": "Cimetidina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p><strong>- ClCr (mg/mL) 0 a 15:</strong> 200mg, 2 vezes ao dia.</p>\r\n<p><strong>- ClCr (mg/mL) 15 a 30:</strong> 200mg, 3 vezes ao dia.</p>\r\n<p><strong>- ClCr (mg/mL) 30 a 50:</strong> 200mg, 4 vezes ao dia.</p>\r\n<p><strong>- ClCr (mg/mL) &gt; 50:</strong> Posologia normal.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Diarreia leve e transit&#243;ria; Cansa&#231;o; Tontura e instabilidade; Erup&#231;&#245;es cut&#226;neas, algumas vezes graves; ginecomastia e galactorr&#233;ia; toxidade hematol&#243;gica.</p>\r\n</div>"
    },
    {
        "content_length": 5209,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><span style=\"color: black; mso-themecolor: text1; background: white;\">- Pessoas al&#233;rgicas aos componentes da f&#243;rmula ou alergia comprovada aos excipientes; crian&#231;as e pacientes menores de 14 anos.<span class=\"apple-converted-space\">&#160;</span></span><span style=\"color: black; mso-themecolor: text1;\"><br> </span></p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>Dose usual:</strong>&#160;S&#227;o de 3 a 4 c&#225;psulas de 250 mg por dia, 6 em 6 ou 8 em 8 horas, ou seja, de 750mg&#8260;dia at&#233; 1000 mg&#8260; dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><span style=\"color: black; mso-themecolor: text1; background: white;\"><strong>Menores de 20 kg:</strong> 15-20 mg/kg.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><span style=\"color: black; mso-themecolor: text1; background: white;\"><strong>Crian&#231;as de 21-35 kg:</strong> 500mg/dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><span style=\"color: black; mso-themecolor: text1; background: white;\"><strong>Crian&#231;as de 36-50 kg:</strong> 750mg/dia.</span></li>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><span style=\"color: black; mso-themecolor: text1; background: white;\"><strong>Maiores de 50 kg:</strong> 750-1.000 mg/dia.&#160;</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2397,
        "indications": "<p><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Indicado na quimioterapia da tuberculose.<span class=\"apple-converted-space\">&#160;</span><span style=\"border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;\">Terizidex</span><span class=\"apple-converted-space\">&#160;</span>deve ser administrado considerando-se sempre as rela&#231;&#245;es de compatibilidade, no caso da sensibilidade do bacilo, em combina&#231;&#227;o com outros agentes usados no tratamento da tuberculose. A terizidona &#233; um agente valioso de reserva, para casos de resist&#234;ncia bacteriana ou principalmente em casos de incompatibilidade (sobretudo hep&#225;tica) a outros produtos usados no tratamento da tuberculose.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 229,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso moderadamente seguro. Monitorar tratamento.</span></p>",
        "last_update": "2019-03-10 03:51:17",
        "name": "Terizidex",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>250mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "terizidex",
        "substance": "Cicloserina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 13.6pt; text-align: justify; line-height: normal; mso-outline-level: 2; background: white;\"><span style=\"color: black; mso-themecolor: text1; background: white;\">- Cefaleia, sonol&#234;ncia, tremores, disartria, vertigem, confus&#227;o, irritabilidade, crises psic&#243;ticas com tend&#234;ncias ao suic&#237;dio, depress&#227;o, contraturas, hiper-reflexia, dist&#250;rbios visuais e paresias. Podem surgir ap&#243;s 2 semanas de uso e regridem com a suspens&#227;o do tratamento.&#160;</span></p>\r\n</div>"
    },
    {
        "content_length": 8807,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Hipersensibilidade &#224;<span class=\"apple-converted-space\">&#160;</span><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;\">Ciclosporina</span><strong><span style=\"mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;\">,&#160;</span></strong>hipertens&#227;o arterial, infec&#231;&#245;es n&#227;o controladas, c&#226;ncer.</span></p>",
        "dosage_adults": "<ul style=\"margin-top: 0pt; margin-bottom: 0pt;\">\r\n<li dir=\"ltr\" style=\"list-style-type: disc;   font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre;\">\r\n<p dir=\"ltr\" style=\"line-height: 1.284; margin-top: 0pt; margin-bottom: 8pt; text-align: justify;\"><span style=\" font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"><strong>Transplantes:</strong> 10 a 15mg/kg de 4h a 12h antes da cirurgia. Repetida a cada 24h por 1 a 2 semanas. Reduzir semanalmente at&#233; a dose de manuten&#231;&#227;o de 3mg a 10mg/kg.</span></p>\r\n</li>\r\n<li dir=\"ltr\" style=\"list-style-type: disc;   font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre;\">\r\n<p dir=\"ltr\" style=\"line-height: 1.284; margin-top: 0pt; margin-bottom: 8pt; text-align: justify;\"><span style=\" font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"><strong>Transplante de medula:</strong> Infus&#227;o intravenosa no dia anterior &#224; cirurgia, seguida de uso oral de 12,5mg a 15mg/kg/dia, nas duas semanas p&#243;s-transplante. O tratamento de manuten&#231;&#227;o &#233; feito com 12,5mg/kg/dia VO, por 3 a 6 meses.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-f5db4ae2-7fff-c390-cdf1-de23a0fe5eac\"><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Posologia idem adultos.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2398,
        "indications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Preven&#231;&#227;o e tratamento da rejei&#231;&#227;o do<span class=\"apple-converted-space\">&#160;</span><span class=\"posttip\">enxerto</span><span class=\"apple-converted-space\">&#160;</span>em transplantes alog&#234;nicose da rea&#231;&#227;o<span class=\"apple-converted-space\">&#160;</span><span class=\"posttip\">enxerto</span>-versus-hospedeiro. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span class=\"posttip\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Uve&#237;te</span></span><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">&#160;de etiol</span></span><span class=\"posttip\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">ogia</span></span><span class=\"apple-converted-space\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">&#160;</span></span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">n&#227;o infecciosa<span class=\"posttip\">, psor&#237;ase, s&#237;ndrome nefr&#243;tica.</span></span></p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-11-18 15:08:54",
        "name": "Ciclosporina",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>Comprimido:</strong> 25mg, 50mg e 100mg.</span></li>\r\n<li><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>Solu&#231;&#227;o oral:</strong> 100mg/mL.</span></li>\r\n<li><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 50mg/mL.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ciclosporina",
        "substance": "Ciclosporina",
        "trade_names": "",
        "warnings": "<div>\r\n<p style=\"line-height: 107%; background: white; margin: 0cm 0cm 8.0pt 0cm;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">Ajustes:</span></strong></p>\r\n<p style=\"line-height: 107%; background: white; margin: 0cm 0cm 8.0pt 0cm;\"><span style=\"line-height: 107%; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">-</span><span style=\"color: #000000;\"><span style=\"line-height: 107%;\"> Na Insufici&#234;ncia Renal r</span><span style=\"line-height: 107%;\">ecomenda-se monitoramento cuidadoso da fun&#231;&#227;o renal. </span></span></p>\r\n<p style=\"line-height: 107%; background: white; margin: 0cm 0cm 8.0pt 0cm;\"><span style=\"line-height: 107%; color: #000000;\">- Em pacientes com s&#237;ndrome nefr&#243;tica com preju&#237;zo da fun&#231;&#227;o renal, a dose inicial n&#227;o deve exceder 2,5 mg/kg por dia.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">&#160;</span></strong><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Indu&#231;&#227;o de hipertens&#227;o arterial;&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">Miopatia, tremor, tonturas, cafal&#233;ia, parestesia, convuls&#245;es, confus&#227;o mental, fadiga;&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">N&#225;usea, v&#244;mito, anorexia, diarr&#233;ia, dor abdominal e colite;&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">Hipomagnesemia, hipocalemia ou hipercalemia, hiperuricemia, hipercolesterolemia, nefrotoxicidade, hepatotoxicidade, neurotoxicidade, hipertricose,hiperplasia gengival, dismenorr&#233;ia ou amenorreia, ginecomastia, rea&#231;&#245;es de hipersensibilidade, trombocitopenia, pancreatite, suscetibilidade a infec&#231;&#245;es, dist&#250;rbios linfoproliferativos e c&#226;ncer.</span></p>\r\n</div>"
    },
    {
        "content_length": 2409,
        "contraindications": "<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula, hipertens&#227;o n&#227;o controlada, hist&#243;ria pr&#233;via de AVC e AIT, insufici&#234;ncia hep&#225;tica grave, doen&#231;a card&#237;aca isqu&#234;mica e vasoespasmo coron&#225;rio/angina de Prinzmetal.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose habitual:</strong> 2,5 a 5mg, VO, durante a crise, repetir ap&#243;s 2 horas, se necess&#225;rio.</li>\r\n<li><strong>Dose m&#225;xima</strong>: 10 mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as maiores de 12 anos:&#160;</strong>2,5 a 5mg VO durante crise, repetir ap&#243;s 2 horas se necess&#225;rio. N&#227;o exceder 10mg.</li>\r\n<li><span id=\"docs-internal-guid-6e760aea-7fff-a136-16d5-65c8250f6f13\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">N&#227;o estabelecido para menores de 12 anos.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2401,
        "indications": "<p>- Tratamento agudo da enxaqueca com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 282,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-13 12:28:26",
        "name": "Zomig OD",
        "presentation": "<ul>\r\n<li><strong>Comprimidos orodispers&#237;veis:</strong> 2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "zomig",
        "substance": "Zolmitriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-N&#225;usea, tontura, sonol&#234;ncia, sensa&#231;&#227;o de calor, astenia, boca seca, taquicardia, palpita&#231;&#245;es, precordialgia, mialgia, fraqueza muscular, parestesia, anafilaxia, rea&#231;&#245;es anafilact&#243;ides, urtic&#225;ria e angioedema, dor abdominal, diarreia.</p>\r\n<hr>\r\n<p><strong>Ajustes:&#160;</strong></p>\r\n<p><strong>-</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2407,
        "contraindications": "<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula, hipertens&#227;o n&#227;o controlada, hist&#243;ria pr&#233;via de AVC e AIT, insufici&#234;ncia hep&#225;tica grave, doen&#231;a card&#237;aca isqu&#234;mica e vasoespasmo coron&#225;rio/angina de Prinzmetal.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose habitual:</strong> 2,5 a 5mg, VO, durante a crise, repetir ap&#243;s 2 horas, se necess&#225;rio.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 10mg/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Crian&#231;as maiores de 12 anos:&#160;</strong>2,5 a 5mg VO durante crise, repetir ap&#243;s 2 horas se necess&#225;rio. N&#227;o exceder 10mg.</li>\r\n<li><span id=\"docs-internal-guid-6e760aea-7fff-a136-16d5-65c8250f6f13\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">N&#227;o estabelecido para menores de 12 anos.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2404,
        "indications": "<p>- Tratamento agudo da enxaqueca com ou sem aura.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 282,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-13 12:28:18",
        "name": "Zomig",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "zomig",
        "substance": "Zolmitriptana",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;usea, tontura, sonol&#234;ncia, sensa&#231;&#227;o de calor, astenia, boca seca, taquicardia, palpita&#231;&#245;es, precordialgia, mialgia, fraqueza muscular, parestesia, anafilaxia, rea&#231;&#245;es anafilact&#243;ides, urtic&#225;ria e angioedema, dor abdominal, diarreia.</p>\r\n<hr>\r\n<p><strong>Ajustes:&#160;</strong></p>\r\n<p><strong>-&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 4898,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white; text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Hipersensibilidade ao cilazapril ou a outros inibidores da ECA e em pacientes com hist&#243;ria pr&#233;via de angioedema causado por inibidores da ECA, assim como angioedema idiop&#225;tico ou heredit&#225;rio;&#160;</span>gravidez e lacta&#231;&#227;o.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Hipertens&#227;o essencial:</strong> iniciar com 1 a 1,25 mg uma vez ao dia &#8211; a dose geralmente varia de 2,5 a 5,0 mg uma vez ao dia. </span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-3e178189-7fff-6fab-3912-db0ef0d32cc5\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria D:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2406,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Tratamento de todos os graus de hipertens&#227;o arterial essencial e renal, insufici&#234;ncia card&#237;aca congestiva, geralmente como terapia adjunta aos digit&#225;licos e/ou diur&#233;ticos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 04:53:26",
        "name": "Vascase",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Comprimido:</strong> 1mg, 2,5mg e 5,0mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "vascase",
        "substance": "Cilazapril",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Ajustes</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- N&#227;o estabelecido. Doses reduzidas podem ser necess&#225;rias em pacientes com disfun&#231;&#227;o renal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Efeitos Adversos:</span></strong></p>\r\n<p><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">-&#160;Hipotens&#227;o, infarto do mioc&#225;rdio, taquicardia, palpita&#231;&#227;o e dor no peito;&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">cefaleia, vertigens, fadiga; t</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">osse seca, n&#225;usea, dispepsia,neutropenia,agranulocitose,trombocitopenia, anemia, pancreatite, angioedema,edema de laringe, eritema multiforme, necr&#243;liseepid&#233;rmicat&#243;xica, fotossensibilidade, alopecia e insufici&#234;ncia renal aguda.</span></p>\r\n</div>"
    },
    {
        "content_length": 4908,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Hipersensibilidade ao cilazapril ou a outros inibidores da ECA ou hidroclorotiazida e em pacientes com hist&#243;ria pr&#233;via de angioedema causado por inibidores da ECA, assim como angioedema idiop&#225;tico ou heredit&#225;rio;&#160;</span>gravidez e lacta&#231;&#227;o. Insufici&#234;ncia renal grave ou hipocalemia grave.</p>",
        "dosage_adults": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Dose usual:</strong> 1 comprimido 1x/dia, preferencialmente pela manh&#227;.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-29a3b63e-7fff-2922-2a1e-e64bfcccf5c8\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria X:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 2407,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Tratamento de todos os graus de hipertens&#227;o arterial essencial em pacientes que n&#227;o estabilizaram sua press&#227;o com o uso de um dos dois f&#225;rmacos isoladamente (cilazapril e hidroclorotiazida).</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 33,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Contraindicado.</span></p>",
        "last_update": "2019-03-10 04:53:41",
        "name": "Vascase Plus",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Comprimido:</strong>&#160;5mg Cilazapril + 12,5mg Hidroclorotiazida.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "VascasePlus",
        "substance": "Cilazapril + Hidroclorotiazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong>Efeitos Adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Hipotens&#227;o, infarto do mioc&#225;rdio, taquicardia, palpita&#231;&#227;o e dor no peito;&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">cefal&#233;ia, vertigens, fadiga; t</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">osse seca, n&#225;usea, dispepsia, neutropenia, agranulocitose, trombocitopenia, anemia, pancreatite, angioedema, edema de laringe, eritema multiforme, necr&#243;lise epid&#233;rmica t&#243;xica, fotossensibilidade, alop&#233;cia e insufici&#234;ncia renal aguda, hipocalemia.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Ajustes</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- N&#227;o estabelecido. Doses reduzidas podem ser necess&#225;rias em pacientes com disfun&#231;&#227;o renal. N&#227;o utilizar combina&#231;&#227;o com diur&#233;tico em insufici&#234;ncia renal grave.</span></p>\r\n</div>"
    },
    {
        "content_length": 1829,
        "contraindications": "<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula, prolongamento conhecido do intervalo QT no ECG, infarto recente do mioc&#225;rdio, insufici&#234;ncia card&#237;aca descompensada, arritmias card&#237;acas.</p>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Dose inicial:</strong> 40mg, VO 2 vezes ao dia.</li>\r\n<li><strong>Dose m&#225;xima:&#160;</strong>80mg, VO 2 vezes ao dia.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<p>- N&#227;o recomendado.</p>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2416,
        "indications": "<p>- Esquizofrenia, transtornos esquizoafetivo e esquizofreniforme, estados de agita&#231;&#227;o psic&#243;tica,&#160;mania bipolar aguda, autismo com altera&#231;&#245;es comportamentais.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 15:01:15",
        "name": "Ziprasidona",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:&#160;</strong>40mg e 80mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>- Receita de controle especial.</p>",
        "record_status": 1,
        "slug": "geodon",
        "substance": "Ziprasidona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, sonol&#234;ncia, seda&#231;&#227;o, n&#225;useas, v&#244;mitos, taquicardia, hipertens&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 3007,
        "contraindications": "<p>- Hipersensibilidade ao f&#225;rmaco, pacientes com baixa contagem de neutr&#243;filos (menos que 0,75 x 10 9 /litro), pacientes com n&#237;veis anormais de hemoglobina (menos de 7,5g/dL), neonatos com hiperbilirrubinemia, que necessitam de tratamento adicional &#224; fototerapia ou com aumento das transaminases, com valores de hemoglobina abaixo de 10 g/dL e/ou contagem de neutrofilos inferior a 1.000/mm3.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 200mg de zidovudina a cada 4 horas (1.200mg/dia) &#233; recomendada para pacientes com peso m&#233;dio de 70kg.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Crian&#231;as com 3 meses a 12 anos:&#160;</strong>180mg/m&#178; de&#160;superf&#237;cie corporal a cada 6 horas (720mg/m&#178;/dia).</li>\r\n<li><strong>Crian&#231;as maiores de 12 anos:&#160;</strong>200mg a cada 4 horas.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2417,
        "indications": "<p>- &#201; indicado para o tratamento da imunodefici&#234;ncia humana causada por infec&#231;&#227;o pelo HIV-1, na preven&#231;&#227;o da transmiss&#227;o materno-fetal do HIV e na profilaxia p&#243;s-exposi&#231;&#227;o &#224; infec&#231;&#227;o pelo HIV.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 230,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-10 14:56:19",
        "name": "Zidovudina",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas: </strong>100mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p>- Receita de controle especial (C4- anti-retrovirais - Formul&#225;rio pr&#243;prio/DST/AIDS).</p>",
        "record_status": 1,
        "slug": "zidovudina",
        "substance": "Zidovudina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Anemia, neutropenia, leucopenia, trombocitopenia,pancitopenia, anemia apl&#225;stica, hiperlactatemia, acidose l&#225;tica, anorexia,&#160;ansiedade, depress&#227;o, cefaleia, vertigem, ins&#244;nia, parestesia, v&#244;mitos, diarreia, mialgia, rash cut&#226;neo,&#160;eleva&#231;&#227;o de transaminases e bilirrubina, cardiomiopatia.&#160;</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Taxas de hemoglobina inferiores a 7,5 g/dl ou contagens de granul&#243;citos inferiores a 750/mm3 podem exigir ajustes de dose, interrup&#231;&#227;o no uso do medicamento, transfus&#227;o de sangue ou tratamento com eritropoietina nos pacientes com baixa eritopoetina end&#243;gena.&#160;Clearance de creatinina (ml/min): 10-50; 300mg 2x/dia &lt;10: 300mg 1x/dia. Na insuficiencia hep&#225;tica usar m&#225;ximo de 400mg por dia.</p>\r\n</div>"
    },
    {
        "content_length": 2293,
        "contraindications": "<p style=\"text-align: justify;\">- Hipersensibilidade ao princ&#237;pio ativo ou a qualquer um dos excipientes, ou a qualquer outro anti-inflamat&#243;rio n&#227;o-esteroide.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\">1 gota no olho afetado 3x/dia, come&#231;ando no dia anterior ao da cirurgia e continuando no dia da cirurgia e pelas pr&#243;ximas 2 semanas no p&#243;s-operat&#243;rio.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>- Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2419,
        "indications": "<ul>\r\n<li>Tratamento da dor e inflama&#231;&#227;o associadas &#224; cirurgia de catarata.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-05 01:42:24",
        "name": "Nevanac",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oft&#225;lmica:</strong>&#160;1mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nevanac",
        "substance": "Nepafenaco",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Ceratite; Perda da fun&#231;&#227;o endotelial, afinamento da c&#243;rnea, eros&#227;o, ulcera&#231;&#227;o ou perfura&#231;&#227;o da c&#243;rnea; Hifema, irrita&#231;&#227;o ocular.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3301,
        "contraindications": "<p>- Hipersensibilidade conhecida a qualquer componente da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Tratamento da gripe:&#160;</strong>2 inala&#231;&#245;es, oral e com dispositivo, (de 5mg cada uma), 12/12 horas, durante 5 dias, sendo administrada dose di&#225;ria total de 20mg. O tratamento deve come&#231;ar o mais precocemente poss&#237;vel dentro de 48 horas ap&#243;s o in&#237;cio dos sintomas.</li>\r\n<li><strong>Profilaxia da gripe:&#160;</strong>2 inala&#231;&#245;es, oral e com dispositivo,(de 5mg cada uma), 12/12 horas, durante 10 dias, sendo administrada dose di&#225;ria total de 10mg. A terapia pode ser prolongada por at&#233; um m&#234;s caso o per&#237;odo de risco de exposi&#231;&#227;o se estender al&#233;m de 10 dias.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><strong>Crian&#231;as maiores de 5 anos:</strong></p>\r\n<ul>\r\n<li><strong>Tratamento da gripe:&#160;</strong>2 inala&#231;&#245;es, oral e com dispositivo, (de 5mg cada uma), 12/12 horas, durante 5 dias, sendo administrada dose di&#225;ria total de 20mg. O tratamento deve come&#231;ar o mais precocemente poss&#237;vel: dentro de 36 horas ap&#243;s o in&#237;cio dos sintomas.</li>\r\n<li><strong>Profilaxia da gripe:&#160;</strong>2 inala&#231;&#245;es, oral e com dispositivo,(de 5mg cada uma),12/12 horas, durante 10 dias, sendo administrada dose di&#225;ria total de 10mg. A terapia pode ser prolongada por at&#233; um m&#234;s caso o per&#237;odo de risco de exposi&#231;&#227;o se estender al&#233;m de 10 dias.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2420,
        "indications": "<p>- Profilaxia da gripe causada pelo v&#237;rus influenza tipos A e B, em adultos e crian&#231;as (com idade maior ou igual a 5 anos).</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 212,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2019-03-09 02:32:02",
        "name": "Relenza",
        "presentation": "<ul>\r\n<li><strong>P&#243; para inala&#231;&#227;o:</strong> 5mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-bidi- mso-bidi-theme-font: minor-bidi; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Receita de controle especial (C4- anti-retrovirais - Formul&#225;rio pr&#243;prio/DST/AIDS).</span></p>",
        "record_status": 1,
        "slug": "relenza",
        "substance": "Zanamivir",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-Rea&#231;&#245;es al&#233;rgicas, edema facial e orofar&#237;ngeo, broncoespasmo, dispneia, rash cut&#226;neo, urtic&#225;ria, eritema multiforme, s&#237;ndrome de Steve-Johnson, necr&#243;lise epid&#233;rmica t&#243;xica, rea&#231;&#245;es do tipo vasovagal.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p><strong>-</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 0,
        "contraindications": "<p>- Hipersensibilidade ao f&#225;rmaco, estado asm&#225;tico, insufici&#234;ncia hep&#225;tica, uso na gravidez.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose habitual:</strong> 20 mg 2x/dia VO.</li>\r\n<li><strong>Dose m&#225;xima:</strong> 40 mg 2x/dia VO. Utilizar com cuidado em idosos.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Crian&#231;as menores de 5 anos: </strong>n<span id=\"docs-internal-guid-424cfc5f-7fff-28a5-3121-af748ef34d16\"><span style=\"  background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">&#227;o estabelecido.</span></span></li>\r\n<li><strong>Crian&#231;as de 6 a 12 anos:&#160;</strong>10 mg/dose, 2x VO.</li>\r\n<li><strong>Crian&#231;as maiores de 12 anos:</strong> idem posologia adulta.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p><strong>-&#160;</strong><span style=\"background-color: transparent;   font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Categoria C:</span><span style=\"background-color: transparent;   font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2421,
        "indications": "<p>- Profilaxia e no tratamento de manuten&#231;&#227;o da asma em adultos. Pacientes asm&#225;ticos que n&#227;o est&#227;o controlados adequadamente com um beta-agonista.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2018-09-21 18:01:00",
        "name": "Accolate",
        "presentation": "<ul>\r\n<li><strong>Comprimido: </strong>20mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitur&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "accolate",
        "substance": "Zafirlucaste",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-Ins&#244;nia, mal-estar, erup&#231;&#245;es cut&#226;neas, incluindo forma&#231;&#227;o de bolhas, prurido e edema, rea&#231;&#227;o de hipersensibilidade, incluindo urtic&#225;ria e angioedema, hematomas, dist&#250;rbios de sangramento e edema dos membros inferiores, agranulocitose, disfun&#231;&#227;o hep&#225;tica, artralgia, mialgia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p><strong>-</strong>N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1775,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria adulta.</span></p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>1 gota em cada saco conjuntival do rec&#233;m-nascido na primeira hora ap&#243;s o parto.</li>\r\n</ul>",
        "gestation": 6,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "id": 2423,
        "indications": "<p>- Profilaxia da oftalmia do rec&#233;m-nascido.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": 194,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-05 01:49:08",
        "name": "Nitrato de Prata",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oft&#225;lmica:&#160;</strong>10mg/ml.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nitrato-de-prata",
        "substance": "Nitrato de Prata",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;Conjuntivite qu&#237;mica de pequena intensidade e curso autolimitado; Raramente ocorre metemoglobinemia e trombocitopenia idiop&#225;tica.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2323,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula; Primeiro trimestre de gravidez.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>&#160;</strong>3 a 5 colheres de ch&#225; ou 4 a 6 c&#225;psulas por dia, VO.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p><span style=\"color: #333333;\"><strong>Rec&#233;m-nascidos e&#160;</strong></span><strong><span class=\"postTip word_cnt_1591397_3\" style=\"box-sizing: border-box; word-break: break-word; color: #333333; border-bottom: 1px dashed #b2c0d0; line-height: 27px;\">lactentes</span></strong><span style=\"color: #333333;\"><strong>:</strong> </span></p>\r\n<ul>\r\n<li><span style=\"color: #333333;\">1 a 3 colheres de ch&#225; (ou copo-dose) por dia, VO.</span></li>\r\n</ul>\r\n<p><span style=\"color: #333333;\"><strong>Maiores de 5 anos:</strong> </span></p>\r\n<ul>\r\n<li><span style=\"color: #333333;\">3 a 5 colheres de ch&#225; ou 4 a 6 c&#225;psulas por dia, VO.&#160;</span></li>\r\n</ul>\r\n</div>",
        "gestation": 6,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "id": 2425,
        "indications": "<p>- Anti-s&#233;ptico intestinal nas colites agudas e inflamat&#243;rias, toxiinfec&#231;&#245;es alimentares;</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 166,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-06 17:09:44",
        "name": "Passifuril",
        "presentation": "<ul>\r\n<li><strong>Suspens&#227;o oral:&#160;</strong>200mg/5ml.</li>\r\n<li><strong>C&#225;psulas:</strong> 150mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "passifuril",
        "substance": "Nifuroxazida",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#227;o foram descritos.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2944,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Hipersensibilidade aos componentes; Hemorragia genital de causa desconhecida; Antecedente de tromboembolismo venoso idiop&#225;tico ou quadro de tromboembolismo (flebite, embolismo pulmonar); Antecedente recente ou progressivo de tromboembolismo arterial (tal como infarto do mioc&#225;rdio); Doen&#231;a hep&#225;tica aguda ou hist&#243;rico de doen&#231;a hep&#225;tica; Homens.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p>&#160;<strong>Pr&#233;-menopausa:</strong></p>\r\n<ul>\r\n<li>5mg, VO, 1xdia, do 16&#176; ao 25&#176; dia do ciclo menstrual.</li>\r\n</ul>\r\n<p><strong>P&#243;s-menopausa:</strong></p>\r\n<ul>\r\n<li>5mg, VO, 1x/dia, durante 12 a 14 dias por m&#234;s.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>- Categoria D:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></p>",
        "id": 2426,
        "indications": "<p>- Tratamento de dist&#250;rbios menstruais pr&#233;-menopausa.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 151,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-04 01:13:17",
        "name": "Lutenil",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "lutenil",
        "substance": "Nomegestrol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Ins&#244;nia; Dist&#250;rbios oculares;&#160;Agravamento de insufici&#234;ncia venosa de membros inferiores, tromboembolismo venoso;&#160;Dist&#250;rbios gastrointestinais;&#160;Alergias cut&#226;neas, hirsutismo;&#160;Modifica&#231;&#227;o do ciclo menstrual, amenorr&#233;ia, sangramento intercorrente;&#160;Pirexia;&#160;Ganho de peso.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2924,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula; Presen&#231;a ou risco de tromboembolismo venoso ou arterial; Pancreatite ou hist&#243;rico depancreatite associado a hipertrigliceridemia grave; Presen&#231;a ou hist&#243;ria de doen&#231;a hep&#225;tica grave, sem retorno de enzimas hep&#225;ticas aos n&#237;veis normais; Presen&#231;a ou antecedentes de tumores hep&#225;ticos; Presen&#231;a ou suspeita de neoplasias malignas sens&#237;veis a ester&#243;ides sexuais (ex: mama, &#243;rg&#227;os genitais); Hemorragia vagina n&#227;o-diagnosticada.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:</strong> 1cp VO ao dia, do 1&#176; ao 28&#176; dia do ciclo menstrual; iniciar a pr&#243;xima cartela imediatamente ap&#243;s, sem intervalo.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 2428,
        "indications": "<ul>\r\n<li>Contracep&#231;&#227;o oral.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 191,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-09 17:16:28",
        "name": "Stezza",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> Estradiol 1,5mg + Nomegestrol 2,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "stezza",
        "substance": "Estradiol + Nomegestrol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Acne; Hemorragia de priva&#231;&#227;o anormal; Diminui&#231;&#227;o da libido, depress&#227;o, altera&#231;&#245;es do humor; Cefal&#233;ia, enxaqueca; N&#225;useas;&#160;Metrorragia, menorragia, dor mam&#225;ria, dor p&#233;lvica; Aumento de peso; Apetite aumentado; Rubor, distens&#227;o abdominal; Hiperidrose, alopecia, prurido, seborr&#233;ia, xerose cut&#226;nea; Irritabilidade, edema, aumento de transaminases.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-&#160;<strong>Doen&#231;a hep&#225;tica:</strong> contraindicado se os valores de fun&#231;&#227;o hep&#225;tica n&#227;o estiverem normalizados.</p>\r\n</div>"
    },
    {
        "content_length": 2939,
        "contraindications": "<div>\r\n<p style=\"text-align: justify;\">- Suspeita ou confirma&#231;&#227;o de gravidez;&#160;Suspeita ou confirma&#231;&#227;o de c&#226;ncer de mama;&#160;Sangramento vaginal anormal n&#227;o diagnosticado;&#160;Hipersensibilidade a algum dos componentes da formula&#231;&#227;o.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\">&#160;0,35mg, VO, 1x/dia, iniciando o tratamento a partir do primeiro dia da menstrua&#231;&#227;o, sempre no mesmo hor&#225;rio.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 2429,
        "indications": "<p style=\"text-align: justify;\">- Contracep&#231;&#227;o; Tratamento das hemorragias uterinas disfuncionais e dist&#250;rbios do ciclo menstrual; Dismenorr&#233;ia; Tens&#227;o pr&#233;-menstrual; Algias p&#233;lvicas; Mastod&#237;nia; Dist&#250;rbios da fertilidade por insufici&#234;ncia progest&#237;nica.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:23:07",
        "name": "Micronor",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 0,35mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "micronor",
        "substance": "Noretisterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Dor de cabe&#231;a, tontura;&#160;N&#225;usea, v&#244;mito;&#160;Metrorragia, amenorr&#233;ia, sensibilidade das mamas;&#160;Fadiga, aumento de peso;&#160;Depress&#227;o, nervosismo, acne, hisrutismo, secre&#231;&#227;o genital, edema.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 2924,
        "contraindications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Suspeita ou confirma&#231;&#227;o de gravidez;&#160;Suspeita ou confirma&#231;&#227;o de c&#226;ncer de mama;&#160;Sangramento vaginal anormal n&#227;o diagnosticado;&#160;Hipersensibilidade a algum dos componentes da formula&#231;&#227;o</span>.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\">&#160;0,35mg, VO, 1x/dia, iniciando o tratamento a partir do primeiro dia da menstrua&#231;&#227;o, sempre no mesmo hor&#225;rio.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 2430,
        "indications": "<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">- Contracep&#231;&#227;o; Tratamento das hemorragias uterinas disfuncionais e dist&#250;rbios do ciclo menstrual; Dismenorr&#233;ia; Tens&#227;o pr&#233;-menstrual; Algias p&#233;lvicas; Mastod&#237;nia; Dist&#250;rbios da fertilidade por insufici&#234;ncia progest&#237;nica.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 01:55:12",
        "name": "Norestin",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 0,35mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "norestin",
        "substance": "Noretisterona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Dor de cabe&#231;a, tontura;&#160;N&#225;usea, v&#244;mito;&#160;Metrorragia, amenorr&#233;ia, sensibilidade das mamas;&#160;Fadiga, aumento de peso;&#160;Depress&#227;o, nervosismo, acne, hisrutismo, secre&#231;&#227;o genital, edema.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3086,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Acima de 2 anos:&#160;</strong>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2431,
        "indications": "<ul>\r\n<li>Dermatoses: psor&#237;ase, dermatite at&#243;pica e dermatite al&#233;rgica de contato.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 86,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-04 01:52:21",
        "name": "Elocom",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico/Pomada dermatol&#243;gica:</strong> 1mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "elocom",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>- Creme:</strong>&#160;parestesia, prurido e sinais de atrofia cut&#226;nea; abscessos, queima&#231;&#227;o, exacerba&#231;&#227;o de infec&#231;&#245;es, pele seca, eritema, fur&#250;nculos e erup&#231;&#245;es.</p>\r\n<p><strong>- Pomada:&#160;</strong>ardor, prurido, formigamento/dor local aguda moment&#226;nea e sinais de atrofia cut&#226;nea; sinais al&#233;rgicos, dermatite, eritema, fur&#250;nculos, aumento da zona de les&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3085,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Acima de 2 anos:&#160;</strong>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2432,
        "indications": "<ul>\r\n<li>Dermatoses: psor&#237;ase, dermatite at&#243;pica e dermatite al&#233;rgica de contato.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 4,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-09 02:36:49",
        "name": "Resgat",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico/Pomada dermatol&#243;gica:</strong> 1mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "resgat",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>- Creme:</strong>&#160;parestesia, prurido e sinais de atrofia cut&#226;nea; abscessos, queima&#231;&#227;o, exacerba&#231;&#227;o de infec&#231;&#245;es, pele seca, eritema, fur&#250;nculos e erup&#231;&#245;es.</p>\r\n<p><strong>- Pomada:&#160;</strong>ardor, prurido, formigamento/dor local aguda moment&#226;nea e sinais de atrofia cut&#226;nea; sinais al&#233;rgicos, dermatite, eritema, fur&#250;nculos, aumento da zona de les&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3081,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Acima de 2 anos:&#160;</strong>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2433,
        "indications": "<ul>\r\n<li>Dermatoses: psor&#237;ase, dermatite at&#243;pica e dermatite al&#233;rgica de contato.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-10 04:10:50",
        "name": "Topison",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico/Pomada dermatol&#243;gica:</strong> 1mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "topison",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>- Creme:</strong>&#160;parestesia, prurido e sinais de atrofia cut&#226;nea; abscessos, queima&#231;&#227;o, exacerba&#231;&#227;o de infec&#231;&#245;es, pele seca, eritema, fur&#250;nculos e erup&#231;&#245;es.</p>\r\n<p><strong>- Pomada:&#160;</strong>ardor, prurido, formigamento/dor local aguda moment&#226;nea e sinais de atrofia cut&#226;nea; sinais al&#233;rgicos, dermatite, eritema, fur&#250;nculos, aumento da zona de les&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3089,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Acima de 2 anos:&#160;</strong>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2434,
        "indications": "<ul>\r\n<li>Dermatoses: psor&#237;ase, dermatite at&#243;pica e dermatite al&#233;rgica de contato.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 92,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-01-13 20:30:24",
        "name": "Dermotil",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico/Pomada dermatol&#243;gica:</strong> 1mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "dermotil",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>- Creme:</strong>&#160;parestesia, prurido e sinais de atrofia cut&#226;nea; abscessos, queima&#231;&#227;o, exacerba&#231;&#227;o de infec&#231;&#245;es, pele seca, eritema, fur&#250;nculos e erup&#231;&#245;es.</p>\r\n<p><strong>- Pomada:&#160;</strong>ardor, prurido, formigamento/dor local aguda moment&#226;nea e sinais de atrofia cut&#226;nea; sinais al&#233;rgicos, dermatite, eritema, fur&#250;nculos, aumento da zona de les&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3093,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Acima de 2 anos:&#160;</strong>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2435,
        "indications": "<ul>\r\n<li>Dermatoses: psor&#237;ase, dermatite at&#243;pica e dermatite al&#233;rgica de contato.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 27,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-10 04:11:09",
        "name": "Topliv",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico/Pomada dermatol&#243;gica:</strong> 1mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "topliv",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>- Creme:</strong>&#160;parestesia, prurido e sinais de atrofia cut&#226;nea; abscessos, queima&#231;&#227;o, exacerba&#231;&#227;o de infec&#231;&#245;es, pele seca, eritema, fur&#250;nculos e erup&#231;&#245;es.</p>\r\n<p><strong>- Pomada:&#160;</strong>ardor, prurido, formigamento/dor local aguda moment&#226;nea e sinais de atrofia cut&#226;nea; sinais al&#233;rgicos, dermatite, eritema, fur&#250;nculos, aumento da zona de les&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3086,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Acima de 2 anos:&#160;</strong>Aplicar uma fina camada que cubra toda a &#225;rea afetada 1x/dia, ap&#243;s lavagem e secagem da mesma.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2436,
        "indications": "<ul>\r\n<li>Dermatoses: psor&#237;ase, dermatite at&#243;pica e dermatite al&#233;rgica de contato.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:35:18",
        "name": "Mometasona",
        "presentation": "<ul>\r\n<li><strong>Creme dermatol&#243;gico/Pomada dermatol&#243;gica:</strong> 1mg/g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "mometasona",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><strong>- Creme:</strong>&#160;parestesia, prurido e sinais de atrofia cut&#226;nea; abscessos, queima&#231;&#227;o, exacerba&#231;&#227;o de infec&#231;&#245;es, pele seca, eritema, fur&#250;nculos e erup&#231;&#245;es.</p>\r\n<p><strong>- Pomada:&#160;</strong>ardor, prurido, formigamento/dor local aguda moment&#226;nea e sinais de atrofia cut&#226;nea; sinais al&#233;rgicos, dermatite, eritema, fur&#250;nculos, aumento da zona de les&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3397,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Rinite al&#233;rgica:</strong> 1-2 atomiza&#231;&#245;es em cada narina 1x/dia;</li>\r\n<li><strong>Tratamento complementar de sinusite:</strong> 2-4 atomiza&#231;&#245;es em cada narina 1x/dia;</li>\r\n<li><strong>P&#243;lipos nasais:</strong> 2 atomiza&#231;&#245;es em cada narina 1-2x/dia;</li>\r\n<li><strong>Rinossinusite aguda:</strong> 2 atomiza&#231;&#245;es em cada narina 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Rinite al&#233;rgica (entre 2-11 anos de idade):</strong>&#160;1 atomiza&#231;&#227;o em cada narina 1x/dia;<strong>Tratamento complementar de sinusite (adolescentes):</strong>&#160;2-4 atomiza&#231;&#245;es em cada narina 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2437,
        "indications": "<ul>\r\n<li>Rinite al&#233;rgica;</li>\r\n<li>Tratamento complementar de epis&#243;dios agudos de sinusite;</li>\r\n<li>P&#243;lipos nasais;</li>\r\n<li>Rinossinusite aguda.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 65,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 00:54:12",
        "name": "Nasonex",
        "presentation": "<ul>\r\n<li><strong>Spray nasal:</strong>&#160;50mcg/atomiza&#231;&#227;o.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nasonex",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefal&#233;ia;</p>\r\n<p>- Infec&#231;&#227;o viral;</p>\r\n<p>- Faringite;</p>\r\n<p>- Epistaxe;</p>\r\n<p>- Tosse;</p>\r\n<p>- Infec&#231;&#227;o de vias a&#233;reas superiores;</p>\r\n<p>- Dismenorr&#233;ia;</p>\r\n<p>- Dor musculoesquel&#233;tica;</p>\r\n<p>- Sinusite;</p>\r\n<p>- V&#244;mitos.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3398,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula;</p>\r\n<p>- Menores de 2 anos de idade.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Rinite al&#233;rgica:</strong> 1-2 atomiza&#231;&#245;es em cada narina 1x/dia;</li>\r\n<li><strong>Tratamento complementar de sinusite:</strong> 2-4 atomiza&#231;&#245;es em cada narina 1x/dia;</li>\r\n<li><strong>P&#243;lipos nasais:</strong> 2 atomiza&#231;&#245;es em cada narina 1-2x/dia;</li>\r\n<li><strong>Rinossinusite aguda:</strong> 2 atomiza&#231;&#245;es em cada narina 2x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Rinite al&#233;rgica (entre 2-11 anos de idade):</strong>&#160;1 atomiza&#231;&#227;o em cada narina 1x/dia;<strong>Tratamento complementar de sinusite (adolescentes):</strong>&#160;2-4 atomiza&#231;&#245;es em cada narina 1x/dia.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2438,
        "indications": "<ul>\r\n<li>Rinite al&#233;rgica;</li>\r\n<li>Tratamento complementar de epis&#243;dios agudos de sinusite;</li>\r\n<li>P&#243;lipos nasais;</li>\r\n<li>Rinossinusite aguda.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 191,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-05 01:48:52",
        "name": "Nites",
        "presentation": "<ul>\r\n<li><strong>Spray nasal:</strong>&#160;50mcg/atomiza&#231;&#227;o.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "nites",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefal&#233;ia;</p>\r\n<p>- Infec&#231;&#227;o viral;</p>\r\n<p>- Faringite;</p>\r\n<p>- Epistaxe;</p>\r\n<p>- Tosse;</p>\r\n<p>- Infec&#231;&#227;o de vias a&#233;reas superiores;</p>\r\n<p>- Dismenorr&#233;ia;</p>\r\n<p>- Dor musculoesquel&#233;tica;</p>\r\n<p>- Sinusite;</p>\r\n<p>- V&#244;mitos.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3524,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes da f&#243;rmula (mometasona, lactose);</p>\r\n<p>- Tratamento prim&#225;rio do estado de mal asm&#225;tico ou outros epis&#243;dios agudos de asma nos quais h&#225; necessidade de medidas intensivas;</p>\r\n<p>- Tuberculose pulmonar ativa ou latente, infec&#231;&#245;es f&#250;ngicas, bacterianas, virais ou parasit&#225;rias n&#227;o tratadas e em casos de herpes simples, inclusive o ocular.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Asma:</strong> 200-400mcg/dia via inalat&#243;ria em 1 ou 2 doses.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>Asma (crian&#231;as &#224; partir de 12 anos de idade):</strong>&#160;200-400mcg/dia via inalat&#243;ria em 1 ou 2 doses.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Categoria C:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></span></p>",
        "id": 2439,
        "indications": "<ul>\r\n<li>Controle dos sinais e sintomas no tratamento e na profilaxia da asma.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-06 16:57:03",
        "name": "Oximax",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas com p&#243; para inala&#231;&#227;o oral:</strong>&#160;200mcg e 400mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "oximax",
        "substance": "Mometasona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Cefaleia, rinite al&#233;rgica com asma, faringite aguda, infec&#231;&#227;o aguda das vias a&#233;reas superiores, dor articular e depress&#227;o;</p>\r\n<p>- Sinusite, candid&#237;ase oral, dismenorreia, dor musculoesquel&#233;tica, dor lombar, dispepsia, mialgia, dor abdominal e p&#233;lvica, n&#225;useas e v&#244;mitos, fadiga, s&#237;ndrome semelhante &#224; gripe (calafrios com febre, mialgia), gastrenterite (gastrenterite e colite n&#227;o infecciosas), anorexia, otalgia, infec&#231;&#227;o, disfonia, epistaxe;</p>\r\n<p>- Glaucoma, press&#227;o intraocular aumentada, catarata.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3263,
        "contraindications": "<div>\r\n<p>- Trombose venosa profunda (hist&#243;ria anterior ou atual); Tromboembolismo (hist&#243;ria anterior ou atual); Doen&#231;a vascular cerebral ou coronariana arterial; Valvulopatias trombog&#234;nicas; Dist&#250;rbios trombog&#234;nicos, trombofilias heredit&#225;rias ou adquiridas; Cefal&#233;ia com sintomas neurol&#243;gicos focais tais como aura; Diabetes com envolvimento vascular,; Hipertens&#227;o n&#227;o-controlada Carcinoma da mama conhecido ou suspeito ou outra neoplasia estrog&#234;nio-dependente conhecida ou suspeita; Adenomas ou carcinomas hep&#225;ticos, ou doen&#231;a hep&#225;tica ativa, desde que a fun&#231;&#227;o hep&#225;tica n&#227;o tenha retornado ao normal; Sangramento vaginal de etiologia a esclarecer; Gravidez confirmada ou suspeita, hipersensibilidade a qualquer um dos componentes.</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose recomendada:</strong> 1cp VO ao dia, iniciando o tratamento a partir do primeiro dia do ciclo menstrual, por 21 dias; suspender o uso por 7 dias e posteriormente recome&#231;ar o uso.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 5,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>- Categoria X:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>",
        "id": 2440,
        "indications": "<ul>\r\n<li>Contracep&#231;&#227;o e tratamento de dist&#250;rbios menstruais.</li>\r\n</ul>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 74,
        "lactation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%; mso-fareast- mso-fareast-theme-font: minor-latin; mso-ansi-language: PT-BR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">&#160;Uso liberado na lacta&#231;&#227;o.</span></span></p>",
        "last_update": "2019-03-04 00:32:21",
        "name": "Anfertil",
        "presentation": "<ul>\r\n<li><strong>Comprimidos:</strong> Etinilestradiol 0,05mg + Norgestrel 0,5mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "anfertil",
        "substance": "Etinilestradiol + Norgestrel",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Dor de cabe&#231;a, tontura; N&#225;usea, v&#244;mito; Metrorragia, amenorr&#233;ia, sensibilidade das mamas; Fadiga, aumento de peso; Depress&#227;o, nervosismo, acne, hisrutismo, secre&#231;&#227;o genital, edema.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 3056,
        "contraindications": "<p>-&#160;Hipersensibilidade seus componentes ou &#224; risperidona, lacta&#231;&#227;o.&#160;</p>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose usual:</strong> 6mg VO pela manh&#227;, aumentando 3mg a cada 5 dias.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Dose m&#225;xima:&#160;</strong>12mg/dia.</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><strong>&gt;12 anos:</strong> 3mg/dia VO, pela manh&#227;, aumentando 3 mg/dia em intervalos maiores do que 5 dias.</li>\r\n<li><strong>Dose m&#225;xima:&#160;</strong>12mg/dia.</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm 0cm 0.0001pt; vertical-align: baseline; text-align: justify;\"><span class=\"normaltextrun\"><strong>Categoria C:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2455,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Tratamento da esquizofrenia e transtorno esquizoafetivo.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 46,
        "lactation_text": "<p><strong>-&#160;</strong>Contraindicado.&#160;</p>",
        "last_update": "2019-03-03 20:58:47",
        "name": "Invega",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 3mg, 6mg ou 9mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receita de controle especial (C1).</span></p>",
        "record_status": 1,
        "slug": "invega",
        "substance": "Paliperidona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Sonol&#234;ncia, dor de cabe&#231;a, tontura, astenia, fadiga, v&#244;mito, boca seca, dor abdominal, discinesias, tremor, hipertonia ou movimentos involunt&#225;rios, hipotens&#227;o ortost&#225;tica, taquicardia e palpita&#231;&#245;es,&#160;hipersecre&#231;&#227;o salivar,&#160;sintoma extrapiramidal, sonol&#234;ncia, acatisia, tremor, hipertonia, distonia, seda&#231;&#227;o, parkinsonismo,&#160;bloqueio de ramo, arritmia sinusal, bloqueio atrioventricular de 1&#186; grau.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>ClCr 80-50 ml/min: Dose m&#225;xima de 3-6 mg/dia.<strong>- </strong>ClCr 50-10 ml/min: 3 mg/dia, VO.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 0,
        "contraindications": "<div>\r\n<p>- Hipersensibilidade aos componentes, uso de inibidores da MAO.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose habitual:</strong> 10mg, VO, 1x/dia. A dose pode ser aumentada at&#233;, no m&#225;ximo, 20mg, VO, por dia ou reduzida at&#233; o m&#237;nimo de 5mg, VO, 1x/dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-dcaead86-d4ed-721f-a10f-45d257274a55\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong>&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2457,
        "indications": "<p>- Indicado para o tratamento de transtorno depressivo maior em adultos.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 104,
        "lactation_text": "<p>- N&#227;o recomendado.</p>",
        "last_update": "2018-07-27 23:41:43",
        "name": "Brintellix",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos:&#160;</strong>5mg e 10mg.</li>\r\n</ul>",
        "recipient": 6,
        "recipient_type": "<p><span id=\"docs-internal-guid-f2ca69bd-d4eb-f9b5-e599-20299a493010\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Receita de controle especial.</span></span></p>",
        "record_status": 1,
        "slug": "brintellix",
        "substance": "Vortioxetina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;usea, diarreia, constipa&#231;&#227;o, v&#244;mitos, tontura, prurido, redu&#231;&#227;o do apetite, sonhos anormais, ranger os dentes, vermelhid&#227;o, sudorese noturna.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Recomenda-se o uso com cautela em pacientes com fun&#231;&#227;o renal reduzida e/ou fun&#231;&#227;o hep&#225;tica reduzida.</p>\r\n</div>"
    },
    {
        "content_length": 3276,
        "contraindications": "<p>-&#160;Hipersensibilidade aos seus componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>N&#225;useas e v&#244;mitos induzidos por quimioterapia:</strong> 0,25mg IV 30min antes da quimioterapia.</p>\r\n</li>\r\n<li>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>N&#225;useas e v&#244;mitos no p&#243;s-operat&#243;rio:</strong> 0,075mg IV antes da indu&#231;&#227;o anest&#233;sica.&#160;</p>\r\n</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">\r\n<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></p>\r\n</li>\r\n</ul>",
        "gestation": 2,
        "gestation_text": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\"><strong>Categoria B:</strong></span><span class=\"normaltextrun\">&#160;Prescri&#231;&#227;o com cautela.</span></p>",
        "id": 2458,
        "indications": "<p class=\"MsoNormal\" style=\"text-align: justify;\">- Preven&#231;&#227;o de n&#225;useas e v&#244;mitos associados a ciclos iniciais e de repeti&#231;&#227;o de quimioterapia contra o c&#226;ncer moderadamente emetog&#234;nico ou altamente emetog&#234;nico e preven&#231;&#227;o das n&#225;useas e v&#244;mitos no p&#243;s-operat&#243;rio por at&#233; 24 horas depois da cirurgia.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 65,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Alto risco:</span></strong><span style=\"line-height: 107%;\"> Uso inseguro. Avaliar alternativas mais seguras.</span></p>",
        "last_update": "2019-03-06 16:32:32",
        "name": "Onicit",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel:&#160;</strong>0,05mg/ml.&#160;</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"paragraph\" style=\"margin: 0cm; margin-bottom: .0001pt; vertical-align: baseline;\"><span class=\"normaltextrun\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "onicit",
        "substance": "Palonosetrona",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\">- Prurido, constipa&#231;&#227;o, diarreia, eleva&#231;&#227;o das enzimas hep&#225;ticas, cefaleia, tontura, ansiedade, taquicardia, hipotens&#227;o, hipertens&#227;o, fraqueza muscular, hipercalemia, febre, hiperglicemia, glicos&#250;ria e acidose metab&#243;lica, aumentos transit&#243;rios assintom&#225;ticos em AST e/ou ALT e bilirrubina,&#160;sonol&#234;ncia, ins&#244;nia, hipersonia, parestesia.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes na Insufici&#234;ncia Renal:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong>Ajustes na Insufici&#234;ncia Hep&#225;tica:&#160;</strong>N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 5626,
        "contraindications": "<div>\r\n<p>- Menores de 2 anos de idade, hipersensibilidade aos seus componentes coadministra&#231;&#227;o de substratos do CYP3A4, tais como terfenadina, astemizol, cisaprida,pimozida ou quinidina, coadministra&#231;&#227;o de rifabutina, rifampicina, carbamazepina e barbit&#250;ricos de longa a&#231;&#227;o, coadministra&#231;&#227;o de alcaloides do ergot, coadministra&#231;&#227;o de altas doses de ritonavir coadministra&#231;&#227;o de doses de efavirenz de 400 mg uma vez ao dia ou superior.</p>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Via intravenosa:</strong> Dose de ataque 6 mg/kg, IV, em 2 doses nas primeiras 24 horas, seguido de 3 - 4mg/kg IV de 12/12 horas.</li>\r\n<li><strong>Uso VO: </strong>apenas ap&#243;s uso intravenoso e diante de um paciente clinicamente melhor. 200mg a cada 12 horas para pacientes com 40kg ou mais e 100mg para pacientes abaixo de 40 kg.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><span id=\"docs-internal-guid-71789573-d4de-e332-99ce-2a29c6e0bf97\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 2 anos.</span></span></li>\r\n</ul>\r\n<hr>\r\n<p><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Uso IV:</span></p>\r\n<ul>\r\n<li><strong>Crian&#231;as de 2 a 11 anos: </strong>via intravenosa: 7mg/kg de 12/12 horas.</li>\r\n<li><strong>Crin&#231;as de 12 a 18 anos:</strong> p<span id=\"docs-internal-guid-a2fc6380-d4de-5731-096a-94a59e79372c\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">osologia idem adultos.</span></span></li>\r\n</ul>\r\n<hr>\r\n<p>Uso VO:&#160;</p>\r\n<ul>\r\n<li><strong>Crian&#231;as de 2 a 11 anos:</strong> 200mg a cada 12 horas.</li>\r\n<li><strong>Crin&#231;as de 12 a 18 anos:</strong>&#160;p<span id=\"docs-internal-guid-a2fc6380-d4de-5731-096a-94a59e79372c\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">osologia idem adultos.</span></span></li>\r\n</ul>\r\n</div>",
        "gestation": 4,
        "gestation_text": "<div>\r\n<p><strong>- Categoria D:</strong> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</p>\r\n<p>&#160;</p>\r\n</div>",
        "id": 2463,
        "indications": "<p>- Aspergilose invasiva, infec&#231;&#245;es invasivas graves por Candida, incluindo candidemia e candid&#237;ase esof&#225;gica (incluindoC. krusei), infec&#231;&#245;es f&#250;ngicas graves causadas por Scedosporium spp. e Fusarium spp.</p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-10 14:39:46",
        "name": "Voriconazol",
        "presentation": "<ul>\r\n<li><strong>Comprimidos revestidos: </strong>50mg e 200mg.</li>\r\n<li><span id=\"docs-internal-guid-6d0adbee-d4db-734d-3076-731ed72535e4\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">P&#243; liofilizado para solu&#231;&#227;o injet&#225;vel:</span><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> 200mg.</span></span></li>\r\n</ul>",
        "recipient": 2,
        "recipient_type": "<p>- Receitu&#225;rio simples, em duas vias</p>",
        "record_status": 1,
        "slug": "voriconazol",
        "substance": "Voriconazol",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Dist&#250;rbios visuais, febre, rash, v&#244;mitos, n&#225;usea, diarr&#233;ia, cefal&#233;ia, edema perif&#233;rico, dor abdominal, sinusite, icter&#237;cia, hiponatremia, hipocalemia, edema pulmonar, hipotens&#227;o, arritmia supraventricular, taquicardia, bradicardia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p><strong>-&#160;</strong>Se os pacientes n&#227;o tolerarem o tratamento de 4 mg/kg a cada 12 horas, reduzir a dose intravenosa de manuten&#231;&#227;o para o m&#237;nimo de 3 mg/kg a cada 12 horas.&#160;Em pacientes com insufici&#234;ncia renal moderada a grave (clearance de creatinina &lt; 50 mL/min) ocorre ac&#250;mulo do ve&#237;culo utilizado na formula&#231;&#227;o intravenosa, SBECD (sulfobutil-&#233;ter &#946;-ciclodextrina s&#243;dica). Nestes pacientes deve ser administrada a formula&#231;&#227;o oral de voriconazol, exceto quando a avalia&#231;&#227;o de risco-benef&#237;cio para o paciente justifique o uso da formula&#231;&#227;o intravenosa.&#160;Para pacientes com cirrose hep&#225;tica de grau leve a moderado (classe A e B de Child-Pugh), em tratamento com voriconazol IV, recomenda-se o uso dos regimes de dose de ataque padr&#227;o, mas somente metade da dose de manuten&#231;&#227;o.</p>\r\n</div>"
    },
    {
        "content_length": 2139,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Suplementa&#231;&#227;o, profilaxia,&#160;necessidade aumentada, dist&#250;rbios de absor&#231;&#227;o:</strong>&#160;at&#233; 400 mg (1 c&#225;psula ao dia) VO.</li>\r\n<li><strong>Terap&#234;utica,&#160;afec&#231;&#245;es hematol&#243;gicas heredit&#225;rias, deslipoproteinemias:</strong>&#160;at&#233; 800 mg (2 c&#225;psulas ao dia) VO.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2465,
        "indications": "<p>- Suplemento vitam&#237;nico com a&#231;&#227;o antioxidante. Est&#225; indicado na defici&#234;ncia de vitamina E e em dietas restritivas e inadequadas.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 134,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-10 14:25:55",
        "name": "Vinoq",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": null,
        "recipient_type": "<p><span id=\"docs-internal-guid-21cb5e6d-ae6f-ed2e-7854-74e0bdc2708c\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Receitu&#225;rio simples.</span></span></p>",
        "record_status": 1,
        "slug": "bio-e",
        "substance": "Tocoferol (Vitamina E)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-N&#225;useas, flatul&#234;ncias, diarreia, cefaleia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1942,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Suplementa&#231;&#227;o, profilaxia,&#160;necessidade aumentada, dist&#250;rbios de absor&#231;&#227;o:</strong>&#160;at&#233; 400 mg (1 c&#225;psula ao dia) VO.</li>\r\n<li><strong>Terap&#234;utica,&#160;afec&#231;&#245;es hematol&#243;gicas heredit&#225;rias, deslipoproteinemias:</strong>&#160;at&#233; 800 mg (2 c&#225;psulas ao dia) VO.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2466,
        "indications": "<p>- Suplemento vitam&#237;nico com a&#231;&#227;o antioxidante. Est&#225; indicado na defici&#234;ncia de vitamina E e em dietas restritivas e inadequadas.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 105,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-10 14:32:38",
        "name": "Vitamin E",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": null,
        "recipient_type": "<p><span style=\"white-space: pre-wrap;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "bio-e",
        "substance": "Tocoferol (Vitamina E)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-N&#225;useas, flatul&#234;ncias, diarreia, cefaleia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1947,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Suplementa&#231;&#227;o, profilaxia,&#160;necessidade aumentada, dist&#250;rbios de absor&#231;&#227;o:</strong>&#160;at&#233; 400 mg (1 c&#225;psula ao dia) VO.</li>\r\n<li><strong>Terap&#234;utica,&#160;afec&#231;&#245;es hematol&#243;gicas heredit&#225;rias, deslipoproteinemias:</strong>&#160;at&#233; 800 mg (2 c&#225;psulas ao dia) VO.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2467,
        "indications": "<p>- Suplemento vitam&#237;nico com a&#231;&#227;o antioxidante. Est&#225; indicado na defici&#234;ncia de vitamina E e em dietas restritivas e inadequadas.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 158,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-10 14:32:59",
        "name": "Vitamina E Delta",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": null,
        "recipient_type": "<p><span style=\"white-space: pre-wrap;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "bio-e",
        "substance": "Tocoferol (Vitamina E)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-N&#225;useas, flatul&#234;ncias, diarreia, cefaleia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1939,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Suplementa&#231;&#227;o, profilaxia,&#160;necessidade aumentada, dist&#250;rbios de absor&#231;&#227;o:</strong>&#160;at&#233; 400 mg (1 c&#225;psula ao dia) VO.</li>\r\n<li><strong>Terap&#234;utica,&#160;afec&#231;&#245;es hematol&#243;gicas heredit&#225;rias, deslipoproteinemias:</strong>&#160;at&#233; 800 mg (2 c&#225;psulas ao dia) VO.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2468,
        "indications": "<p>- Suplemento vitam&#237;nico com a&#231;&#227;o antioxidante. Est&#225; indicado na defici&#234;ncia de vitamina E e em dietas restritivas e inadequadas.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 72,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-10 15:01:48",
        "name": "Zirvit E",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": null,
        "recipient_type": "<p><span style=\"white-space: pre-wrap;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "bio-e",
        "substance": "Tocoferol (Vitamina E)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-N&#225;useas, flatul&#234;ncias, diarreia, cefaleia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 1948,
        "contraindications": "<p>- Hipersensibilidade aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Suplementa&#231;&#227;o, profilaxia,&#160;necessidade aumentada, dist&#250;rbios de absor&#231;&#227;o:</strong>&#160;at&#233; 400 mg (1 c&#225;psula ao dia) VO.</li>\r\n<li><strong>Terap&#234;utica,&#160;afec&#231;&#245;es hematol&#243;gicas heredit&#225;rias, deslipoproteinemias:</strong>&#160;at&#233; 800 mg (2 c&#225;psulas ao dia) VO.</li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2469,
        "indications": "<p>- Suplemento vitam&#237;nico com a&#231;&#227;o antioxidante. Est&#225; indicado na defici&#234;ncia de vitamina E e em dietas restritivas e inadequadas.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 34,
        "lactation_text": "<p>- Contraindicado.</p>",
        "last_update": "2019-03-10 14:33:07",
        "name": "Vitamina E Sandoz",
        "presentation": "<ul>\r\n<li><strong>Comprimido:&#160;</strong>400mg.</li>\r\n</ul>",
        "recipient": null,
        "recipient_type": "<p><span style=\"white-space: pre-wrap;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "bio-e",
        "substance": "Tocoferol (Vitamina E)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-N&#225;useas, flatul&#234;ncias, diarreia, cefaleia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 2188,
        "contraindications": "<p style=\"text-align: justify;\">- Pacientes que apresentam hipersensibilidade aos componentes da f&#243;rmula, pacientes com hipervitaminose D, hipercalcemia ou osteodistrofia renal com hiperfostatemia.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><strong>Dose usual:</strong> A dosagem varia em uma faixa terap&#234;utica, entre 1.000 a 50.000 UI ,VO, dependendo da patologia e do n&#237;vel s&#233;rico de vitamina D.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>N&#227;o estabelecido.</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p><strong>- Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 2470,
        "indications": "<p style=\"text-align: justify;\">- Indicado no tratamento auxiliar da desmineraliza&#231;&#227;o &#243;ssea pr&#233; e p&#243;s-menopausa, do raquitismo, da osteomal&#225;cia, da osteoporose e na preven&#231;&#227;o de quedas e fraturas em idosos com defici&#234;ncia de Vitamina D.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 101,
        "lactation_text": "<p><strong>- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-03 16:34:12",
        "name": "Addera D3",
        "presentation": "<ul>\r\n<li><strong>Comprimido: </strong>1000UI, 5000UI, 7000UI, 10000UI, 50000UI.&#160;</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "addera-d3",
        "substance": "Colecalciferol (Vitamina D)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p style=\"text-align: justify;\">- Secura da boca, cefaleia, polidipsia, poli&#250;ria, perda de apetite, n&#225;useas, v&#244;mitos, fadiga, sensa&#231;&#227;o de fraqueza, aumento da press&#227;o arterial, dor muscular, prurido e perda de peso, hipercalcemia, v&#244;mitos, dores abdominais, polidipsia, poli&#250;ria, diarreias e eventual desidrata&#231;&#227;o.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 7731,
        "contraindications": "<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><span style=\"mso-bidi-  mso-fareast- color: black; background: white;\">- Hipersensibilidade &#224; ocitocina ou a qualquer excipiente da formula&#231;&#227;o, hipertonia uterina, sofrimento fetal quando a expuls&#227;o n&#227;o &#233; iminente, despropor&#231;&#227;o c&#233;falo-p&#233;lvica significativa, m&#225; apresenta&#231;&#227;o fetal, placenta pr&#233;via e vasos pr&#233;vios, descolamento prematuro da placenta, apresenta&#231;&#227;o ou prolapso do cord&#227;o umbilical, distens&#227;o uterina excessiva ou diminui&#231;&#227;o da resist&#234;ncia uterina &#224; ruptura, poli-hidr&#226;mnios, grande multiparidade, p</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">resen&#231;a de cicatriz uterina resultante de interven&#231;&#245;es cir&#250;rgicas, inclusive da opera&#231;&#227;o ces&#225;rea cl&#225;ssica</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">.</span></p>",
        "dosage_adults": "<div>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Indu&#231;&#227;o do parto ou estimulo a contra&#231;&#245;es:</strong>&#160;</span></p>\r\n<ul>\r\n<li>5UI em 500 ml de SF 0,9% ou SG 5%, IV. Velocidade inicial de infus&#227;o 2 a 8 gotas/min com aumentos gradativos (em intervalos n&#227;o inferiores a 20 minutos) de 2 a 4 gotas/min (Dose m&#225;xima: 40 gotas/minuto).</li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Abortamento incompleto, inevit&#225;vel ou retido:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, seguida, se necess&#225;rio, por uma infus&#227;o IV de 20 a 40 miliunidades/min.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Ces&#225;rea:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\">5UI, IV, correr em 5 min.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Preven&#231;&#227;o da hemorragia uterina p&#243;s-parto:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, ap&#243;s expuls&#227;o da placenta.</span></li>\r\n</ul>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Tratamento da hemorragia uterina p&#243;s-parto:</strong> </span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, seguida, nos casos graves, de infus&#227;o IV de uma solu&#231;&#227;o com 5-20 UI.</span></li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2489,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>Pr&#233;-parto:&#160;</strong></span><span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\">i</span>ndu&#231;&#227;o do parto em casos de&#160;gesta&#231;&#227;o p&#243;s-termo, ruptura prematura das membranas, hipertens&#227;o induzida pela gravidez (pr&#233;-ecl&#226;mpsia), est&#237;mulo das contra&#231;&#245;es em casos selecionados de in&#233;rcia uterina, est&#225;gios iniciais da gravidez como terapia auxiliar do abortamento incompleto, inevit&#225;vel ou retido.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 15pt; line-height: normal; text-align: justify;\">-&#160;<span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>P&#243;s-Parto: </strong>d</span>urante a opera&#231;&#227;o ces&#225;rea depois da retirada da crian&#231;a, preven&#231;&#227;o e tratamento da atonia uterina e hemorragia p&#243;s-parto.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-05 02:07:33",
        "name": "Ocitocina",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5UI/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ocitocina",
        "substance": "Ocitocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Rea&#231;&#245;es adversas maternas: rea&#231;&#227;o anafil&#225;tica/anafilactoide associada &#224; dispneia, hipotens&#227;o, cefaleia, taquicardia, bradicardia, arritmia, isquemia do mioc&#225;rdio, prolongamento do intervalo QTc no eletrocardiograma, hipotens&#227;o, n&#225;usea, v&#244;mito, erup&#231;&#245;es cut&#226;neas (rash), hipertonicidade uterina, contra&#231;&#245;es tet&#226;nicas do &#250;tero, ruptura uterina, hiponatremia, edema pulmonar agudo, coagula&#231;&#227;o intravascular disseminada, angioedema.</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5.0pt 0cm 5.0pt 0cm;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Rea&#231;&#245;es adversas no feto: s&#237;ndrome do sofrimento fetal, asfixia e morte, hiponatremia neonatal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 8805,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><strong><span style=\"mso-bidi-  mso-fareast- color: black; background: white;\">- Solu&#231;&#227;o spray nasal:&#160;</span></strong>Hipersensibilidade &#224; ocitocina ou a qualquer excipiente da formula&#231;&#227;o,&#160;gravidez ou para tratamento do trabalho de parto, uma vez que, a resposta do &#250;tero &#224; ocitocina inalada &#233; vari&#225;vel.</p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><span style=\"mso-bidi-  mso-fareast- color: black; background: white;\"><strong>- Solu&#231;&#227;o injet&#225;vel:</strong> Hipersensibilidade &#224; ocitocina ou a qualquer excipiente da formula&#231;&#227;o, hipertonia uterina, sofrimento fetal quando a expuls&#227;o n&#227;o &#233; iminente, despropor&#231;&#227;o c&#233;falo-p&#233;lvica significativa, m&#225; apresenta&#231;&#227;o fetal, placenta pr&#233;via e vasos pr&#233;vios, descolamento prematuro da placenta, apresenta&#231;&#227;o ou prolapso do cord&#227;o umbilical, distens&#227;o uterina excessiva ou diminui&#231;&#227;o da resist&#234;ncia uterina &#224; ruptura, poli-hidr&#226;mnios, grande multiparidade, p</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">resen&#231;a de cicatriz uterina resultante de interven&#231;&#245;es cir&#250;rgicas, inclusive da opera&#231;&#227;o ces&#225;rea cl&#225;ssica</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Spray nasal: </strong></span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\">uma pulveriza&#231;&#227;o administrada 2 a 5 minutos antes de colocar o beb&#234; para mamar ou de usar a bomba na mama.</span></li>\r\n</ul>\r\n<p><strong>Indu&#231;&#227;o do parto ou estimulo a contra&#231;&#245;es:</strong>&#160;</p>\r\n<ul>\r\n<li>5UI em 500 ml de SF 0,9% ou SG 5%, IV. Velocidade inicial de infus&#227;o 2 a 8 gotas/min com aumentos gradativos (em intervalos n&#227;o inferiores a 20 minutos) de 2 a 4 gotas/min (Dose m&#225;xima: 40 gotas/minuto).</li>\r\n</ul>\r\n<p><strong>Abortamento incompleto, inevit&#225;vel ou retido:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, seguida, se necess&#225;rio, por uma infus&#227;o IV de 20 a 40 miliunidades/min.</li>\r\n</ul>\r\n<p><strong>Ces&#225;rea:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min.</li>\r\n</ul>\r\n<p><strong>Preven&#231;&#227;o da hemorragia uterina p&#243;s-parto:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, ap&#243;s expuls&#227;o da placenta.</li>\r\n</ul>\r\n<p><strong>Tratamento da hemorragia uterina p&#243;s-parto:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, seguida, nos casos graves, de infus&#227;o IV de uma solu&#231;&#227;o com 5-20 UI.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- <span style=\"text-decoration: underline;\">Solu&#231;&#227;o injet&#225;vel:</span> Categoria C-</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 107%;\">- <strong><span style=\"text-decoration: underline;\">Spray nasal:</span>&#160;</strong></span><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">Categoria X-</span></strong><span style=\"line-height: 107%;\">&#160;Prescri&#231;&#227;o proibitiva (contraindicado).</span></p>\r\n</div>",
        "id": 2491,
        "indications": "<div>\r\n<p style=\"text-align: justify;\"><span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>- Spray nasal: </strong>&#233; indicado para estimular a secre&#231;&#227;o de leite e facilitar a amamenta&#231;&#227;o ou a extra&#231;&#227;o do leite da mama.</span></p>\r\n<p style=\"text-align: justify;\"><span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>- Pr&#233;-parto:</strong> i</span>ndu&#231;&#227;o do parto em casos de&#160;gesta&#231;&#227;o p&#243;s-termo, ruptura prematura das membranas, hipertens&#227;o induzida pela gravidez (pr&#233;-ecl&#226;mpsia), est&#237;mulo das contra&#231;&#245;es em casos selecionados de in&#233;rcia uterina, est&#225;gios iniciais da gravidez como terapia auxiliar do abortamento incompleto, inevit&#225;vel ou retido.</p>\r\n<p style=\"text-align: justify;\"><span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>- P&#243;s-Parto: </strong>d</span>urante a opera&#231;&#227;o ces&#225;rea depois da retirada da crian&#231;a, preven&#231;&#227;o e tratamento da atonia uterina e hemorragia p&#243;s-parto.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-10 03:23:57",
        "name": "Syntocinon",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5UI/ml.</span></li>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Solu&#231;&#227;o nasal spray:</strong> 40UI/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "syntocinon",
        "substance": "Ocitocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Rea&#231;&#245;es adversas maternas: rea&#231;&#227;o anafil&#225;tica/anafilactoide associada &#224; dispneia, hipotens&#227;o, cefaleia, taquicardia, bradicardia, arritmia, isquemia do mioc&#225;rdio, prolongamento do intervalo QTc no eletrocardiograma, hipotens&#227;o, n&#225;usea, v&#244;mito, erup&#231;&#245;es cut&#226;neas (rash), hipertonicidade uterina, contra&#231;&#245;es tet&#226;nicas do &#250;tero, ruptura uterina, hiponatremia, edema pulmonar agudo, coagula&#231;&#227;o intravascular disseminada, angioedema.</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5.0pt 0cm 5.0pt 0cm;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Rea&#231;&#245;es adversas no feto: s&#237;ndrome do sofrimento fetal, asfixia e morte, hiponatremia neonatal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes:</span></strong>&#160;</p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 7040,
        "contraindications": "<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><span style=\"mso-bidi-  mso-fareast- color: black; background: white;\">- Hipersensibilidade &#224; ocitocina ou a qualquer excipiente da formula&#231;&#227;o, hipertonia uterina, sofrimento fetal quando a expuls&#227;o n&#227;o &#233; iminente, despropor&#231;&#227;o c&#233;falo-p&#233;lvica significativa, m&#225; apresenta&#231;&#227;o fetal, placenta pr&#233;via e vasos pr&#233;vios, descolamento prematuro da placenta, apresenta&#231;&#227;o ou prolapso do cord&#227;o umbilical, distens&#227;o uterina excessiva ou diminui&#231;&#227;o da resist&#234;ncia uterina &#224; ruptura, poli-hidr&#226;mnios, grande multiparidade, p</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">resen&#231;a de cicatriz uterina resultante de interven&#231;&#245;es cir&#250;rgicas, inclusive da opera&#231;&#227;o ces&#225;rea cl&#225;ssica</span><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">.</span></p>",
        "dosage_adults": "<div>\r\n<p><strong>Indu&#231;&#227;o do parto ou estimulo a contra&#231;&#245;es:</strong>&#160;</p>\r\n<ul>\r\n<li>5UI em 500 ml de SF 0,9% ou SG 5%, IV. Velocidade inicial de infus&#227;o 2 a 8 gotas/min com aumentos gradativos (em intervalos n&#227;o inferiores a 20 minutos) de 2 a 4 gotas/min (Dose m&#225;xima: 40 gotas/minuto).</li>\r\n</ul>\r\n<p><strong>Abortamento incompleto, inevit&#225;vel ou retido:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, seguida, se necess&#225;rio, por uma infus&#227;o IV de 20 a 40 miliunidades/min.</li>\r\n</ul>\r\n<p><strong>Ces&#225;rea:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min.</li>\r\n</ul>\r\n<p><strong>Preven&#231;&#227;o da hemorragia uterina p&#243;s-parto:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, ap&#243;s expuls&#227;o da placenta.</li>\r\n</ul>\r\n<p><strong>Tratamento da hemorragia uterina p&#243;s-parto:</strong></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\">5UI, IV, correr em 5 min OU fazer 5UI a 10UI, IM, seguida, nos casos graves, de infus&#227;o IV de uma solu&#231;&#227;o com 5-20 UI.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2493,
        "indications": "<div>\r\n<p style=\"text-align: justify;\">-&#160;<span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>Pr&#233;-parto:&#160;</strong></span><span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\">i</span>ndu&#231;&#227;o do parto em casos de&#160;gesta&#231;&#227;o p&#243;s-termo, ruptura prematura das membranas, hipertens&#227;o induzida pela gravidez (pr&#233;-ecl&#226;mpsia), est&#237;mulo das contra&#231;&#245;es em casos selecionados de in&#233;rcia uterina, est&#225;gios iniciais da gravidez como terapia auxiliar do abortamento incompleto, inevit&#225;vel ou retido.</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 15pt; line-height: normal; text-align: justify;\">-&#160;<span style=\"mso-bidi-  mso-fareast- mso-bidi- color: black; background: white;\"><strong>P&#243;s-Parto:&#160;</strong>d</span>urante a opera&#231;&#227;o ces&#225;rea depois da retirada da crian&#231;a, preven&#231;&#227;o e tratamento da atonia uterina e hemorragia p&#243;s-parto.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 37,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Muito baixo risco:</span></strong><span style=\"line-height: 107%;\"> Uso liberado na lacta&#231;&#227;o.</span></p>",
        "last_update": "2019-03-06 16:57:33",
        "name": "Oxiton",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"mso-bidi- line-height: 107%; mso-fareast- color: black;\"><strong>Solu&#231;&#227;o injet&#225;vel:</strong> 5UI/ml.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "ocitocina",
        "substance": "Ocitocina",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 107%;\">Efeitos adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5pt 0cm; text-align: justify;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Rea&#231;&#245;es adversas maternas: rea&#231;&#227;o anafil&#225;tica/anafilactoide associada &#224; dispneia, hipotens&#227;o, cefaleia, taquicardia, bradicardia, arritmia, isquemia do mioc&#225;rdio, prolongamento do intervalo QTc no eletrocardiograma, hipotens&#227;o, n&#225;usea, v&#244;mito, erup&#231;&#245;es cut&#226;neas (rash), hipertonicidade uterina, contra&#231;&#245;es tet&#226;nicas do &#250;tero, ruptura uterina, hiponatremia, edema pulmonar agudo, coagula&#231;&#227;o intravascular disseminada, angioedema.</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal; margin: 5.0pt 0cm 5.0pt 0cm;\"><span style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Rea&#231;&#245;es adversas no feto: s&#237;ndrome do sofrimento fetal, asfixia e morte, hiponatremia neonatal.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><strong><span style=\"line-height: 17.12px;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"line-height: 17.12px;\">- N&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 1793,
        "contraindications": "<p>- Hipersensibilidade aos componentes, crian&#231;as, doen&#231;a de Leber.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Dose usual:</strong> 1 ampola de 500mcg/mL ou 2500mcg/mL diariamente, IM.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2496,
        "indications": "<p>- Anemia perniciosa, profilaxia e tratamento de defici&#234;ncia vitam&#237;nica devido a nutri&#231;&#227;o inadequada ou m&#225; absor&#231;&#227;o intestinal, suplemento em pacientes que recebem nutri&#231;&#227;o parenteral.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 232,
        "lactation_text": "<p><strong>- Baixo risco:</strong> Uso moderadamente seguro. Monitorar tratamento.</p>",
        "last_update": "2019-03-03 23:54:34",
        "name": "Amicored",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel: </strong>500mcg/mL e 2500mcg/mL.&#160;</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "amicored",
        "substance": "Cianocobalamina (Vitamina B12)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Prurido, exantema, sibil&#226;ncia.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2013,
        "contraindications": "<p>- Hipersensibilidade aos componentes.</p>",
        "dosage_adults": "<ul>\r\n<li>1 comprimido VO 3-5x/dia.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<p>- Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</p>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<div>\r\n<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>\r\n<p>&#160;</p>\r\n</div>",
        "id": 2498,
        "indications": "<p>- Preven&#231;&#227;o e tratamento de defici&#234;ncias de piridoxina (vitamina B6) nos seguintes casos: dietas restritivas e inadequadas, necessidades aumentada na gesta&#231;&#227;o e no aleitamento, doen&#231;as cr&#244;nicas onde ocorre diminui&#231;&#227;o dos n&#237;veis de vitaminas no organismo.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 73,
        "lactation_text": "<p>- N&#227;o estabelecido.&#160;</p>",
        "last_update": "2019-03-05 01:21:02",
        "name": "Neuri B6",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 40mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neuri-b6",
        "substance": "Piridoxina (Vitamina B6)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- N&#225;useas, v&#244;mitos, s&#237;ndrome de m&#225; absor&#231;&#227;o, dores abdominais, indigest&#227;o, falta de apetite, perda de sensibilidade das m&#227;os e p&#233;s e dificuldade para caminhar, diminui&#231;&#227;o do leite materno, s&#237;ndrome de depend&#234;ncia &#224; piridoxina.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- Pacientes em hemodi&#225;lise devem receber doses maiores do que as recomendadas.</p>\r\n</div>"
    },
    {
        "content_length": 1577,
        "contraindications": "<p>- Hipersensibilidade aos componentes,&#160;&#250;lcera p&#233;ptica, polionefrite, esteatose hep&#225;tica na gravidez, bem como diabetes mellitus descompensado por cetoacidose e tirotoxicose.</p>",
        "dosage_adults": "<ul>\r\n<li>1 comprimido VO 3x/dia por tr&#234;s dias.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 1,
        "gestation_text": "<div>\r\n<p><strong>- Categoria A:&#160;</strong>prescri&#231;&#227;o liberada.</p>\r\n</div>",
        "id": 2499,
        "indications": "<p>- N&#225;useas e v&#244;mitos no primeiro trimestre da gravidez.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 12,
        "lactation_text": "<p>- N&#227;o estabelecido.&#160;</p>",
        "last_update": "2019-03-03 20:19:48",
        "name": "Gob6",
        "presentation": "<ul>\r\n<li><strong>Comprimido:</strong> 25mg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "neuri-b6",
        "substance": "Piridoxina (Vitamina B6)",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>- Trombocitopenia, ins&#244;nia, disfun&#231;&#227;o de mem&#243;ria, seda&#231;&#227;o, fotossensibilidade.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 0,
        "contraindications": "<p>- Hipersensibilidade aos componentes. N&#227;o deve ser administrada como suplemento diet&#233;tico antes de asseguar-se de que n&#227;o setrata de uma anemia perniciosa ou defici&#234;ncia de &#225;cido f&#243;lico, doen&#231;a de Leber.</p>",
        "dosage_adults": "<ul>\r\n<li><strong>Neurite e neuralgia:</strong> 1 ampola a cada 3 dias IM</li>\r\n<li><strong>Anemia perniciosa:</strong> 1 ampola a cada 2 ou 3 dias IM. Em casos graves administrar em dias alternados.</li>\r\n<li><strong>Dr&#225;geas:</strong> 1 dr&#225;gea 3x ao dia.</li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-92ffd60c-a431-a6ce-45ac-2204034f0e73\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p><strong>- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2501,
        "indications": "<p>- Antineur&#237;tico, antineur&#225;lgico.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 26,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-07-16 18:49:32",
        "name": "Citoneurin",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o injet&#225;vel: </strong>100mg de Tiamina + 100mg Piridoxina + 5000mcg/mL ou 1000mcg/ml de Cianocobalamina.&#160;</li>\r\n<li><strong>Comprimidos:</strong> 100mg de Tiamina + 100mg de Piridoxina + 5000mcg de Cianocobalamina.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "citoneurin",
        "substance": "Tiamina + Piridoxina + Cianocobalamina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-Urtic&#225;ria, prurido, exantema, s&#237;ndromes neurop&#225;ticas e sensoriais, diarreia, dor abdominal, trombose perif&#233;rica.</p>\r\n<p>&#160;</p>\r\n</div>"
    },
    {
        "content_length": 2185,
        "contraindications": "<p>-Alergia a qualquer componente da f&#243;rmula, hipervitaminose pr&#233;-existente ou que apresentaram sinais de intoler&#226;ncia &#224; tiamina.</p>",
        "dosage_adults": "<ul>\r\n<li>Dissolver o conte&#250;do do frasco-ampola com 5,0 mL de &#225;gua para inje&#231;&#227;o imediatamente antes do uso. IM ou IV. No caso de uso IV administrar lentamente (pelo menos 10 minutos) ou,&#160;por perfus&#227;o, em solu&#231;&#227;o salina isot&#244;nica ou solu&#231;&#227;o de glicose.</li>\r\n</ul>",
        "dosage_children": "<div>\r\n<ul>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 11 anos.</span></li>\r\n<li class=\"MsoNormal\"><span style=\"line-height: 107%;\">Maiores de 11 anos obedecem a posologia adulta.</span></li>\r\n</ul>\r\n<p>&#160;</p>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p><strong>Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2502,
        "indications": "<p>Suplementa&#231;&#227;o em pacientes na qual a via oral &#233; contraindicada. Desnutri&#231;&#227;o, m&#225;-absor&#231;&#227;o digestiva, nutri&#231;&#227;o parenteral.</p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 9,
        "lactation_text": "<p>N&#227;o estabelecido.</p>",
        "last_update": "2019-01-14 00:51:57",
        "name": "Cerne 12",
        "presentation": "<ul>\r\n<li><strong>P&#243; liofilizado: </strong>5mL</li>\r\n</ul>",
        "recipient": 7,
        "recipient_type": "<p>Uso hospitalar.</p>",
        "record_status": 1,
        "slug": "cerne-12",
        "substance": "Riboflavina",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos: </strong></p>\r\n<p>-Rea&#231;&#245;es anafil&#225;ticas em pacientes que apresentam um hist&#243;rico al&#233;rgico, h&#225; possibilidade de dor no local da inje&#231;&#227;o intramuscular.</p>\r\n<hr>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>-N&#227;o estabelecido.</p>\r\n</div>"
    },
    {
        "content_length": 5817,
        "contraindications": "<div>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade aos sais de ferro.</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Hemocromatose.</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Anemias associadas a leucemias agudas ou cr&#244;nicas.</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Hepatopatia aguda.</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Anemias n&#227;o ferrop&#234;nicas.</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Processos que impedem a absor&#231;&#227;o de ferro por via oral.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong><span style=\"mso-bidi- line-height: 107%;\">Flaconetes: </span></strong><span style=\"mso-bidi- line-height: 107%;\">1 a 2 flaconetes 1x/dia.</span></li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimidos de 150 mg:</strong> 1 a 2 comprimidos&#160;</span>1x/dia.</li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido de 300 mg:</strong> 1 comprimido&#160;</span>1x/dia.</li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimido de 500 mg:</strong> 1 comprimido 1x/dia.</span></li>\r\n</ul>\r\n<hr>\r\n<p><strong>Gr&#225;vidas:</strong></p>\r\n<ul>\r\n<li><strong><span style=\"mso-bidi- line-height: 107%;\">Flaconetes:&#160;</span></strong><span style=\"mso-bidi- line-height: 107%;\">1 a 2 flaconetes 1x/dia.</span></li>\r\n<li><span style=\"line-height: 17.12px;\"><strong>Comprimidos de 150 mg:</strong>&#160;1 a 2 comprimidos&#160;</span>1x/dia.</li>\r\n<li><span style=\"line-height: 17.12px;\"><strong>Comprimido de 300 mg:</strong>&#160;1 comprimido&#160;</span>1x/dia.</li>\r\n<li><span style=\"line-height: 17.12px;\"><strong>Comprimido de 500 mg:</strong>&#160;1 comprimido 1x/dia.</span></li>\r\n<li><strong>Gotas:</strong> 20 gotas 1x/dia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong><span style=\"mso-bidi- line-height: 107%;\">Prematuros, lactentes e crian&#231;as at&#233; 4 anos:</span></strong></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Gotas:</strong> dose di&#225;ria total recomendada de 1 gota/kg/dia em dose &#250;nica para crian&#231;as de at&#233; 20 Kg. Acima de 20 Kg, administrar 20 gotas ao dia.</span></li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Flaconetes:</strong> 0,5 a 1 flaconete&#160;</span>1x/dia.</li>\r\n</ul>\r\n<hr>\r\n<p><span style=\"mso-bidi- line-height: 107%;\"><strong>Crian&#231;as de 4 a 12 anos:</strong></span></p>\r\n<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Gotas:</strong> dose di&#225;ria total recomendada de 1 a 2 gotas/kg/dia em dose &#250;nica para crian&#231;as de at&#233; 20 Kg. Acima de 20 Kg, administras 20 gotas ao dia.</span></li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Flaconetes:</strong> 0,5 a 2 flaconetes&#160;</span>1x/dia.</li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimidos de 150 mg:</strong> 1 comprimido&#160;</span>1x/dia.</li>\r\n</ul>\r\n</div>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 2503,
        "indications": "<p><span style=\"mso-bidi- line-height: 107%;\">- Tratamento e profilaxia das s&#237;ndromes ferrop&#234;nicas latentes e moderadas, anemia ferropriva devido a subnutri&#231;&#227;o e/ou car&#234;ncias alimentares quantitativas e qualitativas, anemia das s&#237;ndromes disbsortivas intestinais, anemia ferropriva da gravidez e da lacta&#231;&#227;o, anemia por hemorragias agudas ou cr&#244;nicas, condi&#231;&#245;es onde seja conveniente a suplementa&#231;&#227;o dos fatores hematog&#234;nicos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:42:09",
        "name": "Neutrofer",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 250 mg/ml (50 mg de ferro elementar).</li>\r\n<li><strong>Comprimido:</strong> 150 mg, 300 mg e 500 mg (30 mg, 60 mg e 100 mg de ferro elementar).</li>\r\n<li><strong>Flaconetes:&#160;</strong>250 mg/5ml (50 mg de ferro elementar).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Glicinato ferroso",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;<span style=\"text-align: justify;\">Sensa&#231;&#227;o de plenitude, dor epig&#225;strica, n&#225;usea, constipa&#231;&#227;o ou diarreia, rea&#231;&#245;es de hipersensibilidade</span>&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4077,
        "contraindications": "<div>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Hipersensibilidade aos sais de ferro</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Hemocromatose</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Anemias associadas a leucemias agudas ou cr&#244;nicas</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Hepatopatia aguda</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Anemias n&#227;o ferrop&#234;nicas</span></p>\r\n<p class=\"Standard\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: 107%;\"><span style=\"mso-bidi- line-height: 107%;\">- Processos que impedem a absor&#231;&#227;o de ferro por via oral</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong><span style=\"mso-bidi- line-height: 107%;\">Flaconetes: </span></strong><span style=\"mso-bidi- line-height: 107%;\">1 a 2 flaconetes 1x/dia.</span></li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Comprimidos:</strong> 1 a 2 comprimidos&#160;</span>1x/dia.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Gotas:</strong>&#160;1 gota/kg/dia&#160;</span>1x/dia (m&#225;ximo 36 gotas/dia).</li>\r\n<li><span style=\"mso-bidi- line-height: 107%;\"><strong>Flaconetes:</strong> 0,5 a 1 flaconete&#160;</span>1x/dia.</li>\r\n</ul>",
        "gestation": 1,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria A:</strong> Prescri&#231;&#227;o liberada.</p>",
        "id": 2504,
        "indications": "<p><span style=\"mso-bidi- line-height: 107%;\">- Tratamento e profilaxia das s&#237;ndromes ferrop&#234;nicas latentes e moderadas, anemia ferropriva devido a subnutri&#231;&#227;o e/ou car&#234;ncias alimentares quantitativas e qualitativas, anemia das s&#237;ndromes disbsortivas intestinais, anemia ferropriva da gravidez e da lacta&#231;&#227;o, anemia por hemorragias agudas ou cr&#244;nicas, condi&#231;&#245;es onde seja conveniente a suplementa&#231;&#227;o dos fatores hematog&#234;nicos.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 18,
        "lactation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Muito baixo risco:</strong> Uso liberado na lacta&#231;&#227;o.</p>",
        "last_update": "2019-03-05 01:42:16",
        "name": "Neutrofer Fólico",
        "presentation": "<ul>\r\n<li><strong>Solu&#231;&#227;o oral (gotas):</strong> 250 mg/ml&#160;+ &#225;cido f&#243;lico 0,20 mg/ml (50 mg de ferro elementar).</li>\r\n<li><strong>Comprimido:</strong> 150 mg&#160;+ &#225;cido f&#243;lico 5 mg (30 mg de ferro elementar).</li>\r\n<li><strong>Flaconetes: </strong>75&#160;mg/5ml + &#225;cido f&#243;lico 2,5 mg/5ml (15 mg de ferro elementar).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\">- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "noripurum",
        "substance": "Glicinato ferroso",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p>-&#160;<span style=\"text-align: justify;\">Sensa&#231;&#227;o de plenitude, dor epig&#225;strica, n&#225;usea, constipa&#231;&#227;o ou diarreia, rea&#231;&#245;es de hipersensibilidade</span>&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.</p>\r\n</div>"
    },
    {
        "content_length": 4465,
        "contraindications": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Hipersensibilidade aos componentes da f&#243;rmula.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Arritmias card&#237;acas severas. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Insufici&#234;ncia card&#237;aca grave.</span></p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Asma:&#160;</strong>1 a 2 c&#225;psulas de 12/12 horas.</li>\r\n<li><strong>Profilaxia broncoespasmo induzido por exerc&#237;cios:&#160;</strong>1 a 2 c&#225;psulas (no geral 1) 15 minutos antes do exerc&#237;cio.</li>\r\n<li><strong>DPOC:&#160;</strong>1 a 2 c&#225;psulas de 12/12 horas.</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<ul>\r\n<li><strong>Asma:&#160;</strong>1 c&#225;psula de 12/12 horas.</li>\r\n<li><strong>Profilaxia broncoespasmo induzido por exerc&#237;cios:&#160;</strong>1 c&#225;psula 15 minutos antes do exerc&#237;cio.</li>\r\n<li><span style=\"line-height: 107%;\">Medica&#231;&#227;o n&#227;o recomendada para menores de 5 anos.</span></li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2506,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Tratamento de manuten&#231;&#227;o da asma e DPOC.</span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o estabelecido.</span></p>",
        "last_update": "2019-03-03 19:17:43",
        "name": "Foradil",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o:</strong> 12mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- Receitu&#225;rio simples.</span></p>",
        "record_status": 1,
        "slug": "fluir",
        "substance": "Formoterol",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Rea&#231;&#245;es adversas:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Frequentes: infec&#231;&#227;o viral. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Comuns: dor tor&#225;cica, ansiedade, tontura, febre, ins&#244;nia, disfonia, <em>rash, </em>dor abdominal, dispepsia, gastroenterite, n&#225;usea, xerostomia, exacerba&#231;&#227;o de asma, bronquite, faringite, sinusite e dispneia. </span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\">- Menos frequentes: rea&#231;&#245;es anafil&#225;ticas, angina, arritmia, hiperglicemia, hipertens&#227;o, hipocalemia e acidose metab&#243;lica.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><strong><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Usar com cautela em pacientes com doen&#231;a cardiovascular (arritmia, hipertens&#227;o, ICC), diabetes, glaucoma, hipertireoidismo, hipocalemia e dist&#250;rbios convulsivos.</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin;\">- Insufic&#234;ncia Renal: n&#227;o h&#225; ajuste.</span></p>\r\n</div>"
    },
    {
        "content_length": 2759,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Uso de c&#225;psulas de budesonida em pacientes com tuberculose pulmonar ativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<ul>\r\n<li><strong>Uso inalat&#243;rio por via oral:&#160;</strong>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 48 mcg formoterol / 1600 mcg budesonida).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<ul>\r\n<li><strong>Uso inalat&#243;rio por via oral:&#160;</strong>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 24 mcg formoterol / 800 mcg budesonida).</li>\r\n<li>Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2508,
        "indications": "<div>\r\n<p>- Indicado para o tratamento regular da asma em adultos e adolescentes com 12 anos ou mais.</p>\r\n<p>- Pacientes n&#227;o adequadamente controlados com corticosteroide inalat&#243;rio e quando necess&#225;rio agonista seletivo do receptor beta2 adren&#233;rgico de curta a&#231;&#227;o.</p>\r\n<p>- Pacientes j&#225; controlados adequadamente com ambos, corticosteroide inalat&#243;rio e beta2-agonista de longa dura&#231;&#227;o.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-03 19:18:01",
        "name": "Foraseq TM",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o:</strong> 12 mcg/200 mcg e 12 mcg/400 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Formoterol + Budesonida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 3951,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Uso de c&#225;psulas de budesonida em pacientes com tuberculose pulmonar ativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>C&#225;psulas para inala&#231;&#227;o:&#160;6 mcg/100 mcg</strong></p>\r\n<ul>\r\n<li>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 48 mcg formoterol / 800 mcg budesonida).</li>\r\n</ul>\r\n<p><strong>C&#225;psulas para inala&#231;&#227;o:&#160;6 mcg/200 mcg</strong></p>\r\n<ul>\r\n<li>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 48 mcg formoterol / 1600 mcg budesonida).</li>\r\n</ul>\r\n<p><strong>C&#225;psulas para inala&#231;&#227;o:&#160;12 mcg/400 mcg</strong></p>\r\n<ul>\r\n<li>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 48 mcg formoterol / 1600 mcg budesonida).</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>C&#225;psulas para inala&#231;&#227;o:&#160;6 mcg/100 mcg</strong></p>\r\n<ul>\r\n<li>1 c&#225;psula 1x/dia ou 2 c&#225;psulas de 12/12 horas (m&#225;ximo de 24 mcg formoterol / 400 mcg budesonida)</li>\r\n<li><strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</li>\r\n</ul>\r\n<p><strong>C&#225;psulas para inala&#231;&#227;o:&#160;6 mcg/200 mcg</strong></p>\r\n<ul>\r\n<li>1 c&#225;psula 1x/dia ou de 12/12 horas (m&#225;ximo de 24 mcg formoterol / 800 mcg budesonida)</li>\r\n<li><strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</li>\r\n</ul>\r\n<p><strong>C&#225;psulas para inala&#231;&#227;o:&#160;12 mcg/400 mcg</strong></p>\r\n<ul>\r\n<li>1 c&#225;psula 1x/dia ou de 12/12 horas (m&#225;ximo de 24 mcg formoterol / 800 mcg budesonida)</li>\r\n<li><strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2509,
        "indications": "<div>\r\n<p>- Indicado para o tratamento regular da asma em adultos e adolescentes com 12 anos ou mais.</p>\r\n<p>- Pacientes n&#227;o adequadamente controlados com corticosteroide inalat&#243;rio e quando necess&#225;rio agonista seletivo do receptor beta2 adren&#233;rgico de curta a&#231;&#227;o.</p>\r\n<p>- Pacientes j&#225; controlados adequadamente com ambos, corticosteroide inalat&#243;rio e beta2-agonista de longa dura&#231;&#227;o.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 13,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-03 17:17:50",
        "name": "Alenia",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o:</strong>&#160;6 mcg/100 mcg, 6 mcg/200 mcg e 12 mcg/400 mcg.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Formoterol + Budesonida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 5124,
        "contraindications": "<div>\r\n<p>- Indiv&#237;duos com hist&#243;ria de hipersensibilidade a qualquer componente da f&#243;rmula.&#160;</p>\r\n<p>- Uso de c&#225;psulas de budesonida em pacientes com tuberculose pulmonar ativa.</p>\r\n</div>",
        "dosage_adults": "<div>\r\n<p><strong>C&#225;psulas:</strong></p>\r\n<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o (6 mcg/100 mcg):&#160;</strong>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 48 mcg formoterol / 800 mcg budesonida)</li>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o (6 mcg/200 mcg):&#160;</strong>1 a 2 c&#225;psulas, de 12/12 horas (m&#225;ximo de 48 mcg formoterol / 1600 mcg budesonida)</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Symbicort Turbuhaler&#174;:</strong></p>\r\n<ul>\r\n<li><strong>P&#243; para inala&#231;&#227;o:&#160;6 mcg/100 mcg:&#160;</strong>2 inala&#231;&#245;es 1x/dia ou de 12/12 horas (m&#225;ximo de 8 inala&#231;&#245;es/dia)</li>\r\n<li><strong>P&#243;</strong><strong>&#160;para inala&#231;&#227;o:&#160;6 mcg/200 mcg:&#160;</strong>2 inala&#231;&#245;es 1x/dia ou de 12/12 horas&#160;(m&#225;ximo de 4 inala&#231;&#245;es/dia)</li>\r\n<li><strong>P&#243;</strong><strong>&#160;para inala&#231;&#227;o:&#160;12 mcg/400 mcg:&#160;</strong>1 inala&#231;&#227;o 1x/dia ou de 12/12 horas&#160;(m&#225;ximo de 2 inala&#231;&#245;es/dia)</li>\r\n</ul>\r\n</div>",
        "dosage_children": "<div>\r\n<p><strong>C&#225;psulas:</strong></p>\r\n<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o (6 mcg/100 mcg):&#160;</strong>1 c&#225;psula 1x/dia ou 2 c&#225;psulas de 12/12 horas (m&#225;ximo de 24 mcg formoterol / 400 mcg budesonida).&#160;<strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</li>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o (6 mcg/200 mcg):&#160;</strong>1 c&#225;psula 1x/dia ou de 12/12 horas (m&#225;ximo de 24 mcg formoterol / 800 mcg budesonida).&#160;<strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 6 anos.</li>\r\n</ul>\r\n<hr>\r\n<p><strong>Symbicort Turbuhaler&#174;:</strong></p>\r\n<ul>\r\n<li><strong>P&#243;</strong><strong>&#160;para inala&#231;&#227;o (6 mcg/100 mcg):&#160;</strong>1 a 2 inala&#231;&#245;es 1x/dia ou de 12/12 horas&#160;(m&#225;ximo de 4 inala&#231;&#245;es/dia).&#160;<strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</li>\r\n<li><strong>P&#243;</strong><strong>&#160;para inala&#231;&#227;o (6 mcg/200 mcg):&#160;</strong>1 inala&#231;&#227;o 1x/dia ou de 12/12 horas ou 2 inala&#231;&#245;es 1x/dia (m&#225;ximo de 2 inala&#231;&#245;es/dia).&#160;<strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 4 anos.</li>\r\n<li><strong>P&#243;</strong><strong>&#160;para inala&#231;&#227;o (12 mcg/400 mcg):&#160;</strong><strong>Obs:</strong>&#160;Medica&#231;&#227;o n&#227;o recomendada para menores de 12 anos.</li>\r\n</ul>\r\n</div>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">- Categoria C:</strong> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</p>",
        "id": 2510,
        "indications": "<div>\r\n<p>- Indicado para o tratamento regular da asma em adultos e adolescentes com 12 anos ou mais.</p>\r\n<p>- Pacientes n&#227;o adequadamente controlados com corticosteroide inalat&#243;rio e quando necess&#225;rio agonista seletivo do receptor beta2 adren&#233;rgico de curta a&#231;&#227;o.</p>\r\n<p>- Pacientes j&#225; controlados adequadamente com ambos, corticosteroide inalat&#243;rio e beta2-agonista de longa dura&#231;&#227;o.</p>\r\n</div>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 62,
        "lactation_text": "<p class=\"MsoNormal\"><span style=\"line-height: 107%;\">- N&#227;o recomendado.</span></p>",
        "last_update": "2019-03-10 03:23:05",
        "name": "Symbicort",
        "presentation": "<ul>\r\n<li><strong>C&#225;psulas para inala&#231;&#227;o:</strong>&#160;6 mcg/100 mcg, 6 mcg/200 mcg.</li>\r\n<li><strong>P&#243; para inala&#231;&#227;o:</strong>&#160;6 mcg/100 mcg, 6 mcg/200 mcg e 12 mcg/400 mcg (Symbicort Turbuhaler&#174;).</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "flixotide",
        "substance": "Formoterol + Budesonida",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Efeitos adversos:</strong></p>\r\n<p class=\"MsoNormal\">- Cefaleia e infec&#231;&#227;o do trato respirat&#243;rio superior, tontura, febre, pele seca, prurido, irrita&#231;&#227;o da pele, irrita&#231;&#227;o na garganta e disfonia.&#160;</p>\r\n<hr>\r\n<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\">Ajustes na Insufici&#234;ncia Renal:</strong></p>\r\n<p class=\"MsoNormal\">- N&#227;o h&#225; ajuste.&#160;</p>\r\n</div>"
    },
    {
        "content_length": 5530,
        "contraindications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Hipocalcemia (c&#225;lcio s&#233;rico &lt; 8,4 mg/dL)<strong>,&#160;</strong></span>Hipersensibilidade aos componentes, menores de 18 anos.</p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Hiperparatireoidismo secund&#225;rio:</strong> Iniciar com 30mg, 1vez/dia. Ajustes devem ser realizados a cada 2-4 semanas de acordo com os n&#237;veis s&#233;ricos de PTH. Dose m&#225;xima de 180mg, 1vez/dia (meta de manter n&#237;veis de PTH entre 150-300pg/mL). </span></li>\r\n<li style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Hipercalcemia no carcinoma de paratireoide:</strong> Iniciar com 30mg, 2vez/dia. Dose m&#225;xima de 360 mg/dia, na forma de 90mg, 4vez/dia.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span id=\"docs-internal-guid-7fdf90ca-7fff-28a7-152d-66a92e7b17c0\"><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">Medica&#231;&#227;o n&#227;o recomendada para pacientes da faixa et&#225;ria pedi&#225;trica.</span></span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2511,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\">- Tratamento do hiperparatiroidismo secund&#225;rio em doentes com insufici&#234;ncia renal cr&#243;nica, em fase terminal, em di&#225;lise. Redu&#231;&#227;o da hipercalcemia em doentes com: carcinoma da paratiroide. Hiperparatiroidismo prim&#225;rio com indica&#231;&#227;o para paratiroidectomia com base nos valores s&#233;ricos de c&#225;lcio (conforme estabelecido nas orienta&#231;&#245;es terap&#234;uticas aplic&#225;veis), mas nos quais a indica&#231;&#227;o para paratiroidectomia n&#227;o &#233; clinicamente adequada ou &#233; contraindicada.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-11-19 17:19:56",
        "name": "Cinacalcet",
        "presentation": "<ul>\r\n<li class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Comprimidos:</strong> 30mg e 60</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">mg.</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cinacalcet",
        "substance": "Cinacalcet",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- N&#227;o estabelecidos. Usar com cuidado na insufici&#234;ncia hep&#225;tica.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Efeitos Adversos:</span></strong></p>\r\n<p><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Hipertens&#227;o,&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">astenia,convuls&#227;o, tontura,&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">n&#225;usea, v&#244;mito, diarreia, anorexia,&#160;</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">mialgia, hipocalcemia, diminui&#231;&#227;o dos n&#237;veis de testosterona.</span></p>\r\n</div>"
    },
    {
        "content_length": 6175,
        "contraindications": "<p><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Hipersensibilidade aos componentes da formula. Pacientes com Doen&#231;a de Parkinson, deve ser administrado apenas se os benef&#237;cios forem superiores aos poss&#237;veis riscos de agravamento da doen&#231;a.<span class=\"apple-converted-space\">&#160;P</span>ode causar sonol&#234;ncia, especialmente no in&#237;cio do tratamento. Portanto, deve-se tomar cuidado com o uso concomitante de &#225;lcool ou depressores do SNC.</span></p>",
        "dosage_adults": "<ul>\r\n<li style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Dist&#250;rbios circulat&#243;rios cerebrais:</strong> 1 comprimido de 25 mg 3 vezes ao dia, ou 1 comprimido de 75 mg diariamente.<span class=\"apple-converted-space\">&#160;</span>Dist&#250;rbios circulat&#243;rios perif&#233;ricos: 2 a 3 comprimidos de 25 mg 3 vezes ao dia, ou 2 a 3 comprimidos de 75 mg ao dia.<span class=\"apple-converted-space\">&#160;</span></span></li>\r\n<li style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Dist&#250;rbios do equil&#237;brio:</strong> 1 comprimido de 25 mg 3 vezes ao dia, ou 1 comprimido de 75 mg diariamente.<span class=\"apple-converted-space\">&#160;</span></span></li>\r\n<li style=\"text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\"><strong>Dist&#250;rbios do movimento:</strong> 1 comprimido de 25 mg meia hora antes de viajar e repetindo cada 6 horas.<span class=\"apple-converted-space\">&#160;</span> A dose m&#225;xima recomendada n&#227;o deve exceder 225 mg (9 comprimidos de 25 mg ou 3 comprimidos de 75 mg por dia). Como o efeito sobre vertigens &#233; dose dependente, a dose deve ser aumentada progressivamente.</span></li>\r\n</ul>",
        "dosage_children": "<p>- N&#227;o estabelecido.</p>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2513,
        "indications": "<p class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 107%; background: white; text-align: justify;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Indicado para profilaxia e tratamento dos sintomas de espasmo vascular cerebral e arteriosclerose como tontura, zumbido no ouvido, cefaleia vascular, falta de sociabilidade e irritabilidade, fadiga, dist&#250;rbios do sono como despertar precoce, depress&#227;o de involu&#231;&#227;o, perda de mem&#243;ria falta de concentra&#231;&#227;o, incontin&#234;ncia e outros dist&#250;rbios devidos &#224; idade; sequelas de traumas cr&#226;nio-encef&#225;licos; sequelas funcionais p&#243;s-apopl&#233;ticas; enxaqueca. Em d</span><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;\"><span style=\"background: white;\">ist&#250;rbios circulat&#243;rios perif&#233;ricos como&#160;profilaxia e tratamento dos sintomas que acompanham os dist&#250;rbios circulat&#243;rios perif&#233;ricos (arteriosclerose, tromboangeite obliterante, mol&#233;s- tia de Raynaud, diabete, acrocianose, etc), tais como: claudi- ca&#231;&#227;o intermitente, dist&#250;rbios tr&#243;ficos, pr&#233;-gangrena, &#250;lceras varicosas, parestesia, c&#227;imbra noturna, extremidades frias e em d</span><span style=\"background: white;\">ist&#250;rbios do equil&#237;brio: profilaxia e tratamento dos sintomas dos dist&#250;rbios do equil&#237;brio (arteriosclerose labir&#237;ntica, irritabili- dade do labirinto, S&#237;ndrome de Meni&#232;re), tais como vertigem, tontura, zumbido, nistagmo, n&#225;useas e v&#244;mitos; profilaxia dos dist&#250;rbios de movimento.</span></span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-11-19 17:26:05",
        "name": "Cinarizina",
        "presentation": "<ul>\r\n<li><span style=\"line-height: 115%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><strong>Comprimidos:</strong> 25mg e 75mg.&#160;</span></li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cinarizina",
        "substance": "Cinarizina",
        "trade_names": "",
        "warnings": "<div><p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Efeitos Adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">-&#160;Sonol&#234;ncia, depress&#227;o, cefal&#233;ia,&#160;</span>dist&#250;rbios gastrintestinais, boca seca, ganho de peso,transpira&#231;&#227;o ou rea&#231;&#227;o l&#237;quen plano e sintomas lupus-like, icter&#237;cia colest&#225;ticas e sintomas extrapiramidais.</p></div>"
    },
    {
        "content_length": 3324,
        "contraindications": "<p>- Alergia aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<div><p><span style=\"color: #000000;\">Afec&#231;&#245;es externas (Creme)</span></p>\r\n<ul>\r\n<li class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"color: #000000;\"><strong>Dose usual:</strong>&#160;Aplicar na &#225;rea afetada cerca de 2cm de pomada&#160;2-3x/dia, at&#233; melhora dos sintomas.</span></li>\r\n</ul>\r\n<p style=\"box-sizing: border-box; margin: 0px 0px 10px; -webkit-font-smoothing: antialiased; line-height: 1.58; color: #333333;\"><span style=\"color: #000000;\">Afec&#231;&#245;es internas (Suposit&#243;rio)</span></p>\r\n<ul>\r\n<li style=\"box-sizing: border-box; margin: 0px 0px 10px; -webkit-font-smoothing: antialiased; line-height: 1.58; color: #333333;\"><span style=\"color: #000000;\"><strong>Uso habitual:</strong> Aplica&#231;&#227;o profunda de um suposit&#243;rio no &#226;nus ap&#243;s evacua&#231;&#227;o pr&#233;via, duas ou tr&#234;s vezes ao dia, at&#233; a melhora dos sintomas. Continuar o tratamento com aplica&#231;&#227;o de um suposit&#243;rio ao dia, de prefer&#234;ncia, ao deitar, at&#233; o completo desaparecimento dos sintomas ou das les&#245;es inflamat&#243;rias, ou de acordo com a recomenda&#231;&#227;o m&#233;dica.</span></li>\r\n</ul></div>",
        "dosage_children": "<ul>\r\n<li><span style=\"color: #000000;\">N&#227;o estabelecido.</span></li>\r\n</ul>",
        "gestation": 3,
        "gestation_text": "<p class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"line-height: 107%;\">- Categoria C:</span></strong><span style=\"line-height: 107%;\"> Prescri&#231;&#227;o com risco. Este tipo de medicamento deve ser utilizado apenas se o benef&#237;cio potencial justificar o risco potencial para o feto.</span></p>",
        "id": 2523,
        "indications": "<p><span style=\"color: #000000;\">- Tratamento de hemorroidas, em especial aquelas acompanhadas de inflama&#231;&#227;o e sangramento, fissuras, prurido (coceira) e eczemas (irrita&#231;&#227;o com vermelhid&#227;o) da regi&#227;o do &#226;nus provocados por afec&#231;&#245;es anorretais, e como curativo ap&#243;s cirurgias proctol&#243;gicas.</span></p>",
        "is_active": 1,
        "is_generic": 1,
        "is_popular_pharmacy": 0,
        "laboratory_id": null,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2018-11-19 17:42:28",
        "name": "Cinchocaína + Policresuleno",
        "presentation": "<ul>\r\n<li><strong>Creme:</strong> 0,1g de policresuleno + 0,01g de cinchoca&#237;na por/g de pomada.&#160;</li>\r\n<li><strong>Suposit&#243;rio:</strong> 100mg de policresuleno + 27mg de cinchoca&#237;na.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "cinchocaina-policresuleno",
        "substance": "Cinchocaína + Policresuleno",
        "trade_names": "",
        "warnings": "<div>\r\n<p><strong>Ajustes:</strong></p>\r\n<p>- N&#227;o estabelecido.</p>\r\n<hr>\r\n<p><strong>Efeitos adversos:</strong></p>\r\n<p><span style=\"color: #000000;\">-&#160;Ard&#234;ncia e coceira locais s&#227;o causadas pela subst&#226;ncia ativa. Na maioria dos casos, desaparecem com o uso continuado do produto.</span></p>\r\n</div>"
    },
    {
        "content_length": 4068,
        "contraindications": "<p>- Alergia aos componentes da f&#243;rmula.</p>",
        "dosage_adults": "<ul>\r\n<li><span style=\"text-align: justify;\"><strong>Dose usual:</strong> A pomada deve ser aplicada 1 a 3 vezes ao dia. A quantidade aplicada n&#227;o deve exceder 10 a 15g por aplica&#231;&#227;o (aproximadamente 2/3 do tubo). A dose m&#225;xima di&#225;ria deve estar limitada a 30g (aproximadamente um tubo e meio) para adultos.</span></li>\r\n</ul>",
        "dosage_children": "<ul>\r\n<li><span style=\"text-align: justify;\"><strong>Dose usual:</strong> A pomada deve ser aplicada 1 a 3 vezes ao dia. A quantidade aplicada n&#227;o deve exceder 10 a 15g por aplica&#231;&#227;o (aproximadamente 2/3 do tubo).</span><span style=\"text-align: justify;\">&#160;</span><span style=\"text-align: justify;\">A dose m&#225;xima di&#225;ria deve estar limitada</span><span style=\"text-align: justify;\">&#160;a 7g (aproximadamente meio tubo) para crian&#231;as.</span></li>\r\n</ul>",
        "gestation": 4,
        "gestation_text": "<p class=\"MsoNormal\"><span id=\"docs-internal-guid-6ec4c576-7fff-efed-76af-095eda0548fd\"><span style=\"background-color: transparent; font-weight: bold; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">- Categoria D:</span><span style=\"background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"> Prescri&#231;&#227;o com alto risco. J&#225; existe evid&#234;ncia de risco para os fetos humanos, mas os benef&#237;cios em certas situa&#231;&#245;es, como nas doen&#231;as graves ou em situa&#231;&#245;es que p&#245;em em risco a vida, e para as quais n&#227;o existe alternativa terap&#234;utica, podem justificar seu uso durante a gravidez, apesar dos riscos.</span></span></p>",
        "id": 2526,
        "indications": "<p><span style=\"color: #000000;\">- Indicado no tratamento da&#160;<span style=\"background: white;\">coceira senil; coceira vulvar; fissura anal; hemorr&#243;ida; picada de inseto e queimadura solar.</span></span></p>",
        "is_active": 1,
        "is_generic": 0,
        "is_popular_pharmacy": 0,
        "laboratory_id": 30,
        "lactation_text": "<p>- N&#227;o estabelecido.</p>",
        "last_update": "2019-03-05 02:05:38",
        "name": "Nupercainal",
        "presentation": "<ul>\r\n<li><strong>Creme:</strong>&#160;20g.</li>\r\n</ul>",
        "recipient": 1,
        "recipient_type": "<p>- Receitu&#225;rio simples.</p>",
        "record_status": 1,
        "slug": "Nupercainal",
        "substance": "Cinchocaína",
        "trade_names": "",
        "warnings": "<div>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Ajustes:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">- N&#227;o h&#225; ajuste.</span></p>\r\n<hr>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"mso-fareast- mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; mso-fareast-language: PT-BR;\">Efeitos Adversos:</span></strong></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom: 8.0pt; text-align: justify; line-height: 107%; mso-outline-level: 2; background: white;\"><span style=\"mso-bidi- mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1; background: white;\">- Rea&#231;&#227;o al&#233;rgica (dermatite de contato).</span></p>\r\n</div>"
    }
]}
